Citrus Sinensis ID: 046791
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1018 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LW83 | 850 | G-type lectin S-receptor- | yes | no | 0.722 | 0.864 | 0.429 | 1e-165 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.709 | 0.882 | 0.434 | 1e-164 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.673 | 0.808 | 0.359 | 1e-122 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.658 | 0.788 | 0.365 | 1e-122 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.678 | 0.815 | 0.353 | 1e-120 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.667 | 0.806 | 0.345 | 1e-119 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.697 | 0.843 | 0.343 | 1e-117 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.666 | 0.815 | 0.341 | 1e-116 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.688 | 0.817 | 0.353 | 1e-116 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.674 | 0.806 | 0.354 | 1e-116 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 583 bits (1504), Expect = e-165, Method: Compositional matrix adjust.
Identities = 370/861 (42%), Positives = 495/861 (57%), Gaps = 126/861 (14%)
Query: 9 LLISFSFFVLLTGPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWY 68
L F+F++ L C QTDTLL GQ LKDG ELVSAF F++ FF++ +S + YLGIWY
Sbjct: 7 FLTLFTFYLFLGQSC-CQTDTLLQGQYLKDGQELVSAFNIFKLKFFNFENSSNWYLGIWY 65
Query: 69 HRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVS 128
+ + ++ VW+ANRN P+ +SGSLT+DS G L+ILR + + +S
Sbjct: 66 N-------------NFYLSGAVWIANRNNPVLGRSGSLTVDSL-GRLRILRGASSLLELS 111
Query: 129 SVQAMGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEW 188
S + GNT+ L ++GN L EM+ GSM+R LWQSFDYPTD LLPGMKLG N++TG W
Sbjct: 112 STETTGNTTLKLLDSGNLQLQEMDSDGSMKRTLWQSFDYPTDTLLPGMKLGFNVKTGKRW 171
Query: 189 FLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLF--PHWRAVDLDSD-FHF 245
L SW + PA G F +D N++N+L I G V W GL+ + L+++ F F
Sbjct: 172 ELTSWLGDTLPASGSFVFGMDDNITNRLTILWLGNVYWASGLWFKGGFSLEKLNTNGFIF 231
Query: 246 SYTSNEKERYFNYSLNGNFTS--FPTLQIDSKGSL----------------TVTGA-LPI 286
S+ S E E YF YS + N+ FP ++ID +GSL +V G L
Sbjct: 232 SFVSTESEHYFMYSGDENYGGPLFPRIRIDQQGSLQKINLDGVKKHVHCSPSVFGEELEY 291
Query: 287 SC----------------PGSEGCVRLSSCKGYFLDDFELNWARKRGFM--------SVD 322
C GS C Y ++L++ + G+ + +
Sbjct: 292 GCYQQNFRNCVPARYKEVTGSWDCSPFGFGYTYTRKTYDLSYCSRFGYTFRETVSPSAEN 351
Query: 323 GFKFKG-SNNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRGSKFIEDNNNTDARY 381
GF F +S DC KCL NCSC+A+A TN + T CEIW+ E++ + R
Sbjct: 352 GFVFNEIGRRLSSYDCYVKCLQNCSCVAYASTN-GDGTGCEIWNTDPT-NENSASHHPRT 409
Query: 382 ISVWEPKGIEEKKCWLCLIIPLAVALPVGILSCSLCFLARRKYKANEKWWISLTIAISAA 441
I + KG + WL ++ L + +PV L + +L RK+K I T +S +
Sbjct: 410 IYI-RIKGSKLAATWLVVVASLFLIIPVTWL---IIYLVLRKFK------IKGTNFVSES 459
Query: 442 LTFIPLLSYLCYLIYGKIKT-KVERIMNQKKLLRELGENLSLPSTNGDGKRKGNDHNSMK 500
L I S C L ++ T +V ++Q+ LL ELG + + N++N
Sbjct: 460 LKMIS--SQSCSLTNKRLSTLRVGSTIDQEMLLLELG----IERRRRGKRSARNNNNE-- 511
Query: 501 YGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFK 560
L+IF F++++ AT+ FS NKLGEGGFGPVYKG+L++G+EVAIKRLS SGQG+VEFK
Sbjct: 512 --LQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFK 569
Query: 561 NEAKLIAKLQHTNLT-----------------------------DSRRNNRLNWETRFSI 591
NEA LIAKLQHTNL D R L+W+ RF I
Sbjct: 570 NEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRI 629
Query: 592 IEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651
+EGI QGLLYLHKYSRL+VIHRD+KA NILLD+ MNPKISDFGMARIFG +S+ NT RV
Sbjct: 630 MEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRV 689
Query: 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR-TDHPLNLIGYAWQLW 710
GT+GYMSPEY G+ S K+DVFSFGVL+LEI+ G+KNN + ++ PLNLI + W L+
Sbjct: 690 AGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLF 749
Query: 711 NEGKVLELVDIALEGSFSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVSML---ANESLS 766
E +V E++D +L S N +VLRC+ V LLCVQ A DRP+M DVVSM+ N +LS
Sbjct: 750 KENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALS 809
Query: 767 LPAPKQPAFFINITAEEPPVS 787
L PK+PAF+ + PP S
Sbjct: 810 L--PKEPAFY-----DGPPRS 823
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 579 bits (1493), Expect = e-164, Method: Compositional matrix adjust.
Identities = 349/803 (43%), Positives = 477/803 (59%), Gaps = 81/803 (10%)
Query: 21 GPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWS 80
G S+TDTL GQ LKDG ELVSAF F++ FF++ +S + YLGIW++ +DS
Sbjct: 18 GKSCSETDTLHQGQFLKDGQELVSAFKIFKLKFFNFKNSENLYLGIWFNNLYLNTDSQ-- 75
Query: 81 YGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGNTSAAL 140
++PVW+ANRN PI+D+SGSLT+DS G LKILR + +SS++ NT+ L
Sbjct: 76 ------DRPVWIANRNNPISDRSGSLTVDSL-GRLKILRGASTMLELSSIETTRNTTLQL 128
Query: 141 YETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPA 200
++GN L EM+ GSM+R LWQSFDYPTD LLPGMKLG + +T W L SW + PA
Sbjct: 129 LDSGNLQLQEMDADGSMKRVLWQSFDYPTDTLLPGMKLGFDGKTRKRWELTSWLGDTLPA 188
Query: 201 EGEFTLNIDPNVSNQLIIQRRGEVLWTCGLFPHWRAVDLDSD---FHFSYTSNEKERYFN 257
G F +D N++N L I RG + W+ GL+ R + + + F FS+ S + +YF
Sbjct: 189 SGSFVFGMDTNITNVLTILWRGNMYWSSGLWNKGRFSEEELNECGFLFSFVSTKSGQYFM 248
Query: 258 YSLNGN--FTSFPTLQIDSKGSL---TVTGALPISCPGSEGCVRLSSCKGYFLDDFELNW 312
YS + + T FPT+ ID +G L + + C+ GY + D +
Sbjct: 249 YSGDQDDARTFFPTIMIDEQGILRREQMHRQRNRQNYRNRNCL----AAGYVVRDEPYGF 304
Query: 313 ARKRGFMSV---DGFKFKGSNNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRGSK 369
R +S +GF G+ S DC+ CL N SC+A+A T + + T CEIW+
Sbjct: 305 TSFRVTVSSSASNGFVLSGT--FSSVDCSAICLQNSSCLAYAST-EPDGTGCEIWNT--- 358
Query: 370 FIEDNNNTDARYISVWEPKGIEEKK--CWLCLIIPLAVALPVGILSCSLCFLARRKYKAN 427
N + + +G E KK W ++ L + P+ + +L RK+
Sbjct: 359 -YPTNKGSASHSPRTIYIRGNENKKVAAWHIVVATLFLMTPIIWF---IIYLVLRKFNVK 414
Query: 428 EKWWISLTIAISAALTFIPLLSYLCYLIYGKIKTKVERIMNQKKLLRELGENLSLPSTNG 487
+ I +T + ++ + LL+ + ++ + + ++Q+ LLRELG + S +
Sbjct: 415 GRNCIRITHK-TVLVSMVFLLTMIGFIRRRILSLRFGSTIDQEMLLRELGIDRS--CIHK 471
Query: 488 DGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKR 547
+RK N+ L+IF F+++ +AT++FS NKLGEGGFGPVYKG+LLNG+EVAIKR
Sbjct: 472 RNERKSNNE------LQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKR 525
Query: 548 LSRRSGQGIVEFKNEAKLIAKLQHTNLT-----------------------------DSR 578
LS SGQG+VEFKNEA LIAKLQHTNL D
Sbjct: 526 LSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPL 585
Query: 579 RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638
R N L+W RF I+EGI QGLLYLHKYSRL+VIHRD+KASNILLD+ MNPKISDFG+ARI
Sbjct: 586 RKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARI 645
Query: 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR-TD 697
FG ++ NT RV GT+GYMSPEY G+ S K+DVFSFGVL+LEI+ G+KNN + +
Sbjct: 646 FGAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLE 705
Query: 698 HPLNLIGYAWQLWNEGKVLELVDIALEGS-FSPNEVLRCIHVGLLCVQDQATDRPAMPDV 756
PLNLI + W L+ E K+ E++D++L S +VLRC+ V LLCVQ+ A DRP+M DV
Sbjct: 706 GPLNLIVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDV 765
Query: 757 VSML---ANESLSLPAPKQPAFF 776
VSM+ N +LSL PK+PAF+
Sbjct: 766 VSMIYGEGNNALSL--PKEPAFY 786
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-122, Method: Compositional matrix adjust.
Identities = 306/852 (35%), Positives = 434/852 (50%), Gaps = 166/852 (19%)
Query: 27 TDTLLLGQLLKDG---DELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGS 83
+T+ G+ L+DG LVS F +GFFS SS R+LGIWY G+
Sbjct: 26 ANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWY-------------GN 72
Query: 84 PKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVV------SSVQAMGNTS 137
+ VWVANR TPI+D+SG L I S DGNL +L G +I V SS N
Sbjct: 73 IEDKAVVWVANRATPISDQSGVLMI-SNDGNLVLL--DGKNITVWSSNIESSTTNNNNRV 129
Query: 138 AALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSED 197
++++TGNFVL E + +R +W+SF++PTD LP M++ +N QTG SW SE
Sbjct: 130 VSIHDTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSET 185
Query: 198 SPAEGEFTLNIDPNVSNQLIIQ--------RRGEVLWTCGLFPHWRAVDLDSDFHFS--- 246
P+ G ++L +DP+ + ++++ R G+ W +F + L +++ +
Sbjct: 186 DPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQ--WNSAIFTGIPNMSLLTNYLYGFKL 243
Query: 247 ----------------------------YTSNEKERYFNYSLNG--NFTSFPTLQIDSKG 276
Y E+E +N +L F S P + D
Sbjct: 244 SSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYN 303
Query: 277 SLTVTGALPISCPGSEGCVRLSSCKGYFLDDFELNWAR-----------------KRGFM 319
G + GS G + SC + NW+R + F+
Sbjct: 304 RCGKFGICDMK--GSNG---ICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGEDEFL 358
Query: 320 SVDG-----FKFKGSNNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRGSKFIED- 373
++ F+ N + +DC +CL NCSC A+++ C IW++ ++
Sbjct: 359 TLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNAYSLVG---GIGCMIWNQDLVDLQQF 415
Query: 374 NNNTDARYISVWEPKGIEEKKCWLCLIIPLAVA-LPVGILSCSLCFLARRKYKANEKWWI 432
+ +I + + + E +K + +I+ + V + +GI + L R+K
Sbjct: 416 EAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKK--------- 466
Query: 433 SLTIAISAALTFIPLLSYLCYLIYGKIKTKVERIMNQKKLLRELGENLSLPSTNGDGKRK 492
+S A Y T ++ L + E S S + D +
Sbjct: 467 ----DVSGA--------------YCGKNTDTSVVVAD---LTKSKETTSAFSGSVDIMIE 505
Query: 493 GNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS 552
G N+ + L +F I+ ATN+F N+LG GGFGPVYKG L +G+E+A+KRLS +S
Sbjct: 506 GKAVNTSE--LPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKS 563
Query: 553 GQGIVEFKNEAKLIAKLQHTNLT-----------------------------DSRRNNRL 583
GQG+ EFKNE LIAKLQH NL D + +
Sbjct: 564 GQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALI 623
Query: 584 NWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643
+W+ RFSIIEGIA+GLLYLH+ SRLR+IHRDLK SN+LLD +MNPKISDFGMARIFG NQ
Sbjct: 624 DWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQ 683
Query: 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703
+E NT RVVGTYGYMSPEYAM G+ S+K+DV+SFGVL+LEIVSGK+N ++H +LI
Sbjct: 684 NEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLI 742
Query: 704 GYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763
GYAW L+ G+ ELVD + + S E LRCIHV +LCVQD A +RP M V+ ML ++
Sbjct: 743 GYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESD 802
Query: 764 SLSLPAPKQPAF 775
+ +L AP+QP F
Sbjct: 803 TATLAAPRQPTF 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 305/834 (36%), Positives = 428/834 (51%), Gaps = 164/834 (19%)
Query: 42 LVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITD 101
+VS F +GFF YLGIWY + S +Y VWVANR+TP++
Sbjct: 46 IVSPGNVFELGFFKPGLDSRWYLGIWYK-----AISKRTY--------VWVANRDTPLSS 92
Query: 102 KSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGNTS---AALYETGNFVLYEMNPSGSME 158
G+L I D NL +L + + +++ S A L + GNFVL + S +
Sbjct: 93 SIGTLKIS--DSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAP-D 149
Query: 159 RELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLII 218
LWQSFD+PTD LLP MKLG + +TG F+RSW S D P+ G+F+ ++ ++ +
Sbjct: 150 GVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFL 209
Query: 219 QRRGEVLWTCGLFPHWR--AVDLDSDFH---FSYTSNEKERYFNYSLNG----------- 262
R ++ G + R V F F++T++++E +++ +
Sbjct: 210 WNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISS 269
Query: 263 --------------NFTSF---PTLQIDSKGSLTVTG-----ALPI-SC----------- 288
N+ F P Q D V G P+ +C
Sbjct: 270 SGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQV 329
Query: 289 ----PGSEGCVR--LSSCKGYFLDDFELNWARKRGFMSVDGFKFKGSNNMSRD------D 336
GS+GCVR L SC G GF+ + K + S D +
Sbjct: 330 WGLRDGSDGCVRKTLLSCGG------------GDGFVRLKKMKLPDTTTASVDRGIGVKE 377
Query: 337 CATKCLSNCSCIAFAITN-KNNNTACEIWSRGSKFIEDNNNTDARYISV-WEPKGIEEKK 394
C KCL +C+C AFA T+ + + + C W+ G F N + + V +E+K+
Sbjct: 378 CEQKCLRDCNCTAFANTDIRGSGSGCVTWT-GELFDIRNYAKGGQDLYVRLAATDLEDKR 436
Query: 395 CWLCLIIPLAVALPVGIL-SCSLCFLARRKYKANEKWWISLTIAISAALTFIPLLSYLCY 453
II ++ + V +L S + FL +RK K +I I
Sbjct: 437 NRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKR--------SILIETP------------ 476
Query: 454 LIYGKIKTKVERIMNQKKLLRELGENLSLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISA 513
I++ + R+L N + S+ + ++N+ L + +F+ ++
Sbjct: 477 ------------IVDHQLRSRDLLMNEVVISSR---RHISRENNTDDLELPLMEFEEVAM 521
Query: 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN 573
ATNNFS NKLG+GGFG VYKG+LL+GQE+A+KRLS+ S QG EFKNE KLIA+LQH N
Sbjct: 522 ATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHIN 581
Query: 574 LT-----------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHK 604
L D RN++LNW+ RF II GIA+GLLYLH+
Sbjct: 582 LVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQ 641
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
SR R+IHRDLKASNILLD M PKISDFGMARIFG +++E NT +VVGTYGYMSPEYAM
Sbjct: 642 DSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAM 701
Query: 665 SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724
G+ S+K+DVFSFGVL+LEI+S K+N G Y +D LNL+G W+ W EGK LE++D +
Sbjct: 702 DGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIIT 761
Query: 725 GS---FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPAF 775
S F +E+LRCI +GLLCVQ++A DRP M V+ ML +ES ++P PK P +
Sbjct: 762 DSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGY 815
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 433 bits (1114), Expect = e-120, Method: Compositional matrix adjust.
Identities = 300/849 (35%), Positives = 427/849 (50%), Gaps = 158/849 (18%)
Query: 24 YSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGS 83
+S T++L + ++S F +GFF+ SS YLGIWY
Sbjct: 30 FSATESLTISS----NKTIISPSQIFELGFFNPDSSSRWYLGIWYK-------------I 72
Query: 84 PKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSV---QAMGNTSAAL 140
I VWVANR+ P++ +G+L I D NL I + + +++ +A L
Sbjct: 73 IPIRTYVWVANRDNPLSSSNGTLKIS--DNNLVIFDQSDRPVWSTNITGGDVRSPVAAEL 130
Query: 141 YETGNFVLYEMN---PSGSMERELWQSFDYPTDILLPGMKLGL-NLQTGHEWFLRSWTSE 196
+ GNFVL + PSG LWQSFD+PTD LL MK+G N G LRSW +
Sbjct: 131 LDYGNFVLRDSKNNKPSGF----LWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTT 186
Query: 197 DSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLF--------PHWRAVDLDSDFHFSYT 248
D P+ G+F+ + + + I + + + G + P + VD + S+T
Sbjct: 187 DDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDN---SFT 243
Query: 249 SNEKERYFNYSLNGNFTSFPTLQIDSKGSLTVTGALPIS-------------CPGSEGCV 295
N ++ ++Y +N + L + S G L + + C + C
Sbjct: 244 ENNQQVVYSYRVNKT-NIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECG 302
Query: 296 RLSSC-----------KGY-------FLDDFELNWARKR--------GFMSVDGFKFKGS 329
C KG+ L D + RK GF+ + + +
Sbjct: 303 NYGYCDANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDT 362
Query: 330 NNMSRD------DCATKCLSNCSCIAFAITN-KNNNTACEIWSRGSKFIEDNNNTDARYI 382
S D +C +CL C+C AFA T+ +N + C IWS G F N + +
Sbjct: 363 TETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWS-GGLFDIRNYAKGGQDL 421
Query: 383 SVWEPKG-IEEKKCWLCLIIPLAVALPVGILSCSLCFLARRKYKANEKWWISLTIAISAA 441
V G +E+K+ II ++ + + +L L F+ +K +K I++ I
Sbjct: 422 YVRVAAGDLEDKRIKSKKIIGSSIGVSILLL---LSFIIFHFWKRKQKRSITIQTPI--- 475
Query: 442 LTFIPLLSYLCYLIYGKIKTKVERIMNQKKLLRELGENLSLPSTNGDGKRKGNDHNSMKY 501
V+ + +Q L+ EL + S + K D+
Sbjct: 476 ---------------------VDLVRSQDSLMNELVK----ASRSYTSKENKTDY----L 506
Query: 502 GLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKN 561
L + +++ ++ ATNNFS NKLG+GGFG VYKG LL+G+E+A+KRLS+ S QG EF N
Sbjct: 507 ELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMN 566
Query: 562 EAKLIAKLQHTNLT-----------------------------DSRRNNRLNWETRFSII 592
E +LIAKLQH NL D R++ LNW+ RF II
Sbjct: 567 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 626
Query: 593 EGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVV 652
GIA+GLLYLH+ SR R+IHRDLKASN+LLD M PKISDFGMARIFG ++E NT RVV
Sbjct: 627 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 686
Query: 653 GTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712
GTYGYMSPEYAM G+ S+K+DVFSFGVL+LEI+SGK+N G Y ++ LNL+G+ W+ W E
Sbjct: 687 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 746
Query: 713 GKVLELVDI----ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLP 768
GK LE+VD AL F +E+LRCI +GLLCVQ++A DRP M V+ ML +E+ ++P
Sbjct: 747 GKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIP 806
Query: 769 APKQPAFFI 777
PK+P F +
Sbjct: 807 QPKRPGFCV 815
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 431 bits (1107), Expect = e-119, Method: Compositional matrix adjust.
Identities = 299/866 (34%), Positives = 435/866 (50%), Gaps = 186/866 (21%)
Query: 42 LVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITD 101
++S F +GFF+ SS YLGIWY I VWVANR+ P++
Sbjct: 44 IISPSQIFELGFFNPASSSRWYLGIWYK-------------IIPIRTYVWVANRDNPLSS 90
Query: 102 KSGSLTIDSRDGNLKILRKGGNSIVVSSV---QAMGNTSAALYETGNFVLYEMNPSGSME 158
+G+L I NL I + + +++ +A L + GNF+L + N
Sbjct: 91 SNGTLKISG--NNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSN-----N 143
Query: 159 RELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLII 218
R LWQSFD+PTD LL MKLG + +TG LRSW + D P+ GEF+ ++ + + I
Sbjct: 144 RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYI 203
Query: 219 QRRGEVLWTCGLFPHWRAVDLDSDFH-----FSYTSNEKERYFNYSLNGNFTSFPTLQID 273
+ +L+ G + R + +++T++++E ++Y +N + L ++
Sbjct: 204 CSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKT-NLYSRLYLN 262
Query: 274 SKGSLT--------------------------------------------VTGALPISCP 289
S G L + G P++
Sbjct: 263 SAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQ 322
Query: 290 ------GSEGCVRLS--SCKGYFLDDFELNWARKRGFMSVDGFKFKGSNNMSRDD----- 336
GS GC+R + SC G + GF + K + D
Sbjct: 323 AWDLRDGSAGCMRKTRLSCDG------------RDGFTRLKRMKLPDTTATIVDREIGLK 370
Query: 337 -CATKCLSNCSCIAFAITN-KNNNTACEIWSRGSKFIEDNNNTDARYISVWEPKGIEEKK 394
C +CL +C+C AFA + +N + C IW+R I D N KG ++
Sbjct: 371 VCKERCLEDCNCTAFANADIRNGGSGCVIWTRE---ILDMRNY---------AKGGQD-- 416
Query: 395 CWLCLIIPLAVALPVGILSCSLCFLARRKYKANEKWWISLTIAISAALTFIPLLSYLCYL 454
L + LA A L ++ K NEK I S ++ + LLS++ +
Sbjct: 417 ----LYVRLAAAE-----------LEDKRIK-NEK-----IIGSSIGVSILLLLSFVIFH 455
Query: 455 IYGKIKTK--------VERIMNQKKLLRELGENLSLPSTNGDGKRKGNDHNSMKYGLEIF 506
+ + + + V+++ +Q L+ ++ + S G + + S L +
Sbjct: 456 FWKRKQKRSITIQTPNVDQVRSQDSLINDV-----VVSRRGYTSK---EKKSEYLELPLL 507
Query: 507 DFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLI 566
+ + ++ ATNNFS NKLG+GGFG VYKG+LL+G+E+A+KRLS+ S QG EF NE +LI
Sbjct: 508 ELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLI 567
Query: 567 AKLQHTNLT-----------------------------DSRRNNRLNWETRFSIIEGIAQ 597
AKLQH NL D R++ LNW+ RF II GIA+
Sbjct: 568 AKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIAR 627
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
GLLYLH+ SR R+IHRDLKASN+LLD M PKISDFGMARIFG ++E NT RVVGTYGY
Sbjct: 628 GLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGY 687
Query: 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717
MSPEYAM G+ S+K+DVFSFGVL+LEI+SGK+N G Y ++ LNL+G+ W+ W EG LE
Sbjct: 688 MSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELE 747
Query: 718 LVDI----ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQP 773
+VD +L F +E+LRCI +GLLCVQ++A DRP M V+ ML +E+ ++P PK+P
Sbjct: 748 IVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRP 807
Query: 774 AFFINITAEEPPVSESNA--ECCSIN 797
F I + E S S + C++N
Sbjct: 808 GFCIGRSPLEADSSSSTQRDDECTVN 833
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 300/873 (34%), Positives = 430/873 (49%), Gaps = 163/873 (18%)
Query: 23 CYSQTDTLLLGQLLKDGDE--LVSAFGNFRMGFFSYMSSGDR--YLGIWYHRPTDPSDSH 78
C+ + D + +KD + L+ G FR GFF+ ++S R Y+GIWY +
Sbjct: 27 CFGE-DRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIP------ 79
Query: 79 WSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIV----VSSVQAMG 134
I VWVAN+++PI D SG ++I +DGNL + G N +V VS A
Sbjct: 80 -------IQTVVWVANKDSPINDTSGVISI-YQDGNLAVT-DGRNRLVWSTNVSVPVAPN 130
Query: 135 NTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWT 194
T L ++GN +L + +G + LW+SF +P D +P M LG + +TG L SWT
Sbjct: 131 ATWVQLMDSGNLMLQDNRNNGEI---LWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWT 187
Query: 195 SEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLF--------PHWRAV------DLD 240
S D P+ G +T I P +L+I + W G + P+ ++ +L+
Sbjct: 188 SHDDPSTGNYTAGIAPFTFPELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLN 247
Query: 241 SD----FHFSYTSNEKERYFNYSLNGNF---------------TSFPTLQIDSKGSLTVT 281
SD SY ++ +FN G FP D+ G
Sbjct: 248 SDNQGTISMSYANDSFMYHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRF 307
Query: 282 GAL------PISCPG---------------SEGCVRLS--SCKGYFLDDFELNWARKRGF 318
G+ P C S GC+R + C+ + GF
Sbjct: 308 GSCHAGENPPCKCVKGFVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGF 367
Query: 319 MSVDGFKFKGS---NNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRGSKFIEDNN 375
+ + K S + S C CL NCSC A+A + C +WS + D
Sbjct: 368 LKLQKMKVPISAERSEASEQVCPKVCLDNCSCTAYAY---DRGIGCMLWSGD---LVDMQ 421
Query: 376 NTDARYISVWEPKGIEEKKCWLCLIIPLAVALPVGILSCSLC-FLARRKYKANEKWWISL 434
+ I ++ E K L + +A + +L ++C LA RKYK +
Sbjct: 422 SFLGSGIDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRP----AP 477
Query: 435 TIAISAALTFIPLLSYLCYLIYGKIKTKVERIMNQKKLLRELGENLSLPSTNGDGKRKGN 494
SA L F + + + + E NQ KL
Sbjct: 478 AKDRSAELMFKRMEA---------LTSDNESASNQIKLKE-------------------- 508
Query: 495 DHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ 554
L +F+FQ ++ +T++FS NKLG+GGFGPVYKG+L GQE+A+KRLSR+SGQ
Sbjct: 509 --------LPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQ 560
Query: 555 GIVEFKNEAKLIAKLQHTNLT-----------------------------DSRRNNRLNW 585
G+ E NE +I+KLQH NL D + L+W
Sbjct: 561 GLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDW 620
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645
+TRF+I+EGI +GLLYLH+ SRL++IHRDLKASNILLD+ +NPKISDFG+ARIF N+ E
Sbjct: 621 KTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDE 680
Query: 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGY 705
NT RVVGTYGYMSPEYAM G S K+DVFS GV+ LEI+SG++N+ ++ ++ LNL+ Y
Sbjct: 681 ANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAY 740
Query: 706 AWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765
AW+LWN+G+ L D A+ E+ +C+H+GLLCVQ+ A DRP + +V+ ML E++
Sbjct: 741 AWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENM 800
Query: 766 SLPAPKQPAFFINITAEEPPVSESNAECCSINN 798
SL PKQPAF + A E S+ +++ SIN+
Sbjct: 801 SLADPKQPAFIVRRGASEAESSDQSSQKVSIND 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 291/852 (34%), Positives = 405/852 (47%), Gaps = 173/852 (20%)
Query: 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKI 86
DT++ Q L+DG+ ++SA F GFFS S RY+GIWY + + +
Sbjct: 19 VDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQT----------- 67
Query: 87 NQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGNT-----SAALY 141
VWVANR+ PI D SG + +R GNL + + ++ S + A L
Sbjct: 68 --IVWVANRDHPINDTSGMVKFSNR-GNLSVYASDNETELIWSTNVSDSMLEPTLVATLS 124
Query: 142 ETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPAE 201
+ GN VL++ R W+SFD+PTD LP M+LG + G + L SW S P
Sbjct: 125 DLGNLVLFDPVTG----RSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGS 180
Query: 202 GEFTLNIDPNVSNQLIIQRRGEVLWTCGLFP--HWRAVD---LDSDFHFSYTSNEKERYF 256
G+ L ++ QLI+ + W G + W V + F+ S+ +NE E F
Sbjct: 181 GDLILRMERRGFPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSF 240
Query: 257 NYSLN----------------------------GNFTSFPTLQIDSKGSLTVTGALPISC 288
Y + +F S P Q D+ G
Sbjct: 241 TYGVTDASVITRTMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPS 300
Query: 289 PGSEGCVRLSSCKGYFLDDFELNW------------------ARKRGFMSVDGFKFKGSN 330
+ C +C F F +W + K GF+ + K ++
Sbjct: 301 SKTFEC----TCLPGFEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTS 356
Query: 331 NMSRD------DCATKCLSNCSCIAFAIT---NKNNNTACEIWSRG----SKFIEDNNN- 376
+ S D +C +CL NCSC+A+A +K C W G ++ +
Sbjct: 357 DASVDMNITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDF 416
Query: 377 ---TDARYISVWEPKGIEEKKCWLCLIIPLAVALPVGILSCSLCFLARRKYKANEKWWIS 433
D ++ W G+ K+ L ++I L A V +L+ L + R + K+N
Sbjct: 417 YIRVDKEELARWNRNGLSGKRRVLLILISLIAA--VMLLTVILFCVVRERRKSNRH---- 470
Query: 434 LTIAISAALTFIPLLSYLCYLIYGKIKTKVERIMNQKKLLRELGENLSLPSTNGDGKRKG 493
S++ F P+ P + R
Sbjct: 471 ----RSSSANFAPV-----------------------------------PFDFDESFRFE 491
Query: 494 NDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG 553
D + L +FD TI AATNNFS+ NKLG GGFGPVYKG L N E+A+KRLSR SG
Sbjct: 492 QD-KARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSG 550
Query: 554 QGIVEFKNEAKLIAKLQHTNLT-----------------------------DSRRNNRLN 584
QG+ EFKNE KLI+KLQH NL + L+
Sbjct: 551 QGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELD 610
Query: 585 WETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644
W R I+ GIA+G+LYLH+ SRLR+IHRDLKASNILLD +M PKISDFGMARIFG NQ
Sbjct: 611 WPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQM 670
Query: 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG 704
E T+RVVGT+GYM+PEYAM G SIK+DV+SFGVL+LEI++GKKN+ + + NL+G
Sbjct: 671 EGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLVG 728
Query: 705 YAWQLWNEGKVLELVDIAL-EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763
+ W LW G+ E++D + + ++ EV++CI +GLLCVQ+ A+DR M VV ML +
Sbjct: 729 HIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHN 788
Query: 764 SLSLPAPKQPAF 775
+ +LP PK PAF
Sbjct: 789 ATNLPNPKHPAF 800
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 419 bits (1076), Expect = e-116, Method: Compositional matrix adjust.
Identities = 304/861 (35%), Positives = 418/861 (48%), Gaps = 160/861 (18%)
Query: 42 LVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITD 101
LVS F +GFF ++ YLG+WY + +D + VWVANR+ P+++
Sbjct: 50 LVSPGSIFEVGFFR--TNSRWYLGMWYKKVSDRT-------------YVWVANRDNPLSN 94
Query: 102 KSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGN----TSAALYETGNFVLYEMNPSGSM 157
G+L I GN +L N V + GN A L GNFV+ + + + +
Sbjct: 95 AIGTLKIS---GNNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRDSSNNDAS 151
Query: 158 ERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLI 217
E LWQSFDYPTD LLP MKLG NL+TG FL SW S D P+ G F+ ++ +
Sbjct: 152 EY-LWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFY 210
Query: 218 IQRRGEVLWTCGLFPHWRAVDLDSDFHFSY-----TSNEKERYFNYSLNGNFTSFPTLQI 272
+ R + G + R + D SY N +E + + + N + + L +
Sbjct: 211 LSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNN-SFYSRLTL 269
Query: 273 DSKG---SLTVTGALPI-----SCPGSEGCVRLSSCKGYFLDDFELN------------- 311
S+G LT ++ I S P C C Y D +
Sbjct: 270 ISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQGFNPRN 329
Query: 312 --------WA-----RKRGFMSVDGF------KFKGSNNMSRD------DCATKCLSNCS 346
WA R + S DGF K + + D +C +C+S+C+
Sbjct: 330 IQQWDQRVWAGGCIRRTQLSCSGDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCN 389
Query: 347 CIAFAITN-KNNNTACEIWSRGSKFIEDNNNTDA-----RYISVWEPKGIEEKKCWLCLI 400
C AFA + +N + C IW+ + I N TDA Y+ + I +K+ I
Sbjct: 390 CTAFANADIRNGGSGCVIWTERLEDIR-NYATDAIDGQDLYVRL-AAADIAKKRNASGKI 447
Query: 401 IPLAVALPVGILSCSLCFLARRKYKANEKWWISLTIAISAALTFIPLLSYLCYLIYGKIK 460
I L V + V +L C R++ +A AIS A T
Sbjct: 448 ISLTVGVSVLLLLIMFCLWKRKQKRAKAS-------AISIANT----------------- 483
Query: 461 TKVERIMNQKKLLRELGENLSLPSTNGDGKRK-GNDHNSMKYGLEIFDFQTISAATNNFS 519
+ +NL + KR+ ++ + L + + +T+ AT NFS
Sbjct: 484 --------------QRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFS 529
Query: 520 AVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD--- 576
+ NKLG+GGFG VYKG+LL+G+E+A+KRLS+ S QG EF NE LIA+LQH NL
Sbjct: 530 SCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLG 589
Query: 577 --------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRV 610
R ++LNW RF I G+A+GLLYLH+ SR R+
Sbjct: 590 CCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRI 649
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
IHRDLK SNILLD M PKISDFGMARIF +++E NT +VVGTYGYMSPEYAM G+ S
Sbjct: 650 IHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSE 709
Query: 671 KTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS---- 726
K+DVFSFGV+VLEIVSGKKN G Y D+ +L+ Y W W EG+ LE+VD + S
Sbjct: 710 KSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQ 769
Query: 727 ---FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPAFFINITAEE 783
F P EVL+CI +GLLCVQ+ A RPAM VV M +E+ +P PK P + + + E
Sbjct: 770 PSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYE 829
Query: 784 PPVSESNAECCSINNSDKLQQ 804
+ S++ C N S + Q
Sbjct: 830 --LDPSSSWQCDENESWTVNQ 848
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 419 bits (1076), Expect = e-116, Method: Compositional matrix adjust.
Identities = 305/860 (35%), Positives = 421/860 (48%), Gaps = 173/860 (20%)
Query: 27 TDTLLLGQLL---KDGDELVSAFGNFRMGFFSYMSSGD--RYLGIWYHRPTDPSDSHWSY 81
+ TL G L G+ LVSA F +GFF+ S D RYLGIW++ +
Sbjct: 26 SKTLFKGSTLINDSHGETLVSAGQRFELGFFTPNGSSDERRYLGIWFYNLHPLT------ 79
Query: 82 GSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGG-----NSIVVSSVQAMGNT 136
VWVANR +P+ D+S TI S+DGNL+++ G + SSV A
Sbjct: 80 -------VVWVANRESPVLDRSCIFTI-SKDGNLEVIDSKGRVYWDTGVKPSSVSA--ER 129
Query: 137 SAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSE 196
L + GN VL G+ +WQSF PTD LPGM++ N+ L SW S
Sbjct: 130 MVKLMDNGNLVLIS---DGNEANVVWQSFQNPTDTFLPGMRMDENMT------LSSWRSF 180
Query: 197 DSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLFPHWRAVDLDSDFHFSY---TSNEKE 253
+ P+ G FT +D Q II +R W G+ + D + + SY E
Sbjct: 181 NDPSHGNFTFQMDQEEDKQFIIWKRSMRYWKSGISGKFIGSD-EMPYAISYFLSNFTETV 239
Query: 254 RYFNYSLNGNFTSFPT--------------LQIDSKGSLTVTGALPI-SCPGSEGCVRLS 298
N S+ FTS T ++D + A P C C
Sbjct: 240 TVHNASVPPLFTSLYTNTRFTMSSSGQAQYFRLDGERFWAQIWAEPRDECSVYNACGNFG 299
Query: 299 SCKGY----------FLDDFELNWAR---------------KRGFMSVDGF--------- 324
SC F +F W + K G + D F
Sbjct: 300 SCNSKNEEMCKCLPGFRPNFLEKWVKGDFSGGCSRESRICGKDGVVVGDMFLNLSVVEVG 359
Query: 325 ----KFKGSNNMSRDDCATKCLSNCSCIAFAITNKN---NNTACEIWSRGSKFIEDNNNT 377
+F N +C +CL+NC C A++ + +NT C IW +ED NN
Sbjct: 360 SPDSQFDAHN---EKECRAECLNNCQCQAYSYEEVDILQSNTKCWIW------LEDLNNL 410
Query: 378 DARYISVWEPKGIEEKKCWLCLIIPLAVALP-VGILSCSLCFLARRKY-KANEKWWISLT 435
Y+ + + VA+P +G S R +Y +A + +
Sbjct: 411 KEGYLGSRN--------------VFIRVAVPDIG----SHVERGRGRYGEAKTPVVLIIV 452
Query: 436 IAISAALTFIPLLSYLCYLIYGKIKTKVE--------RIMNQKKLLRELGENLSLPSTNG 487
+ ++A + L S Y+ + K E + + ++ ++EL E+
Sbjct: 453 VTFTSAAILVVLSSTASYVFLQRRKVNKELGSIPRGVHLCDSERHIKELIES-------- 504
Query: 488 DGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKR 547
G+ K +D S + F+ +TI AT+NFS NKLG+GGFGPVYKG QE+A+KR
Sbjct: 505 -GRFKQDD--SQGIDVPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKR 561
Query: 548 LSRRSGQGIVEFKNEAKLIAKLQHTNLT-----------------------------DSR 578
LSR SGQG+ EFKNE LIAKLQH NL D +
Sbjct: 562 LSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRK 621
Query: 579 RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638
RL+W+ R +II GIA+GLLYLH+ SRLR+IHRDLK SNILLD++MNPKISDFG+ARI
Sbjct: 622 LCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARI 681
Query: 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDH 698
FG +++ NTNRVVGTYGYMSPEYA+ G+ S K+DVFSFGV+V+E +SGK+N G + +
Sbjct: 682 FGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEK 741
Query: 699 PLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758
L+L+G+AW LW + +EL+D AL+ S L+C++VGLLCVQ+ DRP M +VV
Sbjct: 742 SLSLLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVF 801
Query: 759 ML-ANESLSLPAPKQPAFFI 777
ML ++E+ +LP PKQPAF +
Sbjct: 802 MLGSSEAATLPTPKQPAFVL 821
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1018 | ||||||
| 255550026 | 795 | Serine/threonine-protein kinase PBS1, pu | 0.697 | 0.893 | 0.472 | 0.0 | |
| 255550034 | 789 | receptor protein kinase, putative [Ricin | 0.713 | 0.920 | 0.465 | 0.0 | |
| 359482600 | 789 | PREDICTED: G-type lectin S-receptor-like | 0.716 | 0.923 | 0.461 | 1e-179 | |
| 15233263 | 850 | lectin receptor kinase CES101 [Arabidops | 0.722 | 0.864 | 0.429 | 1e-163 | |
| 322510097 | 818 | RecName: Full=G-type lectin S-receptor-l | 0.709 | 0.882 | 0.434 | 1e-162 | |
| 12324679 | 833 | putative receptor protein kinase [Arabid | 0.704 | 0.860 | 0.431 | 1e-160 | |
| 397134748 | 881 | S domain subfamily 1 receptor-like kinas | 0.723 | 0.836 | 0.426 | 1e-158 | |
| 9294449 | 805 | receptor kinase 1 [Arabidopsis thaliana] | 0.678 | 0.858 | 0.418 | 1e-156 | |
| 397134747 | 852 | S domain subfamily receptor-like kinase | 0.703 | 0.840 | 0.423 | 1e-156 | |
| 225463860 | 795 | PREDICTED: G-type lectin S-receptor-like | 0.691 | 0.885 | 0.428 | 1e-153 |
| >gi|255550026|ref|XP_002516064.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223544969|gb|EEF46484.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 673 bits (1737), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/833 (47%), Positives = 499/833 (59%), Gaps = 123/833 (14%)
Query: 20 TGPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSG---DRYLGIWYHRPTDPSD 76
T P +SQT T+L G LK ELVSA G F++ F + SG D YLGIWY+
Sbjct: 21 TRPSHSQTRTILQGGELKYDQELVSADGMFKLKFGTVGESGESSDSYLGIWYN------- 73
Query: 77 SHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQ-AMGN 135
Y K PVWVANR+TPI SG LT+DS+ GNLKILR G SIV+ SVQ A+ N
Sbjct: 74 ----YIEEKF--PVWVANRDTPIFGNSGILTVDSQ-GNLKILRDKGRSIVLYSVQKAIYN 126
Query: 136 TSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTS 195
A L +TGNF+L E+N +GS+++ LWQSFDYPTD LPGMKLG+NL+TG +W + SW S
Sbjct: 127 AIATLEDTGNFILRELNSNGSIKQVLWQSFDYPTDTFLPGMKLGINLKTGQQWSVISWRS 186
Query: 196 EDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWT----CGLFPHWRAVDLDSDFHFSYTSNE 251
+SPA G F L DP+ NQL+I R+G + W G F + + ++FSY S+E
Sbjct: 187 FESPARGTFVLGTDPDSKNQLVIWRQGHIYWASGSWVGQFSLLGGLSFNVLYNFSYFSDE 246
Query: 252 KERYFNYSLNGNFTSFPTLQIDSKGSLTVTGALP------ISCPGSE-------GCVR-- 296
E YF YS+N + FP L I+++G L G L + C S GC+
Sbjct: 247 NESYFIYSINKANSIFPRLTINAEGVLI--GFLKYDYHEEVKCITSYDYMSPTVGCLEQN 304
Query: 297 LSSCKG---YFLDDFELNWARKRGFMSVDGFKFKGSNNMSRDDCATKCLSNCSCIAFAIT 353
L +C+ FL + + G+M DGFK+ S N++ DC CL NCSCIA+A
Sbjct: 305 LPNCRSPSDAFL------FKPRTGYMYSDGFKYSDSENLTMIDCKLNCLKNCSCIAYASK 358
Query: 354 NKNNNTACEIWSRGSKFIEDNNNTDARYISVWEPKGIEEKKCWLCLIIPLAVALPVGILS 413
N++ T CEIW FI +++ D+R I +++
Sbjct: 359 NEDG-TGCEIWRSARSFIGSSSD-DSRKIYIFDEV------------------------- 391
Query: 414 CSLCFLARRKYKANEKWWISLTIAISAALTFIPLLSYLCYLIYGKIKTKVERIMNQKKLL 473
KWW+ +TI + + IP L Y I+ K N K L
Sbjct: 392 --------------NKWWLPVTITL-GGIFLIPALCAFLYAIWKKCSRTGNGKTNLKNLW 436
Query: 474 RELGENLSLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVY 533
EL N +T + + N+ + L IF F+ I+ AT F NKLGEGGFGPVY
Sbjct: 437 NELEGNALSLTTYDTLRTQKNEWDE----LHIFCFEIIAIATKYFKPENKLGEGGFGPVY 492
Query: 534 KGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT------------------ 575
KG+LL+GQE+AIKRLSR SGQG+VEFKNEA LIAKLQHTNL
Sbjct: 493 KGKLLDGQEIAIKRLSRSSGQGLVEFKNEAILIAKLQHTNLVKLLGFCVDGEERILVYEY 552
Query: 576 -----------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD 624
DS + + L+W+ RF II+GI QGLLYLHKYSRL+VIHRDLKASNILLDD
Sbjct: 553 MPKKSLDIYLFDSHKKSELDWKKRFKIIDGITQGLLYLHKYSRLKVIHRDLKASNILLDD 612
Query: 625 QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEI 684
+MNPKISDFGMARIFGL +SE NTNR+VGTYGYMSPEYAM+GVVS KTDVFSFGVL+LEI
Sbjct: 613 EMNPKISDFGMARIFGLKESEANTNRIVGTYGYMSPEYAMNGVVSTKTDVFSFGVLLLEI 672
Query: 685 VSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQ 744
+SG+KN + ++ P+NLIGYAW LW + + LEL+D L+ N+VLRCIH+GLLCVQ
Sbjct: 673 ISGRKNTSFHYSECPINLIGYAWLLWKDNRGLELIDPKLDEFLPQNQVLRCIHIGLLCVQ 732
Query: 745 DQATDRPAMPDVVSMLANESLSLPAPKQPAFFINITAEEPPVSESNAECCSIN 797
D A DRP + DVVSML+NE++ L PKQPAFF+N +EP + ++ CSIN
Sbjct: 733 DHAADRPTVFDVVSMLSNETILLATPKQPAFFVNAVVQEPGEPRNRSDKCSIN 785
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550034|ref|XP_002516068.1| receptor protein kinase, putative [Ricinus communis] gi|223544973|gb|EEF46488.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/834 (46%), Positives = 487/834 (58%), Gaps = 108/834 (12%)
Query: 9 LLISFSFFVLLTGPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWY 68
+L+ S F+LL G +S TDTLL GQ LKDGD+LVSA G F + FF S YLGIWY
Sbjct: 9 ILVILSCFMLLLGSSWSVTDTLLQGQKLKDGDQLVSASGIFLLRFFR---SDKHYLGIWY 65
Query: 69 HRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKI-LRKGGNSIVV 127
+ + + S K+ VWVANRN PI DKSG LTI RDGNLKI GG++I +
Sbjct: 66 NMTDEQESINEFELSSKV---VWVANRNNPIVDKSGILTI-GRDGNLKISYGSGGDNISL 121
Query: 128 SSVQAMGNTS---AALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQT 184
+SVQ GN + A L ++GN VL E+ + S R LWQSFDYPT L PGMK+G+NLQT
Sbjct: 122 TSVQKSGNNTNITATLLDSGNLVLRELYTNRSASRLLWQSFDYPTHALFPGMKIGINLQT 181
Query: 185 GHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGL-----FPHWRAVDL 239
GH W L SW + SPA G FT +D N NQLII G+V W G F W +
Sbjct: 182 GHSWSLTSWINTQSPAIGSFTFGMDRNGMNQLIIWWAGDVYWISGNWVDGGFKFWHMLSA 241
Query: 240 DSDFHFSYTSNEKERYFNYSLNGNFTSFPTLQIDSKGSLTVTGALP-ISCPG------SE 292
+HF Y SNE E YF Y+ + N FP L I+ G L+ + A P ISC +
Sbjct: 242 QEGYHFRYFSNENETYFTYNASENAKYFPMLWINDFG-LSSSFARPLISCRSQYDYMNTI 300
Query: 293 GCVRLSSCKGYFLDDFELNWARKRGFMSVDGFKFKGSNNMSRDDCATKCLSNCSCIAFAI 352
GCV+ +FE A G D FKF S+++S DDC KCL NCSC+A++
Sbjct: 301 GCVQSRPICPKKATEFEYETAAVSG----DSFKFNESDHLSLDDCLEKCLRNCSCVAYSP 356
Query: 353 TNKNNNTACEIWSRGSKFIEDNNNTDARYISVWEPKGIEEKKCWLCLIIPLAVALPVGIL 412
TN+ + T CEIWS+ + ++ D R+ W P V +L
Sbjct: 357 TNEIDGTGCEIWSK----VTIESSADGRH---WRP---------------------VFVL 388
Query: 413 SCSLCFLARRKYKANEKWWISLTIAISAALTFIPLLSYLCYLIYGKIKTKVERIMNQKKL 472
K+ EK W+ + +A I LL + CYL++ K K + + +++ L
Sbjct: 389 ------------KSEEKKWVWWLVIAAAGSLIITLLLFSCYLLWRKFK-EAKTDTDKEML 435
Query: 473 LRELGENLSLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPV 532
L ELG D N H + L+ F F+T+++ATNNF++ NKLG+GG+GPV
Sbjct: 436 LHELGM---------DANYTPNTHEKSSHELQFFKFETVASATNNFASTNKLGQGGYGPV 486
Query: 533 YKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT----------------- 575
YKG+L +GQEVA+KRLS S QG VEF NE K+IAKLQH NL
Sbjct: 487 YKGKLPDGQEVAMKRLSTNSRQGSVEFGNEIKVIAKLQHNNLVRLVGCCIEKEEKILIYE 546
Query: 576 ------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623
D N L+W RF+IIEGI QGLLYLHKYSRL++IHRDLKA NILLD
Sbjct: 547 YMPNKSLDLFLFDPIDKNVLDWRKRFNIIEGIIQGLLYLHKYSRLKIIHRDLKAGNILLD 606
Query: 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLE 683
+MNPKISDFGMARIFG +++ NTN VVGTYGYMSPEYAM G+ S K+DVFSFGVL+LE
Sbjct: 607 SKMNPKISDFGMARIFGSEETKANTNTVVGTYGYMSPEYAMEGIFSTKSDVFSFGVLLLE 666
Query: 684 IVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCV 743
IVSGKKNN +D PL+LI YAW LW E +VLEL D + G EVLRCIH+GLLCV
Sbjct: 667 IVSGKKNNSFQYSDGPLSLIAYAWNLWIEERVLELTDPII-GDPDQTEVLRCIHIGLLCV 725
Query: 744 QDQATDRPAMPDVVSMLANESLSLPAPKQPAFFINITAEEPPVSESNAECCSIN 797
Q+ DRP+M DV SM+ NE+ LP+P QPAF+ + + E +C S N
Sbjct: 726 QENPMDRPSMLDVTSMIYNEANQLPSPNQPAFYYRKNFQYTEILEQKQDCLSQN 779
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482600|ref|XP_003632790.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase CES101-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 636 bits (1641), Expect = e-179, Method: Compositional matrix adjust.
Identities = 391/847 (46%), Positives = 489/847 (57%), Gaps = 118/847 (13%)
Query: 1 MGIKQRIDLLISFSFFVLLTGPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSG 60
M +K RI + +FS F L CYS DTLL G+ L+D + LVSA F +GFF+ SS
Sbjct: 1 MAVKGRILIPFTFSCFFLFLSTCYSTRDTLLQGKPLRDWERLVSANYAFTLGFFTQGSSD 60
Query: 61 DRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRK 120
+RYLGIWY S ++ + VWVANRN P+ D SG+L ID LKI
Sbjct: 61 NRYLGIWY-------------TSFEVRR-VWVANRNDPVPDTSGNLMID-HAWKLKITYN 105
Query: 121 GGNSIVVSSVQAMGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGL 180
GG V + Q NTSA L + GNF+L E G+ R LWQSFDYPTD LLPGMKLG+
Sbjct: 106 GGFIAVSNYSQIASNTSAILQDNGNFILREHMSDGTT-RVLWQSFDYPTDTLLPGMKLGI 164
Query: 181 NLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGL-------FPH 233
NL+TGH+W L SW + PA G F+ D ++QLI RG++ WT G F +
Sbjct: 165 NLRTGHQWSLTSWLTNQIPATGYFSFGADFRNNSQLITWWRGKIYWTSGFWHNGNLSFDN 224
Query: 234 WRAVDLDSD-----FHFSYTSNEKERYFNYSLNGNFTSFPTLQIDSKGSLTVTGALPISC 288
RA D + F Y SN+KE YF++ N + FP L + G L + C
Sbjct: 225 LRASLPQKDHWNDGYGFRYMSNKKEMYFSFHPNES-VFFPMLVLLPSGVLKSLLRTYVHC 283
Query: 289 PGS---EGCVR--LSSCKGYFLDDFELNWARKRGFMSVDGFKFKGSNNMSRDDCATKCLS 343
+GCV+ L C+ F+ G++ +GF F +N + DC +C +
Sbjct: 284 ESHIERQGCVKPDLPKCRNPASQRFQYT---DGGYVVSEGFMF--DDNATSVDCHFRCWN 338
Query: 344 NCSCIAFAITNKNNNTACEIWSRGSKFIEDNNNTDARYISVWEPKGIEEKKCWLCLIIPL 403
NCSC+AF++ T C IWSR R V E + I
Sbjct: 339 NCSCVAFSLHLAE--TRCVIWSR----------IQPRKYFVGESQQI------------- 373
Query: 404 AVALPVGILSCSLCFLARRKYKANEKWWISLTIAISAALTFIPLLSYLCYLIYGKIKTKV 463
++ + A + WWI L A A+ I L S LC L + K+K +
Sbjct: 374 --------------YVLQTDKAARKMWWIWLVTAAGGAV-IILLASSLCCLGWKKLKLQE 418
Query: 464 ERIMNQKKLLRELGENLSLPSTNGDGKRK---GNDHNSMKYGLEIFDFQTISAATNNFSA 520
E Q++LL ELG ++ P T + K+ G N L++F FQ+++AATNNFS
Sbjct: 419 EN-KRQQELLFELGA-ITKPFTKHNSKKHEKVGKKTNE----LQLFSFQSLAAATNNFSI 472
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT----- 575
NKLGEGGFGPVYKG+LL+GQE+AIKRLS+ S QG+VEFKNE LIAKLQH NL
Sbjct: 473 ENKLGEGGFGPVYKGKLLDGQEIAIKRLSKSSRQGLVEFKNEIALIAKLQHDNLVKLLGC 532
Query: 576 ------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
D + N LNW+ R++IIEGI QGLLYLHK+SRLRVI
Sbjct: 533 CIKEEEKILIYEYLPNKSLDFFIFDPSKKNLLNWKKRYNIIEGITQGLLYLHKFSRLRVI 592
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIK 671
HRDLKASNILLD++MNPKISDFGMARIFG ++ E NTNRVVGTYGYMSPEY M G+ S K
Sbjct: 593 HRDLKASNILLDNEMNPKISDFGMARIFGQDECEANTNRVVGTYGYMSPEYVMQGIFSTK 652
Query: 672 TDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL-EGSFSPN 730
+DVFSFGVL+LEIVS KKN+ Y + PLNLIGYAW+LW EGK LEL+D L +G S N
Sbjct: 653 SDVFSFGVLLLEIVSSKKNHSNYHYERPLNLIGYAWELWKEGKELELMDQTLCDGPSSNN 712
Query: 731 EVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPAFFINITAEEPPVSESN 790
V RCIHVGLLCVQ+ DRP M DVV MLANES+ L PKQPAFFI +E + + N
Sbjct: 713 VVKRCIHVGLLCVQENPKDRPTMSDVVLMLANESMQLSIPKQPAFFIRGIEQELEIPKRN 772
Query: 791 AECCSIN 797
+E CS+N
Sbjct: 773 SENCSLN 779
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233263|ref|NP_188224.1| lectin receptor kinase CES101 [Arabidopsis thaliana] gi|313118276|sp|Q9LW83.2|CE101_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase CES101; AltName: Full=Protein CALLUS EXPRESSION OF RBCS 101; Flags: Precursor gi|332642243|gb|AEE75764.1| lectin receptor kinase CES101 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1504), Expect = e-163, Method: Compositional matrix adjust.
Identities = 370/861 (42%), Positives = 495/861 (57%), Gaps = 126/861 (14%)
Query: 9 LLISFSFFVLLTGPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWY 68
L F+F++ L C QTDTLL GQ LKDG ELVSAF F++ FF++ +S + YLGIWY
Sbjct: 7 FLTLFTFYLFLGQSC-CQTDTLLQGQYLKDGQELVSAFNIFKLKFFNFENSSNWYLGIWY 65
Query: 69 HRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVS 128
+ + ++ VW+ANRN P+ +SGSLT+DS G L+ILR + + +S
Sbjct: 66 N-------------NFYLSGAVWIANRNNPVLGRSGSLTVDSL-GRLRILRGASSLLELS 111
Query: 129 SVQAMGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEW 188
S + GNT+ L ++GN L EM+ GSM+R LWQSFDYPTD LLPGMKLG N++TG W
Sbjct: 112 STETTGNTTLKLLDSGNLQLQEMDSDGSMKRTLWQSFDYPTDTLLPGMKLGFNVKTGKRW 171
Query: 189 FLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLF--PHWRAVDLDSD-FHF 245
L SW + PA G F +D N++N+L I G V W GL+ + L+++ F F
Sbjct: 172 ELTSWLGDTLPASGSFVFGMDDNITNRLTILWLGNVYWASGLWFKGGFSLEKLNTNGFIF 231
Query: 246 SYTSNEKERYFNYSLNGNFTS--FPTLQIDSKGSL----------------TVTGA-LPI 286
S+ S E E YF YS + N+ FP ++ID +GSL +V G L
Sbjct: 232 SFVSTESEHYFMYSGDENYGGPLFPRIRIDQQGSLQKINLDGVKKHVHCSPSVFGEELEY 291
Query: 287 SC----------------PGSEGCVRLSSCKGYFLDDFELNWARKRGFM--------SVD 322
C GS C Y ++L++ + G+ + +
Sbjct: 292 GCYQQNFRNCVPARYKEVTGSWDCSPFGFGYTYTRKTYDLSYCSRFGYTFRETVSPSAEN 351
Query: 323 GFKFKG-SNNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRGSKFIEDNNNTDARY 381
GF F +S DC KCL NCSC+A+A TN + T CEIW+ E++ + R
Sbjct: 352 GFVFNEIGRRLSSYDCYVKCLQNCSCVAYASTN-GDGTGCEIWNTDPT-NENSASHHPRT 409
Query: 382 ISVWEPKGIEEKKCWLCLIIPLAVALPVGILSCSLCFLARRKYKANEKWWISLTIAISAA 441
I + KG + WL ++ L + +PV L + +L RK+K I T +S +
Sbjct: 410 IYI-RIKGSKLAATWLVVVASLFLIIPVTWL---IIYLVLRKFK------IKGTNFVSES 459
Query: 442 LTFIPLLSYLCYLIYGKIKT-KVERIMNQKKLLRELGENLSLPSTNGDGKRKGNDHNSMK 500
L I S C L ++ T +V ++Q+ LL ELG + + N++N
Sbjct: 460 LKMIS--SQSCSLTNKRLSTLRVGSTIDQEMLLLELG----IERRRRGKRSARNNNNE-- 511
Query: 501 YGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFK 560
L+IF F++++ AT+ FS NKLGEGGFGPVYKG+L++G+EVAIKRLS SGQG+VEFK
Sbjct: 512 --LQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFK 569
Query: 561 NEAKLIAKLQHTNLT-----------------------------DSRRNNRLNWETRFSI 591
NEA LIAKLQHTNL D R L+W+ RF I
Sbjct: 570 NEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRI 629
Query: 592 IEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651
+EGI QGLLYLHKYSRL+VIHRD+KA NILLD+ MNPKISDFGMARIFG +S+ NT RV
Sbjct: 630 MEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRV 689
Query: 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR-TDHPLNLIGYAWQLW 710
GT+GYMSPEY G+ S K+DVFSFGVL+LEI+ G+KNN + ++ PLNLI + W L+
Sbjct: 690 AGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLF 749
Query: 711 NEGKVLELVDIALEGSFSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVSML---ANESLS 766
E +V E++D +L S N +VLRC+ V LLCVQ A DRP+M DVVSM+ N +LS
Sbjct: 750 KENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALS 809
Query: 767 LPAPKQPAFFINITAEEPPVS 787
L PK+PAF+ + PP S
Sbjct: 810 L--PKEPAFY-----DGPPRS 823
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|322510097|sp|O64793.3|Y1675_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520; Flags: Precursor | Back alignment and taxonomy information |
|---|
Score = 579 bits (1493), Expect = e-162, Method: Compositional matrix adjust.
Identities = 349/803 (43%), Positives = 477/803 (59%), Gaps = 81/803 (10%)
Query: 21 GPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWS 80
G S+TDTL GQ LKDG ELVSAF F++ FF++ +S + YLGIW++ +DS
Sbjct: 18 GKSCSETDTLHQGQFLKDGQELVSAFKIFKLKFFNFKNSENLYLGIWFNNLYLNTDSQ-- 75
Query: 81 YGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGNTSAAL 140
++PVW+ANRN PI+D+SGSLT+DS G LKILR + +SS++ NT+ L
Sbjct: 76 ------DRPVWIANRNNPISDRSGSLTVDSL-GRLKILRGASTMLELSSIETTRNTTLQL 128
Query: 141 YETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPA 200
++GN L EM+ GSM+R LWQSFDYPTD LLPGMKLG + +T W L SW + PA
Sbjct: 129 LDSGNLQLQEMDADGSMKRVLWQSFDYPTDTLLPGMKLGFDGKTRKRWELTSWLGDTLPA 188
Query: 201 EGEFTLNIDPNVSNQLIIQRRGEVLWTCGLFPHWRAVDLDSD---FHFSYTSNEKERYFN 257
G F +D N++N L I RG + W+ GL+ R + + + F FS+ S + +YF
Sbjct: 189 SGSFVFGMDTNITNVLTILWRGNMYWSSGLWNKGRFSEEELNECGFLFSFVSTKSGQYFM 248
Query: 258 YSLNGN--FTSFPTLQIDSKGSL---TVTGALPISCPGSEGCVRLSSCKGYFLDDFELNW 312
YS + + T FPT+ ID +G L + + C+ GY + D +
Sbjct: 249 YSGDQDDARTFFPTIMIDEQGILRREQMHRQRNRQNYRNRNCL----AAGYVVRDEPYGF 304
Query: 313 ARKRGFMSV---DGFKFKGSNNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRGSK 369
R +S +GF G+ S DC+ CL N SC+A+A T + + T CEIW+
Sbjct: 305 TSFRVTVSSSASNGFVLSGT--FSSVDCSAICLQNSSCLAYAST-EPDGTGCEIWNT--- 358
Query: 370 FIEDNNNTDARYISVWEPKGIEEKK--CWLCLIIPLAVALPVGILSCSLCFLARRKYKAN 427
N + + +G E KK W ++ L + P+ + +L RK+
Sbjct: 359 -YPTNKGSASHSPRTIYIRGNENKKVAAWHIVVATLFLMTPIIWF---IIYLVLRKFNVK 414
Query: 428 EKWWISLTIAISAALTFIPLLSYLCYLIYGKIKTKVERIMNQKKLLRELGENLSLPSTNG 487
+ I +T + ++ + LL+ + ++ + + ++Q+ LLRELG + S +
Sbjct: 415 GRNCIRITHK-TVLVSMVFLLTMIGFIRRRILSLRFGSTIDQEMLLRELGIDRS--CIHK 471
Query: 488 DGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKR 547
+RK N+ L+IF F+++ +AT++FS NKLGEGGFGPVYKG+LLNG+EVAIKR
Sbjct: 472 RNERKSNNE------LQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKR 525
Query: 548 LSRRSGQGIVEFKNEAKLIAKLQHTNLT-----------------------------DSR 578
LS SGQG+VEFKNEA LIAKLQHTNL D
Sbjct: 526 LSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPL 585
Query: 579 RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638
R N L+W RF I+EGI QGLLYLHKYSRL+VIHRD+KASNILLD+ MNPKISDFG+ARI
Sbjct: 586 RKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARI 645
Query: 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR-TD 697
FG ++ NT RV GT+GYMSPEY G+ S K+DVFSFGVL+LEI+ G+KNN + +
Sbjct: 646 FGAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLE 705
Query: 698 HPLNLIGYAWQLWNEGKVLELVDIALEGS-FSPNEVLRCIHVGLLCVQDQATDRPAMPDV 756
PLNLI + W L+ E K+ E++D++L S +VLRC+ V LLCVQ+ A DRP+M DV
Sbjct: 706 GPLNLIVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDV 765
Query: 757 VSML---ANESLSLPAPKQPAFF 776
VSM+ N +LSL PK+PAF+
Sbjct: 766 VSMIYGEGNNALSL--PKEPAFY 786
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|12324679|gb|AAG52302.1|AC011020_9 putative receptor protein kinase [Arabidopsis thaliana] gi|3176659|gb|AAC18783.1| Strong similarity to receptor kinase gb|M80238 from A. thaliana [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 355/823 (43%), Positives = 482/823 (58%), Gaps = 106/823 (12%)
Query: 21 GPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWS 80
G S+TDTL GQ LKDG ELVSAF F++ FF++ +S + YLGIW++ +DS
Sbjct: 18 GKSCSETDTLHQGQFLKDGQELVSAFKIFKLKFFNFKNSENLYLGIWFNNLYLNTDSQ-- 75
Query: 81 YGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGNTSAAL 140
++PVW+ANRN PI+D+SGSLT+DS G LKILR + +SS++ NT+ L
Sbjct: 76 ------DRPVWIANRNNPISDRSGSLTVDSL-GRLKILRGASTMLELSSIETTRNTTLQL 128
Query: 141 YETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPA 200
++GN L EM+ GSM+R LWQSFDYPTD LLPGMKLG + +T W L SW + PA
Sbjct: 129 LDSGNLQLQEMDADGSMKRVLWQSFDYPTDTLLPGMKLGFDGKTRKRWELTSWLGDTLPA 188
Query: 201 EGEFTLNIDPNVSNQLIIQRRGEVLWTCGLFPHWRAVDLDSD---FHFSYTSNEKERYFN 257
G F +D N++N L I RG + W+ GL+ R + + + F FS+ S + +YF
Sbjct: 189 SGSFVFGMDTNITNVLTILWRGNMYWSSGLWNKGRFSEEELNECGFLFSFVSTKSGQYFM 248
Query: 258 YSLNGN--FTSFPTLQIDSKGSL---TVTGALPISCPGSEGCVRLSSCKGYFLDDFELNW 312
YS + + T FPT+ ID +G L + + C+ GY + D +
Sbjct: 249 YSGDQDDARTFFPTIMIDEQGILRREQMHRQRNRQNYRNRNCL----AAGYVVRDEPYGF 304
Query: 313 ARKRGFMSV---DGFKFKGSNNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWS---- 365
R +S +GF G+ S DC+ CL N SC+A+A T + + T CEIW+
Sbjct: 305 TSFRVTVSSSASNGFVLSGT--FSSVDCSAICLQNSSCLAYAST-EPDGTGCEIWNTYPT 361
Query: 366 -RGSKFIEDNNNTDARYISVWEPKGIEEKK--CWLCLIIPLAVALPVGILSCSLCFLARR 422
+GS + R I + G E KK W ++ L + P+ + +L R
Sbjct: 362 NKGSA------SHSPRTIYI-RGNGQENKKVAAWHIVVATLFLMTPIIWF---IIYLVLR 411
Query: 423 KYKANEKWWISLT---IAISAALTFIPLLSYLCYLI------------YGKIKTKVERIM 467
K+ + I +T + +S S+ ++I YG+ + + ++
Sbjct: 412 KFNVKGRNCIRITHKTVLVSMVFLLTSSPSFFLFMIQDVFYFVEYTTFYGE--SSLLKV- 468
Query: 468 NQKKLLRELGENLSLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEG 527
+Q+ LLRELG + S + +RK N+ L+IF F+++ +AT++FS NKLGEG
Sbjct: 469 HQEMLLRELGIDRS--CIHKRNERKSNNE------LQIFSFESVVSATDDFSDENKLGEG 520
Query: 528 GFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT------------ 575
GFGPVYKG+LLNG+EVAIKRLS SGQG+VEFKNEA LIAKLQHTNL
Sbjct: 521 GFGPVYKGKLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEK 580
Query: 576 -----------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKAS 618
D R N L+W RF I+EGI QGLLYLHKYSRL+VIHRD+KAS
Sbjct: 581 MLIYEYMQNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAS 640
Query: 619 NILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFG 678
NILLD+ MNPKISDFG+ARIFG ++ NT RV GT+GYMSPEY G+ S K+DVFSFG
Sbjct: 641 NILLDEDMNPKISDFGLARIFGAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFG 700
Query: 679 VLVLEIVSGKKNNGCYR-TDHPLNLIGYAWQLWNEGKVLELVDIALEGS-FSPNEVLRCI 736
VL+LEI+ G+KNN + + PLNLI + W L+ E K+ E++D++L S +VLRC+
Sbjct: 701 VLMLEIICGRKNNSFHHDLEGPLNLIVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCV 760
Query: 737 HVGLLCVQDQATDRPAMPDVVSML---ANESLSLPAPKQPAFF 776
V LLCVQ+ A DRP+M DVVSM+ N +LSL PK+PAF+
Sbjct: 761 QVALLCVQENAEDRPSMLDVVSMIYGEGNNALSL--PKEPAFY 801
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|397134748|gb|AFO11039.1| S domain subfamily 1 receptor-like kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1462), Expect = e-158, Method: Compositional matrix adjust.
Identities = 372/873 (42%), Positives = 493/873 (56%), Gaps = 136/873 (15%)
Query: 9 LLISFSFFVLLTGPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDR-YLGIW 67
L F+ +LL C + TDTL GQ LKDG+EL S F F++ FF+ +S + YLGIW
Sbjct: 7 FLTIFTLSLLLGQSCCA-TDTLQQGQYLKDGEELNSPFNIFKLKFFNLKNSSNWWYLGIW 65
Query: 68 YHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVV 127
Y+ H S ++ VW+ANR+ PI+ +SGSLT+DS G LKILR + + +
Sbjct: 66 YNSLY----LHNSNNYDSEDRAVWIANRDNPISGRSGSLTVDSL-GRLKILRGSSSLLDL 120
Query: 128 SSVQAMGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHE 187
SS + GNT L ++GN L EM+ GSM+R LWQSFDYPTD LLPGMKLG N++TG
Sbjct: 121 SSTETTGNTILKLLDSGNLQLQEMDSGGSMKRILWQSFDYPTDTLLPGMKLGFNVETGKR 180
Query: 188 WFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLFPHWRAVDLDSD----- 242
W L SW + SPA G F +D NV+N+L I RG + W GL W D
Sbjct: 181 WELTSWLGDTSPASGSFVFGMDANVTNRLTILWRGNLFWASGL---WFKGQFLMDEVYNK 237
Query: 243 --FHFSYTSNEKERYFNYSLNGNF--TSFPTLQIDSKGSLTVTGAL-----PISCP---G 290
F S+ S + E+YF YS + N+ T FP ++ID G+L T L + C G
Sbjct: 238 LGFGVSFVSTKSEQYFIYSGDQNYGGTLFPRIRIDQHGTLQTTIDLNSVKRHVRCSPVFG 297
Query: 291 SE---GCVRLSS--CKGYFLDDFELN---------WARKRGFMSV------DGFKFKGSN 330
E GC +S C D + N W+ F +GF ++
Sbjct: 298 GELDYGCYLKNSMNCVHKVYGDVDKNGNCPQHRNCWSFDDNFRDTVFPSLGNGFIISETD 357
Query: 331 -NMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWS-------RGSKFIEDNNNTDARYI 382
+S DC KCL NCSC+A+A T + + + CEIW+ GS F + R
Sbjct: 358 GRLSSYDCYVKCLQNCSCLAYAST-RADGSGCEIWNTDPTTTNNGSSF-HTPRTVNVRVK 415
Query: 383 SVWEPKGI---EEKKCWLCLIIPLAVALPVGILSCSLCFLARRKYKANEKWWISLTIAIS 439
W KG E+ WL ++ L + +P L+C + +L RK+K + +T+
Sbjct: 416 DFWY-KGDHYNEKAATWLVVVASLFLIIP---LTCLIMYLVLRKFK------LKVTVIFH 465
Query: 440 AALTF-----IPLLSY----LCYLIYGKI-------------KTKVERIMNQKKLLRELG 477
F IP ++ + Y ++GK+ +V ++Q+ LLRELG
Sbjct: 466 EMFYFLRGKVIPQMAVIFRGMFYFLWGKVIPQMIGCIRRRLSTQRVGSTIDQEMLLRELG 525
Query: 478 ENLSLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQL 537
+ + N++N L+IF F+T++ AT+ FS VNKLGEGGFGPVYKG+L
Sbjct: 526 ----IDRRRRGKRSARNNNNE----LQIFSFETVAFATDYFSDVNKLGEGGFGPVYKGRL 577
Query: 538 LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT---------------------- 575
++G+EVAIKRLS SGQG+VEFKNEA LIAKLQHTNL
Sbjct: 578 IDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVMLLGCCVEKEEKMLIYEYMSNK 637
Query: 576 -------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628
D R N L+W RF I+EGI QGLLYLHKYSRL+VIHRD+KASNILLD+ MNP
Sbjct: 638 SLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNP 697
Query: 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
KISDFGMARIFG +S+ NT RV GT+GYMSPEY G+ S K+DVFSFGVL+LEI+ G+
Sbjct: 698 KISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGR 757
Query: 689 KNNGCYR-TDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN-EVLRCIHVGLLCVQDQ 746
KNN + ++ PLNLI + W L+ E ++ E++D +L S N +VLRC+ V LLCVQ
Sbjct: 758 KNNSFHHDSEGPLNLIVHVWNLFKEDRIHEVIDPSLGDSAVENPQVLRCVQVALLCVQQN 817
Query: 747 ATDRPAMPDVVSML---ANESLSLPAPKQPAFF 776
A DRP+M DVVSM+ N +LSL PK+PAF+
Sbjct: 818 ADDRPSMLDVVSMIYGDGNNALSL--PKEPAFY 848
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9294449|dbj|BAB02668.1| receptor kinase 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1444), Expect = e-156, Method: Compositional matrix adjust.
Identities = 360/860 (41%), Positives = 472/860 (54%), Gaps = 169/860 (19%)
Query: 9 LLISFSFFVLLTGPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWY 68
L F+F++ L C QTDTLL GQ LKDG ELVSAF F++ FF++ +S + YLGIWY
Sbjct: 7 FLTLFTFYLFLGQSC-CQTDTLLQGQYLKDGQELVSAFNIFKLKFFNFENSSNWYLGIWY 65
Query: 69 HRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVS 128
+ S + YG K ++ VW+ANRN P+ +SGSLT+DS G L+ILR + + +S
Sbjct: 66 NNFY-LSGGNKKYGDIK-DKAVWIANRNNPVLGRSGSLTVDSL-GRLRILRGASSLLELS 122
Query: 129 SVQAMGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEW 188
S + GNT+ L ++GN L EM+ GSM+R LWQSFDYPTD LLPGMKLG N++TG W
Sbjct: 123 STETTGNTTLKLLDSGNLQLQEMDSDGSMKRTLWQSFDYPTDTLLPGMKLGFNVKTGKRW 182
Query: 189 FLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLF--PHWRAVDLDSD-FHF 245
L SW + PA G F +D N++N+L I G V W GL+ + L+++ F F
Sbjct: 183 ELTSWLGDTLPASGSFVFGMDDNITNRLTILWLGNVYWASGLWFKGGFSLEKLNTNGFIF 242
Query: 246 SYTSNEKERYFNYSLNGNFTS--FPTLQIDSKGSL----------------TVTGA-LPI 286
S+ S E E YF YS + N+ FP ++ID +GSL +V G L
Sbjct: 243 SFVSTESEHYFMYSGDENYGGPLFPRIRIDQQGSLQKINLDGVKKHVHCSPSVFGEELEY 302
Query: 287 SC----------------PGSEGCVRLSSCKGYFLDDFELNWARKRGFM--------SVD 322
C GS C Y ++L++ + G+ + +
Sbjct: 303 GCYQQNFRNCVPARYKEVTGSWDCSPFGFGYTYTRKTYDLSYCSRFGYTFRETVSPSAEN 362
Query: 323 GFKFKG-SNNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRGSKFIEDNNNTDARY 381
GF F +S DC KCL NCSC+A+A TN G + D N
Sbjct: 363 GFVFNEIGRRLSSYDCYVKCLQNCSCVAYASTN------------GDGVVVDQGN----- 405
Query: 382 ISVWEPKGIEEKKCWLCLIIPLAVALPVGILSCSLCFLARRKYKANEKWWISLTIAISAA 441
E+ WL ++ L + +PV W I
Sbjct: 406 ---------EKAATWLVVVASLFLIIPV-------------------TWLI--------- 428
Query: 442 LTFIPLLSYLCYLIYGKIKTKVERIMNQKKLLRELGENLSLPSTNGDGKRKGNDHNSMKY 501
YL+ K K K +Q+ LL ELG + + N++N
Sbjct: 429 ----------IYLVLRKFKIK-----DQEMLLLELG----IERRRRGKRSARNNNNE--- 466
Query: 502 GLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKN 561
L+IF F++++ AT+ FS NKLGEGGFGPVYKG+L++G+EVAIKRLS SGQG+VEFKN
Sbjct: 467 -LQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKN 525
Query: 562 EAKLIAKLQHTNLT-----------------------------DSRRNNRLNWETRFSII 592
EA LIAKLQHTNL D R L+W+ RF I+
Sbjct: 526 EAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIM 585
Query: 593 EGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVV 652
EGI QGLLYLHKYSRL+VIHRD+KA NILLD+ MNPKISDFGMARIFG +S+ NT RV
Sbjct: 586 EGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVA 645
Query: 653 GTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR-TDHPLNLIGYAWQLWN 711
GT+GYMSPEY G+ S K+DVFSFGVL+LEI+ G+KNN + ++ PLNLI + W L+
Sbjct: 646 GTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFK 705
Query: 712 EGKVLELVDIALEGSFSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVSML---ANESLSL 767
E +V E++D +L S N +VLRC+ V LLCVQ A DRP+M DVVSM+ N +LSL
Sbjct: 706 ENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSL 765
Query: 768 PAPKQPAFFINITAEEPPVS 787
PK+PAF+ + PP S
Sbjct: 766 --PKEPAFY-----DGPPRS 778
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|397134747|gb|AFO11038.1| S domain subfamily receptor-like kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1442), Expect = e-156, Method: Compositional matrix adjust.
Identities = 357/842 (42%), Positives = 474/842 (56%), Gaps = 126/842 (14%)
Query: 21 GPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWS 80
G +TDTLL GQ LKDG ELVS F F++ FF++ +S + YLGIWY+ S +
Sbjct: 18 GQSCCETDTLLQGQYLKDGQELVSTFNIFKVKFFNFENSSNWYLGIWYNNFY-LSGGNKK 76
Query: 81 YGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGNTSAAL 140
YG K ++ VW+ANRN P+ +SGSLT+DS G L+ILR + + +SS + GNT+ L
Sbjct: 77 YGDIK-DKAVWIANRNNPVLGRSGSLTVDSL-GRLRILRGASSLLELSSTETTGNTTLKL 134
Query: 141 YETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPA 200
++GN L EM+ GSM R LWQSFDYPTD LLPGMKLG N++ G W L SW + PA
Sbjct: 135 LDSGNLQLQEMDSDGSMMRILWQSFDYPTDTLLPGMKLGFNVKNGKRWELTSWLGDTLPA 194
Query: 201 EGEFTLNIDPNVSNQLIIQRRGEVLWTCGL-FPHWRAVDL--DSDFHFSYTSNEKERYFN 257
G +D N++N+L I RG + W GL F +++ D F FS+ S E E YF
Sbjct: 195 SGSLVFGMDANITNRLTILWRGNMYWASGLWFKGGFSLEELNDYGFLFSFISTESEHYFM 254
Query: 258 YSLNGNF--TSFPTLQIDSKGSLTVTGALPISCPGSEGCVRLS------SCKGYFLD-DF 308
YS + + T FP + ID +G L + RL C + LD D
Sbjct: 255 YSGDQKYAGTFFPAIMIDQQGILRI--------------YRLDRERLYVHCSPFTLDEDS 300
Query: 309 ELNWARK--------------RGFMSVDGFKF----------------KGSNNMSRDDCA 338
N R+ R S GF+F + S DC
Sbjct: 301 NFNCYRRNSRDCLHAGCIVPERQNESFYGFRFFRETVSAFSSNGFVLNETGGRFSSADCR 360
Query: 339 TKCLSNCSCIAFAITNKNNNTACEIWSRGSKFIEDNNNTDARYISVW-EPKGI------E 391
C+ N SC+A+A TN + T CEIW+ + D ++ +++ KG E
Sbjct: 361 AICMQNASCLAYASTNLDG-TGCEIWN---TYPTDKRSSPQSPRTIYIRVKGFVVNHENE 416
Query: 392 EKKCWLCLIIPLAVALPVGILSCSLCFLARRKYKANEKWWISLTIAISAALTFI--PLLS 449
+ WL ++ L + +PV + + +L RK+K + +TI F+ ++
Sbjct: 417 KAATWLVVVASLFLMIPV---TWFIIYLVLRKFK------VKVTIIFRGMFYFLWGKVIP 467
Query: 450 YLCYLIYGKIKT-KVERIMNQKKLLRELGENLSLPSTNGDGKRKGNDHNSMKYGLEIFDF 508
+ I ++ T +V ++Q+ LLRELG + RK N+ L+IF F
Sbjct: 468 QMIGFIRRRLPTLRVGSTIDQEMLLRELG--IDRRRRGKRSARKNNNE------LQIFSF 519
Query: 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK 568
++++ AT+ FS NKLGEGGFGPVYKG L++G+EVAIKRLS SGQG+VEFKNEA LIAK
Sbjct: 520 ESVALATDYFSDANKLGEGGFGPVYKGSLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAK 579
Query: 569 LQHTNLT-----------------------------DSRRNNRLNWETRFSIIEGIAQGL 599
LQHTNL D R N L+W RF I+EGI QGL
Sbjct: 580 LQHTNLVQLLGCCIEKDEKMLIYEYMPNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGL 639
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659
LYLHKYSRL+VIHRD+KASNILLD+ MNPKISDFGMARIFG +S+ NT RV GT+GYMS
Sbjct: 640 LYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGMARIFGAQESKANTKRVAGTFGYMS 699
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR-TDHPLNLIGYAWQLWNEGKVLEL 718
PEY G+ S K+DVFSFGVL+LEI+ G+KNN + ++ PLNLI + W L+ E V E+
Sbjct: 700 PEYFREGLFSTKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFKENHVREV 759
Query: 719 VDIALEGSFSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVSML---ANESLSLPAPKQPA 774
+D +L S N +VLRC+ V LLCVQ A DRP+M VVSM+ N +LSL PK+PA
Sbjct: 760 IDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLHVVSMIYGDGNNALSL--PKEPA 817
Query: 775 FF 776
F+
Sbjct: 818 FY 819
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225463860|ref|XP_002268342.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1413), Expect = e-153, Method: Compositional matrix adjust.
Identities = 352/822 (42%), Positives = 458/822 (55%), Gaps = 118/822 (14%)
Query: 25 SQTDTLLLGQLLKDGDEL-VSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGS 83
+QTDT+ G+ L+ ++L VSA G F +GFFS + SG YLGIWY TD D H
Sbjct: 30 AQTDTIKPGEELQFSEKLLVSAKGTFTLGFFS-LESGS-YLGIWY--TTD--DYH----- 78
Query: 84 PKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGNTSAALYET 143
+ VWVANR+ I+ +LT+D+ DG L I GG+ IV++S QA N++A L ++
Sbjct: 79 ----KKVWVANRDKAISGTDANLTLDA-DGKLMITHSGGDPIVLNSNQAARNSTATLLDS 133
Query: 144 GNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPAEGE 203
GNFVL E N GS++ +LW SFD PTD LLPGMKLG+NL+TG W L SW SE PA G
Sbjct: 134 GNFVLEEFNSDGSLKEKLWASFDNPTDTLLPGMKLGINLKTGRNWSLASWISEQVPAPGT 193
Query: 204 FTLNIDPNVSNQLIIQRRGEVLWTCG--------LFPHWRAVD-LDSDFHFSYTSNEKER 254
FTL + QL+++RRG W+ G P + D ++ + F+ SN E
Sbjct: 194 FTLEWN---GTQLVMKRRGGTYWSSGTLKDRSFEFIPWLMSSDTFNNIYSFNSVSNANEI 250
Query: 255 YFNYSLNGNFTSFPTLQIDSKGSLTVTGALPISCPGSEGCVRLSSCKGYFLDDFELNWAR 314
YF+YS+ S L S+G L T + P+ + C R G + + +R
Sbjct: 251 YFSYSVPEGVVSDWVLT--SEGGLFDT-SRPVFVLDDQ-CARYEEYPGCAVQNPPTCRSR 306
Query: 315 KRGFM------SVDGFKFKGSNNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWS-RG 367
K GFM S K +++ DC C ++CSC A+ + N T C WS +
Sbjct: 307 KDGFMKQSVLISGSPSSIKEKSSLGLRDCKALCWNDCSCTAYN-SLYTNGTGCRFWSTKF 365
Query: 368 SKFIEDNNNTDARYISVWEPKGIEEKKCWLCLIIPLAVALPVGILSCSLCFLARRKYKAN 427
++ ++D+ N + Y+ LS S
Sbjct: 366 AQALKDDANQEELYV-----------------------------LSSSRV--------TG 388
Query: 428 EKWWISLTIA--ISAALTFIPLLSYLCYLIYGKIKTKVERIMNQKKLLRELGENLSLPST 485
WWI + IA + L + +L L Y + K + ER M + LL L+ ++
Sbjct: 389 SSWWIWVIIAGVVLVVLLVLVVLLLTGSLYYSRRKFRGEREMEEAALLE-----LTTSNS 443
Query: 486 NGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAI 545
D K +D + L++F F +I AATNNFS+ NKLGEGGFG VYKG+L GQE+A+
Sbjct: 444 FSDSKDVEHDGKRGAHDLKLFSFDSIVAATNNFSSENKLGEGGFGQVYKGKLPEGQEIAV 503
Query: 546 KRLSRRSGQGIVEFKNEAKLIAKLQHTNLT-----------------------------D 576
KRLSR S QG+VEFKNE +LI KLQH NL D
Sbjct: 504 KRLSRGSSQGLVEFKNEIRLIVKLQHMNLVRLLGCCIKGEEKMLIYEFMPNKSLDFFLFD 563
Query: 577 SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636
R L+W+ R +IIEGIAQGLLYLHKYSRLR+IHRDLKASNILLD +NPKISDFGMA
Sbjct: 564 PARRKILDWKRRHNIIEGIAQGLLYLHKYSRLRIIHRDLKASNILLDHDLNPKISDFGMA 623
Query: 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRT 696
R FG N SE NTNR+VGTYGYM PEYAM G+ S+K+DV+SFGVL+LEIVSG+KN +
Sbjct: 624 RTFGRNASEANTNRIVGTYGYMPPEYAMEGIFSVKSDVYSFGVLLLEIVSGRKNKS-FHH 682
Query: 697 DH---PLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAM 753
+H +NL YAW LW EG LELVD LE S+S ++LRCIH+ LLCVQ+ A DRP M
Sbjct: 683 NHGAFAINLAVYAWDLWKEGTSLELVDPMLEDSYSTTQMLRCIHIALLCVQESAADRPTM 742
Query: 754 PDVVSMLANESLSLPAPKQPAFFINITAEEPPVSESNAECCS 795
V+SML NE++ LP P PAF + E + E CS
Sbjct: 743 SAVISMLTNETVPLPNPNLPAFSTHHKVSELDSHKGRPESCS 784
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1018 | ||||||
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.439 | 0.525 | 0.406 | 6e-133 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.207 | 0.258 | 0.576 | 3.9e-124 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.220 | 0.269 | 0.561 | 9.6e-123 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.196 | 0.255 | 0.589 | 5.9e-118 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.220 | 0.266 | 0.533 | 1.9e-110 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.200 | 0.240 | 0.583 | 1.3e-108 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.459 | 0.550 | 0.392 | 5.6e-105 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.478 | 0.574 | 0.379 | 1.3e-101 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.247 | 0.296 | 0.526 | 5.9e-101 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.219 | 0.277 | 0.511 | 2e-100 |
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 742 (266.3 bits), Expect = 6.0e-133, Sum P(2) = 6.0e-133
Identities = 204/502 (40%), Positives = 276/502 (54%)
Query: 322 DGFKFKG-SNNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRGSKFIEDNNNTDAR 380
+GF F +S DC KCL NCSC+A+A TN + T CEIW+ E++ + R
Sbjct: 351 NGFVFNEIGRRLSSYDCYVKCLQNCSCVAYASTN-GDGTGCEIWNTDPTN-ENSASHHPR 408
Query: 381 YISVWEPKGIEEKKCWLCLIIPLAVALPVGILSCSLCFLARRKYKANEKWWISLTIAISA 440
I + KG + WL ++ L + +PV L + +L RK+K I T +S
Sbjct: 409 TIYI-RIKGSKLAATWLVVVASLFLIIPVTWL---IIYLVLRKFK------IKGTNFVSE 458
Query: 441 ALTFIPLLSYLCYLIYGKIKT-KVERIMNQKKLLRELGENLSLPSTNGDGKRKGNDHNSM 499
+L I S C L ++ T +V ++Q+ LL ELG G + N++
Sbjct: 459 SLKMIS--SQSCSLTNKRLSTLRVGSTIDQEMLLLELGIERR---RRGKRSARNNNNELQ 513
Query: 500 KYGLEIFDFQT--ISAATN----NFSAVNK--LGEGGFGPVYKGQLLNGQE-VAIKR--- 547
+ E F T S A F V K L +G + + L +GQ V K
Sbjct: 514 IFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNEAM 573
Query: 548 -LSRRSGQGIVEF------KNEAKLIAKLQHTN-----LTDSRRNNRLNWETRFSIIEGI 595
+++ +V+ K+E LI + L D R L+W+ RF I+EGI
Sbjct: 574 LIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIMEGI 633
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY 655
QGLLYLHKYSRL+VIHRD+KA NILLD+ MNPKISDFGMARIFG +S+ NT RV GT+
Sbjct: 634 IQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAGTF 693
Query: 656 GYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR-TDHPLNLIGYAWQLWNEGK 714
GYMSPEY G+ S K+DVFSFGVL+LEI+ G+KNN + ++ PLNLI + W L+ E +
Sbjct: 694 GYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFKENR 753
Query: 715 VLELVDIALEGSFSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVSML---ANESLSLPAP 770
V E++D +L S N +VLRC+ V LLCVQ A DRP+M DVVSM+ N +LSLP
Sbjct: 754 VREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSLP-- 811
Query: 771 KQPAFFINITAEEPPVSESNAE 792
K+PAF+ + PP S E
Sbjct: 812 KEPAFY-----DGPPRSSPEME 828
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 635 (228.6 bits), Expect = 3.9e-124, Sum P(4) = 3.9e-124
Identities = 124/215 (57%), Positives = 158/215 (73%)
Query: 576 DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM 635
D RR+ L+W+ R +II G+A+G+LYLH+ SRLR+IHRDLKA N+LLD+ MNPKISDFG+
Sbjct: 587 DERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGL 646
Query: 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR 695
A+ FG +QSE++TNRVVGTYGYM PEYA+ G S+K+DVFSFGVLVLEI++GK N G
Sbjct: 647 AKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRH 706
Query: 696 TDHPLNLIGYAWQLWNEGKVLELVDIA-LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMP 754
DH LNL+G+ W++W E + +E+ + LE + EVLRCIHV LLCVQ + DRP M
Sbjct: 707 ADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMA 766
Query: 755 DVVSMLANESLSLPAPKQPAFFINITAEEPPVSES 789
VV M ++S SLP P QP FF N P +S S
Sbjct: 767 SVVLMFGSDS-SLPHPTQPGFFTNRNV--PDISSS 798
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 646 (232.5 bits), Expect = 9.6e-123, Sum P(4) = 9.6e-123
Identities = 127/226 (56%), Positives = 164/226 (72%)
Query: 574 LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633
L D + L+W+TRF+II+GI +GL+YLH+ SRL++IHRDLKASNILLD+ +NPKISDF
Sbjct: 597 LFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDF 656
Query: 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGC 693
G+ARIF N+ E +T RVVGTYGYM+PEYAM G+ S K+DVFS GV++LEIVSG++N+
Sbjct: 657 GLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSF 716
Query: 694 YRTDHPLNLIGYAWQLWNEGKVLELVD-IALEGSFSPNEVLRCIHVGLLCVQDQATDRPA 752
Y NL YAW+LWN G+ + LVD + E F NE+ RC+HVGLLCVQD A DRP+
Sbjct: 717 YNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFE-NEIRRCVHVGLLCVQDHANDRPS 775
Query: 753 MPDVVSMLANESLSLPAPKQPAFFINITAEEPPVSESNAECCSINN 798
+ V+ ML++E+ +LP PKQPAF E S + SINN
Sbjct: 776 VATVIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINN 821
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 601 (216.6 bits), Expect = 5.9e-118, Sum P(3) = 5.9e-118
Identities = 119/202 (58%), Positives = 149/202 (73%)
Query: 576 DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM 635
D R L+W R II+GIA+G+LYLH+ SRLR+IHRDLKASN+LLD MN KISDFG+
Sbjct: 552 DKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGL 611
Query: 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR 695
AR G +++E NT RVVGTYGYMSPEY + G S+K+DVFSFGVLVLEIVSG++N G
Sbjct: 612 ARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRN 671
Query: 696 TDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP-NEVLRCIHVGLLCVQDQATDRPAMP 754
+H LNL+G+AW+ + E K E++D A+ S + +EVLR IH+GLLCVQ DRP M
Sbjct: 672 EEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMS 731
Query: 755 DVVSMLANESLSLPAPKQPAFF 776
VV ML++E L L P+QP FF
Sbjct: 732 VVVLMLSSEMLLLD-PRQPGFF 752
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 629 (226.5 bits), Expect = 1.9e-110, Sum P(3) = 1.9e-110
Identities = 120/225 (53%), Positives = 158/225 (70%)
Query: 574 LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633
L D + L+W R+ +I GIA+GLLYLH+ SRL++IHRDLKASNILLD +MNPKISDF
Sbjct: 610 LFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDF 669
Query: 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGC 693
GMARIF Q NT RVVGTYGYM+PEYAM G+ S K+DV+SFGVL+LEIVSG+KN
Sbjct: 670 GMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSF 729
Query: 694 YRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAM 753
TDH +LIGYAW LW++GK E++D ++ + E +RCIHVG+LC QD RP M
Sbjct: 730 RGTDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNM 788
Query: 754 PDVVSMLANESLSLPAPKQPAFFINITAEEPPVSESNAECCSINN 798
V+ ML +++ LP P+QP F + + + ++ + S+N+
Sbjct: 789 GSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVASVND 833
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 643 (231.4 bits), Expect = 1.3e-108, Sum P(3) = 1.3e-108
Identities = 119/204 (58%), Positives = 154/204 (75%)
Query: 574 LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633
L + + L+W+ RF IIEGIA+GLLYLH+ SRLRV+HRDLKASNILLD M PKISDF
Sbjct: 615 LFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDF 674
Query: 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGC 693
GMAR+FG +Q++ NTNRVVGT+GYMSPEYAM G+ S+K+DV+ FGVL+LEI++GK+
Sbjct: 675 GMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSF 734
Query: 694 YRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAM 753
+ + LN+ GYAW+ WNE EL+D + S S +VLRCIH+ LLCVQD A +RP +
Sbjct: 735 HCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDI 794
Query: 754 PDVVSMLANESLSLPAPKQPAFFI 777
P V+ ML+N+S SLP P+ P +
Sbjct: 795 PTVILMLSNDSSSLPNPRPPTLML 818
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 5.6e-105, Sum P(3) = 5.6e-105
Identities = 196/499 (39%), Positives = 277/499 (55%)
Query: 290 GSEGCVR--LSSCKGYFLDDFELNWARKRGFMSVDGFKFKGSNNMSRDDCATKCLSNCSC 347
GS+GCVR L SC G D F R + D + +C KCL +C+C
Sbjct: 335 GSDGCVRKTLLSCGGG--DGF----VRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNC 388
Query: 348 IAFAITN-KNNNTACEIWSRGSKFIEDNNNTDARYISV-WEPKGIEEKKCWLCLIIPLAV 405
AFA T+ + + + C W+ G F N + + V +E+K+ II ++
Sbjct: 389 TAFANTDIRGSGSGCVTWT-GELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSSI 447
Query: 406 ALPVGIL-SCSLCFLARRKYKANEKWWISLTIAISAALTFIPLLSYLCYLIYGKIKTKVE 464
+ V +L S + FL +RK K + + T + L LL +I + E
Sbjct: 448 GVSVLLLLSFIIFFLWKRKQKRSI---LIETPIVDHQLRSRDLLMNEV-VISSRRHISRE 503
Query: 465 RIMNQKKL-LRELGENLSLPSTNGDGKRK-GNDHNSMKYGLEIFDFQTISAATNNFSAVN 522
+ +L L E E +++ + N K G + Y ++ D Q + A S +
Sbjct: 504 NNTDDLELPLMEF-EEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM--AVKRLSKTS 560
Query: 523 KLGEGGFGPVYKGQLLNGQEVAIKRLSR---RSGQGIVEFKNEAKLIAKLQHTNLTDSRR 579
G F K + Q + + RL +G+ ++ ++ L L ++L D R
Sbjct: 561 VQGTDEFKNEVK-LIARLQHINLVRLLACCVDAGEKMLIYEYLENL--SLD-SHLFDKSR 616
Query: 580 NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639
N++LNW+ RF II GIA+GLLYLH+ SR R+IHRDLKASNILLD M PKISDFGMARIF
Sbjct: 617 NSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIF 676
Query: 640 GLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP 699
G +++E NT +VVGTYGYMSPEYAM G+ S+K+DVFSFGVL+LEI+S K+N G Y +D
Sbjct: 677 GRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRD 736
Query: 700 LNLIGYAWQLWNEGKVLELVD-IALEGS--FSPNEVLRCIHVGLLCVQDQATDRPAMPDV 756
LNL+G W+ W EGK LE++D I + S F +E+LRCI +GLLCVQ++A DRP M V
Sbjct: 737 LNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLV 796
Query: 757 VSMLANESLSLPAPKQPAF 775
+ ML +ES ++P PK P +
Sbjct: 797 ILMLGSESTTIPQPKAPGY 815
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 755 (270.8 bits), Expect = 1.3e-101, Sum P(3) = 1.3e-101
Identities = 199/524 (37%), Positives = 287/524 (54%)
Query: 291 SEGCVRLS--SCKGYFLDDFELNWARKRGFMSVDGFKFKGSNNMSRDDCATKCLSNCSCI 348
S GCVR + SC G D F R + D + + +C +CL C+C
Sbjct: 334 SVGCVRKTKLSCDGR--DGF----VRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCT 387
Query: 349 AFAITN-KNNNTACEIWSRGSKFIEDNNNTDARYISVWEPKG-IEEKKCWLCLIIPLAVA 406
AFA T+ +N + C IWS G F N + + V G +E+K+ II ++
Sbjct: 388 AFANTDIRNGGSGCVIWS-GGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSIG 446
Query: 407 LPVGILSCSLCFLARRKYKANEKWWISL-TIAISAALTFIPLLSYLCYLIYGKIKTKVER 465
+ + +L L F+ +K +K I++ T + + L++ L + T E
Sbjct: 447 VSILLL---LSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKA--SRSYTSKEN 501
Query: 466 IMNQKKLLRELGENLSLPSTNGDGKRK-GNDHNSMKYGLEIFDFQTISAATNNFSAVNKL 524
+ +L + L++ + N K G + Y + D + I A S ++
Sbjct: 502 KTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEI--AVKRLSKMSSQ 559
Query: 525 GEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK-LQH----TNLTDSRR 579
G F + + Q + + RL G K E LI + L++ ++L D R
Sbjct: 560 GTDEFMNEVR-LIAKLQHINLVRLL-----GCCVDKGEKMLIYEYLENLSLDSHLFDQTR 613
Query: 580 NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639
++ LNW+ RF II GIA+GLLYLH+ SR R+IHRDLKASN+LLD M PKISDFGMARIF
Sbjct: 614 SSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIF 673
Query: 640 GLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP 699
G ++E NT RVVGTYGYMSPEYAM G+ S+K+DVFSFGVL+LEI+SGK+N G Y ++
Sbjct: 674 GREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRD 733
Query: 700 LNLIGYAWQLWNEGKVLELVDI----ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPD 755
LNL+G+ W+ W EGK LE+VD AL F +E+LRCI +GLLCVQ++A DRP M
Sbjct: 734 LNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSS 793
Query: 756 VVSMLANESLSLPAPKQPAFFINITAEEPPVSESNA--ECCSIN 797
V+ ML +E+ ++P PK+P F + ++ E S S + C++N
Sbjct: 794 VMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVN 837
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 5.9e-101, Sum P(3) = 5.9e-101
Identities = 139/264 (52%), Positives = 182/264 (68%)
Query: 520 AVNKL-GEGGFG-PVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN---- 573
AV +L G+ G G +K +++ ++ + L R G F+ E K++ N
Sbjct: 555 AVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLG---CCFEGEEKMLVYEYMPNKSLD 611
Query: 574 --LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS 631
L D + ++W+ RFSIIEGIA+GLLYLH+ SRLR+IHRDLK SN+LLD +MNPKIS
Sbjct: 612 FFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKIS 671
Query: 632 DFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNN 691
DFGMARIFG NQ+E NT RVVGTYGYMSPEYAM G+ S+K+DV+SFGVL+LEIVSGK+N
Sbjct: 672 DFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNT 731
Query: 692 GCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRP 751
++H +LIGYAW L+ G+ ELVD + + S E LRCIHV +LCVQD A +RP
Sbjct: 732 SLRSSEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERP 790
Query: 752 AMPDVVSMLANESLSLPAPKQPAF 775
M V+ ML +++ +L AP+QP F
Sbjct: 791 NMASVLLMLESDTATLAAPRQPTF 814
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 568 (205.0 bits), Expect = 2.0e-100, Sum P(4) = 2.0e-100
Identities = 115/225 (51%), Positives = 154/225 (68%)
Query: 583 LNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642
L+W RF+II+GIA+GLLYLH+ SRLRVIHRDLK SNILLDD+MNPKISDFG+AR+F
Sbjct: 582 LDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGT 641
Query: 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNL 702
Q + NT RVVGT GYMSPEYA +G+ S K+D++SFGVL+LEI+SGK+ + D L
Sbjct: 642 QYQDNTRRVVGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGL 701
Query: 703 IGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762
+ Y W W E L+D L + EV RC+ +GLLCVQ +A DRP V+SML +
Sbjct: 702 LAYTWDSWCETGGSNLLDRDLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTS 761
Query: 763 ESLSLPAPKQPAFFINITAEEPPVSESNAECCSINN-SDKLQQGQ 806
+ LP PKQP F ++ + P + ++ + S+N ++ + QG+
Sbjct: 762 AT-DLPVPKQPIFAVHTLNDMPMLQANSQDFLSVNEMTESMIQGR 805
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1018 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-27 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-22 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 4e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-19 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-08 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 6e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-08 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 9e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-07 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-05 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-04 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 64/196 (32%), Positives = 91/196 (46%), Gaps = 35/196 (17%)
Query: 523 KLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNL----- 574
KLG G FG VYK + G+ VA+K L +RS + + E +++ +L H N+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 575 ---TDS------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
R L+ + I I +GL YLH +IHR
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHR 122
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE-YAMSGVVSIKT 672
DLK NILLD+ KI+DFG+A+ + S T VGT YM+PE K
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPKV 180
Query: 673 DVFSFGVLVLEIVSGK 688
DV+S GV++ E+++GK
Sbjct: 181 DVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 62/192 (32%), Positives = 95/192 (49%), Gaps = 36/192 (18%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTN-------- 573
LGEGGFG VY + G++VAIK + + ++E E +++ KL H N
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 574 -----------------LTD--SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRD 614
L D +L+ + I+ I +GL YLH +IHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 615 LKASNILLD-DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGV-VSIKT 672
LK NILLD D K++DFG++++ ++S T +VGT YM+PE + S K+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 673 DVFSFGVLVLEI 684
D++S GV++ E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 68/201 (33%), Positives = 93/201 (46%), Gaps = 44/201 (21%)
Query: 523 KLGEGGFGPVYKGQLLNG-----QEVAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL-- 574
KLGEG FG VYKG L EVA+K L S Q I EF EA+++ KL H N+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 575 -----TDS---------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
T+ R L+ S IA+G+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYAMS 665
IHRDL A N L+ + + KISDFG++R + + + +V G +M+PE
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 666 GVVSIKTDVFSFGVLVLEIVS 686
G + K+DV+SFGVL+ EI +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 36/200 (18%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLT 575
+ + KLGEG FG VY + G+ VAIK + ++ + E E K++ KL+H N+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 576 ---DS-----------------------RRNNRLN-WETRFSIIEGIAQGLLYLHKYSRL 608
D ++ RL+ E RF + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-YLRQILSALEYLHS---K 116
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
++HRDLK NILLD+ + K++DFG+AR VGT YM+PE +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
D++S GV++ E+++GK
Sbjct: 174 GKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 70/200 (35%), Positives = 95/200 (47%), Gaps = 43/200 (21%)
Query: 523 KLGEGGFGPVYKGQLL-----NGQEVAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL-- 574
KLGEG FG VYKG+L EVA+K L S Q I EF EA+++ KL H N+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 575 -----TDSR------------------RNNR--LNWETRFSIIEGIAQGLLYLHKYSRLR 609
T+ R NR L+ S IA+G+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKN 122
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYAMSG 666
IHRDL A N L+ + + KISDFG++R + + + R G +M+PE G
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 667 VVSIKTDVFSFGVLVLEIVS 686
+ K+DV+SFGVL+ EI +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 45/206 (21%)
Query: 522 NKLGEGGFGPVYKGQLLNGQ----EVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTN--- 573
KLGEG FG VYKG+L EVA+K L S + +F EA+++ KL H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 574 --------------------------LTDSRRN------NRLNWETRFSIIEGIAQGLLY 601
L SR + L+ + S IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVGTYGYMSP 660
L + +HRDL A N L+ + + KISDFG++R ++ + T + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 661 EYAMSGVVSIKTDVFSFGVLVLEIVS 686
E G+ + K+DV+SFGVL+ EI +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 42/201 (20%)
Query: 523 KLGEGGFGPVYKGQLL-----NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNL-- 574
KLGEG FG VYKG L +VA+K L + + EF EA ++ KL H N+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 575 -----TDS--------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLR 609
T + +L + + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKN 122
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG---YMSPEYAMSG 666
+HRDL A N L+ + + KISDFG++R + + + R G +M+PE G
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKR-GGGKLPIKWMAPESLKDG 179
Query: 667 VVSIKTDVFSFGVLVLEIVSG 687
+ K+DV+SFGVL+ EI +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 34/199 (17%)
Query: 521 VNKLGEGGFGPVYKGQLL-NGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTNLT-- 575
LG G FG VY G+ +A+K LS S + + + E ++++ LQH N+
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 576 -DSRRNNRLNWETRF----------SIIEG---------------IAQGLLYLHKYSRLR 609
S R+ N F S+++ I +GL YLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNG 121
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVS 669
++HRD+K +NIL+D K++DFG A+ G ++ T V GT +M+PE
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 670 IKTDVFSFGVLVLEIVSGK 688
D++S G V+E+ +GK
Sbjct: 182 RAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 36/200 (18%)
Query: 518 FSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN--- 573
F + K+G+GGFG VYK G+EVAIK + S + + NE +++ K +H N
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 574 ----------------------LTD--SRRNNRLNWETRFS-IIEGIAQGLLYLHKYSRL 608
L D N L E++ + + + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLT-ESQIAYVCKELLKGLEYLHSN--- 117
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
+IHRD+KA+NILL K+ DFG++ N +VGT +M+PE
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
K D++S G+ +E+ GK
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 49/114 (42%), Positives = 61/114 (53%), Gaps = 10/114 (8%)
Query: 89 PVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAM--GNTSAALYETGNF 146
VWVANR P+TD S +L + S DGNL + G +V SS + A L + GN
Sbjct: 4 VVWVANRLNPLTDSSYTLILQS-DGNLVLYD-GNGRVVWSSNTSGKGSGCVAVLQDDGNL 61
Query: 147 VLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPA 200
VLY + + LWQSFD+PTD LLPG K G N+ G L SW S P+
Sbjct: 62 VLY-----DNSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 38/203 (18%)
Query: 517 NFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLS--RRSGQGIVEFKNEAKLIAKLQHTN 573
N+ + +G G FG VYKG L G VAIK++S + + + E L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 574 --------------------------LTDSRRNNRLNWETRFSI-IEGIAQGLLYLHKYS 606
++ E+ ++ + + QGL YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLVAVYVYQVLQGLAYLHEQG 119
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE-YAMS 665
VIHRD+KA+NIL K++DFG+A LN + VVGT +M+PE MS
Sbjct: 120 ---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
G S +D++S G V+E+++G
Sbjct: 175 G-ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 3e-23
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 50/212 (23%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKR--LSRRSGQGIVEFKNEAKLIAKLQHTN 573
+ + ++G+G FG VY + +G+ +K LS S + + NE K++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 574 LT------------------------DSRRNNRLNWETRFS---IIEGIAQ---GLLYLH 603
+ + + F I++ Q L YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE-- 661
SR +++HRD+K NI L K+ DFG++++ L+ + VVGT Y+SPE
Sbjct: 121 --SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC 175
Query: 662 ----YAMSGVVSIKTDVFSFGVLVLEIVSGKK 689
Y + K+D++S G ++ E+ + K
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 40/204 (19%)
Query: 515 TNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQH 571
+ + K+GEG G VYK G+EVAIK RL +++ + I+ NE ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKH 74
Query: 572 TN-------------------------LTDSRRNN--RLNWETRFS-IIEGIAQGLLYLH 603
N LTD N R+N E + + + + QGL YLH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMN-EPQIAYVCREVLQGLEYLH 133
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
VIHRD+K+ NILL + K++DFG A L + ++ N VVGT +M+PE
Sbjct: 134 S---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQ--LTKEKSKRNSVVGTPYWMAPEVI 188
Query: 664 MSGVVSIKTDVFSFGVLVLEIVSG 687
K D++S G++ +E+ G
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 38/214 (17%)
Query: 518 FSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN--- 573
F + KLGEG +G VYK GQ VAIK + + + E E ++ +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 574 -----LTDS-------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLR 609
++ N L E +I+ +GL YLH +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NK 119
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVS 669
IHRD+KA NILL+++ K++DFG++ ++ NT V+GT +M+PE +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYN 177
Query: 670 IKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703
K D++S G+ +E+ GK Y HP+ I
Sbjct: 178 NKADIWSLGITAIEMAEGKPP---YSDIHPMRAI 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 42/206 (20%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIK------RLSRRSGQGIVEFKNEAKLIAK 568
++ V LG+G G VYK + G+ A+K R + E K +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRS 55
Query: 569 LQHTNLTDSR----RNNRL-------NWETRFSIIEG---------------IAQGLLYL 602
+ + + + + + +++ I +GL YL
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
H + +IHRD+K SN+L++ + KI+DFG++++ L + N VGT YMSPE
Sbjct: 116 HT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPER 171
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVSGK 688
S D++S G+ +LE GK
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 41/203 (20%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNL 574
+ KLG G FG V+ G +VA+K L + G E F EA+++ KL+H L
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKL 63
Query: 575 ----------------TDSRRN------------NRLNWETRFSIIEGIAQGLLYLHKYS 606
T+ +L + IA+G+ YL
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--- 120
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYA 663
IHRDL A NIL+ + + KI+DFG+AR+ ++ G + +PE A
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAA 176
Query: 664 MSGVVSIKTDVFSFGVLVLEIVS 686
G +IK+DV+SFG+L+ EIV+
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 3e-22
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 43/199 (21%)
Query: 524 LGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFK------NEAKLIAKLQHTNL-- 574
LG+G FG V + + G+ A+K L ++ I++ K E +++++ H +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK---IIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 575 ------TDS------------------RRNNRLN-WETRFSIIEGIAQGLLYLHKYSRLR 609
T+ + R + RF E I L YLH L
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE-IVLALEYLH---SLG 113
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVS 669
+I+RDLK NILLD + K++DFG+A+ S TNT GT Y++PE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYG 171
Query: 670 IKTDVFSFGVLVLEIVSGK 688
D +S GVL+ E+++GK
Sbjct: 172 KAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 4e-21
Identities = 49/136 (36%), Positives = 61/136 (44%), Gaps = 22/136 (16%)
Query: 34 QLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVA 93
L G LVS+ F +GFF + Y I Y GS + VWVA
Sbjct: 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYK------------GSSR--TVVWVA 47
Query: 94 NRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAM-GNTSAALYETGNFVLYEMN 152
NR+ P + S +LT+ S DGNL I G + S+ + GN L + GN VLY
Sbjct: 48 NRDNP-SGSSCTLTLQS-DGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLY--- 102
Query: 153 PSGSMERELWQSFDYP 168
S LWQSFDYP
Sbjct: 103 --DSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 8e-21
Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 42/203 (20%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVE---FKNEAKLIAKLQHT 572
V KLG G FG V+ G +VAIK L QG + F EA L+ +LQH
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLK----QGSMSPEAFLAEANLMKQLQHP 61
Query: 573 NL---------------TDSRRNN------------RLNWETRFSIIEGIAQGLLYLHKY 605
L T+ N +L + IA+G+ ++
Sbjct: 62 RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE-- 119
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYA 663
R IHRDL+A+NIL+ + + KI+DFG+AR+ N+ T R + + +PE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAI 175
Query: 664 MSGVVSIKTDVFSFGVLVLEIVS 686
G +IK+DV+SFG+L+ EIV+
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 33/197 (16%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL--- 574
F+ KLG G FG V++G N VAIK L +F+ E + + +L+H +L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 575 -------------TDSRRNNRL-----NWETR-------FSIIEGIAQGLLYLHKYSRLR 609
T+ L + E + + +A+G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVS 669
IHRDL A NIL+ + + K++DFG+AR+ + ++ ++ Y + +PE A G S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFS 182
Query: 670 IKTDVFSFGVLVLEIVS 686
K+DV+SFG+L+ E+ +
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.8 bits (234), Expect = 1e-20
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 46/213 (21%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTN 573
++ + KLGEG FG VY + + + VA+K L+++ + + F E +++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 574 ------------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLH 603
L R L+ I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 604 KYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETN----TNRVVGTYGYM 658
+IHRD+K NILLD D K+ DFG+A++ S ++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 659 SPEYAMSGV---VSIKTDVFSFGVLVLEIVSGK 688
+PE + S +D++S G+ + E+++G
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 54/223 (24%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---------------------SG 553
++F +GEG F V + +E AIK L +R +G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 554 Q-GIVE----FKNEAKLIAKLQHTN----LTDSRRNNRLNWE-TRFSIIEGIAQGLLYLH 603
GI++ F++E L L++ L R+ L+ + TRF E I L YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE-ILLALEYLH 119
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV------------ 651
+IHRDLK NILLD M+ KI+DFG A++ N S +
Sbjct: 120 S---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 652 ------VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
VGT Y+SPE +D+++ G ++ ++++GK
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 35/201 (17%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN--EAKLIAKLQHTN- 573
+ + K+GEG +G VYK + L G+ VAIK++ R + E KL+ +L H N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 574 ------------------LTDS------RRNNRLNWETRF-SIIEGIAQGLLYLHKYSRL 608
D+ + R E+ S + + QGL + H +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-SGV 667
++HRDLK N+L++ + K++DFG+AR FG + T+ VV T Y +PE +
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVV-TRWYRAPELLLGDKG 175
Query: 668 VSIKTDVFSFGVLVLEIVSGK 688
S D++S G + E++S +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 39/197 (19%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
+ KLG G FG V++G N VA+K L + +F EA+++ KL+H L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 575 ----------TDSRRNNRL------------NWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
T+ + L + +A G+ YL + IH
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYAMSGVVS 669
RDL A N+L+ + K++DFG+AR+ + E G + +PE A+ S
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFS 182
Query: 670 IKTDVFSFGVLVLEIVS 686
IK+DV+SFG+L+ EIV+
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 54/213 (25%)
Query: 524 LGEGGFGPVYKGQL--LNGQE----VAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNL-- 574
LGEG FG VYKG+L N + VAIK L + EF+ EA+L++ LQH N+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 575 ----------------------------------------TDSRRNNRLNWETRFSIIEG 594
D + L+ I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVG 653
IA G+ YL S +HRDL A N L+ + + KISDFG++R I+ + + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M PE + G + ++D++SFGV++ EI S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 38/204 (18%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSG-QGI-VEFKNEAKLIAKLQHTNL 574
+ + ++GEG +G VYK + G+ VA+K++ + +G + E KL+ KL+H N+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 575 -------TDSRRNN---------------RLNWETRFSI--IEGIAQ----GLLYLHKYS 606
T + + + E +F+ I+ + GL YLH
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH--- 117
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
++HRD+K SNIL+++ K++DFG+AR + S TNRV+ T Y PE + G
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLL-G 175
Query: 667 VVSIKT--DVFSFGVLVLEIVSGK 688
D++S G ++ E+ GK
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 71/288 (24%), Positives = 121/288 (42%), Gaps = 62/288 (21%)
Query: 521 VNKLGEGGFGPVYKGQLLN-----GQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNL 574
+ +LGEG FG V + G++VA+K L+ Q +F+ E +++ L H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 575 T--------DSRRN---------------------NRLNWETRFSIIEGIAQGLLYLHKY 605
R+ +++N + I +G+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS- 127
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE----TNTNRVVGTYGYMSPE 661
R IHRDL A NIL++ + KISDFG+A++ L + + + Y +PE
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKV--LPEDKDYYYVKEPGESPIFWY-APE 182
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720
+ S +DV+SFGV + E+ + G + L +IG A ++LEL
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPS--QSPPAEFLRMIGIAQGQMIVTRLLEL-- 238
Query: 721 IALEGSFS-------PNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761
L+ P+EV + LC + + DRP+ D++ ++
Sbjct: 239 --LKEGERLPRPPSCPDEVY---DLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 52/193 (26%), Positives = 82/193 (42%), Gaps = 42/193 (21%)
Query: 524 LGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD------- 576
+G+G FG V G GQ+VA+K L + F EA ++ L+H NL
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 577 ---------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
SR + + + +G+ YL + +HRDL
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDL 128
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYAMSGVVSIKTD 673
A N+L+ + + K+SDFG+A+ E + + G + +PE S K+D
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSD 181
Query: 674 VFSFGVLVLEIVS 686
V+SFG+L+ EI S
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 76/294 (25%), Positives = 119/294 (40%), Gaps = 85/294 (28%)
Query: 524 LGEGGFGPVYKGQLLN------GQEVAIKRLSRRSGQG-IVEFKNEAK------------ 564
LG+G FG VY+G VAIK ++ + +EF NEA
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 565 ---LIAKLQHT----------NLTDSRRNNRLNWE--------TRFSIIE---GIAQGLL 600
+++ Q T +L R+ R E T I+ IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVGT----Y 655
YL + +HRDL A N ++ + + KI DFGM R I+ ET+ R G
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPV 185
Query: 656 GYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-------GKKNNGCYRTDHPLNLIGYAWQ 708
+M+PE GV + K+DV+SFGV++ E+ + G N + L +
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLKFVI---- 235
Query: 709 LWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762
+G L+L + P+++L + +C Q RP ++VS L +
Sbjct: 236 ---DGGHLDLPENC------PDKLLE---LMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-19
Identities = 47/135 (34%), Positives = 63/135 (46%), Gaps = 23/135 (17%)
Query: 34 QLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVA 93
L G LVS F +GFF+ + D Y I Y S + VWVA
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQND-YNLILYK------------SSSR--TVVWVA 46
Query: 94 NRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQ-AMGNTSAALYETGNFVLYEMN 152
NR+ P++D S +LT+ S DGNL + G + S+ A GN L + GN V+Y+ +
Sbjct: 47 NRDNPVSD-SCTLTLQS-DGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSD 104
Query: 153 PSGSMERELWQSFDY 167
LWQSFDY
Sbjct: 105 -----GNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 48/205 (23%)
Query: 524 LGEGGFGPVYKGQLL-----NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTN---- 573
LG G FG VYKG + VAIK L + + E +EA ++A + H +
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 574 --------------------LTDSRRNNR--------LNWETRFSIIEGIAQGLLYLHKY 605
L D RN++ LNW + IA+G+ YL +
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEK 128
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
R++HRDL A N+L+ + KI+DFG+A++ +++ E + +M+ E +
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 666 GVVSIKTDVFSFGVLVLEIVS-GKK 689
+ + K+DV+S+GV V E+++ G K
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 44/207 (21%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGIVEFK------NEAKLIAKL 569
+F + +G+G FG V Q + +++ A+K +++ Q VE NE +++ +L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK---QKCVEKGSVRNVLNERRILQEL 57
Query: 570 QH---TNL-------------------TDSR----RNNRLNWET-RFSIIEGIAQGLLYL 602
H NL D R + + + E +F I E I L YL
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-IVLALEYL 116
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
H +IHRD+K NILLD+Q + I+DF +A +T T GT GYM+PE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEV 170
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVSGKK 689
S+ D +S GV E + GK+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-19
Identities = 62/196 (31%), Positives = 90/196 (45%), Gaps = 32/196 (16%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
V ++G G FG V+ G L ++VAIK + R +F EA+++ KL H L
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 575 -------------------TDSRRNNR--LNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
+D R R + ET + + +G+ YL + VIHR
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTD 673
DL A N L+ + K+SDFGM R F L+ T++ + SPE S K+D
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 674 VFSFGVLVLEIVSGKK 689
V+SFGVL+ E+ S K
Sbjct: 184 VWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 71/289 (24%), Positives = 125/289 (43%), Gaps = 73/289 (25%)
Query: 517 NFSAVNKLGEGGFGPVYK------GQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ 570
+F +NK+G+G FG V+K ++ +++ + +++RR + E +EA+++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE---EAIDEARVLAKLD 57
Query: 571 HT----------------------------NLTDSRRNNRLNWETRFSIIEGIAQGLLYL 602
+ L +R L + + I GL +L
Sbjct: 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
H +++HRD+K+ N+ LD N KI D G+A++ N + NT +VGT Y+SPE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPEL 172
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG----KVLEL 718
+ K+DV++ GV++ E +GK HP + N+G K++
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK---------HPFD-------ANNQGALILKIIRG 216
Query: 719 VDIALEGSFSPN--EVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765
V + +S +++ C+ R PD +L N SL
Sbjct: 217 VFPPVSQMYSQQLAQLID------QCLTKDYRQR---PDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 47/208 (22%)
Query: 522 NKLGEGGFGPVYKGQLLN-GQEVAIK-----RLSRRSGQGIVEFKNEAKLIAKLQHTN-- 573
+G+G FG V K + + G+ + K ++ + Q +V +E ++ +L+H N
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIV 62
Query: 574 ----------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLH-- 603
L + R E F I + Q LL L+
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF-IWRILTQLLLALYEC 121
Query: 604 ---KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSP 660
V+HRDLK +NI LD N K+ DFG+A+I G + S T VGT YMSP
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSP 179
Query: 661 EYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
E K+D++S G L+ E+ +
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 3e-18
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 51/209 (24%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFK----NEAKLIAKLQHT 572
+ + KLGEG +G VYK + G+ VA+K++ R E L+ +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 573 NL---------------------TDSRR---NNRLNWETRF--SIIEGIAQGLLYLHKYS 606
N+ D ++ SI+ + +GL Y H S
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--S 116
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE----- 661
R++HRDLK NIL++ K++DFG+AR FG+ T T+ VV T Y +PE
Sbjct: 117 H-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWYRAPEILLGS 173
Query: 662 --YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y S D++S G + E+++GK
Sbjct: 174 KHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 32/198 (16%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQG-IVEFKNEAKLIAKLQHTNLT 575
F+ + +G+G FG VYK Q VAIK + + I + + E + +++ + +T
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 576 -------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRV 610
D + +L+ I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GK 119
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
IHRD+KA+NILL ++ + K++DFG++ S+ NT VGT +M+PE
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYDE 177
Query: 671 KTDVFSFGVLVLEIVSGK 688
K D++S G+ +E+ G+
Sbjct: 178 KADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 57/198 (28%), Positives = 85/198 (42%), Gaps = 32/198 (16%)
Query: 519 SAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD-- 576
+ + +LG G FG V+ G+ +VAIK + R +F EAK++ KL H NL
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLY 65
Query: 577 -------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
R +L E + + + + YL I
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIK 671
HRDL A N L+ + K+SDFG+AR + L+ T++ + PE S K
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 672 TDVFSFGVLVLEIVSGKK 689
+DV+SFGVL+ E+ S K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 36/98 (36%), Positives = 59/98 (60%), Gaps = 6/98 (6%)
Query: 591 IIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650
I + +GL YLH + ++IHRD+K SNIL++ + K+ DFG++ L S T
Sbjct: 105 IAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ--LVNSLAKTF- 159
Query: 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
VGT YM+PE S+K+D++S G+ ++E+ +G+
Sbjct: 160 -VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 41/207 (19%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGI-------VEFKNEAK--L 565
+++LGEG G V K +L N + A+K ++ + +E K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 566 IAKLQHTNLTDS------------------------RRNNRLNWETRFSIIEGIAQGLLY 601
I K L +S +R R+ + I E + +GL Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
LH SR ++IHRD+K SNILL + K+ DFG++ + + T T GT YM+PE
Sbjct: 121 LH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPE 173
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
SI +DV+S G+ +LE+ +
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 65/219 (29%), Positives = 91/219 (41%), Gaps = 48/219 (21%)
Query: 512 SAATNNFSAVNKLGEGGFGPVYKGQL--LNG----QEVAIKRL-SRRSGQGIVEFKNEAK 564
++ + + LG G FG VY+G +G +VA+K L S Q +F EA
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 565 LIAKLQHTN-------------------------LTDSRRNNRLNWETRFS--------I 591
+++K H N L R NR E S
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 592 IEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMAR-IFGLNQSETN 647
+A+G YL + IHRD+ A N LL KI+DFGMAR I+ +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
R + +M PE + G+ + KTDV+SFGVL+ EI S
Sbjct: 179 -GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 39/197 (19%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLT---- 575
V KLG G FG V+ G N +VA+K L + G V+ F EA L+ LQH L
Sbjct: 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 576 ------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
S ++ IA+G+ Y+ + + I
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YI 125
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYAMSGVVS 669
HRDL+A+N+L+ + + KI+DFG+AR+ N+ T R + + +PE G +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFT 182
Query: 670 IKTDVFSFGVLVLEIVS 686
IK+DV+SFG+L+ EIV+
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 57/198 (28%), Positives = 83/198 (41%), Gaps = 40/198 (20%)
Query: 524 LGEGGFGPVYKGQLLN-GQEVAIK-----RLSRRSGQ--GIVE----------------- 558
LG+GGFG V Q+ G+ A K RL +R G+ + E
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 559 -FKNEAKLIAKLQHTNLTD-----SRRNNRLNWETR--FSIIEGIAQGLLYLHKYSRLRV 610
F+ + L + N D E R F + I GL +LH + R+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QRRI 116
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
++RDLK N+LLDD N +ISD G+A + GT GYM+PE V
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 671 KTDVFSFGVLVLEIVSGK 688
D F+ G + E+++G+
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 37/204 (18%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRS-GQGIVEFK-NEAKLIAKLQHTN 573
+++ + K+GEG +G VYKG+ GQ VA+K++ S +G+ E L+ +LQH N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 574 --------LTDSR--------------------RNNRLNWETRFSIIEGIAQGLLYLHKY 605
+ +SR + ++ E S + I QG+L+ H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH-- 118
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
RV+HRDLK N+L+D++ K++DFG+AR FG+ T+ VV T Y +PE +
Sbjct: 119 -SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLLG 175
Query: 666 GV-VSIKTDVFSFGVLVLEIVSGK 688
S D++S G + E+ + K
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 56/226 (24%)
Query: 511 ISAATNNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRSGQGI-VEFKNEA 563
I+ +T F + +LGE FG VYKG L Q VAIK L ++ + EFK+EA
Sbjct: 2 INLSTVRF--MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 564 KLIAKLQHTNL----------------------------------------TDSRRNNRL 583
+ ++LQH N+ TD + +
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 584 NWETR--FSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFG 640
E I+ IA G+ +L S V+H+DL N+L+ D++N KISD G+ R ++
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+ + N ++ +MSPE M G SI +D++S+GV++ E+ S
Sbjct: 177 ADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 63/232 (27%), Positives = 88/232 (37%), Gaps = 66/232 (28%)
Query: 522 NKLGEGGFGPVYKGQLL--NGQE--VAIKRLSR-RSGQGIVEFKNEAKLIAKLQHTN--- 573
+LG G FG V KG L +G+E VA+K L + G EF EA ++A+L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 574 ---------------------LTDSRRNNR-------LNWETRFSIIEGIAQGLLYLHKY 605
L + R + +A G+ YL
Sbjct: 61 LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES- 113
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN----QSETNTNRVVGTYGYMSPE 661
+HRDL A N+LL ++ KISDFGM+R G ++ T + Y +PE
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APE 168
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVS-------GKKNN-------GCYRTDHP 699
G S K+DV+S+GV + E S K R P
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 35/195 (17%)
Query: 524 LGEGGFGPVYKGQL-LNGQE---VAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL---- 574
+G G FG V +G+L L G++ VAIK L + S + ++F EA ++ + H N+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 575 ---TDSR------------------RNN--RLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
T SR R N + ++ GIA G+ YL S + +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYV 128
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIK 671
HRDL A NIL++ + K+SDFG++R +++ T + +PE +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSA 188
Query: 672 TDVFSFGVLVLEIVS 686
+DV+SFG+++ E++S
Sbjct: 189 SDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 56/210 (26%)
Query: 521 VNKLGEGGFGPVYKG-QLLNGQEVAIK--RLSRRSGQ--GIVEFKN-----EAKLIAKLQ 570
KLGEG + VYK G+ VAIK +L R GI N E KL+ +L+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI----NFTALREIKLLQELK 60
Query: 571 HTNLTD------SRRNNRL--------------NWETRF------SIIEGIAQGLLYLHK 604
H N+ + N L + S + +GL YLH
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
++HRDLK +N+L+ K++DFG+AR FG + + T++VV T Y +PE
Sbjct: 121 NW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TRWYRAPELLF 175
Query: 665 ------SGVVSIKTDVFSFGVLVLEIVSGK 688
GV D++S G + E++
Sbjct: 176 GARHYGVGV-----DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 39/98 (39%), Positives = 60/98 (61%), Gaps = 6/98 (6%)
Query: 591 IIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650
I + +GL YL Y+ R++HRD+K SNIL++ + K+ DFG++ L S +T
Sbjct: 108 IAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADT-- 161
Query: 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
VGT YMSPE G ++K+DV+S G+ ++E+ GK
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 43/205 (20%)
Query: 524 LGEGGFGPVYKG-QLLNGQEVAIKRL---------SRRSGQGIVEFKNEAKLIAKLQHTN 573
+G G FG VY G +G+ +A+K++ R + E L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 574 ----LTDSRRNNRLNWETRF----------------------SIIEGIAQGLLYLHKYSR 607
L S + LN + + + I +GL YLH +R
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH--NR 125
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN--QSETNTNR--VVGTYGYMSPEYA 663
+IHRD+K +NIL+D++ KISDFG+++ N ++TN R + G+ +M+PE
Sbjct: 126 -GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 664 MSGVVSIKTDVFSFGVLVLEIVSGK 688
+ K D++S G LV+E+++GK
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 55/199 (27%)
Query: 512 SAATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRL---SRRSGQGIVEFKNEAKLIA 567
+ ++ + KLGEG FG VYK Q+ G+ VA+K++ + + G I + E K++
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62
Query: 568 KLQHTNLT-----------DSRR---------------------NNRLNWETRFSIIEGI 595
KL+H N+ S+R N + S I+
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE--SQIKCY 120
Query: 596 A----QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF---------GLN 642
+G+ YLH+ ++HRD+KA+NIL+D+Q KI+DFG+AR + G
Sbjct: 121 MLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 643 QSETNTNRVVGTYGYMSPE 661
+V T Y PE
Sbjct: 178 GGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 59/218 (27%)
Query: 524 LGEGGFGPVYKGQLLNGQE------VAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNL-- 574
LGEG FG V+ G+ + + VA+K L + + F+ EA+L+ QH N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 575 -----TDS-------------------RRNN--------------RLNWETRFSIIEGIA 596
T+ R + L I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 597 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT-- 654
G++YL + +HRDL N L+ + KI DFGM+R + T+ RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 655 --YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKK 689
+M PE M + ++DV+SFGV++ EI + GK+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 38/196 (19%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLTD--- 576
+ KLG G FG V+ G +VA+K L + G E F EA+++ KL+H L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 577 --SRR----------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
S L + +A G+ Y+ R+ IH
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYAMSGVVSI 670
RDL+++NIL+ D + KI+DFG+AR+ N+ T R + + +PE A+ G +I
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTI 182
Query: 671 KTDVFSFGVLVLEIVS 686
K+DV+SFG+L+ E+V+
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 72/278 (25%), Positives = 105/278 (37%), Gaps = 62/278 (22%)
Query: 523 KLGEGGFGPVYKGQLLNGQ----EVAIKRLSRRSGQGIV-EFKNEAKLIAKLQHTN---- 573
KLG+G FG V +G+ VA+K L I+ +F EA ++ L H N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 574 --------------------LTDSRRNNRLNWETRFSII----EGIAQGLLYLHKYSRLR 609
L D R + L S + IA G+ YL S+ R
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRYLE--SK-R 117
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS--ETNTNRVVGTYGYMSPEYAMSGV 667
IHRDL A NILL KI DFG+ R N+ + V + + +PE +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRT 176
Query: 668 VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW---NEGKVLELVDIALE 724
S +DV+ FGV + E+ + Y + W + ++L+ +D E
Sbjct: 177 FSHASDVWMFGVTLWEMFT------------------YGEEPWAGLSGSQILKKIDKEGE 218
Query: 725 GSFSPNEVLRCIH-VGLLCVQDQATDRPAMPDVVSMLA 761
P + I+ V L C DRP + L
Sbjct: 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 44/208 (21%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLLNGQ------EVAIKRLSRRSGQGIVEFKNEAKLIAKLQ 570
+ + +G G FG V+ + Q ++ ++++++ +NE +++ L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLS 57
Query: 571 HTN----------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYL 602
H N R N+ L+ +T I+ Q LL L
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT---ILHFFVQILLAL 114
Query: 603 HKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
H ++HRDLK NILLD +M KI DFG+++I S++ VVGT Y+SPE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPE 171
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGKK 689
+ K+D+++ G ++ E+ S K+
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 62/194 (31%), Positives = 94/194 (48%), Gaps = 38/194 (19%)
Query: 523 KLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLT------ 575
KLG+G FG V+ G +VAIK L + G + E F EA+++ KL+H L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 576 ---------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRD 614
L + IA G+ Y+ R+ IHRD
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 615 LKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYAMSGVVSIKT 672
L+A+NIL+ D + KI+DFG+AR+ N+ T R + + +PE A+ G +IK+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 673 DVFSFGVLVLEIVS 686
DV+SFG+L+ E+V+
Sbjct: 185 DVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 43/200 (21%)
Query: 524 LGEGGFGPVYKG-QLLNGQEVAIKRLS-----RRSGQGIVEFKNEAKLIAKLQHTNL--- 574
LG G FG VY+G L +G A+K +S + + + + + E L++KLQH N+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 575 -----TDSRRNNRLNWETRFSI------------------IEGIAQGLLYLHKYSRLRVI 611
+ L S+ I GL YLH R +
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH--DR-NTV 124
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN--TNRVVGTYGYMSPEYAMS-GVV 668
HRD+K +NIL+D K++DFGMA+ Q G+ +M+PE G
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
+ D++S G VLE+ +GK
Sbjct: 180 GLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 38/194 (19%)
Query: 523 KLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLTD----- 576
KLG+G FG V+ G VAIK L + G E F EA+++ KL+H L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 577 ----------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRD 614
L + IA G+ Y+ R+ +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 615 LKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYAMSGVVSIKT 672
L+A+NIL+ + + K++DFG+AR+ N+ T R + + +PE A+ G +IK+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 673 DVFSFGVLVLEIVS 686
DV+SFG+L+ E+ +
Sbjct: 185 DVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 40/205 (19%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKR--LSRRSGQGIVEFKNEAKLIAKLQHTN 573
+F + KLG+G +G VYK + L + Q A+K L S + + NE +++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 574 LT-------DSRR-----------------------NNRLNWETRFSIIEGIAQGLLYLH 603
+ D + + + + I + +GL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
+ +++HRDLK++NILL KI D G++++ L ++ T +GT YM+PE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT--QIGTPHYMAPEVW 173
Query: 664 MSGVVSIKTDVFSFGVLVLEIVSGK 688
S K+D++S G L+ E+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 36/193 (18%)
Query: 523 KLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT------- 575
KLG G FG V+ +VA+K + + + F EA ++ LQH L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 576 --------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
S ++ IA+G+ ++ + + IHRDL
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDL 128
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYAMSGVVSIKTD 673
+A+NIL+ + KI+DFG+AR+ N+ T R + + +PE G +IK+D
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 674 VFSFGVLVLEIVS 686
V+SFG+L++EIV+
Sbjct: 186 VWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 80/320 (25%), Positives = 134/320 (41%), Gaps = 86/320 (26%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE-----VAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNL 574
V LG G FG VYKG + E VAIK L+ +G + VEF +EA ++A + H +L
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 575 T---------------------------DSRRNN-----RLNWETRFSIIEGIAQGLLYL 602
++N LNW + IA+G++YL
Sbjct: 72 VRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
+ R++HRDL A N+L+ + KI+DFG+AR+ ++ E N + +M+ E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVS--GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720
+ ++DV+S+GV + E+++ GK +G E+ D
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------------------PTREIPD 222
Query: 721 IALEGSFSPNEVLRCIHVGLL---CVQDQATDRPAMPDVVSMLA--------------NE 763
+ +G P + I V ++ C A RP ++ + + ++
Sbjct: 223 LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDD 282
Query: 764 SLSLPAPKQPAFFINITAEE 783
+ LP+P FF N+ EE
Sbjct: 283 RMKLPSPNDSKFFQNLLDEE 302
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 38/204 (18%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIK--RLSRRSGQGIVEFK-NEAKLIAKLQHT 572
NF V K+GEG +G VYK + L G+ VA+K RL + +G+ E L+ +L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59
Query: 573 N---LTDSRRNNR--------LNWETR----FSIIEGIA------------QGLLYLHKY 605
N L D L+ + + S + GI QGL + H +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM- 664
RV+HRDLK N+L++ + K++DFG+AR FG+ T T+ VV T Y +PE +
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLG 174
Query: 665 SGVVSIKTDVFSFGVLVLEIVSGK 688
S D++S G + E+V+ +
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-15
Identities = 41/106 (38%), Positives = 56/106 (52%), Gaps = 24/106 (22%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
I G+ YLH R ++HRD+K SN+L++ N KI+DFG++RI L Q+ N VGT
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGT 231
Query: 655 YGYMSPEYAMSGVVSIKT------------DVFSFGVLVLEIVSGK 688
YMSPE I T D++S GV +LE G+
Sbjct: 232 IAYMSPE-------RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 42/204 (20%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---EAKLIAKLQHTN 573
F+ + ++G G FG VY + + + VAIK++S Q ++++ E + + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 574 LTDSR--------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+ + L +I G QGL YLH + R
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE--YAM- 664
IHRD+KA NILL + K++DFG A + + N VGT +M+PE AM
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSASLV------SPANSFVGTPYWMAPEVILAMD 187
Query: 665 SGVVSIKTDVFSFGVLVLEIVSGK 688
G K DV+S G+ +E+ K
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 42/205 (20%)
Query: 524 LGEGGFGPVYKG-QLLNGQEVAIKR--LSRRSG-------QGIVE-FKNEAKLIAKLQHT 572
+G+G +G VY + G+ +A+K+ L + +V+ ++E + + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 573 NLTDS--------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
N+ R R + E + +GL YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE--YAM 664
++HRDLKA N+L+D KISDFG+++ + G+ +M+PE ++
Sbjct: 129 ---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 665 SGVVSIKTDVFSFGVLVLEIVSGKK 689
S S K D++S G +VLE+ +G++
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLT 575
F+ + ++G+G FG VYKG +EV AIK + + +E + E ++++ +T
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 576 -------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRV 610
D + L +I+ I +GL YLH R
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RK 122
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
IHRD+KA+N+LL +Q + K++DFG+A L ++ N VGT +M+PE
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 671 KTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703
K D++S G+ +E+ G+ HP+ ++
Sbjct: 181 KADIWSLGITAIELAKGEPP---NSDLHPMRVL 210
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 44/199 (22%)
Query: 524 LGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGIVE------FKNEAKLIAKLQHTN--- 573
LG GGFG V ++ + A+K + +R IVE +E +++ + H
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH---IVETGQQEHIFSEKEILEECNHPFIVK 57
Query: 574 -------------LTDS----------RRNNRLN-WETRFSIIEGIAQGLLYLHKYSRLR 609
L + R + + RF I + YLH
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLAFEYLH---NRG 113
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVS 669
+I+RDLK N+LLD K+ DFG A+ + +T T GT Y++PE ++
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWT--FCGTPEYVAPEIILNKGYD 170
Query: 670 IKTDVFSFGVLVLEIVSGK 688
D +S G+L+ E+++G+
Sbjct: 171 FSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 40/197 (20%)
Query: 524 LGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIV-EFKNEAKLIAKLQHT---NLTDSR 578
+G G +G VY+G + G+ VA+K ++ + V + + E L+++L+ + N+T +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT--K 66
Query: 579 RNNRLNWETRFSIIEGIAQG---------------------------LLYLHKYSRLRVI 611
R II A+G L Y+HK VI
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VI 123
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV-SI 670
HRD+KA+NIL+ + N K+ DFG+A + N S+ +T VGT +M+PE G
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYYDT 181
Query: 671 KTDVFSFGVLVLEIVSG 687
K D++S G+ + E+ +G
Sbjct: 182 KADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 36/206 (17%)
Query: 523 KLGEGGFGPV-YKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN-------- 573
K+GEG G V + +G++VA+K + R Q NE ++ QH N
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 574 -----------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLK 616
LTD RLN E ++ E + Q L YLH VIHRD+K
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIK 144
Query: 617 ASNILLDDQMNPKISDFGM-ARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675
+ +ILL K+SDFG A+I ++ +VGT +M+PE + D++
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 676 SFGVLVLEIVSGKKNNGCYRTDHPLN 701
S G++V+E+V G+ Y +D P+
Sbjct: 202 SLGIMVIEMVDGEPP---YFSDSPVQ 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 36/203 (17%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFK-NEAKLIAKLQHTNL 574
NF + KLGEG + VYKG+ G+ VA+K + + +G E L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 575 T---------------------------DSRRNNR-LNWETRFSIIEGIAQGLLYLHKYS 606
D+ L+ T S + +G+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN- 119
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-S 665
RV+HRDLK N+L++ + K++DFG+AR FG+ + T +N VV T Y +P+ + S
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVV-TLWYRAPDVLLGS 175
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
S D++S G ++ E+++G+
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 63/212 (29%)
Query: 521 VNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN--------EAKLIAKLQ- 570
+ +LG+G FG VY + G+ VAIK++ ++ F + E K + KL
Sbjct: 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKK-------FYSWEECMNLREVKSLRKLNE 56
Query: 571 HTN---------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLH 603
H N L R+ + SII I QGL ++H
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 604 K--YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV----VGTYGY 657
K + HRDLK N+L+ KI+DFG+AR E + V T Y
Sbjct: 117 KHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWY 164
Query: 658 MSPEYAM-SGVVSIKTDVFSFGVLVLEIVSGK 688
+PE + S S D+++ G ++ E+ + +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 59/199 (29%), Positives = 86/199 (43%), Gaps = 43/199 (21%)
Query: 523 KLGEGGFGPVYKGQLLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTN------- 573
K+G+G FG VYKG L EVA+K R + +F EA+++ + H N
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGV 60
Query: 574 -------------------LTDSRRN-NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
LT R+ NRL + + A G+ YL S+ IHR
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE--SK-NCIHR 117
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG-----YMSPEYAMSGVV 668
DL A N L+ + KISDFGM+R + E V + +PE G
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 669 SIKTDVFSFGVLVLEIVSG 687
+ ++DV+S+G+L+ E S
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 32/196 (16%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD---- 576
+ +LG G FG V+ G+ +VAIK + +F EAK++ KL H L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 577 -----------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
+R +L+ + S+ + + +G+ YL + S IHR
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTD 673
DL A N L+ K+SDFGM R + L+ T+++ + PE S K+D
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 674 VFSFGVLVLEIVSGKK 689
V+SFGVL+ E+ + K
Sbjct: 184 VWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 36/202 (17%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKR--------------------LSRRSGQGI 556
+ V K+GEG +G VYK + L G+ VA+K+ L + I
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 557 VEFKN----EAKLIAKLQHTNL-----TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
V + E KL + +L DS L+ S + + QG+ Y H S
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH 118
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG- 666
RV+HRDLK N+L+D + K++DFG+AR FG+ T T+ VV T Y +PE +
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGSR 175
Query: 667 VVSIKTDVFSFGVLVLEIVSGK 688
S D++S G + E+V+ +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 55/210 (26%)
Query: 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLS-RRSGQGIVEFKNEAKLIAKLQHTNLTDSRR 579
+G G VY L N ++VAIKR+ + + E + E + +++ H N+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV----- 61
Query: 580 NNRLNWETRFS-------------------------------------IIEGIAQGLLYL 602
+ + T F +++ + +GL YL
Sbjct: 62 ---VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR--VVGTYGYMSP 660
H + IHRD+KA NILL + + KI+DFG++ T R VGT +M+P
Sbjct: 119 HSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 661 EYAMSGVV--SIKTDVFSFGVLVLEIVSGK 688
E M V K D++SFG+ +E+ +G
Sbjct: 176 E-VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 44/205 (21%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLS---RRSGQGIVEFKNEAKLIAKLQHTN 573
FS + ++G G FG VY + + N + VAIK++S ++S + + E + + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 574 LTDSRRNNRLNWETRFSIIE---------------------------GIAQGLLYLHKYS 606
T R L T + ++E G QGL YLH ++
Sbjct: 77 -TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS- 665
+IHRD+KA NILL + K+ DFG A I N VGT +M+PE ++
Sbjct: 136 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAM 186
Query: 666 --GVVSIKTDVFSFGVLVLEIVSGK 688
G K DV+S G+ +E+ K
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 54/216 (25%)
Query: 521 VNKLGEGGFGPVYKGQLL-----NGQEVAIKRLSR-RSGQGIVEFKNEAKLIAKLQHTNL 574
+ +LGE FG +YKG L + Q VAIK L + Q EF+ EA L+A+L H N+
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 575 T-------------------------------------------DSRRNNRLNWETRFSI 591
D + L+ I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 592 IEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNR 650
IA G+ YL + +H+DL A NIL+ +Q++ KISD G++R I+ +
Sbjct: 130 AIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
++ +M PE M G S +D++SFGV++ EI S
Sbjct: 187 LLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 51/210 (24%)
Query: 524 LGEGGFGPVYKGQLLN-------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTN-- 573
LG G FG VY+G + VA+K L + + Q EF EA L++ H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 574 -------LTDSR----------------RNNR--------LNWETRFSIIEGIAQGLLYL 602
L + + R+ R L + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNP-----KISDFGMAR-IFGLNQSETNTNRVVGTYG 656
++ IHRDL A N L+ ++ KI DFG+AR I+ + ++
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 657 YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+PE + G + ++DV+SFGVL+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 41/212 (19%)
Query: 508 FQTISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN--EAK 564
F T+ TN + + +G G FG V + L GQ VAIK++ + ++ + E K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 565 LIAKLQHTNL----------------------TDSRR---NNRLNWETRFS--IIEGIAQ 597
L+ L+H N+ TD R + L E +F + I +
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPL--EKQFIQYFLYQILR 119
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
GL Y+H V+HRDLK SNIL+++ + KI DFG+ARI Q T V Y Y
Sbjct: 120 GLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-Y 171
Query: 658 MSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGK 688
+PE ++ ++ D++S G + E++ GK
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 38/203 (18%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT- 575
+ + ++G G +G VYK + + G+ VAIK + G + E ++ + +H N+
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 576 ---DSRRNNRLNW----------------ETRFSIIEG-IA-------QGLLYLHKYSRL 608
R ++L W TR + E IA +GL YLH+
Sbjct: 65 YFGSYLRRDKL-WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---T 120
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA---MS 665
IHRD+K +NILL + + K++DFG++ L + +GT +M+PE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
G K D+++ G+ +E+ +
Sbjct: 179 GGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 37/170 (21%)
Query: 523 KLGEGGFGPVYK-GQLLNGQEVAIKRL-SRRSGQGI-VEFKNEAKLIAKLQHTNLTDSRR 579
++GEG G V+K G+ VA+K++ RR GI + E K + QH +
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL- 65
Query: 580 NNRLNWETRFSII--------------------EGIAQGLL--------YLHKYSRLRVI 611
+ + F ++ E + + Y+H ++
Sbjct: 66 -DVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIM 121
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
HRDLK +N+L+ KI+DFG+AR+F + +++ V T Y +PE
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 52/187 (27%), Positives = 90/187 (48%), Gaps = 46/187 (24%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRL---SRRSGQGIVEFKNEAKLIAKLQH 571
+ + + K+G+G FG V+K + Q VA+K++ + + G I + E K++ L+H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKH 70
Query: 572 TNLTD--------SRRNNRL--------------------NWETRFS------IIEGIAQ 597
N+ + + NR N +F+ +++ +
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN---TNRVVGT 654
GL Y+H R +++HRD+KA+NIL+ K++DFG+AR F L+++ TNRVV T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 655 YGYMSPE 661
Y PE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 39/205 (19%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRL---SRRSGQGIVEFKNEAKLIAKLQHT 572
F +N++GEG +G VY+ + +G+ VA+K++ + R G I + E L+ L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 573 NLTDSRR---NNRL-------------------NWETRFSI--IEGIAQ----GLLYLHK 604
N+ + + L N T FS ++ + GL YLH
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH- 125
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
+IHRDLK SN+LL D+ KI+DFG+AR +GL T +VV T Y +PE +
Sbjct: 126 --ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKVV-TLWYRAPELLL 181
Query: 665 SGVVSIKT-DVFSFGVLVLEIVSGK 688
D+++ G ++ E+++ K
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 36/198 (18%)
Query: 524 LGEGGFGPVYKGQLLN-GQEVAIKR-----LSRRSGQGIVEFKNEAKLIAKLQHTNLTD- 576
LG+G FG VY ++ G+E+A+K+ S + + + + E +L+ LQH +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 577 ---SRRNNRLNWETRF----SIIEGIA------------------QGLLYLHKYSRLRVI 611
R + L+ + S+ + + +G+ YLH ++
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMIV 126
Query: 612 HRDLKASNILLDDQMNPKISDFGMA-RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
HRD+K +NIL D N K+ DFG + R+ + S T V GT +MSPE
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186
Query: 671 KTDVFSFGVLVLEIVSGK 688
K DV+S G V+E+++ K
Sbjct: 187 KADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 40/192 (20%)
Query: 523 KLGEGGFGPVYKGQLLNGQEVAIKRLS-RRSGQGIVEFKNEAKLIAKLQHTNLTD----- 576
+GEG FG V +G+ GQ+VA+K + + Q F E ++ KL H NL
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 577 ------------SRRN--NRLNWETRF--SIIE------GIAQGLLYLHKYSRLRVIHRD 614
S+ N N L R S+I+ +A+G+ YL +++HRD
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 615 LKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDV 674
L A NIL+ + K+SDFG+AR+ + +++ + +PE S K+DV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSDV 180
Query: 675 FSFGVLVLEIVS 686
+S+GVL+ E+ S
Sbjct: 181 WSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 39/204 (19%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKR------LSRRSGQGIVEFKNEAKLIAKL 569
NF K+G G F VY+ LL+ + VA+K+ + ++ Q V+ E L+ +L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59
Query: 570 QHTNLT---DSR-RNNRLNWETRFSIIEGIAQGLLYLHKYSRL----------------- 608
H N+ DS +N LN + ++Q + Y K RL
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 609 ------RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
RV+HRD+K +N+ + K+ D G+ R F + T + +VGT YMSPE
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 177
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVS 686
+ K+D++S G L+ E+ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 47/207 (22%)
Query: 522 NKLGEGGFGPVYK------GQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN-- 573
NK+G G FG VY G+L+ +E+ I+ ++ + I +E K++ L+H N
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEI---ADEMKVLELLKHPNLV 62
Query: 574 -----------------------LTDSRRNNRLNWET---RFSIIEGIAQGLLYLHKYSR 607
L + + R+ E +++ + +GL YLH +
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL--QLLEGLAYLHSH-- 118
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE--TNTNRVVGTYGYMSPEYAMS 665
++HRD+K +NI LD K+ DFG A N + + GT YM+PE
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 666 GVVSIK---TDVFSFGVLVLEIVSGKK 689
G D++S G +VLE+ +GK+
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 70/281 (24%), Positives = 107/281 (38%), Gaps = 83/281 (29%)
Query: 522 NKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--- 577
+KLG G +G VY+G VA+K L + + EF EA ++ +++H NL
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 578 -----------------------RRNNR--LNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
R NR +N + I+ + YL K + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYAMSGVVSI 670
RDL A N L+ + K++DFG++R L +T T + + +PE SI
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 671 KTDVFSFGVLVLEI---------------VSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV 715
K+DV++FGVL+ EI V G YR + P EG
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERP------------EG-- 229
Query: 716 LELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDV 756
P +V + C Q +DRP+ ++
Sbjct: 230 ------------CPPKVYELMRA---CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 59/218 (27%), Positives = 87/218 (39%), Gaps = 49/218 (22%)
Query: 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QH 571
T F V +GEG +G VYK + GQ VAIK + E K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62
Query: 572 TNLTD------------------------------------SRRNNRLNWETRFSIIEGI 595
N+ ++ RL E I+
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY 655
+GL YLH+ +VIHRD+K NILL K+ DFG++ L+ + N +GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTP 177
Query: 656 GYMSPE-----YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+M+PE ++DV+S G+ +E+ GK
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 38/108 (35%), Positives = 56/108 (51%), Gaps = 12/108 (11%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
R I E I L YLH +IHRDLK NIL+D + K++DFG+++ GL + +
Sbjct: 95 ARIYIAE-IVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQI 149
Query: 647 N-------TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687
N R+VGT Y++PE + S D +S G ++ E + G
Sbjct: 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 44/205 (21%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLNGQE-VAIKRLSRRSGQGIVEFKN---EAKLIAKLQHTN 573
F+ + ++G G FG VY + + E VAIK++S Q ++++ E K + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 574 LTDSRRNNRLNWETRFSIIE---------------------------GIAQGLLYLHKYS 606
+ + L T + ++E G QGL YLH ++
Sbjct: 87 SIE-YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS- 665
+IHRD+KA NILL + K++DFG A I + N VGT +M+PE ++
Sbjct: 146 ---MIHRDIKAGNILLTEPGQVKLADFGSASIA------SPANSFVGTPYWMAPEVILAM 196
Query: 666 --GVVSIKTDVFSFGVLVLEIVSGK 688
G K DV+S G+ +E+ K
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLT 575
F+ + ++G+G FG V+KG Q+V AIK + + +E + E ++++ +T
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 576 -------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRV 610
D R + ++++ I +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK--- 122
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
IHRD+KA+N+LL +Q + K++DFG+A L ++ N VGT +M+PE
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 671 KTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703
K D++S G+ +E+ G+ N HP+ ++
Sbjct: 181 KADIWSLGITAIELAKGEPPNS---DMHPMRVL 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 35/200 (17%)
Query: 517 NFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN-- 573
K+GEG G V G++VA+K++ R Q NE ++ QH N
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 574 -----------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRV 610
LTD + R+N E ++ + + L +LH V
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GV 136
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR--VVGTYGYMSPEYAMSGVV 668
IHRD+K+ +ILL K+SDFG F S+ R +VGT +M+PE
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
+ D++S G++V+E+V G+
Sbjct: 193 GTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 53/211 (25%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---------EAK 564
NF K+G+G F VYK LL+G+ VA+K++ I E + E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ------IFEMMDAKARQDCLKEID 54
Query: 565 LIAKLQHTN----LTDSRRNNRLN----W----------------------ETRFSIIEG 594
L+ +L H N L NN LN T +
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN-TNRVVG 653
+ L ++H S+ R++HRD+K +N+ + K+ D G+ R F S+T + +VG
Sbjct: 115 LCSALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVG 168
Query: 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEI 684
T YMSPE + K+D++S G L+ E+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 58/212 (27%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGIVEFK------NEAKLIAK 568
++F + LG G FG V + + A+K LS+ IV+ K NE +++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK---AKIVKLKQVEHVLNEKRILQS 57
Query: 569 LQH---TNLTDS-----------------------RRNNRL-NWETRFSIIEGIAQGLLY 601
++H NL S R++ R RF + + L Y
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ-VVLALEY 116
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
LH L +++RDLK N+LLD KI+DFG A+ + T + GT Y++PE
Sbjct: 117 LH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV-----KGRTYTLCGTPEYLAPE 168
Query: 662 ------YAMSGVVSIKTDVFSFGVLVLEIVSG 687
Y + D ++ G+L+ E+++G
Sbjct: 169 IILSKGYGKA------VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 45/207 (21%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLS-RRSGQGIVEFK-NEAKLIAKLQHTNL 574
+ V K+GEG +G VYK + + + +A+K++ + +G+ E L+ ++QH N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 575 T-------------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLH 603
D +N RL + I+ GIA Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCH 119
Query: 604 KYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
+ RV+HRDLK N+L+D + N K++DFG+AR FG+ T T+ VV T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWYRAPEI 174
Query: 663 AM-SGVVSIKTDVFSFGVLVLEIVSGK 688
+ S S D++S G + E+V+ K
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 62/197 (31%), Positives = 89/197 (45%), Gaps = 38/197 (19%)
Query: 524 LGEGGFGPVYKGQLLN-GQEVAIK-----RLSRRSGQGIVEFKNE------AKLIAKL-- 569
LG+GGFG V Q+ N G+ A K RL ++SG+ + + E + I L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 570 -----QHTNLTDSRRNNR-------------LNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
H L S N L E I G+L+LH + ++
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIK 671
+RD+K N+LLDDQ N ++SD G+A L +T T R GT GYM+PE S
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR-AGTNGYMAPEILKEEPYSYP 174
Query: 672 TDVFSFGVLVLEIVSGK 688
D F+ G + E+V+G+
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 58/221 (26%)
Query: 522 NKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN--------------EAKLI 566
LGEG +G V K L G+ VAIK++ V E K++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 567 AKLQHTNLTDSR-------------------------RNNRLNWETRFSIIEGIAQGLLY 601
+++H N+ R RL I+ I GL
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG-------LNQSETN------T 648
LHK+ +HRDL +NI ++ + KI+DFG+AR +G L++ ET T
Sbjct: 135 LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 649 NRVVGTYGYMSPEYAM-SGVVSIKTDVFSFGVLVLEIVSGK 688
++VV T Y +PE M + D++S G + E+++GK
Sbjct: 192 SKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 48/212 (22%), Positives = 83/212 (39%), Gaps = 46/212 (21%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLLNGQE------VAIKRLSRRSGQGI-VEFKNEAKLIAKL 569
N + LG G FG V+ + +E V +K L + + + EF+ E + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 570 QHTNLT-----------------------------------DSRRNNRLNWETRFSIIEG 594
H N+ + + L+ + + ++
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
IA G+ +L S R +HRDL A N L+ Q K+S +++ N +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV-YNSEYYKLRNALIP 181
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+++PE S K+DV+SFGVL+ E+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 32/198 (16%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGIVE---------FKNEAKLIA 567
F+ + K+G+G FG V+KG Q+V AIK + + +E + ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 568 KLQHTNLTDSRRNNRLNW----------------ETRF-SIIEGIAQGLLYLHKYSRLRV 610
K + L D++ + + ET+ +I+ I +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK--- 122
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
IHRD+KA+N+LL + K++DFG+A L ++ N VGT +M+PE
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 671 KTDVFSFGVLVLEIVSGK 688
K D++S G+ +E+ G+
Sbjct: 181 KADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 39/205 (19%)
Query: 517 NFSAVNKLGEGGFGPVY--KGQLLNGQEVAIKR--LSRRSGQGIVEFKNEAKLIAKLQHT 572
+ + K+GEG FG +Y K + + V IK L++ + K E L+AK++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 573 NL----TDSRRNNRL----------NWETRFSIIEG--------------IAQGLLYLHK 604
N+ + N RL + R + G I+ GL ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 605 YSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
+++HRD+K+ NI L + M K+ DFG+AR LN S VGT Y+SPE
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEIC 174
Query: 664 MSGVVSIKTDVFSFGVLVLEIVSGK 688
+ + KTD++S G ++ E+ + K
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 75/277 (27%), Positives = 126/277 (45%), Gaps = 63/277 (22%)
Query: 524 LGEGGFGPVYKGQL-LNGQE---VAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTN----- 573
+G G FG V +G+L L G+ VAIK L S + + +F +EA ++ + H N
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 574 -----------LTDSRRNN------RLNWETRFSIIE------GIAQGLLYLHKYSRLRV 610
+T+ N R N + +F++I+ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYL---SEMNY 127
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE-TNTNRVVGTYG--YMSPEYAMSGV 667
+HRDL A NIL++ + K+SDFG++R + S+ T T+ + G + +PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 668 VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727
+ +DV+S+G+++ E++S + P W + N+ V A+E +
Sbjct: 188 FTSASDVWSYGIVMWEVMS--------YGERPY------WDMSNQD-----VINAIEQDY 228
Query: 728 ---SPNEVLRCIHVGLL-CVQDQATDRPAMPDVVSML 760
P + +H +L C Q RP +VS L
Sbjct: 229 RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 42/207 (20%)
Query: 524 LGEGGFGPVY------KGQLLNGQEVAIKRLSRRSG-QG-IVE----------------- 558
LG+GGFG V G+L +++ KRL +R G +G +VE
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 559 -FKNEAKLIAKLQHTNLTDSR-------RNNRLNWETRFSIIEG-IAQGLLYLHKYSRLR 609
F+ + L + N D R N E R I GL +LH+ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVS 669
+I+RDLK N+LLD+ N +ISD G+A L ++ T GT G+M+PE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 670 IKTDVFSFGVLVLEIVSGKKNNGCYRT 696
D F+ GV + E+++ + G +R
Sbjct: 176 FSVDYFALGVTLYEMIAAR---GPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 42/203 (20%)
Query: 521 VNKLGEGGFGPVYKG-----QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL- 574
+ +LG+G FG V Q G+ VA+K+L + + + +F+ E +++ LQH N+
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 575 -------TDSRRNNRLNWE---------------TRFSIIE------GIAQGLLYLHKYS 606
+ RRN RL E R + I +G+ YL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---G 125
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG---TYGYMSPEYA 663
R +HRDL NIL++ + KI DFG+ ++ ++ E R G + Y +PE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESL 183
Query: 664 MSGVVSIKTDVFSFGVLVLEIVS 686
S+ +DV+SFGV++ E+ +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 518 FSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD 576
++ K+G+G G VY + GQEVAIK+++ + NE ++ + +H N+ +
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 577 SRRNNRLNWETRFSIIEGIA--------------------------QGLLYLHKYSRLRV 610
++ L + + ++E +A Q L +LH +V
Sbjct: 81 YL-DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 136
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
IHRD+K+ NILL + K++DFG QS+ +T +VGT +M+PE
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 194
Query: 671 KTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700
K D++S G++ +E+V G+ Y ++PL
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP---YLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 50/184 (27%), Positives = 88/184 (47%), Gaps = 45/184 (24%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRL---SRRSGQGIVEFKNEAKLIAKLQHTN 573
F + ++GEG +G VYK + G+ VA+K++ + + G I + E K++ +L H N
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 574 L-------------TDSRRNNR-----------------------LNWETRFSIIEGIAQ 597
+ D +++ + + S ++ + +
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
GL Y HK + L HRD+K SNILL+++ K++DFG+AR++ +S TN+V+ T Y
Sbjct: 128 GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWY 183
Query: 658 MSPE 661
PE
Sbjct: 184 RPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 51/224 (22%)
Query: 517 NFSAVNKLGEGGFGP--VYK----GQLLNGQEVAIKRLS---RRSGQGIVEFKNEAKLIA 567
++ + LG+G FG +Y+ L+ +EV + RLS RR NE +++
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL------NEIVILS 54
Query: 568 KLQHTNLTD----------------------------SRRNNRLNWETRFSIIEGIAQGL 599
LQH N+ ++ E + I +
Sbjct: 55 LLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659
Y+HK ++HRD+K NI L K+ DFG+++I G S T VVGT YMS
Sbjct: 115 SYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMS 169
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703
PE + K+D+++ G ++ E+++ K+ + +PLNL+
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRT---FDATNPLNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 71/276 (25%), Positives = 124/276 (44%), Gaps = 63/276 (22%)
Query: 524 LGEGGFGPVYKGQL-LNGQE---VAIKRLSR-RSGQGIVEFKNEAKLIAKLQHTNL---- 574
+G G FG V++G L + G++ VAIK L + + +F +EA ++ + H N+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 575 ------------TDSRRNNRLNWETR-----FSIIE------GIAQGLLYLHKYSRLRVI 611
T+ N L+ R FS + GIA G+ YL S + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYV 129
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG------YMSPEYAMS 665
HRDL A NIL++ + K+SDFG++R+ + T T T G + +PE
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGGKIPIRWTAPEAIAY 184
Query: 666 GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725
+ +DV+SFG+++ E++S + P W + N +V++ ++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS--------FGERPY------WDMSNH-EVMKAINDGFRL 229
Query: 726 SFSPNEVLRCIHVGLL-CVQDQATDRPAMPDVVSML 760
+P + ++ +L C Q RP D+V++L
Sbjct: 230 P-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 59/219 (26%)
Query: 523 KLGEGGFGPVYKGQ---LLNGQE---VAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL-- 574
+LGEG FG V+ + LL Q+ VA+K L S +F+ EA+L+ LQH ++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 575 -----TDSR---------RNNRLNWETR-------------------------FSIIEGI 595
T+ R R+ LN R +I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG-- 653
A G++YL + L +HRDL N L+ + KI DFGM+R + T+ RV G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 184
Query: 654 --TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKK 689
+M PE + + ++D++SFGV++ EI + GK+
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 44/205 (21%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLNGQE-VAIKRLSRRSGQGIVEFKN---EAKLIAKLQHTN 573
F ++++G G FG VY + E VA+K++S Q ++++ E K + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 574 LTDSRRNNRLNWETRFSIIE---------------------------GIAQGLLYLHKYS 606
T + L T + ++E G QGL YLH ++
Sbjct: 83 -TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS- 665
IHRD+KA NILL + K++DFG A + N VGT +M+PE ++
Sbjct: 142 M---IHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAM 192
Query: 666 --GVVSIKTDVFSFGVLVLEIVSGK 688
G K DV+S G+ +E+ K
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 69/276 (25%), Positives = 118/276 (42%), Gaps = 66/276 (23%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLN--GQEVAIKRL---SRRSGQGIVEFKNEAKL--IAKLQ 570
+ V ++GEG +G V+K + L G+ VA+KR+ + G + + A L + +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 571 HTN---LTDSRRNNRLNWETRFSII----------------------EGIA-------QG 598
H N L D +R + ET+ +++ E I +G
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 599 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYM 658
L +LH + RV+HRDLK NIL+ K++DFG+ARI+ + VV T Y
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYR 176
Query: 659 SPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718
+PE + + D++S G + E+ K +R ++ QL GK+L++
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVD------QL---GKILDV 224
Query: 719 VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMP 754
+ + E + P + V L + + A P
Sbjct: 225 IGLPGEEDW-PRD------VAL--PRQAFHSKSAQP 251
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 45/210 (21%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH------ 571
F V +G G +G VYKG+ + ++A ++ +G E K E ++ K H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 572 -----------------------------TNLTDSRRNNRLNWETRFSIIEGIAQGLLYL 602
T+L + + N L E I I +GL +L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
H++ +VIHRD+K N+LL + K+ DFG++ L+++ N +GT +M+PE
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEV 182
Query: 663 AM-----SGVVSIKTDVFSFGVLVLEIVSG 687
K+D++S G+ +E+ G
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 39/205 (19%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRL---SRRSGQGIVEFKNEAKLIAKLQHT 572
+ +N++ EG +G VY+ + G+ VA+K+L + G I + E ++ KLQH
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHP 64
Query: 573 NLTDSRR---NNRLN----------------WET---RFSIIE--GIAQGLL----YLHK 604
N+ + + L+ ET F E + LL +LH
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
++HRDLK SN+LL+++ KI DFG+AR +G T VV T Y +PE +
Sbjct: 125 NW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVV-TLWYRAPELLL 179
Query: 665 S-GVVSIKTDVFSFGVLVLEIVSGK 688
S D++S G + E+++ K
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 36/218 (16%)
Query: 510 TISAATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK 568
+I ++ K+G+G G V+ + GQEVAIK+++ + NE ++ +
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 569 LQHTNLTDSRRNNRLNWETRFSIIEGIA--------------------------QGLLYL 602
L++ N+ + ++ L + F ++E +A Q L +L
Sbjct: 73 LKNPNIVNFL-DSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFL 131
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
H +VIHRD+K+ N+LL + K++DFG QS+ +T +VGT +M+PE
Sbjct: 132 HAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEV 186
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700
K D++S G++ +E+V G+ Y ++PL
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 42/200 (21%)
Query: 524 LGEGGFGPVYKGQLLNGQ-EVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL-----TDS 577
LG+G +G VY + L+ Q +AIK + R + + E L + L+H N+ +DS
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 578 RRNN-----------------RLNW-------ETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
R W +T + I +GL YLH +++HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHR 132
Query: 614 DLKASNILLDDQMNP-KISDFGMA-RIFGLNQ-SETNTNRVVGTYGYMSPEYAMSGV--V 668
D+K N+L++ KISDFG + R+ G+N +ET T GT YM+PE G
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT----GTLQYMAPEVIDKGPRGY 188
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
D++S G ++E+ +GK
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 39/199 (19%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
+ +LG G FG V G+ +VAIK + + EF EAK++ KL H L
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 575 -TDSR------------------RNNRLNWETR--FSIIEGIAQGLLYLHKYSRLRVIHR 613
T R R + ++ + + + +G+ YL + IHR
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYAMSGVVSI 670
DL A N L+DDQ K+SDFG++R + L+ T++ VG+ + PE + S
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSS---VGSKFPVRWSPPEVLLYSKFSS 180
Query: 671 KTDVFSFGVLVLEIVS-GK 688
K+DV++FGVL+ E+ S GK
Sbjct: 181 KSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 31/192 (16%)
Query: 523 KLGEGGFGPV-YKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN-------- 573
K+GEG G V + G++VA+K++ R Q NE ++ H N
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 574 -----------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLK 616
LTD + R+N E ++ + + L YLH VIHRD+K
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIK 145
Query: 617 ASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFS 676
+ +ILL K+SDFG +++ +VGT +M+PE + D++S
Sbjct: 146 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 677 FGVLVLEIVSGK 688
G++V+E++ G+
Sbjct: 204 LGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 47/207 (22%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLNGQE-----VAIKRLSR-RSGQGIVEFKNEAKLIAKLQH 571
F + LG G FG VYKG + E VAIK L S + E +EA ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 572 TN------------------------LTDSRRNNR--------LNWETRFSIIEGIAQGL 599
+ L D R ++ LNW + IA+G+
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 122
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659
YL + R++HRDL A N+L+ + KI+DFG+A++ G ++ E + +M+
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVS 686
E + + + ++DV+S+GV V E+++
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 43/203 (21%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLS----RRSGQGIV--EFKNEAKLIAKLQHTNLT- 575
LG G F Y+ + + G +A+K+++ S Q V + E +L+A+L H ++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 576 -------DSRRNNRLNWETRFSI------------------IEGIAQGLLYLHKYSRLRV 610
DS N + W S+ E + +GL YLH+ ++
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QI 124
Query: 611 IHRDLKASNILLDDQ-MNPKISDFGMARIFGLNQSETNTN----RVVGTYGYMSPEYAMS 665
IHRD+K +N+L+D +I+DFG A L T +++GT +M+PE
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAA--ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
DV+S G +++E+ + K
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 44/202 (21%)
Query: 521 VNKLGEGGFGPVYKGQ-LLNGQEVAIKRLS-RRSGQGIVEFK-NEAKLIAKLQ---HTN- 573
+ ++GEG +G VYK + L G+ VA+K++ S +GI E L+ +L+ H N
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 574 --LTDSRRNNRLNWETRFSII-EGIAQ----------------------------GLLYL 602
L D R + E + +++ E + Q G+ +L
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
H + R++HRDLK NIL+ KI+DFG+ARI+ + T+ VV T Y +PE
Sbjct: 124 HSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS---VVVTLWYRAPEV 177
Query: 663 AMSGVVSIKTDVFSFGVLVLEI 684
+ + D++S G + E+
Sbjct: 178 LLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 31/192 (16%)
Query: 523 KLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN-------- 573
K+GEG G V + +G+ VA+K++ R Q NE ++ QH N
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 574 -----------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLK 616
LTD + R+N E ++ + + L LH VIHRD+K
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIK 143
Query: 617 ASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFS 676
+ +ILL K+SDFG +++ +VGT +M+PE + D++S
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 677 FGVLVLEIVSGK 688
G++V+E+V G+
Sbjct: 202 LGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 79/284 (27%)
Query: 524 LGEGGFGPVYKGQL-LNGQE---VAIKRL-------SRRSGQGIVEFKNEAKLIAKLQHT 572
+G G FG V G+L L G+ VAIK L RR +F +EA ++ + H
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR------DFLSEASIMGQFDHP 65
Query: 573 NL----------------TDSRRNNRLNW-----ETRFSIIE------GIAQGLLYLHKY 605
N+ T+ N L+ + +F++I+ GIA G+ YL
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL--- 122
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG------YMS 659
S + +HRDL A NIL++ + K+SDFG++R+ E + T G + +
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTA 177
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719
PE + +DV+S+G+++ E++S + P W++ N+ V++ +
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMS--------YGERPY------WEMSNQ-DVIKAI 222
Query: 720 DIALEGSF--SPNEVLRCIHVGLL-CVQDQATDRPAMPDVVSML 760
+ EG +P + +H +L C Q +RP +VS+L
Sbjct: 223 E---EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 54/196 (27%), Positives = 87/196 (44%), Gaps = 37/196 (18%)
Query: 523 KLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFK---NEAKLIAKLQHTNLTD-- 576
K+GEG +G V+K + GQ VAIK+ +++ K E +++ +L+H NL +
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALREIRMLKQLKHPNLVNLI 66
Query: 577 --SRRNNRLNWETRF----------------------SIIEGIAQGLLYLHKYSRLRVIH 612
RR +L+ + II Q + + HK++ IH
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIH 123
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV-SIK 671
RD+K NIL+ Q K+ DFG ARI L + V T Y +PE +
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVGDTQYGPP 181
Query: 672 TDVFSFGVLVLEIVSG 687
DV++ G + E+++G
Sbjct: 182 VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 13/101 (12%)
Query: 594 GIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG-LNQSETNTNRVV 652
I + L YLH S+L VIHRD+K SN+L++ K+ DFG I G L S T
Sbjct: 111 SIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTID-A 164
Query: 653 GTYGYMSPE-----YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
G YM+PE G +K+DV+S G+ ++E+ +G+
Sbjct: 165 GCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 50/203 (24%)
Query: 524 LGEGGFGPVYKGQL-LNGQEVAIKRLS-----RRSGQGIVEFKNEAKLIAKLQHTNLTDS 577
LG+GGFG V Q+ G+ A K+L +R G+ + NE +++ K+ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVV-- 63
Query: 578 RRNNRLNWETR------FSIIEG--------------------------IAQGLLYLHKY 605
+ +ET+ +++ G I GL LH
Sbjct: 64 --SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH-- 119
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
R R+++RDLK NILLDD + +ISD G+A + + ET R VGT GYM+PE +
Sbjct: 120 -RERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGR-VGTVGYMAPEVVKN 175
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
+ D + G L+ E++ GK
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 36/205 (17%)
Query: 514 ATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFK--NEAKLIAKLQ 570
A ++ + KLGEG + VYKG +NGQ VA+K +S ++ +G V F EA L+ L+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLK 61
Query: 571 HTNL---------------------TD-----SRRNNRLNWETRFSIIEGIAQGLLYLHK 604
H N+ TD + L+ + + +GL Y+H
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH- 120
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
++HRDLK N+L+ K++DFG+AR + S+T ++ VV T Y P+ +
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPPDVLL 176
Query: 665 SGV-VSIKTDVFSFGVLVLEIVSGK 688
S D++ G + +E++ G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 44/136 (32%), Positives = 68/136 (50%), Gaps = 12/136 (8%)
Query: 559 FKNEAKLIAKLQHTNLTD-----SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
F+ + KL L + N + +R + E R I E I L +LH+ L +I+R
Sbjct: 74 FQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAE-IVLALDHLHQ---LGIIYR 129
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV--SIK 671
D+K NILLD + + ++DFG+++ F L + E GT YM+PE G
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKA 188
Query: 672 TDVFSFGVLVLEIVSG 687
D +S GVL E+++G
Sbjct: 189 VDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
I++G+ YL + ++++HRDL A N+L+ + KISDFG++R S ++
Sbjct: 136 ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP 192
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714
+M+ E + + ++DV+SFGVL+ EIV+ N Y P L + L G
Sbjct: 193 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIAPERL----FNLLKTGY 246
Query: 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
+E + E ++ + L C + + RP D+ L
Sbjct: 247 RMERPENCSEEMYN---------LMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 48/213 (22%)
Query: 517 NFSAVNKLGEGGFGPVYK-------GQLLNGQEV-----AIKRLSRRSGQGIVEFKNEAK 564
++ + LG G FG VYK LL +E+ A + R + I + +E
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 565 LIAK-LQHTNLTDSRR----NNRL--------------------------NWETRFSIIE 593
+I + L+H N+ + N+RL E ++I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 594 GIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653
+ L YLHK R ++HRDL +NI+L + I+DFG+A+ Q E+ VVG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVG 175
Query: 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
T Y PE + K DV++FG ++ ++ +
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 50/203 (24%)
Query: 524 LGEGGFGPV------YKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS 577
LG+GGFG V G++ +++ KR+ +R G+ + NE +++ K+ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 578 RRNNRLNWETR------FSIIEGIAQGLLYLHKYS------------------------- 606
+ET+ +I+ G G L H Y+
Sbjct: 66 A----YAYETKDALCLVLTIMNG---GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 607 -RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
R R+++RDLK NILLDD+ + +ISD G+A + + ET R VGT GYM+PE +
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGR-VGTVGYMAPEVINN 175
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
+ D + G L+ E++ G+
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 39/203 (19%)
Query: 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIV------EFKNEAKLIAKLQHTN-- 573
LG+G +G VY G GQ +A+K++ + + + + E L+ L+H N
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 574 --LTDSRRNNRLNWETRF-------SII---------------EGIAQGLLYLHKYSRLR 609
L +N ++ F SI+ + I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMAR---IFGLNQSETNTNRVV-GTYGYMSPEYAMS 665
V+HRD+K +N++L K+ DFG AR GL+ + +N + + GT +M+PE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
K+D++S G V E+ +GK
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 47/201 (23%)
Query: 524 LGEGGFGPVYKGQLLNGQE-----VAIKRLSRR-SGQGIVEFKNEAKLIAK--------- 568
LG G FG VYKG + E VAIK L S + E +EA ++A
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 569 ---------------LQHTNLTDSRRNNR--------LNWETRFSIIEGIAQGLLYLHKY 605
+ + L D R N+ LNW + IA+G+ YL +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE- 127
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+R++HRDL A N+L+ + KI+DFG+AR+ ++++E + + +M+ E +
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 666 GVVSIKTDVFSFGVLVLEIVS 686
+ ++DV+S+GV V E+++
Sbjct: 186 RRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 510 TISAATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK 568
++ ++ K+G+G G VY + GQEVAIK+++ + NE ++ +
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 569 LQHTN-------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLH 603
++ N LTD ++ ++ Q L +LH
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
+VIHRD+K+ NILL + K++DFG QS+ +T +VGT +M+PE
Sbjct: 133 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 187
Query: 664 MSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700
K D++S G++ +E+V G+ Y ++PL
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP---YLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 49/189 (25%), Positives = 76/189 (40%), Gaps = 50/189 (26%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLN---GQEVAIKRL--SRRSGQGIV-----------EFKN 561
+ +G G +G VYK + N G+E AIK+ + GI E K+
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 562 EAKLIAKLQHTNLTDS----------------------RRNNRLNWETRF--SIIEGIAQ 597
E + L L + R+ R++ S++ I
Sbjct: 62 EN--VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 598 GLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARIF-GLNQSETNTNRVV 652
G+ YLH V+HRDLK +NIL+ ++ KI D G+AR+F + + + VV
Sbjct: 120 GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 653 GTYGYMSPE 661
T Y +PE
Sbjct: 177 VTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLS---RRSGQGIVEFKNEAKLIAKLQHT 572
NF K+G G F VY+ LL+G VA+K++ + + E L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 573 NLTDSR----RNNRLNWETRFSIIEGIAQGLLYLHKYSRL-------------------- 608
N+ +N LN + +++ + + K RL
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 609 ---RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
RV+HRD+K +N+ + K+ D G+ R F + T + +VGT YMSPE
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHE 180
Query: 666 GVVSIKTDVFSFGVLVLEIVS 686
+ K+D++S G L+ E+ +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 44/206 (21%)
Query: 518 FSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD 576
F LG+GGFG V Q+ G+ A K+L ++ I + K E+ + + Q +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR---IKKRKGESMALNEKQILEKVN 58
Query: 577 SRRNNRLNW--ETR------FSIIEG--------------------------IAQGLLYL 602
SR L + ET+ +++ G I GL L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
H + R+++RDLK NILLDD + +ISD G+A + + +T R VGT GYM+PE
Sbjct: 119 H---QERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEV 172
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVSGK 688
+ + D ++ G L+ E+++G+
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 17/135 (12%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++E+ N L+ +Q + D R RF E I GL +LHK +I+RDL
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAE-IICGLQFLHKKG---IIYRDL 122
Query: 616 KASNILLDDQMNPKISDFGMAR--IFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTD 673
K N+LLD + KI+DFGM + + G E + GT Y++PE + D
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYIAPEILKGQKYNESVD 178
Query: 674 VFSFGVLVLEIVSGK 688
+SFGVL+ E++ G+
Sbjct: 179 WWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 50/202 (24%)
Query: 523 KLGEGGFGPVYKGQ-LLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTNL----- 574
KLGEG + VYKG+ L GQ VA+K RL G + EA L+ L+H N+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 575 ----------------TD------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
TD S N RL F ++ G+A Y H+
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRL---FLFQLLRGLA----YCHQR- 122
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-S 665
RV+HRDLK N+L+ ++ K++DFG+AR + S+T +N VV T Y P+ + S
Sbjct: 123 --RVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TLWYRPPDVLLGS 178
Query: 666 GVVSIKTDVFSFGVLVLEIVSG 687
S D++ G + E+ +G
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-11
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 44/203 (21%)
Query: 521 VNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKN---EAKLIAKLQHTNL-- 574
++ +G G +G V G++VAIK+LSR Q + K E +L+ + H N+
Sbjct: 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHMDHENVIG 78
Query: 575 ------TDSRRNN----------------------RLNWETRFSIIEGIAQGLLYLHKYS 606
S + +L+ + ++ I +GL Y+H
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS-- 136
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
+IHRDLK SNI +++ KI DFG+AR ++ V T Y +PE ++
Sbjct: 137 -AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNW 190
Query: 667 VVSIKT-DVFSFGVLVLEIVSGK 688
+ +T D++S G ++ E+++GK
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645
E RF E I GL ++H +R V++RDLK +NILLD+ + +ISD G+A F S+
Sbjct: 98 EMRFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDF----SK 149
Query: 646 TNTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG 704
+ VGT+GYM+PE GV D FS G ++ +++ G ++T +
Sbjct: 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-- 207
Query: 705 YAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLL 741
++ + + L SFSP LR + GLL
Sbjct: 208 --------DRMTLTMAVELPDSFSPE--LRSLLEGLL 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
RF E I GL +LH+ +I+RDLK N+LLD + + KI+DFGM + L T
Sbjct: 98 ARFYAAE-IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153
Query: 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+T GT Y++PE D ++ GVL+ E+++G+
Sbjct: 154 ST--FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 44/209 (21%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN--EAKLIAKLQH--- 571
+ V ++G G +G VYK + +G VA+K + ++ + + E L+ +L+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 572 ---TNLTDSRRNNRLNWETRFSII-EGIAQ----------------------------GL 599
L D +R + ET+ +++ E + Q GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659
+LH ++HRDLK NIL+ K++DFG+ARI+ + T VV T Y +
Sbjct: 122 DFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP---VVVTLWYRA 175
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
PE + + D++S G + E+ K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 57/220 (25%)
Query: 519 SAVNKLGEGGFGPVYKGQLL------NGQEVAIKRL-SRRSGQGIVEFKNEA---KLIAK 568
+ LGEG FG V K + + VA+K L + + + + +E K+I K
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 569 -----------------------LQHTNLTDSRRNNR-----LNWETRFSIIEGI----- 595
H NL D R R + + E +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 596 -------AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETN 647
A+G+ +L + + IHRDL A N+L+ + KI+DFG+AR I ++
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 648 TN-RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
TN R+ +M+PE V + ++DV+SFGVL+ EI +
Sbjct: 192 TNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 36/202 (17%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHT 572
+++ + KLGEG + VYKG+ +NG+ VA+K RL G + EA L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 573 NL---------------------TD-----SRRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
N+ TD + L+ E + + +GL Y+H+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-S 665
++HRDLK N+L+ D K++DFG+AR + S T +N VV T Y P+ + S
Sbjct: 124 ---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVLLGS 178
Query: 666 GVVSIKTDVFSFGVLVLEIVSG 687
S D++ G + +E++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 54/199 (27%), Positives = 85/199 (42%), Gaps = 48/199 (24%)
Query: 524 LGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGI-VEFKNEAKLIAKLQHTNLTD------ 576
LG+G FG V+KG L + VA+K Q + ++F +EA+++ + H N+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 577 ---------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++ + L + A G+ YL + IHRDL
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDL 119
Query: 616 KASNILLDDQMNPKISDFGMAR-----IF---GLNQSETNTNRVVGTYGYMSPEYAMSGV 667
A N L+ + KISDFGM+R I+ GL Q + +PE G
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK---------WTAPEALNYGR 170
Query: 668 VSIKTDVFSFGVLVLEIVS 686
S ++DV+S+G+L+ E S
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-11
Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 577 SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636
++R+ L + I + I +GL YLH R+IHRD+K NI ++D I D G A
Sbjct: 148 TKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204
Query: 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+ + GT +PE + K D++S G+++ E+++
Sbjct: 205 Q---FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 36/198 (18%)
Query: 521 VNKLGEGGFGPVYKGQL-LNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTNLT-- 575
++KLGEG + VYKG+ L VA+K RL G + E L+ L+H N+
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 576 -------------------DSRR-----NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
D ++ N +N + + +GL Y H R +V+
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVL 126
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-SGVVSI 670
HRDLK N+L++++ K++DFG+AR + ++T +N VV T Y P+ + S S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 671 KTDVFSFGVLVLEIVSGK 688
+ D++ G + E+ +G+
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 60/227 (26%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ---LLNGQE---VAIKRLSRR-SGQGIVEFKNEAKLIAK 568
NN V +G+G FG V++ + LL + VA+K L S +F+ EA L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 569 LQHTN-------------------------LTDSRRNNRLNWETRFS------------- 590
H N L + R+ + S
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 591 ----------IIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IF 639
I + +A G+ YL S + +HRDL N L+ + M KI+DFG++R I+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 640 GLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+ + + N + +M PE + ++DV+++GV++ EI S
Sbjct: 182 SADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-11
Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR--IFGLNQSETNTNRVV 652
IA GL +LH +I+RDLK N++LD + + KI+DFGM + IFG T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG----GKTTRTFC 162
Query: 653 GTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
GT Y++PE D ++FGVL+ E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 9e-11
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 58/216 (26%)
Query: 518 FSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKN---------EAKLIA 567
+ + +G G +G V G++VAIK++S F + E KL+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLR 54
Query: 568 KLQHTNL--------------------------TDSRR----NNRLNWETRFSIIEGIAQ 597
L+H N+ TD + L + + I +
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN--TNRVVGTY 655
GL YLH VIHRDLK SNIL++ + KI DFG+AR ++ E T VV T
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TR 170
Query: 656 GYMSPEYAMSGV---VSIKTDVFSFGVLVLEIVSGK 688
Y +PE +S +I D++S G + E+++ K
Sbjct: 171 WYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 40/204 (19%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN 573
+ + + +LG+G FG VYK Q G A K + S + + +F E ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 574 LT---DSRRNNRLNW----------------ETRFSIIEG--------IAQGLLYLHKYS 606
+ ++ W E + E + + L +LH +
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH- 122
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT-NRVVGTYGYMSPEYAM- 664
+VIHRDLKA NILL + K++DFG++ N+S + +GT +M+PE
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVS---AKNKSTLQKRDTFIGTPYWMAPEVVAC 177
Query: 665 ----SGVVSIKTDVFSFGVLVLEI 684
K D++S G+ ++E+
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 38/200 (19%)
Query: 524 LGEGGFGPVY------KGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS 577
LG+G FG VY G+ L ++V S + + + + E +L+ LQH +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 578 RRNNRLNWETRFSII----------------------------EGIAQGLLYLHKYSRLR 609
R E +I I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---M 126
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMA-RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
++HRD+K +NIL D N K+ DFG + R+ + S T V GT +MSPE
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
K DV+S G V+E+++ K
Sbjct: 187 GRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 38/200 (19%)
Query: 524 LGEGGFGPVYKGQLLN-GQEVAIKRL-----SRRSGQGIVEFKNEAKLIAKLQHTNLTDS 577
LG G FG VY + G+E+A+K++ S+ + + + + E +L+ L+H +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 578 RRNNRLNWETRFSII----------------------------EGIAQGLLYLHKYSRLR 609
R E + SI I QG+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---M 126
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMA-RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
++HRD+K +NIL D N K+ DFG + RI + S T V GT +MSPE
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY 186
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
K DV+S V+E+++ K
Sbjct: 187 GRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 29/169 (17%)
Query: 591 IIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650
I + +GL YL L+++HRD+K SN+L++ + K+ DFG++ L S T
Sbjct: 100 IAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVST--QLVNSIAKT-- 152
Query: 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK-------KNNGCYRTDHPLNLI 703
VGT YM+PE I +DV+S G+ +E+ G+ KN G PL L+
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM---PLQLL 209
Query: 704 GYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPA 752
+ V E + G FS + +H C++ Q +RPA
Sbjct: 210 --------QCIVDEDPPVLPVGQFSE----KFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 46/225 (20%)
Query: 517 NFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKR-------------------LSRRSGQGI 556
+ ++ +GEG +G V G +VAIK+ L R + I
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 557 VEFK-----------NEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKY 605
+ N+ ++ +L T+L + L+ + + I +GL Y+H
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA 125
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT-NRVVGTYGYMSPEYAM 664
+ V+HRDLK SN+LL+ + KI DFG+ARI T V T Y +PE +
Sbjct: 126 N---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182
Query: 665 SGVVSIKT-DVFSFGVLVLEIVSGK-----KNNGCYRTDHPLNLI 703
+ K D++S G ++ E++S + K+ Y H LNLI
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YL--HQLNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 36/202 (17%)
Query: 518 FSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRL--SRRSGQGIVEFKNEAKLIAKLQH 571
+ V K+GEG FG K L+ +G++ IK + S+ S + E + E +++ ++H
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 572 TNLTDSRRN--------------------NRLNWE--TRFS---IIEGIAQGLLYLHKYS 606
N+ + + ++N + F I++ Q L L
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
+++HRD+K+ NI L K+ DFG+AR+ LN + +GT Y+SPE +
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENR 176
Query: 667 VVSIKTDVFSFGVLVLEIVSGK 688
+ K+D+++ G ++ E+ + K
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 34/217 (15%)
Query: 510 TISAATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK 568
++ ++ K+G+G G VY + GQEVAI++++ + NE ++ +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 569 LQHTN-------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLH 603
++ N LTD ++ ++ Q L +LH
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
+VIHRD+K+ NILL + K++DFG QS+ + +VGT +M+PE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVV 188
Query: 664 MSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700
K D++S G++ +E++ G+ Y ++PL
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 38/198 (19%)
Query: 524 LGEGGFGPVYKGQLL--NGQEV--AIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLT--- 575
+G+G FG VY G L+ +GQ++ A+K L+R + VE F E ++ H N+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 576 --------------------DSR---RNNRLNWETRFSIIEG--IAQGLLYLHKYSRLRV 610
D R R+ N + I G +A+G+ YL + +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKF 119
Query: 611 IHRDLKASNILLDDQMNPKISDFGMAR-IFGLN-QSETNTNRVVGTYGYMSPEYAMSGVV 668
+HRDL A N +LD+ K++DFG+AR I+ S N +M+ E +
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 669 SIKTDVFSFGVLVLEIVS 686
+ K+DV+SFGVL+ E+++
Sbjct: 180 TTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 70/279 (25%), Positives = 106/279 (37%), Gaps = 54/279 (19%)
Query: 524 LGEGGFGPV--YKGQLLN---GQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTN---- 573
LGEG FG V Y N G+ VA+K L R GQ +K E ++ L H N
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 574 -----------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRV 610
L D ++LN + I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HY 128
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQ-----SETNTNRVVGTYGYMSPEYAMS 665
IHRDL A N+LLD+ KI DFG+A+ E + V + + E
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAVECLKE 184
Query: 666 GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP----LNLIGYAWQLWNEGKVLELVDI 721
S +DV+SFGV + E+++ C P +IG +++EL++
Sbjct: 185 NKFSYASDVWSFGVTLYELLT-----HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239
Query: 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
+ N + C + +A RP ++ +L
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 47/226 (20%)
Query: 503 LEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN 561
L+ D + F V +G G +G VYKG+ + GQ AIK + + E K
Sbjct: 3 LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKL 61
Query: 562 EAKLIAKLQH-----------------------------------TNLTDSRRNNRLNWE 586
E ++ K H T+L + + N L +
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
I I +GL +LH + +VIHRD+K N+LL + K+ DFG++ L+++
Sbjct: 122 WIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVG 176
Query: 647 NTNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSG 687
N +GT +M+PE ++D++S G+ +E+ G
Sbjct: 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 34/202 (16%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFK--NEAKLIAKLQHT 572
N + + +GEG +G V K + G+ VAIK+ V+ E K++ +L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 573 NLTD----SRRNNR----------------------LNWETRFSIIEGIAQGLLYLHKYS 606
N+ + RR R L + S I + Q + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH--- 117
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
+IHRD+K NIL+ + K+ DFG AR + T+ V T Y +PE +
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGD 176
Query: 667 VVSIK-TDVFSFGVLVLEIVSG 687
K DV++ G ++ E++ G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
I +GL YLH ++HRD+K N+L++ KI DFG+AR+ ++S+ T VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 655 YGYMSPEYAM-SGVVSIKTDVFSFGVLVLEIVSGK 688
Y Y +PE M S + D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 40/100 (40%), Positives = 55/100 (55%), Gaps = 13/100 (13%)
Query: 595 IAQGLLYL-HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG-LNQSETNTNRVV 652
I + L YL K+ VIHRD+K SNILLD N K+ DFG I G L S+ T R
Sbjct: 123 IVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFG---ISGRLVDSKAKT-RSA 175
Query: 653 GTYGYMSPEY----AMSGVVSIKTDVFSFGVLVLEIVSGK 688
G YM+PE + I+ DV+S G+ ++E+ +G+
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 47/201 (23%)
Query: 524 LGEGGFGPVYKGQLLNGQE-----VAIKRLSRRSGQ-------------GIVEFKNEAKL 565
LG G FG V+KG + + VAIK + RSG+ G ++ +L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 566 I-----AKLQ-------HTNLTDSRRNNR--------LNWETRFSIIEGIAQGLLYLHKY 605
+ A LQ +L D R +R LNW + IA+G+ YL ++
Sbjct: 75 LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEEH 128
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
R++HR+L A NILL +I+DFG+A + + + + +M+ E +
Sbjct: 129 ---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 666 GVVSIKTDVFSFGVLVLEIVS 686
G + ++DV+S+GV V E++S
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-10
Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 35/184 (19%)
Query: 540 GQEVAIKRLSRRSGQG---IVEFKNEAKLIAKLQHTN---LTDSRRNNRLNWETRFSIIE 593
G EVAIK L + + F+ E L A+L H N L DS F +
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 594 GI-------AQGLLYLHKYSRLR--------------VIHRDLKASNILL---DDQMNPK 629
G A G L + RL ++HRDLK NI++ + + K
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 630 ISDFGMARIF-----GLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEI 684
+ DFG+ + + T T V+GT Y +PE V+ +D++++G++ LE
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLEC 182
Query: 685 VSGK 688
++G+
Sbjct: 183 LTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 40/103 (38%), Positives = 59/103 (57%), Gaps = 9/103 (8%)
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645
E RF E I GL ++H +R V++RDLK +NILLD+ + +ISD G+A F S+
Sbjct: 98 EMRFYATE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDF----SK 149
Query: 646 TNTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSG 687
+ VGT+GYM+PE G D FS G ++ +++ G
Sbjct: 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR +
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+PE V + ++DV+SFGVL+ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 34/95 (35%), Positives = 58/95 (61%), Gaps = 9/95 (9%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQS--ETNTNRV 651
IA G+ YLHK VIH+D+ A N ++D+++ KI+D ++R +F ++ N NR
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
V +M+ E ++ S +DV+SFGVL+ E+++
Sbjct: 183 V---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 50/209 (23%)
Query: 518 FSAVNKLGEGGFGPV------YKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH 571
F LG+GGFG V G++ + + KR+ +R G+ + NE +++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 572 TNLTDSRRNNRLNWETR------FSIIEG--------------------------IAQGL 599
+ N +ET+ +I+ G I GL
Sbjct: 60 QFVV----NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659
LH R ++RDLK NILLDD + +ISD G+A + + E+ R VGT GYM+
Sbjct: 116 EDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMA 169
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
PE + ++ D + G L+ E++ G+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 36/198 (18%)
Query: 521 VNKLGEGGFGPVYKGQL-LNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTNL--- 574
+ KLGEG + V+KG+ L VA+K RL G + E L+ L+H N+
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69
Query: 575 -----TDSRRN------------------NRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
TD N ++ + I +GL Y H R +V+
Sbjct: 70 HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVL 126
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-SGVVSI 670
HRDLK N+L++++ K++DFG+AR + ++T +N VV T Y P+ + S S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 671 KTDVFSFGVLVLEIVSGK 688
+ D++ G + E+ SG+
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
I GL +LH +++RDLK NILLD + KI+DFGM + L ++T T GT
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT--FCGT 159
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y++PE + + D +SFGVL+ E++ G+
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 54/211 (25%)
Query: 523 KLGEGGFGPVYKG---QLLNGQ---EVAIKRLSRR-SGQGIVEFKNEAKL---------- 565
+LG+G FG VY+G ++ G+ VA+K ++ S + +EF NEA +
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 566 -----IAKLQ----------HTNLTDSRRNNRLNWE--------TRFSIIE---GIAQGL 599
++K Q H +L R+ R E T +I+ IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT----Y 655
YL+ + +HRDL A N ++ KI DFGM R + ET+ R G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 656 GYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+PE GV + +D++SFGV++ EI S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 42/208 (20%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLLNGQEV----AIKRLSR-------------RSGQGIVEF 559
NF + LG G +G V+ + + G + A+K L + R+ + ++E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 560 KNEAKLIAKLQHTNLTDSR-------------------RNNRLNWETRFSIIEGIAQGLL 600
++ + L + T+++ R+N E RF E I L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE-IILALE 119
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSP 660
+LHK L +++RD+K NILLD + + ++DFG+++ F L++ + T GT YM+P
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMAP 175
Query: 661 EYAMSGVVSIK-TDVFSFGVLVLEIVSG 687
E K D +S G+L+ E+++G
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 48/207 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQE-VAIKRLSRRSGQGIVEFKNE------------ 562
+F + ++G+GG+G V+ + + E VA+KR+ + ++ NE
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKS----LLFKLNEVRHVLTERDILT 56
Query: 563 -------AKLIAKLQHTNLT----------DSRR---NNRL--NWETRFSIIEGIAQGLL 600
KL+ Q D R N + RF + E +
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-AVD 115
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSP 660
LH L IHRDLK N L+D + K++DFG+++ T N VVG+ YM+P
Sbjct: 116 ALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVVGSPDYMAP 167
Query: 661 EYAMSGVVSIKTDVFSFGVLVLEIVSG 687
E D +S G ++ E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 32/84 (38%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGV 667
L++IHRD+K SNILLD N K+ DFG I G R G YM+PE
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 668 VS---IKTDVFSFGVLVLEIVSGK 688
+++DV+S G+ + E+ +GK
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 38/200 (19%)
Query: 524 LGEGGFGPVYKGQLLN-GQEVAIKRL-----SRRSGQGIVEFKNEAKLIAKLQHTNLTDS 577
LG+G FG VY + G+E+A+K++ S + + + + E +L+ L H +
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 578 RRNNRLNWETRFSII----------------------------EGIAQGLLYLHKYSRLR 609
R E SI I +G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---M 126
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMA-RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
++HRD+K +NIL D N K+ DFG + R+ + S T V GT +MSPE
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
K D++S G V+E+++ K
Sbjct: 187 GRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 59/220 (26%), Positives = 88/220 (40%), Gaps = 60/220 (27%)
Query: 523 KLGEGGFGPVYKGQLLN------GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN--- 573
+LGEG FG V+ + N VA+K L + +F+ EA+L+ LQH +
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 574 ------------------------------------LTDSR---RNNRLNWETRFSIIEG 594
L D + L I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG- 653
IA G++YL + +HRDL N L+ + KI DFGM+R + T+ RV G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184
Query: 654 ---TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKK 689
+M PE M + ++DV+SFGV++ EI + GK+
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 43/133 (32%), Positives = 71/133 (53%), Gaps = 13/133 (9%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++E+ N L+ ++Q + D R +RF E + L++LH++ VI+RDL
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPR-------SRFYAAE-VTLALMFLHRHG---VIYRDL 122
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675
K NILLD + + K++DFGM + LN T T GT Y++PE D +
Sbjct: 123 KLDNILLDAEGHCKLADFGMCKEGILNGVTTTT--FCGTPDYIAPEILQELEYGPSVDWW 180
Query: 676 SFGVLVLEIVSGK 688
+ GVL+ E+++G+
Sbjct: 181 ALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 57/224 (25%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLN---GQE---VAIKRLSRRSGQGIVEFKNEAKLIAKL 569
+N +LGEG FG V+ + N Q+ VA+K L S +F EA+L+ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 570 QHTNLT----------------DSRRNNRLNWETR-----------------------FS 590
QH ++ + ++ LN R
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 591 IIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650
I + IA G++YL + +HRDL N L+ + + KI DFGM+R + T+ R
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYR 177
Query: 651 VVG----TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKK 689
V G +M PE M + ++DV+S GV++ EI + GK+
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 33/95 (34%), Positives = 59/95 (62%), Gaps = 8/95 (8%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG-LNQSETNTNRVVG 653
+ +GL YL + + +++HRD+K SNIL++ + K+ DFG++ G L S N+ VG
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS--FVG 160
Query: 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
T YMSPE ++++D++S G+ ++E+ G+
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR--IFGLNQSETNTNRVV 652
I GL +LH +I+RDLK N++LD + KI+DFGM + +FG N++ T
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST----FC 157
Query: 653 GTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
GT Y++PE + D +SFGVL+ E++ G+
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 39/202 (19%)
Query: 521 VNKLGEGGFGPV----YKGQLLN-GQEVAIKRLSRRSGQG-IVEFKNEAKLIAKLQHTNL 574
+ LGEG FG V Y + N G++VA+K L SG I + K E +++ L H N+
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 575 TD-----------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKY 605
R N++N + + I +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG-- 126
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS-ETNTNRVVGTYGYMSPEYAM 664
SR + +HRDL A N+L++ + KI DFG+ + ++ T + + + +PE +
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 665 SGVVSIKTDVFSFGVLVLEIVS 686
I +DV+SFGV + E+++
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 20/151 (13%)
Query: 559 FKNEAKLIAKLQHTNLTD----SRRNNRLNWE-TRFSIIEGIAQGLLYLHKYSRLRVIHR 613
F+ E++L +++ N D +R +L E RF E I+ L YLH+ +I+R
Sbjct: 65 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---IIYR 120
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTD 673
DLK N+LLD + + K++D+GM + GL +T T+ GT Y++PE D
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDT-TSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 674 VFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG 704
++ GVL+ E+++G+ P +++G
Sbjct: 179 WWALGVLMFEMMAGRS---------PFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645
+ +F + E +A L +LH L +I+RDLK NILLD++ + K++DFG+++ E
Sbjct: 99 DVKFYLAE-LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHE 152
Query: 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687
GT YM+PE + D +SFGVL+ E+++G
Sbjct: 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR +
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+PE V +I++DV+SFGVL+ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 42/133 (31%), Positives = 64/133 (48%), Gaps = 15/133 (11%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++ F N +L LQ D R RF A+ L L + VI+RDL
Sbjct: 71 VLAFINGGELFHHLQREGRFDLSR-------ARFYT----AELLCALENLHKFNVIYRDL 119
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETN-TNRVVGTYGYMSPEYAMSGVVSIKTDV 674
K NILLD Q + + DFG+ + LN + + TN GT Y++PE + + D
Sbjct: 120 KPENILLDYQGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 675 FSFGVLVLEIVSG 687
++ GVL+ E+++G
Sbjct: 177 WTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 39/108 (36%), Positives = 59/108 (54%), Gaps = 15/108 (13%)
Query: 588 RFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647
RFS +AQG+ +L + IHRD+ A N+LL D KI DFG+AR +
Sbjct: 216 RFSS--QVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMND 265
Query: 648 TNRVVGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKN 690
+N VV +M+PE V ++++DV+S+G+L+ EI S K+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 36/198 (18%)
Query: 521 VNKLGEGGFGPVYKGQL-LNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTN---- 573
++KLGEG + V+KG+ L VA+K RL G + E L+ L+H N
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTL 68
Query: 574 --LTDSRRNNRLNWETRFSIIE--------------------GIAQGLLYLHKYSRLRVI 611
+ + R L +E S ++ + +GL Y HK +++
Sbjct: 69 HDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KIL 125
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-SGVVSI 670
HRDLK N+L++++ K++DFG+AR + ++T +N VV T Y P+ + S S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 671 KTDVFSFGVLVLEIVSGK 688
D++ G ++ E+ +G+
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 51/207 (24%)
Query: 521 VNKLGEGGFGPV-YKGQLLNGQEVAIKRL-----SRRSGQGIVEFKNEAKLIAKLQHTNL 574
V +G+G +G V +G++ IK+L SRR + + EA+L+++L+H N+
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA---EQEAQLLSQLKHPNI 61
Query: 575 TDSRRNNRLNWETR---FSIIEG------------------------------IAQGLLY 601
R + WE I+ G IA L Y
Sbjct: 62 VAYRES----WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
LH+ ++HRDLK N+ L K+ D G+AR+ NQ + + ++GT YMSPE
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMAST-LIGTPYYMSPE 172
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+ + K+DV++ G V E+ + K
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-09
Identities = 62/267 (23%), Positives = 120/267 (44%), Gaps = 34/267 (12%)
Query: 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRL--------SRRSGQGIVEFKNEAKLIA----- 567
N + G G YKG+ + NG + +K + S + G ++ N KLI
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE 755
Query: 568 --------KLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASN 619
++ NL++ RN L+WE R I GIA+ L +LH V+ +L
Sbjct: 756 KGAYLIHEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813
Query: 620 ILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGV 679
I++D + P + L + + Y++PE + ++ K+D++ FG+
Sbjct: 814 IIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGL 866
Query: 680 LVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG--SFSPNEVLRCIH 737
+++E+++GK H +++ +A +++ + +D ++ G S + NE++ ++
Sbjct: 867 ILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMN 925
Query: 738 VGLLCVQDQATDRPAMPDVVSMLANES 764
+ L C T RP DV+ L + S
Sbjct: 926 LALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 71/241 (29%)
Query: 524 LGEGGFGPVYKGQLLNG---QEVAIKRLSRRSGQGI-VEFKNEAKLIAKL---------- 569
+GEG FG V K ++ + AIKR+ + + +F E +++ KL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 570 ----------------QHTNLTDSRRNNR-LNWETRFSIIEG----------------IA 596
H NL D R +R L + F+I +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 597 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG 656
+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R E + +G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 186
Query: 657 --YMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGC--------------YRTDHPL 700
+M+ E V + +DV+S+GVL+ EIVS C YR + PL
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 246
Query: 701 N 701
N
Sbjct: 247 N 247
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 37/199 (18%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT 575
+F + ++G G +G VYK + +N G+ AIK + G+ + E ++ +H+N+
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 576 ----DSRRNNRLNW----------------------ETRFSII-EGIAQGLLYLHKYSRL 608
R ++L W E++ + + QGL YLH +
Sbjct: 70 AYFGSYLRRDKL-WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK- 127
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM---S 665
+HRD+K +NILL D + K++DFG++ + + +GT +M+PE A
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 666 GVVSIKTDVFSFGVLVLEI 684
G + D+++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 4e-09
Identities = 38/99 (38%), Positives = 50/99 (50%), Gaps = 21/99 (21%)
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV----VGTYG 656
Y+H S VIHRDLK SNILL+ K++DFG+AR E N V V T
Sbjct: 122 YIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLTDYVATRW 177
Query: 657 YMSPE-------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y +PE Y GV D++S G ++ E++ GK
Sbjct: 178 YRAPEILLGSTRYT-KGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 51/209 (24%)
Query: 524 LGEGGFGPVYKGQLL---NGQEVAIKRLSRRSGQGI-VEFKNEAKLIAKLQH-------- 571
+GEG FG V + + AIK L + + +F E +++ KL H
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 572 ------------------TNLTDSRRNNR-LNWETRFSIIEGIAQGLLY----------- 601
NL D R +R L + F+ G A L
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 602 --LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG--Y 657
+ S + IHRDL A N+L+ + + KI+DFG++R E + +G +
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRLPVRW 184
Query: 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
M+ E V + K+DV+SFGVL+ EIVS
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 6/95 (6%)
Query: 594 GIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653
+ +GL YL + + +++HRD+K SNIL++ + K+ DFG++ ++ N VG
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVG 164
Query: 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
T YMSPE S+++D++S G+ ++E+ G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-09
Identities = 33/93 (35%), Positives = 52/93 (55%)
Query: 597 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG 656
Q LL +H +IHRD+K++NILL K+ DFG ++++ S+ GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 657 YMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKK 689
Y++PE S K D+FS GVL+ E+++ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 31/95 (32%), Positives = 57/95 (60%), Gaps = 6/95 (6%)
Query: 594 GIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653
+ +GL YL + + +++HRD+K SNIL++ + K+ DFG++ ++ N VG
Sbjct: 111 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVG 164
Query: 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
T YMSPE S+++D++S G+ ++E+ G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 48/217 (22%)
Query: 509 QTISAATNNFSAVNKLGEGGFGPV---YKGQLLNGQEVAIKRLSRRSGQGIVEFKN---E 562
+T+ + + +G G +G V Y +L Q+VA+K+LSR Q ++ + E
Sbjct: 8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSR-PFQSLIHARRTYRE 64
Query: 563 AKLIAKLQH-------------------------TNLTDSRRNN-----RLNWETRFSII 592
+L+ ++H TNL + NN +L+ E +I
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI 124
Query: 593 EGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVV 652
+ +GL Y+H +IHRDLK SN+ +++ +I DFG+AR Q++ V
Sbjct: 125 YQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYV 176
Query: 653 GTYGYMSPEYAMSGVVSIKT-DVFSFGVLVLEIVSGK 688
T Y +PE ++ + +T D++S G ++ E++ GK
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 42/132 (31%), Positives = 66/132 (50%), Gaps = 13/132 (9%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++EF N L+ +Q + D R RF E I L++LH +I+RDL
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEAR-------ARFYAAE-ITSALMFLHDKG---IIYRDL 122
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675
K N+LLD + + K++DFGM + N T+T GT Y++PE + D +
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGTPDYIAPEILQEMLYGPSVDWW 180
Query: 676 SFGVLVLEIVSG 687
+ GVL+ E++ G
Sbjct: 181 AMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 41/208 (19%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLLNGQEV----AIKRLSR-------------RSGQGIVEF 559
NF + LG G +G V+ + ++G + A+K L + R+ + ++E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 560 KNEAKLIAKLQHTNLTDSRRN------------NRLNWETRFS------IIEGIAQGLLY 601
++ + L + TD++ + L+ RF I L +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
LHK L +I+RD+K NILLD + ++DFG+++ F ++ E + GT YM+P+
Sbjct: 121 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPD 176
Query: 662 YAMSGVV--SIKTDVFSFGVLVLEIVSG 687
G D +S GVL+ E+++G
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 36/96 (37%), Positives = 52/96 (54%), Gaps = 11/96 (11%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
IA G+ YL+ + +HRDL A N ++ + KI DFGM R + ET+ R G
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 655 ----YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+MSPE GV + +DV+SFGV++ EI +
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 37/96 (38%), Positives = 59/96 (61%), Gaps = 11/96 (11%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ----SETNTNR 650
+A+G+ YL SR R IHRDL A N+L+ + KI+DFG+AR G++ +T+ R
Sbjct: 143 VARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTSNGR 197
Query: 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+ +M+PE V + ++DV+SFG+L+ EI +
Sbjct: 198 L--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 36/108 (33%), Positives = 62/108 (57%), Gaps = 5/108 (4%)
Query: 580 NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-I 638
+L ++ S +A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
++ + TN + +M+PE V + ++DV+SFGVL+ EI +
Sbjct: 185 HNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 32/154 (20%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLLNGQE-VAIKRLSRRS-GQGIVEFK-NEAKLIAKLQHTN 573
+ + K+GEG +G V+K + E VA+KR+ +G+ E L+ +L+H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 574 LT---------------------DSRR-----NNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+ D ++ N ++ E S + + +GL + H +
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH-- 118
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641
V+HRDLK N+L++ K++DFG+AR FG+
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
I+ GL +LH+ +I+RDLK N++LD + + KI+DFGM + ++ T T GT
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGT 164
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y++PE D +++GVL+ E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 46/199 (23%), Positives = 82/199 (41%), Gaps = 36/199 (18%)
Query: 523 KLGEGGFGPVYKG--QLLNGQE--VAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNL--- 574
+GEG FG VY+G ++ VA+K + + E F EA ++ + H ++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 575 ----TDS-------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
T++ L+ + ++ L YL R +
Sbjct: 73 IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFV 129
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIK 671
HRD+ A N+L+ K+ DFG++R ++S ++ +M+PE +
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRRFTSA 188
Query: 672 TDVFSFGVLVLEIVS-GKK 689
+DV+ FGV + EI+ G K
Sbjct: 189 SDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 51/209 (24%)
Query: 524 LGEGGFGPVYKGQL----LNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTN---- 573
LGEG FG V +GQL + +VA+K +L + I EF +EA + H N
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 574 ----LTDSRRNN------------------------------RLNWETRFSIIEGIAQGL 599
S +L +T + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVGT-YGY 657
YL S IHRDL A N +L + M ++DFG+++ I+ + R+ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY--SGDYYRQGRIAKMPVKW 181
Query: 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
++ E V + K+DV++FGV + EI +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+PE V + ++DV+SFGVL+ EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 46/201 (22%)
Query: 521 VNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSRR 579
+ +LG+G FG VYK + G A K + +S + + ++ E +++A H + +
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIV--KL 74
Query: 580 NNRLNWETRFSII-----------------------------EGIAQGLLYLHKYSRLRV 610
W+ + I+ + + L YLH +++
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKI 131
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR--VVGTYGYMSPEYAMSGVV 668
IHRDLKA N+LL + K++DFG++ +T R +GT +M+PE M +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 669 S-----IKTDVFSFGVLVLEI 684
K D++S G+ ++E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 46/213 (21%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKR-LSRRSGQGI----------VEFKNEA 563
+ + + K+GEG +G VYK + G+ VA+K+ +GI ++ +E+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 564 KLIAKL---QHT---------------------NLTDSRR---NNRLNWETRFSIIEGIA 596
I +L +H DS L +T S + +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 597 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARIFGLNQSETNTNRVVGTY 655
+G+ + HK+ V+HRDLK N+L+D Q KI+D G+ R F + ++ T+ +V T
Sbjct: 121 KGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TL 175
Query: 656 GYMSPEYAMSGV-VSIKTDVFSFGVLVLEIVSG 687
Y +PE + S D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 42/198 (21%)
Query: 523 KLGEGGFGPVY---------KGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH-- 571
+LG+G FG VY + +L +E+ + L+ V+ EA+L++KL H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDHPA 63
Query: 572 -----------------------TNLTDSRRNNRLNWET--RFSIIEGIAQGLLYLHKYS 606
+L + +T + E Q LL +H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
+ R++HRDLKA NI L + + KI DFG++R+ L S GT YMSPE
Sbjct: 124 QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 667 VVSIKTDVFSFGVLVLEI 684
K+D++S G ++ E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
IA GL +LH +I+RDLK N++LD + + KI+DFGM + + T T GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGT 164
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y++PE D ++FGVL+ E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY 655
A+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R E + +G
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173
Query: 656 G--YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+ E V + +DV+S+GVL+ EIVS
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 41/211 (19%)
Query: 518 FSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL-- 574
+ + LG G G V+ + VA+K++ Q + E K+I +L H N+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 575 -------TDSRRNNRLNWETRFSII------------EGIAQGLL-----YLHKYSRLR- 609
+ S + T + + + QG L L Y LR
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRG 126
Query: 610 --------VIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETN--TNRVVGTYGYM 658
V+HRDLK +N+ ++ + + KI DFG+ARI + S + +V + Y
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YR 185
Query: 659 SPEYAMSGVVSIKT-DVFSFGVLVLEIVSGK 688
SP +S K D+++ G + E+++GK
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 559 FKNEAKLIAKLQHTNLTD----SRRNNRLNWE-TRFSIIEGIAQGLLYLHKYSRLRVIHR 613
F+ ++L +++ N D +R +L E RF E I L +LH+ +I+R
Sbjct: 65 FQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG---IIYR 120
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTD 673
DLK N+LLD + K++D+GM + GL +T T+ GT Y++PE D
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDT-TSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 674 VFSFGVLVLEIVSGKKNNGCYRTDHP-LNLIGYAWQL 709
++ GVL+ E+++G+ TD+P +N Y +Q+
Sbjct: 179 WWALGVLMFEMMAGRSPFDII-TDNPDMNTEDYLFQV 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 34/93 (36%), Positives = 57/93 (61%), Gaps = 5/93 (5%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVG 653
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR + ++ + TN +
Sbjct: 146 VARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202
Query: 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+PE V + ++DV+SFGVL+ EI +
Sbjct: 203 V-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
G+ LH+ +IHRD+K N+L+D + K++DFG++R N+ + VGT Y
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDY 159
Query: 658 MSPEYAMSGVVSIK-TDVFSFGVLVLEIVSG 687
++PE + GV K +D +S G ++ E + G
Sbjct: 160 LAPETIL-GVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 42/198 (21%)
Query: 523 KLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGI-VEFKNEAKLIAKLQHTNLTD---- 576
++G G FG V+ G+L + VA+K + +F EA+++ + H N+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 577 -----------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
RL + ++E A G+ YL IHR
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG-----TYGYMSPEYAMSGVV 668
DL A N L+ ++ KISDFGM+R + E G + +PE G
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 669 SIKTDVFSFGVLVLEIVS 686
S ++DV+SFG+L+ E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 50/240 (20%)
Query: 478 ENLSL-PSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQ 536
+NL L + D ++ N MKY +F+ + LG G FG V
Sbjct: 5 KNLQLHKKKDSDSTKEPKRKNKMKY--------------EDFNFIRTLGTGSFGRVILAT 50
Query: 537 LLNGQ--EVAIKRLSR----RSGQGIVEFKNEAKLIAKLQH---TNLTDSRRNNR----- 582
N VAIKR + + Q + +E K++ + H NL S ++
Sbjct: 51 YKNEDFPPVAIKRFEKSKIIKQKQ-VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109
Query: 583 ------------LNWETRFSIIEGI---AQGLLYLHKYSRLRVIHRDLKASNILLDDQMN 627
L RF G AQ +L L +++RDLK N+LLD
Sbjct: 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 628 PKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687
K++DFG A++ +T T + GT Y++PE ++ D ++ G+ + EI+ G
Sbjct: 170 IKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 583 LNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642
L+ E S +A+G+ +L + IHRDL A NILL KI DFG+AR
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR----- 262
Query: 643 QSETNTNRVVGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
++N VV +M+PE + V + ++DV+S+G+L+ EI S
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 29/192 (15%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLS-RRSGQGIVEFKNEAKLIAKLQHTNLTDSR--- 578
+GEG FG Q + + Q+ A+K + +S + + + EA L+AK++H N+ +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 579 ----------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLK 616
+ R +I++ Q L + RV+HRD+K
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIK 127
Query: 617 ASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFS 676
+ NI L K+ DFG AR+ + T VGT Y+ PE + + K+D++S
Sbjct: 128 SKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWS 185
Query: 677 FGVLVLEIVSGK 688
G ++ E+ + K
Sbjct: 186 LGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 37/200 (18%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574
+++ + ++G G +G VYK + L G+ A+K + G + E ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 575 TDSRRNNRLNWETRFSIIE--------------------GIA-------QGLLYLHKYSR 607
+ + L+ E + +E IA QGL YLH +
Sbjct: 69 V-AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM--- 664
+ HRD+K +NILL D + K++DFG+A + + +GT +M+PE A
Sbjct: 128 M---HRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 665 SGVVSIKTDVFSFGVLVLEI 684
+G + D+++ G+ +E+
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 37/203 (18%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVE--FKNEAKLIAKLQHT 572
+ + +GEG +G V K + GQ VAIK+ +V+ E +++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 573 NLTD----SRRNNR----------------------LNWETRFSIIEGIAQGLLYLHKYS 606
NL + RR R L+ + I +G+ + H ++
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+IHRD+K NIL+ K+ DFG AR + + T+ V T Y +PE +
Sbjct: 121 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELLVG 174
Query: 666 GVVSIK-TDVFSFGVLVLEIVSG 687
+ D+++ G LV E+++G
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 39/119 (32%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 573 NLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD 632
N +R + L E S +A+G+ +L + IHRDL A N+LL KI D
Sbjct: 128 NFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICD 184
Query: 633 FGMARIFGLNQSETNTNRVVG-----TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
FG+AR ++N VV +M+PE + V + ++DV+S+G+L+ EI S
Sbjct: 185 FGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 44/215 (20%)
Query: 509 QTISAATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKN---EAK 564
+TI + ++ +G G +G V G VA+K+LSR Q I+ K E +
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 68
Query: 565 LIAKLQH-------------------------TNLTDSRRNN-----RLNWETRFSIIEG 594
L+ ++H T+L + NN +L + +I
Sbjct: 69 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 128
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR ++ V T
Sbjct: 129 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVAT 180
Query: 655 YGYMSPEYAMSGV-VSIKTDVFSFGVLVLEIVSGK 688
Y +PE ++ + + D++S G ++ E+++G+
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 34/93 (36%), Positives = 57/93 (61%), Gaps = 5/93 (5%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVG 653
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR I ++ + TN +
Sbjct: 149 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+PE + + ++DV+SFGVL+ EI +
Sbjct: 206 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 40/192 (20%)
Query: 524 LGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD------- 576
+G+G FG V G G +VA+K + ++ F EA ++ +L+H+NL
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 577 ----------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRD 614
SR + L + + + + YL + +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127
Query: 615 LKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDV 674
L A N+L+ + K+SDFG+ + Q +T ++ + +PE S K+DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKSDV 182
Query: 675 FSFGVLVLEIVS 686
+SFG+L+ EI S
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 51/215 (23%)
Query: 523 KLGEGGFGPVYKGQLLNGQE---------------VAIKRL-SRRSGQGIVEFKNEAKLI 566
KLGEG FG V+ + E VA+K L + + +F E K++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 567 AKLQHTNL----------------TDSRRNNRLNW-------ETRFSIIEGIA----QGL 599
++L++ N+ T+ N LN E+ F+ I L
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 600 LYLH-------KY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651
LY+ KY + L +HRDL N L+ + KI+DFGM+R R
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRA 191
Query: 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
V +M+ E + G + +DV++FGV + E+ +
Sbjct: 192 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 50/203 (24%)
Query: 521 VNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN---LTD 576
+ +LG+G FG VYK Q G A K + +S + + ++ E ++A H N L D
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 577 S--RRNN---------------------RLNWETRFSII-EGIAQGLLYLHKYSRLRVIH 612
+ NN R E + ++ + + L YLH+ ++IH
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV------VGTYGYMSPEYAMSG 666
RDLKA NIL + K++DFG+ S NT + +GT +M+PE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV--------SAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 667 V-----VSIKTDVFSFGVLVLEI 684
K DV+S G+ ++E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 4e-08
Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 39/198 (19%)
Query: 521 VNKLGEGGFGPVYKGQ-LLNGQEVAIKRLS-------------------RRSGQG----I 556
+ K+GEG F V K Q G+ AIK + R S +
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 557 VEFKNEAK-----LIAKLQHTNLTDSRRNNR--LNWETRFSIIEGIAQGLLYLHKYSRLR 609
+E + K L+ +L NL + + + L + S + + + L ++H R
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNG 120
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-SGVV 668
+ HRD+K NIL+ D K++DFG R G+ T + T Y +PE + G
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYT-EYISTRWYRAPECLLTDGYY 176
Query: 669 SIKTDVFSFGVLVLEIVS 686
K D+++ G + EI+S
Sbjct: 177 GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 14/133 (10%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
+ ++ + +L LQ R +F I E + L +LHKY +++RDL
Sbjct: 74 VTDYMSGGELFWHLQKEGRFSEDR-------AKFYIAE-LVLALEHLHKYD---IVYRDL 122
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIK-TDV 674
K NILLD + + DFG+++ L ++T TN GT Y++PE + K D
Sbjct: 123 KPENILLDATGHIALCDFGLSKA-NLTDNKT-TNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 675 FSFGVLVLEIVSG 687
+S GVLV E+ G
Sbjct: 181 WSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-08
Identities = 55/230 (23%), Positives = 87/230 (37%), Gaps = 74/230 (32%)
Query: 521 VNKLGEGGFGPVYKG-QLLNGQEVAIKR----------LSRRSGQGIVEFKNEAKLIAKL 569
+ +G+GG G VY + + VA+K+ L +R F EAK+ A L
Sbjct: 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-------FLREAKIAADL 59
Query: 570 QH-----------------------------TNLTDSRRNNRLNWE--------TRFSII 592
H + L + L+ E SI
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 593 EGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE------- 645
I + Y+H S+ V+HRDLK NILL I D+G A L + +
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 646 ---------TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
T ++VGT YM+PE + S TD+++ GV++ ++++
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-08
Identities = 20/73 (27%), Positives = 30/73 (41%), Gaps = 15/73 (20%)
Query: 298 SSCKGYFLDDFELNWARKRGFMSVDGFKF----KGSNNMSRDDCATKCLSNCSCIAFAIT 353
+C G D GF+ + K +S ++C CLSNCSC A+A
Sbjct: 3 LNCGGDGSTD---------GFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYA-- 51
Query: 354 NKNNNTACEIWSR 366
N + C +W+
Sbjct: 52 YNNGSGGCLLWNG 64
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 51/214 (23%), Positives = 97/214 (45%), Gaps = 42/214 (19%)
Query: 509 QTISAATNNFSAVNKLGEGGFGPV-YKGQLLNGQEVAIKRLSR--RSGQGIVEFKNEAKL 565
+TI + + + ++G G +G V G +VAIK+L R +S E +L
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 566 IAKLQH------------------------------TNLTDSRRNNRLNWETRFSIIEGI 595
+ ++H T+L ++ +L+ + ++ +
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY 655
+GL Y+H +IHRDLK N+ +++ KI DFG+AR Q+++ V T
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTR 179
Query: 656 GYMSPEYAMSGVVSIKT-DVFSFGVLVLEIVSGK 688
Y +PE ++ + +T D++S G ++ E+++GK
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 8e-08
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 41/204 (20%)
Query: 518 FSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFK--NEAKLIAKLQHTNL 574
++++ ++G G +G V G++VAIK+LSR I + E L+ +QH N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 575 ---------------------------TDSR--RNNRLNWETRFSIIEGIAQGLLYLHKY 605
TD + + L+ + ++ + GL Y+H
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+IHRDLK N+ +++ KI DFG+AR ++ V T Y +PE ++
Sbjct: 137 G---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILN 188
Query: 666 GVVSIKT-DVFSFGVLVLEIVSGK 688
+ +T D++S G ++ E+++GK
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV--- 651
+ +GL Y+H + VIHRDLK SN+L+++ +I DFGMAR GL+ S T
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYFMTE 170
Query: 652 -VGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIV 685
V T Y +PE +S + D++S G + E++
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 41/202 (20%)
Query: 523 KLGEGGFGPVYKG--QLLNGQE-VAIKRLSRRSGQGIV--EFKNEAKLIAKLQHTNLTDS 577
+LG G FG V KG ++ ++ VA+K L + + E EA ++ +L + +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 578 -------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
++N + + ++ ++ G+ YL + + +H
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVH 118
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLN----QSETNTNRVVGTYGYMSPEYAMSGVV 668
RDL A N+LL Q KISDFG+++ G + +++T+ V Y +PE
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APECMNYYKF 175
Query: 669 SIKTDVFSFGVLVLEIVS-GKK 689
S K+DV+SFGVL+ E S G+K
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 9e-08
Identities = 13/34 (38%), Positives = 20/34 (58%)
Query: 331 NMSRDDCATKCLSNCSCIAFAITNKNNNTACEIW 364
++ +C +CLSNCSC A+A + + C IW
Sbjct: 26 SIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIW 59
|
Length = 66 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 41/134 (30%), Positives = 71/134 (52%), Gaps = 15/134 (11%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWE-TRFSIIEGIAQGLLYLHKYSRLRVIHRD 614
++EF + L+ +Q R +L E RF E I+ L +LH+ +I+RD
Sbjct: 74 VIEFVSGGDLMFHMQ--------RQRKLPEEHARFYSAE-ISLALNFLHERG---IIYRD 121
Query: 615 LKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDV 674
LK N+LLD + + K++D+GM + G+ +T T+ GT Y++PE D
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDT-TSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 675 FSFGVLVLEIVSGK 688
++ GVL+ E+++G+
Sbjct: 180 WALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 42/132 (31%), Positives = 64/132 (48%), Gaps = 13/132 (9%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
+++F N +L LQ R RF E IA L YLH + +++RDL
Sbjct: 74 VLDFVNGGELFFHLQRERSFPEPR-------ARFYAAE-IASALGYLHS---INIVYRDL 122
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675
K NILLD Q + ++DFG+ + G+ QS+T T GT Y++PE D +
Sbjct: 123 KPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTT-FCGTPEYLAPEVIRKQPYDNTVDWW 180
Query: 676 SFGVLVLEIVSG 687
G ++ E++ G
Sbjct: 181 CLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
G+ +LH +IHRDLK SNI++ KI DFG+AR G S T VV Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-Y 183
Query: 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+PE + D++S G ++ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 12/104 (11%)
Query: 591 IIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650
I + +GL +L + +IHRD+K +N+L++ K+ DFG++ L S TN
Sbjct: 107 ITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTN- 161
Query: 651 VVGTYGYMSPEYAMSG------VVSIKTDVFSFGVLVLEIVSGK 688
+G YM+PE SG ++++DV+S G+ +LE+ G+
Sbjct: 162 -IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSP 660
YLH +I+RDLK N+LLD++ + K++DFG A+ + T + GT Y++P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 661 EYAMSGVVSIKTDVFSFGVLVLEIVSG 687
E S D ++ GVL+ E ++G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 66/227 (29%)
Query: 523 KLGEGGFGPVYKGQLLNGQEVAIKR--LSRRSGQGIV----------------EFKNEAK 564
KLGEG FG V+ +++N Q++ + + R G+ ++ +F E K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 565 LIAKLQHTNL----------------TDSRRNNRLN------------------------ 584
++++L+ N+ T+ N LN
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 585 -----WETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639
+ + + IA G+ YL S L +HRDL N L+ + + KI+DFGM+R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 640 GLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
R V +M+ E + G + +DV++FGV + EI+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 58/226 (25%), Positives = 88/226 (38%), Gaps = 68/226 (30%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE-----------------VAIKRLSRRSG--QGIVEFKN 561
V KLGEG FG V+ + Q+ VA+K L R +F
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAREDFLK 68
Query: 562 EAKLIAKLQHTNL----------------TDSRRNNRLNWETRFSIIEG----------- 594
E K++++L N+ + N LN + + E
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 595 ----------IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644
IA G+ YL L +HRDL N L+ KI+DFGM+R N
Sbjct: 129 FSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLY 181
Query: 645 ETNTNRVVGT----YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
++ RV G +M+ E + G + K+DV++FGV + EI++
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 39/103 (37%), Positives = 53/103 (51%), Gaps = 8/103 (7%)
Query: 590 SIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN-- 647
S I I GL Y+H + V+HRDLK N+L++ KI DFG+AR F N E
Sbjct: 109 SFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 648 -TNRVVGTYGYMSPEYAMSGVVSIKT-DVFSFGVLVLEIVSGK 688
T V T Y +PE +S K DV+S G ++ E++ K
Sbjct: 166 MTE-YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 31/81 (38%), Positives = 34/81 (41%), Gaps = 10/81 (12%)
Query: 806 QVLRDGDQLVSAFGRFRLAFFSPRSTTKHYLGIWYDKSEDELLVWDANRDTPV------- 858
L G LVS F L FF+ Y I Y S +VW ANRD PV
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTL-IMQNDYNLILYKSSSRT-VVWVANRDNPVSDSCTLT 59
Query: 859 LDKSGRLVKTDGTIKRVLWLS 879
L G LV DG RV+W S
Sbjct: 60 LQSDGNLVLYDGD-GRVVWSS 79
|
Length = 114 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 49/208 (23%)
Query: 524 LGEGGFGPVYKGQLL----NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTD- 576
LG+G FG V + QL + Q+VA+K L S I EF EA + + H N+
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 577 ------SRRNNRL-------------------------------NWETRFSIIEGIAQGL 599
SR RL +T + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVGTYGYM 658
YL S IHRDL A N +L++ M ++DFG+++ I+ + + ++
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV-KWL 182
Query: 659 SPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+ E V + +DV++FGV + EI++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-07
Identities = 36/129 (27%), Positives = 53/129 (41%), Gaps = 31/129 (24%)
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA--------- 636
RF I E + L +HK L IHRD+K NIL+D + K++DFG+
Sbjct: 102 TARFYIAE-LVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157
Query: 637 ------------------RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFG 678
R Q N VGT Y++PE ++ D +S G
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG 217
Query: 679 VLVLEIVSG 687
V++ E++ G
Sbjct: 218 VILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-07
Identities = 29/81 (35%), Positives = 35/81 (43%), Gaps = 9/81 (11%)
Query: 806 QVLRDGDQLVSAFGRFRLAFFSPRSTTKHYLGIWYDKSEDELLVWDANRDTPV------- 858
L G LVS+ F L FF ++ Y I Y S +VW ANRD P
Sbjct: 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRT-VVWVANRDNPSGSSCTLT 60
Query: 859 LDKSGRLVKTDGTIKRVLWLS 879
L G LV DG+ V+W S
Sbjct: 61 LQSDGNLVIYDGS-GTVVWSS 80
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 14/164 (8%)
Query: 540 GQEVAI-KRLSRRSG-QGIVEFKNEAKL---IAKLQHTNLTDSRRNNRLNWETRFSIIEG 594
G+E+ I K +S R+ I ++ ++ + + K + T R+ L E +I
Sbjct: 134 GREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRR 193
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+ + L YLH +IHRD+K NI LD+ N + DFG A + GT
Sbjct: 194 LLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS------GKKNNG 692
SPE KTD++S G+++ E+ GK+
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
I+ L +LH+ +I+RDLK NILLD Q + K++DFG+ + + T+T GT
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGT 163
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687
YM+PE M D +S G L+ ++++G
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 37/200 (18%)
Query: 523 KLGEGGFGPVYKG--QLLNGQ-EVAIKRLSRRSGQGIV-EFKNEAKLIAKLQHT------ 572
+LG G FG V KG ++ Q +VAIK L + + + E EA+++ +L +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 573 --------------------NLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
N S + + + ++ ++ G+ YL + +H
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYAMSGVVSI 670
RDL A N+LL +Q KISDFG+++ G + S R G + + +PE S
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRKFSS 177
Query: 671 KTDVFSFGVLVLEIVS-GKK 689
++DV+S+G+ + E S G+K
Sbjct: 178 RSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 60/236 (25%), Positives = 93/236 (39%), Gaps = 57/236 (24%)
Query: 496 HNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYK-GQLLNGQEVAIKRLSRRSGQ 554
+NS GLE ++ T+ + + +G+G +G VYK +G A+K L S
Sbjct: 7 YNSSMLGLE-----SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV 61
Query: 555 GIVEFKNEAKLIAKL-QHTNLTDS-----------------------------------R 578
E + E ++ L H N+
Sbjct: 62 D-EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 579 RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638
RL+ I+ G GL +LH R+IHRD+K +NILL + K+ DFG++
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA- 176
Query: 639 FGLNQSETNTNRVVGTYGYMSPE-------YAMSGVVSIKTDVFSFGVLVLEIVSG 687
L + N VGT +M+PE Y S + DV+S G+ +E+ G
Sbjct: 177 -QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYS--YDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 43/134 (32%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 559 FKNEAKLIAKLQHTNLTD-----SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
F+ KL L + N + R + RF E IA L YLH L +I+R
Sbjct: 65 FQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-IASALGYLHS---LNIIYR 120
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTD 673
DLK NILLD Q + ++DFG+ + G+ S+T T+ GT Y++PE D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-EGIEHSKT-TSTFCGTPEYLAPEVLRKQPYDRTVD 178
Query: 674 VFSFGVLVLEIVSG 687
+ G ++ E++ G
Sbjct: 179 WWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 16/100 (16%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN---TNRV 651
+ +GL Y+H + V+HRDLK SN+LL+ + KI DFG+AR SE T V
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART----TSEKGDFMTEYV 169
Query: 652 VGTYGYMSPEYAMSG---VVSIKTDVFSFGVLVLEIVSGK 688
V T Y +PE ++ +I DV+S G + E++ K
Sbjct: 170 V-TRWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
IA G+ YL S L +HRDL N L+ KI+DFGM+R R V
Sbjct: 139 IASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLP 195
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+MS E + G + +DV++FGV + EI++
Sbjct: 196 IRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 48/207 (23%)
Query: 524 LGEGGFGPVYKGQLLNGQ---EVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTN----- 573
LGEG FG V +GQL +VA+K +++ + + +F +EA + + H N
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 574 ------------------------------LTDSRRNNR---LNWETRFSIIEGIAQGLL 600
L SR + L + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT-YGYMS 659
YL S IHRDL A N +L++ MN ++DFG+++ N R+ +++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKMPVKWIA 182
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVS 686
E V + K+DV+SFGV + EI +
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV-VG 653
IA+ +L +H +L +HRD+K N+LLD + +++DFG +NQ T + V VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC--LKMNQDGTVQSSVAVG 165
Query: 654 TYGYMSPEY--AMS---GVVSIKTDVFSFGVLVLEIVSGK 688
T Y+SPE AM G + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 40/215 (18%)
Query: 523 KLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGI-VEFKNEAKLIAKLQHTNLTDSRR-- 579
K+G G +G VYK + +G++ L + G GI + E L+ +L+H N+ ++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 580 ---NNRLNW-----------------------ETRFSIIEGIAQGLLY-----LHKYSRL 608
+R W + + G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 609 RVIHRDLKASNILL----DDQMNPKISDFGMARIFGLN-QSETNTNRVVGTYGYMSPEYA 663
V+HRDLK +NIL+ ++ KI+D G AR+F + + + VV T+ Y +PE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 664 MSGVVSIKT-DVFSFGVLVLEIVSGKKNNGCYRTD 697
+ K D+++ G + E+++ + C + D
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 44/205 (21%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQH- 571
+ + +G G FG V+ + ++ A+K ++ + NE +++ ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 572 ----------------------------TNLTDSRRNNRLNWETRFSIIEGIAQGLLYLH 603
+ L +S R + N F E I L YLH
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFS--NSTGLFYASE-IVCALEYLH 118
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
+++RDLK NILLD + + K++DFG A+ + T + GT Y++PE
Sbjct: 119 S---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVI 170
Query: 664 MSGVVSIKTDVFSFGVLVLEIVSGK 688
S + D ++ G+L+ E++ G
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 31/201 (15%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQE-VAIKRLSRRSGQGIVEFKN----EAKLIAKLQ 570
N F + +GEG +G V K + +E VAIK+ + + E K E K++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 571 HTNLTD----SRRNNRLNW------ETRFSIIEGIAQGLL-------------YLHKYSR 607
N+ + RR +L + ++E + G+ +H +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGV 667
++HRD+K N+L+ K+ DFG AR S N V T Y SPE +
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAP 177
Query: 668 VSIKTDVFSFGVLVLEIVSGK 688
D++S G ++ E+ G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 597 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT--NRVVGT 654
+ L Y+H + V HRDLK NIL + KI DFG+AR+ N + T V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVAT 169
Query: 655 YGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGK 688
Y +PE S + D++S G + E+++GK
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET-NTNRVVG 653
+A+ +L + +L +HRD+K N+LLD + +++DFG L T +N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSC--LRLLADGTVQSNVAVG 165
Query: 654 TYGYMSPEY--AM---SGVVSIKTDVFSFGVLVLEIVSGK 688
T Y+SPE AM G + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 13/132 (9%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++++ N +L LQ R L RF E +A + YLH L +I+RDL
Sbjct: 74 VLDYVNGGELFFHLQ-------RERCFLEPRARFYAAE-VASAIGYLHS---LNIIYRDL 122
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675
K NILLD Q + ++DFG+ + G+ ET T+ GT Y++PE D +
Sbjct: 123 KPENILLDSQGHVVLTDFGLCK-EGVEPEET-TSTFCGTPEYLAPEVLRKEPYDRTVDWW 180
Query: 676 SFGVLVLEIVSG 687
G ++ E++ G
Sbjct: 181 CLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
GL YLH+ ++++RDLK N+LLD + KI+DFG+ + G+ + T+ GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDR-TSTFCGTPEF 167
Query: 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687
++PE + D + GVL+ E++ G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+A+G+ +L + +HRDL A N+LL KI DFG+AR + + +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+PE + + +DV+S+G+L+ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 46/218 (21%)
Query: 523 KLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGI-VEFKNEAKLIAKLQHTN-------- 573
K+G G +G VYK + +G++ L + G GI + E L+ +L+H N
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 574 LTDSRRNNRLNWE---------TRF-------------------SIIEGIAQGLLYLHKY 605
L+ S R L ++ +F S++ I G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 606 SRLRVIHRDLKASNILL----DDQMNPKISDFGMARIFGLN-QSETNTNRVVGTYGYMSP 660
V+HRDLK +NIL+ ++ KI+D G AR+F + + + VV T+ Y +P
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 661 EYAMSGVVSIKT-DVFSFGVLVLEIVSGKKNNGCYRTD 697
E + K D+++ G + E+++ + C + D
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-06
Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
G+ +LH +IHRDLK SNI++ KI DFG+AR G S T VV Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-Y 191
Query: 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+PE + D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++++ N +L LQ R L RF E IA L YLH L +++RDL
Sbjct: 74 VLDYINGGELFYHLQ-------RERCFLEPRARFYAAE-IASALGYLHS---LNIVYRDL 122
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675
K NILLD Q + ++DFG+ + + T+T GT Y++PE D +
Sbjct: 123 KPENILLDSQGHIVLTDFGLCKENIEHNGTTST--FCGTPEYLAPEVLHKQPYDRTVDWW 180
Query: 676 SFGVLVLEIVSG 687
G ++ E++ G
Sbjct: 181 CLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 46/221 (20%)
Query: 508 FQTISAATNNFSAVNKLGEGGFGPVYK-GQLLNGQEVAIKRL------------------ 548
F + ++ + + +G+G +G V+K NG + A+K L
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK 69
Query: 549 SRRSGQGIVEF---------KNEAKLIAKLQHTN---LTDS-----RRNNRLNWETRFSI 591
+ +V+F KN +L L+ N +TD +R R+ I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 592 IEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651
+ GL +LH + IHRD+K +NILL + K+ DFG++ L + N
Sbjct: 130 LHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTSTRLRRNTS 184
Query: 652 VGTYGYMSPEY-----AMSGVVSIKTDVFSFGVLVLEIVSG 687
VGT +M+PE + + DV+S G+ +E+ G
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 13/133 (9%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++E+ N +L L + R RF E I L YLH V++RDL
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDR-------ARFYGAE-IVSALGYLH---SCDVVYRDL 121
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675
K N++LD + KI+DFG+ + G++ T GT Y++PE D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK-EGISDGAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 676 SFGVLVLEIVSGK 688
GV++ E++ G+
Sbjct: 180 GLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 17/109 (15%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG----MARIFGLN 642
RF E + L +H IHRD+K N+LLD + K++DFG M G+
Sbjct: 144 ARFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMV 198
Query: 643 QSETNTNRVVGTYGYMSPEYAMS----GVVSIKTDVFSFGVLVLEIVSG 687
+ +T VGT Y+SPE S G + D +S GV + E++ G
Sbjct: 199 RCDT----AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 31/100 (31%), Positives = 56/100 (56%), Gaps = 7/100 (7%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+A+ +L +H ++ +HRD+K N+L+D + K++DFG A N+ N+ VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGT 166
Query: 655 YGYMSPEY--AMSG----VVSIKTDVFSFGVLVLEIVSGK 688
Y++PE M+G ++ D +S GV+ E++ G+
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (117), Expect = 1e-05
Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 61/231 (26%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQE------VAIKRLSRRSGQGIV------------ 557
N + + K+G G FG V+ + QE ++ + L R +V
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 558 -------EFKNEA--KLIAKLQHTNLTDSRRN--------NRLNWETRFSIIEGIAQGLL 600
F N+A KL ++ + D RN ++ I + L
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 601 YLHKY----SRLRVIHRDLKASNILLDD----------QMN-------PKISDFGMARIF 639
Y H + RV+HRDLK NI L Q N KI DFG+++
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 640 GLNQSETNTNRVVGTYGYMSPEYAMSGVVSI--KTDVFSFGVLVLEIVSGK 688
G+ E+ + VGT Y SPE + S K+D+++ G ++ E+ SGK
Sbjct: 193 GI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 42/143 (29%), Positives = 64/143 (44%), Gaps = 14/143 (9%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++E+ N +L L + R RF E I L YLH S V++RDL
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDR-------ARFYGAE-IVSALDYLH--SEKNVVYRDL 122
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675
K N++LD + KI+DFG+ + G+ T GT Y++PE D +
Sbjct: 123 KLENLMLDKDGHIKITDFGLCK-EGIKDGAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 676 SFGVLVLEIVSGKKNNGCYRTDH 698
GV++ E++ G+ Y DH
Sbjct: 181 GLGVVMYEMMCGRLP--FYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 33/90 (36%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
G+ +LH +IHRDLK SNI++ KI DFG+AR N T VV Y Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRY-Y 188
Query: 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687
+PE + D++S G ++ E+V G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 18/103 (17%)
Query: 599 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT---------- 648
L YLH Y ++HRDLK N+L+ + K++DFG+++I GL TN
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI-GLMSLTTNLYEGHIEKDTR 169
Query: 649 ----NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687
+V GT Y++PE + D ++ G+++ E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 38/133 (28%), Positives = 63/133 (47%), Gaps = 13/133 (9%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++E+ N +L L + R TRF E I L YLH ++++RDL
Sbjct: 73 VMEYVNGGELFFHLSRERVFSEDR-------TRFYGAE-IVSALDYLHSG---KIVYRDL 121
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675
K N++LD + KI+DFG+ + G+ + T GT Y++PE D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK-EGITDAAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 676 SFGVLVLEIVSGK 688
GV++ E++ G+
Sbjct: 180 GLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
G+ +LH +IHRDLK SNI++ KI DFG+AR G S T VV Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-Y 184
Query: 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+PE + D++S G ++ E+V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 28/92 (30%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+A G+ +L + +HRDL A N+L+ + KI DFG+AR + + +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+PE + + + +DV+SFG+L+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 37/141 (26%), Positives = 69/141 (48%), Gaps = 9/141 (6%)
Query: 555 GIV----EFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLY-----LHKY 605
GIV +FK++ KL+ +++ + D + + + E L Y L +
Sbjct: 126 GIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+++HRDLK++NI L K+ DFG ++ + + S + GT Y++PE
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER 245
Query: 666 GVVSIKTDVFSFGVLVLEIVS 686
S K D++S GV++ E+++
Sbjct: 246 KRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 36/138 (26%), Positives = 57/138 (41%), Gaps = 40/138 (28%)
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG----- 640
ETRF I E I L + +L IHRD+K N+LLD + + K+SDFG+
Sbjct: 102 ETRFYIAETI----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
Query: 641 -----LNQSETNTNR--------------------------VVGTYGYMSPEYAMSGVVS 669
L+ + + VGT Y++PE + +
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN 217
Query: 670 IKTDVFSFGVLVLEIVSG 687
+ D +S GV++ E++ G
Sbjct: 218 KECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-05
Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 585 WETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644
+TR +I++ + + Y+H ++IHRD+K NI L+ + DFG A F +
Sbjct: 267 KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-KER 321
Query: 645 ETNTNRVVGTYGYMSPE-YAMSGVVSIKTDVFSFGVLVLEIVS 686
E VGT SPE A G I TD++S G+++L+++S
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 15/143 (10%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++E+ N +L L + R RF E I L YLH V++RD+
Sbjct: 73 VMEYANGGELFFHLSRERVFTEER-------ARFYGAE-IVSALEYLHSRD---VVYRDI 121
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675
K N++LD + KI+DFG+ + + + T GT Y++PE D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 676 SFGVLVLEIVSGKKNNGCYRTDH 698
GV++ E++ G+ Y DH
Sbjct: 180 GLGVVMYEMMCGRLP--FYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR---VV 652
A+ +L L + +IHRD+K N+LLD + K++DFG + ET R V
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC----MKMDETGMVRCDTAV 204
Query: 653 GTYGYMSPEYAMS----GVVSIKTDVFSFGVLVLEIVSG 687
GT Y+SPE S G + D +S GV + E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 24/87 (27%), Positives = 33/87 (37%), Gaps = 39/87 (44%)
Query: 847 LLVWDANRDTPVLDKSGRLV-KTDGTIK-------------------------------- 873
+VW ANR P+ D S L+ ++DG +
Sbjct: 3 TVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNLV 62
Query: 874 ------RVLWLSFEYPADTLLHGMKLG 894
+VLW SF++P DTLL G K G
Sbjct: 63 LYDNSGKVLWQSFDHPTDTLLPGQKDG 89
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 23/110 (20%)
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARIFGLNQS 644
E + II + + L LHK+ +IH D+K N+L D + + D+G+ +I G
Sbjct: 110 EVKK-IIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC 165
Query: 645 ETNTNRVVGTYGYMSPE------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
GT Y SPE Y +S D ++ GVL E+++GK
Sbjct: 166 YD------GTLDYFSPEKIKGHNYDVS------FDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 26/82 (31%), Positives = 39/82 (47%), Gaps = 14/82 (17%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF------- 639
TRF + E + L + +L IHRD+K NIL+D + K+SDFG++ F
Sbjct: 103 TRFYMAECV----LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158
Query: 640 ---GLNQSETNTNRVVGTYGYM 658
L Q ++N NR+
Sbjct: 159 YYQKLLQGKSNKNRIDNRNSVA 180
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-04
Identities = 19/53 (35%), Positives = 34/53 (64%), Gaps = 3/53 (5%)
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638
E I +A L YLH++ +IHRDLK N+L+ ++ + K++DFG++++
Sbjct: 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 40/197 (20%)
Query: 524 LGEGGFGPVYKG--QLLNGQE--VAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL---- 574
LG G FG + +G +L + +E VAI L + S + F EA + + H+N+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 575 ------------TDSRRNNRLNWETR-----------FSIIEGIAQGLLYLHKYSRLRVI 611
T+ N L+ R ++ G+A G+ YL S + +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYV 129
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSET--NTNRVVGTYGYMSPEYAMSGVVS 669
H+ L A +L++ + KIS F + ++SE T + +PE S
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 670 IKTDVFSFGVLVLEIVS 686
+DV+SFG+++ E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 36/126 (28%), Positives = 55/126 (43%), Gaps = 33/126 (26%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF----------GLNQS 644
IA+ +L + +L IHRD+K N+LLD + + K+SDFG+ LN S
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 645 --------ETNTNR---------------VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLV 681
N+ R VGT Y++PE M + D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 682 LEIVSG 687
E++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY 655
A+ +L L + IHRD+K N+LLD + K++DFG + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTP 207
Query: 656 GYMSPEYAMS----GVVSIKTDVFSFGVLVLEIVSG 687
Y+SPE S G + D +S GV + E++ G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+A+ ++ + +L +HRD+K NIL+D + +++DFG + ++ VGT
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGT 166
Query: 655 YGYMSPEYAMS-----GVVSIKTDVFSFGVLVLEIVSGK 688
Y+SPE + G + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 26/100 (26%), Positives = 48/100 (48%), Gaps = 4/100 (4%)
Query: 589 FSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648
+I + + + YLH+ R+IHRD+KA NI ++ + + DFG A F ++ +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKY 240
Query: 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
GT +PE D++S G+++ E+ +
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-04
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 50/206 (24%)
Query: 522 NKLGEGGFGPVYKGQLLNGQE-VAIKRLSRRSGQGIVEFKNEAKLIAK-LQHTNL----- 574
N +G G FG VY+ ++ E VAIK++ + ++KN LI K L H N+
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 575 ---TDSRRNNRLNWETRFSIIEGIAQG------------------LLYLHKYSRLRVI-- 611
T+ + N N ++E I Q L+ L+ Y R +
Sbjct: 127 YYYTECFKKNEKNIFLNV-VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 612 -------HRDLKASNILLDDQMNP-KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
HRDLK N+L+D + K+ DFG A+ L + + + + + Y +PE
Sbjct: 186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRF-YRAPEL- 241
Query: 664 MSGVVSIKT--DVFSFGVLVLEIVSG 687
M G + T D++S G ++ E++ G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 19/51 (37%), Positives = 26/51 (50%), Gaps = 3/51 (5%)
Query: 319 MSVDGFKFKGSNNMSRDDCATKCL-SNCSCIAFAITNKNNNTACEIWSRGS 368
+ GF + S ++CA+KCL SNCSC +F N C +WS S
Sbjct: 12 TKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKG--CLLWSESS 60
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 37/137 (27%), Positives = 58/137 (42%), Gaps = 41/137 (29%)
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645
T+F I E + L + +L IHRD+K N+LLD + + K+SDFG+ GL ++
Sbjct: 102 ATQFYIAETV----LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAH 155
Query: 646 --------------------TNTNR---------------VVGTYGYMSPEYAMSGVVSI 670
N+ R VGT Y++PE M +
Sbjct: 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215
Query: 671 KTDVFSFGVLVLEIVSG 687
D +S GV++ E++ G
Sbjct: 216 LCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 55/228 (24%)
Query: 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK 568
+ I +T F ++ LGEG FG V + +E ++ R + + K E + + K
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181
Query: 569 LQHTNLTDSR---------RNNR--------------LNWETR---FS------IIEGIA 596
++ + D +N L+W + FS II
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTG 241
Query: 597 QGLLYLHKYSRLRVIHRDLKASNILL---DDQMNP-------------KISDFGMARIFG 640
L Y H + L ++H DLK NIL+ D ++P +I D G G
Sbjct: 242 VALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-----G 294
Query: 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+ +V T Y SPE + TD++S G ++ E+ +GK
Sbjct: 295 CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1018 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.94 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.93 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.93 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.91 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.91 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.9 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.9 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.87 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.87 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.86 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.86 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.86 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.85 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.85 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.83 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.83 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.81 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.81 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.69 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.66 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.66 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.61 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.6 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.54 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.52 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.5 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.5 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.48 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.43 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.41 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.38 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.35 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.34 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.32 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.27 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.25 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.25 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.24 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.24 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.2 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.16 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.15 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.09 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.05 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.96 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.86 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.81 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.79 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.69 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.46 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.21 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.12 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.94 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.69 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.69 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 97.65 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 97.58 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.24 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.93 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.81 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.64 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.58 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.35 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.04 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.01 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.93 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.78 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 95.48 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.42 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.32 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 95.14 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 94.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 94.92 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 94.78 | |
| PLN02236 | 344 | choline kinase | 94.76 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.54 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.44 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 94.33 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 94.27 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 94.13 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.44 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 92.89 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 91.48 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 91.47 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 90.75 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 90.65 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 89.28 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=412.51 Aligned_cols=261 Identities=44% Similarity=0.751 Sum_probs=230.0
Q ss_pred CccceeHHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----
Q 046791 502 GLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---- 577 (1018)
Q Consensus 502 ~~~~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---- 577 (1018)
....|++.+|..||++|+..++||+|+||.||+|.+.+|+.||||++.....+...+|.+|+.++.+++|||||.+
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 5778999999999999999999999999999999999999999998877654325679999999999999999832
Q ss_pred -----------------------c-CCC-CCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeee
Q 046791 578 -----------------------R-RNN-RLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD 632 (1018)
Q Consensus 578 -----------------------~-~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~D 632 (1018)
. ... .|+|.+|++|+.++|+||+|||+...++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 1 112 789999999999999999999999999999999999999999999999999
Q ss_pred ecceeeecCCCCcccceee-ecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhh
Q 046791 633 FGMARIFGLNQSETNTNRV-VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWN 711 (1018)
Q Consensus 633 FGla~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 711 (1018)
||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+...+.....+..|++..+.
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999765421 1111122 899999999999999999999999999999999999999887666666679999999999
Q ss_pred cCcchhhhhhhhc-CCCCh-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 712 EGKVLELVDIALE-GSFSP-NEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 712 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
++.+.+++|+.+. +.++. +++.++..++.+|++.+|.+||+|.||+++|+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999999999987 56664 68999999999999999999999999999996543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=345.21 Aligned_cols=219 Identities=25% Similarity=0.417 Sum_probs=186.7
Q ss_pred CCcceeeeeccCCCcCeEEEEe-cccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
.+|...+.||+|||+.+|+++. ..|+.||+|++.+. .....+...+|+++.+.|+|||||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 67999999999774 3455677899999999999999983
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
...++.+++.+++.+++||+.||.|||+++ |+|||||..|+||+++.++||+|||||..+..+...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 235688999999999999999999999999 999999999999999999999999999988654333
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc-
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE- 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~- 724 (1018)
....+||+.|+|||++.....+..+||||+|||||-||+|++||+... +.+..+..-.
T Consensus 175 --k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------------------vkety~~Ik~~ 233 (592)
T KOG0575|consen 175 --KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------------------VKETYNKIKLN 233 (592)
T ss_pred --cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------------------HHHHHHHHHhc
Confidence 335899999999999999999999999999999999999999996322 1222222221
Q ss_pred -CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 -GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 -~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+|.....+..+|+..+|+.||.+|||+++|+.
T Consensus 234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1334456677889999999999999999999997
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=343.15 Aligned_cols=228 Identities=31% Similarity=0.465 Sum_probs=184.2
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEecccccc--cHHHHHHHHHHHHHhcCCCccc----------------------
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ--GIVEFKNEAKLIAKLQHTNLTD---------------------- 576 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~H~nlv~---------------------- 576 (1018)
.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||.
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3569999999999999965555999999765322 2568999999999999999982
Q ss_pred -----cc--CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-CceeeeecceeeecCCCCcccc
Q 046791 577 -----SR--RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 577 -----~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
+. ....+++..+++|+.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccc
Confidence 11 35789999999999999999999999984 99999999999999997 99999999998765322 233
Q ss_pred eeeecccccCChhhhc--cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 649 NRVVGTYGYMSPEYAM--SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~--~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
....||+.|||||++. ...++.|+|||||||+||||+||+.||..... ...+. .++....+..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~---------~v~~~~~Rp~ 266 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVAS---------AVVVGGLRPP 266 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHH---------HHHhcCCCCC
Confidence 3478999999999999 56999999999999999999999999865432 11111 1222223334
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCC
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSL 767 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~l 767 (1018)
.+....+.+..++.+||+.||..||++.||+.+|+......
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 44557788889999999999999999999999999754433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=312.74 Aligned_cols=225 Identities=26% Similarity=0.414 Sum_probs=184.4
Q ss_pred CcceeeeeccCCCcCeEEEE-ecccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCccc-----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTD----------------- 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~----------------- 576 (1018)
.|+++++||+|.||+|||++ +.+|..+|.|.++-. .....+....|+.+|++|+|||||+
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 58888999999999999997 567999999998643 3455677899999999999999982
Q ss_pred ---------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCC-cEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 577 ---------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL-RVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 577 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
....+.+++..+++++.|+++||.++|.+-+. .|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 13456799999999999999999999994321 39999999999999999999999999999886
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.. ...+...+||+.||+||.+.+..|+.||||||+||++|||+.-++||... ...++-.
T Consensus 180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------------------n~~~L~~ 238 (375)
T KOG0591|consen 180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------------------NLLSLCK 238 (375)
T ss_pred ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------------------cHHHHHH
Confidence 43 33445689999999999999999999999999999999999999998532 1222222
Q ss_pred hhhcCCCC----hHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 721 IALEGSFS----PNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 721 ~~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
++-+++++ ......+.+|+..|+..||+.||+...++..+..
T Consensus 239 KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 239 KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 33333332 3456788899999999999999996666665554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.93 Aligned_cols=225 Identities=25% Similarity=0.365 Sum_probs=183.1
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------ 577 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------ 577 (1018)
++..+|+. .+.||+|..|+|||++++ +++.+|+|.+.... ....+++.+|++++++.+||+||..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 44555554 479999999999999876 48889999995443 4456789999999999999999831
Q ss_pred ---------------------cCCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeeeecc
Q 046791 578 ---------------------RRNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGM 635 (1018)
Q Consensus 578 ---------------------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~DFGl 635 (1018)
...+++++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|++||||||.
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence 123568999999999999999999996 66 99999999999999999999999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV 715 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 715 (1018)
++.+... ....++||..|||||.+.+..|+.++||||||++++|+.+|+.|+...... ....
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~--------------~~~~ 287 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP--------------YLDI 287 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC--------------CCCH
Confidence 9876432 456789999999999999999999999999999999999999998654111 1123
Q ss_pred hhhhhhhhcC---CCChH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 LELVDIALEG---SFSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 ~~~~d~~l~~---~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.++++....+ ..+.. ..+++..++..||+.||.+||++.|+++
T Consensus 288 ~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 288 FELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 3444444432 22232 5678999999999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=327.82 Aligned_cols=244 Identities=27% Similarity=0.458 Sum_probs=187.2
Q ss_pred HHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCccc----------
Q 046791 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTD---------- 576 (1018)
Q Consensus 509 ~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~---------- 576 (1018)
++.+...+...+...||+|.||+||+|++.. .||||.++.. ..+..+.|++|+.++++-+|.||+-
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 3334444556677899999999999999854 6999999765 3456788999999999999999871
Q ss_pred ----------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 577 ----------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 577 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
......++..+.+.|++|||+||.|||.++ |||||||..||+|.+++.+||+|||++..-.
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeee
Confidence 012356788899999999999999999999 9999999999999999999999999997544
Q ss_pred CCCCcccceeeecccccCChhhhcc---CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMS---GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
.-..........|...|||||+++. .+|++.+||||||+++|||++|..||.....+... |.-|.-.-
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi---------fmVGrG~l 610 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII---------FMVGRGYL 610 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE---------EEeccccc
Confidence 3323333445678889999999974 57999999999999999999999998733222211 11111111
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPA 769 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp~ 769 (1018)
..|... .......++.+|+..||..++++||.+.+|+.+|+....++|.
T Consensus 611 ~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 611 MPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred Cccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 111111 1123456788888999999999999999999999987655543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.05 Aligned_cols=226 Identities=25% Similarity=0.355 Sum_probs=177.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccc-------cHHHHHHHHHHHHHhcCCCcccc---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQ-------GIVEFKNEAKLIAKLQHTNLTDS--------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~-------~~~~f~~E~~~l~~l~H~nlv~~--------- 577 (1018)
.+.|.+.+.||+|+||.|-+|.. .+|+.||||++++.... ......+|+++|++|+|||||++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45688889999999999999975 45999999999765311 12235799999999999999842
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC---CCceeeeeccee
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMAR 637 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~---~~~kL~DFGla~ 637 (1018)
..++.+.+.....+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence 34567888888999999999999999999 9999999999999765 679999999999
Q ss_pred eecCCCCcccceeeecccccCChhhhccCC---CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSGV---VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
..+ ....+...+||+.|.|||++.+.. +..|.|+||+||+||-+++|.+||.....+.. +.+ ....|.
T Consensus 328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~e----QI~~G~ 398 (475)
T KOG0615|consen 328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKE----QILKGR 398 (475)
T ss_pred ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHH----HHhcCc
Confidence 875 344556789999999999998644 33478999999999999999999975443321 111 111111
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... ......+..++..+++.+||..||++|||+.|+++
T Consensus 399 y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 399 YAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 110 01122345678899999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=328.85 Aligned_cols=225 Identities=30% Similarity=0.451 Sum_probs=187.5
Q ss_pred ceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc---------------------
Q 046791 519 SAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------------------- 577 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------------------- 577 (1018)
..++.||+|-||+||.|.+.....||||.++.. ....+.|.+|+++|++|+|+|||++
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 345899999999999999988889999999765 3456789999999999999999831
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+. ......
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~ 363 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEG 363 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc-eeecCC
Confidence 23567889999999999999999999999 9999999999999999999999999999554332 222223
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
..-...|.|||.+..+.++.|||||||||+||||+| |+.|+..... .++.+.++...+-..|+
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------------~ev~~~le~GyRlp~P~ 427 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------------EEVLELLERGYRLPRPE 427 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------HHHHHHHhccCcCCCCC
Confidence 344678999999999999999999999999999998 6666543321 12344555555556778
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.++..+.+|+..||+.+|++|||++.+...|+...
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 88999999999999999999999999999998754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.06 Aligned_cols=213 Identities=26% Similarity=0.383 Sum_probs=176.7
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD-------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~-------------- 576 (1018)
.++|+++++||+|+||.||.++..+ ++.+|+|++++.. ....+..++|..+|.+++||.||+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999998665 8899999997763 345667899999999999999983
Q ss_pred ------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 577 ------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 577 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
+.+.+.+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++.....
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-- 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-- 178 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC--
Confidence 344678899999999999999999999999 999999999999999999999999999964322
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
...+..++||+.|||||++.+..++..+|.||||+++|||++|.+||.... ..+..+..+.
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-------------------~~~~~~~I~~ 239 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-------------------VKKMYDKILK 239 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-------------------HHHHHHHHhc
Confidence 234445899999999999999999999999999999999999999985322 2222333332
Q ss_pred CC---CChHHHHHHHHHHHhccccCCCCCC
Q 046791 725 GS---FSPNEVLRCIHVGLLCVQDQATDRP 751 (1018)
Q Consensus 725 ~~---~~~~~~~~l~~li~~Cl~~dP~~RP 751 (1018)
+. .+.-...+..+++...|+.||++|-
T Consensus 240 ~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 240 GKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 22 2222456778889999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=302.19 Aligned_cols=238 Identities=23% Similarity=0.325 Sum_probs=182.3
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEeccccc-ccH-HHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG-QGI-VEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-~~~-~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
+.|+.+.++|+|+||.|||.+.++ |+.||||++..... ... +-.++|+++|++|+|+|||.+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888999999999999999876 99999999965533 223 346899999999999999832
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
+....++.+...+++.|+++|+.|+|+++ +|||||||+||||..++.+||||||+|+.+.. ...
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 12345788899999999999999999999 99999999999999999999999999998753 233
Q ss_pred cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHH--------HHHHHhhcCcchh
Q 046791 647 NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG--------YAWQLWNEGKVLE 717 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~~~~~ 717 (1018)
..+..+.|..|.|||.+.+ ..|....||||+||++.||++|.+.|....+-+...++. ...+.+.......
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 4445788999999999987 789999999999999999999999987655443322221 1222222221111
Q ss_pred -hhhhhhc-----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 -LVDIALE-----GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 -~~d~~l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+.-|... +.--+....-+++++..||+.||++|++-+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1101111 0111233457789999999999999999999876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=341.28 Aligned_cols=230 Identities=28% Similarity=0.412 Sum_probs=187.9
Q ss_pred CcceeeeeccCCCcCeEEEEecc------cccceEEEecccccc-cHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
+....+.||+|.||+||+|+..+ .+.||||.++..... ..++|++|++++..|+|||||++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 34455899999999999998543 457999999887655 78899999999999999999821
Q ss_pred ------------------------cC----CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCce
Q 046791 578 ------------------------RR----NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK 629 (1018)
Q Consensus 578 ------------------------~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~k 629 (1018)
.. ..+|+..+.+.|+.|||.||.||-++. +|||||..+|+||.++..+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 11 233889999999999999999999998 99999999999999999999
Q ss_pred eeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHH
Q 046791 630 ISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQ 708 (1018)
Q Consensus 630 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~ 708 (1018)
|+||||++.+...+.........-.++|||||.+..++++++||||||||+|||+++ |+.|+.....++ +.+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe 716 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIE 716 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHH
Confidence 999999997654443333333445679999999999999999999999999999998 788875444322 222
Q ss_pred HhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 709 LWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 709 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
....+++ -..++..+.++..|++.||+.+|++||+++||-..|+....
T Consensus 717 ~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 717 CIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 2333332 24677788999999999999999999999999999987544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.82 Aligned_cols=174 Identities=33% Similarity=0.545 Sum_probs=153.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
..+|.+.+.||+|+||+||+|++.. +.+||||.+.+. .....+.+..|+.+|+.++|+|||.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4678888999999999999999764 889999999776 4555667899999999999999983
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC------CCceeeeecceeee
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ------MNPKISDFGMARIF 639 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~------~~~kL~DFGla~~~ 639 (1018)
+...+.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 234568999999999999999999999999 9999999999999864 45899999999988
Q ss_pred cCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCC
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCY 694 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~ 694 (1018)
. ........+|++.|||||+++.+.|+.|+|+||+|+|||++++|+.||+..
T Consensus 166 ~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 Q---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred C---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 6 334455689999999999999999999999999999999999999998643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=314.53 Aligned_cols=219 Identities=25% Similarity=0.417 Sum_probs=186.2
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~---------------- 576 (1018)
++|.+.+.||+|+||.||||+.+. .+.||+|.+.+.. ....+.+.+|++++++++||||++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578889999999999999998654 8899999997653 445667899999999999999983
Q ss_pred ---------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 577 ---------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 577 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
+...+.|+++.+..|+.+++.||.|||+.+ |+|||+||+||||+..+.+|++|||+|+.+.. ....
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 234678999999999999999999999999 99999999999999999999999999998754 2334
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC-
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS- 726 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~- 726 (1018)
.....||+-|||||...+++|+..+|.||+|||+||+.+|++||-. ..+.+++..++.+.
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------------------~si~~Lv~~I~~d~v 217 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------------------RSITQLVKSILKDPV 217 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------------------HHHHHHHHHHhcCCC
Confidence 4568999999999999999999999999999999999999999831 12334444444332
Q ss_pred -CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 727 -FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 727 -~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+......+..++...|+.||..|.+-.+++.
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 34466778889999999999999999999886
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=311.23 Aligned_cols=236 Identities=26% Similarity=0.313 Sum_probs=183.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHH--HHHHHHHHHHhc-CCCcccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVE--FKNEAKLIAKLQ-HTNLTDS------------ 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~--f~~E~~~l~~l~-H~nlv~~------------ 577 (1018)
.-++|.++++||.|.||.||+|+. ..|..||||++++.... .++ =.+|++.|++|+ ||||+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 346899999999999999999985 45889999999776433 333 368999999999 9999831
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.+++.+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+...
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC
Confidence 23678999999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcccceeeecccccCChhhhc-cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc---h--
Q 046791 643 QSETNTNRVVGTYGYMSPEYAM-SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV---L-- 716 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~-- 716 (1018)
...+..+.|+.|+|||++. .+.|+.+.|+|++|||++||.+-++.|.+..+.++.. .+.+.+..... .
T Consensus 164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~---KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY---KICEVLGTPDKDSWPEG 237 (538)
T ss_pred ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH---HHHHHhCCCccccchhH
Confidence 3344568899999999876 5789999999999999999999999987654433221 11111111100 0
Q ss_pred hhhhhhhcCC-----------CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 717 ELVDIALEGS-----------FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 717 ~~~d~~l~~~-----------~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
..+...+.-. .-+....++++++.+|++.||.+|||+.|.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111111111 112366788999999999999999999999984
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=317.27 Aligned_cols=232 Identities=26% Similarity=0.368 Sum_probs=178.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEe------cccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccccC-------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL------LNGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSRR------- 579 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~~------- 579 (1018)
.++|++.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.++ +||||++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999974 235689999997543 23346789999999999 8999873110
Q ss_pred --------------------------------------------------------------------------------
Q 046791 580 -------------------------------------------------------------------------------- 579 (1018)
Q Consensus 580 -------------------------------------------------------------------------------- 579 (1018)
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence
Q ss_pred --CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeeccccc
Q 046791 580 --NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657 (1018)
Q Consensus 580 --~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y 657 (1018)
...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 123667788899999999999999998 999999999999999999999999999865432222222234556789
Q ss_pred CChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHH
Q 046791 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCI 736 (1018)
Q Consensus 658 ~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 736 (1018)
+|||++.+..++.++||||||+++|||++ |..||....... ........+.. ...+....+.+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR---------MRAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC---------CCCCCCCCHHHH
Confidence 99999999999999999999999999997 999986433211 11111111111 111233456788
Q ss_pred HHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 737 HVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 737 ~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
+++.+||+.||++||++.||+++|+...
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=284.88 Aligned_cols=248 Identities=26% Similarity=0.356 Sum_probs=185.5
Q ss_pred CCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccc-c-HHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQ-G-IVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~-~-~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.+|..+++||+|.||.||+|+. .+|+.||||+++..... + .....+|+++|+.++|+||+++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999985 45999999999765322 2 3457899999999999999842
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.+...|...+...++.++++||+|||++. |+||||||.|+|++.++.+||+|||+|+.+.......
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 23456788899999999999999999999 9999999999999999999999999999887544333
Q ss_pred cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC------cchhhh
Q 046791 647 NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG------KVLELV 719 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~~~ 719 (1018)
.. .+-|..|.|||.+.+ ..|+...|+||.|||+.||+.|.+-|....+-++...+ .+.+... ++..+.
T Consensus 159 ~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I---f~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 159 TH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI---FRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH---HHHcCCCCcccCccccccc
Confidence 22 377899999999987 67999999999999999999999877654432222111 1111110 011111
Q ss_pred h---------hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCCCCCCCc
Q 046791 720 D---------IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPA 774 (1018)
Q Consensus 720 d---------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp~p~~p~ 774 (1018)
| +.++ ..-+......++++..++..||.+|+++.|++++=- ...+|.|..|.
T Consensus 234 dY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y--f~~~P~pt~~~ 294 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY--FKSLPLPTPPS 294 (318)
T ss_pred cHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcchh--hhcCCCCCChh
Confidence 1 1111 122345566799999999999999999999988532 22245554443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=308.23 Aligned_cols=227 Identities=24% Similarity=0.359 Sum_probs=183.6
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHh-cCCCcccc----------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKL-QHTNLTDS---------- 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nlv~~---------- 577 (1018)
+..++|...+.||+|+|++|++|+.. .++++|||++.+. .....+....|-.+|.+| .||.|+++
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34567888999999999999999865 4899999999765 234455678899999999 89998831
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.+-+.+++...+.++.+|+.||+|||++| ||||||||+|||||.++++||+|||.|+.+..
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 23467899999999999999999999999 99999999999999999999999999998753
Q ss_pred CCCc---------cc--ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh
Q 046791 642 NQSE---------TN--TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 642 ~~~~---------~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
.... .. ...++||..|.+||++.....+..+|+|+||||||.|+.|.+||....+- ..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---li-------- 295 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LI-------- 295 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HH--------
Confidence 2221 11 14589999999999999999999999999999999999999998643211 00
Q ss_pred hcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 711 NEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 711 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+..+++ +.-.+++.-.+.+.+|+.+.|..||.+|++..||.+.
T Consensus 296 ----FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 ----FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111111 1224555556778899999999999999999999884
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=307.59 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=181.7
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.-.+.|+.+++||+|.||.||+|+. .+|+.||+|+++... .....-..+|+.||++|.||||+++
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3446788889999999999999985 569999999987654 3344556899999999999999842
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
...-.+++.++..+++|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+++..
T Consensus 194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 12346899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH-----HHhhcCcc
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW-----QLWNEGKV 715 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~~ 715 (1018)
..... .+..+-|..|.|||.+.+ ..|+.+.|+||.||||.||++|++.+....+-++...+-... ..|...++
T Consensus 271 ~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 271 SGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 44333 445677999999999987 579999999999999999999999987654333222211110 00110001
Q ss_pred h--hhh------hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 L--ELV------DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 ~--~~~------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. ..+ ...+++. -.......++|+..+|..||.+|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 000 1111111 1122356678889999999999999998876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.49 Aligned_cols=228 Identities=25% Similarity=0.395 Sum_probs=180.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR---------------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~---------------- 578 (1018)
.++...+.||+|+||.||++...+ |+..|||.+........+.+.+|+.+|.+++|||||+..
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778899999999999998765 899999998776444467799999999999999998311
Q ss_pred ------------C-CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-CCCceeeeecceeeecC-CC
Q 046791 579 ------------R-NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARIFGL-NQ 643 (1018)
Q Consensus 579 ------------~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~~~~~-~~ 643 (1018)
. ...|++..+..+.+||++||.|||+++ ||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 1 126999999999999999999999999 999999999999999 79999999999987653 11
Q ss_pred CcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.........||+.|||||++.++ ....++|||||||++.||+||++||... .....+........
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~--------- 239 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED--------- 239 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC---------
Confidence 22233457899999999999964 3446999999999999999999998653 11111111111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
.....+........+++..|++.+|++|||+.++++..
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11134455667788999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=323.81 Aligned_cols=229 Identities=25% Similarity=0.404 Sum_probs=189.6
Q ss_pred CCcceeeeeccCCCcCeEEEEecc----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
....+.++||.|.||+||+|+++- ...||||.|+... +....+|+.|+.||.++.||||+++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345678999999999999999764 3469999998764 5567789999999999999999742
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.+.+.+.+.+...++++||.||.||-+.+ +|||||.++|||++.+..+|++|||+++.+.++.
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 22456888899999999999999999999 9999999999999999999999999999876544
Q ss_pred Ccccceeeec--ccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 644 SETNTNRVVG--TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 644 ~~~~~~~~~g--t~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
....+..-| ..+|.|||.+..++++.++|||||||+|||+++ |.+|+-... +.++...++
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----------------NQdVIkaIe 848 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----------------NQDVIKAIE 848 (996)
T ss_pred -CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc----------------hHHHHHHHH
Confidence 222222222 468999999999999999999999999999986 888863322 223444455
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
...+-..|.+.+..+.+|++.|||.|-.+||.+.||+.+|++..
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 55566678889999999999999999999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=298.57 Aligned_cols=234 Identities=23% Similarity=0.341 Sum_probs=180.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEeccccccc-HHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQG-IVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~-~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.+.|++.+.||.|..++||+|+. +.++.||||++.-..... .+.+.+|+..+..++||||+..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46799999999999999999984 568999999997665433 5889999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.-...+++..+..|++++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 11345889999999999999999999999 99999999999999999999999999876644332
Q ss_pred cc-cc-eeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 645 ET-NT-NRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 645 ~~-~~-~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.. .. ...+||+.|||||+++. ..|+.|+||||||++.+||.+|..||..+.+-. .....+. +......-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLq-n~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQ-NDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhc-CCCCCccc
Confidence 11 11 45789999999999654 569999999999999999999999997554321 1111111 11111111
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+..+........+.+++..||+.||.+|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111111222346778899999999999999999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=278.71 Aligned_cols=236 Identities=24% Similarity=0.278 Sum_probs=188.5
Q ss_pred HHhCCcceeeeeccCCCcCeEEEE-ecccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
...++|++.++||+|||+-||+++ +.++..+|+|++.-.+.++.+..++|++..++++|||+++
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999998 5678899999998777788889999999999999999862
Q ss_pred --------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 577 --------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 577 --------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
...+..+++.+.+.|+.+|.+||++||+.. ++++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 123457899999999999999999999987 57999999999999999999999999998
Q ss_pred eeecCCCC-------cccceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHH
Q 046791 637 RIFGLNQS-------ETNTNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYA 706 (1018)
Q Consensus 637 ~~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 706 (1018)
......-. .........|..|.|||.+. +..+++++|||||||+||+|+.|..||+.....
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------- 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------- 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence 76532110 11122356789999999875 567899999999999999999999998643221
Q ss_pred HHHhhcCcc-hhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 707 WQLWNEGKV-LELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 707 ~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.+.+ ..+....+.-.......+.+.+++.+|++.||.+||++.+++..++..
T Consensus 248 -----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 -----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 112222222122233678899999999999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=306.48 Aligned_cols=223 Identities=26% Similarity=0.364 Sum_probs=182.8
Q ss_pred CcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc-------------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD------------------- 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~------------------- 576 (1018)
.|....+||+|+.|.||.++. .+++.||||++........+-..+|+.+|+..+|+|||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 455667999999999999974 458899999998776666677899999999999999983
Q ss_pred ------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 577 ------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 577 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
......+++.++..|++++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+..... ....
T Consensus 354 ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~T 428 (550)
T KOG0578|consen 354 GGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRST 428 (550)
T ss_pred CCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--cccc
Confidence 223456889999999999999999999999 99999999999999999999999999998765443 3445
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
.+||+.|||||+.....|.+|.||||||++++||+-|++||-...+- .-.+.....|.. .-..++.
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyLIa~ng~P--------~lk~~~k 494 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGTP--------KLKNPEK 494 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHHHhhcCCC--------CcCCccc
Confidence 89999999999999999999999999999999999999998432211 111111112211 1123445
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+.+++.+||+.|+++||++.|+|+
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 5678889999999999999999999987
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=294.96 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=179.8
Q ss_pred cceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHH--hcCCCccc-------------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK--LQHTNLTD------------------- 576 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~nlv~------------------- 576 (1018)
.+..++||+|+||.||||.+. ++.||||++... ..+.|.+|-+|.+. ++|+||++
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345578999999999999994 489999999654 45678888887765 58999873
Q ss_pred ----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCC------CCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 577 ----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYS------RLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 577 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
......++|....+|+..|++||+|||+.- +++|+|||||.+||||.+|++..|+|||+|..+.
T Consensus 288 ~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred eeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 123456899999999999999999999743 4789999999999999999999999999999988
Q ss_pred CCCCcccceeeecccccCChhhhccCC-CC-----ccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGV-VS-----IKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-----~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
.......+...+||.+|||||++.+.. +. .+.||||+|.|||||+++..-... .+..++.+. +..+.-....
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlp-fe~evG~hPt 445 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLP-FEAEVGNHPT 445 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCc-hhHHhcCCCC
Confidence 776666666789999999999998632 22 458999999999999998765432 111111111 0011111111
Q ss_pred chhh----hhhhhcCCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 715 VLEL----VDIALEGSFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 715 ~~~~----~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
+.++ +....+..++ ...+.-+.+.+..||.+||+.|-|+.-|.+++.+...
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111 1111122221 1346778889999999999999999999999987655
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=293.60 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=186.5
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecc--cccccHHHHHHHHHHHHHhcCCCccc------------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSR--RSGQGIVEFKNEAKLIAKLQHTNLTD------------ 576 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~H~nlv~------------ 576 (1018)
..+...|..++.||+|+||.|..+... +|+.||||++.. ......++-.+|+++|++++|+||+.
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 334566777899999999999999865 589999999973 34455678899999999999999872
Q ss_pred ------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 577 ------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 577 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
+..+..|+......++.||++||.|+|+.+ |+||||||+|+|++.+-.+||+|||+|+.
T Consensus 98 f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 98 FNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred cceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 123445999999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH--------HH
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW--------QL 709 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~ 709 (1018)
..........+..+.|..|.|||++.. ..|+.+.||||.|||+.||++|++.|.+...-++..++.... ..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 754433334456788999999998765 789999999999999999999999997765444333332211 11
Q ss_pred hhcCcchhhhhhhh-cCCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 710 WNEGKVLELVDIAL-EGSFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l-~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.........+.... ....+ +...+..++|+.+||..||.+|+|++|.++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111111111100 00111 233467789999999999999999999987
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=291.15 Aligned_cols=230 Identities=23% Similarity=0.323 Sum_probs=175.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
-.|...+++|.|+||.||+|++.. +++||||+.-..... -.+|+++|+++.|||||++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 357778999999999999999755 789999998554332 2579999999999999842
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC-CCceeeeecceeee
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARIF 639 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kL~DFGla~~~ 639 (1018)
..+..++...+.-+..||.+||.|||+.+ |+||||||+|+|+|.+ +.+||||||.|+.+
T Consensus 100 VleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 100 VLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 12455666677778999999999999998 9999999999999965 99999999999988
Q ss_pred cCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc---
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV--- 715 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 715 (1018)
..++.. .....|+.|.|||.+.+ ..|+.+.||||.|||+.||+.|++.|......++. .. ..+.+.....
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL--~e-Iik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL--VE-IIKVLGTPTREDI 250 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH--HH-HHHHhCCCCHHHH
Confidence 654433 34678899999999987 67999999999999999999999998764433222 11 1111111111
Q ss_pred -------hhhhhhhhc-----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 -------LELVDIALE-----GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 -------~~~~d~~l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+...+.+. ........++.++++.++++.+|.+|.++.|++.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111111111 1133455678899999999999999999999887
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-33 Score=305.19 Aligned_cols=228 Identities=27% Similarity=0.409 Sum_probs=182.9
Q ss_pred cceeHHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc-------
Q 046791 504 EIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD------- 576 (1018)
Q Consensus 504 ~~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~------- 576 (1018)
-.+.|++|.. ++-||.|+.|.||+|++ .++.||||+++.-. ..+++-|++|+|+||+.
T Consensus 119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence 3455666644 37899999999999999 45889999885433 46788899999999983
Q ss_pred -------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 577 -------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 577 -------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
++....+.......|..+||.||.|||.+. |||||||.-||||..+..+||+|||.++
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence 345677888899999999999999999998 9999999999999999999999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
..... ...-.+.||..|||||++++.+.++|.|||||||||||||||..||......... | .
T Consensus 261 e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII------w---------G 322 (904)
T KOG4721|consen 261 ELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII------W---------G 322 (904)
T ss_pred hhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE------E---------e
Confidence 76432 3334589999999999999999999999999999999999999998643322110 1 0
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCC
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSL 767 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~l 767 (1018)
+=...+.-..+...++-+.-|+.+||+..|..||++++|+..|+-....+
T Consensus 323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 11112222445666777888899999999999999999999998544333
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=305.40 Aligned_cols=222 Identities=23% Similarity=0.337 Sum_probs=179.7
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc----cc-ccHHHHHHHHHHHHHhc-CCCcccc--------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR----SG-QGIVEFKNEAKLIAKLQ-HTNLTDS-------- 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~----~~-~~~~~f~~E~~~l~~l~-H~nlv~~-------- 577 (1018)
...++|.+.+.||+|+||.|++|+.. +++.||||.+.+. .. ...+...+|+.++++++ ||||+++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45678999999999999999999754 5899999977654 12 23456678999999999 9999831
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC-CCceeeeecceee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARI 638 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kL~DFGla~~ 638 (1018)
...+++.+.++..+++|++.|++|||+++ |+||||||+|||+|.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 22578999999999999999999999999 9999999999999999 9999999999998
Q ss_pred ecCCCCcccceeeecccccCChhhhccCC-CC-ccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGV-VS-IKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ...
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~------------ 230 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPN------------ 230 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHH------------
Confidence 74 2233445579999999999999876 75 78999999999999999999997411 111
Q ss_pred hhhhhhhcC--CCChHH-HHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 ELVDIALEG--SFSPNE-VLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 ~~~d~~l~~--~~~~~~-~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+......+ .++... ...+..++.+||+.||.+|+++.+|++
T Consensus 231 -l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 231 -LYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -HHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11111111 223333 778889999999999999999999994
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=294.70 Aligned_cols=221 Identities=26% Similarity=0.391 Sum_probs=179.8
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccc------------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTD------------------ 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~------------------ 576 (1018)
.|...+.||+|.||.||+|... .++.||+|++.-.. ....++...|+.++.+++++||.+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666789999999999999864 48899999997653 455678999999999999999852
Q ss_pred --------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 577 --------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 577 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
+.....+++....-|++++..||.|||+++ .+|||||+.|||+..+|.+||+|||++..+.......
T Consensus 94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-- 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-- 168 (467)
T ss_pred cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc--
Confidence 233444588888899999999999999999 9999999999999999999999999998876544333
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.....+ +.+-.-|.+.+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~--- 233 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDG--- 233 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCcccc---
Confidence 568999999999999998999999999999999999999999865544221111 11111122222
Q ss_pred hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....+.+++..||..||+.||++.++++
T Consensus 234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 -DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 33456888999999999999999999987
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=293.19 Aligned_cols=230 Identities=26% Similarity=0.361 Sum_probs=182.8
Q ss_pred HHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--------------ccHHHHHHHHHHHHHhcCCC
Q 046791 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--------------QGIVEFKNEAKLIAKLQHTN 573 (1018)
Q Consensus 509 ~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--------------~~~~~f~~E~~~l~~l~H~n 573 (1018)
.+-.+..++|.+++.||+|.||.|-+|+.. +++.||||++.+... ...+..++|+.+|++++|+|
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 334456689999999999999999999865 588999999965421 12457899999999999999
Q ss_pred cccc---------------------------cCCCC-CChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC
Q 046791 574 LTDS---------------------------RRNNR-LNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ 625 (1018)
Q Consensus 574 lv~~---------------------------~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~ 625 (1018)
+|++ ...++ |++.++++++++++.||+|||.++ ||||||||+|+||+++
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9842 12334 889999999999999999999999 9999999999999999
Q ss_pred CCceeeeecceeeecCC---CCcccceeeecccccCChhhhccCC----CCccccchhHhHHHHHHHhCCCCCCCCCCCC
Q 046791 626 MNPKISDFGMARIFGLN---QSETNTNRVVGTYGYMSPEYAMSGV----VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDH 698 (1018)
Q Consensus 626 ~~~kL~DFGla~~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDV~SlGvvl~elltG~~p~~~~~~~~ 698 (1018)
+++||+|||.+..+... .........+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-..
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~---- 322 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD---- 322 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc----
Confidence 99999999999876322 1222334478999999999987633 457899999999999999999998421
Q ss_pred CCchHHHHHHHhhcCcchhhhhhhh----cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 699 PLNLIGYAWQLWNEGKVLELVDIAL----EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 699 ~~~l~~~~~~~~~~~~~~~~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
...++.+++. .-...++..+++.+|+.++|+.||++|.++.+|....
T Consensus 323 ---------------~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 323 ---------------FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ---------------hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1222333333 2223345678889999999999999999999998754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=310.21 Aligned_cols=230 Identities=26% Similarity=0.356 Sum_probs=176.1
Q ss_pred CCcceeeeeccCCCcCeEEEEe------cccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccccC--------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL------LNGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSRR-------- 579 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~~-------- 579 (1018)
++|++.+.||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.++..+ +||||+++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999963 235689999996543 33456789999999999 8999874210
Q ss_pred --------------------------------------------------------------------------------
Q 046791 580 -------------------------------------------------------------------------------- 579 (1018)
Q Consensus 580 -------------------------------------------------------------------------------- 579 (1018)
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence
Q ss_pred -------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 580 -------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 580 -------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 124778889999999999999999998 9999999999999999999999999998764332222
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ........+. ..
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~---------~~ 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGY---------RM 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCc---------cC
Confidence 2222345668999999999999999999999999999998 888875432211 1111111111 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
..+.....++.+|+.+||+.||++||++.||+++|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11222345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=309.76 Aligned_cols=230 Identities=25% Similarity=0.380 Sum_probs=175.6
Q ss_pred CCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccccC--------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSRR-------- 579 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~~-------- 579 (1018)
++|++.+.||+|+||.||+|+.. ++..||||+++... ......+.+|+.+++++ +|+||+....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 47888999999999999999742 24579999997543 33345688999999999 8999873110
Q ss_pred --------------------------------------------------------------------------------
Q 046791 580 -------------------------------------------------------------------------------- 579 (1018)
Q Consensus 580 -------------------------------------------------------------------------------- 579 (1018)
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence
Q ss_pred --------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceee
Q 046791 580 --------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651 (1018)
Q Consensus 580 --------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 651 (1018)
..++++.++++++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 124677888999999999999999998 999999999999999999999999999865433222222223
Q ss_pred ecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
.++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ..... ........+..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~---------~~~~~~~~~~~ 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMV---------KRGYQMSRPDF 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHH---------HcccCccCCCC
Confidence 45668999999999999999999999999999997 999986432211 0 01111 11111112222
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
....+.+++.+||+.||++||++.+|+++|++.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=329.07 Aligned_cols=231 Identities=30% Similarity=0.448 Sum_probs=182.7
Q ss_pred CCcceeeeeccCCCcCeEEEEecc--cc----cceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN--GQ----EVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~--g~----~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
.+-...+.||+|.||.||+|...+ |. .||||.+++. +.+...+|.+|+.+|++++|||||++
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345667899999999999998654 43 3899999776 45667789999999999999999831
Q ss_pred ----------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecc
Q 046791 578 ----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM 635 (1018)
Q Consensus 578 ----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGl 635 (1018)
.....|.....+.++.|||+|+.|||+++ +|||||.++|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 11456888999999999999999999999 99999999999999999999999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
|+.+...+.........-...|||||.+..+.++.|+|||||||+||||+| |..||......+ .. ....+.+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~---~~~~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VL---LDVLEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HH---HHHHhCC-
Confidence 995543332222222233568999999999999999999999999999998 667775433211 00 0011122
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
+-..+...+..+.+|+..||+.+|++||++..|++.++.+..
T Consensus 922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 224566778899999999999999999999999998887543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=281.25 Aligned_cols=258 Identities=24% Similarity=0.287 Sum_probs=189.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccc--cHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ--GIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
+.|+.++.|++|.||.||+|+.. +++.||+|+++..... -.--..+|+.+|.+++|||||+.
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35777899999999999999975 4889999999765321 11235899999999999999842
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
....++...+..-++.|+++||+|||... |+||||||+|+|+...|.+||+|||+|+.++..
T Consensus 156 Me~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-- 230 (419)
T KOG0663|consen 156 MEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-- 230 (419)
T ss_pred HHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC--
Confidence 12457888999999999999999999999 999999999999999999999999999987643
Q ss_pred cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHH--------HHHhhcC--
Q 046791 645 ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYA--------WQLWNEG-- 713 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~-- 713 (1018)
....+..+-|..|.|||.+.+ ..|+++.|+||+|||+.||+++++.|......++.+.+-.. |..+..-
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 333455778999999999987 57999999999999999999999988765543332222111 0000000
Q ss_pred ----cchhhhhhhhcCCCChH-HHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCCCCCCCcceeccc
Q 046791 714 ----KVLELVDIALEGSFSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPAFFINIT 780 (1018)
Q Consensus 714 ----~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp~p~~p~~~~~~~ 780 (1018)
...+.....++..+... ..+.-.+|+...|..||.+|.|+.|.++. +-....|.|..|.++....
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~Pt~P 380 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFPTWP 380 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcCCCc
Confidence 00011111112222222 33566788889999999999999988763 2233456677676665443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=300.66 Aligned_cols=230 Identities=25% Similarity=0.424 Sum_probs=177.4
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cc----cceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc-----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQ----EVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR----------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~----------- 578 (1018)
.+|++.+.||+|+||.||+|++.. ++ .||||.++... ....+++.+|+.+++.++|+||++..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 468999999999999999998643 33 38999986543 34456899999999999999998311
Q ss_pred ---------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 579 ---------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 579 ---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCC
Confidence 1235778888999999999999999998 9999999999999999999999999998765433
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||...... . .......+
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~-~~~~~~~~--------- 227 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E-ISSILEKG--------- 227 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHhCC---------
Confidence 3222222334668999999999999999999999999999998 99987532111 0 11111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.....+......+.+++.+||+.+|++||++.+++..|....
T Consensus 228 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 228 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111122233456788999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=297.41 Aligned_cols=235 Identities=25% Similarity=0.371 Sum_probs=175.0
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-----------------cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-----------------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~ 577 (1018)
++|.+.++||+|+||.||+++..+ +..||||.+.... .....+|.+|++++.+++|+||++.
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 3369999987643 3345679999999999999998731
Q ss_pred c----------------C-----------------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEe
Q 046791 578 R----------------R-----------------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612 (1018)
Q Consensus 578 ~----------------~-----------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 612 (1018)
. . ...+++..+.+++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 0 0 023567788999999999999999999 999
Q ss_pred cccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhC--CCC
Q 046791 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG--KKN 690 (1018)
Q Consensus 613 ~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG--~~p 690 (1018)
|||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433222222334557889999999989999999999999999999974 456
Q ss_pred CCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 691 NGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 691 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
|...... .........+..... ......++..+..+.+++.+||+.+|++|||+.||.+.|++
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5432211 111111111111100 00111223445678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=276.94 Aligned_cols=208 Identities=27% Similarity=0.371 Sum_probs=176.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
++|++++.||.|+||.|.+++.+. |..+|+|++++.. -.+.+...+|..+|+.+.||.++.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 467888999999999999998754 8889999997753 345567889999999999999873
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
+++.+++++..+.-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 345678999999999999999999999999 9999999999999999999999999999874
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
..+...+||+.|+|||++....+..++|-|||||++|||+.|.+||....+ .++.++++.+
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------------------~~iY~KI~~~ 256 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------------------IQIYEKILEG 256 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------------------HHHHHHHHhC
Confidence 235568999999999999999999999999999999999999999854332 2233333333
Q ss_pred --CCChHHHHHHHHHHHhccccCCCCC
Q 046791 726 --SFSPNEVLRCIHVGLLCVQDQATDR 750 (1018)
Q Consensus 726 --~~~~~~~~~l~~li~~Cl~~dP~~R 750 (1018)
.+|.--...+.+|+...|+.|-.+|
T Consensus 257 ~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 3555566777888889999999988
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=294.59 Aligned_cols=223 Identities=24% Similarity=0.325 Sum_probs=173.6
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.|+..+.||+|+||.||++... +++.||||.+.... ......+.+|+.++.+++|+|++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4788899999999999999864 68999999986542 2334568899999999999998721
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 11235788899999999999999999999 9999999999999999999999999998753221
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .......... ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~----------~~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKE----------DQ 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhc----------cc
Confidence 12235689999999999999999999999999999999999999864332211 0101100000 01
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
..++......+.+|+.+||+.||.+||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1223334567888999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=302.69 Aligned_cols=232 Identities=27% Similarity=0.385 Sum_probs=178.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccccC-------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSRR------- 579 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~~------- 579 (1018)
.++|++.+.||+|+||.||+|+.. .++.||+|+++... ....+.+..|+.++.++ +|+||+....
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357999999999999999999642 24689999987543 23345678899999999 8999863110
Q ss_pred --------------------------------------------------------------------------------
Q 046791 580 -------------------------------------------------------------------------------- 579 (1018)
Q Consensus 580 -------------------------------------------------------------------------------- 579 (1018)
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence
Q ss_pred -CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccC
Q 046791 580 -NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYM 658 (1018)
Q Consensus 580 -~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~ 658 (1018)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 125788889999999999999999998 9999999999999999999999999998764332222233345677899
Q ss_pred ChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHH
Q 046791 659 SPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIH 737 (1018)
Q Consensus 659 aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 737 (1018)
|||++.+..++.++|||||||++|||++ |..||....... ........+. ....+.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGT---------RMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccC---------CCCCCccCCHHHHH
Confidence 9999999999999999999999999998 999985432211 0111111111 11122334567889
Q ss_pred HHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 738 VGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 738 li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
++.+||+.+|++||++.||+++|+...
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=316.06 Aligned_cols=232 Identities=20% Similarity=0.287 Sum_probs=181.9
Q ss_pred HHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc--------
Q 046791 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS-------- 577 (1018)
Q Consensus 509 ~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~-------- 577 (1018)
.++....++|.+.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++..++|+|++..
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344555689999999999999999999854 5899999998654 23445678899999999999987631
Q ss_pred ------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC
Q 046791 578 ------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN 627 (1018)
Q Consensus 578 ------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 627 (1018)
.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 01235677888899999999999999998 999999999999999999
Q ss_pred ceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH
Q 046791 628 PKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 628 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 707 (1018)
+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMH 255 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHH
Confidence 99999999987654333333345679999999999999999999999999999999999999985321 111111
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
... .+. ....++...+.+.+++.+||+.+|.+||++.++++.
T Consensus 256 ~~~-~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTL-AGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHh-cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 111 111233455678899999999999999999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=301.75 Aligned_cols=236 Identities=23% Similarity=0.314 Sum_probs=174.1
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.++||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999865 5889999998643 22344578999999999999998732
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 12345788999999999999999999999 9999999999999999999999999998653221
Q ss_pred C-cccceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHH-----------H
Q 046791 644 S-ETNTNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQ-----------L 709 (1018)
Q Consensus 644 ~-~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----------~ 709 (1018)
. ........||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....... .
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPETISR 234 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHH
Confidence 1 112234578999999999876 678999999999999999999999986432211 0000000 0
Q ss_pred hhcCcchhhhhhhhcCC-C-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 710 WNEGKVLELVDIALEGS-F-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~-~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+......+.+....... . .+.....+.+++.+||+.||++||+++|+++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00111111111100000 0 0112356789999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=293.53 Aligned_cols=233 Identities=20% Similarity=0.290 Sum_probs=179.1
Q ss_pred ccceeHHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEeccccccc---HHHHHHHHHHHHHhcCCCcccc--
Q 046791 503 LEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQG---IVEFKNEAKLIAKLQHTNLTDS-- 577 (1018)
Q Consensus 503 ~~~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~---~~~f~~E~~~l~~l~H~nlv~~-- 577 (1018)
+..++.+++. ......||+|++|.||+|+. +|+.||||+++...... .+.|.+|+.++.+++||||++.
T Consensus 12 ~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 4445556652 22235799999999999988 78899999997653333 4678899999999999998732
Q ss_pred ----------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCCCc
Q 046791 578 ----------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 578 ----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
.....+++.....++.|++.||.|||+. + ++||||||+|||+++++.+
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcE
Confidence 1234578888999999999999999984 6 7899999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYA 706 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 706 (1018)
||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+.
T Consensus 163 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~--- 231 (283)
T PHA02988 163 KIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIY--- 231 (283)
T ss_pred EEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHH---
Confidence 99999998865321 123467889999999976 78999999999999999999999998643211 111
Q ss_pred HHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 707 WQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 707 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
...... ......+......+.+++.+||+.||++|||+.||++.|+...
T Consensus 232 ~~i~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 232 DLIINK---------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHhc---------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111111 1111223345667889999999999999999999999998653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=292.32 Aligned_cols=228 Identities=29% Similarity=0.435 Sum_probs=177.9
Q ss_pred CCcceeeeeccCCCcCeEEEEecc------cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR---------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~---------- 578 (1018)
++|++.+.||+|+||.||+|.... ...||+|.+.... .....+|.+|+.++.+++|+||+...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367888999999999999998643 2579999986543 23456789999999999999987210
Q ss_pred ----------------C----------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC
Q 046791 579 ----------------R----------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM 626 (1018)
Q Consensus 579 ----------------~----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~ 626 (1018)
. ...+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 0 045777888999999999999999999 99999999999999999
Q ss_pred CceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHH
Q 046791 627 NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGY 705 (1018)
Q Consensus 627 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~ 705 (1018)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------~ 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------E 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 999999999986543322222334456788999999999999999999999999999998 99997543211 1
Q ss_pred HHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 706 AWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 706 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
....+..+ .....+...+.++.+|+.+||+.+|++||++.||++.|++
T Consensus 235 ~~~~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 1112234456788899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=294.90 Aligned_cols=234 Identities=25% Similarity=0.342 Sum_probs=171.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec--ccccceEEEecccc--cccHHHHHHHHHHHHHh---cCCCccccc----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL--NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKL---QHTNLTDSR---------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~--~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nlv~~~---------- 578 (1018)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++++ +||||++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 36789999986542 22334567788777766 699987421
Q ss_pred ----------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 579 ----------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 579 ----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 1234788899999999999999999999 999999999999999999999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc---C
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE---G 713 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~ 713 (1018)
+..... .......|+..|+|||.+.+..++.++|||||||++|||++|++||....... ........... .
T Consensus 158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~ 231 (290)
T cd07862 158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 231 (290)
T ss_pred EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 875432 22334578999999999999899999999999999999999999986543211 11111110000 0
Q ss_pred cchh---hhhhhhc--CC-----CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 KVLE---LVDIALE--GS-----FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~~~~---~~d~~l~--~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.... ....... .. ..+.....+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000000 00 01123356678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=303.95 Aligned_cols=234 Identities=17% Similarity=0.152 Sum_probs=171.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|++.+.||+|+||.||+++.. +++.||||... ...+.+|++++++++||||+++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999865 48899999753 2357899999999999999842
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 165 ~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~ 240 (391)
T PHA03212 165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANKY 240 (391)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-ccccc
Confidence 12346788899999999999999999998 999999999999999999999999999753221 11122
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCC----CchHHHHHHHhhc----------Cc
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP----LNLIGYAWQLWNE----------GK 714 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~----~~l~~~~~~~~~~----------~~ 714 (1018)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+-....... ............. ..
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 345799999999999999999999999999999999999987643221100 0011111110000 00
Q ss_pred chhhhhhhh----cC--CCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 VLELVDIAL----EG--SFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ~~~~~d~~l----~~--~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+...... .. ..+ ......+.+++.+||+.||++|||+.|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 00 000 123456788999999999999999999986
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=295.15 Aligned_cols=235 Identities=20% Similarity=0.312 Sum_probs=173.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++|+||++.
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56999999999999999999865 48899999986543 2334568899999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~ 159 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KT 159 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--cc
Confidence 11234678889999999999999999999 9999999999999999999999999998653221 12
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc------------Cc
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE------------GK 714 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------~~ 714 (1018)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE---ELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHHhhccccchh
Confidence 223567899999999875 568999999999999999999999986433211 11111111100 00
Q ss_pred chhhhhhhhcCC----CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 VLELVDIALEGS----FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ~~~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+..... ..+.....+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 01122356789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=285.59 Aligned_cols=227 Identities=28% Similarity=0.422 Sum_probs=178.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.++|++.+.||+|++|.||+|...+++.||||.++... ...+++.+|+.++++++|+|++..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688999999999999999998778889999986543 345779999999999999998721
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence 11235889999999999999999999998 99999999999999999999999999987652211 1
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......+..|+|||++.+..++.++||||||+++|||++ |+.||...... ........ ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~---------~~~~ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQ---------GYRM 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHc---------CCCC
Confidence 1111223457999999999999999999999999999999 99887532211 01111111 1111
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1223445778899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=310.87 Aligned_cols=230 Identities=24% Similarity=0.311 Sum_probs=187.3
Q ss_pred HhCCcceeeeeccCCCcCeEEEEeccc-ccceEEEecccccccHHHHHHHHHHHHHhc-CCCcccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLNG-QEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNLTDS-------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nlv~~-------------- 577 (1018)
...++++.+.|.+|||+.||.|+...+ .++|+|++-...+...+..++|+++|++|. |+|||.+
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 445788999999999999999998775 999999998778888999999999999997 9999821
Q ss_pred ---------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 578 ---------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 578 ---------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
+....|++.++++|+.|+++|+++||... ++|||||||-|||||..+++.||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 11335899999999999999999999986 78999999999999999999999999999
Q ss_pred eeecCCCCccc-------ceeeecccccCChhhh---ccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHH
Q 046791 637 RIFGLNQSETN-------TNRVVGTYGYMSPEYA---MSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYA 706 (1018)
Q Consensus 637 ~~~~~~~~~~~-------~~~~~gt~~Y~aPE~~---~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 706 (1018)
...-....... .-....|+.|+|||++ .+..+++|+|||+|||+||.|+....||+...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----------- 262 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----------- 262 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence 75322211000 0123568999999987 47889999999999999999999999986321
Q ss_pred HHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 707 WQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 707 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
...+++....-...+....++.+||..||+.||.+||++-+|++.+-..
T Consensus 263 --------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 263 --------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred --------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 1223333222233357889999999999999999999999999977543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=294.15 Aligned_cols=239 Identities=23% Similarity=0.264 Sum_probs=176.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++|+||+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999976 47889999986542 3345678899999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-A 156 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-c
Confidence 12346888899999999999999999998 99999999999999999999999999987643221 1
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHH--------HHHHh-hcCcchh
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGY--------AWQLW-NEGKVLE 717 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~-~~~~~~~ 717 (1018)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.............. ....+ .......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 22245789999999999998999999999999999999999999864332110000000 00000 0000000
Q ss_pred hhhhhhcC------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALEG------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+.... .........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=287.05 Aligned_cols=226 Identities=29% Similarity=0.453 Sum_probs=177.7
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+|++..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5788999999999999999998888899999986543 345789999999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++......... .
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-A 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-c
Confidence 11345778888999999999999999998 999999999999999999999999999876432211 1
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
.....++..|+|||++....++.++||||||+++|||++ |+.||...... .. ......+. ...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~----~~~~~~~~---------~~~ 224 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DV----MSALQRGY---------RMP 224 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCC---------CCC
Confidence 122345678999999998899999999999999999998 99988532211 11 11111110 111
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
........+.+++.+|++.+|++||+++++.++|++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112334568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=292.85 Aligned_cols=237 Identities=22% Similarity=0.303 Sum_probs=173.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++|+||+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 588999999875432 234567899999999999999731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 158 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--H 158 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC--c
Confidence 12345788899999999999999999999 9999999999999999999999999997643221 1
Q ss_pred cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc------hh--
Q 046791 647 NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV------LE-- 717 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~-- 717 (1018)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...... ................ ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhcc
Confidence 2223567899999999875 45889999999999999999999999643211 0111111111100000 00
Q ss_pred hhhh-hhcCCCC---------hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDI-ALEGSFS---------PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~-~l~~~~~---------~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..++ ......+ ......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 0000000 011245778999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=293.15 Aligned_cols=227 Identities=30% Similarity=0.417 Sum_probs=174.7
Q ss_pred CcceeeeeccCCCcCeEEEEecc------cccceEEEecccccc-cHHHHHHHHHHHHHhcCCCccccc-----------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDSR----------- 578 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~~----------- 578 (1018)
+|++.+.||+|+||.||+|+..+ ++.||||+++..... ..++|.+|+.++.+++|+||++..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46777899999999999998632 468999999755432 346689999999999999987310
Q ss_pred -------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC
Q 046791 579 -------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN 627 (1018)
Q Consensus 579 -------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 627 (1018)
....+++..+..++.|+++||.|||+++ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 0124777888999999999999999998 999999999999999999
Q ss_pred ceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHH
Q 046791 628 PKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYA 706 (1018)
Q Consensus 628 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 706 (1018)
+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||...... . .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~-~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D-V 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------H-H
Confidence 99999999886543322222233455778999999998899999999999999999998 77777532211 1 1
Q ss_pred HHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 707 WQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 707 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
......+. ....+......+.+++..||+.+|++||++.+|++.|+.
T Consensus 236 ~~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 112233455668899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=290.20 Aligned_cols=231 Identities=26% Similarity=0.385 Sum_probs=176.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccc----cceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQ----EVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++|++.+.||+|+||.||+|+.. +++ .+++|.+..... ....++..|+.+++++.|+||++.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 46778899999999999999864 344 477888754432 334678888999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 12346789999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.........++..|+|||.+.++.++.++||||||+++|||++ |+.||...... ........+...
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~------ 230 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERL------ 230 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcC------
Confidence 2222333556778999999999999999999999999999998 99887533211 111111111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
..+......+.+++.+|++.+|++||++.|+++.|+....
T Consensus 231 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 ---AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111223456788999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=299.68 Aligned_cols=219 Identities=24% Similarity=0.325 Sum_probs=182.1
Q ss_pred CCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
+-|++.+-||.|+.|.|-+|+. .+|+.+|||++.+.. ........+|+.+|+.+.|||++.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577888999999999999985 569999999997763 233456789999999999999873
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
+...++|++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-. ..
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV---PG 165 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc---CC
Confidence 234678999999999999999999999999 9999999999999999999999999998643 22
Q ss_pred ccceeeecccccCChhhhccCCCC-ccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVS-IKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.....-+|+++|+|||++++.+|. .++||||.|||||.||+|+.||+. +++..++.+.-+
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-------------------dNir~LLlKV~~ 226 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-------------------DNIRVLLLKVQR 226 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-------------------ccHHHHHHHHHc
Confidence 334457899999999999998874 889999999999999999999962 222333333333
Q ss_pred CC--CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 725 GS--FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 725 ~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+. .|.....++.+|+.+|+..||++|.|++||++.
T Consensus 227 G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 227 GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 32 344566788899999999999999999999993
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=293.41 Aligned_cols=218 Identities=24% Similarity=0.293 Sum_probs=173.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999875 58899999986532 2345668899999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---- 153 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC----
Confidence 22346788899999999999999999999 99999999999999999999999999986532
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... . .......+. .
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~-~~~~i~~~~----------~ 215 (291)
T cd05612 154 -RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------G-IYEKILAGK----------L 215 (291)
T ss_pred -CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCC----------c
Confidence 122356899999999999989999999999999999999999998542211 1 111111111 1
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
.++......+.+++.+||+.||.+||+ +.|+++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 122333557789999999999999995 777775
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=287.66 Aligned_cols=228 Identities=27% Similarity=0.424 Sum_probs=182.9
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
...+|++.++||+|+||.||+|...+++.+|+|.+.........++.+|+.+++.++|+|+++.
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4567889999999999999999988899999999987766567789999999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++.++..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 12345788999999999999999999998 999999999999999999999999999865432111
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... .+.....
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~-------------~~~~~~~ 222 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYD-------------QITAGYR 222 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH-------------HHHhCCc
Confidence 112345678999999998899999999999999999998 88888533211 0111 1111111
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
...+....+.+.+++.+||+.+|.+|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 22334556778899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=297.92 Aligned_cols=218 Identities=26% Similarity=0.338 Sum_probs=173.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+..
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999876 48899999986542 2345678999999999999999731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 12356788889999999999999999999 999999999999999999999999999875322
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ........+..
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~-~~~~~i~~~~~---------- 232 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------F-RIYEKILAGRL---------- 232 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------H-HHHHHHhcCCc----------
Confidence 2235789999999999999999999999999999999999999853211 0 11111111110
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
..+.....++.+++.+||+.||.+||+ ++++++
T Consensus 233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 122223456788999999999999997 677764
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=290.81 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=180.1
Q ss_pred CCc-ceeeeeccCCCcCeEEEEe-----cccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 516 NNF-SAVNKLGEGGFGPVYKGQL-----LNGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 516 ~~y-~~~~~lG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
++| ++.+.||+|+||+||++.. .+++.||+|.+.... ......|.+|++++++++|+|++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8889999999999988653 347789999987543 2345678999999999999998731
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++.++..++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 11235789999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCccc-ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 642 NQSETN-TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 642 ~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
...... .....++..|+|||.+.+..++.++||||||+++|||++|..|+....... .................+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence 222111 112234567999999998899999999999999999999999975432211 000000000001111222222
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.......+......+.+++.+||+.+|++||++++|+++|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2222223344567888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=297.17 Aligned_cols=215 Identities=22% Similarity=0.275 Sum_probs=169.4
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------------- 577 (1018)
+.||+|+||.||+++.. +|+.||||+++... .....++.+|+.++++++||||+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999865 58899999997542 2344568899999999999998731
Q ss_pred ------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceee
Q 046791 578 ------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651 (1018)
Q Consensus 578 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 651 (1018)
.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccce
Confidence 12456788999999999999999999999 999999999999999999999999998753211 1222346
Q ss_pred ecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHH
Q 046791 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNE 731 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 731 (1018)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......+ ...++...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~-~~~~~~~~----------~~~~p~~~ 218 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------K-LFELILME----------EIRFPRTL 218 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------H-HHHHHHcC----------CCCCCCCC
Confidence 7999999999999999999999999999999999999998532210 0 01111011 11223344
Q ss_pred HHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 732 VLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 732 ~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
...+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 56788999999999999999 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=288.42 Aligned_cols=228 Identities=26% Similarity=0.399 Sum_probs=177.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecc------cccceEEEecccccc-cHHHHHHHHHHHHHhcCCCccccc----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDSR---------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~~---------- 578 (1018)
++|.+.+.||+|+||.||+|+..+ ++.||||.++..... ..+.|.+|++++++++|+|++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998643 468999999765443 457899999999999999987310
Q ss_pred ------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCc
Q 046791 579 ------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 579 ------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
....+++.++..++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 1234678889999999999999999999 9999999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 707 (1018)
||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~---- 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVI---- 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----
Confidence 9999999986533222222223345678999999999999999999999999999998 99997533211 111
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
.....+.. ...+......+.+++.+||+.||++||++.||+++|+.
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ECITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111111 11222345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=307.73 Aligned_cols=232 Identities=20% Similarity=0.268 Sum_probs=171.5
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR-------------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~-------------- 578 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+|+.++++++|+||+.+.
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999875 48899999885432 2345799999999999987420
Q ss_pred -----------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-Cceeeeec
Q 046791 579 -----------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFG 634 (1018)
Q Consensus 579 -----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kL~DFG 634 (1018)
....+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 1245677788899999999999999999 99999999999999664 69999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG 713 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 713 (1018)
+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||....... ............
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLVRIIQVLGTP 290 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC
Confidence 998654222 1223567899999999876 468999999999999999999999986432211 111111111100
Q ss_pred cch---------------hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 KVL---------------ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~~~---------------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... ......+...++.....++.+|+.+||+.||.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 000011111122234467889999999999999999999986
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=315.63 Aligned_cols=297 Identities=21% Similarity=0.264 Sum_probs=202.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
++|++.++||+|+||.||+|+.. +++.||||++.... ....++|.+|++++++++|||++...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999875 48899999997542 22345799999999999999988310
Q ss_pred ---C---------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeec
Q 046791 579 ---R---------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 634 (1018)
Q Consensus 579 ---~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFG 634 (1018)
. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 0 122445667889999999999999998 9999999999999999999999999
Q ss_pred ceeeecCCCC----------------cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCC
Q 046791 635 MARIFGLNQS----------------ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDH 698 (1018)
Q Consensus 635 la~~~~~~~~----------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~ 698 (1018)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 011123568999999999999999999999999999999999999986422110
Q ss_pred CCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCcCCCCC--CC----
Q 046791 699 PLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRP-AMPDVVSMLANESLSLPA--PK---- 771 (1018)
Q Consensus 699 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~Le~~~~~lp~--p~---- 771 (1018)
.. . .... .++. ......+.+..+.+++.+|++.||++|| +++++++.|+......|. |+
T Consensus 239 ---i~---~----~~~i---~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~~~~~l~ 304 (932)
T PRK13184 239 ---IS---Y----RDVI---LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWTVKATLM 304 (932)
T ss_pred ---hh---h----hhhc---cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcccccccccc
Confidence 00 0 0000 0000 0000113345677899999999999995 677777777764332221 00
Q ss_pred --CC-cceec--cc-CC-CCCCCCCccccccccCCccccCCcccccCCceeccccceeeeeecCCC
Q 046791 772 --QP-AFFIN--IT-AE-EPPVSESNAECCSINNSDKLQQGQVLRDGDQLVSAFGRFRLAFFSPRS 830 (1018)
Q Consensus 772 --~p-~~~~~--~~-~~-~~~~~~~~~~~~s~~~~dti~~~~~l~~~~~l~s~~~~f~~gf~~~~~ 830 (1018)
.+ .+... .. .. .+-...+.....+. ..+.+...+.++...+...+...+.+||+.+..
T Consensus 305 ~~~~~~wk~~e~iLlsk~~~~l~~s~~~w~s~-~is~ie~~~~~rie~~~~~~~~~~~~g~~l~p~ 369 (932)
T PRK13184 305 TKKKSCWKFYEPILLSKYFPMLESSPAQWYSL-MISKIESSSETRLEYTVTKKGLHEGFGILLPPS 369 (932)
T ss_pred cccchhccccchhhhhhhcccccCCchhheec-cccccccccceeeeeeeccCccccccceecCcc
Confidence 00 00000 00 00 00000111122222 245566666777777788888899999998743
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=283.61 Aligned_cols=226 Identities=27% Similarity=0.449 Sum_probs=178.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|++.++||+|+||.||+|...++..+|+|.+..... ..+.|.+|+.++++++|+|++..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 46888999999999999999988888999999876433 45679999999999999998621
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++......... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 160 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-AR 160 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cc
Confidence 11235788999999999999999999998 999999999999999999999999999876432211 11
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ... ... ........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~-~~~---------~~~~~~~~ 224 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVL-EQV---------ERGYRMPC 224 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHH-HHH---------HcCCCCCC
Confidence 12334568999999988899999999999999999999 88887532211 111 111 11111122
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
+......+.+++.+|++.+|++|||++++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 33445678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=288.23 Aligned_cols=223 Identities=31% Similarity=0.465 Sum_probs=170.2
Q ss_pred ceeeeeccCCCcCeEEEEec-----ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 519 SAVNKLGEGGFGPVYKGQLL-----NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.+.+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++.+++++|+||++.
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999986 25689999996543 3347889999999999999998731
Q ss_pred -----------cC--CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -----------RR--NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -----------~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.. ...+++.++..|+.||++||.|||+++ ++|+||+++||+++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 11 357899999999999999999999998 99999999999999999999999999987632222
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
............|+|||.+....++.++||||||+++|||++ |+.|+.... ...... .+.++.
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~-~~~~~~--------- 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIE-KLKQGQ--------- 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHH-HHHTTE---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccc-cccccc---------
Confidence 222233456789999999999999999999999999999999 678864331 111111 111111
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
....+......+.+++.+||+.+|++||++.+|++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122334466788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=299.24 Aligned_cols=225 Identities=25% Similarity=0.377 Sum_probs=169.9
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
+|+..++||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|+||++.
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556789999999999999865 58999999986543 2334678999999999999999731
Q ss_pred -----cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeee
Q 046791 578 -----RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVV 652 (1018)
Q Consensus 578 -----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 652 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++.+..... ......
T Consensus 155 ~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~ 229 (353)
T PLN00034 155 DGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSV 229 (353)
T ss_pred CCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccc
Confidence 11234567778899999999999999999 99999999999999999999999999987643211 123457
Q ss_pred cccccCChhhhcc-----CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 653 GTYGYMSPEYAMS-----GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 653 gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
||..|+|||++.. ...+.++|||||||++|||++|+.||....... ......... .......
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~----------~~~~~~~ 296 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAIC----------MSQPPEA 296 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHh----------ccCCCCC
Confidence 8999999998743 234578999999999999999999986322111 110000000 0001112
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+......+.+++.+||+.||++||++.||++.
T Consensus 297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 23345678899999999999999999999873
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=284.70 Aligned_cols=229 Identities=25% Similarity=0.403 Sum_probs=177.7
Q ss_pred CCcceeeeeccCCCcCeEEEEecc----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
++|++.+.||+|+||.||+|+... ...||||.++... .....+|.+|+.++.+++|+||++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999998743 3579999986543 3345679999999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++.++..++.|++.||.|||+.+ |+|+||||+|||+++++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 11236889999999999999999999998 9999999999999999999999999998775222
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~--------- 224 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAVEDG--------- 224 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcC---------
Confidence 2222222344678999999999999999999999999999998 99887432211 011111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.....+......+.+++.+|++.+|++||++.||+++|+..
T Consensus 225 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112233456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=286.32 Aligned_cols=231 Identities=26% Similarity=0.425 Sum_probs=177.7
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccc----cceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQ----EVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
.++|++.++||+|+||+||+|+.. +++ .||+|.++... .....++.+|+.++..++|+|++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l 85 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL 85 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence 357888899999999999999853 444 47999986543 3345678999999999999998621
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 11346889999999999999999999998 999999999999999999999999999876533
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+ ......+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~------- 228 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EI----PDLLEKGE------- 228 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHHCCC-------
Confidence 22222222344678999999999999999999999999999998 88887532211 11 11111111
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
....+......+.+++.+||+.||++||++.++++.|+...
T Consensus 229 --~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 --RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11112234567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=285.94 Aligned_cols=229 Identities=22% Similarity=0.306 Sum_probs=176.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEec----ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++.+++||||++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999753 35689999987653 2334578999999999999998731
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++.+++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 11346889999999999999999999998 999999999999999999999999987653211
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
. ........++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .. .....++.
T Consensus 161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~----~~~~~~~~------- 225 (266)
T cd05064 161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DV----IKAVEDGF------- 225 (266)
T ss_pred c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HH----HHHHHCCC-------
Confidence 1 111112334678999999999999999999999999999875 99998543211 01 11111111
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
....+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus 226 --~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 --RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122334456788899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=283.98 Aligned_cols=227 Identities=26% Similarity=0.387 Sum_probs=177.2
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
..|.+.+.||+|+||.||+|...+ ++.||+|++... .....++.+|++++++++|+||++.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 357888999999999999998654 888999998654 3446789999999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~ 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence 11235788899999999999999999998 99999999999999999999999999986543211 1
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+ ........ ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~---------~~~~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEK---------GYRM 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHC---------CCCC
Confidence 1112233568999999999999999999999999999998 88887532211 11111111 1112
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
..+...+..+.+++.+||+.+|++||++.+++++|++.
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 23334456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=282.90 Aligned_cols=227 Identities=30% Similarity=0.455 Sum_probs=179.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.++|++.++||+|+||.||+|...+++.||+|.+.... ....+|.+|+.++++++|+|++..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 35788999999999999999998889999999987543 345689999999999999998621
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-cc
Confidence 12345788899999999999999999998 99999999999999999999999999987642221 11
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
.....++..|+|||++....++.++||||||+++|||++ |+.||...... .. ......+ ....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~---------~~~~ 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EV----IQNLERG---------YRMP 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HH----HHHHHcC---------CCCC
Confidence 122345678999999998899999999999999999999 99998533211 01 1111111 1111
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
.+.....++.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 222334578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=282.89 Aligned_cols=227 Identities=27% Similarity=0.423 Sum_probs=178.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|++.++||+|+||.||+|+..+...||+|+++... ...++|.+|++++++++|+|++..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 5699999999999999999988777789999997533 345679999999999999998731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.+..+..... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~ 160 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR 160 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-ccc
Confidence 11234788899999999999999999998 99999999999999999999999999987643221 112
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....++..|+|||+..+..++.++||||||+++|||++ |+.||...... ........+ .....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~---------~~~~~ 224 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERG---------YRMPC 224 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcC---------CCCCC
Confidence 23345678999999998899999999999999999999 78787532211 011111111 01112
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
+.+....+.+++.+|++.+|++||++.+++++|+..
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 334556788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=284.00 Aligned_cols=227 Identities=25% Similarity=0.360 Sum_probs=175.0
Q ss_pred cceeeeeccCCCcCeEEEEecc----cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
|.+.+.||+|+||.||+|.+.. +..||||+++... .....++.+|+++++.++|+|+++..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998643 3679999987542 33456799999999999999987311
Q ss_pred -------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeee
Q 046791 579 -------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633 (1018)
Q Consensus 579 -------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DF 633 (1018)
....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 1125778888999999999999999998 999999999999999999999999
Q ss_pred cceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 634 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
|+++................+..|+|||.+.+..++.++||||||+++|||++ |..||...... ... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~----~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIY----DYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHc
Confidence 99987643322222222344678999999998999999999999999999999 88887532211 111 11111
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
+. ....+......+.+++.+||+.||++||++.||++.|++.
T Consensus 231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1112334556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=289.87 Aligned_cols=231 Identities=26% Similarity=0.373 Sum_probs=180.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec------ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+|++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999743 345689999877666666789999999999999998721
Q ss_pred ----c--------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC
Q 046791 578 ----R--------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN 627 (1018)
Q Consensus 578 ----~--------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 627 (1018)
. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 0 1134788999999999999999999999 999999999999999999
Q ss_pred ceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHH
Q 046791 628 PKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYA 706 (1018)
Q Consensus 628 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 706 (1018)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543222222223456788999999999999999999999999999999 999875432110 1
Q ss_pred HHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 707 WQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 707 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.+....+... ..+...+..+.+++.+||+.+|++||++.+|+++|+....
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111121111 1122345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=289.56 Aligned_cols=239 Identities=22% Similarity=0.395 Sum_probs=178.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-----ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-----NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.++|++.+.||+|+||.||++... +++.||||++........+.|.+|++++++++|+|++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357889999999999999999742 477899999977666667789999999999999998731
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 11235788899999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCccc-ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc-----
Q 046791 641 LNQSETN-TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK----- 714 (1018)
Q Consensus 641 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----- 714 (1018)
....... .....++..|+|||++.+..++.++||||||+++|||++|..++...... .. ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~---~~~~~~~~~~~~~ 232 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FM---RMMGNDKQGQMIV 232 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hh---hhcccccccccch
Confidence 3222111 11122344699999999889999999999999999999988765322110 00 00000000
Q ss_pred --chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 715 --VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 715 --~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
+.+.+........+......+.+++.+||+.+|++|||+.||+++|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0111111111112233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=285.09 Aligned_cols=226 Identities=26% Similarity=0.363 Sum_probs=173.2
Q ss_pred ceeeeeccCCCcCeEEEEecc-cc--cceEEEeccc--ccccHHHHHHHHHHHHHhcCCCccccc---------------
Q 046791 519 SAVNKLGEGGFGPVYKGQLLN-GQ--EVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDSR--------------- 578 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~~--------------- 578 (1018)
.+.+.||+|+||.||+|+..+ ++ .+|+|.++.. .....+.|..|+.++++++|+|+++..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 466899999999999998765 32 5899988654 234467789999999999999987421
Q ss_pred -----------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecc
Q 046791 579 -----------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM 635 (1018)
Q Consensus 579 -----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGl 635 (1018)
....+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 1123678888999999999999999998 99999999999999999999999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCC
Confidence 987643222111222345678999999999999999999999999999999 78887532211 1111122211
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.. ..+......+.+++.+||+.+|++|||+.+|++.|++.
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 11223456688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=289.11 Aligned_cols=231 Identities=28% Similarity=0.394 Sum_probs=179.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec------ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc-----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR----------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~----------- 578 (1018)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++|+||+...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888999999999999999752 2456899998776656677899999999999999987210
Q ss_pred ----------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCcee
Q 046791 579 ----------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI 630 (1018)
Q Consensus 579 ----------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL 630 (1018)
....+++.+++.++.|++.||+|||+++ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 1124889999999999999999999998 999999999999999999999
Q ss_pred eeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHH
Q 046791 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 99999986543222222223345678999999999999999999999999999998 888875332110 1111
Q ss_pred hhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 710 WNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
...+... ..+......+.+++.+||+.+|.+||++.||++.|++...
T Consensus 235 i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111111 1112234568899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=299.45 Aligned_cols=227 Identities=20% Similarity=0.280 Sum_probs=176.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+|+..+ ++.||||+++... ......+.+|+.++.+++|+||++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 479999999999999999999764 8899999997542 2345678899999999999999731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 12356788999999999999999999999 99999999999999999999999999986532
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ...... ...+......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~----~~i~~~--~~~~~~~~~~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TW----ENLKYW--KETLQRPVYD 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HH----HHHHhc--cccccCCCCC
Confidence 2234678999999999999999999999999999999999999986432211 10 011000 0000000000
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.........+.+++.+||+.+|.+||++.|+++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011335677889999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=295.56 Aligned_cols=218 Identities=22% Similarity=0.303 Sum_probs=184.4
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccc---ccccHHHHHHHHHHHHHhc-CCCccc----------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQ-HTNLTD---------- 576 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~-H~nlv~---------- 576 (1018)
....++|..+++||+|.||.|+++..+. ++.+|||.+++. .....+..+.|.+++.... ||-|+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3445789999999999999999999765 789999999886 3566778899999988885 998873
Q ss_pred ---------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 577 ---------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 577 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
......+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|.+||+|||+++.-..
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence 233467899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
....+.+++||+.|||||++.+..|+.+.|.|||||+|||||.|..||....+ .++.|.
T Consensus 521 --~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------------------ee~Fds 579 (694)
T KOG0694|consen 521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------------------EEVFDS 579 (694)
T ss_pred --CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------------------HHHHHH
Confidence 23356679999999999999999999999999999999999999999864332 234455
Q ss_pred hhcC--CCChHHHHHHHHHHHhccccCCCCCCCH
Q 046791 722 ALEG--SFSPNEVLRCIHVGLLCVQDQATDRPAM 753 (1018)
Q Consensus 722 ~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 753 (1018)
++.. .+|.....+.+.|+.+++..+|++|--+
T Consensus 580 I~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 4443 3566677888999999999999999866
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=286.66 Aligned_cols=228 Identities=30% Similarity=0.418 Sum_probs=174.6
Q ss_pred CCcceeeeeccCCCcCeEEEEe-----cccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc-----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-----LNGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR----------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~----------- 578 (1018)
..|++.++||+|+||.||+|+. .+++.||+|.+.... .....+|.+|+.++++++|+||++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999984 245789999997543 33446789999999999999987210
Q ss_pred -----C---------------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC
Q 046791 579 -----R---------------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM 626 (1018)
Q Consensus 579 -----~---------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~ 626 (1018)
. ...+++.+.+.++.|++.||.|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 0 123677888999999999999999998 99999999999999999
Q ss_pred CceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHH
Q 046791 627 NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGY 705 (1018)
Q Consensus 627 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~ 705 (1018)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------E 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 999999999986543322222223445678999999998889999999999999999998 88887532210 1
Q ss_pred HHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 706 AWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 706 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..+....... ...+.....++.+++.+|++.+|++||++.+|+++|..
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111111 11223345678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=295.05 Aligned_cols=236 Identities=22% Similarity=0.272 Sum_probs=176.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|++++++++|+||++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999876 47889999987543 2335679999999999999999731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----
Confidence 12345788889999999999999999853 3999999999999999999999999998765321
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhh---------------
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWN--------------- 711 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--------------- 711 (1018)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... +.........
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcccc
Confidence 2233568999999999999999999999999999999999999985432110 0000000000
Q ss_pred ---------------cCcchhhhhhhhcCCC----ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 712 ---------------EGKVLELVDIALEGSF----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 712 ---------------~~~~~~~~d~~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.....+..+....... .......+.+++.+||+.||++|||+.||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000111111111111 11234678899999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=282.27 Aligned_cols=225 Identities=27% Similarity=0.378 Sum_probs=174.6
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
+.|++.+.||+|+||.||+++..++..+|+|.+... .....+|.+|+.++++++|+||++.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999888888999988643 3345679999999999999998731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....... ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence 11235788999999999999999999999 99999999999999999999999999876532211 111
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...... ...+.. ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~-i~~~~~---------~~~ 222 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEM-ISRGFR---------LYR 222 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HHCCCC---------CCC
Confidence 12345568999999998889999999999999999999 8888753221 111111 111110 011
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
+......+.+++.+||+.+|++||++.+++++|.
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2223457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=293.82 Aligned_cols=215 Identities=22% Similarity=0.286 Sum_probs=166.9
Q ss_pred eccCCCcCeEEEEecc-cccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc----------------------
Q 046791 524 LGEGGFGPVYKGQLLN-GQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 577 (1018)
Q Consensus 524 lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~---------------------- 577 (1018)
||+|+||.||+++..+ ++.||+|++... .......+.+|+.++.+++||||+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999998754 788999998653 23445678899999999999998731
Q ss_pred ----cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeec
Q 046791 578 ----RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653 (1018)
Q Consensus 578 ----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 653 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 155 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCG 155 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccC
Confidence 22456889999999999999999999999 9999999999999999999999999997543221 22334678
Q ss_pred ccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHH
Q 046791 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVL 733 (1018)
Q Consensus 654 t~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 733 (1018)
|+.|+|||++.+..++.++|||||||++|||++|+.||.... ......... .+ ...++.....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~-~~----------~~~~~~~~~~ 218 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKIL-QE----------PLRFPDGFDR 218 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHH-cC----------CCCCCCcCCH
Confidence 999999999999999999999999999999999999985321 111111111 10 0112333456
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 734 RCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 734 ~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
.+.+++.+||+.||++||++.++.+.|
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 778899999999999998654444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=287.96 Aligned_cols=236 Identities=24% Similarity=0.358 Sum_probs=188.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccc-cHHHHHHHHHHHHHhcCCCccccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDSR---------------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~~---------------- 578 (1018)
....+.++||+|-||+|.+.....+..||||.++..... ...+|.+|+++|.+++||||+++.
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 456677899999999999999988899999999887544 458899999999999999998421
Q ss_pred ------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 579 ------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 579 ------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
....+..+...+|+.|||.||+||.+.+ +|||||.++|+|+|.++++||+|||+++.+.......
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 1122456677889999999999999998 9999999999999999999999999999776555555
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh--CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS--GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
...+.+-.++|||||.+..++++.++|||+||+++||+++ ...||+....++ .++.+...+..+.....
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~------ 765 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVV------ 765 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCccee------
Confidence 5566777889999999999999999999999999999874 677876443321 22222222222221111
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
...|+-.+..+.+++++||..|-.+||+++++...|.+.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 134556678888999999999999999999999998754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=332.50 Aligned_cols=245 Identities=23% Similarity=0.427 Sum_probs=190.9
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc------
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR------ 578 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~------ 578 (1018)
++++++. ..|...+.||+|+||.||+|+. .+++.||||++...... ...|++++++++||||++..
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4444443 4577788999999999999987 46899999998654322 23568899999999998421
Q ss_pred ----------CC-------CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 579 ----------RN-------NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 579 ----------~~-------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.. ..++|.++.+|+.|||+||+|||+++.++|+||||||+||+++.++.+++. ||.+.....
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 11 247899999999999999999997766679999999999999999988875 666543221
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.....++..|+|||++.+..++.++|||||||++|||++|+.|++.... .......|+............+|+
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCc
Confidence 1123678899999999999999999999999999999999999854322 234566666655555555566666
Q ss_pred hhcC--CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 722 ALEG--SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 722 ~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.+.. ..+.++..++.+++.+||+.+|++||+|+||+++|+....
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 6644 3345677788999999999999999999999999997644
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=288.50 Aligned_cols=229 Identities=25% Similarity=0.370 Sum_probs=176.5
Q ss_pred CcceeeeeccCCCcCeEEEEecc------cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc-----------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR----------- 578 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~----------- 578 (1018)
+|++.+.||+|+||.||+|+... ...+|+|.+.... .....++.+|+.+++.++||||++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999997532 3468899886543 23456799999999999999987310
Q ss_pred ---------------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCc
Q 046791 579 ---------------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASN 619 (1018)
Q Consensus 579 ---------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~N 619 (1018)
....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 0124778888999999999999999998 9999999999
Q ss_pred EEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCC
Q 046791 620 ILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDH 698 (1018)
Q Consensus 620 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~ 698 (1018)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222223345678999999998899999999999999999998 99887532211
Q ss_pred CCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 699 PLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 699 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
..+... ........+......+.+++.+||+.+|++||++.|+++.|++..
T Consensus 237 ------~~~~~~---------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 ------RLFNLL---------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ------HHHHHH---------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111111 111112223334567889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=286.82 Aligned_cols=231 Identities=23% Similarity=0.322 Sum_probs=179.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
.++|++.+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+|++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4688999999999999999998765 6789999986542 3345678999999999999998721
Q ss_pred ------------------c-C-----CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeee
Q 046791 578 ------------------R-R-----NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633 (1018)
Q Consensus 578 ------------------~-~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DF 633 (1018)
. . ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 0 0 145788999999999999999999998 999999999999999999999999
Q ss_pred cceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 634 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
|+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+. .....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMA----AYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHH----HHHHc
Confidence 99986543222211222345678999999999899999999999999999999 9999853221 1111 11111
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
+. ....+......+.+++.+||+.+|++||++.+++++|+...
T Consensus 235 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11 11112223457889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=281.48 Aligned_cols=221 Identities=27% Similarity=0.376 Sum_probs=172.0
Q ss_pred eeccCCCcCeEEEEec---ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc--------------------
Q 046791 523 KLGEGGFGPVYKGQLL---NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------------- 577 (1018)
Q Consensus 523 ~lG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~-------------------- 577 (1018)
.||+|+||.||+|... +++.+|+|+++... ....+++.+|+.+++++.|+||++.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 6899999999999653 47789999986543 2345679999999999999998731
Q ss_pred -----cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc-ceee
Q 046791 578 -----RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN-TNRV 651 (1018)
Q Consensus 578 -----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~~~~ 651 (1018)
.....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 12346788999999999999999999998 99999999999999999999999999987643322111 1122
Q ss_pred ecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
.++..|+|||.+....++.++||||||+++|||++ |+.||...... . .......+ .....+..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~-~~~~i~~~---------~~~~~~~~ 222 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------E-VTQMIESG---------ERMECPQR 222 (257)
T ss_pred CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHCC---------CCCCCCCC
Confidence 33578999999988889999999999999999998 99998543211 1 11111111 11123334
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
....+.+++.+||+.||++||++.+|.++|++
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 55778899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=286.05 Aligned_cols=230 Identities=25% Similarity=0.379 Sum_probs=174.2
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc--------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR-------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~-------- 578 (1018)
++++|++.+.||+|+||.||+|... .+..||||.+.... .....+|.+|+.++++++|+|+++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999753 24679999986432 23456789999999999999987210
Q ss_pred --------C--------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCcee
Q 046791 579 --------R--------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI 630 (1018)
Q Consensus 579 --------~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL 630 (1018)
. ...+++..++.++.|+++||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 0 112466778899999999999999998 999999999999999999999
Q ss_pred eeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHH
Q 046791 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence 99999876543222111122345678999999999999999999999999999999 67887532211 01111
Q ss_pred hhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 710 WNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
...+.. ...+......+.+++.+||+.+|++||++.|++++|+.
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 11222345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=292.71 Aligned_cols=224 Identities=28% Similarity=0.405 Sum_probs=187.7
Q ss_pred eeeeccCCCcCeEEEEe-ccc----ccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 521 VNKLGEGGFGPVYKGQL-LNG----QEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~-~~g----~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.++||+|+||+||+|.+ +.| -+||||++... ..+..+++.+|+-+|.++.|+||+++
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP 780 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMP 780 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcc
Confidence 47999999999999974 344 37899998665 34567899999999999999998742
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
..+..+.....+.|..|||+||.|||++. +|||||..+|||+.....+||.|||+++....+..+...
T Consensus 781 ~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 781 LGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred cchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 23567788889999999999999999988 999999999999999999999999999998877666666
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....-.+.|||-|.+....++.++|||||||++||++| |..|++....+ ++.++++...+-..
T Consensus 858 ~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----------------eI~dlle~geRLsq 921 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----------------EIPDLLEKGERLSQ 921 (1177)
T ss_pred cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------------HhhHHHhccccCCC
Confidence 55555678999999999999999999999999999998 88887544322 23344444444567
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
++.....+..++.+||..|++.||+++++.+.+..-
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 788889999999999999999999999999988764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=298.07 Aligned_cols=236 Identities=21% Similarity=0.286 Sum_probs=174.7
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|+||.||+++.. +++.||||++.... ....+++.+|+++++.++|+||+..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999864 58999999986542 2345678999999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 12345788899999999999999999999 9999999999999999999999999998654322
Q ss_pred CcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhh----
Q 046791 644 SETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL---- 718 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~---- 718 (1018)
. .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...............++
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 158 S-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred c-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhh
Confidence 1 12223467889999999887 457999999999999999999999986543221 11111111110000000
Q ss_pred ------hhh-hhc-------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 719 ------VDI-ALE-------GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 719 ------~d~-~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+.. ... ........+.+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 000 01112235678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=298.44 Aligned_cols=237 Identities=20% Similarity=0.271 Sum_probs=176.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEec---ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL---NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
..+|.+.+.||+|+||.||++... .++.||||.+... ..+.+|++++++++|+||+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 468999999999999999999753 3568999988643 245689999999999999842
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 166 e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 166 PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred hhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 12456899999999999999999999999 9999999999999999999999999998665433323
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc-------hhh-
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV-------LEL- 718 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-------~~~- 718 (1018)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........................ ..+
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 333467999999999999999999999999999999999999998654433211111111111110000 000
Q ss_pred -----hhhhhcCCCC-------hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 719 -----VDIALEGSFS-------PNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 719 -----~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.....+.... ......+.+++.+||+.||++||++.|++..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000010011 0123456788999999999999999999885
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=283.79 Aligned_cols=229 Identities=29% Similarity=0.396 Sum_probs=174.2
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc------cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc--------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR-------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~-------- 578 (1018)
.+++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......|.+|+.++++++|+||++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35679999999999999999998753 4678999886543 33445799999999999999987210
Q ss_pred -------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC---Ccee
Q 046791 579 -------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM---NPKI 630 (1018)
Q Consensus 579 -------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kL 630 (1018)
....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 0124788899999999999999999998 99999999999998654 5899
Q ss_pred eeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHH
Q 046791 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~------ 231 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVM------ 231 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH------
Confidence 99999987632221111112233568999999999999999999999999999997 98888533211 111
Q ss_pred hhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 710 WNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
+.+........+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 232 -------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 -------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111111223344567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=297.65 Aligned_cols=238 Identities=21% Similarity=0.219 Sum_probs=176.4
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccccC----------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSRR---------- 579 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~~---------- 579 (1018)
...++|++.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++|+||+....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35579999999999999999999865 48899999997542 234467889999999999999974211
Q ss_pred -------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 580 -------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 580 -------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
...+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 123677788899999999999999999 9999999999999999999999999998653
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc--------
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE-------- 712 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-------- 712 (1018)
.. .......+|..|+|||++.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 171 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 171 TS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred Cc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHh
Confidence 22 12234578999999999999999999999999999999999999986432110 00000000000
Q ss_pred --Ccchhhhh----------hh------h--cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 713 --GKVLELVD----------IA------L--EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 713 --~~~~~~~d----------~~------l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
......++ +. . ...........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 00 0 000111234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=288.87 Aligned_cols=215 Identities=25% Similarity=0.335 Sum_probs=167.5
Q ss_pred CcceeeeeccCCCcCeEEEEecc-cccceEEEeccc---ccccHHHHHHHHHHHHHhcCCC-ccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTN-LTD--------------- 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~n-lv~--------------- 576 (1018)
+|++.+.||+|+||.||+|+..+ ++.||||++... .....+.+..|.+++..+.|++ |+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48889999999999999998764 778999999754 2344567889999999998766 431
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
+.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--G 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC--C
Confidence 112345788999999999999999999998 999999999999999999999999998753211 1
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~----~~i~~~----------~~ 218 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELF----QSIMEH----------NV 218 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHHcC----------CC
Confidence 2233467899999999999999999999999999999999999998633211 011 111110 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAM 753 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 753 (1018)
..+......+.+++.+||+.||.+||+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2233345677899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=298.40 Aligned_cols=236 Identities=22% Similarity=0.220 Sum_probs=175.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccccC-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDSRR----------- 579 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~~~----------- 579 (1018)
..++|++.+.||+|+||.||+++.. +++.||||++... ......++.+|+.+++.++|+||++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999865 4889999998654 2334567889999999999999884211
Q ss_pred ------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 580 ------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 580 ------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 123677888899999999999999999 99999999999999999999999999975432
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc-------
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK------- 714 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------- 714 (1018)
. .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||....... .............
T Consensus 176 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 N---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred C---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCcHHHHHHH
Confidence 1 12233578899999999999999999999999999999999999996442111 0000000000000
Q ss_pred ---chhhhhh--hhc----------------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 ---VLELVDI--ALE----------------GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ---~~~~~d~--~l~----------------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....... ... ..........+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 000 0001112356789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=292.84 Aligned_cols=216 Identities=21% Similarity=0.265 Sum_probs=169.5
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------------- 577 (1018)
+.||+|+||.||+++.. +++.||||++.... .....++.+|+++++.++||||+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 58899999997542 3345678899999999999998731
Q ss_pred ------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceee
Q 046791 578 ------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651 (1018)
Q Consensus 578 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 651 (1018)
.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTF 155 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccc
Confidence 12346889999999999999999999999 999999999999999999999999998753221 1122345
Q ss_pred ecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHH
Q 046791 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNE 731 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 731 (1018)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ....... ...++...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~-~~~~~~~----------~~~~p~~~ 218 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KL-FELILME----------DIKFPRTL 218 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HH-HHHhccC----------CccCCCCC
Confidence 7899999999999999999999999999999999999998532211 00 0011000 01223344
Q ss_pred HHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046791 732 VLRCIHVGLLCVQDQATDRP-----AMPDVVSM 759 (1018)
Q Consensus 732 ~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 759 (1018)
...+.+++.+||+.||++|| ++.|+++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 56778899999999999997 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=305.13 Aligned_cols=223 Identities=18% Similarity=0.177 Sum_probs=174.8
Q ss_pred CcceeeeeccCCCcCeEEEEec-c-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-N-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||++.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3889999999999999999754 3 57789998765554555678899999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 11235788888999999999999999998 99999999999999999999999999987653322
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-~~~~--------- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-YGKY--------- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCC---------
Confidence 2233446799999999999999999999999999999999999999853211 11111111 1110
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0122234467889999999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=278.83 Aligned_cols=236 Identities=24% Similarity=0.315 Sum_probs=175.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccc--cHHHHHHHHHHHHHhcCCC-ccccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ--GIVEFKNEAKLIAKLQHTN-LTDSR------------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~H~n-lv~~~------------- 578 (1018)
..|...++||+|.||+||+|+.. +|+.||+|+++-.... ......+|+.++++++|+| |+.+.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666788999999999999854 5899999999766432 2344689999999999999 76210
Q ss_pred ------------------C-C---CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 579 ------------------R-N---NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 579 ------------------~-~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
. . ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||+|
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 0 1 34666789999999999999999999 999999999999999999999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC--
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG-- 713 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 713 (1018)
+...... ......+.|..|.|||++.+. .|+...||||+|||+.||+++++.|....+. .......+.+...
T Consensus 168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGTPNE 242 (323)
T ss_pred HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCCCCc
Confidence 9654322 224457889999999999885 7999999999999999999999988765442 1222222222111
Q ss_pred -c---chhhhhh--hhcCCC--------ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 714 -K---VLELVDI--ALEGSF--------SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 714 -~---~~~~~d~--~l~~~~--------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
. ...+.+- ...... -+.......+++.+||+.+|++|.|++.++++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 0000010 000000 01112467889999999999999999999885
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=299.07 Aligned_cols=236 Identities=19% Similarity=0.225 Sum_probs=172.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
..+|.+.+.||+|+||.||+++... ++.||||.... ..+.+|++++++++|+||+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999998765 78899996422 346789999999999999832
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.+++.|+.||++||.|||+++ |+||||||+||||+.++.+||+|||+++..........
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 11246899999999999999999999999 99999999999999999999999999987643322222
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCC-CCCCCchHHHHHHHhhcCcc-----h-----
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR-TDHPLNLIGYAWQLWNEGKV-----L----- 716 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~-----~----- 716 (1018)
.....||..|+|||++.+..++.++|||||||++|||++|..++-... ............+....... .
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 234579999999999999999999999999999999999887643221 11111111111111111110 0
Q ss_pred hhhhh---h----hcCCCCh-------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 717 ELVDI---A----LEGSFSP-------NEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 717 ~~~d~---~----l~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.+... . ....... .....+.+|+.+||+.||.+|||+.|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0 0000000 112357789999999999999999999874
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=279.87 Aligned_cols=221 Identities=26% Similarity=0.355 Sum_probs=169.2
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc----------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~---------------------- 577 (1018)
++||+|+||.||+|+.. +++.||+|.+.... ......|.+|++++++++|+||++.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 58899999876543 3345679999999999999998731
Q ss_pred -----cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeee
Q 046791 578 -----RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVV 652 (1018)
Q Consensus 578 -----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 652 (1018)
.....+++.++..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 11235789999999999999999999998 9999999999999999999999999987543211111111122
Q ss_pred cccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHH
Q 046791 653 GTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNE 731 (1018)
Q Consensus 653 gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 731 (1018)
.+..|+|||.+.++.++.++||||||+++|||++ |..|+...... ... ..+........+...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~---------~~~~~~~~~~~~~~~ 221 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTR---------EAIEQGVRLPCPELC 221 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHH---------HHHHcCCCCCCcccC
Confidence 3457999999999999999999999999999998 88887432211 011 111111111223334
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 732 VLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 732 ~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
...+.+++.+|++.+|++||++.+|+++|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=306.25 Aligned_cols=244 Identities=20% Similarity=0.220 Sum_probs=174.0
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCc------cc--
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------TD-- 576 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nl------v~-- 576 (1018)
+..+++...+++|++.++||+|+||+||+|... .++.||||+++... ....++..|+.++.+++|.++ +.
T Consensus 119 ~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 119 VLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred ecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 334556667899999999999999999999865 47889999996532 234567788888888877653 21
Q ss_pred ------------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCC-----
Q 046791 577 ------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQM----- 626 (1018)
Q Consensus 577 ------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~----- 626 (1018)
+.....+++..+..|+.||+.||.|||++ + ||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 11234688889999999999999999984 7 99999999999998765
Q ss_pred -----------CceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCC
Q 046791 627 -----------NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR 695 (1018)
Q Consensus 627 -----------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~ 695 (1018)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999875422 12234678999999999999999999999999999999999999996543
Q ss_pred CCCCCchHHHHH----HHhh----cCcchhhhhhh--hcCCC---------------ChHHHHHHHHHHHhccccCCCCC
Q 046791 696 TDHPLNLIGYAW----QLWN----EGKVLELVDIA--LEGSF---------------SPNEVLRCIHVGLLCVQDQATDR 750 (1018)
Q Consensus 696 ~~~~~~l~~~~~----~~~~----~~~~~~~~d~~--l~~~~---------------~~~~~~~l~~li~~Cl~~dP~~R 750 (1018)
.......+.... ..+. .....++.+.. +.... .......+++|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 211111110000 0000 00000000000 00000 00123457799999999999999
Q ss_pred CCHHHHHH
Q 046791 751 PAMPDVVS 758 (1018)
Q Consensus 751 Ps~~evl~ 758 (1018)
||++|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999997
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=279.57 Aligned_cols=225 Identities=28% Similarity=0.406 Sum_probs=175.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|.+.+.||+|+||.||+|+..++..+|||.+.... ....+|.+|+.++.+++||||++.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999988777789999986543 345779999999999999998731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....... ...
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 11235789999999999999999999998 99999999999999999999999999886543211 111
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . ......+. ....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~~---------~~~~ 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---T----VEKVSQGL---------RLYR 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHhcCC---------CCCC
Confidence 12335678999999998889999999999999999998 998875332110 1 11111111 1111
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2223567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=296.12 Aligned_cols=227 Identities=24% Similarity=0.319 Sum_probs=176.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++..++|+||+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999876 58899999997542 2445678999999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC--
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ-- 643 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~-- 643 (1018)
.....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 12356889999999999999999999998 9999999999999999999999999998654332
Q ss_pred -------------------------CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCC
Q 046791 644 -------------------------SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDH 698 (1018)
Q Consensus 644 -------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~ 698 (1018)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~- 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ- 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH-
Confidence 011223457899999999999999999999999999999999999998643211
Q ss_pred CCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 046791 699 PLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPA-MPDVVSM 759 (1018)
Q Consensus 699 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~ 759 (1018)
.......... ..+.........+.+.+++.+|++ +|.+||+ +.|+++.
T Consensus 237 -----~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 -----ETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----HHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111111000 001111111135677888999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=297.13 Aligned_cols=232 Identities=23% Similarity=0.336 Sum_probs=177.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc------cccceEEEecccc-cccHHHHHHHHHHHHHhc-CCCccccc--------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQ-HTNLTDSR-------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nlv~~~-------- 578 (1018)
.++|.+.++||+|+||.||+|+... +..||||++.... ....+.|.+|+++++++. ||||+++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678899999999999999997532 3469999997543 233467999999999996 99987310
Q ss_pred --------C-----------------------------------------------------------------------
Q 046791 579 --------R----------------------------------------------------------------------- 579 (1018)
Q Consensus 579 --------~----------------------------------------------------------------------- 579 (1018)
.
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 0
Q ss_pred -----------------------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC
Q 046791 580 -----------------------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD 624 (1018)
Q Consensus 580 -----------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~ 624 (1018)
...+++..+..++.||++||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 123677788899999999999999998 999999999999999
Q ss_pred CCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchH
Q 046791 625 QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLI 703 (1018)
Q Consensus 625 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~ 703 (1018)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....+.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~----- 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS----- 347 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence 99999999999987643322222233456778999999999999999999999999999997 888875432111
Q ss_pred HHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 704 GYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 704 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
........+ .....+......+.+++.+||+.+|++||++.+|.++|+...
T Consensus 348 -~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 -TFYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -HHHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 011111111 111122334567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=296.31 Aligned_cols=234 Identities=21% Similarity=0.282 Sum_probs=174.2
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc-----------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR----------- 578 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~----------- 578 (1018)
...++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++|+||++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999864 57899999986542 23345678999999999999987421
Q ss_pred -------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee
Q 046791 579 -------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 579 -------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~ 639 (1018)
....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence 1245888999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... .......... .....+.
T Consensus 169 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~-~~~~~~~ 239 (343)
T cd07878 169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---DQLKRIMEVV-GTPSPEV 239 (343)
T ss_pred CCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHh-CCCCHHH
Confidence 321 223568999999999877 57899999999999999999999998543211 1111111000 0000000
Q ss_pred hhh--------hhc--CCCCh--------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 719 VDI--------ALE--GSFSP--------NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 719 ~d~--------~l~--~~~~~--------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... .+. ...+. ...+.+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000 00010 11235678999999999999999999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=288.01 Aligned_cols=170 Identities=28% Similarity=0.451 Sum_probs=138.4
Q ss_pred eeeeccCCCcCeEEEEec---ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc-------------------
Q 046791 521 VNKLGEGGFGPVYKGQLL---NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR------------------- 578 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~------------------- 578 (1018)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.++++++||||++..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999865 35789999986542 235678999999999999997321
Q ss_pred -----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE----cCCCCceeeeeccee
Q 046791 579 -----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMAR 637 (1018)
Q Consensus 579 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl----d~~~~~kL~DFGla~ 637 (1018)
....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 0124778888999999999999999999 9999999999999 456789999999998
Q ss_pred eecCCCC-cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCC
Q 046791 638 IFGLNQS-ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYR 695 (1018)
Q Consensus 638 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~ 695 (1018)
....... ........+|+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 7643221 122334678999999999987 468999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=285.11 Aligned_cols=236 Identities=25% Similarity=0.372 Sum_probs=176.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-----------------cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccc
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-----------------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTD 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~ 576 (1018)
.++|++.+.||+|+||.||+++..+ +..||+|.+.... ....+++.+|++++++++|+|++.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999997643 2358999987553 344667999999999999999862
Q ss_pred c--------------------------cCC-----------CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCc
Q 046791 577 S--------------------------RRN-----------NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASN 619 (1018)
Q Consensus 577 ~--------------------------~~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~N 619 (1018)
. ... ..+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 1 011 25788999999999999999999998 9999999999
Q ss_pred EEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh--CCCCCCCCCCC
Q 046791 620 ILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS--GKKNNGCYRTD 697 (1018)
Q Consensus 620 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt--G~~p~~~~~~~ 697 (1018)
|+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986543322222333456778999999998899999999999999999998 5666643221
Q ss_pred CCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 698 HPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 698 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..........+...... .....+...+.++.+++.+||+.+|++||++.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111111111110 0111122334678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=278.00 Aligned_cols=226 Identities=29% Similarity=0.443 Sum_probs=176.7
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|.+.++||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|+|++..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 5688999999999999999998777789999886543 345678999999999999998721
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........ ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 160 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TAR 160 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-ccc
Confidence 11234788889999999999999999998 99999999999999999999999999987643221 111
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....++..|+|||...+..++.++||||||+++|||++ |+.||...... .. ......+ .....
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~---------~~~~~ 224 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EV----LEQVERG---------YRMPC 224 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcC---------CCCCC
Confidence 22345678999999998999999999999999999999 88887532211 01 1111111 01112
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
+......+.+++.+||+.+|++||++++|++.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 23345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=286.26 Aligned_cols=229 Identities=28% Similarity=0.450 Sum_probs=174.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccc----cceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQ----EVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++|+..+.||+|+||.||+|+.. +++ .||+|.+..... ....++.+|+.++++++|+||++.
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 46778899999999999999864 344 468888865432 334478999999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcc
Confidence 11225778889999999999999999998 9999999999999999999999999998764333
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .........+..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~------- 229 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGER------- 229 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCC-------
Confidence 2222223445678999999999999999999999999999997 8888753211 111111111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
...+......+.+++..||..+|++||+++++++.|+..
T Consensus 230 --~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 --LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111222345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=280.38 Aligned_cols=230 Identities=21% Similarity=0.347 Sum_probs=178.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +++.||||.++.. .......+.+|++++++++|+|++..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999865 5889999987543 23334568999999999999998721
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 11234788889999999999999999998 99999999999999999999999999987643
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ......
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~-~~~~~~------- 224 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQ-KIEQCD------- 224 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHH-HHhcCC-------
Confidence 221 122346788999999999888999999999999999999999997432211 111111 111100
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
............+.+++.+||+.+|++||++.+|++.|++.
T Consensus 225 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 -YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00011223446788999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=283.27 Aligned_cols=227 Identities=26% Similarity=0.354 Sum_probs=175.5
Q ss_pred CCcceeeeeccCCCcCeEEEEec------ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc-----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR----------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~----------- 578 (1018)
.+|...++||+|+||.||++... ++..+|+|.+..........|.+|++++++++|+||+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 3557999998776666677899999999999999987310
Q ss_pred ---------------C---------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCc
Q 046791 579 ---------------R---------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 579 ---------------~---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
. ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 0 024788999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 707 (1018)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||....... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AIE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HHH
Confidence 9999999986543222112222345678999999999999999999999999999998 888874322110 000
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
....+ .....+......+.+++.+||+.||++||++.||++.|+
T Consensus 236 -~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 -CITQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 01111 011112234466889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=285.93 Aligned_cols=231 Identities=26% Similarity=0.388 Sum_probs=178.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc------cccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccc--------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDS-------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~-------- 577 (1018)
..++|++.+.||+|+||.||++.... ...+|+|.+.... .....++.+|+.++.++ +|+|+++.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578899999999999999998642 3579999987542 33456789999999999 89998721
Q ss_pred ----------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 578 ----------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 578 ----------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
.....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 11245788889999999999999999998 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCch
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l 702 (1018)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence 999999999999987643222222222345678999999999999999999999999999997 88887532211
Q ss_pred HHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 703 IGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
........+ .....+......+.+++.+|++.+|++|||+.|+++.|+..
T Consensus 242 --~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 242 --ELFKLLKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred --HHHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111111 11122334456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=293.74 Aligned_cols=237 Identities=22% Similarity=0.226 Sum_probs=175.9
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccccC-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSRR----------- 579 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~~----------- 579 (1018)
..++|++.+.||+|+||.||++... .++.||||++.... .....++.+|+.+++.++|+||+....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999865 48889999997542 334567889999999999999974211
Q ss_pred ------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 580 ------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 580 ------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 123567888899999999999999998 99999999999999999999999999986532
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhh----------
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWN---------- 711 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---------- 711 (1018)
. .......+|..|+|||++.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 179 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 179 S---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred C---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHhh
Confidence 1 12234578999999999999999999999999999999999999986433211 0000000000
Q ss_pred ---------c-Ccc-----hhhhhhhh---cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 712 ---------E-GKV-----LELVDIAL---EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 712 ---------~-~~~-----~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
. ... .+...... ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000 00000000 000111123567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=291.24 Aligned_cols=225 Identities=20% Similarity=0.290 Sum_probs=171.1
Q ss_pred CcceeeeeccCCCcCeEEEEec----ccccceEEEecccc----cccHHHHHHHHHHHHHh-cCCCcccc----------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRRS----GQGIVEFKNEAKLIAKL-QHTNLTDS---------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nlv~~---------- 577 (1018)
+|++.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+..|+.++.++ +|+||+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999753 47889999986532 23345688999999999 48888621
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 22456889999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... .......||..|+|||++.+. .++.++|||||||++|||++|+.||......... .........
T Consensus 158 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~-------- 225 (332)
T cd05614 158 EEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILK-------- 225 (332)
T ss_pred cCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhc--------
Confidence 222 122346789999999999865 4789999999999999999999998643322111 111111100
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
.....+......+.+++.+||+.||++|| +++++++
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 --CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01122333456678899999999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=291.86 Aligned_cols=220 Identities=25% Similarity=0.336 Sum_probs=174.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc--cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN--GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~--g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.++|++.+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+.++..++||||++.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998654 3689999986532 3345678899999999999999731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 23456888999999999999999999999 99999999999999999999999999987532
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~--------- 244 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGI--------- 244 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCC---------
Confidence 123467899999999999988999999999999999999999998632211 1111111111
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVSM 759 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 759 (1018)
..++......+.+++.+|++.||++|+ +++++++.
T Consensus 245 -~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 012233345677899999999999995 88888774
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=284.86 Aligned_cols=233 Identities=24% Similarity=0.320 Sum_probs=169.4
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHh---cCCCccccc------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKL---QHTNLTDSR------------ 578 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nlv~~~------------ 578 (1018)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++++ +|+||++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999875 48899999986542 22234566787777766 699987311
Q ss_pred --------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 579 --------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 579 --------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 1234788899999999999999999999 99999999999999999999999999986
Q ss_pred ecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh-
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE- 717 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~- 717 (1018)
..... ......++..|+|||++.+..++.++|||||||++|||++|++||....... ................
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 158 YSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChhhC
Confidence 54221 1223567889999999999999999999999999999999999985432111 1111111100000000
Q ss_pred -----hhhhhhc-------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 -----LVDIALE-------GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 -----~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....... ....+.....+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 0011223456789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=291.04 Aligned_cols=215 Identities=23% Similarity=0.286 Sum_probs=168.4
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------------- 577 (1018)
+.||+|+||.||+++.. +|+.||+|+++... ......+.+|+.++++++||||+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999865 58899999997542 3345567889999999999998731
Q ss_pred ------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceee
Q 046791 578 ------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651 (1018)
Q Consensus 578 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 651 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccccc
Confidence 12346889999999999999999999999 999999999999999999999999998753221 1122335
Q ss_pred ecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHH
Q 046791 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNE 731 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 731 (1018)
.||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ....... ....+...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~----~~~~~~~----------~~~~p~~~ 218 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L----FELILME----------EIRFPRTL 218 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---H----HHHHhcC----------CCCCCCCC
Confidence 78999999999999999999999999999999999999985322110 0 0001000 01123344
Q ss_pred HHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 732 VLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 732 ~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
...+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 56778999999999999998 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=292.19 Aligned_cols=231 Identities=27% Similarity=0.368 Sum_probs=174.9
Q ss_pred CCcceeeeeccCCCcCeEEEEe------cccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccccC--------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL------LNGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSRR-------- 579 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~~-------- 579 (1018)
++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+|++....
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5799999999999999999973 346789999997543 23345788999999999 6899863110
Q ss_pred --------------------------------------------------------------------------------
Q 046791 580 -------------------------------------------------------------------------------- 579 (1018)
Q Consensus 580 -------------------------------------------------------------------------------- 579 (1018)
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence
Q ss_pred ------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeec
Q 046791 580 ------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653 (1018)
Q Consensus 580 ------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 653 (1018)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 023567788899999999999999998 99999999999999999999999999986533222222223345
Q ss_pred ccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHH
Q 046791 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEV 732 (1018)
Q Consensus 654 t~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 732 (1018)
+..|+|||.+.+..++.++||||||+++|||++ |..||....... ........+.. ...+....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTR---------MRAPDYTT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCC---------CCCCCCCC
Confidence 678999999999999999999999999999997 888875432110 01111111111 11111223
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 733 LRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 733 ~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
+.+.+++.+||+.+|++||++.||++.|+...
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 56789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=289.51 Aligned_cols=215 Identities=25% Similarity=0.354 Sum_probs=167.4
Q ss_pred eeeccCCCcCeEEEEec----ccccceEEEecccc----cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 522 NKLGEGGFGPVYKGQLL----NGQEVAIKRLSRRS----GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++||+|+||.||+++.. .++.||||+++... ......+.+|+.++++++||||+..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999753 47789999987532 2334567899999999999999831
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+.+..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TV 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--Cc
Confidence 12345677888899999999999999999 9999999999999999999999999987543221 12
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .+ ....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~-~~----------~~~~ 219 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKIL-KG----------KLNL 219 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHH-cC----------CCCC
Confidence 2335789999999999998899999999999999999999999853221 11111111 11 1122
Q ss_pred ChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
+......+.+++.+||+.+|++|| ++.++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 334456788999999999999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-31 Score=265.38 Aligned_cols=226 Identities=22% Similarity=0.297 Sum_probs=176.2
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe-cccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccccC-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDSRR----------- 579 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~~~----------- 579 (1018)
.++.|++.+.||+|.|+.||+... +.|+.+|+|+++.. +..+.+++.+|+++-+.|+||||+++..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999864 56999999987543 4457788999999999999999996432
Q ss_pred ---------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---CCCceeeeecceeeecC
Q 046791 580 ---------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMARIFGL 641 (1018)
Q Consensus 580 ---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kL~DFGla~~~~~ 641 (1018)
+...++..+-..++||+++|.|+|.++ |||||+||+|+||.. .--+||+|||+|..+.
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 123456667788999999999999999 999999999999953 3458999999999886
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
........+||++|||||+++..+++..+|||+.||+||-|+.|.+||...... ..++....+...
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd----- 230 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYD----- 230 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccC-----
Confidence 334445689999999999999999999999999999999999999998532211 111111111110
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+..-+...++..+|+.+||..||++|.|+.|.++
T Consensus 231 -~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 -YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 011111234567788999999999999999998876
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=277.23 Aligned_cols=220 Identities=26% Similarity=0.388 Sum_probs=182.8
Q ss_pred CCcceeeeeccCCCcCeEEEEe-cccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
.+|++.+.||+|.||.|-++.. ..|+.||||.+++. +.+....+++|+++|..|+||||+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4788889999999999999985 56999999999765 4566677899999999999999873
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
....+.|++.++.++++||..|+.|+|.++ ++|||||.+|||||.++++||+|||++.++.. .
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~---~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD---K 206 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc---c
Confidence 234678999999999999999999999999 99999999999999999999999999987653 2
Q ss_pred ccceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
...+.++|++-|.+||++.+.+| .+..|-|||||+||.|+.|..||+..+.. .++..+-+
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------------------~lvrQIs~ 267 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------------------RLVRQISR 267 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------------------HHHHHhhc
Confidence 33456899999999999999887 48899999999999999999999754321 11222222
Q ss_pred CC-CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 725 GS-FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 725 ~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
+. ..++.+....-||.|||-.+|++|.|+.+|....
T Consensus 268 GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 268 GAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 22 2344555667789999999999999999998853
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=280.59 Aligned_cols=229 Identities=21% Similarity=0.283 Sum_probs=174.9
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +++.||+|.+... ......++.+|++++++++|+|++..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999864 5889999998654 23345679999999999999998831
Q ss_pred cC------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceee
Q 046791 578 RR------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651 (1018)
Q Consensus 578 ~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 651 (1018)
.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~ 153 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTY 153 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCC
Confidence 11 234678888999999999999999999 999999999999999999999999999865322 12235
Q ss_pred ecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHH
Q 046791 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNE 731 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 731 (1018)
.++..|+|||++.+..++.++||||||+++|||++|+.||...................... ..........
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 225 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--------DPPVLPVGQF 225 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--------CCCCCCCCcC
Confidence 78899999999999899999999999999999999999986533222111110101111000 0000011223
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 732 VLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 732 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
..++.+++.+|++.+|++||+++|+++.
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 4567899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=283.99 Aligned_cols=235 Identities=23% Similarity=0.328 Sum_probs=173.0
Q ss_pred CCcceeeeeccCCCcCeEEEEecc---------------cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc-
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN---------------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~---------------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~- 578 (1018)
++|++.++||+|+||.||+++... ...||||.++... ......|.+|++++.+++|+|++...
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987542 1248999987542 33456799999999999999987310
Q ss_pred ---------------C----------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEE
Q 046791 579 ---------------R----------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNIL 621 (1018)
Q Consensus 579 ---------------~----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NIL 621 (1018)
. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 0 013677888999999999999999999 999999999999
Q ss_pred EcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh--CCCCCCCCCCCCC
Q 046791 622 LDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS--GKKNNGCYRTDHP 699 (1018)
Q Consensus 622 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt--G~~p~~~~~~~~~ 699 (1018)
++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|||++ +..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 99999999999999976543222222223345678999999999999999999999999999998 45565432211
Q ss_pred CchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 700 LNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 700 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
.........+... ........++..+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 240 -~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 -QVIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111110 0000111222345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=296.37 Aligned_cols=231 Identities=30% Similarity=0.414 Sum_probs=178.0
Q ss_pred CcceeeeeccCCCcCeEEEEecc--c---ccceEEEecc---cccccHHHHHHHHHHHHHhcCCCccc------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN--G---QEVAIKRLSR---RSGQGIVEFKNEAKLIAKLQHTNLTD------------ 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~--g---~~vAvK~l~~---~~~~~~~~f~~E~~~l~~l~H~nlv~------------ 576 (1018)
+-...++||+|+||.||+|++.. + ..||||..+. .......+|.+|++++++++|+|+|+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34445899999999999998754 2 2389999875 34667889999999999999999983
Q ss_pred --------------ccCC-CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 577 --------------SRRN-NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 577 --------------~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
+... ..++..+++.++.+.|.||+|||+++ ++||||.++|+|+..++.+||+|||+++.-.
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~- 313 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS- 313 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc-
Confidence 1222 25999999999999999999999999 9999999999999999999999999987542
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
..........-...|+|||.+..+.++.++|||||||++||+++ |..|+...... . +... ++.
T Consensus 314 -~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~-v~~k--------I~~ 377 (474)
T KOG0194|consen 314 -QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------E-VKAK--------IVK 377 (474)
T ss_pred -ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------H-HHHH--------HHh
Confidence 11111111234578999999999999999999999999999999 78887533211 1 1111 111
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCC
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSL 767 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~l 767 (1018)
...+...+...+..+..++.+||+.+|++||+|.+|.+.|+......
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 12222344456667777888999999999999999999998765433
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=278.13 Aligned_cols=224 Identities=28% Similarity=0.389 Sum_probs=173.8
Q ss_pred CcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-------------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------- 577 (1018)
+|++.+.||+|+||.||+|+..++..+|+|.+.... ....+|.+|+.++++++|+|+++.
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999998777789999986432 334678999999999999998731
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++..++.++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++........ ...
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~ 159 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQ 159 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-ccC
Confidence 11235788899999999999999999999 999999999999999999999999999865422111 111
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . ...... ......+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~---------~~~~~~~ 223 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V----VESVSA---------GYRLYRP 223 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H----HHHHHc---------CCcCCCC
Confidence 1223457999999999999999999999999999999 788875432111 1 111111 1111223
Q ss_pred hHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
.....++.+++.+||+.+|++||++.||+++|.
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 335667889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=288.10 Aligned_cols=235 Identities=22% Similarity=0.344 Sum_probs=172.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|.+.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++|+||+..
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999875 47789999987543 2334567899999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 160 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--T 160 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc--c
Confidence 11335788889999999999999999998 99999999999999999999999999976532221 1
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc---------chh
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK---------VLE 717 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~~~ 717 (1018)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ............ ..+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE---LHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhhcchhh
Confidence 223467889999998865 5689999999999999999999999864432211 111111110000 000
Q ss_pred hhhhhhcC-------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALEG-------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+..... ...+.....+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 001123456778999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=280.50 Aligned_cols=229 Identities=25% Similarity=0.400 Sum_probs=176.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc------cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR--------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~--------- 578 (1018)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... .....++.+|+.++..++|+|+++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578899999999999999998643 3679999986543 23456789999999999999987310
Q ss_pred ---------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceee
Q 046791 579 ---------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS 631 (1018)
Q Consensus 579 ---------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~ 631 (1018)
....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 1123677788999999999999999998 9999999999999999999999
Q ss_pred eecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHh
Q 046791 632 DFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 632 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~----~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EV----LKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HH----HHHH
Confidence 9999986543322222233456788999999998899999999999999999998 88887532211 11 1111
Q ss_pred hcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 711 NEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 711 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..+.. ...+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111 11223345778899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=275.79 Aligned_cols=220 Identities=25% Similarity=0.377 Sum_probs=172.8
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|.+.+.||+|+||.||++.. .+..||+|.++.. ...+.|.+|+.++++++|+|++..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4688899999999999999976 4788999998643 235679999999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 11224778889999999999999999998 9999999999999999999999999988643221
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..... .....+ ...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~-~~~~~~---------~~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVV-PRVEKG---------YKM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHH-HHHhcC---------CCC
Confidence 12334568999999999899999999999999999998 888875321 11111 111111 111
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 2223445678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-30 Score=288.25 Aligned_cols=219 Identities=22% Similarity=0.276 Sum_probs=167.9
Q ss_pred cceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHH---HHhcCCCcccc-------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLI---AKLQHTNLTDS------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l---~~l~H~nlv~~------------- 577 (1018)
|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|++++ .+++||||++.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999865 48899999997542 23345567776655 56689998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--G 155 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC--C
Confidence 12356899999999999999999999999 999999999999999999999999998753221 1
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .... ....+ ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~-~i~~~----------~~ 218 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFD-SIVND----------EV 218 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHH-HHHhC----------CC
Confidence 2223467899999999999999999999999999999999999998533211 0000 01010 01
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
..+......+.+++.+||+.||.+|| ++.++++
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 12333456778899999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=288.47 Aligned_cols=167 Identities=25% Similarity=0.355 Sum_probs=140.7
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
....+|++.+.||+|+||.||+|+... ++.||+|..... ....|+.++++++|+||+++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 445689999999999999999998754 678999975432 23569999999999999842
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++.++..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 137 PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred EccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 12456889999999999999999999998 999999999999999999999999999753211
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNN 691 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~ 691 (1018)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1222456899999999999999999999999999999999976654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=274.73 Aligned_cols=229 Identities=23% Similarity=0.370 Sum_probs=179.7
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999876 6899999988643 22335679999999999999998621
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++.++..++.|+++||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 11345788899999999999999999998 99999999999999999999999999886543
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...... .....+.
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~------- 224 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-KKIEKCD------- 224 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHH-hhhhcCC-------
Confidence 221 12235678899999999988899999999999999999999999753221 111110 0111111
Q ss_pred hhcCCCCh-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 722 ALEGSFSP-NEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 722 ~l~~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
....+. .....+.+++.+||+.+|++||++.+|+++|++.
T Consensus 225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 111122 3445788999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=275.73 Aligned_cols=227 Identities=29% Similarity=0.451 Sum_probs=178.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.++|.+.++||+|+||.||+|...+++.||||.+.... ...+++.+|+.++++++|+|++..
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46789999999999999999998878889999987543 345789999999999999998721
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..... .
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence 11235788999999999999999999998 99999999999999999999999999987643211 1
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..... ....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~----~~~~~---------~~~~ 223 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVL----EQVER---------GYRM 223 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHc---------CCCC
Confidence 1112334568999999999899999999999999999998 99987532211 011 11101 0111
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1222335678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=283.96 Aligned_cols=228 Identities=26% Similarity=0.364 Sum_probs=172.7
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cc--cceEEEeccc-ccccHHHHHHHHHHHHHh-cCCCccccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQ--EVAIKRLSRR-SGQGIVEFKNEAKLIAKL-QHTNLTDSR------------ 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nlv~~~------------ 578 (1018)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|+.++.++ +||||++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998754 33 4788888743 334456799999999999 799987310
Q ss_pred ------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCc
Q 046791 579 ------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 579 ------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 0124778889999999999999999998 9999999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 707 (1018)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... . ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~-~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------E-LY 228 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------H-HH
Confidence 99999998642211 11111223457999999998899999999999999999997 99998533211 0 11
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
... ........+......+.+++.+||+.+|.+||++++|++.|++...
T Consensus 229 ~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 229 EKL---------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHH---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 1111111223345678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=284.69 Aligned_cols=230 Identities=27% Similarity=0.404 Sum_probs=176.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccc---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDS--------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~--------- 577 (1018)
.++|.+.+.||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +|+||++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357899999999999999999742 24579999987553 33346789999999999 79998731
Q ss_pred -------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 -------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.....+++.++..++.|++.||+|||+++ |+|+||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 01123789999999999999999999998 99999999999999999999999999986
Q ss_pred ecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ........+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~---- 260 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEG---- 260 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcC----
Confidence 543322112222345678999999999999999999999999999998 998875332111 011111111
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
.....+.....++.+++.+|++.+|++||++.||++.|+.
T Consensus 261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1111222334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=287.59 Aligned_cols=217 Identities=26% Similarity=0.431 Sum_probs=176.5
Q ss_pred eeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------------
Q 046791 523 KLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------------ 577 (1018)
Q Consensus 523 ~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------------ 577 (1018)
+||+|.||+||.|++.+ ...+|||.+.....+..+.+..|+.+.++|+|.|||+.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999766 55799999988877788889999999999999999842
Q ss_pred ---cCCCCC--ChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-CCCCceeeeecceeeecCCCCcccceee
Q 046791 578 ---RRNNRL--NWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETNTNRV 651 (1018)
Q Consensus 578 ---~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~~~ 651 (1018)
..-++| ++.+.--+.+||++||.|||++. |||||||-+|||++ -.|.+||+|||.++.+..- ..-+..+
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence 112445 66777788999999999999999 99999999999997 6789999999999876432 2334558
Q ss_pred ecccccCChhhhccC--CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 652 VGTYGYMSPEYAMSG--VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~--~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
.||..|||||++..+ .|..++|||||||++.||.||++||-.....+. .+++-|- -......|.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGm------yKvHP~iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGM------YKVHPPIPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcc------eecCCCCcH
Confidence 899999999999864 588999999999999999999999854332211 1111111 112345667
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+...++..++++|+.++|.+||++.++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 77889999999999999999999999987
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=280.87 Aligned_cols=235 Identities=19% Similarity=0.215 Sum_probs=165.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEeccc----ccceEEEecccccccH-----------HHHHHHHHHHHHhcCCCccccc-
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNG----QEVAIKRLSRRSGQGI-----------VEFKNEAKLIAKLQHTNLTDSR- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g----~~vAvK~l~~~~~~~~-----------~~f~~E~~~l~~l~H~nlv~~~- 578 (1018)
.++|++.++||+|+||.||+|+..+. ..+|+|.......... .....+...+..+.|+|++...
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999987543 4556665432221111 1122333445566888875311
Q ss_pred ----------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCcee
Q 046791 579 ----------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI 630 (1018)
Q Consensus 579 ----------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL 630 (1018)
.....++..+..|+.|+++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence 1123467778899999999999999998 999999999999999999999
Q ss_pred eeecceeeecCCCCc-----ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHH
Q 046791 631 SDFGMARIFGLNQSE-----TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGY 705 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~ 705 (1018)
+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+...
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~~~~ 245 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NLIHA 245 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HHHHH
Confidence 999999876432211 11223569999999999999999999999999999999999999997553221 11111
Q ss_pred HHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 706 AWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 706 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
....+ ...+...... .+.....+.+++..|++.+|++||++.+|++.|+
T Consensus 246 ~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDF----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHH----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11000 0111111111 1123466889999999999999999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=285.37 Aligned_cols=230 Identities=19% Similarity=0.266 Sum_probs=178.3
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc-----------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD----------- 576 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~----------- 576 (1018)
....++|+++.+||+|+||.||+++-++ |..+|+|++++.. ..+.+..+.|-.+|....++.||+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 3356789999999999999999998665 9999999998763 455677899999999999999984
Q ss_pred ---------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 577 ---------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 577 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
+.....|++..+.-++.+++.|+..||+.| +|||||||+|+|||..|++||+||||+.-+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 234578999999999999999999999999 99999999999999999999999999853321
Q ss_pred C--------------------CCccc-------------------------ceeeecccccCChhhhccCCCCccccchh
Q 046791 642 N--------------------QSETN-------------------------TNRVVGTYGYMSPEYAMSGVVSIKTDVFS 676 (1018)
Q Consensus 642 ~--------------------~~~~~-------------------------~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S 676 (1018)
. ..... ....+|||.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 00000 01268999999999999999999999999
Q ss_pred HhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCC---H
Q 046791 677 FGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPA---M 753 (1018)
Q Consensus 677 lGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~ 753 (1018)
||||+||||.|-+||....+... ++.+.. ....+..........+..+||.+|+. ||++|-- +
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T-------~rkI~n------wr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQET-------YRKIVN------WRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHH-------HHHHHH------HhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 99999999999999975443321 111100 00111111122334778899999998 9999975 5
Q ss_pred HHHHH
Q 046791 754 PDVVS 758 (1018)
Q Consensus 754 ~evl~ 758 (1018)
+||.+
T Consensus 440 ~EIK~ 444 (550)
T KOG0605|consen 440 EEIKK 444 (550)
T ss_pred HHHhc
Confidence 55554
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=278.84 Aligned_cols=223 Identities=26% Similarity=0.315 Sum_probs=173.2
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
+|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++|+||+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999864 58899999986542 2233557889999999999998721
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 11245889999999999999999999998 9999999999999999999999999998754222
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ....... .+.. ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~---------~~~~-~~ 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVER---------RVKE-DQ 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHH---------Hhhh-cc
Confidence 1223468899999999999999999999999999999999999986432211 0011100 0100 01
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
...+......+.+++.+||+.||++|| +++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 122334556788999999999999999 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=260.68 Aligned_cols=220 Identities=25% Similarity=0.337 Sum_probs=180.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD-------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~-------------- 576 (1018)
.++|++.+.||+|-||.||.|+.+. +-.||+|++.+.. .+..+++.+|+++-..|+||||++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3578899999999999999998654 6789999997653 344567999999999999999873
Q ss_pred ------------c--cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 577 ------------S--RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 577 ------------~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
+ ....++++.....++.|+|.||.|+|..+ |+||||||+|+|++.++..||+|||-+....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 1 24567889999999999999999999999 9999999999999999999999999987643
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.......+||..|.|||...+...+.+.|+|++|++.||++.|.+||.....+ ..++.+ ..
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------etYkrI--------~k-- 236 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------ETYKRI--------RK-- 236 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------HHHHHH--------HH--
Confidence 23334589999999999999999999999999999999999999999643311 111111 11
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+-.++......+.+++.+|+..+|.+|.+..|+++
T Consensus 237 ~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 237 VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 111234555677889999999999999999999986
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=277.04 Aligned_cols=230 Identities=23% Similarity=0.361 Sum_probs=177.9
Q ss_pred CCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+++. .+++.+|||.+.... .....++.+|+.+++.++|+||+..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 468899999886532 2344678999999999999998721
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 11345788999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
... ......++..|+|||.+.+..++.++||||||+++|||++|..||.....+ ..... ..... ..
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~-----~~-- 224 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQ-----CD-- 224 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHh-hhhhc-----CC--
Confidence 221 122346888999999999989999999999999999999999998532211 00000 00000 00
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
............+.+++.+||+.+|++||||.+|+++++..
T Consensus 225 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00011123456788999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=286.49 Aligned_cols=217 Identities=23% Similarity=0.304 Sum_probs=165.8
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+++.. +++.||+|++++.. ......+..|+.++.++ +||||+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 47889999997642 23445678899888876 89998731
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcccc
Confidence 12356888999999999999999999999 999999999999999999999999998753221 112234
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCC--CchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP--LNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
..||..|+|||++.+..++.++||||||+++|||++|+.||........ .....+......... ...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCCC
Confidence 6789999999999999999999999999999999999999864322111 111112221111111 1233
Q ss_pred hHHHHHHHHHHHhccccCCCCCCCH
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPAM 753 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs~ 753 (1018)
......+.+++.+||+.||++||++
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 4445677899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=280.94 Aligned_cols=235 Identities=24% Similarity=0.333 Sum_probs=173.0
Q ss_pred CCcceeeeeccCCCcCeEEEEec-----------------ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-----------------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-----------------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~ 577 (1018)
++|++.++||+|+||.||+++.. ++..||+|.++... .....+|.+|+.++++++|+|++..
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 23468999987543 3345689999999999999998621
Q ss_pred c-------------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcE
Q 046791 578 R-------------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNI 620 (1018)
Q Consensus 578 ~-------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NI 620 (1018)
. ....+++.++..++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 0 0123667789999999999999999999 99999999999
Q ss_pred EEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh--CCCCCCCCCCCC
Q 046791 621 LLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS--GKKNNGCYRTDH 698 (1018)
Q Consensus 621 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt--G~~p~~~~~~~~ 698 (1018)
|++.++.+||+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543222122222344678999999988899999999999999999998 667765332211
Q ss_pred CCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 699 PLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 699 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
........+..... ......+......+.+++.+||+.||.+||++.||++.|++
T Consensus 242 ---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ---VIENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111000 00001122344678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=293.04 Aligned_cols=226 Identities=21% Similarity=0.277 Sum_probs=171.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++|+||+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999875 48899999997542 2344568899999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 22456889999999999999999999999 999999999999999999999999999765321110
Q ss_pred c------------------------------------cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCC
Q 046791 646 T------------------------------------NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKK 689 (1018)
Q Consensus 646 ~------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~ 689 (1018)
. ......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 0112468999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 046791 690 NNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPA---MPDVVS 758 (1018)
Q Consensus 690 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 758 (1018)
||...... ............ +.........+.+.+++.+|+. +|.+|++ +.|+++
T Consensus 238 Pf~~~~~~------~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNPQ------ETYRKIINWKET-------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCHH------HHHHHHHcCCCc-------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 98643211 111111110000 0000111224566778888886 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=288.72 Aligned_cols=233 Identities=21% Similarity=0.295 Sum_probs=174.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|++.++||+|+||.||+++.. +++.+|+|.+.... ......+.+|++++++++|+||+..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999876 47889999886543 2344678999999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++.....++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 1234578888899999999999999974 5 999999999999999999999999998754321
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc-------------
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE------------- 712 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------- 712 (1018)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... +. ........
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE---LE-LMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH---HH-HHhcCcccCCccccccCcccC
Confidence 1223568899999999999899999999999999999999999986432110 00 00000000
Q ss_pred ----------------CcchhhhhhhhcCCCC----hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 713 ----------------GKVLELVDIALEGSFS----PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 713 ----------------~~~~~~~d~~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....+.+.......+ .....++.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0001111111111100 112356789999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=283.10 Aligned_cols=169 Identities=28% Similarity=0.461 Sum_probs=137.7
Q ss_pred eeeccCCCcCeEEEEecc---cccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc--------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN---GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR-------------------- 578 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~-------------------- 578 (1018)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++|+|++...
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998653 5689999986543 235678999999999999987310
Q ss_pred ----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE----cCCCCceeeeecceee
Q 046791 579 ----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARI 638 (1018)
Q Consensus 579 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl----d~~~~~kL~DFGla~~ 638 (1018)
....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 1124778888999999999999999999 9999999999999 5667899999999987
Q ss_pred ecCCCC-cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCC
Q 046791 639 FGLNQS-ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYR 695 (1018)
Q Consensus 639 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~ 695 (1018)
...... ........+|..|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 643321 122234578999999999876 458999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=274.57 Aligned_cols=227 Identities=27% Similarity=0.425 Sum_probs=177.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.++|++.++||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++++++|+|++..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 46789999999999999999998778889999886542 345679999999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 159 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TA 159 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-cc
Confidence 11234678888999999999999999998 99999999999999999999999999986643221 11
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
.....++..|+|||++....++.++||||||+++||+++ |+.||...... . .......+.. ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~----~~~~~~~~~~---------~~ 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---E----VIRALERGYR---------MP 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHhCCCC---------CC
Confidence 222345678999999998899999999999999999999 88887532211 0 1111111111 11
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
.+......+.+++.+|++.+|++||++.+++++|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 123345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=286.15 Aligned_cols=222 Identities=23% Similarity=0.298 Sum_probs=169.8
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+++.. +++.||||+++... ......+..|..++.++ +||||+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999875 48899999997642 23345688999999998 79998731
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCcccc
Confidence 12457899999999999999999999999 999999999999999999999999998743211 122234
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCC--CCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDH--PLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
..||..|+|||++.+..++.++|||||||++|||++|+.||+...... ......+..+...... ...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~p 225 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------IRIP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----------CCCC
Confidence 678999999999999999999999999999999999999996433221 1111112222111111 1123
Q ss_pred hHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPA------MPDVVS 758 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs------~~evl~ 758 (1018)
......+.+++.+||+.||.+||+ ++++++
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 334567889999999999999997 567664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=274.94 Aligned_cols=222 Identities=24% Similarity=0.341 Sum_probs=171.2
Q ss_pred eeccCCCcCeEEEEec---ccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc---------------------
Q 046791 523 KLGEGGFGPVYKGQLL---NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS--------------------- 577 (1018)
Q Consensus 523 ~lG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~--------------------- 577 (1018)
.||+|+||.||+|.+. .+..||+|.+..... ...++|.+|+.++++++|+||++.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 4899999999999764 355799999876533 334679999999999999998721
Q ss_pred -----cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc-ceee
Q 046791 578 -----RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN-TNRV 651 (1018)
Q Consensus 578 -----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~~~~ 651 (1018)
.....+++..+.+++.|+++||.|||+++ ++||||||+|||++.++.+||+|||++........... ....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 12346889999999999999999999998 99999999999999999999999999986543222111 1112
Q ss_pred ecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
.++..|+|||.+.+..++.++||||||+++||+++ |..||...... .+......+ .....+..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~~~~~~ 222 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQG---------KRLDCPAE 222 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCC---------CCCCCCCC
Confidence 23568999999998889999999999999999996 99998533211 011111111 11223344
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
..+.+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 567888999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=287.06 Aligned_cols=220 Identities=23% Similarity=0.343 Sum_probs=183.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
++|..++++|+|+||.++..+.+ +++.+++|.+.-. .....+...+|+.++++++|||||..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999765 4778999988654 34445567999999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.+...++++.+..++.||+.|+.|||+.. |+|||||+.|||+..+..+||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 12356889999999999999999999888 9999999999999999999999999999886433
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......+||+.||.||.+.+.+|..|+|||||||++|||++-+++|.... ...++....
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-------------------m~~Li~ki~ 219 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-------------------MSELILKIN 219 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-------------------hHHHHHHHh
Confidence 24456899999999999999999999999999999999999999985432 222222222
Q ss_pred cC---CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 724 EG---SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 724 ~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+. ..+.....++..++..|++.+|+.||++.+++.+
T Consensus 220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22 3455667888899999999999999999999985
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=276.81 Aligned_cols=229 Identities=25% Similarity=0.400 Sum_probs=174.2
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-c---ccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-G---QEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
..|++.+.||+|+||.||+|+... + ..||||.+... ......+|..|+.++++++|||+++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999998754 3 35999998754 33445689999999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 11345788899999999999999999998 9999999999999999999999999987654322
Q ss_pred Cccccee-ee--cccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 644 SETNTNR-VV--GTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 644 ~~~~~~~-~~--gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
....... .. .+..|+|||.+.+..++.++||||||+++|||++ |..||...... .... .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~----~i~~~------ 227 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIN----AIEQD------ 227 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHH----HHHcC------
Confidence 2111111 11 2357999999999999999999999999999986 99987532211 1111 11110
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.....+.+.+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ---YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11112233456678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=283.10 Aligned_cols=231 Identities=26% Similarity=0.369 Sum_probs=176.7
Q ss_pred hCCcceeeeeccCCCcCeEEEEec--------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCccccc------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL--------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSR------ 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~------ 578 (1018)
.++|.+.+.||+|+||.||+++.. ++..||+|.+.... .....++.+|+.++..+ +|+||++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888999999999999999742 24479999986542 34456799999999999 899987310
Q ss_pred ------------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE
Q 046791 579 ------------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL 622 (1018)
Q Consensus 579 ------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl 622 (1018)
....+++.+++.++.||++||.|||+++ ++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 0134677888999999999999999998 9999999999999
Q ss_pred cCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCc
Q 046791 623 DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLN 701 (1018)
Q Consensus 623 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~ 701 (1018)
+.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 9999999999999987643332222223345678999999999899999999999999999998 777764321
Q ss_pred hHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 702 LIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 702 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
... .......+. ....+......+.+++.+||+.+|++||++.||++.|+...
T Consensus 245 ~~~-~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 245 VEE-LFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHH-HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 111 111111111 11122334567888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=288.79 Aligned_cols=216 Identities=22% Similarity=0.265 Sum_probs=168.4
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------------- 577 (1018)
+.||+|+||.||+++.. +++.||+|++.... .....++.+|++++..++|+||+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 58899999997542 2345677899999999999998731
Q ss_pred ------cCCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 ------RRNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 ------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 155 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKT 155 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccccc
Confidence 124568899999999999999999997 67 9999999999999999999999999987543221 12233
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ........ ...++..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~-~~~~i~~~----------~~~~p~~ 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------K-LFELILME----------EIRFPRT 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------H-HHHHHhcC----------CCCCCCC
Confidence 57899999999999999999999999999999999999998532211 0 01111000 0112333
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRP-----AMPDVVSM 759 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 759 (1018)
....+.+++.+||+.||++|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 456778899999999999996 89998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=272.81 Aligned_cols=247 Identities=25% Similarity=0.332 Sum_probs=186.2
Q ss_pred CCccceeHHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHH--hcCCCccc--
Q 046791 501 YGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK--LQHTNLTD-- 576 (1018)
Q Consensus 501 ~~~~~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~nlv~-- 576 (1018)
.+++.+-..++ .++..+.+.||+|.||+||+|++ .|+.||||++.... +..+.+|.++.+. |+|+||+.
T Consensus 199 SGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 199 SGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred CCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhh
Confidence 45555544443 45678899999999999999998 67899999996543 4567888888765 69999872
Q ss_pred ---------------------------ccCCCCCChhhHHHHHHHHHHHHHHHhc-----CCCCcEEecccCCCcEEEcC
Q 046791 577 ---------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHK-----YSRLRVIHRDLKASNILLDD 624 (1018)
Q Consensus 577 ---------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~-----~~~~~ivH~Dlkp~NILld~ 624 (1018)
......++.+..++++..+|.||++||- +|++.|.|||||+.|||+..
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 2334678899999999999999999994 68899999999999999999
Q ss_pred CCCceeeeecceeeecCCC--CcccceeeecccccCChhhhccCC----C--CccccchhHhHHHHHHHhCC--------
Q 046791 625 QMNPKISDFGMARIFGLNQ--SETNTNRVVGTYGYMSPEYAMSGV----V--SIKTDVFSFGVLVLEIVSGK-------- 688 (1018)
Q Consensus 625 ~~~~kL~DFGla~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~~----~--s~ksDV~SlGvvl~elltG~-------- 688 (1018)
++...|+|+|||....... -....+..+||.+|||||++.... + -..+||||||.|+||+..+.
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 9999999999998775442 233456689999999999986521 1 24589999999999998643
Q ss_pred --CCCCCCCCCCCCchHHHHHHHhhcCcchhh-hhhhhcCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 689 --KNNGCYRTDHPLNLIGYAWQLWNEGKVLEL-VDIALEGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 689 --~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
.||....+.++.. .++.++ -...++... +.+.+..+.+++..||..+|+.|-|+-.|.+.|
T Consensus 432 y~~Pyyd~Vp~DPs~-----------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSF-----------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred hcCCcccCCCCCCCH-----------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 4443333322210 011111 122223222 346778899999999999999999999999998
Q ss_pred hcCcC
Q 046791 761 ANESL 765 (1018)
Q Consensus 761 e~~~~ 765 (1018)
.+...
T Consensus 501 ~~l~~ 505 (513)
T KOG2052|consen 501 AKLSN 505 (513)
T ss_pred HHHhc
Confidence 87654
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=275.92 Aligned_cols=230 Identities=26% Similarity=0.433 Sum_probs=176.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cc---cceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQ---EVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~---~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.++|+..+.||+|+||.||+|+... ++ .+|+|.+.... ....+++.+|++++.+++|+|+++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3468888999999999999998753 33 68999986553 3345679999999999999998621
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 12346888999999999999999999998 999999999999999999999999999866432
Q ss_pred CCcccc-eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 643 QSETNT-NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 643 ~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
...... .....+..|+|||++.+..++.++||||||+++|||++ |+.||...... . .......+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~-~~~~i~~~------- 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------E-VMKAINDG------- 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------H-HHHHHhcC-------
Confidence 221111 11223457999999998889999999999999999997 99998532211 1 11111111
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
............+.+++.+|++.+|++||++.+|++.|++.
T Consensus 227 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 --FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112223456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=274.82 Aligned_cols=222 Identities=27% Similarity=0.378 Sum_probs=176.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.++|++.+.||+|+||.||+|... ++.||||.+..... ..+++.+|+.++.+++|+|++..
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999874 78899999976644 56789999999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 11126889999999999999999999999 99999999999999999999999999986532111
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
....+..|+|||++..+.++.++||||||+++|||++ |+.||...... ........+ ...
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~ 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKG---------YRM 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcC---------CCC
Confidence 2234567999999998899999999999999999997 99887533211 111111111 111
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..+...++.+.+++.+||+.+|++||++.|++++|++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1223345778899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=274.63 Aligned_cols=223 Identities=30% Similarity=0.453 Sum_probs=172.5
Q ss_pred eeeccCCCcCeEEEEecc----cccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~------------------- 577 (1018)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++++.|+|++..
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 479999999999997533 26799999876543 345679999999999999998731
Q ss_pred ------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc-cee
Q 046791 578 ------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN-TNR 650 (1018)
Q Consensus 578 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~-~~~ 650 (1018)
.....+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 12345889999999999999999999998 99999999999999999999999999987653332211 112
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
..++..|+|||.+.+..++.++||||||+++|||++ |..||..... .... ....... ....+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~----~~~~~~~---------~~~~~~ 221 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVI----AMLESGE---------RLPRPE 221 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHH----HHHHcCC---------cCCCCC
Confidence 233567999999999999999999999999999998 9999854321 1111 1111111 111223
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.....+.+++.+|++.+|++||++.+|++.|++.
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 3456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=293.67 Aligned_cols=227 Identities=21% Similarity=0.285 Sum_probs=168.9
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.|.+++.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++.+++|+||+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5889999999999999999865 47899999996542 3345678999999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC--
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS-- 644 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~-- 644 (1018)
.....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 12345788888999999999999999998 99999999999999999999999999764321000
Q ss_pred -------------------------------------------cccceeeecccccCChhhhccCCCCccccchhHhHHH
Q 046791 645 -------------------------------------------ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLV 681 (1018)
Q Consensus 645 -------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl 681 (1018)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0001235799999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHh--ccccCCCCCCCHHHHHHH
Q 046791 682 LEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLL--CVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 682 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dP~~RPs~~evl~~ 759 (1018)
|||++|+.||....... .......... .+..........++.+++.+ |+..+|..||++.||++.
T Consensus 239 ~elltG~~Pf~~~~~~~------~~~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTE------TQLKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHH------HHHHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999986432111 0001110000 00001111223456666666 667777789999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=293.64 Aligned_cols=229 Identities=22% Similarity=0.259 Sum_probs=173.8
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
..++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.+++.++|+||+..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999875 4889999998653 22334557899999999999998831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 12235778888999999999999999999 99999999999999999999999999987643221
Q ss_pred cccceeeecccccCChhhhccC----CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSG----VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ............
T Consensus 198 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~------ 264 (370)
T cd05596 198 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKN------ 264 (370)
T ss_pred -ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCC------
Confidence 122345789999999998753 478999999999999999999999864221 111111111000
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATD--RPAMPDVVSM 759 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 759 (1018)
.+.-.........+.+++.+||+.+|.+ ||++.|+++.
T Consensus 265 -~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 -SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000111134567788999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=276.82 Aligned_cols=227 Identities=25% Similarity=0.345 Sum_probs=173.2
Q ss_pred cceeeeeccCCCcCeEEEEec----ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccccC------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDSRR------------ 579 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~~~------------ 579 (1018)
|.+.+.||+|+||.||+|.+. .++.||||++... .....+++.+|++++++++|||+++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999753 3678999998654 2344667899999999999999863110
Q ss_pred --------------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeee
Q 046791 580 --------------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633 (1018)
Q Consensus 580 --------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DF 633 (1018)
...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 013566778999999999999999998 999999999999999999999999
Q ss_pred cceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 634 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.||..... ..+.. ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYN----YLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHH----HHHc
Confidence 99986543222222223345678999999999899999999999999999999 8888753221 11111 1111
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
+. ....++.....+.+++.+|++.+|++||++.|+++.|++.
T Consensus 231 ~~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN---------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 0011233456888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=272.38 Aligned_cols=222 Identities=27% Similarity=0.369 Sum_probs=175.4
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|.+.+.||+|++|.||+++.. +++.|++|.+... .....+++.+|++++++++|+|+++.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999875 4889999998643 34456779999999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 11346788899999999999999999998 99999999999999999999999999987643222
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......++..|+|||++.+..++.++||||||+++|||++|+.||...... ........+. ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~---------~~ 219 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRGV---------FP 219 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC---------CC
Confidence 122356788999999999999999999999999999999999998643210 0011111111 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1222345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=271.99 Aligned_cols=220 Identities=27% Similarity=0.367 Sum_probs=171.0
Q ss_pred eeeccCCCcCeEEEEecccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc-----------------------
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS----------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~----------------------- 577 (1018)
++||+|+||.||+|...+++.+|+|.++.... .....|.+|+.++++++|+|++..
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 37999999999999988889999999876543 234468999999999999998721
Q ss_pred ----cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeec
Q 046791 578 ----RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653 (1018)
Q Consensus 578 ----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 653 (1018)
.....+++..+..++.|++.+|.|||+++ ++||||||+||+++.++.+||+|||++........ .......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 11345788999999999999999999998 99999999999999999999999999876432211 11112234
Q ss_pred ccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHH
Q 046791 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEV 732 (1018)
Q Consensus 654 t~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 732 (1018)
+..|+|||++.+..++.++||||||+++||+++ |..||...... ........+ .....+....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~ 220 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKG---------YRMSCPQKCP 220 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcC---------CCCCCCCCCC
Confidence 567999999998999999999999999999998 88888532211 111111111 1112233445
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 733 LRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 733 ~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 77889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=280.27 Aligned_cols=232 Identities=24% Similarity=0.386 Sum_probs=174.5
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc------cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc--------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR-------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~-------- 578 (1018)
..++|++.++||+|+||.||+|...+ +..||+|.+.... .....++.+|+.++++++|+|+++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999997542 4579999886543 23345688999999999999987310
Q ss_pred ----------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCcee
Q 046791 579 ----------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI 630 (1018)
Q Consensus 579 ----------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL 630 (1018)
....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 0122345677889999999999999998 999999999999999999999
Q ss_pred eeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHH
Q 046791 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...... . ....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~-~~~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------Q-VLKF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHH
Confidence 99999986533222122222345678999999999999999999999999999998 67787532111 1 1111
Q ss_pred hhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 710 WNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
...+.. ...+......+.+++.+||+.+|++||++.++++.|+...
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111111 1112233567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=283.87 Aligned_cols=230 Identities=25% Similarity=0.357 Sum_probs=175.2
Q ss_pred CCcceeeeeccCCCcCeEEEEecc--------cccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCccccc-------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN--------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSR------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~------- 578 (1018)
++|.+.+.||+|+||.||+++... ...+|+|.+.... .....++.+|+.++.++ +|+|+++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 579999999999999999997532 3469999987542 34456788999999999 799987210
Q ss_pred -----------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 579 -----------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 579 -----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
....+++.+++.++.|++.||+|||+.+ ++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 0124788899999999999999999998 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCch
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l 702 (1018)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence 999999999999876542211111212234568999999999999999999999999999998 8888743211
Q ss_pred HHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 703 IGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.........+ .....+......+.+++.+|++.+|++||++.+|++.|+.+.
T Consensus 249 -~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 -EELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred -HHHHHHHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1111111111 111223334567888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=285.46 Aligned_cols=215 Identities=24% Similarity=0.315 Sum_probs=166.4
Q ss_pred eeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~~------------------- 577 (1018)
++||+|+||.||+|+... ++.||||++.... ....+.+..|.+++..+ +||||+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999998754 7899999987542 33445678899988866 79998631
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTT 155 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccc
Confidence 22346788899999999999999999999 9999999999999999999999999987543221 12234
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+. ...+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~-~~~----------~~~p~~ 218 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESIL-HDD----------VLYPVW 218 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHH-cCC----------CCCCCC
Confidence 57899999999999999999999999999999999999998643211 1111111 110 012222
Q ss_pred HHHHHHHHHHhccccCCCCCC-------CHHHHHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRP-------AMPDVVS 758 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RP-------s~~evl~ 758 (1018)
....+.+++..||+.||++|| ++.++++
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 346778899999999999999 7777775
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=271.91 Aligned_cols=221 Identities=26% Similarity=0.367 Sum_probs=171.0
Q ss_pred eeeccCCCcCeEEEEecccccceEEEecccccc-cHHHHHHHHHHHHHhcCCCcccc-----------------------
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDS----------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~----------------------- 577 (1018)
++||+|+||.||++...+++.||+|.+...... ..+++.+|++++++++|+||+..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 55689999999999999998621
Q ss_pred ----cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeec
Q 046791 578 ----RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653 (1018)
Q Consensus 578 ----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 653 (1018)
.....+++..+..++.+++.||.|||+++ ++||||||+|||++.++.+||+|||++.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 11335778888999999999999999998 99999999999999999999999999986542211111112233
Q ss_pred ccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHH
Q 046791 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEV 732 (1018)
Q Consensus 654 t~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 732 (1018)
+..|+|||.+.++.++.++||||||+++|||++ |..||...... . .... +........+....
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~------~-~~~~---------~~~~~~~~~~~~~~ 221 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ------Q-TRER---------IESGYRMPAPQLCP 221 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH------H-HHHH---------HhcCCCCCCCccCC
Confidence 567999999998899999999999999999999 78777433211 0 0111 11111112233345
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 733 LRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 733 ~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
..+.+++.+|++.+|++||++.||++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 67889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=276.96 Aligned_cols=228 Identities=22% Similarity=0.349 Sum_probs=174.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++|+||+..
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 47889999999999999999864 588999999976655556678899999999999998731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~ 163 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KR 163 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc--cc
Confidence 12346788899999999999999999998 99999999999999999999999999987642211 12
Q ss_pred eeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 649 NRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+.......... ...... ...+...
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~---~~~~~~~- 232 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSN---FQPPKLK- 232 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCC---CCCCCCc-
Confidence 2356788999999884 3557889999999999999999999975332111000 000000 0000010
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
........+.+++.+||+.+|++||++++|++.|
T Consensus 233 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 -DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0112346788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=283.03 Aligned_cols=211 Identities=24% Similarity=0.298 Sum_probs=161.3
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHH-HHHHhcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAK-LIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nlv~~------------------- 577 (1018)
+.||+|+||+||+|+.. +++.||||++.... .....++..|.. +++.++||||++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999875 58899999986542 222344555544 5678999999831
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTST 155 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcccc
Confidence 12456788899999999999999999999 999999999999999999999999998753211 122334
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+ . ...++.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~-~~--------~--~~~~~~ 218 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNIL-NK--------P--LRLKPN 218 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHH-cC--------C--CCCCCC
Confidence 5789999999999999999999999999999999999999853221 11111111 10 0 012233
Q ss_pred HHHHHHHHHHhccccCCCCCCCHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMP 754 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~ 754 (1018)
....+.+++.+||+.||++||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 456788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=284.46 Aligned_cols=217 Identities=23% Similarity=0.293 Sum_probs=167.4
Q ss_pred eeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+++... ++.||||+++... ....+.+.+|+.++.++ +|+||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998754 7889999997642 23445688999999888 68998621
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTST 155 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceec
Confidence 12356899999999999999999999999 999999999999999999999999998753211 122234
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....................... ...+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~p~~ 225 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIPRF 225 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCCCCC
Confidence 6789999999999999999999999999999999999999965443332222222222221110 112333
Q ss_pred HHHHHHHHHHhccccCCCCCCCH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAM 753 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~ 753 (1018)
....+.+++.+||+.||++||++
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCC
Confidence 44667889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=278.89 Aligned_cols=229 Identities=27% Similarity=0.409 Sum_probs=174.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR--------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~--------- 578 (1018)
.++|++.+.||+|+||.||+++.. ++..||+|.+.... .....+|.+|+.++++++|+|+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999863 36789999987543 33456799999999999999987310
Q ss_pred -------C--------------------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCc
Q 046791 579 -------R--------------------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASN 619 (1018)
Q Consensus 579 -------~--------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~N 619 (1018)
. ...+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 0 123677788999999999999999998 9999999999
Q ss_pred EEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCC
Q 046791 620 ILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDH 698 (1018)
Q Consensus 620 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~ 698 (1018)
||++.++.+||+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999886543221111222334567999999998999999999999999999998 7777642211
Q ss_pred CCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 699 PLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 699 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
.. .......+... ..+.....++.+++.+||+.+|++||++.||++.|+.
T Consensus 239 ----~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ----EE-VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HH-HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 11111111111 1122345678899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=277.87 Aligned_cols=225 Identities=26% Similarity=0.379 Sum_probs=172.9
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc-------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS------------- 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~------------- 577 (1018)
.+++.|++.+.||+|+||.||+|+..+ ++.||+|++.... ....++..|+.++.++ +|+|++..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 467789999999999999999998754 7889999986543 4456789999999998 69998721
Q ss_pred ---------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 578 ---------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 578 ---------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
.....+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 01235788889999999999999999998 999999999999999999999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhh
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWN 711 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 711 (1018)
....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||....... ......
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------~~~~~~- 229 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLIP- 229 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------HHHHHh-
Confidence 8653221 1223467889999999986 3468889999999999999999999985322110 000000
Q ss_pred cCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 712 EGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 712 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... ............+.+++.+||+.+|.+||++.||++
T Consensus 230 ~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 000111223456789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=277.57 Aligned_cols=217 Identities=24% Similarity=0.314 Sum_probs=167.3
Q ss_pred eccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc----------------------
Q 046791 524 LGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 577 (1018)
Q Consensus 524 lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~---------------------- 577 (1018)
||+|+||+||++... +++.||||.+.... ....+.+..|++++++++|+|++..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 58899999986542 2234567889999999999998721
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 12345888999999999999999999998 99999999999999999999999999986643222 223
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
...||+.|+|||++.+..++.++||||||+++|||++|+.||........ .. .... ...... ...+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~-~~~~--------~~~~~~--~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NK-ELKQ--------RILNDS--VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HH-HHHH--------hhcccC--CCCcc
Confidence 35789999999999999999999999999999999999999864322111 00 0000 000000 11233
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
.....+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 4556788999999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=282.70 Aligned_cols=231 Identities=26% Similarity=0.359 Sum_probs=175.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecc--------cccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCccccc-------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN--------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSR------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~------- 578 (1018)
.+|.+.+.||+|+||.||+++... +..||+|.++... ....+++.+|+.++.++ +|+||++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468899999999999999997421 2368999887542 33457899999999999 899987310
Q ss_pred -----------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 579 -----------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 579 -----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
....+++.+++.++.||++||.|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 1124677888999999999999999998 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCch
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l 702 (1018)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence 999999999999986643222222222334567999999999999999999999999999998 7888743221
Q ss_pred HHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 703 IGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.. .......+ .....+......+.+++.+|++.+|++||++.|+++.|+....
T Consensus 243 ~~-~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EE-LFKLLKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HH-HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 11111111 1111223345678899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=279.56 Aligned_cols=215 Identities=26% Similarity=0.300 Sum_probs=163.8
Q ss_pred eeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHH-hcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAK-LQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~-l~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+|+... ++.||||+++... ....+.+..|..++.. .+|+||+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999998754 7889999997542 2334456667777765 489998731
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence 12346888899999999999999999998 9999999999999999999999999998643222 22334
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ... .....+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~-i~~----------~~~~~~~~ 218 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDS-ILN----------DRPHFPRW 218 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHc----------CCCCCCCC
Confidence 67899999999999999999999999999999999999998643211 01111 100 01122333
Q ss_pred HHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMP-DVVS 758 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~-evl~ 758 (1018)
....+.+++.+||+.+|++||++. ++++
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 445677899999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=272.85 Aligned_cols=221 Identities=32% Similarity=0.463 Sum_probs=175.8
Q ss_pred eeeccCCCcCeEEEEecc----cccceEEEecccccc-cHHHHHHHHHHHHHhcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~------------------- 577 (1018)
+.||+|+||.||++.... +..||||.++..... ..+++.+|++++.+++|+|+++.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 778999999766433 36789999999999999998721
Q ss_pred -------cC---------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 -------RR---------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 -------~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.. ...+++.++..++.|+++||+|||+++ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 11 267899999999999999999999998 99999999999999999999999999987754
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
...........++..|+|||.+....++.++||||||+++|||++ |..||...... ........+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------EVLEYLRKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC-------
Confidence 332223334567889999999998899999999999999999999 58888644211 111111111
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
.....+.....++.+++.+||+.+|.+||++.|+++.|+
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111223334578889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=280.69 Aligned_cols=224 Identities=23% Similarity=0.331 Sum_probs=176.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.+|.+.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.+.|+|++..
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57899999999999999999864 588999999977655566789999999999999998731
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~ 174 (296)
T cd06654 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS 174 (296)
T ss_pred CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccC
Confidence 12345788899999999999999999999 99999999999999999999999999876532221 122
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
...+++.|+|||.+.+..++.++|||||||++|||++|+.||....... ........+. + ....+.
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~------~--~~~~~~ 240 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT------P--ELQNPE 240 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCC------C--CCCCcc
Confidence 3467889999999999889999999999999999999999985432111 0000110000 0 001122
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....+.+++.+||+.+|++||++.||++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 34466788999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=289.37 Aligned_cols=175 Identities=25% Similarity=0.360 Sum_probs=147.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
++|++.+.||+|+||+||+++.. +++.||||+++... ......+.+|+.++.+++|+||+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 48899999997542 233456889999999999999873
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC-
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS- 644 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~- 644 (1018)
+.....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 123457889999999999999999999999 99999999999999999999999999875432110
Q ss_pred --------------------------------cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCC
Q 046791 645 --------------------------------ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNG 692 (1018)
Q Consensus 645 --------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~ 692 (1018)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 000123579999999999999999999999999999999999999986
Q ss_pred C
Q 046791 693 C 693 (1018)
Q Consensus 693 ~ 693 (1018)
.
T Consensus 238 ~ 238 (363)
T cd05628 238 S 238 (363)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=290.99 Aligned_cols=230 Identities=21% Similarity=0.256 Sum_probs=172.4
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc---------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS--------- 577 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~--------- 577 (1018)
+....++|++.+.||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.+++.++||||++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 34456789999999999999999998764 788999998653 22334568899999999999998731
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 12335788889999999999999999999 99999999999999999999999999987642
Q ss_pred CCCcccceeeecccccCChhhhccC----CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSG----VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......
T Consensus 195 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~--------- 258 (370)
T cd05621 195 TG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSK--------- 258 (370)
T ss_pred CC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHH---------
Confidence 21 1122346799999999998753 378999999999999999999999853221 111111
Q ss_pred hhhhhhcCCCC--hHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 046791 718 LVDIALEGSFS--PNEVLRCIHVGLLCVQDQATD--RPAMPDVVSM 759 (1018)
Q Consensus 718 ~~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 759 (1018)
+.+.......+ ......+.+++..|++.++.+ ||++.|+++.
T Consensus 259 i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 259 IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111011111 123456677888888755543 8899998884
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=286.75 Aligned_cols=225 Identities=20% Similarity=0.291 Sum_probs=172.9
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.+++.++|+||+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999865 58899999997642 2345668899999999999998731
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 11246888999999999999999999999 99999999999999999999999999987643322
Q ss_pred cccceeeecccccCChhhhc------cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAM------SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .............
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~--- 227 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRF--- 227 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCc---
Confidence 1 223357899999999987 45678999999999999999999999853221 1111111111100
Q ss_pred hhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 719 VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 719 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+.....+.....+.+++..|++ +|++||++.++++
T Consensus 228 ----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 ----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0101112345667888899998 9999999999886
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=275.08 Aligned_cols=226 Identities=24% Similarity=0.354 Sum_probs=174.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-----cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-----GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++|.+.+.||+|++|.||++... ++++||+|.+.... ......+.+|+.++++++|+||+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999865 58899999886432 1234568999999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 12345778888999999999999999999 9999999999999999999999999998654321
Q ss_pred Cccc-ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETN-TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.... .....++..|+|||++.+..++.++||||||+++|||++|+.||...... ...... ....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~---------~~~~ 223 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKI---------ATQP 223 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHH---------hccC
Confidence 1111 12345778999999999988999999999999999999999998532110 000110 0111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.....+......+.+++.+||+.+|.+||++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1112333445677889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=301.86 Aligned_cols=229 Identities=28% Similarity=0.454 Sum_probs=171.3
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccc-------------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTD------------- 576 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~------------- 576 (1018)
.+...+|++++.||+||||.||+++.+ ||+.+|||++.... ........+|+.++++|+|||+|+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 566778999999999999999999865 79999999996553 334456789999999999999870
Q ss_pred ------------------------------------------------------------------------c-------
Q 046791 577 ------------------------------------------------------------------------S------- 577 (1018)
Q Consensus 577 ------------------------------------------------------------------------~------- 577 (1018)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------------------------cCCCCC--ChhhHHHHHHHHHHHHHHHh
Q 046791 578 ----------------------------------------------------RRNNRL--NWETRFSIIEGIAQGLLYLH 603 (1018)
Q Consensus 578 ----------------------------------------------------~~~~~l--~~~~~~~i~~qia~gL~yLH 603 (1018)
.....+ .....++++++|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 000011 13456789999999999999
Q ss_pred cCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec----------------CCCCcccceeeecccccCChhhhccC-
Q 046791 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG----------------LNQSETNTNRVVGTYGYMSPEYAMSG- 666 (1018)
Q Consensus 604 ~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~----------------~~~~~~~~~~~~gt~~Y~aPE~~~~~- 666 (1018)
++| ||||||||.||+||++..+||+|||+|.... ........+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998721 01112234568999999999999764
Q ss_pred --CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccc
Q 046791 667 --VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQ 744 (1018)
Q Consensus 667 --~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~ 744 (1018)
+|+.|+|+||||||++||+. ||....+ ...+...++.+.+..- ..+..++.+.-..++.++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME------Ra~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSME------RASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHH------HHHHHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 59999999999999999995 3432110 0111122223332221 12334455666789999999
Q ss_pred cCCCCCCCHHHHHH
Q 046791 745 DQATDRPAMPDVVS 758 (1018)
Q Consensus 745 ~dP~~RPs~~evl~ 758 (1018)
+||.+|||+.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999886
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=288.57 Aligned_cols=212 Identities=24% Similarity=0.278 Sum_probs=165.4
Q ss_pred eeeccCCCcCeEEEEe----cccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 522 NKLGEGGFGPVYKGQL----LNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
+.||+|+||.||+++. .+|+.||+|++.... ......+..|++++++++|+||++.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999975 347899999997543 2234567889999999999999731
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Ccee
Confidence 12345889999999999999999999999 9999999999999999999999999988653221 2223
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .. ....+.
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~-~~----------~~~~p~ 219 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMIL-KA----------KLGMPQ 219 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHH-cC----------CCCCCC
Confidence 46789999999999988899999999999999999999999853221 11111111 10 011233
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPD 755 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~e 755 (1018)
.....+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 34566788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=283.55 Aligned_cols=215 Identities=25% Similarity=0.331 Sum_probs=166.1
Q ss_pred CcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhc-CCCccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQ-HTNLTD--------------- 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~-H~nlv~--------------- 576 (1018)
+|++.+.||+|+||.||+|+... ++.||||++.+.. ....+.+..|..++..+. |++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47889999999999999998764 7789999987542 233455777888888774 666541
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
+.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--G 155 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC--C
Confidence 112356788999999999999999999998 999999999999999999999999999754321 1
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ....... ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~----~~~i~~~----------~~ 218 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL----FQSIMEH----------NV 218 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HH----HHHHHhC----------CC
Confidence 2223467899999999999999999999999999999999999998643211 11 1111111 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAM 753 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 753 (1018)
.++.....++.+++.+|++.+|++|++.
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 2233455678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=287.93 Aligned_cols=222 Identities=27% Similarity=0.354 Sum_probs=181.8
Q ss_pred eeeeeccCCCcCeEEEEecc--cc--cceEEEecccccc-cHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 520 AVNKLGEGGFGPVYKGQLLN--GQ--EVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 520 ~~~~lG~G~fG~Vy~~~~~~--g~--~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
..++||+|.||.|++|.+.. |+ .||||+++..... ....|++|+.+|.+|+|+|++++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELap 193 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAP 193 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcc
Confidence 44799999999999998754 44 5899999876533 67889999999999999998742
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....|-......++.|||.||.||.+++ +|||||..+|+||-....+||+||||.+.++.++..+.
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 12344666777889999999999999998 99999999999999999999999999998876665543
Q ss_pred ce-eeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 648 TN-RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 648 ~~-~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.. ...-...|+|||.+....++.++|||+|||+||||++ |+.||.... .-.+.+.+|...+-
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----------------g~qIL~~iD~~erL 334 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----------------GIQILKNIDAGERL 334 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC----------------HHHHHHhccccccC
Confidence 32 2233568999999999999999999999999999998 556764322 22345566655555
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
..++.+.+++.+++..||.++|++|||+..|.+.+
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 66788899999999999999999999999998543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=283.84 Aligned_cols=210 Identities=24% Similarity=0.341 Sum_probs=163.8
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +|+|++..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47899999987542 33456678888888876 69998731
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTST 155 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcccc
Confidence 22456888999999999999999999999 999999999999999999999999998754221 122234
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......+. ...+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~-~~~~i~~~~----------~~~~~~ 218 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------D-LFEAILNDE----------VVYPTW 218 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------H-HHHHHhcCC----------CCCCCC
Confidence 57899999999999999999999999999999999999998643211 1 111111111 012223
Q ss_pred HHHHHHHHHHhccccCCCCCCCH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAM 753 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~ 753 (1018)
....+.+++.+||+.||++||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 45677899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=276.26 Aligned_cols=226 Identities=29% Similarity=0.445 Sum_probs=173.1
Q ss_pred cceeeeeccCCCcCeEEEEecc-cccceEEEecccccccH--HHHHHHHHHHHHhcCCCccc------------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGI--VEFKNEAKLIAKLQHTNLTD------------------ 576 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~--~~f~~E~~~l~~l~H~nlv~------------------ 576 (1018)
|++.+.||+|+||+||+++... ++.+|+|++........ ....+|+.++++++|+||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999765 66899999977643322 23456999999999999872
Q ss_pred --------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 577 --------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 577 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
+.....+++.++..++.||++||.+||+.+ |+|+||||+||++++++.++|+|||.+.... ......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENF 155 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEB
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccccc
Confidence 113567899999999999999999999998 9999999999999999999999999998642 122333
Q ss_pred eeeecccccCChhhhc-cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAM-SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....++..|+|||++. +..++.++||||||+++|+|++|..|+...... .......... ........ ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~----~~~~~~~~---~~ 225 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKIL----KRPLPSSS---QQ 225 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHH----HTHHHHHT---TS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhcc----cccccccc---cc
Confidence 4567889999999998 889999999999999999999999998643100 0000000000 00000000 01
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.......+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112378889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=279.42 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=178.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-----ccccceEEEecccccc-cHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-----NGQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
+.|++.+.||+|+||.||+++.. .+..||||.++..... ..++|.+|++++++++|+||+..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999853 3678999999765443 46789999999999999998731
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 01124788889999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcc-cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 641 LNQSET-NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 641 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ...............+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHHHH
Confidence 222211 111233456799999999889999999999999999999999987543221100 000000000000011111
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
........+.....++.+++.+||+.+|++||++.||+++|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111122233346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=285.65 Aligned_cols=171 Identities=26% Similarity=0.386 Sum_probs=143.1
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhc-CC-----Ccc--------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HT-----NLT-------------- 575 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~-----nlv-------------- 575 (1018)
+|.+.+.||+|.||.|-++... +++.||||++++.. .-..+-..|+.+|..|+ |. |+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999865 59999999997664 33456688999999997 43 233
Q ss_pred -------------cccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC--CCceeeeecceeeec
Q 046791 576 -------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ--MNPKISDFGMARIFG 640 (1018)
Q Consensus 576 -------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~--~~~kL~DFGla~~~~ 640 (1018)
+......++...++.|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|....
T Consensus 266 VfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 266 VFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccC
Confidence 1234556899999999999999999999999 9999999999999754 369999999998753
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCC
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRT 696 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~ 696 (1018)
.. .....-++.|.|||++.+.+|+.+.||||||||+.||++|.+.|....+
T Consensus 343 q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 343 QR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred Cc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 22 1146678899999999999999999999999999999999888765443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=279.08 Aligned_cols=214 Identities=24% Similarity=0.340 Sum_probs=164.1
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++..+ +|+|++..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999876 48899999997542 23445677788888754 89998731
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCceec
Confidence 12346788899999999999999999999 999999999999999999999999998753211 122234
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||..|+|||++.+..++.++|||||||++|||++|+.||...... .+ .+..... ....+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~----~~~~~~~----------~~~~~~~ 218 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---EL----FESIRVD----------TPHYPRW 218 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhC----------CCCCCCC
Confidence 67899999999999999999999999999999999999998532211 01 1111110 1112223
Q ss_pred HHHHHHHHHHhccccCCCCCCCHH-HHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMP-DVV 757 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~-evl 757 (1018)
....+.+++.+||+.||++||++. +++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 445678899999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=286.07 Aligned_cols=215 Identities=22% Similarity=0.299 Sum_probs=163.2
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHH-HHHHhcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAK-LIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+++.. +|+.||||++.... .....++..|.. +++.++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 58899999986542 233345556654 5678999998731
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTT 155 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCccc
Confidence 22456889999999999999999999999 999999999999999999999999998753211 112234
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||..|+|||++.+..++.++|||||||++|||++|+.||..... ........ .. .+ ...+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~-~~--------~~--~~~~~ 218 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNIL-HK--------PL--VLRPG 218 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHH-cC--------Cc--cCCCC
Confidence 6789999999999999999999999999999999999999853221 11111111 11 00 12233
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+.+++.+|++.+|.+||++.+.++
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 4566788999999999999999864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=280.64 Aligned_cols=231 Identities=26% Similarity=0.371 Sum_probs=175.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec--------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCccccc-------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL--------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSR------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~------- 578 (1018)
++|.+.+.||+|+||.||+++.. ....+|+|.++... .....++.+|+.++.++ +|+||++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57888999999999999999742 24468999987543 34456789999999999 699987310
Q ss_pred -----------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 579 -----------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 579 -----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
....+++.++..++.||+.||.|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 1134788888999999999999999998 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCch
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l 702 (1018)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----- 243 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE----- 243 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999986543222111222234467999999999999999999999999999999 88887432211
Q ss_pred HHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 703 IGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
........+.. ...+......+.+++.+||+.+|++||++.|+++.|+....
T Consensus 244 --~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 --ELFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred --HHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111111111 11223345577899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=278.81 Aligned_cols=236 Identities=25% Similarity=0.389 Sum_probs=176.5
Q ss_pred CCcceeeeeccCCCcCeEEEEe-----cccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-----LNGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
+.|++.+.||+|+||.||+++. .++..||+|.++... ......+.+|+.++++++|+|++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 247789999987553 3345679999999999999998621
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++.++..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence 11234788999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCC--------CCCchHHHHHHHhh
Q 046791 641 LNQSE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTD--------HPLNLIGYAWQLWN 711 (1018)
Q Consensus 641 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~--------~~~~l~~~~~~~~~ 711 (1018)
..... .......++..|+|||++.+..++.++||||||+++|||++++.|....... ..............
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 32221 1112345667899999999889999999999999999999988764221100 00000000111111
Q ss_pred cCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 712 EGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 712 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.+ .....+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 241 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 11112233457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=286.73 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=178.7
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
.+++|++.++||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++|+||++..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999864 58899999986432 33456688999999999999987421
Q ss_pred ----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 579 ----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 579 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 1245788899999999999999999999 999999999999999999999999999875432
Q ss_pred CCcc-cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc---hh
Q 046791 643 QSET-NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV---LE 717 (1018)
Q Consensus 643 ~~~~-~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~ 717 (1018)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .........+..... ..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHHHHHH
Confidence 2111 1223567889999998765 56899999999999999999999998543211 111111111111000 00
Q ss_pred hhhhh-------h--cCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCc
Q 046791 718 LVDIA-------L--EGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM--LANES 764 (1018)
Q Consensus 718 ~~d~~-------l--~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--Le~~~ 764 (1018)
+.+.. . .... .+.....+.+++.+||+.+|++||++.|+++. ++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 0 0000 01234568899999999999999999999985 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=275.05 Aligned_cols=230 Identities=26% Similarity=0.426 Sum_probs=177.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cc----cceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQ----EVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~----~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.+|++.+.||+|+||.||+|...+ |. .+|+|.+..... ....++.+|+.++++++|+|++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 567888999999999999998643 33 589998866543 345679999999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 11345889999999999999999999988 9999999999999999999999999998765332
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.........++..|+|||.+....++.++||||||+++||+++ |+.||...... .. ......+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~~--------- 227 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EI-PDLLEKG--------- 227 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HH-HHHHhCC---------
Confidence 2222222233568999999988899999999999999999998 99998543211 11 1111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.....+......+.+++.+||..+|++||++.++++.|+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 228 ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 011122233456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=280.88 Aligned_cols=235 Identities=21% Similarity=0.333 Sum_probs=172.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999875 47899999986543 3334567899999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..+..++.||++||.|||+.+ |+|+||||+|||++.++.+||+|||++........ .
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 160 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T 160 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--c
Confidence 12345788889999999999999999998 99999999999999999999999999976432211 1
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc---Ccchhhhh---
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE---GKVLELVD--- 720 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d--- 720 (1018)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........... ......++
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhcccc
Confidence 223456889999999875 457899999999999999999999986433211 11111111000 00000000
Q ss_pred ------hhhcC----CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 ------IALEG----SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ------~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+.... ...+.....+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 001123456778999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=271.62 Aligned_cols=220 Identities=26% Similarity=0.389 Sum_probs=172.8
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|.+.+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++.+++|+|++..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCC
Confidence 4588899999999999999975 67889999986532 34678999999999999998721
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... .
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~ 154 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----V 154 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----C
Confidence 11235788899999999999999999998 999999999999999999999999998764321 1
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||..... .. .......+ .....
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~-~~~~~~~~---------~~~~~ 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KE-VKECVEKG---------YRMEP 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HH-HHHHHhCC---------CCCCC
Confidence 12233567999999998899999999999999999998 8988753221 11 11111111 11112
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 23345677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=290.02 Aligned_cols=230 Identities=22% Similarity=0.342 Sum_probs=174.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec------ccccceEEEeccccc-ccHHHHHHHHHHHHHhc-CCCccccc---------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQ-HTNLTDSR--------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-H~nlv~~~--------- 578 (1018)
++|.+.++||+|+||.||+|++. .++.||||+++.... ...+.+.+|++++.++. |+||+.+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46778899999999999999853 245799999976532 33457899999999997 99987210
Q ss_pred --------------------------------------------------------------------------------
Q 046791 579 -------------------------------------------------------------------------------- 578 (1018)
Q Consensus 579 -------------------------------------------------------------------------------- 578 (1018)
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence
Q ss_pred -----------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 579 -----------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 579 -----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
....+++...+.++.||+.||.|||+.+ ++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 0013566677889999999999999988 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCch
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l 702 (1018)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~----- 348 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN----- 348 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-----
Confidence 999999999999986543222222223456788999999998889999999999999999998 88887533211
Q ss_pred HHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 703 IGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.........+ .....+......+.+++.+||+.+|++||+++||++.|++.
T Consensus 349 -~~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 -EQFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred -HHHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111111 11122333456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=270.41 Aligned_cols=225 Identities=29% Similarity=0.411 Sum_probs=174.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
..|++.+.||+|+||.||++...+++.+|+|.+.... ....+|.+|++++++++|+|+++.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3678889999999999999988778899999886543 335679999999999999998721
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....++++.+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence 11245788899999999999999999998 99999999999999999999999999986543211 111
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....++..|+|||.+.++.++.++||||||+++|||++ |+.||..... ..... ....+ .....
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~---------~~~~~ 222 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVE-TINAG---------FRLYK 222 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHH-HHhCC---------CCCCC
Confidence 12234578999999998899999999999999999998 8888753221 11111 11111 01011
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
+......+.+++.+||+.+|++||++.|++++|.
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1223467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=269.48 Aligned_cols=222 Identities=24% Similarity=0.382 Sum_probs=175.0
Q ss_pred CcceeeeeccCCCcCeEEEEecc-cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|++|.||+++... ++.||+|++.... ....+.+.+|++++++++|+|++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58899999999999999998654 7889999986542 3445678999999999999998721
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 01235788899999999999999999999 99999999999999999999999999987643222
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......+++.|+|||++.+..++.++||||||++++||++|+.||.... ......... .+..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~-~~~~--------- 219 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRII-EGKL--------- 219 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHH-hcCC---------
Confidence 2233567889999999999999999999999999999999999975321 111111111 1111
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11233455678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=271.19 Aligned_cols=222 Identities=28% Similarity=0.392 Sum_probs=172.3
Q ss_pred eeeccCCCcCeEEEEecc--c--ccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCccccc------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN--G--QEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDSR------------------ 578 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~--g--~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~~------------------ 578 (1018)
++||+|++|.||+|.+.+ + ..||||.+..... ...+++.+|+.++++++|+||+...
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 478999999999998644 3 2589999987655 5667899999999999999987311
Q ss_pred -------CC--CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc-cc
Q 046791 579 -------RN--NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET-NT 648 (1018)
Q Consensus 579 -------~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~-~~ 648 (1018)
.. ..+++.....++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 11 35788999999999999999999998 9999999999999999999999999998765422211 11
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .......... .....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~---------~~~~~ 222 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEG---------ERLER 222 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcC---------CcCCC
Confidence 23456788999999999999999999999999999999 99997532211 1111111000 01111
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 2234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=272.20 Aligned_cols=229 Identities=21% Similarity=0.318 Sum_probs=176.9
Q ss_pred CCcceeeeeccCCCcCeEEEEeccc----ccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNG----QEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g----~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
++|.+.+.||+|+||.||+|...+. ..||||...... ....+.+.+|+.++++++|+|+++.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 4588889999999999999986442 468999887654 4456689999999999999998731
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 11235789999999999999999999998 99999999999999999999999999987643321
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
. ......++..|+|||.+....++.++||||||+++||+++ |..||....... . . .....+..
T Consensus 163 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~-~~~~~~~~-------- 226 (270)
T cd05056 163 Y-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---V---I-GRIENGER-------- 226 (270)
T ss_pred e-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---H---H-HHHHcCCc--------
Confidence 1 1112334568999999988889999999999999999996 999985332111 1 1 11111110
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
...+......+.+++.+|+..+|++||++.++++.|++..
T Consensus 227 -~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 227 -LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122334567888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=270.89 Aligned_cols=222 Identities=23% Similarity=0.335 Sum_probs=174.0
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
+|++.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++|+|++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999865 4889999998643 23445678899999999999998721
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.....++.|++.||.|||+++ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 12345788889999999999999999999 99999999999999999999999999986643221
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||..... ...... ...+... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~---------~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILK-VCQGSYK---------P 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHH-HhcCCCC---------C
Confidence 12235688899999999998999999999999999999999999853211 111111 1111111 1
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.+......+.+++.+||+.||++||++.||+..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122334567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=291.56 Aligned_cols=225 Identities=21% Similarity=0.273 Sum_probs=166.1
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
+|+++++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999865 47889999986542 2345678999999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC--
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS-- 644 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~-- 644 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 22346788888999999999999999999 99999999999999999999999999753311000
Q ss_pred -------------------------------------------cccceeeecccccCChhhhccCCCCccccchhHhHHH
Q 046791 645 -------------------------------------------ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLV 681 (1018)
Q Consensus 645 -------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl 681 (1018)
........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001234689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 046791 682 LEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPA---MPDVVS 758 (1018)
Q Consensus 682 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 758 (1018)
|||++|+.||...... .......... ..+.........+.+.+++.+++ .+|.+|++ +.|+++
T Consensus 239 ~elltG~~Pf~~~~~~------~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 239 YEMLVGQPPFLAQTPL------ETQMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHhCCCCCCCCCHH------HHHHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999998643211 1111111000 00010111122345566666665 49999997 777665
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=278.55 Aligned_cols=227 Identities=27% Similarity=0.399 Sum_probs=171.2
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cc--cceEEEeccc-ccccHHHHHHHHHHHHHh-cCCCccccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQ--EVAIKRLSRR-SGQGIVEFKNEAKLIAKL-QHTNLTDSR------------ 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nlv~~~------------ 578 (1018)
++|++.+.||+|+||.||+|+..+ +. .+|+|.+... ......++.+|+.++.++ +|+|+++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578889999999999999998653 44 4688877643 234456789999999999 899987310
Q ss_pred ------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCc
Q 046791 579 ------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 579 ------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
....+++.+++.++.||++||+|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 0124788899999999999999999998 9999999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 707 (1018)
||+|||++..... ........++..|+|||++.+..++.++||||||+++|||++ |..||...... .. .
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~----~ 233 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL----Y 233 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HH----H
Confidence 9999999864211 111111234567999999988889999999999999999998 99988532211 01 0
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.....+ .....+......+.+++.+||+.+|++||++.+++++|+...
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 234 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111110 011112223456789999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=281.56 Aligned_cols=215 Identities=26% Similarity=0.324 Sum_probs=167.9
Q ss_pred eeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+++... ++.||||++++.. ......+..|..++..+ +|+||+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999998764 7889999997542 33455678899999888 79998731
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTST 155 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcccc
Confidence 12346889999999999999999999998 999999999999999999999999998753221 122234
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... .......... ...+..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~i~~~~----------~~~~~~ 218 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQSILEDE----------VRYPRW 218 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCC----------CCCCCc
Confidence 57899999999999999999999999999999999999998532211 1111111110 112233
Q ss_pred HHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAM-----PDVVS 758 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 758 (1018)
....+.+++.+||+.||.+||++ .++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 45677899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=272.49 Aligned_cols=229 Identities=24% Similarity=0.367 Sum_probs=174.0
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc-----------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR----------- 578 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~----------- 578 (1018)
++.+++++.....||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++|+||++..
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4456667777789999999999999865 4778999998777666677899999999999999987310
Q ss_pred ----------------CCCCC--ChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-CCCceeeeecceeee
Q 046791 579 ----------------RNNRL--NWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARIF 639 (1018)
Q Consensus 579 ----------------~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~~~ 639 (1018)
....+ ++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 11334 67778889999999999999998 999999999999986 678999999999765
Q ss_pred cCCCCcccceeeecccccCChhhhccCC--CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMSGV--VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
..... ......++..|+|||++.+.. ++.++||||||+++|||++|+.|+........ ..+. ..
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~-----~~---- 225 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFK-----VG---- 225 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhh-----hh----
Confidence 42221 122345788999999987643 78999999999999999999999853221110 0000 00
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
-.......+....+.+.+++.+||+.+|++||++.||++
T Consensus 226 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 226 --MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000111223344567889999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=275.17 Aligned_cols=235 Identities=27% Similarity=0.354 Sum_probs=170.7
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|++|.||+|+.. +++.||||+++... ......+.+|+.++.+++|+|+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 58899999986542 2334678899999999999998721
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-- 155 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--
Confidence 11256889999999999999999999998 9999999999999999999999999998654321
Q ss_pred ccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH-------HHhhcCcchh
Q 046791 646 TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW-------QLWNEGKVLE 717 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~-------~~~~~~~~~~ 717 (1018)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ....... ..+.......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 11223456789999998875 457899999999999999999999986432110 0000000 0000000000
Q ss_pred hhhhhh----cC---CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIAL----EG---SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l----~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...... .. .......+++.+++.+||+.||++|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 00 001123456779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=274.76 Aligned_cols=219 Identities=25% Similarity=0.326 Sum_probs=165.1
Q ss_pred eccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc----------------------
Q 046791 524 LGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 577 (1018)
Q Consensus 524 lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~---------------------- 577 (1018)
||+|+||.||+++.. +|+.+|+|++.... ......+..|++++++++||||+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 48999999986432 2223456679999999999998721
Q ss_pred ------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceee
Q 046791 578 ------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651 (1018)
Q Consensus 578 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 651 (1018)
.....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 11234778888999999999999999998 9999999999999999999999999998764321 22235
Q ss_pred ecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHH
Q 046791 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNE 731 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 731 (1018)
.|+..|+|||++.+..++.++|||||||++|||++|+.||........ ......... .. ... ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~--------~~~-~~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL-ED--------EVK-FEHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh-cc--------ccc-cccccC
Confidence 688999999999998899999999999999999999999864322111 011101000 00 000 001123
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 732 VLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 732 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
..++.+++..||+.||++||+++|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 45678999999999999999998776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=274.24 Aligned_cols=222 Identities=26% Similarity=0.389 Sum_probs=175.5
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++|+|++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999875 48899999986553 3445678999999999999998731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||+++...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 11237899999999999999999999998 9999999999999999999999999998775332 122
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
....++..|+|||++.+..++.++||||||+++|||++|+.||...... .. ....... .....+
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~----~~~~~~~---------~~~~~~ 219 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RV----LFLIPKN---------NPPSLE 219 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HH----HHHhhhc---------CCCCCc
Confidence 3356788999999999988999999999999999999999998543211 00 0001111 011111
Q ss_pred hH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 729 PN-EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 729 ~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.. ....+.+++.+||+.+|++||+++++++
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 3456788999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=289.97 Aligned_cols=227 Identities=21% Similarity=0.274 Sum_probs=168.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|.+.+.||+|+||.||+++.. +++.||||++.... .....++.+|++++++++|+||+++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999865 58899999986532 3345678899999999999999731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 12356788888999999999999999999 999999999999999999999999999643210000
Q ss_pred ---------------------------------------------ccceeeecccccCChhhhccCCCCccccchhHhHH
Q 046791 646 ---------------------------------------------TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVL 680 (1018)
Q Consensus 646 ---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvv 680 (1018)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 00012468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCC---CCHHHHH
Q 046791 681 VLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDR---PAMPDVV 757 (1018)
Q Consensus 681 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~evl 757 (1018)
+|||++|+.||...... .. ............. .........+.+++.+|++ +|.+| |++.|++
T Consensus 238 l~elltG~~Pf~~~~~~---~~---~~~i~~~~~~~~~-------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 238 MFECLIGWPPFCSENSH---ET---YRKIINWRETLYF-------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhhcCCCCCCCCCHH---HH---HHHHHccCCccCC-------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 99999999998532211 00 0111100000000 0011234567788889997 66665 5998888
Q ss_pred HH
Q 046791 758 SM 759 (1018)
Q Consensus 758 ~~ 759 (1018)
+.
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=280.89 Aligned_cols=215 Identities=24% Similarity=0.353 Sum_probs=165.8
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCC-ccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTN-LTD--------------- 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~n-lv~--------------- 576 (1018)
+|+..+.||+|+||.||+++.. +++.||||++.... ....+.+..|..++..+.|++ ++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999865 58899999987542 334556888999998887644 431
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
+.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC--
Confidence 112356889999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .... .. ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~~i~-~~----------~~ 218 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELF---QSIM-EH----------NV 218 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-hC----------CC
Confidence 1223356899999999999999999999999999999999999998643211 011 1111 10 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAM 753 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 753 (1018)
..+......+.+++.+||+.+|.+|++.
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 2233345677889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=275.77 Aligned_cols=223 Identities=26% Similarity=0.332 Sum_probs=170.1
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.|+..+.||+|+||+||++... +++.||+|.+.... ......+.+|++++++++|+|++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677899999999999999865 58899999986542 2233457889999999999998721
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 11235889999999999999999999998 9999999999999999999999999997653221
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......|+..|+|||++.+..++.++||||||+++|||++|..||....... ............ .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~----------~ 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLET----------E 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhcc----------c
Confidence 1223468999999999999999999999999999999999999986432111 000000000000 0
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
...+......+.+++..|++.||++||+ +.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1122333456778999999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=271.96 Aligned_cols=229 Identities=25% Similarity=0.407 Sum_probs=174.8
Q ss_pred CCcceeeeeccCCCcCeEEEEecc----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.+|++.+.||+|+||.||+|+... +..+|+|.++... ....+.|.+|+.++.+++||||++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578889999999999999998642 3369999986543 3345679999999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 11245788899999999999999999998 9999999999999999999999999998764322
Q ss_pred Cccc-ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 644 SETN-TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 644 ~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.... .....++..|+|||.+.+..++.++||||||+++||+++ |..||...... ... ....++
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~----~~~~~~-------- 225 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVI----KAIEEG-------- 225 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHH----HHHhCC--------
Confidence 1111 111223467999999998899999999999999999886 99997533211 111 111111
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.....+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 -YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01111223456778999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=291.65 Aligned_cols=227 Identities=21% Similarity=0.267 Sum_probs=168.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.+|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++|+||++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999865 48899999986532 2345668899999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC--
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ-- 643 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~-- 643 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 22345788888999999999999999999 9999999999999999999999999975331000
Q ss_pred ---------------------------------------CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHH
Q 046791 644 ---------------------------------------SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEI 684 (1018)
Q Consensus 644 ---------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~el 684 (1018)
.........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00011234799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCC---CHHHHHHH
Q 046791 685 VSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRP---AMPDVVSM 759 (1018)
Q Consensus 685 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP---s~~evl~~ 759 (1018)
++|+.||....... .......... .+...........+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 238 l~G~~Pf~~~~~~~------~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAE------TQLKVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHH------HHHHHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999986432111 1011100000 0000111123445666777765 5999999 88888863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=271.43 Aligned_cols=223 Identities=25% Similarity=0.342 Sum_probs=165.6
Q ss_pred eeeccCCCcCeEEEEecc----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR------------------ 578 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~------------------ 578 (1018)
+.||+|+||.||+|...+ ...||||++.... ....+.+.+|+.+++.++|+|++...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 3579999986432 34456889999999999999987310
Q ss_pred ----------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc--c
Q 046791 579 ----------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE--T 646 (1018)
Q Consensus 579 ----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~--~ 646 (1018)
....+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||+++........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 1223566777889999999999999998 999999999999999999999999999765322111 1
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCC-CCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK-KNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......++..|+|||.+.+..++.++||||||+++|||++|. +|+.... ......... .+. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~-~~~---------~~ 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLL-QGR---------RL 221 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHh-cCC---------CC
Confidence 112234567899999999889999999999999999999964 4543211 111111111 110 00
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
..+...+..+.+++.+||+.+|++||++.||++.|++.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=272.15 Aligned_cols=224 Identities=25% Similarity=0.380 Sum_probs=168.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-----cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-----GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.+|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999865 48899999886432 2234568899999999999998621
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 12345778888899999999999999998 99999999999999999999999999976532
Q ss_pred CCC-cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 642 NQS-ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 642 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... ........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~-------- 224 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQ-------- 224 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcC--------
Confidence 111 1112234578899999999998899999999999999999999999853211 1111111000
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+....+.+.+++ +|+..+|++||+++||++
T Consensus 225 -~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 -PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 001122222234444555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=279.85 Aligned_cols=215 Identities=26% Similarity=0.359 Sum_probs=165.0
Q ss_pred eeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHH-hcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAK-LQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~-l~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+|+... ++.||||+++... ......+..|..++.. ++||||+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998764 7889999997642 2334557778888876 499998731
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++.++..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCT 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCceee
Confidence 12346888999999999999999999998 999999999999999999999999998753221 122334
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||..|+|||++.+..++.++|||||||++|||++|+.||...... .+ ....... ....+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~----~~~i~~~----------~~~~~~~ 218 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---EL----FQSIRMD----------NPCYPRW 218 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhC----------CCCCCcc
Confidence 67899999999999999999999999999999999999998542211 01 1111100 0112223
Q ss_pred HHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMP-DVVS 758 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~-evl~ 758 (1018)
....+.+++.+||+.||++||++. ++.+
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 345678899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=275.03 Aligned_cols=223 Identities=25% Similarity=0.329 Sum_probs=171.1
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.|+..+.||+|+||.||++... +++.||||.+.... ......+.+|+.++++++|++++..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999865 48899999986542 2223457889999999999998621
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 11235788899999999999999999998 9999999999999999999999999987653222
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ........ +. ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~---------~~-~~ 221 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLV---------KE-VQ 221 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhh---------hh-hh
Confidence 11234689999999999999999999999999999999999999864322110 00001000 00 01
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
...+......+.+++.+||+.||++||| +.|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1122233456788999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=273.95 Aligned_cols=222 Identities=26% Similarity=0.409 Sum_probs=173.5
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+|++..
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667789999999999999865 47889999986543 3445678999999999999998731
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06642 85 GGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--hhhh
Confidence 12345788999999999999999999998 9999999999999999999999999997654321 1222
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
...++..|+|||++.+..++.++||||||+++|||++|+.|+....... .. . ....+ .......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~---~-~~~~~---------~~~~~~~ 223 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VL---F-LIPKN---------SPPTLEG 223 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HH---h-hhhcC---------CCCCCCc
Confidence 3467889999999999899999999999999999999999975322111 00 0 00010 1111222
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.....+.+++.+||+.+|++||++.+|++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 345678899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=282.54 Aligned_cols=211 Identities=21% Similarity=0.278 Sum_probs=161.0
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHH-HHHHhcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAK-LIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nlv~~------------------- 577 (1018)
++||+|+||.||+|+.. +++.||+|++.+.. .....++..|.. +++.++|+||++.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 48899999986542 222344555554 6788999999832
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 155 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTST 155 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcccc
Confidence 12345778888999999999999999998 999999999999999999999999998753211 122334
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .... .... ... ....+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~-~~~i--------~~~--~~~~~~~ 218 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQM-YDNI--------LHK--PLQLPGG 218 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHH-HHHH--------hcC--CCCCCCC
Confidence 578999999999999999999999999999999999999985321 1111 1111 100 0123334
Q ss_pred HHHHHHHHHHhccccCCCCCCCHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMP 754 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~ 754 (1018)
....+.+++.+||+.+|.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 556788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=286.65 Aligned_cols=235 Identities=20% Similarity=0.241 Sum_probs=174.2
Q ss_pred HHHHHHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc------
Q 046791 508 FQTISAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------ 577 (1018)
Q Consensus 508 ~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------ 577 (1018)
+.++....++|++.+.||+|+||.||+++... ++.+|+|++.... ......+.+|+.+++.++||||++.
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 34455566899999999999999999998764 7889999986432 2334568899999999999998731
Q ss_pred -------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 -------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 12245778888999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCcccceeeecccccCChhhhccC----CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMSG----VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ............
T Consensus 192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~ 264 (371)
T cd05622 192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKN 264 (371)
T ss_pred cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC
Confidence 643221 122346799999999998753 378999999999999999999999863221 111111111111
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATD--RPAMPDVVSM 759 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 759 (1018)
. +.-.........+.+++..|++.++.+ ||++.||++.
T Consensus 265 ~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 S-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred c-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0 000111234566778889999844433 7889988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=273.75 Aligned_cols=235 Identities=23% Similarity=0.293 Sum_probs=171.0
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++|+|+++.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5888999999999999999875 58899999986542 2233567889999999999998720
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--C 155 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--C
Confidence 12456899999999999999999999998 99999999999999999999999999986543221 1
Q ss_pred ceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc------chhhhh
Q 046791 648 TNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK------VLELVD 720 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~~d 720 (1018)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ............... ..+..+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 1234568899999998764 4789999999999999999999886322111 111111111100000 000000
Q ss_pred hhhcC---------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEG---------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~---------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... ...+.....+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 011223467788999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=271.72 Aligned_cols=222 Identities=28% Similarity=0.413 Sum_probs=169.0
Q ss_pred eeeccCCCcCeEEEEecc-------cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc---------------
Q 046791 522 NKLGEGGFGPVYKGQLLN-------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR--------------- 578 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~--------------- 578 (1018)
+.||+|+||.||+|+..+ ++.+|||.+.... .....++.+|+.++++++|+||+...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886543 24466799999999999999987210
Q ss_pred ------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-----Cceeeeecc
Q 046791 579 ------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-----NPKISDFGM 635 (1018)
Q Consensus 579 ------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-----~~kL~DFGl 635 (1018)
....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 1233677888999999999999999998 99999999999999877 899999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
++...............++..|+|||++.++.++.++||||||+++|||++ |+.||..... ..... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------~~~~~-~~~~~- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------QEVLQ-HVTAG- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------HHHHH-HHhcC-
Confidence 986543222222223345678999999999999999999999999999998 9998753211 11100 11111
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
.....+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1112223345678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=276.28 Aligned_cols=225 Identities=24% Similarity=0.333 Sum_probs=176.7
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|.+.+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.+++.++|+|++..
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 367999999999999999999864 689999999976655566778999999999999998731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~ 172 (297)
T cd06656 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (297)
T ss_pred cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--Cc
Confidence 11345788899999999999999999998 99999999999999999999999999986543221 12
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .....+ ......+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~--------~~~~~~~ 238 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG--------TPELQNP 238 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC--------CCCCCCc
Confidence 23467889999999999999999999999999999999999985432211100 000000 0000112
Q ss_pred hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+.+++.+||+.+|++||++.+|++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 233456778999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=282.54 Aligned_cols=217 Identities=23% Similarity=0.268 Sum_probs=162.6
Q ss_pred eeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHH-HHHHHhcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEA-KLIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~-~~l~~l~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+++... ++.||+|++.... .....++..|. .+++.++|+||+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999998754 7789999986542 22233444444 45688999999831
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+.+..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTST 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCccc
Confidence 12345777888889999999999999999 999999999999999999999999999754221 122334
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .... ....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i---------~~~~--~~~~~~ 218 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNI---------LNKP--LQLKPN 218 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHH---------HhCC--cCCCCC
Confidence 67899999999999999999999999999999999999998532211 110111 1000 112234
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
....+.+++.+|++.+|.+||++.+.+..+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 456778899999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=277.43 Aligned_cols=224 Identities=23% Similarity=0.322 Sum_probs=176.4
Q ss_pred CCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.+|++.+.||.|++|.||+|.. .+++.||||.+........+.+.+|+.+++.++|+|++..
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999985 4588999999976655566788999999999999998731
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........ ...
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 173 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRS 173 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCC
Confidence 12345889999999999999999999999 99999999999999999999999999876543221 122
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
...++..|+|||.+.+..++.++|||||||++|||++|+.||....... ...... ..... .+ ..+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~-~~~~~-----~~--~~~~ 239 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIA-TNGTP-----EL--QNPE 239 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hcCCc-----cc--CCcc
Confidence 3467889999999999889999999999999999999999985432110 000000 00000 00 1122
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....+.+++.+||+.+|++||++.+|++
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 33456778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=271.69 Aligned_cols=225 Identities=26% Similarity=0.333 Sum_probs=162.2
Q ss_pred eeeccCCCcCeEEEEecc---cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN---GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR------------------- 578 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~------------------- 578 (1018)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++|+|+++..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998644 4568999886553 23345789999999999999987310
Q ss_pred ------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 579 ------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 579 ------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 1123455677789999999999999998 9999999999999999999999999987543322222
Q ss_pred cceeeecccccCChhhhccC-------CCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 647 NTNRVVGTYGYMSPEYAMSG-------VVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||....... .... .. .+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TV-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hh-hcccCCC
Confidence 22234567889999998642 35789999999999999996 999986432211 1100 01 1111111
Q ss_pred hhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 719 VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 719 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
.++.+ .....+.+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1123345677888998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=269.58 Aligned_cols=213 Identities=22% Similarity=0.311 Sum_probs=162.0
Q ss_pred eeeccCCCcCeEEEEecc-------------cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 522 NKLGEGGFGPVYKGQLLN-------------GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
+.||+|+||.||+|+... ...||+|.+..........|.+|+.++..++||||+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 22588998876555556678999999999999998731
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC-------ceeeeec
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-------PKISDFG 634 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~-------~kL~DFG 634 (1018)
.....+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 12345889999999999999999999998 999999999999987654 8999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhc-cCCCCccccchhHhHHHHHHH-hCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAM-SGVVSIKTDVFSFGVLVLEIV-SGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SlGvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
++..... .....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+....... ..... .
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~-~ 223 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFY-E 223 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHH-h
Confidence 9875421 12345778899999887 467899999999999999998 5777764321110 00000 1
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
+. . .........+.+|+.+||+.||.+||++.+|++.|+
T Consensus 224 ~~--------~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQ--------C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cC--------c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 10 0 011123456789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=278.68 Aligned_cols=225 Identities=25% Similarity=0.378 Sum_probs=184.8
Q ss_pred ceeeeeccCCCcCeEEEEecc---cc--cceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 519 SAVNKLGEGGFGPVYKGQLLN---GQ--EVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~~---g~--~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
...++||+|-||.||+|...+ |+ .||||..+.. .....+.|..|+.+|++++||||+++
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL 471 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMEL 471 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEec
Confidence 345789999999999998543 33 5899998774 45557789999999999999999842
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.+...|+......++.||..||+|||+.. +|||||..+|||+.....+||+|||+++.+..+.. .
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y-Y 547 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY-Y 547 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccch-h
Confidence 23556888889999999999999999998 99999999999999999999999999998864433 3
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......-.+.|||||.+.-+.++.++|||.|||++|||+. |.+||...... ++.-.++..-+.
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~iEnGeRl 611 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHIENGERL 611 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEecCCCCC
Confidence 3334455678999999999999999999999999999986 88998654332 223333333444
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
..|+.+++.+..|+.+||..+|.+||++.||...|+..
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 67788899999999999999999999999999888653
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=268.45 Aligned_cols=222 Identities=27% Similarity=0.370 Sum_probs=175.4
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
++|++.+.||+|+||.||+|+..+ ++.+|+|.+..... .+++.+|++++++++|+|++..
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999765 78999999865533 6789999999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 12456889999999999999999999998 99999999999999999999999999987643221 2
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+......... ...... ..+ ....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~-----~~~--~~~~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNK-----PPP--TLSD 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccC-----CCC--CCCc
Confidence 22345788999999999999999999999999999999999998643221100 000000 000 0011
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+......+.+++.+||+.+|++||++.||++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 2223457888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=287.03 Aligned_cols=216 Identities=26% Similarity=0.390 Sum_probs=168.1
Q ss_pred eeeccCCCcCeEEEEecc-cccce---EEEecc-cccccHHHHHHHHHHHHHhcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN-GQEVA---IKRLSR-RSGQGIVEFKNEAKLIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-g~~vA---vK~l~~-~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------- 577 (1018)
.+||+|+|-+||+|.+.. |.+|| ||.-.. ......++|..|+.+|+.|+|+||++.
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 589999999999998754 77776 332211 134456889999999999999999841
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-CCCceeeeecceeeecCCCCccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.+.+.++.+....|++||++||.|||++. +||||||||.+||+|+. .|.+||+|+|||..... ..
T Consensus 126 TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~----s~ 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK----SH 200 (632)
T ss_pred cCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc----cc
Confidence 23456788889999999999999999987 78999999999999984 58899999999998642 23
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
.....||+.|||||++. ..|.+..||||||++|+||+|+..||..-.. ...+++..-.|...+.+.+.
T Consensus 201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~kV----- 268 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSKV----- 268 (632)
T ss_pred cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhcc-----
Confidence 33489999999999887 7899999999999999999999999853221 12223333333333222211
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.-+++.++|.+||.. ..+|||+.|+|+
T Consensus 269 ---~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 ---KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 124566888999999 999999999987
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=279.26 Aligned_cols=227 Identities=25% Similarity=0.335 Sum_probs=176.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecccccceEEEecc--cccccHHHHHHHHHHHHHhc-CCCccccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSR--RSGQGIVEFKNEAKLIAKLQ-HTNLTDSR------------ 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~-H~nlv~~~------------ 578 (1018)
....|+++++||+||.+.||++...+.+.+|+|++.. ...+...-|.+|+.+|.+|+ |.+|+++.
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4467899999999999999999998888899987744 34566778999999999995 66766311
Q ss_pred -------------C-CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 579 -------------R-NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 579 -------------~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
. ...++.-.+..+..||+.++.++|+++ |||.||||.|+|+- .|.+||+|||+|..+..+..
T Consensus 439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 1 112222267788999999999999999 99999999999985 46899999999999887766
Q ss_pred cccceeeecccccCChhhhccC-----------CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSG-----------VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG 713 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 713 (1018)
.......+||+.||+||.+... ..+.++||||||||||+|+.|+.||..+.. . + .
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~--~-------a 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q--I-------A 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H--H-------H
Confidence 6666778999999999998532 267899999999999999999999863221 1 1 1
Q ss_pred cchhhhhhhhcCCCChH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 KVLELVDIALEGSFSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
++..+.|+...-.++.. ...++++++..||+.||.+||++.|+++
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 23344454332223221 1223899999999999999999999987
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=274.26 Aligned_cols=222 Identities=23% Similarity=0.335 Sum_probs=171.6
Q ss_pred cceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-------------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------- 577 (1018)
|++.+.||+|+||.||+|+... +..+|+|.+........+.+.+|+++++.++|+|++..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 6777899999999999998764 77889999876666667789999999999999998731
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 12356889999999999999999999998 9999999999999999999999999987653221 1223
Q ss_pred eeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 650 RVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
...++..|+|||++. +..++.++|||||||++|||++|+.||...... ....... .......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~-~~~~~~~------ 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSEPPTL------ 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHh-hcCCCCC------
Confidence 356888999999984 355788999999999999999999998543211 1111111 0000000
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+......+.+++.+||+.+|.+||++.++++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112223457789999999999999999998875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=269.97 Aligned_cols=223 Identities=26% Similarity=0.387 Sum_probs=172.3
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccccc---------cHHHHHHHHHHHHHhcCCCcccc---------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ---------GIVEFKNEAKLIAKLQHTNLTDS--------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~---------~~~~f~~E~~~l~~l~H~nlv~~--------- 577 (1018)
+|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++|+||++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999865 4789999988654321 23568899999999999998731
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 12345788889999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcc----cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 641 LNQSET----NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 641 ~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-------- 223 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFK-------- 223 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHH--------
Confidence 221111 112345788999999999989999999999999999999999998632110 00000
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... ......+......+.+++.+||+.+|.+||++.||++
T Consensus 224 -~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 -IGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -Hhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 1111223344567888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=254.29 Aligned_cols=222 Identities=24% Similarity=0.351 Sum_probs=173.0
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc----cc----cHHHHHHHHHHHHHh-cCCCcccc----
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS----GQ----GIVEFKNEAKLIAKL-QHTNLTDS---- 577 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~----~~----~~~~f~~E~~~l~~l-~H~nlv~~---- 577 (1018)
...-++|...+.||.|..++|-+...+ +|++.|+|++.... .. -.++-..|+.+|+++ .||+|+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567888889999999999888654 58899999885432 11 233457799999998 79999842
Q ss_pred ----------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecc
Q 046791 578 ----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM 635 (1018)
Q Consensus 578 ----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGl 635 (1018)
...-.++++...+|++|+.+|+.|||..+ ||||||||+|||+|++.++||+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 22345889999999999999999999999 99999999999999999999999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhcc------CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMS------GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
+..+.... .....+||++|+|||.+.- ..|+...|+|++|||||.|+.|.+||- -++.
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw-------------HRkQ 233 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW-------------HRKQ 233 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh-------------HHHH
Confidence 99876433 3445799999999998863 458899999999999999999999972 1100
Q ss_pred hhcCcchhhhhhhhcCCC------ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 710 WNEGKVLELVDIALEGSF------SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.-++...+.+.+ -.+......+|+.+||+.||.+|.|++|+++
T Consensus 234 ------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 234 ------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 011111222221 1234567789999999999999999999987
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=272.58 Aligned_cols=234 Identities=23% Similarity=0.326 Sum_probs=177.8
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHh-cCCCccccc-----
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDSR----- 578 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~~----- 578 (1018)
+.++.+..+.++|++.+.||+|+||.||+++.. +++.+|+|.+.... ....++.+|+.++.++ +|+|++...
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 556777888999999999999999999999875 47899999886532 2346788999999999 699987311
Q ss_pred ------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCc
Q 046791 579 ------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 579 ------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 1234667778889999999999999998 9999999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhcc-----CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS-----GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~ 703 (1018)
||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.|+.......
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----- 236 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----- 236 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----
Confidence 999999998764322 12223568899999998753 457899999999999999999999985432111
Q ss_pred HHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 704 GYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 704 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.... ......... ..+......+.+++.+||+.+|++||++.||++.
T Consensus 237 -~~~~-~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 -ALFK-IPRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -HHhh-ccccCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 000000000 0111223568889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=281.92 Aligned_cols=213 Identities=24% Similarity=0.331 Sum_probs=158.5
Q ss_pred eccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHh---cCCCcccc-------------------
Q 046791 524 LGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL---QHTNLTDS------------------- 577 (1018)
Q Consensus 524 lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l---~H~nlv~~------------------- 577 (1018)
||+|+||+||+|+.. +++.||||++.... ......+..|..++.++ +||||+..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 48899999986532 22334456677777665 69998631
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~ 155 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNT 155 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccC
Confidence 22456888999999999999999999999 9999999999999999999999999987532211 22234
Q ss_pred eecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC-
Q 046791 651 VVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS- 728 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~- 728 (1018)
..||..|+|||++.+. .++.++|||||||++|||++|+.||...... . .......+.. ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~-~~~~i~~~~~----------~~~~ 218 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------Q-MYRNIAFGKV----------RFPK 218 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------H-HHHHHHcCCC----------CCCC
Confidence 6789999999998764 5899999999999999999999998532211 1 1111111110 011
Q ss_pred hHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPA----MPDVVS 758 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs----~~evl~ 758 (1018)
......+.+++.+||+.||++||+ +.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 123456778999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=267.50 Aligned_cols=222 Identities=25% Similarity=0.373 Sum_probs=175.3
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+++.+|++++++++|+|+++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 5788999998653 23445678899999999999998731
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHh-----cCCCCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLH-----KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH-----~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
.....+++..++.++.||++||.||| +.+ ++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 01346788899999999999999999 666 999999999999999999999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..+ ......+
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~----~~~~~~~--- 225 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQL----ASKIKEG--- 225 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHH----HHHHhcC---
Confidence 876533221 2235688999999999998899999999999999999999999864321 011 1111111
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.....+......+.+++.+|++.+|++||++.+|++.
T Consensus 226 ------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 ------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112334455788899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=274.09 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=173.9
Q ss_pred CcceeeeeccCCCcCeEEEEecc---cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccccc------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN---GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDSR------------ 578 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~~------------ 578 (1018)
+|++.++||+|+||.||+|.... ++.||||.+.... ....+.+.+|+.++.+++|||++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48889999999999999998654 7899999997633 34456788999999999999987310
Q ss_pred --------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC----CCCceeeeec
Q 046791 579 --------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD----QMNPKISDFG 634 (1018)
Q Consensus 579 --------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~----~~~~kL~DFG 634 (1018)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 1125778888999999999999999999 999999999999999 8999999999
Q ss_pred ceeeecCCCC-cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCch------HHHH
Q 046791 635 MARIFGLNQS-ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNL------IGYA 706 (1018)
Q Consensus 635 la~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l------~~~~ 706 (1018)
++........ ........++..|+|||.+.+ ..++.++||||||++++||++|+.||........... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987643322 122234567889999998876 4588999999999999999999999875543321000 0000
Q ss_pred HHHhhc------------CcchhhhhhhhcCCCC-----------hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 707 WQLWNE------------GKVLELVDIALEGSFS-----------PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 707 ~~~~~~------------~~~~~~~d~~l~~~~~-----------~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+.. .......+......++ .....++.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 0000000000011111 023456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=272.69 Aligned_cols=235 Identities=23% Similarity=0.301 Sum_probs=172.9
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
++|++.++||+|+||.||+|...+ ++.||+|++..... ...+.+.+|++++++++|+|+++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 478899999999999999999764 88999999865432 234678899999999999998721
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.++..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 155 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence 12335889999999999999999999998 99999999999999999999999999987643322
Q ss_pred cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc--Ccchhh-----
Q 046791 647 NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE--GKVLEL----- 718 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~----- 718 (1018)
......++..|+|||++.+ ..++.++||||||+++|||++|++||...... ............ ......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI---DQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHHHhCCCchhhHHHhccch
Confidence 1223457889999999875 45788999999999999999999888533211 111111100000 000000
Q ss_pred -hhhhhcC---------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 719 -VDIALEG---------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 719 -~d~~l~~---------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+..... ...+.....+.+++.+||+.+|++||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 011233567889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=265.69 Aligned_cols=221 Identities=22% Similarity=0.362 Sum_probs=173.2
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|+||.||+++.. +++.||+|++... ......++.+|+.++++++|+|++..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999865 5889999998643 23345679999999999999998721
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++.+++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 11224678889999999999999999998 99999999999999999999999999986543221
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......++..|+|||++.+..++.++||||||++++||++|+.|+.... ......... .+.. .
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~-~~~~---------~ 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKII-RGSY---------P 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHh-cCCC---------C
Confidence 1223457889999999999899999999999999999999999975321 111111111 1110 1
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+......+.+++.+||+.+|++||++.+|++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 122334567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=277.35 Aligned_cols=233 Identities=24% Similarity=0.372 Sum_probs=186.4
Q ss_pred eHHHHHHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc-------
Q 046791 507 DFQTISAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR------- 578 (1018)
Q Consensus 507 ~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~------- 578 (1018)
+.+|+++. +....++||-|-||.||.|.++. .-.||||.++.. .-..++|+.|+.+|+.++|||||++.
T Consensus 260 DkWEmeRt--dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccch--heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 34444433 45566899999999999999876 568999999654 55688999999999999999998421
Q ss_pred ---------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 579 ---------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 579 ---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
.+..++.-..+.++.||+.||.||..++ +|||||..+|+|+.++..+||+|||+++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 2334566677889999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
++..+...... ...-.+.|.|||-+....++.|+|||+|||+||||.| |..|+...+ -.++.
T Consensus 414 lMtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----------------lSqVY 476 (1157)
T KOG4278|consen 414 LMTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVY 476 (1157)
T ss_pred hhcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----------------HHHHH
Confidence 88543221111 1233568999999999999999999999999999998 666664322 11234
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
++++...+.+.+..+++.+.+|++.||+.+|.+||+++||.+.+|.
T Consensus 477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 4555555566777888999999999999999999999999998874
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=269.54 Aligned_cols=220 Identities=26% Similarity=0.398 Sum_probs=165.8
Q ss_pred eeeccCCCcCeEEEEecc-cc--cceEEEecccc-cccHHHHHHHHHHHHHh-cCCCccccc------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN-GQ--EVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSR------------------ 578 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~------------------ 578 (1018)
+.||+|+||.||+|++.+ +. .+|+|.++... ....+.+.+|++++.++ +|||+++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 43 47889887543 34456789999999999 899987310
Q ss_pred ------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeec
Q 046791 579 ------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 634 (1018)
Q Consensus 579 ------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFG 634 (1018)
....+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 0124778899999999999999999998 9999999999999999999999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcC
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEG 713 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 713 (1018)
++..... .........+..|+|||++....++.++||||||+++|||++ |..||...... . .......+
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~-~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E-LYEKLPQG 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------H-HHHHHhCC
Confidence 9863221 111111233567999999988899999999999999999997 99998532211 0 01111111
Q ss_pred cchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 714 KVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 714 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.....+......+.+++.+|++.+|.+||++.++++.|++.
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 ---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11111223345678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=272.54 Aligned_cols=224 Identities=22% Similarity=0.331 Sum_probs=174.4
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
+.|++.++||+|+||.||+|+... ++.+|+|.+........+++.+|+.++++++|+|++..
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 578899999999999999998754 88999999987766667889999999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++...... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence 11345789999999999999999999998 999999999999999999999999998764321 112
Q ss_pred ceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 648 TNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.....++..|+|||++. ...++.++||||||+++|||++|+.||...... ....... .... +.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~~-----~~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSEP-----PT 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHh-cCCC-----cc
Confidence 23456788999999884 345788999999999999999999998543211 1111111 1100 00
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+......+.+++.+||+.+|++||++.+|++
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 --LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0112233456788999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=275.52 Aligned_cols=234 Identities=22% Similarity=0.290 Sum_probs=172.9
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|++++.+++|+||+..
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999865 47889999886542 2334568899999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.|+++||.|||+ .+ ++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence 123567888999999999999999997 46 999999999999999999999999998754321
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc--------------
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE-------------- 712 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-------------- 712 (1018)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCC
Confidence 1223568889999999988889999999999999999999999985332111 00000000000
Q ss_pred ------CcchhhhhhhhcC---CCC-hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 713 ------GKVLELVDIALEG---SFS-PNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 713 ------~~~~~~~d~~l~~---~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
....+..+..... ..+ ......+.+++.+||+.+|++||++.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111111111 000 1133568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=273.69 Aligned_cols=235 Identities=24% Similarity=0.337 Sum_probs=179.7
Q ss_pred cceeHHHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc----
Q 046791 504 EIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS---- 577 (1018)
Q Consensus 504 ~~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~---- 577 (1018)
..+.+.++..++++|++.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|+|+++.
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 34666778888999999999999999999999875 58899999986542 2346678899999999 89998731
Q ss_pred -------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC
Q 046791 578 -------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM 626 (1018)
Q Consensus 578 -------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~ 626 (1018)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCC
Confidence 01345788889999999999999999998 99999999999999999
Q ss_pred CceeeeecceeeecCCCCcccceeeecccccCChhhhccC-----CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCc
Q 046791 627 NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG-----VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLN 701 (1018)
Q Consensus 627 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~ 701 (1018)
.+||+|||++........ ......++..|+|||.+... .++.++|||||||++|||++|+.||......
T Consensus 166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---- 239 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---- 239 (291)
T ss_pred CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH----
Confidence 999999999886542221 11234678899999998643 3689999999999999999999998532211
Q ss_pred hHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 702 LIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 702 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... ........+ ..+......+.+++.+|++.+|++||++.|+++
T Consensus 240 --~~~~~-~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 --KTLFK-IPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HHHHH-HhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00111 111111000 112233456889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=266.24 Aligned_cols=226 Identities=21% Similarity=0.323 Sum_probs=176.7
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|+.++++++|+|++..
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999875 477899999977665667889999999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 11257889999999999999999999998 9999999999999999999999999987654221 11
Q ss_pred ceeeecccccCChhhhccC---CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 648 TNRVVGTYGYMSPEYAMSG---VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~---~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... ...... .... ....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~~~~~~-~~~~---~~~~-- 225 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------ALFLIS-KSNF---PPPK-- 225 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hccC---CCcc--
Confidence 2235678899999999876 88999999999999999999999985432110 000000 0000 0000
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..........+.+++.+||+.+|++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112334567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=301.40 Aligned_cols=228 Identities=23% Similarity=0.330 Sum_probs=172.4
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCccccc----------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDSR---------- 578 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~~---------- 578 (1018)
....++|.+.++||+|+||.||+++... ++.||+|.+... .......|..|+.++.+|+||||+.+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3455789999999999999999998754 778999988653 233456789999999999999987310
Q ss_pred ----------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCC----CcEEecccCCCcEEEcC--------
Q 046791 579 ----------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSR----LRVIHRDLKASNILLDD-------- 624 (1018)
Q Consensus 579 ----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~----~~ivH~Dlkp~NILld~-------- 624 (1018)
....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 12458889999999999999999998542 34999999999999964
Q ss_pred ---------CCCceeeeecceeeecCCCCcccceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCCCC
Q 046791 625 ---------QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNNGC 693 (1018)
Q Consensus 625 ---------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~ 693 (1018)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2348999999998654221 2234578999999999864 4588999999999999999999999853
Q ss_pred CCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 694 YRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 694 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... ... ....+..+. . .........+.+|+..||+.+|.+||++.|++.
T Consensus 246 ~~~-----~~q-li~~lk~~p-------~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANN-----FSQ-LISELKRGP-------D---LPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCc-----HHH-HHHHHhcCC-------C---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 221 111 111111110 0 001123467889999999999999999999984
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=265.07 Aligned_cols=223 Identities=33% Similarity=0.482 Sum_probs=172.2
Q ss_pred cceeeeeccCCCcCeEEEEecc-----cccceEEEecccccc-cHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLN-----GQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
+.+.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|+.++.+++|+|++..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998754 378999999765433 56789999999999999998731
Q ss_pred ------------cCCCC--CChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 ------------RRNNR--LNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 ------------~~~~~--l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
..... +++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 11122 889999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
..... ...++..|+|||.+.+..++.++||||||++++||++ |+.|+..... ... ......+..
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~-~~~~~~~~~------- 222 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEV-LEYLKKGYR------- 222 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHH-HHHHhcCCC-------
Confidence 21111 2336789999999988899999999999999999998 7777653211 111 111111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
...+.....++.+++.+|++.+|++|||+.|++++|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112223456788899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=271.91 Aligned_cols=236 Identities=25% Similarity=0.310 Sum_probs=173.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+|++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47889999999999999999876 48899999986542 2234568899999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 12346899999999999999999999998 99999999999999999999999999987643321
Q ss_pred cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH----------HHhhcCcc
Q 046791 647 NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW----------QLWNEGKV 715 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~----------~~~~~~~~ 715 (1018)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +..... ..+.....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChHHhhhcccccc
Confidence 1223457789999999876 5678999999999999999999999864332111 000000 00000000
Q ss_pred -hhhhhhhhcCCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 -LELVDIALEGSFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 -~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....+......+ +.....+.+++.+||+.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000000 112466789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=267.67 Aligned_cols=224 Identities=25% Similarity=0.378 Sum_probs=171.0
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc-----cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS-----GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.+|++.+.||+|+||.||+|+..+ ++.||||.+.... ....+.+.+|+.++++++|+||+..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478899999999999999998754 8899999885321 2234578899999999999998731
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++.....++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 11235677888999999999999999999 99999999999999999999999999876532
Q ss_pred CC-CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 642 NQ-SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 642 ~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.. .........++..|+|||.+.+..++.++||||||+++|||++|+.||..... . ...... ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~-~~~~~~---------~~ 223 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----M-AAIFKI---------AT 223 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----H-HHHHHH---------hc
Confidence 11 11122234688899999999988899999999999999999999999853211 0 000111 00
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.......+......+.+++.+|+. +|++||+++||++
T Consensus 224 ~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011122344455677788889985 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=270.07 Aligned_cols=226 Identities=22% Similarity=0.354 Sum_probs=172.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
++|.+.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++|+|++..
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57888899999999999999865 488999999876655555678899999999999998731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...... ....
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~ 163 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKR 163 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--cccc
Confidence 12456889999999999999999999999 999999999999999999999999999765422 1122
Q ss_pred eeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 649 NRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
....|+..|+|||++. ...++.++|||||||++|||++|+.|+........ ..... .... ..+....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~-~~~~---~~~~~~~ 233 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMT-KSNF---QPPKLKD 233 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhh-ccCC---CCCcccc
Confidence 3457889999999975 45688999999999999999999999743221110 00000 0000 0000000
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.......+.+++.+|++.+|++||++++|++
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0112345778999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=273.60 Aligned_cols=217 Identities=30% Similarity=0.428 Sum_probs=174.7
Q ss_pred cceeeeeccCCCcCeEEEEec-ccccceEEEeccccccc---HHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQG---IVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~---~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
|.-++.||.|+||.||-++.. +.+.||||+++....+. ..++..|++.|.+++|||+++.
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 566789999999999999864 57789999997664443 4568999999999999999842
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
...++|.+.++..|+.+.++||+|||+++ .||||||+.||||.+.|.+||+|||.|.... .
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------P 178 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA------P 178 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC------c
Confidence 12567888999999999999999999999 9999999999999999999999999998653 4
Q ss_pred ceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 648 TNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.+.++||+.|||||++. .+.|+-|+||||||++..||.-.++|.-.+. ...-.+....+. .|.+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALYHIAQNe------sPtL- 245 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNE------SPTL- 245 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHHHHHhcC------CCCC-
Confidence 45689999999999986 4889999999999999999999999853221 111111111110 0111
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+-...+..++-.||+.-|.+|||.+++++
T Consensus 246 --qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 --QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 13455677889999999999999999998876
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=269.86 Aligned_cols=227 Identities=25% Similarity=0.362 Sum_probs=174.4
Q ss_pred CCcceeeeeccCCCcCeEEEEecc------cccceEEEecccccc-cHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
++|++.+.||+|+||.||+|+... .+.||+|.+...... ...++.+|++++++++|+||+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578889999999999999998642 457999988655433 45789999999999999998721
Q ss_pred ---------------cCCC---------CCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeee
Q 046791 578 ---------------RRNN---------RLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633 (1018)
Q Consensus 578 ---------------~~~~---------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DF 633 (1018)
.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 1112 5889999999999999999999999 999999999999999999999999
Q ss_pred cceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 634 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
|++...... .........++..|+|||.+.+..++.++||||||+++|||++ |..||...... .. ......
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~----~~~~~~ 233 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EV----LNRLQA 233 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HH----HHHHHc
Confidence 998754321 1122223456778999999998889999999999999999999 77787432211 01 111111
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
+.. ....+......+.+++.+||+.+|++||++.|++++|+
T Consensus 234 ~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111 11112234467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=280.04 Aligned_cols=241 Identities=22% Similarity=0.302 Sum_probs=178.0
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCccccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDSR------------ 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~~------------ 578 (1018)
+.++|.+.+.||+|+||.||+++.. +++.||||.+... ......++.+|+.++++++|+||++..
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3568999999999999999999864 5889999998653 233455778999999999999997321
Q ss_pred ------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 579 ------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 579 ------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 2356789999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh---------
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW--------- 710 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------- 710 (1018)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 160 EKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEEDLG 234 (337)
T ss_pred CCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChHHhh
Confidence 321 11223467889999998875 56899999999999999999999998643211 0111111100
Q ss_pred --hcCcchhhhhhhhcC------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhc
Q 046791 711 --NEGKVLELVDIALEG------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM--LAN 762 (1018)
Q Consensus 711 --~~~~~~~~~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--Le~ 762 (1018)
........+...... ...+.....+.+++.+||+.+|++||+++|+++. ++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000111111000000 0112345678899999999999999999999985 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=269.29 Aligned_cols=213 Identities=22% Similarity=0.330 Sum_probs=162.8
Q ss_pred eeeccCCCcCeEEEEecc--------cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 522 NKLGEGGFGPVYKGQLLN--------GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+.||+|+||.||+|.... ..+||+|.+........+++.+|+.+++.++|+|++..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997532 23589998876555556789999999999999998721
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC--------ceeeeecceee
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN--------PKISDFGMARI 638 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~--------~kL~DFGla~~ 638 (1018)
.....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 11235788999999999999999999998 999999999999987765 58999998865
Q ss_pred ecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCC-CCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGK-KNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...... .. ....
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~-~~~~------ 218 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KK-LQFY------ 218 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HH-HHHH------
Confidence 421 123467889999999986 45899999999999999999995 444321110 00 0000
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
.. ....+......+.+++.+||+.+|++|||+++|++.|+
T Consensus 219 ---~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 ---ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 11223334467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-29 Score=284.71 Aligned_cols=175 Identities=25% Similarity=0.373 Sum_probs=146.7
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++.+++|+||++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 48899999996532 3345678899999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC-
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS- 644 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~- 644 (1018)
.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 23456889999999999999999999999 99999999999999999999999999875432110
Q ss_pred --------------------------------cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCC
Q 046791 645 --------------------------------ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNG 692 (1018)
Q Consensus 645 --------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~ 692 (1018)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 001123578999999999999999999999999999999999999986
Q ss_pred C
Q 046791 693 C 693 (1018)
Q Consensus 693 ~ 693 (1018)
.
T Consensus 238 ~ 238 (360)
T cd05627 238 S 238 (360)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=269.92 Aligned_cols=225 Identities=21% Similarity=0.282 Sum_probs=159.3
Q ss_pred eeeccCCCcCeEEEEecc---cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN---GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR------------------- 578 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~------------------- 578 (1018)
+.||+|+||.||+|+..+ ...+|+|.+.... .....+|.+|+.+++.++|+||++..
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997644 3467888775443 23345789999999999999997310
Q ss_pred ------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 579 ------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 579 ------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 0122356677899999999999999998 9999999999999999999999999987543222111
Q ss_pred cceeeecccccCChhhhcc-------CCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 647 NTNRVVGTYGYMSPEYAMS-------GVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
......++..|+|||++.. ..++.++||||||+++|||++ |..||...... .......... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-CccC
Confidence 1223345678999998753 456889999999999999999 77787533211 0111111111 1111
Q ss_pred hhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 719 VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 719 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
.++ ..+......+.+++..|+ .||++||+++||+++|.
T Consensus 231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 112233455667778888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=292.71 Aligned_cols=241 Identities=20% Similarity=0.278 Sum_probs=163.0
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEecc--cccceEE------------------EecccccccHHHHHHHHHHHHHhcC
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLLN--GQEVAIK------------------RLSRRSGQGIVEFKNEAKLIAKLQH 571 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~~--g~~vAvK------------------~l~~~~~~~~~~f~~E~~~l~~l~H 571 (1018)
....++|++++.||+|+||+||++.... +..+++| .+. ........+.+|+.++++++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 3456799999999999999999987543 2222222 111 112234568899999999999
Q ss_pred CCcccccC------------------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEE
Q 046791 572 TNLTDSRR------------------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNIL 621 (1018)
Q Consensus 572 ~nlv~~~~------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NIL 621 (1018)
+||+++.. .......+...|+.||+.||.|||+++ |+||||||+|||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99984210 111224556789999999999999999 999999999999
Q ss_pred EcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCC-CCCCCCCCCC
Q 046791 622 LDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKN-NGCYRTDHPL 700 (1018)
Q Consensus 622 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p-~~~~~~~~~~ 700 (1018)
++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999987643222 122235789999999999999999999999999999999998854 3222111111
Q ss_pred chHHHHHHHhh--cCc-------chhhhhhhhcCC---CCh------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 701 NLIGYAWQLWN--EGK-------VLELVDIALEGS---FSP------NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 701 ~l~~~~~~~~~--~~~-------~~~~~d~~l~~~---~~~------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+.... ..+. ... ..+.++...... ..+ .....+.+++.+||+.||++|||+.|+++
T Consensus 379 ~~~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111110 0000 000 000000000000 000 11234567788999999999999999987
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=270.91 Aligned_cols=238 Identities=23% Similarity=0.297 Sum_probs=172.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++|+||+..
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999865 588999999865432 233467899999999999998721
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+.+..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 11234677888899999999999999998 99999999999999999999999999976432211
Q ss_pred ccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc---------c
Q 046791 646 TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK---------V 715 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~ 715 (1018)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .......+..+.... .
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1223456889999999876 45788999999999999999999998643321 111111111110000 0
Q ss_pred hhhhhhhhcCCC---------ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 LELVDIALEGSF---------SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 ~~~~d~~l~~~~---------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
............ .......+.+++.+|++.||.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 0012456778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=263.79 Aligned_cols=223 Identities=24% Similarity=0.357 Sum_probs=175.2
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|+..+.||+|+||.||.++.. +++.+++|.+... ......++.+|+.++++++|+|++..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999999854 4888999988654 34456678999999999999998721
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++.++..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 11245788899999999999999999998 99999999999999999999999999987643321
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....... ..+...
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~--------- 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKI-VQGNYT--------- 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH-HcCCCC---------
Confidence 22345688999999999888899999999999999999999999853221 1111111 111110
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
..+......+.+++.+||+.+|++||++.++++.+
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123356788899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=269.87 Aligned_cols=235 Identities=23% Similarity=0.288 Sum_probs=172.3
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccccc-----cHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ-----GIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
+|++.+.||+|+||.||+|... +++.||||.+...... ....+..|++++++++|+|++..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999865 5889999999765322 23457889999999999998731
Q ss_pred ------------cCCC-CCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 ------------RRNN-RLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 ------------~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.... .+++..+..++.||++||.|||+++ |+|+||||+|||++.++.+||+|||++........
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 1222 6899999999999999999999999 99999999999999999999999999987643221
Q ss_pred cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC---------c
Q 046791 645 ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG---------K 714 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------~ 714 (1018)
......++..|+|||.+.+ ..++.++||||||+++|||++|.++|...... ............. .
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 158 --KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred --cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhhccc
Confidence 1222356778999998865 56789999999999999999998776532211 1111111110000 0
Q ss_pred chhhhhhhhcCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 715 VLELVDIALEGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 715 ~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
............. .......+.+++.+||+.+|++|||+.||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000011 12235678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=268.91 Aligned_cols=225 Identities=24% Similarity=0.362 Sum_probs=172.9
Q ss_pred CcceeeeeccCCCcCeEEEEecccccceEEEecccc------cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS------GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
+|.+.+.||+|+||.||+|...+++.+|||.+.... ......+.+|++++++++|+||+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886432 1223568899999999999998721
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 12346788899999999999999999998 99999999999999999999999999876432111
Q ss_pred ----cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 645 ----ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 645 ----~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
........++..|+|||++.+..++.++||||||+++|||++|+.||....... .. ...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~-~~~~~~---~---- 224 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AM-FYIGAH---R---- 224 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HH-HHhhhc---c----
Confidence 111223568889999999999889999999999999999999999985332110 00 000000 0
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+......+.+++.+||+.+|++||++.|+++
T Consensus 225 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 -GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011123334567789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=271.37 Aligned_cols=230 Identities=23% Similarity=0.334 Sum_probs=175.5
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.+.||+|+||+||+++.. +++.||+|++.... ....+++.+|++++..++|+||+..
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999865 48889999886543 3345779999999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
...+.+++..+..++.+++.||.|||+ ++ ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---- 157 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---- 157 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence 123467888999999999999999997 46 999999999999999999999999998654221
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc--
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE-- 724 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-- 724 (1018)
......++..|+|||++.+..++.++|||||||++|||++|+.||............ ...+.+.+.....
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 229 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD--------PMGILDLLQQIVQEP 229 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh--------hhHHHHHHHHHhhcc
Confidence 122357889999999998889999999999999999999999998754332110000 0000111111111
Q ss_pred -CCCC-hHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 725 -GSFS-PNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 725 -~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
...+ ......+.+++.+|++.||++||++.||+++.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111 12345688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=278.30 Aligned_cols=236 Identities=23% Similarity=0.237 Sum_probs=175.5
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccccC-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDSRR----------- 579 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~~~----------- 579 (1018)
..++|++.+.||+|+||.||+++.. +++.||||++... ......++.+|+.++++++|+|+++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 5889999998643 2334456788999999999999874210
Q ss_pred ------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 580 ------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 580 ------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
...++...+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 113677888899999999999999998 99999999999999999999999999987543
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhh----------
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWN---------- 711 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---------- 711 (1018)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ........+.
T Consensus 171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 171 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID---QWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHh
Confidence 21 1223467889999999999999999999999999999999999986432110 0000000000
Q ss_pred ---------cCc------chhhhhhhhc----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 712 ---------EGK------VLELVDIALE----GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 712 ---------~~~------~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... ..+.....+. ..........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0000000000 0001123566789999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=273.30 Aligned_cols=220 Identities=24% Similarity=0.319 Sum_probs=170.7
Q ss_pred eeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc-----------------------
Q 046791 521 VNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD----------------------- 576 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~----------------------- 576 (1018)
...||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+|++.
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 457999999999999865 48899999987655556677999999999999999872
Q ss_pred --ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecc
Q 046791 577 --SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654 (1018)
Q Consensus 577 --~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt 654 (1018)
......+++.++..++.||+.||.|||+++ |+||||||+||++++++.+||+|||++....... .......++
T Consensus 107 ~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~ 181 (292)
T cd06658 107 TDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGT 181 (292)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecC
Confidence 112346788999999999999999999998 9999999999999999999999999987653222 122345688
Q ss_pred cccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHH
Q 046791 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLR 734 (1018)
Q Consensus 655 ~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 734 (1018)
..|+|||.+.+..++.++||||||+++|||++|+.||...... ... .... ....+... ........
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~----~~~~-----~~~~~~~~--~~~~~~~~ 247 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAM----RRIR-----DNLPPRVK--DSHKVSSV 247 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHH-----hcCCCccc--cccccCHH
Confidence 9999999999889999999999999999999999998532211 000 0000 00111111 11123446
Q ss_pred HHHHHHhccccCCCCCCCHHHHHHH
Q 046791 735 CIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 735 l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+.+++.+|++.+|++|||++|+++.
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhC
Confidence 7788999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=274.15 Aligned_cols=237 Identities=24% Similarity=0.355 Sum_probs=171.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
.++|++.+.||+|+||.||+|+.. +|+.||+|.++.... .....+.+|+.++++++|+|+++..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999875 488999999865432 2234567899999999999987310
Q ss_pred ---------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 579 ---------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 579 ---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
....+++.++..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 1245788899999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC--cch-hhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG--KVL-ELV 719 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~-~~~ 719 (1018)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ............ ... ...
T Consensus 163 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 163 K--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred C--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhh
Confidence 1 1122345778999999875 567899999999999999999999986432211 111111110000 000 000
Q ss_pred -----hh-hhcCC-C------ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 720 -----DI-ALEGS-F------SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 720 -----d~-~l~~~-~------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.. .+... . .....+.+.+++.+|++.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00000 0 01124567789999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=267.03 Aligned_cols=225 Identities=26% Similarity=0.394 Sum_probs=172.0
Q ss_pred CcceeeeeccCCCcCeEEEEecc--cccceEEEeccc----------ccccHHHHHHHHHHHHH-hcCCCcccc------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN--GQEVAIKRLSRR----------SGQGIVEFKNEAKLIAK-LQHTNLTDS------ 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~--g~~vAvK~l~~~----------~~~~~~~f~~E~~~l~~-l~H~nlv~~------ 577 (1018)
+|++.+.||+|+||.||+|+... ++.+|||.+... ......++..|+.++.+ ++|+|++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999765 678999987532 22234567888888865 799998721
Q ss_pred ------------------------cCCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeee
Q 046791 578 ------------------------RRNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISD 632 (1018)
Q Consensus 578 ------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~D 632 (1018)
.....+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 123457888899999999999999996 56 99999999999999999999999
Q ss_pred ecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 633 FGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 633 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ...+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~-~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLAT-KIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHH-HHhh
Confidence 99998754322 22345688899999999998899999999999999999999999753211 11111 1111
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
+.. ...........+.+++.+||+.||++||++.||.+++++
T Consensus 228 ~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111 100111234678889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=272.32 Aligned_cols=236 Identities=22% Similarity=0.314 Sum_probs=176.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++|+|++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47899999999999999999876 47899999986542 3345678999999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.++..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~ 156 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S 156 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence 12345788999999999999999999998 99999999999999999999999999987653322 1
Q ss_pred cceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhh------------cC
Q 046791 647 NTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWN------------EG 713 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~------------~~ 713 (1018)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....... ........+. ..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcccCc
Confidence 22235678899999999887 88999999999999999999999986432111 0000000000 00
Q ss_pred cc-----hhhhhh-hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 KV-----LELVDI-ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~~-----~~~~d~-~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.. .+..++ .....++......+.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 000000 0000122223677899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=268.37 Aligned_cols=222 Identities=26% Similarity=0.378 Sum_probs=175.4
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.|+..+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+++++.|+|++..
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5777889999999999999875 48899999986543 3455679999999999999998721
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 85 ~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06640 85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccc
Confidence 12345788888999999999999999998 99999999999999999999999999987643221 222
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
...++..|+|||++.+..++.++||||||+++|||++|..|+........ . ..+..........
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~---------~~~~~~~~~~~~~ 223 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------L---------FLIPKNNPPTLTG 223 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------h---------hhhhcCCCCCCch
Confidence 34678899999999988999999999999999999999999854321110 0 0011111112333
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 456778899999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=270.62 Aligned_cols=232 Identities=25% Similarity=0.374 Sum_probs=176.0
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc------
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS------ 577 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~------ 577 (1018)
.++.++....+.|++.+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.++.++ +|+|+++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 355666677889999999999999999999874 47899999886543 3446788999999998 69998731
Q ss_pred ----------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCce
Q 046791 578 ----------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK 629 (1018)
Q Consensus 578 ----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~k 629 (1018)
.....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 01234677778899999999999999998 99999999999999999999
Q ss_pred eeeecceeeecCCCCcccceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHH
Q 046791 630 ISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG 704 (1018)
Q Consensus 630 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~ 704 (1018)
|+|||++....... .......|+..|+|||.+. +..++.++||||||+++|||++|+.||........
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----- 234 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----- 234 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-----
Confidence 99999987653211 1223356888999999876 35678899999999999999999999853321110
Q ss_pred HHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 705 YAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 705 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.. ..................+.+++.+||+.||.+||++.||++
T Consensus 235 -~~---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 -LF---------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hh---------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000000000111123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=272.35 Aligned_cols=226 Identities=23% Similarity=0.330 Sum_probs=171.2
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhc-CCCccccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQ-HTNLTDSR--------------- 578 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nlv~~~--------------- 578 (1018)
+|...+.||+|+||.||+++.. +++.||||.+.... ......+.+|+.++.++. |+||++..
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556679999999999999865 48899999987543 234567899999999996 99987310
Q ss_pred ---------------CCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 579 ---------------RNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 579 ---------------~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 124578888999999999999999975 6 999999999999999999999999999765322
Q ss_pred CCcccceeeecccccCChhhhccC---CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSG---VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.... .......+.. .+.
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~-~~~----- 227 (288)
T cd06616 162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVV-KGD----- 227 (288)
T ss_pred C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhc-CCC-----
Confidence 1 11234678899999998876 68999999999999999999999985432 1111111111 010
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.+.+...........+.+++.+||+.+|++||++.+|++.
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112222345678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=267.86 Aligned_cols=222 Identities=23% Similarity=0.357 Sum_probs=166.7
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHH-HHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKL-IAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~-l~~l~H~nlv~~--------------- 577 (1018)
++|++.+.||+|+||.||+++.. +|+.||||+++... .....++..|+.+ ++.++|+|+++.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999875 58999999987543 2233455666664 666789998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 1234688999999999999999999987 6 999999999999999999999999999865321
Q ss_pred CCcccceeeecccccCChhhhcc----CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMS----GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
.......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ........ .+..
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~--- 225 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVV-EEPS--- 225 (283)
T ss_pred ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHH-hcCC---
Confidence 11223467889999998865 45689999999999999999999998532211 01111111 0000
Q ss_pred hhhhhcCCCC-hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 719 VDIALEGSFS-PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 719 ~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+ ......+.+++.+||+.+|++||++.+|++
T Consensus 226 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 ------PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=267.44 Aligned_cols=228 Identities=25% Similarity=0.375 Sum_probs=170.8
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc----------ccHHHHHHHHHHHHHhcCCCccc---------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG----------QGIVEFKNEAKLIAKLQHTNLTD--------- 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~----------~~~~~f~~E~~~l~~l~H~nlv~--------- 576 (1018)
+|.+.+.||+|+||.||+|... +++.||||.++.... ...+.+.+|+.++++++|+|++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5778899999999999999864 588999998853211 12346888999999999999862
Q ss_pred -----------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee
Q 046791 577 -----------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 577 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~ 639 (1018)
+.....+++..+..++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 112356888899999999999999999998 999999999999999999999999999765
Q ss_pred cCCCCcccceeeecccccCChhhhccCC--CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMSGV--VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
.............++..|+|||.+.... ++.++|+||||+++||+++|..|+..... ........... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKR-SAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccc-cCC
Confidence 4322222223456788999999987654 88999999999999999999999853211 11111111110 000
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+ ...........+.+++.+||+.+|++||++.+|++
T Consensus 232 ~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00 11111233567888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=264.23 Aligned_cols=221 Identities=26% Similarity=0.397 Sum_probs=173.3
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-----cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-----GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+|+++.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999876 68899999886543 2345679999999999999998731
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 12345788999999999999999999998 9999999999999999999999999988754322
Q ss_pred cccceeeecccccCChhhhccCC-CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGV-VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ............
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~--------- 219 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKE--------- 219 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhccc---------
Confidence 223456788999999988766 89999999999999999999999854321 111111110000
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+......+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11223334567788999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=269.75 Aligned_cols=225 Identities=23% Similarity=0.346 Sum_probs=174.7
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|++.+.||+|+||.||+++.. +++.||+|.+........+.|.+|++++++++|+|+++.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 357899999999999999999875 588999999977666666789999999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 11346889999999999999999999999 9999999999999999999999999987643221 1
Q ss_pred cceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 647 NTNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
......++..|+|||.+. ...++.++||||||+++|||++|+.||...... ...... ..+.. +
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~-----~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKI-LKSEP-----P 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHH-hcCCC-----C
Confidence 223456889999999975 345788999999999999999999998543211 111111 11100 0
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+ ..+......+.+++.+||+.+|++||++.+|++
T Consensus 227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00 112223456788999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=265.20 Aligned_cols=228 Identities=25% Similarity=0.414 Sum_probs=175.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.+.||.|+||+||+|... ++..+|+|++.... ......+.+|+++++.++|+|++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999865 57889999986543 3356789999999999999998721
Q ss_pred ----------cC---CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 ----------RR---NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 ----------~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.. ...+++.....++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 01 245788899999999999999999998 99999999999999999999999999876653322
Q ss_pred cc--cceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 645 ET--NTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 645 ~~--~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.. ......++..|+|||++... .++.++|+||||+++|||++|+.||....... ........ . .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~-~-----~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQN-D-----PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcC-C-----CC
Confidence 21 22345688899999998876 78999999999999999999999986432211 00111111 0 00
Q ss_pred hhcCCC-ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALEGSF-SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+.... .......+.+++.+||+.||++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111 1233467789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=279.01 Aligned_cols=238 Identities=21% Similarity=0.293 Sum_probs=174.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||++..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 479999999999999999999864 58999999986532 22345688999999999999987321
Q ss_pred ----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 579 ----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 579 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
....+++..+..++.|+++||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 0125788888999999999999999998 99999999999999999999999999876432
Q ss_pred CCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh-----------
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW----------- 710 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----------- 710 (1018)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........
T Consensus 170 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 170 ----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred ----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHHHHh
Confidence 1123467889999999876 56899999999999999999999998643211 1111111100
Q ss_pred hcCcchhhhhh---hhcCCC---ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 046791 711 NEGKVLELVDI---ALEGSF---SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM--LANE 763 (1018)
Q Consensus 711 ~~~~~~~~~d~---~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--Le~~ 763 (1018)
........... ...... .+.....+.+++.+||+.||++||++.|+++. ++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000000 000000 01234567899999999999999999999863 5543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=268.58 Aligned_cols=233 Identities=24% Similarity=0.328 Sum_probs=169.6
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|++|.||+|+.. +++.||||++.... ......+.+|++++++++|+|+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999875 58899999886542 2234578999999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 155 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 155 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--
Confidence 12346788999999999999999999998 99999999999999999999999999876542211
Q ss_pred cceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc------chhhh
Q 046791 647 NTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK------VLELV 719 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~~ 719 (1018)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... .+.. ......... ...+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFR-IFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHHhCCCChhhhhhhhHHH
Confidence 12223567889999988764 46889999999999999999999985422110 0100 000000000 00000
Q ss_pred ----------hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 720 ----------DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 720 ----------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+. ...+.....+.+++.+|++.||++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000 001122355678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=263.00 Aligned_cols=220 Identities=25% Similarity=0.391 Sum_probs=171.7
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|+..+.||+|+||.||++... +++.+|||.+... .......+.+|++++++++|+|++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 5788999998654 23445679999999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC-CCceeeeecceeeecCCCC
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.|++++|.|||+++ ++|+||||+||+++.+ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 11234788899999999999999999998 9999999999999855 458999999998764322
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ....... .+. .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~-~~~---------~ 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIM-SGT---------F 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHH-hcC---------C
Confidence 122356788999999999888999999999999999999999998543211 1111111 000 1
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+......+.+++.+||+.+|++|||+.|+++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1122234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=272.37 Aligned_cols=228 Identities=21% Similarity=0.295 Sum_probs=167.0
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.|.+|..++..++|+||+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999865 4889999998653 22344568899999999999998731
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 11346788899999999999999999999 99999999999999999999999999976543222
Q ss_pred cccceeeecccccCChhhhcc-----CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMS-----GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ................+.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKEHFQFP 230 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHHHHHHHHcCCCcccCC
Confidence 12223568999999999873 457889999999999999999999985321 111111111111100000
Q ss_pred hhhhcCCCChHHHHHHHHHHHhcccc--CCCCCCCHHHHHHH
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQD--QATDRPAMPDVVSM 759 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPs~~evl~~ 759 (1018)
.........+.+++.+|+.. ++..||++.++++.
T Consensus 231 ------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 ------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 01112345566677776644 44448899888874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=274.29 Aligned_cols=228 Identities=20% Similarity=0.275 Sum_probs=166.9
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.++||+|+||.||+++... ++.+|+|++.+.. ......+.+|+.++..++|++|+..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999998765 7789999986432 2234458899999999999998621
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 11356888899999999999999999999 99999999999999999999999999976532221
Q ss_pred cccceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.... .................
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~~- 229 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQF- 229 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCccccC-
Confidence 1222357899999999986 3568899999999999999999999985322 11111111111100000
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCC--CCCCCHHHHHHH
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQA--TDRPAMPDVVSM 759 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP--~~RPs~~evl~~ 759 (1018)
..........+.+++.+|+..++ ..||++.|+++.
T Consensus 230 -----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00111234566777788775444 447899988875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=265.80 Aligned_cols=212 Identities=23% Similarity=0.364 Sum_probs=163.0
Q ss_pred eeeccCCCcCeEEEEecccc-----------cceEEEecccccccHHHHHHHHHHHHHhcCCCccccc------------
Q 046791 522 NKLGEGGFGPVYKGQLLNGQ-----------EVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR------------ 578 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~-----------~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~------------ 578 (1018)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++|+|++...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 47999999999999876532 4788877654433 67899999999999999987311
Q ss_pred -------------C-CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-------Cceeeeeccee
Q 046791 579 -------------R-NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-------NPKISDFGMAR 637 (1018)
Q Consensus 579 -------------~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-------~~kL~DFGla~ 637 (1018)
. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 1 125788899999999999999999998 99999999999999887 79999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhccC--CCCccccchhHhHHHHHHHhC-CCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSG--VVSIKTDVFSFGVLVLEIVSG-KKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
.... .....++..|+|||++... .++.++||||||+++|||++| ..|+....... . ...+...
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~----~~~~~~~- 222 (259)
T cd05037 157 TVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---K----ERFYQDQ- 222 (259)
T ss_pred cccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---H----HHHHhcC-
Confidence 6532 2224566789999999876 789999999999999999994 66664332111 0 0001000
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
...+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 223 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 ----------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111112267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=268.33 Aligned_cols=212 Identities=22% Similarity=0.309 Sum_probs=160.6
Q ss_pred eeccCCCcCeEEEEecc-------------------------cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc
Q 046791 523 KLGEGGFGPVYKGQLLN-------------------------GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS 577 (1018)
Q Consensus 523 ~lG~G~fG~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~ 577 (1018)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|+.++++++|+||++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13488998876555555679999999999999998731
Q ss_pred ---------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC----
Q 046791 578 ---------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM---- 626 (1018)
Q Consensus 578 ---------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---- 626 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 12456889999999999999999999998 99999999999997643
Q ss_pred ---CceeeeecceeeecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHH-hCCCCCCCCCCCCCCc
Q 046791 627 ---NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIV-SGKKNNGCYRTDHPLN 701 (1018)
Q Consensus 627 ---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ell-tG~~p~~~~~~~~~~~ 701 (1018)
.+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--- 229 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence 3799999998643211 12346778999998875 56899999999999999995 6888875432211
Q ss_pred hHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 702 LIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 702 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
.. ... .... ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 230 ~~----~~~---------~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KE----RFY---------EKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH----HHH---------Hhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 001 1000 111222356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=274.47 Aligned_cols=239 Identities=22% Similarity=0.322 Sum_probs=177.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++|+||+..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999865 48999999987542 2345678889999999999998731
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 12456899999999999999999999998 999999999999999999999999999875432
Q ss_pred CCc--ccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH----------
Q 046791 643 QSE--TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL---------- 709 (1018)
Q Consensus 643 ~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---------- 709 (1018)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSEEVLN 237 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChhHhhh
Confidence 211 11123578889999999866 568999999999999999999999985432211 01100000
Q ss_pred -hhcCcchhhhhhhh-cCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 710 -WNEGKVLELVDIAL-EGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 710 -~~~~~~~~~~d~~l-~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.....+.+..+... .... .+.....+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00011111111000 0011 12235778899999999999999999998883
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=264.77 Aligned_cols=227 Identities=22% Similarity=0.413 Sum_probs=174.3
Q ss_pred CcceeeeeccCCCcCeEEEEe-cccccceEEEeccccc------ccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSG------QGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
+|+..+.||+|++|.||+++. .+++.||+|.+..... ...+.+.+|++++++++|+||+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999986 4588999999865431 134678999999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-CceeeeecceeeecCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||+.||.|||+++ ++|+||||+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 12346788999999999999999999999 99999999999998776 5999999999876432
Q ss_pred CCc--ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 643 QSE--TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 643 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... .......++..|+|||.+.+..++.++||||||++++||++|+.||........ ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~---------~~ 225 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKI---------AS 225 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHH---------hc
Confidence 111 112235678899999999888899999999999999999999999854322111 1111110 00
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.......+......+.+++.+|++.+|++||++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01112233445577889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=268.05 Aligned_cols=223 Identities=22% Similarity=0.361 Sum_probs=170.9
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++.+++|+||++.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888899999999999999876 5889999988654 23335678999999999999998621
Q ss_pred ----------cC---CCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 ----------RR---NNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 ----------~~---~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.. ...+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 01 23688999999999999999999974 6 999999999999999999999999998765322
Q ss_pred CcccceeeecccccCChhhhccC------CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSG------VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ...... ..
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~---------~~ 221 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQL---------SA 221 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHH---------HH
Confidence 11234578899999998654 3588999999999999999999998532211 111000 00
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+. .....+......+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 222 IVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred Hhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1110 011233345677889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=267.16 Aligned_cols=221 Identities=20% Similarity=0.341 Sum_probs=180.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.+-|.+.+.||+|-|+.|-+++. -.|..||||++.+.. .-....+..|++.|+.++|||||++
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34577778999999999999974 479999999997763 3344568999999999999999842
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-CCCCceeeeecceeeecCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+.+..+.+++.||+.|+.|+|+.+ +|||||||+||.+- .-|-+||.|||++..+..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-- 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-- 171 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC--
Confidence 23456889999999999999999999998 99999999998764 668899999999987653
Q ss_pred CcccceeeecccccCChhhhccCCCC-ccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVS-IKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.......+|+..|.|||++.+..|+ ++.||||||||||-|++|++||+...+.+. +..++|-.
T Consensus 172 -G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCK 235 (864)
T KOG4717|consen 172 -GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCK 235 (864)
T ss_pred -cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhccc
Confidence 3344567999999999999998886 678999999999999999999975443321 22233322
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...|.....++.+||..||+.||.+|.+.+||+.
T Consensus 236 --YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 --YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2356677889999999999999999999999986
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=272.59 Aligned_cols=220 Identities=25% Similarity=0.319 Sum_probs=171.2
Q ss_pred eeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------------
Q 046791 521 VNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 577 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------------- 577 (1018)
...||+|+||.||++... +++.||||.+........+.+.+|+.++..++|+|++..
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 357999999999999865 588999999876555556778999999999999998731
Q ss_pred ---cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecc
Q 046791 578 ---RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654 (1018)
Q Consensus 578 ---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt 654 (1018)
.....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ......++
T Consensus 106 ~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~ 180 (297)
T cd06659 106 TDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGT 180 (297)
T ss_pred HHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecC
Confidence 12346788999999999999999999998 99999999999999999999999999875543221 22335688
Q ss_pred cccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHH
Q 046791 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLR 734 (1018)
Q Consensus 655 ~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 734 (1018)
..|+|||++.+..++.++||||||+++|||++|+.||...... .... ....... ... .........
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~-~~~~~~~-----~~~--~~~~~~~~~ 246 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMK-RLRDSPP-----PKL--KNAHKISPV 246 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHhccCC-----CCc--cccCCCCHH
Confidence 9999999999889999999999999999999999998532211 1111 1111100 000 111223456
Q ss_pred HHHHHHhccccCCCCCCCHHHHHHH
Q 046791 735 CIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 735 l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+.+++.+||+.+|++||++.+|++.
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 7789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=271.37 Aligned_cols=225 Identities=22% Similarity=0.306 Sum_probs=173.4
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEeccccc---ccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG---QGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|++|.||++...+ ++.||+|.+..... ...+.+..|++++.+++|+||+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 478999999999999999998765 88999999976532 245678999999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 12356888999999999999999999998 9999999999999999999999999987543211
Q ss_pred Cc---------------------------ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCC
Q 046791 644 SE---------------------------TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRT 696 (1018)
Q Consensus 644 ~~---------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~ 696 (1018)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 111234678899999999998899999999999999999999999864322
Q ss_pred CCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 046791 697 DHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPA----MPDVVS 758 (1018)
Q Consensus 697 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~evl~ 758 (1018)
.. . ...+.+..............+.+++.+||+.+|++||+ ++|+++
T Consensus 238 ~~------~---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DE------T---------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH------H---------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 10 0 01111111111111124677889999999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=263.25 Aligned_cols=224 Identities=26% Similarity=0.434 Sum_probs=173.7
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|+||.||+|... +++.||+|.+..... ....++.+|+.++++++|+||++.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999865 588999999876544 356789999999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 12345788999999999999999999999 99999999999999999999999999987643322111
Q ss_pred --ceeeecccccCChhhhccCC---CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 648 --TNRVVGTYGYMSPEYAMSGV---VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 648 --~~~~~gt~~Y~aPE~~~~~~---~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ........ .+.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~-------- 223 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVG-AGH-------- 223 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHh-cCC--------
Confidence 12356788999999998766 899999999999999999999998643211 00111000 000
Q ss_pred hcCCCChH--HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSPN--EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~--~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+.. ....+.+++.+||+.+|.+||++.|++.
T Consensus 224 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111111 2566778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=274.76 Aligned_cols=225 Identities=23% Similarity=0.314 Sum_probs=181.9
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccc---cHHHHHHHHHHHHHhc-CCCcccc-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQ---GIVEFKNEAKLIAKLQ-HTNLTDS----------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~-H~nlv~~----------- 577 (1018)
....|++.+.||+|.||.||+++... |+.+|+|.+.+.... ..+...+|+.+|+++. |||++.+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45678888999999999999998765 999999999776432 4468999999999999 9998831
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC----CCceeeeecceee
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ----MNPKISDFGMARI 638 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~----~~~kL~DFGla~~ 638 (1018)
... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||++..
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 111 2899999999999999999999999 9999999999999633 5799999999998
Q ss_pred ecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
... .......+||+.|+|||++....++.++||||+|+++|.|++|.+||......... .....++.
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~--- 255 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDF--- 255 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCC---
Confidence 764 34456689999999999999999999999999999999999999998654422110 01111111
Q ss_pred hhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 719 VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 719 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......-+.....+.+++..++..||.+|+|+.++++
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1122223345677889999999999999999999998
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=268.51 Aligned_cols=238 Identities=22% Similarity=0.315 Sum_probs=172.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
.++|++.++||+|+||.||+|+.. +++.+|||++..... .....+.+|++++++++|+||++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 488999999865432 2234678999999999999988421
Q ss_pred ---------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 579 ---------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 579 ---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
....+++.++..++.|+++||.|||+++ |+|+||||+||++++++.+||+|||++.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence 1246889999999999999999999999 9999999999999999999999999997
Q ss_pred eecCCCCcc---------cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH
Q 046791 638 IFGLNQSET---------NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 638 ~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 707 (1018)
......... ......++..|+|||.+.+ ..++.++||||||+++|||++|++||....... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~~~~ 240 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLHLIF 240 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 654322111 1123466888999998865 458899999999999999999999986433211 111111
Q ss_pred HHhhcC---------cchhhhhhhhcCCCC-------hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 708 QLWNEG---------KVLELVDIALEGSFS-------PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 708 ~~~~~~---------~~~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...... ......+.......+ ....+.+.+++.+||+.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 110000 000000000000000 112256789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=268.20 Aligned_cols=226 Identities=25% Similarity=0.347 Sum_probs=176.7
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++|||++..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368899999999999999999864 578899999876555556789999999999999998731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~ 172 (293)
T cd06647 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (293)
T ss_pred CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence 11235788889999999999999999999 99999999999999999999999999876543222 12
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
....+++.|+|||.+.+..++.++||||||+++||+++|+.||........... ....+ ......+
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~--------~~~~~~~ 238 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPELQNP 238 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC--------CCCCCCc
Confidence 234688899999999988899999999999999999999999864332211000 00000 0000112
Q ss_pred hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
......+.+++.+||+.+|++||++.+++..
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2234567789999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=271.59 Aligned_cols=238 Identities=22% Similarity=0.302 Sum_probs=171.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
-++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||++..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999875 58899999886442 22334567899999999999987321
Q ss_pred ---------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 579 ---------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 579 ---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
....+++.++..++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 1125788899999999999999999998 9999999999999999999999999998
Q ss_pred eecCCCCc--ccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhh---
Q 046791 638 IFGLNQSE--TNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWN--- 711 (1018)
Q Consensus 638 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 711 (1018)
........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ..........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~~~~~~ 244 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQLCGSIT 244 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 66432211 112234577889999988764 47899999999999999999999986433211 1111111100
Q ss_pred -----cCcchhhhhhhh-cCC---------CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 712 -----EGKVLELVDIAL-EGS---------FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 712 -----~~~~~~~~d~~l-~~~---------~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....+..+... ... .+......+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000000 000 00112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=278.36 Aligned_cols=241 Identities=22% Similarity=0.276 Sum_probs=178.2
Q ss_pred HHHHHHHhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc------
Q 046791 508 FQTISAATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR------ 578 (1018)
Q Consensus 508 ~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~------ 578 (1018)
..++..++++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.+++|+||+...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 456777889999999999999999999985 458899999987542 22345688999999999999987421
Q ss_pred ------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeec
Q 046791 579 ------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 634 (1018)
Q Consensus 579 ------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFG 634 (1018)
....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccc
Confidence 1235788899999999999999999999 9999999999999999999999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh---
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW--- 710 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--- 710 (1018)
++..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .........
T Consensus 166 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~ 237 (345)
T cd07877 166 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTP 237 (345)
T ss_pred ccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCC
Confidence 9876432 1223467889999999876 568899999999999999999999985432111 111100000
Q ss_pred --------hcCcchhhh---hhhhcCCC---ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 711 --------NEGKVLELV---DIALEGSF---SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 711 --------~~~~~~~~~---d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
........+ +......+ .......+.+++.+|++.||.+||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000 00000000 01124567899999999999999999998873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=265.97 Aligned_cols=236 Identities=22% Similarity=0.327 Sum_probs=170.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.+.||+|++|.||+|+.. +++.||||.+..... .....+.+|++++++++|+||+..
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999876 588999999865432 233557889999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~ 159 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--T 159 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc--c
Confidence 11235788899999999999999999998 99999999999999999999999999875432111 1
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh---h-----
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE---L----- 718 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---~----- 718 (1018)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .......+.......... .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 122346788999999875 56889999999999999999999998543311 111111111110000000 0
Q ss_pred -h--------hhhhcCCC-ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 719 -V--------DIALEGSF-SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 719 -~--------d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. ...+.... .......+.+++.+||+.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000000 0111256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=263.27 Aligned_cols=231 Identities=25% Similarity=0.293 Sum_probs=174.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCccccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDSR--------------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~~--------------- 578 (1018)
++|+..+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++|+||+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46889999999999999999975 478999999875432 3456799999999999999987310
Q ss_pred -----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 579 -----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 579 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
....+++.....++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 1233667778899999999999999999 99999999999999999999999999875432
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...... ..........+.+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~ 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELL-SYIVNMPNPELKDE 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHH-HHHhcCCchhhccC
Confidence 21 1134567899999999999999999999999999999999999875432111 111111 11111111111100
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. .......+.+.+++.+||+.+|++|||+.||++
T Consensus 232 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 P---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 001123567889999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=277.12 Aligned_cols=240 Identities=22% Similarity=0.277 Sum_probs=175.9
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHh-cCCCcccccC----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKL-QHTNLTDSRR---------- 579 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l-~H~nlv~~~~---------- 579 (1018)
..++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.++.++ +|+||+....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999875 4789999988543 233445678899999999 9999874211
Q ss_pred ----------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 580 ----------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 580 ----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 125788888999999999999999998 9999999999999999999999999998664332
Q ss_pred Cc---ccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH----------
Q 046791 644 SE---TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL---------- 709 (1018)
Q Consensus 644 ~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---------- 709 (1018)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHH
Confidence 21 12234568899999998765 567899999999999999999999985432211 11100000
Q ss_pred -hhcCcchhhhhhhhcC------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 710 -WNEGKVLELVDIALEG------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 710 -~~~~~~~~~~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+.......+++..... ...+.....+.+++.+||+.+|++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000001111100000 0111235678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=273.55 Aligned_cols=228 Identities=19% Similarity=0.276 Sum_probs=168.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+++.. +++.||+|.+.+.. ......+.+|..++..++|+||+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999875 47889999986532 2334558899999999999998621
Q ss_pred ------------c-CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 ------------R-RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 ------------~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 1 1356888899999999999999999999 99999999999999999999999999987643222
Q ss_pred cccceeeecccccCChhhhcc-----CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMS-----GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
.......||+.|+|||++.+ +.++.++||||||+++|||++|+.||..... ...............
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~-- 228 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQ-- 228 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCccc--
Confidence 11223568999999999875 5688999999999999999999999853221 111111111110000
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATD--RPAMPDVVSM 759 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 759 (1018)
+ .........++.+++.+|++.++++ |++++++++.
T Consensus 229 ---~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 ---F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0011123466778888888765544 4678887763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=267.97 Aligned_cols=235 Identities=21% Similarity=0.243 Sum_probs=169.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhc-CCCccccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQ-HTNLTDSR------------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~-H~nlv~~~------------- 578 (1018)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.+++++. |+|+++..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999875 58899999886543 223467889999999995 58886210
Q ss_pred ----------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-CCCceeeeecc
Q 046791 579 ----------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGM 635 (1018)
Q Consensus 579 ----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kL~DFGl 635 (1018)
....+++..+..++.||++||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 0235788999999999999999999998 999999999999998 88999999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||....... .............
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (295)
T cd07837 158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ---QLLHIFKLLGTPT 232 (295)
T ss_pred ceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 986532211 1122356788999998865 567999999999999999999999986432111 0000000000000
Q ss_pred c------hhhhhhhhcC--------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 V------LELVDIALEG--------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ~------~~~~d~~l~~--------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. ....+..... ...+....++.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000000000 001223466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=261.88 Aligned_cols=226 Identities=25% Similarity=0.361 Sum_probs=179.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.+.||+|++|.||+++... ++.||||++..... ....++.+|+..+.+++|+|+++.
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468889999999999999998765 89999999876543 446789999999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 123568889999999999999999999 88 999999999999999999999999999876433222
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ......... .. ....
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~-~~---------~~~~ 222 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAIC-DG---------PPPS 222 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHh-cC---------CCCC
Confidence 123567889999999999999999999999999999999999986443211 111111111 00 0111
Q ss_pred CChH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 727 FSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 727 ~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.+.. ....+.+++.+||+.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2222 45678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=267.62 Aligned_cols=236 Identities=21% Similarity=0.310 Sum_probs=174.0
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+|+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999875 58899999987653 3345679999999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.++..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL 156 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence 12345889999999999999999999998 99999999999999999999999999987643321 12
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc------hhhhh
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV------LELVD 720 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~~~d 720 (1018)
.....++..|+|||.+.+ ..++.++||||||+++|||++|.++|..... ..........+..... .++.+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccCcch
Confidence 233568889999998865 4568999999999999999999877753221 1111111111100000 00000
Q ss_pred --hh---hc-----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 721 --IA---LE-----GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 721 --~~---l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.. .. ....++....+.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00 00112234788899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=260.97 Aligned_cols=224 Identities=19% Similarity=0.261 Sum_probs=158.1
Q ss_pred eeccCCCcCeEEEEecccc---cceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc--------------------
Q 046791 523 KLGEGGFGPVYKGQLLNGQ---EVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR-------------------- 578 (1018)
Q Consensus 523 ~lG~G~fG~Vy~~~~~~g~---~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~-------------------- 578 (1018)
.||+|+||.||+|+..++. .+++|.+.... ....+.|.+|+.+++.++|||+++..
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999999865543 35566665443 33456899999999999999997310
Q ss_pred ----------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 579 ----------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 579 ----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
....+++.....++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 0123455566789999999999999998 999999999999999999999999998643221111122
Q ss_pred eeeecccccCChhhhcc-------CCCCccccchhHhHHHHHHHhC-CCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 649 NRVVGTYGYMSPEYAMS-------GVVSIKTDVFSFGVLVLEIVSG-KKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~-------~~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||..... ......... +....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccCC
Confidence 23567889999998753 2457899999999999999975 556643221 111111111 11122222
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
+.+. .....++.+++..|| .+|++||+++||++.|.
T Consensus 232 ~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222 223456777888899 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=269.01 Aligned_cols=235 Identities=23% Similarity=0.312 Sum_probs=173.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +++.+|+|.++.... .....+.+|+.++.+++|+|++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888899999999999999976 488999999865432 223457889999999999998731
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 11234789999999999999999999999 9999999999999999999999999998765332
Q ss_pred cccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHH-----------HHHhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYA-----------WQLWNE 712 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~-----------~~~~~~ 712 (1018)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ..... |..+..
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID---QLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchHHHHHhhc
Confidence 122234567899999998764 46899999999999999999999986432211 11110 000000
Q ss_pred ------CcchhhhhhhhcCCCChH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 713 ------GKVLELVDIALEGSFSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 713 ------~~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..........+...++.. ..+.+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111111122222 3566788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=245.92 Aligned_cols=222 Identities=25% Similarity=0.369 Sum_probs=170.2
Q ss_pred ceeeeeccCCCcCeEEEEecc-cccceEEEecccc-cccHHHHHHHHHHHHHhc-CCCccc-------------------
Q 046791 519 SAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQ-HTNLTD------------------- 576 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nlv~------------------- 576 (1018)
+.+..||.|..|.|++++... |..+|||.+.+.. .+..++.+..+.++.+-+ .|.||+
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 344689999999999998654 8899999997663 455667777888776665 788873
Q ss_pred -------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 577 -------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 577 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.+-.+++++..+-++...++.||.||.+++ .|+|||+||+|||+|+.|++||||||++-.+-.... ..
T Consensus 175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---ht 249 (391)
T KOG0983|consen 175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HT 249 (391)
T ss_pred HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---cc
Confidence 133567888888899999999999998866 599999999999999999999999999987653322 23
Q ss_pred eeecccccCChhhhcc---CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 650 RVVGTYGYMSPEYAMS---GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
...|.+.|||||.+.- ..|+.++||||||+.++||.||+.||.....+-. . ....+++ ..+.+.+.
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~---ltkvln~------ePP~L~~~ 318 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--V---LTKVLNE------EPPLLPGH 318 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--H---HHHHHhc------CCCCCCcc
Confidence 4578899999998863 5789999999999999999999999875433311 0 1111111 01222211
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..-.+.+++++..||+.|+.+||...++++
T Consensus 319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred --cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 114567889999999999999999999887
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=275.74 Aligned_cols=241 Identities=22% Similarity=0.255 Sum_probs=173.3
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR--------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~--------------- 578 (1018)
..+|.+.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++|+||+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999875 4889999998776666677899999999999999987421
Q ss_pred -----------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-CCCCceeeeec
Q 046791 579 -----------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFG 634 (1018)
Q Consensus 579 -----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kL~DFG 634 (1018)
....+++..+..++.||++||.|||+.+ |+||||||+||+++ ++..+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcc
Confidence 1235788899999999999999999998 99999999999997 45678999999
Q ss_pred ceeeecCCCCc-ccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHH-------
Q 046791 635 MARIFGLNQSE-TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGY------- 705 (1018)
Q Consensus 635 la~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~------- 705 (1018)
++......... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99865322111 11122357889999998754 5688999999999999999999999864321110000000
Q ss_pred -HHHHhhcCcchhhhhhhhcCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 706 -AWQLWNEGKVLELVDIALEGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 706 -~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...................... .+....++.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000000000000 1123456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=262.25 Aligned_cols=221 Identities=25% Similarity=0.312 Sum_probs=175.0
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
+|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999876 48899999997543 2456789999999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.++..++.||++||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence 11347889999999999999999999998 9999999999999999999999999988654322
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .......... ....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~~~ 220 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------ADVL 220 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cccc
Confidence 2233567889999999998889999999999999999999999986443221 1111111100 1122
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAM--PDVV 757 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~--~evl 757 (1018)
.+......+.+++.+||+.+|.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 333445788899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=264.27 Aligned_cols=225 Identities=22% Similarity=0.324 Sum_probs=173.9
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|+..+.||+|++|.||++... +++.+|+|++.... ....+++.+|++++++++|+||+..
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778889999999999999876 48899999987653 3445678999999999999998731
Q ss_pred ----------cC-CCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ----------RR-NNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ----------~~-~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.. ...+++.....++.|+++||+|||+ .+ ++|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 11 2567888899999999999999999 88 99999999999999999999999999876532111
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ........... ... ..
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~---------~~ 222 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV-NEP---------PP 222 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh-cCC---------CC
Confidence 12667889999999999999999999999999999999999986432211 11111111111 000 00
Q ss_pred CCChH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPN-EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+.. ....+.+++.+||+.+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11111 4456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=264.20 Aligned_cols=226 Identities=28% Similarity=0.382 Sum_probs=173.6
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHh-cCCCccccc------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDSR------------ 578 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~~------------ 578 (1018)
.++++|++.+.||+|++|.||+|+.. +++.+++|.+..... ..+++.+|+.+++++ +|+|+++..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46789999999999999999999975 478899999865543 456799999999999 799976310
Q ss_pred ------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeec
Q 046791 579 ------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 634 (1018)
Q Consensus 579 ------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFG 634 (1018)
....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 0246788888999999999999999998 9999999999999999999999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhcc-----CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAMS-----GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
++....... .......++..|+|||++.. ..++.++||||||+++|||++|+.||...... ....+
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~- 229 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFK- 229 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHH-
Confidence 998654222 12223568889999998753 35778999999999999999999998532111 00011
Q ss_pred hhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 710 WNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....... ....+......+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPP-------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCC-------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1011000 00112224567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=266.51 Aligned_cols=234 Identities=23% Similarity=0.326 Sum_probs=172.6
Q ss_pred cceeeeeccCCCcCeEEEEecc-cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc----------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR---------------- 578 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~---------------- 578 (1018)
|++.+.||+|+||.||+|+..+ ++.+|+|++.... ......+.+|+.++++++|+|++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 6778999999999999998764 8899999997653 33446788999999999999987310
Q ss_pred ------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 579 ------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 579 ------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
....+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++........ .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-A 156 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-c
Confidence 1246888999999999999999999998 99999999999999999999999999987654322 1
Q ss_pred cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC------cc----
Q 046791 647 NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG------KV---- 715 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~---- 715 (1018)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ............ ..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccch
Confidence 1223456788999998765 467899999999999999999999986433211 111111110000 00
Q ss_pred -------hhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 -------LELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 -------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.......+...........+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000111111112567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=268.54 Aligned_cols=220 Identities=28% Similarity=0.403 Sum_probs=170.9
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc---ccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG---QGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
+.|++.+.||+|+||.||+|+.. +++.||+|.+..... ....++.+|+.++++++|+|++..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999875 588999999864432 334568899999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 12346889999999999999999999998 999999999999999999999999998765321
Q ss_pred ccceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 646 TNTNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
....++..|+|||++. ...++.++||||||+++|||++|+.|+..... ........ ....
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~-~~~~------- 231 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIA-QNDS------- 231 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHh-cCCC-------
Confidence 2345778999999874 46688999999999999999999999753221 11111110 0000
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
...........+.+++.+||+.+|++||++.+|++.
T Consensus 232 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000112234678899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=268.67 Aligned_cols=230 Identities=17% Similarity=0.255 Sum_probs=173.8
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
++|++.+.||+|+||.||+++... ++.||+|.+.... ......+.+|+++++.++|+||+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 478899999999999999998754 7889999986543 234557889999999999999872
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC-
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS- 644 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~- 644 (1018)
+.....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 112356788889999999999999999998 99999999999999999999999999874211000
Q ss_pred ------------cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 645 ------------ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 645 ------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
........++..|+|||.+.+..++.++||||||+++|||++|..||...... . .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~-~~~~~~~ 230 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------E-LFGQVIS 230 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHh
Confidence 00111245778999999999889999999999999999999999998532111 0 0111101
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
+.. ..+ .........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 ~~~---~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDI---EWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccc---CCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000 000 0111234567899999999999999998888888775
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=263.38 Aligned_cols=221 Identities=26% Similarity=0.400 Sum_probs=172.7
Q ss_pred cceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
|++.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++|+|++..
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667789999999999999864 57899999886443 3344678999999999999998721
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 86 ~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~ 160 (277)
T cd06641 86 GGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNT 160 (277)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--hhhcc
Confidence 12356889999999999999999999998 9999999999999999999999999987654321 11223
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..++..|+|||.+.+..++.++||||||+++|||++|..|+...... .... ...... ....+..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~-~~~~~~---------~~~~~~~ 224 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLF-LIPKNN---------PPTLEGN 224 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHH-HHhcCC---------CCCCCcc
Confidence 46788999999999888999999999999999999999998532211 0001 011110 1112233
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
....+.+++.+||+.+|.+||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 45667889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=264.70 Aligned_cols=233 Identities=24% Similarity=0.327 Sum_probs=169.6
Q ss_pred cceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
|++.+.||+|++|.||+|+.. +|+.||||++.... ......+.+|++++++++|+|+++.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999865 58999999986543 2234578899999999999998731
Q ss_pred --------cCC--CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 --------RRN--NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 --------~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
... ..+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~ 155 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--T 155 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--c
Confidence 111 25889999999999999999999998 99999999999999999999999999976542211 1
Q ss_pred ceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC---------cchh
Q 046791 648 TNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG---------KVLE 717 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------~~~~ 717 (1018)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+... ....... ...+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRI-FRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HHHhCCCChHHhhhhhhchh
Confidence 1223567899999987664 57899999999999999999999985432110 00000 0000000 0000
Q ss_pred hhhhhhc------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALE------GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....... ....+.....+.+++.+|++.+|++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 0111223367889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=267.67 Aligned_cols=238 Identities=22% Similarity=0.309 Sum_probs=174.4
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc-----------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR----------- 578 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~----------- 578 (1018)
.+.++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++++++|||++...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999976 48899999986543 23345678999999999999987421
Q ss_pred -------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeee
Q 046791 579 -------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633 (1018)
Q Consensus 579 -------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DF 633 (1018)
....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcc
Confidence 1135788999999999999999999998 999999999999999999999999
Q ss_pred cceeeecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 634 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
|++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|++||...... ............
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~~ 236 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCGS 236 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Confidence 99987643221 11122345778999998865 45789999999999999999999998643211 111111111111
Q ss_pred Ccc---hhhh--------hh------hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 713 GKV---LELV--------DI------ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 713 ~~~---~~~~--------d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... ..+. +. .... ........+.+++.+||+.+|++||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0000 00 0000 00112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=264.97 Aligned_cols=218 Identities=26% Similarity=0.333 Sum_probs=172.7
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++|+||+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999875 48899999986542 2345678999999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.|+++||.|||+.+ ++|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 12456889999999999999999999998 999999999999999999999999999876432
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||..... .........+. .
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~----------~ 215 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGK----------V 215 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCC----------c
Confidence 2234678899999999888899999999999999999999999853221 01111111111 1
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
..+......+.+++.+||+.+|.+|| +++|+++
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 12233356778999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=263.95 Aligned_cols=233 Identities=24% Similarity=0.324 Sum_probs=173.2
Q ss_pred cceeeeeccCCCcCeEEEEec-ccccceEEEecccccc--cHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ--GIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
|++.+.||+|++|.||+++.. +++.+|+|++...... ....+.+|+.++++++|+|+++.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 5889999998765322 45678899999999999998731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||.+....... ...
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~ 155 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY 155 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence 11247889999999999999999999999 9999999999999999999999999998765433 112
Q ss_pred eeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc---chhhhh----
Q 046791 649 NRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK---VLELVD---- 720 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d---- 720 (1018)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ............. .....+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhhh
Confidence 234577889999998876 78999999999999999999999985433211 1111111100000 000000
Q ss_pred --hhhc-------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 --IALE-------GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 --~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.... ....+.....+.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=256.83 Aligned_cols=225 Identities=24% Similarity=0.387 Sum_probs=178.4
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 588999999876542 456789999999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 11236788999999999999999999988 999999999999999999999999999877544321
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......++..|+|||.+.....+.++||||||+++++|++|..||.... ......+... ......
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~---------~~~~~~ 223 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIG---------SSGEPP 223 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhcc---------ccCCCc
Confidence 12334567889999999998889999999999999999999999986443 1111111111 011111
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+......+.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 223334678889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=256.78 Aligned_cols=222 Identities=28% Similarity=0.415 Sum_probs=175.3
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
.|...+.||+|++|.||++... +++.+++|++.........++.+|+.++++++|+|++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999976 588999999977665567789999999999999998621
Q ss_pred --------cC-CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 --------RR-NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 --------~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 01 147899999999999999999999988 99999999999999999999999999987653321 3
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ... ........... ..
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~~~-------~~ 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALF-KIATNGPPGLR-------NP 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHH-HHHhcCCCCcC-------cc
Confidence 34678889999999998889999999999999999999999985432110 000 00000000000 01
Q ss_pred hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+.+++.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111467889999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=256.28 Aligned_cols=236 Identities=23% Similarity=0.274 Sum_probs=186.5
Q ss_pred HHHHHHHhCCcceeeeeccCCCcCeEEEEec------ccccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCccc----
Q 046791 508 FQTISAATNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTD---- 576 (1018)
Q Consensus 508 ~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~---- 576 (1018)
.++|.....+++...++-+|.||.||+|.+. +.+.|-||.++.. +.-+...+..|..++..+.||||..
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 5677777888999999999999999999653 3567888988665 3445667999999999999999861
Q ss_pred -------------------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC
Q 046791 577 -------------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ 625 (1018)
Q Consensus 577 -------------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~ 625 (1018)
......+...+...++.|++.|++|||.++ +||.||..+|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 112334667788899999999999999999 9999999999999999
Q ss_pred CCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHH
Q 046791 626 MNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIG 704 (1018)
Q Consensus 626 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~ 704 (1018)
.++||+|=.+++.+-..+.............||+||.+.+..|+.++||||||++||||+| |+.|+...++.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 9999999999986644443333333445678999999999999999999999999999998 777864332211
Q ss_pred HHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 705 YAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 705 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
....+++|. +-..|...+.++..++.-||...|++||+++|++.-|.+
T Consensus 507 -m~~ylkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 507 -MEHYLKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -HHHHHhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 112222222 223456678889999999999999999999999998875
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=270.52 Aligned_cols=229 Identities=19% Similarity=0.268 Sum_probs=164.6
Q ss_pred eeeeeccC--CCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 520 AVNKLGEG--GFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 520 ~~~~lG~G--~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
++++||+| +|++||+++.. +|+.||||++.... ....+.+.+|+.+++.++||||++.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 67899999864 58999999997543 2334567889999999999999731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc-
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE- 645 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~- 645 (1018)
.....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 11245888999999999999999999999 999999999999999999999999875433211110
Q ss_pred ----ccceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 646 ----TNTNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 646 ----~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .... . ..+......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~----~-~~~~~~~~~ 231 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLE----K-LNGTVPCLL 231 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHH----H-hcCCccccc
Confidence 01112346778999999976 468999999999999999999999986432111 0000 0 000000000
Q ss_pred h-------------------hhh-----------------cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 720 D-------------------IAL-----------------EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 720 d-------------------~~l-----------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+ ... ...........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 000 00011223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=260.72 Aligned_cols=219 Identities=27% Similarity=0.351 Sum_probs=174.7
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCccc------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTD------------ 576 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~------------ 576 (1018)
..-+.|+.-++||+||||.||-.+..+ |+.+|.|++.+. ..++...-++|-.+|.+++.+-||.
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 334678888999999999999998654 999999998654 2445566789999999999998772
Q ss_pred --------------c--cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 577 --------------S--RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 577 --------------~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
+ .....+++..++-++.+|+-||++||... ||.|||||+|||||+.|+++|+|+|+|..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 1 12346899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
..+.. ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||....... -.+-+|
T Consensus 339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----------------k~eEvd 399 (591)
T KOG0986|consen 339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----------------KREEVD 399 (591)
T ss_pred CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----------------hHHHHH
Confidence 44332 23489999999999999999999999999999999999999985432211 112223
Q ss_pred hhhc---CCCChHHHHHHHHHHHhccccCCCCCCCH
Q 046791 721 IALE---GSFSPNEVLRCIHVGLLCVQDQATDRPAM 753 (1018)
Q Consensus 721 ~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 753 (1018)
.+.. ..++..-.+++..|....|+.||.+|-.-
T Consensus 400 rr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 400 RRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 3222 13444555677778888899999999654
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=262.19 Aligned_cols=222 Identities=25% Similarity=0.420 Sum_probs=171.9
Q ss_pred CcceeeeeccCCCcCeEEEEe-cccccceEEEeccc-ccccHHHHHHHHHHHHHhc---CCCcccc--------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQ---HTNLTDS-------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~---H~nlv~~-------------- 577 (1018)
.|++.+.||+|+||.||+|+. .+++.||||.+... ......++.+|+.++++++ |+|+++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 577889999999999999986 45889999998654 3345567899999999997 9998621
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.....++.|+++||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-- 156 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence 12346888999999999999999999999 99999999999999999999999999987653321
Q ss_pred cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ . ...... ..+.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~~-----~~~~~~~ 224 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPKS-----KPPRLED 224 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hccccC-----CCCCCCc
Confidence 2223568889999999875 4578999999999999999999999864322110 0 000000 0011110
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+.+++.+||+.||++||++.|+++
T Consensus 225 ---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 ---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 113457888999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=263.32 Aligned_cols=234 Identities=24% Similarity=0.350 Sum_probs=171.8
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
+|++.+.||+|++|.||+|+.. +|+.||||+++.... .....+.+|+.++++++|+|+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999975 488999999876532 234667899999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 11245899999999999999999999998 99999999999999999999999999976532211
Q ss_pred cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc---chhhhh-h
Q 046791 647 NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK---VLELVD-I 721 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d-~ 721 (1018)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ............. ...+.+ +
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcCc
Confidence 1123456889999998866 457899999999999999999999986433211 1111111000000 000000 0
Q ss_pred hhc-----------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALE-----------GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~-----------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... ....+.....+.+++.+|++.||.+||++.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0111223466789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=258.20 Aligned_cols=221 Identities=26% Similarity=0.389 Sum_probs=171.6
Q ss_pred CcceeeeeccCCCcCeEEEEecc-cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|+||.||+|.... |..+|+|.+.... ....+.+.+|+.++++++|+|++..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58889999999999999998764 7889999986542 2345678899999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC-ceeeeecceeeecCCCC
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-PKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~-~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++. +||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 11224788999999999999999999998 999999999999998754 69999999986643221
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.... ......... .+..
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~--------- 219 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKIC-QGYF--------- 219 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHh-cccC---------
Confidence 1223468889999999998889999999999999999999999975321 111111111 1110
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+.....+.+++.+|++.+|++||++.||++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=263.33 Aligned_cols=222 Identities=24% Similarity=0.310 Sum_probs=171.4
Q ss_pred cceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-------------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------- 577 (1018)
|...+.||+|++|.||++... +++.+|+|++........+.+.+|+.+++.+.|+|++..
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 588999999876555556678999999999999998731
Q ss_pred ------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceee
Q 046791 578 ------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651 (1018)
Q Consensus 578 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 651 (1018)
.....+++.++..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++........ .....
T Consensus 101 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~ 175 (285)
T cd06648 101 GALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSL 175 (285)
T ss_pred CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccc
Confidence 11245788899999999999999999999 99999999999999999999999998875532211 12234
Q ss_pred ecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHH
Q 046791 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNE 731 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 731 (1018)
.|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ....... +... .....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~-~~~~~~~-----~~~~--~~~~~ 241 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMK-RIRDNLP-----PKLK--NLHKV 241 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHH-HHHhcCC-----CCCc--ccccC
Confidence 688899999999988899999999999999999999999753211 11111 1111100 0010 11123
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 732 VLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 732 ~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+.+++.+||+.+|++||++.++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 467889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=271.57 Aligned_cols=224 Identities=22% Similarity=0.353 Sum_probs=177.0
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
+.|.|+..||.|+||.||++..++ +-..|.|.+...+....+.|+-|++||....||+||.+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 356677889999999999998765 45568899988888889999999999999999999842
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.-...|.+.++..+++|++.||.|||++. |||||||+.|||+.-+|.++|+|||.+.... .....
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQK 186 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHHhh
Confidence 22467899999999999999999999999 9999999999999999999999999986532 22333
Q ss_pred ceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 648 TNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
...+.||+.|||||+.. ..+|+.++||||||++|.||.-+.+|-.. .+......... .....-++
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKia-KSePPTLl--- 256 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIA-KSEPPTLL--- 256 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHHh-hcCCCccc---
Confidence 44689999999999875 47899999999999999999999988432 11111111111 11111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.|..-...+.+++.+||..||..||++.++++
T Consensus 257 ----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 ----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12334567788999999999999999999886
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=293.55 Aligned_cols=231 Identities=24% Similarity=0.314 Sum_probs=179.8
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------- 577 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------- 577 (1018)
+...+-+++....||.|.||.||-+... +|...|+|.++... ........+|+.++..|+|||+|+.
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 4556677888889999999999999854 58899999876542 4455678899999999999999841
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
......++.....+..|++.|+.|||++| ||||||||+||+|+.+|.+|++|||.|..+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 12334556666778899999999999999 99999999999999999999999999998864
Q ss_pred CC--CcccceeeecccccCChhhhccC---CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 642 NQ--SETNTNRVVGTYGYMSPEYAMSG---VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 642 ~~--~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
.. .....+...||+.|||||++.+. ....++||||+|||++||+||+.||...+.+-. . .
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-------I--------M 1451 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-------I--------M 1451 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-------H--------H
Confidence 42 12233567899999999999763 356789999999999999999999976544321 1 1
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
--+...-....|.....+-.+++.+||+.||.+|-++.|+++.
T Consensus 1452 y~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 YHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111112233445556677789999999999999888877764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=268.90 Aligned_cols=238 Identities=23% Similarity=0.299 Sum_probs=174.7
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc---------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR--------- 578 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~--------- 578 (1018)
+....++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++|+||+...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4446788999999999999999999854 58899999986432 22345688999999999999987321
Q ss_pred ---------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 579 ---------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 579 ---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 90 DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 1246788999999999999999999998 9999999999999999999999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHH----------H
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGY----------A 706 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~----------~ 706 (1018)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... ..... .
T Consensus 167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHH
Confidence 65321 223456889999999876 468899999999999999999999986432110 00000 0
Q ss_pred HHHhhcCcchhhhhhhhcC------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 707 WQLWNEGKVLELVDIALEG------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 707 ~~~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+............... ...+.....+.+++.+|++.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000000 011123446789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=258.86 Aligned_cols=224 Identities=25% Similarity=0.348 Sum_probs=172.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc-----ccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR-----SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.+|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.++++++|+||+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999865 4889999987532 22345678999999999999998721
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 11245778888999999999999999999 99999999999999999999999999986532
Q ss_pred CC-CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 642 NQ-SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 642 ~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.. .........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... +...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~---------~~~~ 223 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIF---------KIAT 223 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHH---------HHHc
Confidence 11 11112235688899999999988899999999999999999999999853211 00001 1111
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.......+....+.+.+++.+|++ +|..||++.++++
T Consensus 224 ~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 224 QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111123344555778899999999 5799999998775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=255.90 Aligned_cols=225 Identities=20% Similarity=0.306 Sum_probs=180.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
++|++++.||.|.-|+||++++.+ +...|+|++.+.. .....+...|.+||+.+.||-|..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778999999999999999876 5789999997763 344566788999999999999862
Q ss_pred -------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC--
Q 046791 577 -------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL-- 641 (1018)
Q Consensus 577 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~-- 641 (1018)
....+.+++..+.-++.+++-||+|||-.| ||.|||||+||||.++|++.|+||.|+..+..
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 234667999999999999999999999999 99999999999999999999999998754311
Q ss_pred -------------------------------CCC---------------------cccceeeecccccCChhhhccCCCC
Q 046791 642 -------------------------------NQS---------------------ETNTNRVVGTYGYMSPEYAMSGVVS 669 (1018)
Q Consensus 642 -------------------------------~~~---------------------~~~~~~~~gt~~Y~aPE~~~~~~~s 669 (1018)
... ......++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 0112347899999999999999999
Q ss_pred ccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCC
Q 046791 670 IKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATD 749 (1018)
Q Consensus 670 ~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~ 749 (1018)
.++|.|+|||++|||+.|..||....... .+..++...+.-...+..+..+.+||.+.|..||.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999999999999999997654332 223333333332333455678889999999999999
Q ss_pred CCC----HHHHHH
Q 046791 750 RPA----MPDVVS 758 (1018)
Q Consensus 750 RPs----~~evl~ 758 (1018)
|-. +.||-+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 998 777766
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=271.11 Aligned_cols=236 Identities=25% Similarity=0.307 Sum_probs=170.8
Q ss_pred CcceeeeeccCCCcCeEEEEecc---cccceEEEecccc--cccHHHHHHHHHHHHHh-cCCCccccc------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN---GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKL-QHTNLTDSR------------ 578 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l-~H~nlv~~~------------ 578 (1018)
+|++.+.||+|+||.||+++... +..||||++.... ....+.+.+|+.+++++ +|+||+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 57889999999999999998643 6789999986532 22356788999999999 599987321
Q ss_pred -----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 579 -----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 579 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 2345788899999999999999999999 99999999999999999999999999986543
Q ss_pred CCCc--ccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh--------
Q 046791 642 NQSE--TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW-------- 710 (1018)
Q Consensus 642 ~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-------- 710 (1018)
.... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ..........
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCCCHHHH
Confidence 2211 11233578899999998765 56899999999999999999999998643211 1111100000
Q ss_pred ---hcCcchhhhhh---hhcC---CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 711 ---NEGKVLELVDI---ALEG---SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 711 ---~~~~~~~~~d~---~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
........... .... ...+.....+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0000 001122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=264.95 Aligned_cols=225 Identities=24% Similarity=0.363 Sum_probs=168.6
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc-cccHHHHHHHHHHHHHhc-CCCccccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQ-HTNLTDSR-------------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nlv~~~-------------- 578 (1018)
++|++.+.||+|+||.||+|...+ ++.||||.++... .....++..|+.++.+.. |+||+...
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568888999999999999999865 8899999997543 234456777887777775 99987321
Q ss_pred ------------CCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 579 ------------RNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 579 ------------~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
....+++..+..++.||++||+|||+ .+ |+||||+|+||++++++.+||+|||++..+.....
T Consensus 95 ~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 95 LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred ccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 13468888999999999999999997 46 99999999999999999999999999876542221
Q ss_pred ccceeeecccccCChhhhccCC----CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGV----VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .......... ...
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~-~~~----- 237 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQE-EPP----- 237 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcC-CCC-----
Confidence 12235778999999987543 889999999999999999999998532111 0111111111 000
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.. ........++.+++.+||+.+|++||++.++++.
T Consensus 238 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0111234678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=266.56 Aligned_cols=221 Identities=28% Similarity=0.396 Sum_probs=170.7
Q ss_pred cceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
|...+.||+|+||.||+++.. +++.||+|++.... .....++.+|++++++++|+|++..
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 677789999999999999865 58899999986442 2234578899999999999998721
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 107 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 12455888999999999999999999998 99999999999999999999999999875432
Q ss_pred ceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 648 TNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.....++..|+|||++. .+.++.++||||||+++|||++|+.||...... .........+ ..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~---------~~ 242 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE---------SP 242 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhcc---------CC
Confidence 12346788999999974 467899999999999999999999997532111 0011111110 00
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..........+.+++.+||+.+|.+||++.+|++.+-.
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 11122334567899999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=270.71 Aligned_cols=237 Identities=24% Similarity=0.299 Sum_probs=177.0
Q ss_pred CcceeeeeccCCCcCeEEEEecc-cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|++|.||+|+... ++.||||++.... ....+.+.+|+.+++.++|+||+..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999999764 8899999987653 3445679999999999999998621
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 12236788889999999999999999999 9999999999999999999999999998765432
Q ss_pred C-cccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh-----------
Q 046791 644 S-ETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW----------- 710 (1018)
Q Consensus 644 ~-~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----------- 710 (1018)
. ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... .........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChhHhhhc
Confidence 1 0122334678899999999887 89999999999999999999999986543211 011000000
Q ss_pred hcCcchhhhhhhh-cC-----CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 711 NEGKVLELVDIAL-EG-----SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 711 ~~~~~~~~~d~~l-~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
......+.+.... .. ...+.....+.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000111111000 00 0112235677899999999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=255.51 Aligned_cols=219 Identities=26% Similarity=0.373 Sum_probs=173.6
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... .....++.+|++++++++|+|++..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999754 57899999986542 3345678899999999999998721
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 01245788889999999999999999999 999999999999999999999999999876433
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .. ......+.
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~-~~~~~~~~--------- 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DL-RYKVQRGK--------- 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHhcCC---------
Confidence 122345788999999999999999999999999999999999998543211 00 11111111
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+......+.+++.+|++.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11222345567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=254.45 Aligned_cols=221 Identities=23% Similarity=0.392 Sum_probs=176.0
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|+||.||++... +++.+|+|++..... ....++.+|++++++++|+|++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999875 488999999876532 456678999999999999998621
Q ss_pred ----------c----CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 ----------R----RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 ----------~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
. ....+++..+..++.++++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 0 1366889999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
.......++..|+|||.+.+..++.++||||||+++++|++|+.|+..... ........ ...
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~--------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL-KGQ--------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh-cCC---------
Confidence 122335688899999999988899999999999999999999999753321 11111111 111
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+......+.+++.+||+.+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11122234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=268.14 Aligned_cols=238 Identities=25% Similarity=0.326 Sum_probs=176.0
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc----------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS---------- 577 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~---------- 577 (1018)
+..++++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++|||+++.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4457889999999999999999999865 5889999988643 22345678899999999999998731
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++.....++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 85 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 85 IYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 12345677888899999999999999999 999999999999999999999999998754321
Q ss_pred CCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH-----------h
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL-----------W 710 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-----------~ 710 (1018)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........ .
T Consensus 162 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 162 -----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN---QFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred -----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHhc
Confidence 122456788999998766 578999999999999999999999985432110 00000000 0
Q ss_pred hcCcchhhhhhh-hcCCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 711 NEGKVLELVDIA-LEGSFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 711 ~~~~~~~~~d~~-l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
..+...+.+... .....+ +.....+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011111111110 011111 1234678899999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=263.44 Aligned_cols=235 Identities=23% Similarity=0.317 Sum_probs=169.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR-------------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~-------------- 578 (1018)
++|++.+.||+|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++|+|++...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 58899999986542 23346788999999999999987311
Q ss_pred -------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-CCCceeeeecceeeecCCCC
Q 046791 579 -------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 579 -------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~~~~~~~~ 644 (1018)
....+++..+..++.||+.||+|||+++ ++|+||||+||+++. +..+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 1122467778899999999999999998 999999999999985 55799999999976543211
Q ss_pred cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc------chh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK------VLE 717 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 717 (1018)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...... .............. ...
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 159 --TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred --ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhcccccc
Confidence 1123456889999999876 46789999999999999999999998643211 11111111000000 000
Q ss_pred hhhh-----hhcC----CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDI-----ALEG----SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~-----~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+.+. .... ...+...+++.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0000 011233466789999999999999999999987
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=257.74 Aligned_cols=231 Identities=22% Similarity=0.277 Sum_probs=167.8
Q ss_pred cceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhc-CCCcccc-----------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQ-HTNLTDS----------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nlv~~----------------- 577 (1018)
|++.+.||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|+++.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677899999999999999865 58899999987642 222334567888999885 9998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.++..++.|++.||.|||+.+ ++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 01246889999999999999999999998 999999999999999 9999999999987643221
Q ss_pred cceeeecccccCChhhhc-cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc-----------Cc
Q 046791 647 NTNRVVGTYGYMSPEYAM-SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE-----------GK 714 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-----------~~ 714 (1018)
.....++..|+|||.+. +..++.++|||||||++|||++|..||...... ............ ..
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhcccc
Confidence 12245788999999765 456789999999999999999999998643221 111111111100 00
Q ss_pred chhhhhhhhcC----CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 VLELVDIALEG----SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ~~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+.... ...+.....+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000 001233578899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=263.39 Aligned_cols=226 Identities=28% Similarity=0.387 Sum_probs=175.5
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
..++.|+..+.||+|++|.||+|... +++.+|+|++..... ..+.+.+|++++++++|+|++..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888999999999999999876 588999999976544 56778999999999999998731
Q ss_pred ------------cCCC-CCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 ------------RRNN-RLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 ------------~~~~-~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 1122 7899999999999999999999988 99999999999999999999999999875432211
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ..... .........
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~------ 236 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFL-ITTKGIPPL------ 236 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhcCCCCC------
Confidence 122345778999999999888999999999999999999999997532211 00000 000000000
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.........+.+++.+|++.+|.+||++.+|++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 -KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011113456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=254.83 Aligned_cols=221 Identities=27% Similarity=0.404 Sum_probs=175.4
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+|++.+.||+|++|.||+++.. +++.||+|.+..... ...+.+.+|++++.+++|+|++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 478999999976643 456789999999999999998631
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-- 155 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence 12356899999999999999999999998 999999999999999999999999999876533221
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
.....++..|+|||...+..++.++||||||+++|+|++|+.|+..... . ...+... . ......
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~-~~~~~~~-~---------~~~~~~ 219 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----M-AALFRIV-Q---------DDHPPL 219 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----H-HHHHHHh-c---------cCCCCC
Confidence 2235678899999999888899999999999999999999999853221 0 0011100 0 011122
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+......+.+++.+||+.+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 3334567889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=258.41 Aligned_cols=232 Identities=23% Similarity=0.328 Sum_probs=169.0
Q ss_pred cceeeeeccCCCcCeEEEEecc-cccceEEEeccccc--ccHHHHHHHHHHHHHh---cCCCcccc--------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG--QGIVEFKNEAKLIAKL---QHTNLTDS-------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l---~H~nlv~~-------------- 577 (1018)
|++.+.||+|+||.||+|+... ++.||||+++.... .....+.+|+.++.++ +|+|+++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999865 88999999964422 2234577888887776 59998721
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~ 639 (1018)
.....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 01124788999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch---
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL--- 716 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--- 716 (1018)
..... .....++..|+|||.+.+..++.++||||||+++|||++|++||....... ...............
T Consensus 158 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 158 SFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred cCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHhcC
Confidence 43321 122357889999999999999999999999999999999999886433211 111111100000000
Q ss_pred -------hhhhhhhc---CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 -------ELVDIALE---GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 -------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
........ ....+.....+.+++.+||+.||.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0111233467788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=252.87 Aligned_cols=220 Identities=25% Similarity=0.354 Sum_probs=178.9
Q ss_pred cceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc--------------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD-------------------- 576 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~-------------------- 576 (1018)
|.+..+||+|+||.||++..+ .|+.+|||.+... ...++...|+.++++...+++|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 667789999999999999765 4999999998654 46789999999999999998873
Q ss_pred -------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 577 -------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 577 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
..++++|.+.++..+++..++||+|||... -+|||||+.||||+.+|.+||+|||.|-.+.. .....+
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN 187 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence 134678999999999999999999999876 79999999999999999999999999986642 223345
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
...||+.|||||++..-.|..++||||||++..||.-|++|+....+-.....+ . -.+.-.-.-++
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------P-------T~PPPTF~KPE 253 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------P-------TKPPPTFKKPE 253 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------c-------CCCCCCCCChH
Confidence 689999999999999999999999999999999999999998654433211100 0 00000111233
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.-..++.+++..||-.+|++|-|+.++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 44578889999999999999999988877
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=244.58 Aligned_cols=242 Identities=22% Similarity=0.288 Sum_probs=174.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-----cccceEEEecccccc--cHHHHHHHHHHHHHhcCCCccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-----GQEVAIKRLSRRSGQ--GIVEFKNEAKLIAKLQHTNLTD------------ 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~H~nlv~------------ 576 (1018)
..|+....||+|.||.||+|...+ ...+|||+++..... -.....+|+.+++.++|+|++.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468888999999999999996432 237999999766322 1245689999999999999872
Q ss_pred -------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC----CCceeeee
Q 046791 577 -------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ----MNPKISDF 633 (1018)
Q Consensus 577 -------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~----~~~kL~DF 633 (1018)
....+.++......|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+||
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 122357888899999999999999999998 9999999999999877 89999999
Q ss_pred cceeeecCCCC-cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCC------chHHH
Q 046791 634 GMARIFGLNQS-ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL------NLIGY 705 (1018)
Q Consensus 634 Gla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~------~l~~~ 705 (1018)
|+++.+...-. .......+-|..|.|||.+.+ ..|+.+.|||+.|||+.||++-++.|......... +-...
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99998764322 224456778999999999987 57999999999999999999999888654422111 11111
Q ss_pred HHHHhhcC------------cchhhhhhhhcCCCCh-----------HHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 706 AWQLWNEG------------KVLELVDIALEGSFSP-----------NEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 706 ~~~~~~~~------------~~~~~~d~~l~~~~~~-----------~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
+.+.+... +....+....+..... ...+...+|+..+|+.||-+|.|+++.++..
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 11111100 0000010000000110 0112366788999999999999999888743
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=258.74 Aligned_cols=216 Identities=24% Similarity=0.294 Sum_probs=160.2
Q ss_pred eeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHH---hcCCCccc-------------------
Q 046791 523 KLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAK---LQHTNLTD------------------- 576 (1018)
Q Consensus 523 ~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~---l~H~nlv~------------------- 576 (1018)
.||+|+||.||+++.. +++.+|||.+.... ......+.+|..++.. ..|+|++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 48899999886542 1222334555544443 47888762
Q ss_pred -------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 577 -------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 577 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
+.....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 153 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----cc
Confidence 122456899999999999999999999999 9999999999999999999999999987553221 12
Q ss_pred eeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 650 RVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
...|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ...... .......+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~----------~~~~~~~~ 219 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMT----------LTVNVELP 219 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHh----------hcCCcCCc
Confidence 3468899999999874 56899999999999999999999998644322110 011000 01111233
Q ss_pred hHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRP-----AMPDVVSM 759 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 759 (1018)
.....++.+++.+||+.||++|| +++|+++.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 34456788999999999999999 59988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=255.62 Aligned_cols=219 Identities=22% Similarity=0.334 Sum_probs=169.6
Q ss_pred eccCCCcCeEEEEecc-cccceEEEeccccc---ccHHHHHHHHHHHHHhcCCCcccc----------------------
Q 046791 524 LGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG---QGIVEFKNEAKLIAKLQHTNLTDS---------------------- 577 (1018)
Q Consensus 524 lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nlv~~---------------------- 577 (1018)
||+|+||.||+++... ++.+|+|.+..... ...+.+.+|++++.+++|+|+++.
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 89999999865533 456678999999999999998731
Q ss_pred ----cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC------ccc
Q 046791 578 ----RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS------ETN 647 (1018)
Q Consensus 578 ----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~------~~~ 647 (1018)
.....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 11246789999999999999999999998 99999999999999999999999999876432211 112
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
.....++..|+|||...+...+.++||||||+++|||++|+.||...... ..... ...+.. ..
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~----------~~ 220 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQN-ILNGKI----------EW 220 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HhcCCc----------CC
Confidence 23356788999999999888999999999999999999999998533211 11111 111000 11
Q ss_pred ChH--HHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 728 SPN--EVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 728 ~~~--~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
+.. ....+.+++.+|++.+|.+||++.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 111 25677899999999999999999777777763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=267.94 Aligned_cols=235 Identities=23% Similarity=0.313 Sum_probs=173.7
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
...++|++.+.||+|++|.||+|+.. +++.||||++... .......+.+|+.++++++|+|++..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999875 4789999998653 22334567889999999999998631
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~ 639 (1018)
.....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 11236788999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh--------
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW-------- 710 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-------- 710 (1018)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........
T Consensus 169 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCHHHH
Confidence 322 223457788999999865 46789999999999999999999998533211 1111100000
Q ss_pred ---hcCcchhhhhhhhcC---CC---ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 711 ---NEGKVLELVDIALEG---SF---SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 711 ---~~~~~~~~~d~~l~~---~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
........+...... .+ .......+.+++.+||+.+|++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000011000000 00 0122567889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=255.19 Aligned_cols=216 Identities=23% Similarity=0.316 Sum_probs=168.2
Q ss_pred eccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc----------------------
Q 046791 524 LGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 577 (1018)
Q Consensus 524 lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~---------------------- 577 (1018)
||+|++|.||+++... ++.+|+|.+.... ....+.+.+|+.++++++|+|++..
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999754 8899999986543 2345679999999999999998731
Q ss_pred ----cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeec
Q 046791 578 ----RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653 (1018)
Q Consensus 578 ----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 653 (1018)
.....+++..+..++.||++||.|||+++ ++|+||||+||+++.++.+||+|||++....... ......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~ 154 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG 154 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence 12346788999999999999999999998 9999999999999999999999999998764322 2223467
Q ss_pred ccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHH
Q 046791 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVL 733 (1018)
Q Consensus 654 t~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 733 (1018)
+..|+|||.+.+..++.++|+||||+++|||++|..||.....+. ..... ...+......++.....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~---------~~~~~~~~~~~~~~~~~ 221 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYN---------DILKGNGKLEFPNYIDK 221 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHH---------HHhccCCCCCCCcccCH
Confidence 889999999988889999999999999999999999986443211 11111 11111111223333457
Q ss_pred HHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 734 RCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 734 ~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
.+.+++.+||+.+|++||+ ++|+++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 8899999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=267.12 Aligned_cols=221 Identities=24% Similarity=0.377 Sum_probs=181.8
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccc-------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTD------------- 576 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~------------- 576 (1018)
.-...|.++..||+|.|+.|.+|+.. .+..||||.+.+.. ......+.+|+++|..|+|||||+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34578999999999999999999865 48999999997764 333456899999999999999974
Q ss_pred -------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 577 -------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 577 -------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
+.+..++.+..+..++.|+.+|++|||+++ |||||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec---
Confidence 234566777899999999999999999999 9999999999999999999999999999875
Q ss_pred CcccceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
........+|++.|+|||++.+..+ .+++|+||+|+++|-|+.|..||+... +.++-++.
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-------------------lk~Lr~rv 267 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-------------------LKELRPRV 267 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-------------------cccccchh
Confidence 2334456799999999999998665 688999999999999999999986422 22233333
Q ss_pred hcCC--CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGS--FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+.+. .+.-...++-+++.++|-.+|.+|+++++|.+
T Consensus 268 l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 268 LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 3332 23334567778899999999999999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=268.82 Aligned_cols=234 Identities=24% Similarity=0.337 Sum_probs=173.0
Q ss_pred CcceeeeeccCCCcCeEEEEe-cccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccc------------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTD------------------ 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~------------------ 576 (1018)
.+...+.||+|+||.||+|+. ..|+.||||.++... ....+...+|++++++++|+|||+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 345567899999999999995 459999999998754 445677899999999999999983
Q ss_pred -----------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc--CCC--Cceeeeecc
Q 046791 577 -----------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD--DQM--NPKISDFGM 635 (1018)
Q Consensus 577 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld--~~~--~~kL~DFGl 635 (1018)
..+...|++.+.+.++.+++.||.|||+++ |+||||||.||++- +++ .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 123456899999999999999999999999 99999999999994 333 379999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC-
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG- 713 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 713 (1018)
|+.+..+. .....+||..|.+||.+.+ +.|+..+|.|||||++||.+||..||....... +....++......
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKEIMWHIITKKP 245 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccchhhhhhhccCC
Confidence 99876443 4556899999999999994 899999999999999999999999996554332 1222222222111
Q ss_pred -cchhhhhhhhcC------------CCChHHHHHHHHHHHhccccCCCCCC--CHHHHHH
Q 046791 714 -KVLELVDIALEG------------SFSPNEVLRCIHVGLLCVQDQATDRP--AMPDVVS 758 (1018)
Q Consensus 714 -~~~~~~d~~l~~------------~~~~~~~~~l~~li~~Cl~~dP~~RP--s~~evl~ 758 (1018)
.+.-...+..++ ...+....++-.....++..+|++|- ...+...
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa 305 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFA 305 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHH
Confidence 111111111111 11233445556666777788888887 4433333
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=256.57 Aligned_cols=232 Identities=25% Similarity=0.333 Sum_probs=168.6
Q ss_pred cceeeeeccCCCcCeEEEEecc-cccceEEEeccccc-ccHHHHHHHHHHHHHhc-CCCcccc-----------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQ-HTNLTDS----------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-H~nlv~~----------------- 577 (1018)
|++.+.||+|++|.||+|+..+ ++.||||++..... .......+|+..+.+++ |+|++..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6678899999999999999864 78899999865532 22334567999999999 9998721
Q ss_pred --------cC--CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 --------RR--NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 --------~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.. ...+++.++..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 11 236899999999999999999999998 99999999999999999999999999986543211
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh--------hcC-cchh
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW--------NEG-KVLE 717 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------~~~-~~~~ 717 (1018)
.....++..|+|||++.+ ..++.++|+||||++++||++|+.||........ .......+ .++ ....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH---HHHHHHhcCCCChhhhhhHhhhhc
Confidence 123457889999998754 5689999999999999999999999854432110 00000000 000 0000
Q ss_pred hhhhhhc-------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALE-------GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+..+. ....+.....+.+++.+||+.+|++||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 0001122467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=260.11 Aligned_cols=218 Identities=24% Similarity=0.311 Sum_probs=169.1
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------------- 577 (1018)
.+||+|+||.||++... +++.||||++..........+.+|+.++++++|+|++..
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999874 588999999866555556679999999999999998731
Q ss_pred --cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeeccc
Q 046791 578 --RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY 655 (1018)
Q Consensus 578 --~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~ 655 (1018)
.....+++.....++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++........ ......++.
T Consensus 106 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~ 180 (292)
T cd06657 106 DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTP 180 (292)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCc
Confidence 11345788899999999999999999998 99999999999999999999999999876543221 123356788
Q ss_pred ccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHH
Q 046791 656 GYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRC 735 (1018)
Q Consensus 656 ~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 735 (1018)
.|+|||.+.+..++.++||||||+++|||++|..||...... ... ...... ....+. ........+
T Consensus 181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~----~~~~~~-----~~~~~~--~~~~~~~~l 246 (292)
T cd06657 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM----KMIRDN-----LPPKLK--NLHKVSPSL 246 (292)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhh-----CCcccC--CcccCCHHH
Confidence 999999998888999999999999999999999998532111 000 011000 000110 111234567
Q ss_pred HHHHHhccccCCCCCCCHHHHHH
Q 046791 736 IHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 736 ~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+++.+||+.+|.+||++.++++
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhc
Confidence 78899999999999999999888
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=261.12 Aligned_cols=220 Identities=30% Similarity=0.398 Sum_probs=169.0
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.|...+.||+|+||.||+|+.. +++.+|+|.+... ......++.+|+++++.++|+|++..
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4777789999999999999875 4788999998643 22334568899999999999998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 12345788999999999999999999998 999999999999999999999999998765321
Q ss_pred cceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 647 NTNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+...... ....... .+..
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~~-------- 231 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNES-------- 231 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHh-hcCC--------
Confidence 2346788999999975 356889999999999999999999997532211 0001000 1000
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
...........+.+++.+||+.+|++||++.++++..
T Consensus 232 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0011223445678899999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=260.20 Aligned_cols=218 Identities=28% Similarity=0.398 Sum_probs=167.2
Q ss_pred cceeeeeccCCCcCeEEEEec-ccccceEEEeccccc---ccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG---QGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
|...+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++|+|++..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666678999999999999865 488999999865422 234568899999999999998731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.++..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.... .
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~ 173 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS------P 173 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence 12456889999999999999999999998 9999999999999999999999999986432 1
Q ss_pred ceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 648 TNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.....++..|+|||++. ...++.++||||||+++|||++|..|+..... .......... ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~-~~~-------- 238 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-DSP-------- 238 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc-CCC--------
Confidence 22356888999999984 46688999999999999999999999753321 1111111100 000
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
..........+.+++.+||+.+|.+||++.++++.
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111223457889999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=256.15 Aligned_cols=229 Identities=21% Similarity=0.308 Sum_probs=172.5
Q ss_pred CcceeeeeccCCCcCeEEEEec----ccccceEEEecccc----cccHHHHHHHHHHHHHh-cCCCcccc----------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRRS----GQGIVEFKNEAKLIAKL-QHTNLTDS---------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nlv~~---------- 577 (1018)
+|++.+.||+|++|.||+++.. +++.||||.++... ....+.+.+|+.++.++ +|+|++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999743 46789999986532 23345688999999999 58987621
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.|++++|.|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 12356788899999999999999999998 99999999999999999999999999876543
Q ss_pred CCCcccceeeecccccCChhhhccCC--CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGV--VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
.... ......++..|+|||.+.+.. .+.++||||||+++|||++|..||....... ...........
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~-------- 226 (288)
T cd05583 158 EEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILK-------- 226 (288)
T ss_pred cccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHc--------
Confidence 2211 122346788999999987655 7889999999999999999999985322111 11111111110
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
.....+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 227 ---~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 ---SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0111222334567789999999999999999999888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=266.02 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=170.5
Q ss_pred hCCcce-eeeeccCCCcCeEEEEec-ccccceEEEeccccccc--------------HHHHHHHHHHHHHhcCCCcccc-
Q 046791 515 TNNFSA-VNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQG--------------IVEFKNEAKLIAKLQHTNLTDS- 577 (1018)
Q Consensus 515 t~~y~~-~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~--------------~~~f~~E~~~l~~l~H~nlv~~- 577 (1018)
.++|.. .+.||+|+||.||+|+.. +++.||||.+....... ...+.+|++++.+++|+||+..
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456664 467999999999999865 58899999986542211 1257899999999999998731
Q ss_pred ------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeee
Q 046791 578 ------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633 (1018)
Q Consensus 578 ------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DF 633 (1018)
.....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCc
Confidence 12346788899999999999999999998 999999999999999999999999
Q ss_pred cceeeecCCC------------CcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCC
Q 046791 634 GMARIFGLNQ------------SETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700 (1018)
Q Consensus 634 Gla~~~~~~~------------~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~ 700 (1018)
|++....... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--- 240 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI--- 240 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 9998764111 01111223467889999998764 4789999999999999999999998644321
Q ss_pred chHHHHHHHhhcCcch---hhhh--------hhhcC---CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 701 NLIGYAWQLWNEGKVL---ELVD--------IALEG---SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 701 ~l~~~~~~~~~~~~~~---~~~d--------~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
................ +..+ ..... .........+.+++.+||+.+|++||+++|++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111111111000 0000 00000 001123466789999999999999999999997
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=254.58 Aligned_cols=223 Identities=28% Similarity=0.384 Sum_probs=175.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhc-CCCccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQ-HTNLTD-------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~-H~nlv~-------------- 576 (1018)
++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++.+++ |+||++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999875 5899999998653 2233467889999999999 999872
Q ss_pred ------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 577 ------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 577 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
+.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 112346899999999999999999999999 99999999999999999999999999986643221
Q ss_pred c------------------ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHH
Q 046791 645 E------------------TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYA 706 (1018)
Q Consensus 645 ~------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 706 (1018)
. .......++..|+|||.+.+..++.++||||||++++++++|+.||...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~ 231 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------LTF 231 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------HHH
Confidence 1 2223356788999999999888999999999999999999999998643210 000
Q ss_pred HHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 046791 707 WQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAM----PDVVS 758 (1018)
Q Consensus 707 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~----~evl~ 758 (1018)
. ... ......+....+.+.+++.+||+.+|.+||++ +++++
T Consensus 232 ~---------~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 Q---------KIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H---------HHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 000 11112333446778899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=227.48 Aligned_cols=107 Identities=45% Similarity=0.733 Sum_probs=79.3
Q ss_pred CeeEEEccCCCCCCCC--CCceEEeccCCcEEEEcCCCCeEEEEE-eec-C--cceEEEEeecCcEEEEecCCCCCcccc
Q 046791 87 NQPVWVANRNTPITDK--SGSLTIDSRDGNLKILRKGGNSIVVSS-VQA-M--GNTSAALYETGNFVLYEMNPSGSMERE 160 (1018)
Q Consensus 87 ~t~VWvANr~~Pi~~~--~~~l~~~~~~G~Lvl~~~~~~~~~wss-~~~-~--~~~~a~LldsGNlVl~~~~~~~~~~~~ 160 (1018)
+||||+|||++|+... ...|.++. ||||+|++ .++.++|++ ++. . .+..|+|+|+|||||+|.. +++
T Consensus 2 ~tvvW~an~~~p~~~~s~~~~L~l~~-dGnLvl~~-~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-----~~~ 74 (114)
T PF01453_consen 2 RTVVWVANRNSPLTSSSGNYTLILQS-DGNLVLYD-SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-----GNV 74 (114)
T ss_dssp --------TTEEEEECETTEEEEEET-TSEEEEEE-TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-----SEE
T ss_pred cccccccccccccccccccccceECC-CCeEEEEc-CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-----ceE
Confidence 7899999999999643 47899998 99999999 667789999 554 2 4789999999999999865 789
Q ss_pred eecccCCCcccccCCCeecccccCCCceEEEEecCCCCCC
Q 046791 161 LWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPA 200 (1018)
Q Consensus 161 lWQSFD~PTDTlLPg~klg~~~~tg~~~~L~Swks~~dps 200 (1018)
|||||||||||+||+|+|+.+..+|.+..|+||++.+|||
T Consensus 75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999999999988887777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=244.93 Aligned_cols=215 Identities=23% Similarity=0.301 Sum_probs=172.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLT--------------- 575 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv--------------- 575 (1018)
-++|..+++||+|.||.|-+++-+ .++.+|+|++++.- ......-..|-++|+..+||-|.
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888999999999999999865 48899999998763 34445568899999999999875
Q ss_pred -----------cccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 576 -----------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 576 -----------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
++.+...+++....-+-..|+.||.|||+++ ||.||||.+|.|||.+|++||+|||+++.-- ..
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KY 321 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--cc
Confidence 2344556778888888899999999999999 9999999999999999999999999998532 12
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
...+..++||+.|+|||++....|..+.|.|.+||++|||++|+.||.....+. +.+++-. -.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------------LFeLIl~-ed 384 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------------LFELILM-ED 384 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------HHHHHHh-hh
Confidence 334567899999999999999999999999999999999999999985433221 1111100 01
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRP 751 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RP 751 (1018)
-.+|....++...|+...|..||.+|.
T Consensus 385 ~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 135556667777888889999999995
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=265.03 Aligned_cols=215 Identities=23% Similarity=0.276 Sum_probs=169.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHH-hcCCCccccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAK-LQHTNLTDSR------------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~-l~H~nlv~~~------------- 578 (1018)
.+..|.....+|.|+|+.|-.+... +++..+||++.+... +-.+|+.++.. -+|+|++.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4678888899999999999988754 588999999976622 23556655544 4799987321
Q ss_pred ------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE-cCCCCceeeeecceeeecCCCCc
Q 046791 579 ------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL-DDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 579 ------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl-d~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
...+....++..|+.+|+.|+.|||++| +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 1122333567789999999999999999 9999999999999 58999999999999876533
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
....+-|..|.|||++....+++++|+||||++||+||+|+.||.....+ .++......+
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~i~~~ 529 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTRIQMP 529 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHhhcCC
Confidence 23356688999999999999999999999999999999999998654433 1222222333
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+.........+|+.+||+.||.+||+|.++..
T Consensus 530 ~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 530 KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 344556677889999999999999999999876
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=253.73 Aligned_cols=233 Identities=25% Similarity=0.341 Sum_probs=171.3
Q ss_pred cceeeeeccCCCcCeEEEEecc-cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc----------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR---------------- 578 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~---------------- 578 (1018)
|+..+.||+|++|.||+|+... ++.+|+|.+.... ....+.+..|+.++++++|+|++...
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667899999999999998765 8999999997653 33456788999999999999987311
Q ss_pred ---------C-CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 579 ---------R-NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 579 ---------~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
. ...+++..+..++.|+++||.|||+++ |+||||+|+||++++++.+||+|||++........ ..
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TY 155 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--cc
Confidence 1 146889999999999999999999998 99999999999999999999999999987643221 12
Q ss_pred eeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc---h---hh--h
Q 046791 649 NRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV---L---EL--V 719 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~---~~--~ 719 (1018)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ............... . .+ .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 223456789999998876 8899999999999999999999998543211 111111111000000 0 00 0
Q ss_pred hhhhcC-------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 720 DIALEG-------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 720 d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+..... ...+.....+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 001122467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=254.55 Aligned_cols=225 Identities=21% Similarity=0.320 Sum_probs=168.4
Q ss_pred CcceeeeeccCCCcCeEEEEe----cccccceEEEecccc----cccHHHHHHHHHHHHHh-cCCCcccc----------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQL----LNGQEVAIKRLSRRS----GQGIVEFKNEAKLIAKL-QHTNLTDS---------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nlv~~---------- 577 (1018)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+++.+|+.++.++ +|+||+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 368899999986532 23346788999999999 58988731
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 12345788888999999999999999998 99999999999999999999999999986543
Q ss_pred CCCcccceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ............
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~------- 227 (290)
T cd05613 158 DEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS------- 227 (290)
T ss_pred ccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc-------
Confidence 221 12223568889999999875 346889999999999999999999985322111 111111111100
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
....+......+.+++.+||+.+|++|| ++.++++
T Consensus 228 ----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1112333456778999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=254.39 Aligned_cols=216 Identities=25% Similarity=0.329 Sum_probs=163.7
Q ss_pred eccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc----------------------
Q 046791 524 LGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 577 (1018)
Q Consensus 524 lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~---------------------- 577 (1018)
||+|+||+||++... +|+.||+|.+.... ......+.+|++++++++|+|++..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 58899999986532 2334567889999999999998721
Q ss_pred ----c--CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceee
Q 046791 578 ----R--RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651 (1018)
Q Consensus 578 ----~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 651 (1018)
. ....+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence 1 1126888999999999999999999998 999999999999999999999999998765321 112234
Q ss_pred ecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHH
Q 046791 652 VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNE 731 (1018)
Q Consensus 652 ~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 731 (1018)
.++..|+|||++.+..++.++||||||+++|+|++|+.||.......... . ....... .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~----~~~~~~~------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---E----LKRRTLE------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---H----HHhcccc------ccccCCccC
Confidence 57789999999988889999999999999999999999986443211100 0 0000000 011123334
Q ss_pred HHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 732 VLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 732 ~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
.+.+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 56788999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=248.36 Aligned_cols=220 Identities=24% Similarity=0.347 Sum_probs=167.0
Q ss_pred CcceeeeeccCCCcCeEEEEecc-cccceEEEeccc-----ccccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR-----SGQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++..|+.++++++|||+++.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999998654 455666666432 12334567789999999999998720
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++.+++.++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 12346888999999999999999999998 999999999999976 469999999998764
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.... ......... .+.
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~-~~~------ 221 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIV-EGP------ 221 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH-cCC------
Confidence 3221 2223567889999999988889999999999999999999999974221 111111110 111
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+......+.+++.+||+.+|++||++.|+++
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11123344567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=258.44 Aligned_cols=217 Identities=25% Similarity=0.343 Sum_probs=172.1
Q ss_pred eeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc--------------------
Q 046791 521 VNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS-------------------- 577 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~-------------------- 577 (1018)
.+.||+|-||+||-|+.+ +|+.||||++.+. ...+..++++|+.+|++++||.||.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 378999999999999854 6999999999765 34556789999999999999999831
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC---CCceeeeecceeeecCCCCccc
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~---~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.+.++|++....-++.||+.||.|||.++ |+|+||||+||||... -++||+|||+|+.++... .
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence 24578888888999999999999999999 9999999999999644 358999999999987433 3
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....+||+.|+|||++++..|...-|+||.|||+|--++|..||....+- -+.++ +.. .+ .....
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-----ndQIQ----NAa---FM---yPp~P 787 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-----NDQIQ----NAA---FM---YPPNP 787 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-----hHHhh----ccc---cc---cCCCc
Confidence 34579999999999999999999999999999999999999998532211 00000 000 00 00111
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
-.+.....+++|...||..-.+|.+..+-+.
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1345567889999999999999999877665
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-28 Score=244.35 Aligned_cols=235 Identities=23% Similarity=0.325 Sum_probs=173.4
Q ss_pred ccceeHHHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc-ccHHHHHHHHHHHHHh-cCCCcccc--
Q 046791 503 LEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKL-QHTNLTDS-- 577 (1018)
Q Consensus 503 ~~~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nlv~~-- 577 (1018)
+..|+-+.|+.. ..||.|+||+|+|-..+ .|+..|||+++.... ...++++.|.+...+- +.||||+.
T Consensus 58 ~~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 445655555544 68999999999999764 599999999976643 5567788888865554 67888731
Q ss_pred ----------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCce
Q 046791 578 ----------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK 629 (1018)
Q Consensus 578 ----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~k 629 (1018)
.....+++...-+|....++||.||.+.- .|||||+||+|||||..|.+|
T Consensus 131 a~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEe
Confidence 23456788888888888999999998754 699999999999999999999
Q ss_pred eeeecceeeecCCCCcccceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH
Q 046791 630 ISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 630 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 707 (1018)
|||||++-.+. .....+..+|...|||||.+.. ..|+.+|||||||++|+|+.||+.|+..... ..+...
T Consensus 209 LCDFGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~ 280 (361)
T KOG1006|consen 209 LCDFGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLC 280 (361)
T ss_pred eecccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHH
Confidence 99999987653 2333445688899999999864 4589999999999999999999999753221 111111
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+.. .|....+. ......+....+..++..|+..|..+||...++.++
T Consensus 281 ~Vv-~gdpp~l~----~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 QVV-IGDPPILL----FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHH-cCCCCeec----CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 12111111 001112345678899999999999999999998763
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=255.02 Aligned_cols=231 Identities=18% Similarity=0.194 Sum_probs=160.8
Q ss_pred eeeccCCCcCeEEEEecccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc----------------------
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~---------------------- 577 (1018)
+.+|.|+++.||+++. +++.||||+++.. .....+.+.+|++++++++|+||+..
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3444445545555444 6889999998754 34456789999999999999998731
Q ss_pred ------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC-----cc
Q 046791 578 ------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS-----ET 646 (1018)
Q Consensus 578 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~-----~~ 646 (1018)
.....+++.....++.|+++||.|||+++ |+||||||+||+++.++.+||+|||.+........ ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 11235788889999999999999999998 99999999999999999999999999876532211 11
Q ss_pred cceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH----hhc-------C
Q 046791 647 NTNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL----WNE-------G 713 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~----~~~-------~ 713 (1018)
......++..|+|||++.. ..++.++||||||+++|||++|+.||....... ......... +.. .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcC
Confidence 1223456778999999876 458899999999999999999999986432111 111100000 000 0
Q ss_pred cchh----hhhhhh----cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 KVLE----LVDIAL----EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~~~~----~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.... ..++.. ..........++.+++.+||+.||++|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 000000 00112233467888999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=261.20 Aligned_cols=232 Identities=21% Similarity=0.272 Sum_probs=162.6
Q ss_pred eeeccC--CCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-------------------
Q 046791 522 NKLGEG--GFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G--~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------------- 577 (1018)
..||+| +||+||+++.. +|+.||||++.... ....+.+.+|+.+++.++|+||++.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467776 88999999874 68999999986542 2334678999999999999999731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc--
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET-- 646 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~-- 646 (1018)
.....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 01234778888899999999999999998 9999999999999999999999998654322111100
Q ss_pred ---cceeeecccccCChhhhccC--CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH--------------
Q 046791 647 ---NTNRVVGTYGYMSPEYAMSG--VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW-------------- 707 (1018)
Q Consensus 647 ---~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~-------------- 707 (1018)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....... .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccch
Confidence 01112345679999999763 47899999999999999999999986432110 0000000
Q ss_pred --HHhhc----------------CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 708 --QLWNE----------------GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 708 --~~~~~----------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... .....+.+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 0000011111111222345677899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=251.89 Aligned_cols=215 Identities=25% Similarity=0.314 Sum_probs=159.7
Q ss_pred eeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHH---HHHhcCCCccc-------------------
Q 046791 523 KLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKL---IAKLQHTNLTD------------------- 576 (1018)
Q Consensus 523 ~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~---l~~l~H~nlv~------------------- 576 (1018)
.||+|+||.||+++.. +++.||+|.+.... ......+..|..+ +....|++++.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 48899999986542 1222334555444 44457888762
Q ss_pred -------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 577 -------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 577 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
......+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~ 153 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----Cc
Confidence 112456899999999999999999999998 9999999999999999999999999987553221 12
Q ss_pred eeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 650 RVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
...|+..|+|||.+.++ .++.++||||||+++|||++|+.||.......... ..... .......+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~----------~~~~~~~~ 219 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT----------LTMAVELP 219 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHh----------hccCCCCC
Confidence 34688999999998754 68999999999999999999999986542221110 00000 00011222
Q ss_pred hHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
......+.+++.+|++.+|.+|| ++.++++
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 33456788999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=249.30 Aligned_cols=219 Identities=20% Similarity=0.258 Sum_probs=162.9
Q ss_pred eeeccCCCcCeEEEEec-ccccceEEEeccccc---ccHHHHHHHHHH-HHHhcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG---QGIVEFKNEAKL-IAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~-l~~l~H~nlv~~------------------- 577 (1018)
+.||+|+||.||+|+.. +++.||||.+..... .....+..|..+ ....+|+|++..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 488999999865431 222334555444 445689998731
Q ss_pred -------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccccee
Q 046791 578 -------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650 (1018)
Q Consensus 578 -------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 650 (1018)
.....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~ 152 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK 152 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence 12356888999999999999999999998 99999999999999999999999999876432 223
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChH
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 730 (1018)
..++..|+|||.+.+..++.++||||||+++|||++|..||...... ........+... ........
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~ 219 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRIN------WPEEVKEF 219 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccC------CCCccccc
Confidence 46788999999998888999999999999999999999998532211 111111111100 01111123
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 731 EVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 731 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 45678899999999999999988777776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-27 Score=237.64 Aligned_cols=241 Identities=22% Similarity=0.375 Sum_probs=174.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
..|....+||+|.||+||+|+..+ |+.||+|++--. .+.-...-.+|+++|..|+|+|++++
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345666799999999999998765 788999876432 22223445899999999999997621
Q ss_pred -------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 -------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
....+++..++.+++.++..||.|+|... |+|||+||+|+||+.++.+||+|||+++.
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 12356888899999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCC--cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHH-----Hh
Q 046791 639 FGLNQS--ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQ-----LW 710 (1018)
Q Consensus 639 ~~~~~~--~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~ 710 (1018)
+..... ....+..+-|..|.+||.+.+ ..++++.|||.-|||+.||.+|.+.+..........++..... .|
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 653322 222334566899999999887 6799999999999999999999998876554443333332111 11
Q ss_pred hc---Ccchhhh--hhhhcCCC--ChHH------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 711 NE---GKVLELV--DIALEGSF--SPNE------VLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 711 ~~---~~~~~~~--d~~l~~~~--~~~~------~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.+ -.+.+.+ +|...+.+ -++. -+..++|+..++..||.+|+.+.+++..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11 1111111 11011100 0111 2356788889999999999999998764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=247.32 Aligned_cols=224 Identities=21% Similarity=0.278 Sum_probs=165.1
Q ss_pred HHHHHHHhCCcceeeee--ccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc------
Q 046791 508 FQTISAATNNFSAVNKL--GEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS------ 577 (1018)
Q Consensus 508 ~~~l~~~t~~y~~~~~l--G~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~------ 577 (1018)
..++....++|++.+.+ |+|+||.||+++.. +++.+|+|.+........ |+.....+ +|+|+++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556788887777 99999999999864 478899999865422211 22222222 69998721
Q ss_pred --------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-Cceeeeecce
Q 046791 578 --------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMA 636 (1018)
Q Consensus 578 --------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kL~DFGla 636 (1018)
.....+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 12347899999999999999999999999 99999999999999988 9999999998
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
...... ....++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+....
T Consensus 158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~------- 223 (267)
T PHA03390 158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ------- 223 (267)
T ss_pred eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-------
Confidence 865422 12457889999999999899999999999999999999999986332211 1111111100
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPA-MPDVVS 758 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~ 758 (1018)
.. ...........+.+++.+||+.+|.+||+ ++|+++
T Consensus 224 ---~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ---QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 00112235567889999999999999996 688874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=220.15 Aligned_cols=237 Identities=24% Similarity=0.297 Sum_probs=170.1
Q ss_pred CcceeeeeccCCCcCeEEEEecc-cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc---------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR--------------- 578 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~--------------- 578 (1018)
+|...++||+|.||+||+|+..+ ++.||+|+++-.. +.-.....+|+-+++.++|+|||++.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46677899999999999999655 7889999986543 22234578999999999999998531
Q ss_pred -----------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 579 -----------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 579 -----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
-++.++.+....++.|+++||.++|+++ +.||||||+|.||+.+|++||+|||+++.++..-...
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy- 158 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY- 158 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee-
Confidence 2567888999999999999999999999 9999999999999999999999999999876432222
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcC---cchhhhhhh
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEG---KVLELVDIA 722 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d~~ 722 (1018)
...+-|..|.+|.++.+ .-|+...|+||-|||+.|+.. |++.|.....+++...+-+......+. .+..+.|-.
T Consensus 159 -saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 159 -SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred -eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 23466889999999987 458899999999999999987 444454433222211111111111111 122222222
Q ss_pred hcCCCCh---------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSP---------NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~---------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.-..++. .....-.++.+..+.-+|..|.++++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222221 11122346777788889999999988765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=248.33 Aligned_cols=243 Identities=20% Similarity=0.243 Sum_probs=177.7
Q ss_pred ceeHHHHHHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcC--CC--------
Q 046791 505 IFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH--TN-------- 573 (1018)
Q Consensus 505 ~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H--~n-------- 573 (1018)
+|...+. .+++|.+...+|+|.||.|-+..... +..||||+++... .-.+.-+-|+++++++.+ |+
T Consensus 80 v~~~gD~--l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 80 VYQVGDI--LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEEeccc--cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 4444443 37899999999999999999997644 7889999997653 334566889999999943 22
Q ss_pred -----------cc------------cccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC------
Q 046791 574 -----------LT------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD------ 624 (1018)
Q Consensus 574 -----------lv------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~------ 624 (1018)
|| ......+++..++..|+.|+++++++||+.+ ++|-||||+|||+-+
T Consensus 157 ~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEE
Confidence 11 1223456788999999999999999999999 999999999999821
Q ss_pred --------------CCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCC
Q 046791 625 --------------QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKN 690 (1018)
Q Consensus 625 --------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p 690 (1018)
+..+||+|||.|...... ....+.|..|.|||++.+-.++..+||||+||||.|+.+|...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 345899999999875322 2457889999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchHHHH--------------HHHhhcCcc-----------hhhhhhhh----cCCCChHHHHHHHHHHHh
Q 046791 691 NGCYRTDHPLNLIGYA--------------WQLWNEGKV-----------LELVDIAL----EGSFSPNEVLRCIHVGLL 741 (1018)
Q Consensus 691 ~~~~~~~~~~~l~~~~--------------~~~~~~~~~-----------~~~~d~~l----~~~~~~~~~~~l~~li~~ 741 (1018)
|......+...+.+.+ .+.+..+.+ ..+.++.. .......+..++.+|+.+
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 8765532222121111 111111110 00010000 001234566789999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 046791 742 CVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 742 Cl~~dP~~RPs~~evl~ 758 (1018)
+|..||.+|+|+.|++.
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999876
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-26 Score=273.43 Aligned_cols=230 Identities=27% Similarity=0.387 Sum_probs=176.2
Q ss_pred CCcceeeeeccCCCcCeEEEEecc--------cccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccc--------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN--------GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDS-------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~-------- 577 (1018)
++..+.+.||+|.||.|++|.... ...||||.++... ....+.+..|+++++.+ +|+|++.+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 344555699999999999997531 3469999997653 34567899999999998 59998721
Q ss_pred ------------------cC-C---------------CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 578 ------------------RR-N---------------NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 578 ------------------~~-~---------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
+. + ..|.....+.++.|||.|++||++.. +|||||.++|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 00 1 23888999999999999999999998 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccce-eeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCc
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTN-RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLN 701 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~ 701 (1018)
++..+||+|||+|+............ ...-...|||||.+....++.|+|||||||+||||++ |..|+......
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~---- 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT---- 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH----
Confidence 99999999999999654333322111 1112456999999999999999999999999999998 66776431101
Q ss_pred hHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 702 LIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 702 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
....+.+++|. +...|.....++.++++.||+.+|++||++.|+++.|+..
T Consensus 529 --~~l~~~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 --EELLEFLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --HHHHHHHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11122233332 2234555678888999999999999999999999999884
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=265.02 Aligned_cols=232 Identities=22% Similarity=0.247 Sum_probs=144.6
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-----cccceEEEecccccccHHHHHHHH----------HHHHHhcCCC-----
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-----GQEVAIKRLSRRSGQGIVEFKNEA----------KLIAKLQHTN----- 573 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~f~~E~----------~~l~~l~H~n----- 573 (1018)
..++|++.++||+|+||.||+|++.+ +..||||++...... +.+..|. ..+..+.++.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNERVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHHHHHhhchhhHHHHHHhhhcccccccC
Confidence 56789999999999999999998754 688999988643211 1111110 0111111100
Q ss_pred ----cc----------ccc---------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCC
Q 046791 574 ----LT----------DSR---------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKAS 618 (1018)
Q Consensus 574 ----lv----------~~~---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~ 618 (1018)
|+ +.. .........+..++.||++||.|||+++ |+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHH
Confidence 00 000 0011122345679999999999999998 999999999
Q ss_pred cEEEcC-CCCceeeeecceeeecCCCCcccceeeecccccCChhhhccC----------------------CCCccccch
Q 046791 619 NILLDD-QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG----------------------VVSIKTDVF 675 (1018)
Q Consensus 619 NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~ksDV~ 675 (1018)
|||++. ++.+||+|||+++.+..... .......+++.|+|||.+... .+..++|||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999986 57899999999986543222 222346789999999976422 234567999
Q ss_pred hHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC----------hHHHHHHHHHHHhcccc
Q 046791 676 SFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS----------PNEVLRCIHVGLLCVQD 745 (1018)
Q Consensus 676 SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~----------~~~~~~l~~li~~Cl~~ 745 (1018)
||||+||||+++..+.+. .+..........+............... ........+|+.+||+.
T Consensus 364 SlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999997765321 1111111110001000000000000000 01123455899999999
Q ss_pred CCCCCCCHHHHHH
Q 046791 746 QATDRPAMPDVVS 758 (1018)
Q Consensus 746 dP~~RPs~~evl~ 758 (1018)
||++|||+.|+++
T Consensus 437 dP~kR~ta~e~L~ 449 (566)
T PLN03225 437 KGRQRISAKAALA 449 (566)
T ss_pred CcccCCCHHHHhC
Confidence 9999999999987
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=251.40 Aligned_cols=222 Identities=23% Similarity=0.334 Sum_probs=178.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecccc-cceEEEeccc---ccccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQ-EVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~-~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
.+++++..||-||||.|-+++..... .+|+|++++. .....+....|-.+|...+.+.||+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34455578999999999999875533 4899988765 3455667889999999999988873
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
++.++.++..+..-++..+++|++|||.++ ||.|||||+|.|||.+|-+||.|||+|+.++. .
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---G 573 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc---C
Confidence 355778899999999999999999999999 99999999999999999999999999998863 3
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
..+..++||+.|.|||++.+...+.++|.||||+++|||++|.+||...++-..++++- .-+|. -
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL------------kGid~---i 638 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL------------KGIDK---I 638 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH------------hhhhh---h
Confidence 45567999999999999999999999999999999999999999997654332222111 11111 1
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
.+|........+++.+.+..+|.+|-. +.+|.+
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 345555667778889999999999976 566665
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=240.48 Aligned_cols=210 Identities=25% Similarity=0.320 Sum_probs=165.2
Q ss_pred eccCCCcCeEEEEecc-cccceEEEeccccc---ccHHHHHHHHHHHHHhcCCCcccc----------------------
Q 046791 524 LGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG---QGIVEFKNEAKLIAKLQHTNLTDS---------------------- 577 (1018)
Q Consensus 524 lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nlv~~---------------------- 577 (1018)
||+|+||.||++...+ ++.+|+|.+..... .....+..|+.++++++|+|++..
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999998754 88999999876532 245678999999999999998621
Q ss_pred ----cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeec
Q 046791 578 ----RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653 (1018)
Q Consensus 578 ----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 653 (1018)
.....+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCG 155 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcC
Confidence 12336889999999999999999999988 9999999999999999999999999998764322 12234567
Q ss_pred ccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHH
Q 046791 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVL 733 (1018)
Q Consensus 654 t~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 733 (1018)
+..|+|||.+.+...+.++|+||||+++|||++|+.||..... ........ . .....+.....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~---------~--~~~~~~~~~~~ 218 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKIL---------K--DPLRFPEFLSP 218 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh---------c--CCCCCCCCCCH
Confidence 8899999999988899999999999999999999999853321 00000000 0 01123333357
Q ss_pred HHHHHHHhccccCCCCCCCHHH
Q 046791 734 RCIHVGLLCVQDQATDRPAMPD 755 (1018)
Q Consensus 734 ~l~~li~~Cl~~dP~~RPs~~e 755 (1018)
.+.+++.+||..||++||++.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 7889999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=232.19 Aligned_cols=234 Identities=24% Similarity=0.361 Sum_probs=179.4
Q ss_pred HHHHHHHhCCcceeeeeccCCCcCeEEEE-ecccccceEEEecccccccHHHHHHHHHHHHHh-cCCCccc---------
Q 046791 508 FQTISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTD--------- 576 (1018)
Q Consensus 508 ~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~--------- 576 (1018)
|+++-+.| .+.||+|+|+.|--+. +.+|.++|||++.+.......+..+|++++.+. .|+||++
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 55555554 3689999999998886 667999999999988888889999999999998 4999873
Q ss_pred -----------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC---ceeeeecce
Q 046791 577 -----------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDFGMA 636 (1018)
Q Consensus 577 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kL~DFGla 636 (1018)
+...+.+++.++.+++++|+.||.+||.+| |.||||||+|||-..... +||+||.++
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccc
Confidence 233566899999999999999999999999 999999999999975544 799999988
Q ss_pred eeecCCCCc-----ccceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHH
Q 046791 637 RIFGLNQSE-----TNTNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYA 706 (1018)
Q Consensus 637 ~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 706 (1018)
.-+..+... ......+|+..|||||+.. ...|+.++|.||||||||-||+|.+||...-..+-.
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG------ 300 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG------ 300 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC------
Confidence 654432221 1223578899999999764 246889999999999999999999999776544321
Q ss_pred HHHhhcCcch-----hhhhhhhcC--CCChHH----HHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 707 WQLWNEGKVL-----ELVDIALEG--SFSPNE----VLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 707 ~~~~~~~~~~-----~~~d~~l~~--~~~~~~----~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
|..|+.- .+++.+..+ .+|.++ ..+..+++...+..++.+|-++.+++.
T Consensus 301 ---WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 ---WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ---ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 2233221 223333333 344433 355667888888999999999988877
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-26 Score=229.65 Aligned_cols=240 Identities=21% Similarity=0.267 Sum_probs=175.5
Q ss_pred ceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccc-------------------
Q 046791 519 SAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTD------------------- 576 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~------------------- 576 (1018)
+..+.||-|+||.||.++++ +|+.||+|++.... -...+.+.+|+++|..++|.|++.
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999999875 59999999986542 234577899999999999999651
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
+-.-..|+.....-++.||++||.|||+.+ |.||||||.|.|++.+-.+||+|||+++..+.++..
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 123456788888889999999999999999 999999999999999999999999999976544433
Q ss_pred ccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHH--------HHHHhhcCcch
Q 046791 646 TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGY--------AWQLWNEGKVL 716 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~~ 716 (1018)
. .+..+-|..|.|||++++ ..|+.+.||||.|||+.||+..+..|....+....+++.. +.+..-+|...
T Consensus 213 h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 213 N-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred h-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 3 334566889999999997 6799999999999999999999988765444333322211 11111112111
Q ss_pred hhhhhhhcC-C--------CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 717 ELVDIALEG-S--------FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 717 ~~~d~~l~~-~--------~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
.++....+. . -+...-.+.+.+...++..||++|.+..+.+..+..
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 122111111 0 011222345567778899999999999988876643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=269.72 Aligned_cols=119 Identities=27% Similarity=0.456 Sum_probs=103.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|.+.++||+|+||.||+|+.. +++.||||+++... ......+..|+.++..++|+||+..
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999876 58899999986542 2234678999999999999998731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
.....+++..++.|+.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 12345788889999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=230.54 Aligned_cols=221 Identities=20% Similarity=0.229 Sum_probs=169.4
Q ss_pred HhCCccee-eeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHh-cCCCccc--------------
Q 046791 514 ATNNFSAV-NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTD-------------- 576 (1018)
Q Consensus 514 ~t~~y~~~-~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~-------------- 576 (1018)
.+++|++. ++||-|-.|.|-....+ +++.+|+|++... ...++|+++.-+. .|+|||.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 56677765 57999999999988754 5889999998644 2347788775544 7999872
Q ss_pred ------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc---CCCCceeeeecc
Q 046791 577 ------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGM 635 (1018)
Q Consensus 577 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kL~DFGl 635 (1018)
.+....+++.++-.|++||..|+.|||+.+ |.||||||+|+|.. .|-.+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 123456899999999999999999999999 99999999999996 355689999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV 715 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 715 (1018)
|+.... .......+-|+.|.|||++....|+..+|+||+||++|-|++|-+||-...... +..-....+..|.
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gq- 283 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQ- 283 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccC-
Confidence 987532 334445788999999999999999999999999999999999999985433211 1111111111111
Q ss_pred hhhhhhhhcCCCChH----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 LELVDIALEGSFSPN----EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 ~~~~d~~l~~~~~~~----~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
-.++.+ ..+...++++.+|..+|.+|.|+.|++.
T Consensus 284 ---------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 ---------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ---------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 123333 3466778999999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=229.79 Aligned_cols=212 Identities=26% Similarity=0.315 Sum_probs=164.3
Q ss_pred CCcCeEEEEecc-cccceEEEeccccccc-HHHHHHHHHHHHHhcCCCcccc--------------------------cC
Q 046791 528 GFGPVYKGQLLN-GQEVAIKRLSRRSGQG-IVEFKNEAKLIAKLQHTNLTDS--------------------------RR 579 (1018)
Q Consensus 528 ~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~-~~~f~~E~~~l~~l~H~nlv~~--------------------------~~ 579 (1018)
+||.||+|+... ++.+|+|++....... .+.+.+|++.+++++|+|++.. ..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8899999997765444 6889999999999999998621 11
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCC
Q 046791 580 NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659 (1018)
Q Consensus 580 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 659 (1018)
...+++..+..++.+++++|.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA 154 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence 122788899999999999999999998 9999999999999999999999999998765332 2334567889999
Q ss_pred hhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHH
Q 046791 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVG 739 (1018)
Q Consensus 660 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 739 (1018)
||.+.+..++.++||||||+++++|++|..||...... .........+.... .........++.+++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~i 221 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPF-------PPPEWKISPEAKDLI 221 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCC-------ccccccCCHHHHHHH
Confidence 99999888999999999999999999999998542111 01111111110000 000000446788999
Q ss_pred HhccccCCCCCCCHHHHHH
Q 046791 740 LLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 740 ~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+|+..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-25 Score=233.05 Aligned_cols=215 Identities=24% Similarity=0.328 Sum_probs=165.7
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCC-cc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTN-LT--------------- 575 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~n-lv--------------- 575 (1018)
.+|..+.+||+|+||.|.+|..+. .+.+|||++++.- ....+--+.|-++|+....|- |+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468888999999999999997654 6679999997752 223333455666665544332 22
Q ss_pred -----------cccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 576 -----------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 576 -----------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
+..+-+.+.+..+.-++..||-||-+||+++ ||.||||.+|||||.+|++||+|||+++.-- ..
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FD 503 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc--cC
Confidence 1234466788889999999999999999999 9999999999999999999999999998522 23
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
...+..++||+.|+|||++..++|+..+|.|||||+||||+.|++||+..+++. + ...+.+. .
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---l------------F~aI~eh--n 566 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L------------FQAIMEH--N 566 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---H------------HHHHHHc--c
Confidence 445667999999999999999999999999999999999999999997544321 1 1111111 1
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPA 752 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs 752 (1018)
-.++.....+...+....+...|.+|..
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 2456666777788888888999999853
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=240.16 Aligned_cols=234 Identities=25% Similarity=0.357 Sum_probs=174.4
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc-------cccHHHHHHHHHHHHHhcCCCccc-------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS-------GQGIVEFKNEAKLIAKLQHTNLTD------- 576 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-------~~~~~~f~~E~~~l~~l~H~nlv~------- 576 (1018)
....++|-++.+||+|||+.||++.+ ...+.||||+-.... ..-.+...+|.+|.+.|.||.||+
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34456888999999999999999974 457889999753321 112334678999999999999983
Q ss_pred --------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc---CCCCceeeee
Q 046791 577 --------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDF 633 (1018)
Q Consensus 577 --------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kL~DF 633 (1018)
+...+.+++.++..|+.||+.||.||.+.. +||||-||||.||||- .-|.+||.||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 234667899999999999999999999886 7899999999999995 4578999999
Q ss_pred cceeeecCCCCc-----ccceeeecccccCChhhhcc----CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHH
Q 046791 634 GMARIFGLNQSE-----TNTNRVVGTYGYMSPEYAMS----GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG 704 (1018)
Q Consensus 634 Gla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~ 704 (1018)
|+++.+..+... ..+....||..|++||.+.- ..++.|.||||.|||+|..+.|++||+......
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ------ 691 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ------ 691 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH------
Confidence 999998754432 23445789999999998753 457899999999999999999999996433221
Q ss_pred HHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 046791 705 YAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVV 757 (1018)
Q Consensus 705 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 757 (1018)
..+.+..+...-+- .-..-+....+...+|.+||+..-++|....++.
T Consensus 692 ---dILqeNTIlkAtEV--qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 ---DILQENTILKATEV--QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---HHHhhhchhcceec--cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11112222111110 1111233446777899999999999997765544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=255.72 Aligned_cols=218 Identities=27% Similarity=0.374 Sum_probs=159.7
Q ss_pred cceeeeeccCCCcC-eEEEEecccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc------------------
Q 046791 518 FSAVNKLGEGGFGP-VYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS------------------ 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~------------------ 577 (1018)
|...+.+|.|+-|+ ||+|.. +|++||||++-... .....+|+.+|+.- +||||++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44446789999886 799988 67899999985432 23457899988877 79999831
Q ss_pred ------cCC--C---CCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---C--CCceeeeecceeeecC
Q 046791 578 ------RRN--N---RLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---Q--MNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ------~~~--~---~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~--~~~kL~DFGla~~~~~ 641 (1018)
... . .......+.++.|++.||++||+.+ ||||||||+||||+. + ..++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 011 1 1111345778999999999999988 999999999999975 2 5689999999998865
Q ss_pred CCC-cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhC-CCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 642 NQS-ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG-KKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 642 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
+.. ........||.+|+|||++....-+.++|||||||++|..++| .+||+.....+ ...+....-...+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVHL 735 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceeee
Confidence 443 2234567899999999999998889999999999999999997 88986432111 0111111111111
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...++. +..+||.+|++++|..||++.+|+.
T Consensus 736 ------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 ------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 011111 6778999999999999999999985
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=231.57 Aligned_cols=194 Identities=20% Similarity=0.150 Sum_probs=148.4
Q ss_pred CCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc--------------------------cC
Q 046791 527 GGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------------------------RR 579 (1018)
Q Consensus 527 G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------------------------~~ 579 (1018)
|.+|.||+++.. +++.+|+|++.... .+..|...+....|||++.. ..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 48899999986643 33455666666779998731 12
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCC
Q 046791 580 NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659 (1018)
Q Consensus 580 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 659 (1018)
...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||.+...... .....++..|+|
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 235788999999999999999999998 999999999999999999999999988665321 112345678999
Q ss_pred hhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHH
Q 046791 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVG 739 (1018)
Q Consensus 660 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 739 (1018)
||.+.+..++.++||||+|+++|||++|+.|+....... .. ......+......+.+++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~---------~~~~~~~~~~~~~~~~li 209 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT---------HTTLNIPEWVSEEARSLL 209 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc---------ccccCCcccCCHHHHHHH
Confidence 999988889999999999999999999998764221100 00 000012223346678899
Q ss_pred HhccccCCCCCCCHH
Q 046791 740 LLCVQDQATDRPAMP 754 (1018)
Q Consensus 740 ~~Cl~~dP~~RPs~~ 754 (1018)
.+|++.||++||++.
T Consensus 210 ~~~l~~dp~~R~~~~ 224 (237)
T cd05576 210 QQLLQFNPTERLGAG 224 (237)
T ss_pred HHHccCCHHHhcCCC
Confidence 999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=212.34 Aligned_cols=234 Identities=19% Similarity=0.288 Sum_probs=172.8
Q ss_pred HhCCcceeeeeccCCCcCeEEEE-ecccccceEEEecccccccHHHHHHHHHHHHHhc-CCCcccccC------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNLTDSRR------------ 579 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nlv~~~~------------ 579 (1018)
..++|++.+++|+|.+++||.|. ..+.++++||+++... .+...+|+.+|..|. ||||+.+..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35789999999999999999997 4568899999997654 356799999999998 999984211
Q ss_pred -------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-CCCceeeeecceeeecCCCCc
Q 046791 580 -------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 580 -------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~~~~~~~~~ 645 (1018)
-..|+...+...+.+++.||.|+|+.| |+|||+||.|++||. ...++|+|+|+|.+....
T Consensus 113 iFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~--- 186 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--- 186 (338)
T ss_pred HhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC---
Confidence 123556677788999999999999999 999999999999995 456999999999887533
Q ss_pred ccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh-------
Q 046791 646 TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE------- 717 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------- 717 (1018)
...+..+.+..|.-||.+-. ..++..-|+|||||++.+|+..+.||-- ..+...+++..+.-+ ...++..
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh-G~dN~DQLVkIakVL-Gt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVKIAKVL-GTDELYAYLNKYQI 264 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC-CCCCHHHHHHHHHHh-ChHHHHHHHHHHcc
Confidence 33344677888999999876 6788999999999999999999999842 222223344332211 1100000
Q ss_pred hhhhhhcC---CC------------ChH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALEG---SF------------SPN-EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~~---~~------------~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+|+.... .. ... ..++.++++...|..|-++|||+.|.++
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01221111 00 001 1367788899999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=246.33 Aligned_cols=233 Identities=19% Similarity=0.239 Sum_probs=154.6
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe-----------------cccccceEEEecccccccHHH--------------HHHH
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL-----------------LNGQEVAIKRLSRRSGQGIVE--------------FKNE 562 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~~~~--------------f~~E 562 (1018)
..++|++.++||+|+||.||+|.+ ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 235679999986543332333 3446
Q ss_pred HHHHHHhcCCCccc-----------------------------c----------------------------------cC
Q 046791 563 AKLIAKLQHTNLTD-----------------------------S----------------------------------RR 579 (1018)
Q Consensus 563 ~~~l~~l~H~nlv~-----------------------------~----------------------------------~~ 579 (1018)
+.++.+++|.+++. . ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 67777777765410 0 00
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCC
Q 046791 580 NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659 (1018)
Q Consensus 580 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 659 (1018)
...+++..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||++..+..... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 112456778889999999999999998 99999999999999999999999999976532211 11112234789999
Q ss_pred hhhhccCCC----------------------CccccchhHhHHHHHHHhCCC-CCCCCCCCCCC----chHHHHHHHhhc
Q 046791 660 PEYAMSGVV----------------------SIKTDVFSFGVLVLEIVSGKK-NNGCYRTDHPL----NLIGYAWQLWNE 712 (1018)
Q Consensus 660 PE~~~~~~~----------------------s~ksDV~SlGvvl~elltG~~-p~~~~~~~~~~----~l~~~~~~~~~~ 712 (1018)
||.+..... ..+.||||+||++|||++|.. |+......... ......|+....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998764221 234799999999999999875 55321110000 000001111111
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCC---CCCCCHHHHHH
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQA---TDRPAMPDVVS 758 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPs~~evl~ 758 (1018)
... .-...........+++.++|..+| .+|+|++|+++
T Consensus 459 ~~~--------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKY--------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCC--------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 110 001112334667788899998765 68999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=212.02 Aligned_cols=178 Identities=24% Similarity=0.358 Sum_probs=143.2
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEe-cccccceEEEeccc-ccccHHHHHHHHHHHHHh-cCCCccc-----------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRR-SGQGIVEFKNEAKLIAKL-QHTNLTD----------- 576 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nlv~----------- 576 (1018)
++...+....+..||+|++|.|-+-++ .+|+..|+|++... ..+..++..+|+.+..+- ..|.+|.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444455566678999999999988875 46999999999765 345556678888876654 4555541
Q ss_pred ------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 577 ------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 577 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
+..+..+++...-+|+..+++||.|||++- .++|||+||+||||+.+|++||||||++-.
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 345678899999999999999999999965 699999999999999999999999999987
Q ss_pred ecCCCCcccceeeecccccCChhhhcc----CCCCccccchhHhHHHHHHHhCCCCCCC
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMS----GVVSIKTDVFSFGVLVLEIVSGKKNNGC 693 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDV~SlGvvl~elltG~~p~~~ 693 (1018)
+... ...+...|...|||||.+.. ..|+.|+||||||+.+.||.+++.|++.
T Consensus 199 L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 199 LVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 6422 22223567889999998853 4789999999999999999999999864
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=199.12 Aligned_cols=113 Identities=42% Similarity=0.696 Sum_probs=98.7
Q ss_pred CccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCceEEeccCC
Q 046791 34 QLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDG 113 (1018)
Q Consensus 34 ~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l~~~~~~G 113 (1018)
++|++|++|+|++|.|++|||.+......+.+|||++.+ .++||.|||+.|. ...+.|.++. ||
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~--------------~~~vW~snt~~~~-~~~~~l~l~~-dG 65 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS--------------RTVVWVANRDNPS-GSSCTLTLQS-DG 65 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC--------------CeEEEECCCCCCC-CCCEEEEEec-CC
Confidence 578999999999999999999987654599999998764 5789999999994 4467899987 99
Q ss_pred cEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCC
Q 046791 114 NLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYP 168 (1018)
Q Consensus 114 ~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~P 168 (1018)
+|+|++ .++.++|+++++ ....+|+|+|+|||||++.+ +.+||||||||
T Consensus 66 nLvl~~-~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 66 NLVIYD-GSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred CeEEEc-CCCcEEEEecccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 999998 677899999876 45678999999999999876 78899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-24 Score=221.39 Aligned_cols=221 Identities=23% Similarity=0.354 Sum_probs=171.3
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTD-------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~-------------- 576 (1018)
++|.++++||+|+|+.|..+++.. .+.+|+|++++.- .+...=.+.|-.+..+. +||-||.
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 578889999999999999998754 7889999997752 33344456677766655 6787762
Q ss_pred ------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 577 ------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 577 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
..+...|+++.+.-+...|..||.|||+.| ||.||||..|+|||..|++||.|+|+++.-- ..
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l--~~ 404 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GP 404 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC--CC
Confidence 234567999999999999999999999999 9999999999999999999999999998532 23
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCC-CchHHHHHHHhhcCcchhhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP-LNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
...+..++||+.|+|||++++..|....|.|+|||+++||+.|+.||+....+.+ .+-.++..+.. +++.+
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------lekqi 476 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------LEKQI 476 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------hhhcc
Confidence 3455679999999999999999999999999999999999999999986554332 23333333322 22222
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCC
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRP 751 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP 751 (1018)
+ .+....-+...++..-|..||.+|.
T Consensus 477 r--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 R--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred c--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 2 3334445556677778889999884
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=255.67 Aligned_cols=231 Identities=22% Similarity=0.286 Sum_probs=171.3
Q ss_pred HHHHHHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcc--------
Q 046791 508 FQTISAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLT-------- 575 (1018)
Q Consensus 508 ~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv-------- 575 (1018)
..++....++|.++++||+|+||.|..++... ++.+|+|++++. ......-|..|-.+|..-+.+=|+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 45566677899999999999999999999765 888999999873 233445577777776654332222
Q ss_pred -----------------c-ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 576 -----------------D-SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 576 -----------------~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
. +....++++..+.-++..|+.||.-||+.| +|||||||+|||||..|++||+|||.+.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHH
Confidence 1 122347999999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhcc-----CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMS-----GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
.+..+.. ......+|||.|++||++.. +.|++.+|.||+||++|||+.|..||.. ..++..-....+.
T Consensus 224 km~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm~h 296 (1317)
T KOG0612|consen 224 KMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIMNH 296 (1317)
T ss_pred hcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHhch
Confidence 8764432 33445799999999999963 6799999999999999999999999842 1222221112211
Q ss_pred CcchhhhhhhhcCCCC--hHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 046791 713 GKVLELVDIALEGSFS--PNEVLRCIHVGLLCVQDQATDRPA---MPDVVS 758 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 758 (1018)
.... .+| .+.++...+||...+ -+|+.|-. ++++..
T Consensus 297 k~~l---------~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 297 KESL---------SFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhhc---------CCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 1111 222 234556666776655 47777877 777766
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=243.34 Aligned_cols=234 Identities=24% Similarity=0.380 Sum_probs=184.7
Q ss_pred ceeHHHHHHHhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHh-cCCCccc------
Q 046791 505 IFDFQTISAATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTD------ 576 (1018)
Q Consensus 505 ~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~------ 576 (1018)
...++.+..-++.|++++.||.|.+|.||+++. ++++.+|||++.... ...++...|.++++.+ .|||++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 345556666788999999999999999999984 568999999986653 4456778889988887 6888761
Q ss_pred ---------------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCce
Q 046791 577 ---------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK 629 (1018)
Q Consensus 577 ---------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~k 629 (1018)
-....++.|+.+..|++.+++||.+||... ++|||||-.|||++.++.+|
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 122678999999999999999999999998 99999999999999999999
Q ss_pred eeeecceeeecCCCCcccceeeecccccCChhhhcc-----CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHH
Q 046791 630 ISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS-----GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG 704 (1018)
Q Consensus 630 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~ 704 (1018)
|.|||++..+.. .........||+.|||||++.. ..|+..+|+||||++..||--|.+|+-...+...
T Consensus 164 LvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----- 236 (953)
T KOG0587|consen 164 LVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 236 (953)
T ss_pred Eeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----
Confidence 999999987643 3344556899999999999863 4578899999999999999999999754332211
Q ss_pred HHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 705 YAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 705 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
++. -...|...-..+..-.+++.++|..||..|.++||++.++++
T Consensus 237 ----LF~-----IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 ----LFL-----IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----hcc-----CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 110 000111111234456788999999999999999999988875
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=187.91 Aligned_cols=111 Identities=41% Similarity=0.726 Sum_probs=96.9
Q ss_pred CccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCceEEeccCC
Q 046791 34 QLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDG 113 (1018)
Q Consensus 34 ~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l~~~~~~G 113 (1018)
+.|+.|++|+|++|.|++|||.+... ..+.+|||+..+ .++||+|||+.|+.+ ++.|.+++ ||
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~--------------~~~vW~snt~~~~~~-~~~l~l~~-dG 64 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS--------------RTVVWVANRDNPVSD-SCTLTLQS-DG 64 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC--------------CcEEEECCCCCCCCC-CEEEEEeC-CC
Confidence 56889999999999999999998754 789999998764 468999999999876 47899987 99
Q ss_pred cEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCC
Q 046791 114 NLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDY 167 (1018)
Q Consensus 114 ~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~ 167 (1018)
+|+|++ .++.++|+++++ ....+|+|+|+|||||++.+ +++|||||||
T Consensus 65 nLvl~~-~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~ 114 (114)
T smart00108 65 NLVLYD-GDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSD-----GNFLWQSFDY 114 (114)
T ss_pred CEEEEe-CCCCEEEEecccCCCCceEEEEeCCCCEEEECCC-----CCEEeCCCCC
Confidence 999998 667899999876 55678999999999999876 7799999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-23 Score=224.47 Aligned_cols=244 Identities=22% Similarity=0.233 Sum_probs=172.1
Q ss_pred eHHHHHHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhc---------------
Q 046791 507 DFQTISAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ--------------- 570 (1018)
Q Consensus 507 ~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--------------- 570 (1018)
.+.--+....+|.+....|+|-|++|.+|.... |+.||||++..... -.+.=+.|+++|++|+
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 333344567899999999999999999998755 88999999976531 1122356777777663
Q ss_pred ---CCC---cc-------------cccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-Ccee
Q 046791 571 ---HTN---LT-------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKI 630 (1018)
Q Consensus 571 ---H~n---lv-------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kL 630 (1018)
|.| +| +...+..|....+..++.|+..||..|...+ |+|.||||.|||+++.. .+||
T Consensus 502 ~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred HhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeee
Confidence 333 22 2344556778888999999999999999999 99999999999999764 5899
Q ss_pred eeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHH----
Q 046791 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYA---- 706 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~---- 706 (1018)
||||.|.....++. +...-+..|.|||++.+-+|+...|+||.||+||||.||+..|......+-..+....
T Consensus 579 CDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 579 CDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred ccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 99999987653322 1233456899999999999999999999999999999999988765433211111100
Q ss_pred -HHHhhcCcc---------------------------hhhhhh------hhcC--CCC---hHHHHHHHHHHHhccccCC
Q 046791 707 -WQLWNEGKV---------------------------LELVDI------ALEG--SFS---PNEVLRCIHVGLLCVQDQA 747 (1018)
Q Consensus 707 -~~~~~~~~~---------------------------~~~~d~------~l~~--~~~---~~~~~~l~~li~~Cl~~dP 747 (1018)
..++..+.+ ...+.| .+.+ ..+ +.....+.+|+..|+..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 011111111 000111 1111 122 2345677789999999999
Q ss_pred CCCCCHHHHHH
Q 046791 748 TDRPAMPDVVS 758 (1018)
Q Consensus 748 ~~RPs~~evl~ 758 (1018)
++|.|..+.|+
T Consensus 735 ~KRit~nqAL~ 745 (752)
T KOG0670|consen 735 EKRITVNQALK 745 (752)
T ss_pred hhcCCHHHHhc
Confidence 99999988775
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=203.61 Aligned_cols=183 Identities=33% Similarity=0.571 Sum_probs=154.7
Q ss_pred eccCCCcCeEEEEecc-cccceEEEecccccc-cHHHHHHHHHHHHHhcCCCcccc------------------------
Q 046791 524 LGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDS------------------------ 577 (1018)
Q Consensus 524 lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~------------------------ 577 (1018)
||+|.+|.||+++..+ ++++++|++...... ....+.+|++.++.++|++++..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999999765432 35679999999999999987621
Q ss_pred -cCC--CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-CCCceeeeecceeeecCCCCcccceeeec
Q 046791 578 -RRN--NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARIFGLNQSETNTNRVVG 653 (1018)
Q Consensus 578 -~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~~g 653 (1018)
... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 011 35788899999999999999999998 999999999999999 89999999999987643221 1233557
Q ss_pred ccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHH
Q 046791 654 TYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEV 732 (1018)
Q Consensus 654 t~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 732 (1018)
...|++||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7899999999887 889999999999999998
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 733 LRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 733 ~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 566788899999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-22 Score=220.74 Aligned_cols=180 Identities=23% Similarity=0.345 Sum_probs=145.7
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
.-|-.++.||-|+||+|.+++-.| ...+|.|.|++.. .......+.|-.||.....+-+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457788999999999999997544 6689999997763 344556788999999988777663
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC--C-
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL--N- 642 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~--~- 642 (1018)
+.+-+.+++..+.-++.++..|+++.|..| +|||||||+|||||.+|++||.||||+.-+.- +
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence 233456788888888999999999999999 99999999999999999999999999864320 0
Q ss_pred -----CCc--------------------------------ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHH
Q 046791 643 -----QSE--------------------------------TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIV 685 (1018)
Q Consensus 643 -----~~~--------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ell 685 (1018)
..+ ......+||..|+|||++....++..+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 000 0011268999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCC
Q 046791 686 SGKKNNGCYRTDH 698 (1018)
Q Consensus 686 tG~~p~~~~~~~~ 698 (1018)
.|+.||....+..
T Consensus 866 ~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 866 VGQPPFLADTPGE 878 (1034)
T ss_pred hCCCCccCCCCCc
Confidence 9999997655443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=223.78 Aligned_cols=170 Identities=25% Similarity=0.390 Sum_probs=143.4
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc--------cccHHHHHHHHHHHHHhc---CCCcccc------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--------GQGIVEFKNEAKLIAKLQ---HTNLTDS------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--------~~~~~~f~~E~~~l~~l~---H~nlv~~------ 577 (1018)
..|..++.+|+|+||.|+.+..+. ..+|+||.+.+.. ....-..-.|+++|..++ |+||+++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468899999999999999998765 6689999887653 111222467999999998 9999831
Q ss_pred ---------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 578 ---------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 578 ---------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
.....+++.++..|++||+.|+++||+++ |||||||-+||.++.+|-+||+|||.|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccch
Confidence 23567899999999999999999999999 999999999999999999999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCC-ccccchhHhHHHHHHHhCCCCCC
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVS-IKTDVFSFGVLVLEIVSGKKNNG 692 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SlGvvl~elltG~~p~~ 692 (1018)
.+.. ......++||..|+|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 718 a~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 8763 2334468999999999999998774 56899999999999999888863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=199.22 Aligned_cols=156 Identities=18% Similarity=0.121 Sum_probs=116.6
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCC
Q 046791 580 NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659 (1018)
Q Consensus 580 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 659 (1018)
...+++.+++.|+.||++||.|||+++ ||+|||++.++.+|+ ||+++...... ..||+.|+|
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~~y~a 72 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDPYFMA 72 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-------CCCcccccC
Confidence 346999999999999999999999976 999999999999999 99998764321 257899999
Q ss_pred hhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHH--HHHHH
Q 046791 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEV--LRCIH 737 (1018)
Q Consensus 660 PE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~--~~l~~ 737 (1018)
||++.+..++.++|||||||++|||++|+.||....... ............. ++. ......... ..+.+
T Consensus 73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~~-~~~~~~~~~~~~~~~~ 143 (176)
T smart00750 73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DPR-DRSNLESVSAARSFAD 143 (176)
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Ccc-ccccHHHHHhhhhHHH
Confidence 999999999999999999999999999999985322111 1111110000000 000 000111222 26889
Q ss_pred HHHhccccCCCCCCCHHHHHHHHhc
Q 046791 738 VGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 738 li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
++.+||+.+|++||++.|+++.+..
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHH
Confidence 9999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-22 Score=206.10 Aligned_cols=237 Identities=24% Similarity=0.225 Sum_probs=168.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccccC-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDSRR------------- 579 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~~~------------- 579 (1018)
.+|.-++.+|.|.- .|-.+-+. .++.||+|++... .....++-.+|..++..++|+|++....
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788888887 55555432 4889999988544 2344566789999999999999984211
Q ss_pred ----------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 580 ----------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 580 ----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.-.++-+....|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+.....
T Consensus 96 ~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc-
Confidence 134566778899999999999999999 999999999999999999999999999864322
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCc------------hH----HHHH
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLN------------LI----GYAW 707 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~------------l~----~~~~ 707 (1018)
...+..+.|..|.|||++.+-.+.+.+||||+||++.||++|+..|.....-+... .. ..+.
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 34455778899999999998889999999999999999999998776332111100 00 0011
Q ss_pred HHhhcC------cchhhh-hhhhcC--CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 708 QLWNEG------KVLELV-DIALEG--SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 708 ~~~~~~------~~~~~~-d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
...... ...+.+ |..... ..++.....+-+++.+||-.+|++|.+++++++.
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111100 000000 111000 1112334456678899999999999999999883
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-21 Score=208.99 Aligned_cols=105 Identities=26% Similarity=0.343 Sum_probs=85.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhc-----CCC---ccc---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-----HTN---LTD--------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----H~n---lv~--------- 576 (1018)
.++|.+.++||-|-|++||++.+.. .+.||+|+.+... .-.+.-+.|+++|++++ |++ +|+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4789999999999999999998644 6789999986543 33456789999999984 222 221
Q ss_pred ----------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE
Q 046791 577 ----------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL 622 (1018)
Q Consensus 577 ----------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl 622 (1018)
....+.++...+..|++||+.||.|||.++ .|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 223456888999999999999999999987 69999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=199.31 Aligned_cols=227 Identities=21% Similarity=0.313 Sum_probs=165.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHh-cCCCccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTD----------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~----------------- 576 (1018)
+.|.+.+.||+|.||.+-+++++. .+.+++|.+.+.. ....+|.+|...--.| .|.||+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 468899999999999999998765 7789999887653 3467899988765555 5778762
Q ss_pred ------c---cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc--CCCCceeeeecceeeecCCCCc
Q 046791 577 ------S---RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD--DQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 ------~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld--~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
+ .....+.+....+++.|++.|+.|+|+++ +||||||.+||||- +...+||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~---- 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT---- 175 (378)
T ss_pred cCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc----
Confidence 1 11234677888999999999999999999 99999999999993 344799999999876532
Q ss_pred ccceeeecccccCChhhhcc---C--CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 646 TNTNRVVGTYGYMSPEYAMS---G--VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~---~--~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
......-+..|.|||.... + ...+.+|||.||+++|.++||+.||......+ ..-|.|..|..+....+.+
T Consensus 176 -tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 176 -TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred -eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcccCccCch
Confidence 1222334567999997753 2 34678999999999999999999997443332 2234445555544432221
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 760 (1018)
.. ....+++.++..+-+.++|++|--+.++.++.
T Consensus 252 ~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 252 KF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hh------cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11 11235566777888999999997777766654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=197.72 Aligned_cols=171 Identities=33% Similarity=0.490 Sum_probs=144.3
Q ss_pred cceeeeeccCCCcCeEEEEecc-cccceEEEecccccc-cHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999876 889999999766544 57789999999999999997631
Q ss_pred --------cCCCC-CChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 --------RRNNR-LNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 --------~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
..... +++.....++.+++++|.+||+++ ++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 01123 788889999999999999999998 99999999999999999999999999987754321 122
Q ss_pred eeeecccccCChhhh-ccCCCCccccchhHhHHHHHHHhCCCCCC
Q 046791 649 NRVVGTYGYMSPEYA-MSGVVSIKTDVFSFGVLVLEIVSGKKNNG 692 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~-~~~~~s~ksDV~SlGvvl~elltG~~p~~ 692 (1018)
....++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 345677889999998 66778889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-21 Score=240.99 Aligned_cols=157 Identities=13% Similarity=0.177 Sum_probs=112.2
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-------------------CCCceeeeecceeeecC
Q 046791 581 NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-------------------QMNPKISDFGMARIFGL 641 (1018)
Q Consensus 581 ~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-------------------~~~~kL~DFGla~~~~~ 641 (1018)
..+++.+++.++.||++||.|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 75 ~~~~~~~~~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~ 151 (793)
T PLN00181 75 RSVDAFECFHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEI 151 (793)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccccc
Confidence 45899999999999999999999999 999999999999954 45567777777764321
Q ss_pred CCC--------------cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH
Q 046791 642 NQS--------------ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 642 ~~~--------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 707 (1018)
... ........||+.|||||++.+..++.++|||||||+||||++|..|+.... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~---- 222 (793)
T PLN00181 152 LSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM---- 222 (793)
T ss_pred ccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH----
Confidence 000 000112357888999999999999999999999999999999887753110 000
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... ..+.+ ...........++.+||+.+|.+||+|.||++
T Consensus 223 ~~~~~----~~~~~-----~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 223 SSLRH----RVLPP-----QILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHH----hhcCh-----hhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 00000 00000 01112344567888999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-20 Score=201.25 Aligned_cols=244 Identities=25% Similarity=0.331 Sum_probs=169.9
Q ss_pred HHHHHHhCCcceeeeeccCCCcCeEEEEecc----cccceEEEecccccccHHHHHHHHHHHHHhc-CCCccccc-----
Q 046791 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNLTDSR----- 578 (1018)
Q Consensus 509 ~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nlv~~~----- 578 (1018)
+.+....+.|..+++||+|.|++||++.+.. .+.||+|.+...+. ..+..+|+++|..+. +.|++.+.
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3455667789999999999999999997543 56899999876553 456899999999984 44554210
Q ss_pred -----------C-------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-CCCceeeeecceeee
Q 046791 579 -----------R-------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARIF 639 (1018)
Q Consensus 579 -----------~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~~~ 639 (1018)
. ...++..++...++.+..||.++|.+| ||||||||+|+|.+. .+.-.|.|||+|...
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred CCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHH
Confidence 0 124677888999999999999999999 999999999999984 566899999999721
Q ss_pred cCCC-------------Cc-----------------------------ccceeeecccccCChhhhcc-CCCCccccchh
Q 046791 640 GLNQ-------------SE-----------------------------TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFS 676 (1018)
Q Consensus 640 ~~~~-------------~~-----------------------------~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S 676 (1018)
.... .. .......||++|.|||++.. ...+++.||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1000 00 00012579999999999875 67889999999
Q ss_pred HhHHHHHHHhCCCCCCCCCCCCCCchHHHHH--------HH-hhcCc-----------chhh------h--hhhhcCCC-
Q 046791 677 FGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW--------QL-WNEGK-----------VLEL------V--DIALEGSF- 727 (1018)
Q Consensus 677 lGvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~-~~~~~-----------~~~~------~--d~~l~~~~- 727 (1018)
.|||++-+++++.||-....+. ..+.+.+. +. ...|. +.++ + ........
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred ccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999999985443322 11221110 00 00111 0010 0 00000000
Q ss_pred -------ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 728 -------SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 728 -------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.......+++++.+|++.||.+|.|++|.++
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 1112347789999999999999999999886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.6e-21 Score=214.08 Aligned_cols=227 Identities=21% Similarity=0.294 Sum_probs=174.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~----------------- 576 (1018)
.++|+.+..+|.|.||.|||++... ++..|||+++-.......-...|+-+++..+|+||+.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3578889999999999999999654 8899999998887777777889999999999999982
Q ss_pred ---------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 577 ---------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 577 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
..-..+|++.++..+++..++||+|||+++ =+|||||-.|||+.+.+.+|++|||.+..+.. .-..
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--ti~K 168 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAK 168 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--hhhh
Confidence 122467889999999999999999999999 89999999999999999999999999876542 2223
Q ss_pred ceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 648 TNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
...+.||+.|||||+.. .+.|..++|||++|+...|+---++|.-...+. .+..+... ...++.-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmTk----S~~qpp~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMTK----SGFQPPTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhhc----cCCCCCcc
Confidence 34589999999999864 578999999999999999998877763211110 11111100 01111110
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.-...-.+.+-+++..|+..+|.+||+++.++.
T Consensus 238 -kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 -KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 011123456778999999999999999987665
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5e-18 Score=191.61 Aligned_cols=234 Identities=22% Similarity=0.259 Sum_probs=167.0
Q ss_pred CcceeeeeccCCCcCeEEEEeccc--ccceEEEecccccccHHHHHHHHHHHHHhcC----CCc---c------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLNG--QEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH----TNL---T------------ 575 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~g--~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H----~nl---v------------ 575 (1018)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++ +
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999987553 4788888766543333378889999998873 111 1
Q ss_pred ----------c---ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC-----CCceeeeeccee
Q 046791 576 ----------D---SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ-----MNPKISDFGMAR 637 (1018)
Q Consensus 576 ----------~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-----~~~kL~DFGla~ 637 (1018)
+ ......++..+.+.|+.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||+++
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 0 112467899999999999999999999999 9999999999999754 458999999998
Q ss_pred --eecCCCCc------ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH
Q 046791 638 --IFGLNQSE------TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 638 --~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
........ ......+||..|++++.+.+...+.+.|+||++.++.|++.|..||.............
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~----- 250 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE----- 250 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH-----
Confidence 33222111 11234679999999999999999999999999999999999999985443322111100
Q ss_pred hhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 710 WNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.......... .....+. .+.++...+-..+..++|....+.+.|++...
T Consensus 251 --~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 251 --KDPRKLLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred --HHhhhhcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 0000001100 1112233 33444444445899999999999999876543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=195.08 Aligned_cols=151 Identities=17% Similarity=0.205 Sum_probs=116.1
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEec--ccccceEEEeccc-----ccccHHHHHHHHHHHHHhcCCCccc--------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLL--NGQEVAIKRLSRR-----SGQGIVEFKNEAKLIAKLQHTNLTD-------- 576 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~--~g~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nlv~-------- 576 (1018)
....++|.+.+.||+|+||+||+|+.. +++.||||++... .....+.|.+|++++++++|+|++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~ 93 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKD 93 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCc
Confidence 345678999999999999999999864 4777899987533 1223556999999999999999872
Q ss_pred -----ccCCCCCCh---hhHHHHHHHHHHHHHHHhcCCCCcEEeccc-CCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 577 -----SRRNNRLNW---ETRFSIIEGIAQGLLYLHKYSRLRVIHRDL-KASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 577 -----~~~~~~l~~---~~~~~i~~qia~gL~yLH~~~~~~ivH~Dl-kp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
...+..|.. .....++.|++++|.|||+++ |+|||| ||+|||++.++.+||+|||+|+.+........
T Consensus 94 ~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~ 170 (365)
T PRK09188 94 GLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYR 170 (365)
T ss_pred EEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhh
Confidence 111222211 112578999999999999999 999999 99999999999999999999998754432221
Q ss_pred ------ceeeecccccCChhhhcc
Q 046791 648 ------TNRVVGTYGYMSPEYAMS 665 (1018)
Q Consensus 648 ------~~~~~gt~~Y~aPE~~~~ 665 (1018)
.....+++.|+|||.+..
T Consensus 171 ~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 171 IAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhhhccCccCCcccCCh
Confidence 134667888999998864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=163.28 Aligned_cols=234 Identities=21% Similarity=0.286 Sum_probs=164.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEE-ecccccceEEEecccccccHHHHHHHHHHHHHhcCC----Cccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHT----NLTD------------ 576 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~----nlv~------------ 576 (1018)
..++|.++++||.|+||.+|.|. ..+|.+||||.-+..... -++..|.++...|+|. +|-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34789999999999999999997 567999999987554322 3578899998888763 2221
Q ss_pred -cc----------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---CCCceeeeecceeeecCC
Q 046791 577 -SR----------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 577 -~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kL~DFGla~~~~~~ 642 (1018)
+. -...++..+.+-++-|++.-++|+|.++ +|||||||+|+|..- ...+.|+|||+|+.....
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 10 1345777888999999999999999999 999999999999963 345889999999976533
Q ss_pred CCc-----ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 643 QSE-----TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 643 ~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
.+. .......||..|++-..+.+...+.+.|+=|+|.+|.....|..||............+ ...+.++.-
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE----kI~EkK~s~ 243 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE----KISEKKMST 243 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH----HHHHhhcCC
Confidence 221 12345689999999998888888999999999999999999999997655443222111 111111111
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
.++. +...+ +.++.-.+.-|-...-++-|...-+.+++.
T Consensus 244 ~ie~-LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 244 PIEV-LCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred CHHH-HhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 1111 11112 233444455566667777777655555443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-17 Score=200.89 Aligned_cols=228 Identities=20% Similarity=0.268 Sum_probs=162.0
Q ss_pred eeeeeccCCCcCeEEEEecc-cccceEEEeccc--ccccH----HHHHHHHHHHHHhcCCCccc----------------
Q 046791 520 AVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR--SGQGI----VEFKNEAKLIAKLQHTNLTD---------------- 576 (1018)
Q Consensus 520 ~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~--~~~~~----~~f~~E~~~l~~l~H~nlv~---------------- 576 (1018)
..+.+|.|.+|.|+...... ....+.|..... ..... ..+..|+.+-..+.|+|+++
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45789999999888876433 333444433210 11111 12556777778889999762
Q ss_pred ---------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc--
Q 046791 577 ---------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE-- 645 (1018)
Q Consensus 577 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~-- 645 (1018)
......+...++..++.|++.|+.|||+.| |.|||||++|+++..++.+||+|||.+..+......
T Consensus 402 ~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 402 YCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred cccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 011236777888899999999999999999 999999999999999999999999999877654443
Q ss_pred ccceeeecccccCChhhhccCCCCcc-ccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIK-TDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~k-sDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......|+..|+|||.+.+..|.+. .||||.|+++..|++|+.||......+... ... ..........-..
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~--~~~~~~~~~~~~~---- 551 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTN--NYSDQRNIFEGPN---- 551 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhh--ccccccccccChH----
Confidence 45567899999999999999888765 899999999999999999997655443321 000 0000000000000
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+.+...++.++|+.+|.+|.|+++|++
T Consensus 552 -~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 552 -RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111234456677899999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.8e-17 Score=175.67 Aligned_cols=205 Identities=20% Similarity=0.275 Sum_probs=137.1
Q ss_pred CcceeeeeccCCCcCeEEEEecc-cccceEEEeccc---ccccHHHHHHHHHHHHHhcC-CC---------cc------c
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQH-TN---------LT------D 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H-~n---------lv------~ 576 (1018)
.+...+.||.|+++.||.+++.. ++++|||++... .....+++++|.-.+..+.+ .| ++ .
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34567899999999999999865 899999987543 23456677777766655433 11 10 0
Q ss_pred -------------------------------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEec
Q 046791 577 -------------------------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613 (1018)
Q Consensus 577 -------------------------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~ 613 (1018)
......+....++.+..|+++.+++||+.| ++|+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 000112334456677899999999999999 9999
Q ss_pred ccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhcc--------CCCCccccchhHhHHHHHHH
Q 046791 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS--------GVVSIKTDVFSFGVLVLEIV 685 (1018)
Q Consensus 614 Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDV~SlGvvl~ell 685 (1018)
||||+|++++.+|.++|+||+.....+.... ....+..|.|||.... -.++.+.|.|+||+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999998876432111 1234478999997754 24789999999999999999
Q ss_pred hCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCC
Q 046791 686 SGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDR 750 (1018)
Q Consensus 686 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 750 (1018)
+++.||+.......... .+ ..+. +.++.+..|+..+|+.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999875433221100 11 1233 667778889999999999988
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.4e-16 Score=173.81 Aligned_cols=233 Identities=26% Similarity=0.369 Sum_probs=170.9
Q ss_pred cceeeeeccCCCcCeEEEEecccccceEEEecccccc---cHHHHHHHHHHHHHhcCC-Ccccc----------------
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ---GIVEFKNEAKLIAKLQHT-NLTDS---------------- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~H~-nlv~~---------------- 577 (1018)
|.+.+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999886 78899998766433 367899999999999988 56521
Q ss_pred ----------cCC---CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-CceeeeecceeeecCCC
Q 046791 578 ----------RRN---NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 ----------~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kL~DFGla~~~~~~~ 643 (1018)
... ..+.......++.|++.++.|+|+.+ ++||||||+||+++... .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 111 26888899999999999999999999 99999999999999988 79999999998654333
Q ss_pred Ccc----cceeeecccccCChhhhcc---CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 644 SET----NTNRVVGTYGYMSPEYAMS---GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 644 ~~~----~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
... ......|+..|+|||.+.+ .......|+||+|++++++++|..|+...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 221 3456789999999999987 68899999999999999999999996543321 0011111111111100
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223567788889999999999999887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.5e-16 Score=162.55 Aligned_cols=233 Identities=22% Similarity=0.299 Sum_probs=165.2
Q ss_pred hCCcceeeeeccCCCcCeEEEE-ecccccceEEEecccccccHHHHHHHHHHHHHhcC-CCcc----------------c
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH-TNLT----------------D 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H-~nlv----------------~ 576 (1018)
.-+|++.++||+|.||+++.|+ +-+++.||||.-...+ ..-++..|.+..+.|.+ +.|. +
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3479999999999999999997 5679999999765443 23467788888877754 2221 1
Q ss_pred c----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC-----CCceeeeecceeeecC
Q 046791 577 S----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ-----MNPKISDFGMARIFGL 641 (1018)
Q Consensus 577 ~----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-----~~~kL~DFGla~~~~~ 641 (1018)
+ .-...++.++..-||.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+....
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 1 12467888999999999999999999999 9999999999999643 3489999999998754
Q ss_pred CCCcc-----cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 642 NQSET-----NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 642 ~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
..... ......||.+||+-..+.+...+.+.|+=|||-++...|.|..||.....+....- ++.+.+.+..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k----YeKIGe~Kr~ 257 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK----YEKIGETKRS 257 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH----HHHhcccccc
Confidence 33321 23456899999999999999999999999999999999999999976544332111 1112111111
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
--++.... --+++....++.+.+ .+-.+-|..+=+...+.
T Consensus 258 T~i~~Lc~--g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 258 TPIEVLCE--GFPEEFATYLRYVRR---LDFFETPDYDYLRKLFD 297 (449)
T ss_pred CCHHHHHh--cCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHH
Confidence 11111111 134566666666654 45666677654444443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.4e-17 Score=165.68 Aligned_cols=217 Identities=18% Similarity=0.286 Sum_probs=161.2
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCccc----------------------
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTD---------------------- 576 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~---------------------- 576 (1018)
+.+|.+...|+.|+|+++ |..+++|+++-. ...-.+.|..|.-.|+-+.||||..
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 357888999999999995 456667776543 3344567999999999999999862
Q ss_pred ------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceee--eecceeeecCCCCcccc
Q 046791 577 ------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS--DFGMARIFGLNQSETNT 648 (1018)
Q Consensus 577 ------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~--DFGla~~~~~~~~~~~~ 648 (1018)
....-.++..++.+++.+||+|++|||+..+ -|..--|....+++|++.+++|+ |--++-. .
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq---------e 343 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------E 343 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee---------c
Confidence 1122346778999999999999999999873 23444688999999999998874 2211111 1
Q ss_pred eeeecccccCChhhhccCCCC---ccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVS---IKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s---~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
....-.+.||+||.++..+-+ .++|+|||.+++|||.|...||....+-+.. ..+.-..++.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv 408 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRV 408 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccccc
Confidence 112346789999999876543 5799999999999999999999654432211 1122233455
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
..++.....+.+|+.-|...||.+||.+..|+-.||..
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 67888889999999999999999999999999998853
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.5e-16 Score=186.18 Aligned_cols=227 Identities=20% Similarity=0.216 Sum_probs=156.2
Q ss_pred CcceeeeeccCCCcCeEEEEecccccceEEEecccc-cccHHHHHHHHHH--HHHhcCCCccc-----------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS-GQGIVEFKNEAKL--IAKLQHTNLTD----------------- 576 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~f~~E~~~--l~~l~H~nlv~----------------- 576 (1018)
.+...+.||++.|=.|.+|+.+.|. |+||++-+.. .-..+.|.++++- ...++|||.+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 9999986554 4445555554433 55568999752
Q ss_pred --------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC--CCCcc
Q 046791 577 --------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL--NQSET 646 (1018)
Q Consensus 577 --------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~--~~~~~ 646 (1018)
+..+.-|...+..-|+-|++.||..+|..+ |+|||||.+||||..=.=+.|+||..-+.... +....
T Consensus 103 vkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 103 VKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 222344666777889999999999999999 99999999999999877799999987764322 21111
Q ss_pred cc---eeeecccccCChhhhcc----------C-CCCccccchhHhHHHHHHHhC-CCCCCCCCCCCCCchHHHHHHHhh
Q 046791 647 NT---NRVVGTYGYMSPEYAMS----------G-VVSIKTDVFSFGVLVLEIVSG-KKNNGCYRTDHPLNLIGYAWQLWN 711 (1018)
Q Consensus 647 ~~---~~~~gt~~Y~aPE~~~~----------~-~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~ 711 (1018)
.. .....-..|+|||.+-. . ..+++-||||+||++.||++- +++|... ++.. ++
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a-----Yr 248 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA-----YR 248 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh-----Hh
Confidence 11 11122237999998743 1 267889999999999999984 6666411 0111 11
Q ss_pred cCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 712 EGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 712 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.+. .......++.- +-..+.++++.|++.||.+|-++++.++.-.+.
T Consensus 249 ~~~-~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 SGN-ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ccC-ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111 11111111110 112566788999999999999999999976554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.4e-16 Score=159.34 Aligned_cols=115 Identities=19% Similarity=0.196 Sum_probs=91.5
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEecccccc--c-------HHHH-----------------HHHHHHHHHhcCCCc
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ--G-------IVEF-----------------KNEAKLIAKLQHTNL 574 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~nl 574 (1018)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999654211 1 1122 349999999976653
Q ss_pred cc------------------------ccCCCCCChhhHHHHHHHHHHHHHHH-hcCCCCcEEecccCCCcEEEcCCCCce
Q 046791 575 TD------------------------SRRNNRLNWETRFSIIEGIAQGLLYL-HKYSRLRVIHRDLKASNILLDDQMNPK 629 (1018)
Q Consensus 575 v~------------------------~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivH~Dlkp~NILld~~~~~k 629 (1018)
.. ......++..+...++.|++.+|.|| |+.+ |+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEE
Confidence 20 01234678888999999999999999 6888 99999999999998 47899
Q ss_pred eeeecceeee
Q 046791 630 ISDFGMARIF 639 (1018)
Q Consensus 630 L~DFGla~~~ 639 (1018)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.6e-16 Score=160.87 Aligned_cols=155 Identities=12% Similarity=0.099 Sum_probs=113.8
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHH---------HHHHHHHHHHHhcCCCcccccC---
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIV---------EFKNEAKLIAKLQHTNLTDSRR--- 579 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~---------~f~~E~~~l~~l~H~nlv~~~~--- 579 (1018)
....++|++.++||.|+||.||+... ++..+|||.++........ .|.+|+..+.+++|++|.....
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34578999999999999999999755 5778999999765332222 2689999999999999763110
Q ss_pred ---------------------CCCCChh--hHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 580 ---------------------NNRLNWE--TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 580 ---------------------~~~l~~~--~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
+..+... .......+++.+|..||..+ ++|||+||+||+++.++ ++|+|||..
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~ 181 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGK 181 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCc
Confidence 1111000 00235679999999999999 99999999999999988 999999988
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHH
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIV 685 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ell 685 (1018)
........ ...+.....+..++|+||||+.+.-+.
T Consensus 182 ~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 182 RCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 65421111 011344556678999999999877654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.6e-16 Score=175.33 Aligned_cols=147 Identities=24% Similarity=0.322 Sum_probs=104.9
Q ss_pred ChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC----CcccceeeecccccCC
Q 046791 584 NWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ----SETNTNRVVGTYGYMS 659 (1018)
Q Consensus 584 ~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~----~~~~~~~~~gt~~Y~a 659 (1018)
++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+........ .........||..||+
T Consensus 357 s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~Yms 430 (516)
T KOG1033|consen 357 SLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMS 430 (516)
T ss_pred chhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCC
Confidence 445567889999999999 66 9999999999999999999999999998765443 1223345789999999
Q ss_pred hhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHH
Q 046791 660 PEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHV 738 (1018)
Q Consensus 660 PE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 738 (1018)
||.+.+..|+.|+||||||++|+|++. -...++. ..+...++++.+. +... ..-+.-..+
T Consensus 431 PEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r~g~ip----~~~~-----~d~p~e~~l 491 (516)
T KOG1033|consen 431 PEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIRDGIIP----PEFL-----QDYPEEYTL 491 (516)
T ss_pred HHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhhcCCCC----hHHh-----hcCcHHHHH
Confidence 999999999999999999999999997 2222110 0011111122211 1111 111233467
Q ss_pred HHhccccCCCCCCCHHH
Q 046791 739 GLLCVQDQATDRPAMPD 755 (1018)
Q Consensus 739 i~~Cl~~dP~~RPs~~e 755 (1018)
+++++...|.+||++.+
T Consensus 492 l~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 492 LQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHHhcCCCcccCchHHH
Confidence 88999999999994433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.7e-15 Score=154.96 Aligned_cols=116 Identities=20% Similarity=0.239 Sum_probs=94.3
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEecccccc---------------------c-----HHHHHHHHHHHHHhcCCCc
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ---------------------G-----IVEFKNEAKLIAKLQHTNL 574 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~---------------------~-----~~~f~~E~~~l~~l~H~nl 574 (1018)
.+.||+|++|.||+|+..+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754211 0 1124678999999988875
Q ss_pred c--------------cc----------cCCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCce
Q 046791 575 T--------------DS----------RRNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPK 629 (1018)
Q Consensus 575 v--------------~~----------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~k 629 (1018)
. +. .....++......++.|++.+|.+||+ .+ |+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEE
Confidence 2 11 122346677889999999999999999 88 99999999999999 78999
Q ss_pred eeeecceeeec
Q 046791 630 ISDFGMARIFG 640 (1018)
Q Consensus 630 L~DFGla~~~~ 640 (1018)
|+|||++....
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.9e-14 Score=154.49 Aligned_cols=162 Identities=22% Similarity=0.235 Sum_probs=110.6
Q ss_pred CCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc--CCCC--ceeeeecceeeecCCCC----cccceeeec
Q 046791 582 RLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD--DQMN--PKISDFGMARIFGLNQS----ETNTNRVVG 653 (1018)
Q Consensus 582 ~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld--~~~~--~kL~DFGla~~~~~~~~----~~~~~~~~g 653 (1018)
..+...+.-|+.|+++|+.|||.++ |.|||+|.+||||. +|.. +.|+|||.+-....-.- ....-...|
T Consensus 337 ~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GG 413 (598)
T KOG4158|consen 337 HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGG 413 (598)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCC
Confidence 3456677789999999999999999 99999999999994 4443 68999998754322110 111123456
Q ss_pred ccccCChhhhccCC------CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 654 TYGYMSPEYAMSGV------VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 654 t~~Y~aPE~~~~~~------~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
...-||||+....+ --.|+|.|+.|.+.||++....||.... +...+... +.+.++ ...
T Consensus 414 Na~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~-----Yqe~qL---------Pal 478 (598)
T KOG4158|consen 414 NAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRT-----YQESQL---------PAL 478 (598)
T ss_pred cceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhh-----hhhhhC---------CCC
Confidence 77889999886422 2368999999999999999999985311 11111100 111111 122
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
+....+.+.+++...|+.||.+||+..-....|.
T Consensus 479 p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 479 PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 3344556778888999999999999766665554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.2e-14 Score=171.96 Aligned_cols=174 Identities=24% Similarity=0.285 Sum_probs=136.0
Q ss_pred HHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhc--------C---------C
Q 046791 510 TISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ--------H---------T 572 (1018)
Q Consensus 510 ~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--------H---------~ 572 (1018)
+++.-...|.|.+.||+|+||.||+|...+|+.||+|.-+....- +|.--.+++.+|+ | .
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 445566789999999999999999999888999999987554321 1111222222222 1 0
Q ss_pred C-cc----------c-ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-------CCCCceeeee
Q 046791 573 N-LT----------D-SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-------DQMNPKISDF 633 (1018)
Q Consensus 573 n-lv----------~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-------~~~~~kL~DF 633 (1018)
. |+ + ....+.++|...+.++.|+++-+++||..+ |||+||||+|+||. ....++|+||
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 0 11 1 235677899999999999999999999999 99999999999994 3445899999
Q ss_pred cceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCC
Q 046791 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKK 689 (1018)
Q Consensus 634 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~ 689 (1018)
|.+--+..-.........++|-.+--+|+..+.+++...|.|.|..+++-||.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99976654444455567788999999999999999999999999999999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.1e-15 Score=174.87 Aligned_cols=205 Identities=20% Similarity=0.271 Sum_probs=140.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCccc-----ccCCCCCChhhH
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD-----SRRNNRLNWETR 588 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~-----~~~~~~l~~~~~ 588 (1018)
..+|..++.|..|+||.||..+++. .+..|+|+-+... -.++ ++.....|.+|. +..-+.++.
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvvgDc~tllk~~g~lPv--- 150 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVVGDCATLLKNIGPLPV--- 150 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCcceechhhhhcccCCCCcc---
Confidence 3678899999999999999998764 6788885322211 0111 333334444431 111122332
Q ss_pred HHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC-------------Ccccceeeeccc
Q 046791 589 FSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ-------------SETNTNRVVGTY 655 (1018)
Q Consensus 589 ~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~-------------~~~~~~~~~gt~ 655 (1018)
+++.+++|||+.+ |+|||+||+|.+|..-|++|+.|||+++..-... .+......+||+
T Consensus 151 -----dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTP 222 (1205)
T KOG0606|consen 151 -----DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTP 222 (1205)
T ss_pred -----hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCc
Confidence 2388999999999 9999999999999999999999999987532110 011223468999
Q ss_pred ccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHH
Q 046791 656 GYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRC 735 (1018)
Q Consensus 656 ~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 735 (1018)
.|+|||++....|...+|.|++|+|+||.+.|+.||....+++ +...+. . |...-.+-+.....+.
T Consensus 223 eyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~vi--------s---d~i~wpE~dea~p~Ea 288 (1205)
T KOG0606|consen 223 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVI--------S---DDIEWPEEDEALPPEA 288 (1205)
T ss_pred cccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhh--------h---hhccccccCcCCCHHH
Confidence 9999999999999999999999999999999999986554332 111110 0 0000011123334566
Q ss_pred HHHHHhccccCCCCCCC
Q 046791 736 IHVGLLCVQDQATDRPA 752 (1018)
Q Consensus 736 ~~li~~Cl~~dP~~RPs 752 (1018)
.+++.+.|+.+|.+|--
T Consensus 289 ~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 289 QDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred HHHHHHHHHhChHhhcc
Confidence 77788899999999953
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.4e-14 Score=142.77 Aligned_cols=168 Identities=17% Similarity=0.149 Sum_probs=120.3
Q ss_pred eeeeeccCCCcCeEEEEecccccceEEEecccccc----cHHHHHHHHHHHHHhcC-CCcccc------------cCCCC
Q 046791 520 AVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ----GIVEFKNEAKLIAKLQH-TNLTDS------------RRNNR 582 (1018)
Q Consensus 520 ~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~----~~~~f~~E~~~l~~l~H-~nlv~~------------~~~~~ 582 (1018)
+...|++|+||+||.+.. .+.+++.+.+.....- ....|.+|+++|++|.| +++... .....
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~~ 84 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGAA 84 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCcc
Confidence 457899999999997765 6778888877654321 12258899999999954 444321 11222
Q ss_pred CCh---hhHHHHHHHHHHHHHHHhcCCCCcEEeccc-CCCcEEEcCCCCceeeeecceeeecCCCCc----c--c-----
Q 046791 583 LNW---ETRFSIIEGIAQGLLYLHKYSRLRVIHRDL-KASNILLDDQMNPKISDFGMARIFGLNQSE----T--N----- 647 (1018)
Q Consensus 583 l~~---~~~~~i~~qia~gL~yLH~~~~~~ivH~Dl-kp~NILld~~~~~kL~DFGla~~~~~~~~~----~--~----- 647 (1018)
|.. .....++.|++++|.++|++| |+|||| ||+|||++.++.++|+|||+|......... . .
T Consensus 85 L~~~~~~~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~ll 161 (218)
T PRK12274 85 MYQRPPRGDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLL 161 (218)
T ss_pred HHhhhhhhhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHH
Confidence 211 123467889999999999999 999999 799999999999999999999865433210 0 0
Q ss_pred ceeeecccccCChhhhcc-CCCC-ccccchhHhHHHHHHHhCCCCC
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVS-IKTDVFSFGVLVLEIVSGKKNN 691 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s-~ksDV~SlGvvl~elltG~~p~ 691 (1018)
......++.|++|+...- ...+ ...+.++-|.-+|.++|++.+.
T Consensus 162 k~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 162 KHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 111235778888886543 2333 6678899999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.8e-15 Score=167.71 Aligned_cols=206 Identities=22% Similarity=0.254 Sum_probs=149.9
Q ss_pred eeccCCCcCeEEEEe----cccccceEEEecccccc--cHHHHHHHHHHHHHhc-CCCccc-------------------
Q 046791 523 KLGEGGFGPVYKGQL----LNGQEVAIKRLSRRSGQ--GIVEFKNEAKLIAKLQ-HTNLTD------------------- 576 (1018)
Q Consensus 523 ~lG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~-H~nlv~------------------- 576 (1018)
.+|+|.||.|++++- ..|..+|+|.+++.... .......|..++...+ |+.+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998752 23677899988665311 1125677888888887 877763
Q ss_pred -------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 577 -------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 577 -------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
+......++.........++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-...
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------ 151 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh------
Confidence 122334455566667778999999999999 9999999999999999999999999998653211
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
..+||..|||||++. .....+|-||||++++||++|..||.. +. ...++. .....+.
T Consensus 152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~---------~~~Il~--~~~~~p~ 208 (612)
T KOG0603|consen 152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DT---------MKRILK--AELEMPR 208 (612)
T ss_pred hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HH---------HHHHhh--hccCCch
Confidence 128899999999988 567889999999999999999999853 00 001111 1123455
Q ss_pred HHHHHHHHHHHhccccCCCCCCCH--HHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAM--PDVVSML 760 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~--~evl~~L 760 (1018)
+......+++..++..+|..|--. ..+.+.+
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 555666677788888899998654 3444443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.1e-14 Score=160.90 Aligned_cols=177 Identities=21% Similarity=0.292 Sum_probs=125.1
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCC
Q 046791 580 NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659 (1018)
Q Consensus 580 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 659 (1018)
...+++.-...++++|+.||.|||.-. -..|+.+++.|.++|..+.+||+|||+.................-..-|.|
T Consensus 42 ~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~a 119 (484)
T KOG1023|consen 42 DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTA 119 (484)
T ss_pred ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccC
Confidence 456888889999999999999999865 129999999999999999999999999877642111111112234457999
Q ss_pred hhhhccC-------CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCC-chHHHHHHHhhcCcchhhhhhhhcCCCChHH
Q 046791 660 PEYAMSG-------VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL-NLIGYAWQLWNEGKVLELVDIALEGSFSPNE 731 (1018)
Q Consensus 660 PE~~~~~-------~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 731 (1018)
||.+... ..+.+.||||||++++|+++.+.||+........ .++..+ .+.+. ....|.+... .+.
T Consensus 120 Pellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~---~~~~~--~~~rP~i~~~--~e~ 192 (484)
T KOG1023|consen 120 PELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRV---KKGGS--NPFRPSIELL--NEL 192 (484)
T ss_pred HHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHH---HhcCC--CCcCcchhhh--hhc
Confidence 9998763 2477899999999999999999999764433221 122221 11011 1111111100 023
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 732 VLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 732 ~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.+.++.++.+||..+|++||++++|-..++....
T Consensus 193 ~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 193 PPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred chHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 3478899999999999999999999999886543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.2e-13 Score=140.57 Aligned_cols=130 Identities=22% Similarity=0.195 Sum_probs=99.8
Q ss_pred HHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEeccccc----------------------ccHHHHHHHHHH
Q 046791 508 FQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG----------------------QGIVEFKNEAKL 565 (1018)
Q Consensus 508 ~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~----------------------~~~~~f~~E~~~ 565 (1018)
++++.+....|.+.+.||+|+||.||++...+|+.||||++..... .....+..|..+
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 4566666666888999999999999999988899999998754320 011236778999
Q ss_pred HHHhcCCCcc--------------cccCCC---CCCh-hhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC
Q 046791 566 IAKLQHTNLT--------------DSRRNN---RLNW-ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN 627 (1018)
Q Consensus 566 l~~l~H~nlv--------------~~~~~~---~l~~-~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 627 (1018)
+.++.|+++. +..... .+.. .....++.++++++.++|+.+ |+||||||+||++++++.
T Consensus 87 l~~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 87 LKALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred HHHHHHcCCCCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence 9999887531 111111 1111 456679999999999999998 999999999999999999
Q ss_pred ceeeeecceeeec
Q 046791 628 PKISDFGMARIFG 640 (1018)
Q Consensus 628 ~kL~DFGla~~~~ 640 (1018)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.2e-13 Score=141.76 Aligned_cols=128 Identities=17% Similarity=0.158 Sum_probs=97.3
Q ss_pred HHHHHhCCcceeeeeccCCCcCeEEEE--ecccccceEEEecccccc------------------------cHHHHHHHH
Q 046791 510 TISAATNNFSAVNKLGEGGFGPVYKGQ--LLNGQEVAIKRLSRRSGQ------------------------GIVEFKNEA 563 (1018)
Q Consensus 510 ~l~~~t~~y~~~~~lG~G~fG~Vy~~~--~~~g~~vAvK~l~~~~~~------------------------~~~~f~~E~ 563 (1018)
.+......|++.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 344444468899999999999999998 567999999998653210 012357899
Q ss_pred HHHHHhcCCCcc--------------c----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCc
Q 046791 564 KLIAKLQHTNLT--------------D----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASN 619 (1018)
Q Consensus 564 ~~l~~l~H~nlv--------------~----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~N 619 (1018)
.++.++.+..+. + ......+...+...++.||+.+|.+||+++ .|+||||||+|
T Consensus 102 ~~L~~L~~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred HHHHHHHhcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 999999764321 0 011233445556799999999999999987 49999999999
Q ss_pred EEEcCCCCceeeeecceeeec
Q 046791 620 ILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 620 ILld~~~~~kL~DFGla~~~~ 640 (1018)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987543
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.3e-13 Score=125.25 Aligned_cols=87 Identities=25% Similarity=0.318 Sum_probs=71.0
Q ss_pred EEeCCCC---CcccccCCC--CceeeeeecCceeEEEEEecCCccc-------cceEEEeeeCCce----eccccC-CCC
Q 046791 226 WTCGLFP---HWRAVDLDS--DFHFSYTSNEKERYFNYSLNGNFTS-------FPTLQIDSKGSLT----VTGALP-ISC 288 (1018)
Q Consensus 226 w~sg~w~---~~~~~~~~~--~~~~~~~~n~~e~~~~~~~~~~~~~-------~g~l~~~~~~~~~----~~~~~p-~~C 288 (1018)
||+|||+ +.+.|.|.. .+.+.|+++.+|.+|+|.+.+.+.. +|+++++.|.+.. ..|..| ++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 8999994 556677653 3588899999999999999776522 8999999997654 677888 899
Q ss_pred CCCCCCCCCCCcc------ccccCCCcccc
Q 046791 289 PGSEGCVRLSSCK------GYFLDDFELNW 312 (1018)
Q Consensus 289 ~~~g~CG~~g~C~------c~~~~gf~~~~ 312 (1018)
|+|+.||+||.|. |.|++||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999774 66699999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.35 E-value=5e-13 Score=112.57 Aligned_cols=57 Identities=30% Similarity=0.685 Sum_probs=48.8
Q ss_pred ccCceeecccccccc------CCcccchhhhhhccCCcceeeeeccCCCCcceEEeccCCCcc
Q 046791 315 KRGFMSVDGFKFKGS------NNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRGSKFI 371 (1018)
Q Consensus 315 ~~~f~~~~~~~~~~~------~~~sl~~C~~~Cl~nCsC~Ayay~~~~~~~~C~~w~~~l~~~ 371 (1018)
+++|+++++++++.. .+.++++|++.||+||||+||+|.+..++++|++|+++|+|+
T Consensus 4 ~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 578999999996544 568899999999999999999996533678999999999875
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.7e-12 Score=134.55 Aligned_cols=111 Identities=23% Similarity=0.307 Sum_probs=81.3
Q ss_pred ceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHh-----cCCCccccc---------------
Q 046791 519 SAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-----QHTNLTDSR--------------- 578 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-----~H~nlv~~~--------------- 578 (1018)
...+.||+|+||.||. ...++.. +||++........+.+.+|+.++.++ .||||++..
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 3223444 79988765445567899999999999 579987311
Q ss_pred --C--------------CCCCChhhHHHHHHHHHHHH-HHHhcCCCCcEEecccCCCcEEEcC----CCCceeeeecce
Q 046791 579 --R--------------NNRLNWETRFSIIEGIAQGL-LYLHKYSRLRVIHRDLKASNILLDD----QMNPKISDFGMA 636 (1018)
Q Consensus 579 --~--------------~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~ivH~Dlkp~NILld~----~~~~kL~DFGla 636 (1018)
. ...+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 0 0112222 34577888777 8999999 999999999999973 347999995444
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.5e-12 Score=121.06 Aligned_cols=74 Identities=39% Similarity=0.590 Sum_probs=59.6
Q ss_pred cccccCCceeccccceeeeeecCCCCCccEEEEEEecCCCCeeEEEecCCCCc-------ccCCCcEEEecCCCCeeeEe
Q 046791 806 QVLRDGDQLVSAFGRFRLAFFSPRSTTKHYLGIWYDKSEDELLVWDANRDTPV-------LDKSGRLVKTDGTIKRVLWL 878 (1018)
Q Consensus 806 ~~l~~~~~l~s~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~vw~a~~~~~~-------~~~~g~~~~~~~~~~~~~w~ 878 (1018)
+.|..+++|+|+++.|++|||++......+++|||.+.+ .++||.||++.|. ++.+|+|+|.+. .+.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~ 79 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG-SGTVVWS 79 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcC-CCcEEEE
Confidence 467789999999999999999986554599999999887 8899999998873 667888888875 3345666
Q ss_pred ecC
Q 046791 879 SFE 881 (1018)
Q Consensus 879 sf~ 881 (1018)
|--
T Consensus 80 S~~ 82 (116)
T cd00028 80 SNT 82 (116)
T ss_pred ecc
Confidence 544
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.1e-12 Score=129.40 Aligned_cols=116 Identities=22% Similarity=0.208 Sum_probs=85.2
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEecccccc--cHHH----------------------HHHHHHHHHHhcCCCcc-
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ--GIVE----------------------FKNEAKLIAKLQHTNLT- 575 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~----------------------f~~E~~~l~~l~H~nlv- 575 (1018)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+..+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988653211 1111 13566666666554321
Q ss_pred -------------cccCC-----CCC---Ch-hhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeee
Q 046791 576 -------------DSRRN-----NRL---NW-ETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISD 632 (1018)
Q Consensus 576 -------------~~~~~-----~~l---~~-~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~D 632 (1018)
+.... ..+ .. .+...++.+++.++.++|. .+ |+|+||||+||+++ ++.++|+|
T Consensus 82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liD 157 (187)
T cd05119 82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIID 157 (187)
T ss_pred CceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEE
Confidence 11111 111 11 5678899999999999999 87 99999999999999 88999999
Q ss_pred ecceeeec
Q 046791 633 FGMARIFG 640 (1018)
Q Consensus 633 FGla~~~~ 640 (1018)
||.+....
T Consensus 158 fg~a~~~~ 165 (187)
T cd05119 158 VPQAVEID 165 (187)
T ss_pred Cccccccc
Confidence 99997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.6e-11 Score=128.64 Aligned_cols=111 Identities=23% Similarity=0.326 Sum_probs=85.3
Q ss_pred eeccCCCcCeEEEEecccccceEEEeccccc--------ccHHHHHHHHHHHHHhcCCCccc----------------cc
Q 046791 523 KLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG--------QGIVEFKNEAKLIAKLQHTNLTD----------------SR 578 (1018)
Q Consensus 523 ~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~nlv~----------------~~ 578 (1018)
.||+|+||.||+|.. ++..|++|....... ....++.+|++++..++|+++.. ..
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 678899998654321 11356788999999999887531 11
Q ss_pred CCCCCChhhHH---HHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 579 RNNRLNWETRF---SIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 579 ~~~~l~~~~~~---~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.+..+...... .++.+++++|.+||+.+ ++|+|++|.||+++ ++.++|+|||++..
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 12222221111 78999999999999999 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.8e-11 Score=129.48 Aligned_cols=112 Identities=21% Similarity=0.294 Sum_probs=87.4
Q ss_pred eeeccCCCcCeEEEEecccccceEEEecccccc--------cHHHHHHHHHHHHHhcCCCccc----------------c
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ--------GIVEFKNEAKLIAKLQHTNLTD----------------S 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~f~~E~~~l~~l~H~nlv~----------------~ 577 (1018)
+.||+|++|.||+|.. +|..|+||+....... ....+.+|+.++.+++|+++.. .
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7788999986543211 1245788999999999988641 1
Q ss_pred cCCCCCCh------hhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 RRNNRLNW------ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 ~~~~~l~~------~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
..+..+.. ..+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGMEELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 11111111 145689999999999999999 99999999999999 78899999999864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.24 E-value=1e-11 Score=149.83 Aligned_cols=125 Identities=18% Similarity=0.267 Sum_probs=91.9
Q ss_pred HHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEe-ccccc-------ccHHHHHHHHHHHHHhcCCCcccc---
Q 046791 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRL-SRRSG-------QGIVEFKNEAKLIAKLQHTNLTDS--- 577 (1018)
Q Consensus 509 ~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l-~~~~~-------~~~~~f~~E~~~l~~l~H~nlv~~--- 577 (1018)
.........|...++||+|+||.||+|..... .+++|+. .+... ...+++.+|++++.+++|++++..
T Consensus 326 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 326 IKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred ccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 33344455667789999999999999987544 4444432 22111 123568899999999999987521
Q ss_pred -------------cCCCCCChh--hHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 -------------RRNNRLNWE--TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 -------------~~~~~l~~~--~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.....|... ....++.+++++|.|||+.+ ++||||||+|||+ .++.++|+|||+++.
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 112223222 35778999999999999999 9999999999999 677899999999975
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.2e-12 Score=108.88 Aligned_cols=68 Identities=19% Similarity=0.313 Sum_probs=59.4
Q ss_pred ccCceeeccccccccCCcccchhhhhhcc---CCcceeeeeccCCCCcceEEeccCC-CccccC-CCCceEEEEE
Q 046791 315 KRGFMSVDGFKFKGSNNMSRDDCATKCLS---NCSCIAFAITNKNNNTACEIWSRGS-KFIEDN-NNTDARYISV 384 (1018)
Q Consensus 315 ~~~f~~~~~~~~~~~~~~sl~~C~~~Cl~---nCsC~Ayay~~~~~~~~C~~w~~~l-~~~~~~-~~~~~~y~r~ 384 (1018)
+.+|+.+.+++.+.....+++||+++|++ ||||+||+|.+. +.+|++|.++| .+++.. ..+.++|+|.
T Consensus 8 ~g~fl~~~~~klpd~~~~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~~~~g~~Ly~r~ 80 (80)
T cd00129 8 AGTTLIKIALKIKTTKANTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKEFSHGFDLYENK 80 (80)
T ss_pred CCeEEEeecccCCcccccCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhccCCCceeEeEC
Confidence 45799999999888888999999999999 999999999642 46899999999 999888 5588999973
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.9e-12 Score=154.15 Aligned_cols=226 Identities=19% Similarity=0.245 Sum_probs=162.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecc--cccceEEEecccc--cccHHHHHHHHHHHHHhc-CCCccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN--GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQ-HTNLTD-------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~--g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~-H~nlv~-------------- 576 (1018)
..|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |.|++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 356677889999999998887644 3456677665443 223334455777777776 988762
Q ss_pred ------------c-cCCC-CCChhhHHHHHHHHHHHHHHHh-cCCCCcEEecccCCCcEEEcCCC-Cceeeeecceeeec
Q 046791 577 ------------S-RRNN-RLNWETRFSIIEGIAQGLLYLH-KYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARIFG 640 (1018)
Q Consensus 577 ------------~-~~~~-~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivH~Dlkp~NILld~~~-~~kL~DFGla~~~~ 640 (1018)
. .... ..+....-..+.|+..++.|+| +.+ +.|+||||+|.+++..+ ..+++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 1 1111 4566778889999999999999 888 99999999999999999 99999999999877
Q ss_pred C-CCCcccceeeec-ccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 641 L-NQSETNTNRVVG-TYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 641 ~-~~~~~~~~~~~g-t~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
. +..........| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+......... ...
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------~~~ 242 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------YSS 242 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------cee
Confidence 6 555555666788 999999999888 45677899999999999999999998755433211 011
Q ss_pred hhhhhhc--CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALE--GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+.... ............++...++..+|..|.+.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1111100 1111223345566777888899999999877654
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.6e-11 Score=111.97 Aligned_cols=94 Identities=35% Similarity=0.491 Sum_probs=72.4
Q ss_pred cccccCCceeccccceeeeeecCCCCCccEEEEEEecCCCCeeEEEecCCCCc-------ccCCCcEEEecCCCCeeeEe
Q 046791 806 QVLRDGDQLVSAFGRFRLAFFSPRSTTKHYLGIWYDKSEDELLVWDANRDTPV-------LDKSGRLVKTDGTIKRVLWL 878 (1018)
Q Consensus 806 ~~l~~~~~l~s~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~vw~a~~~~~~-------~~~~g~~~~~~~~~~~~~w~ 878 (1018)
+.|..++.|+|+++.|++|||.+.. ...+++|||...+ .++||.||++.|+ +.++|||+|.+. .+.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~-q~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~ 78 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIM-QNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG-DGRVVWS 78 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCC-CCCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC-CCCEEEE
Confidence 3567789999999999999999754 4689999999887 8899999999885 568999999987 4678999
Q ss_pred ecCCCCccccCCCeeeecCCCceeEee
Q 046791 879 SFEYPADTLLHGMKLGINPKGQVLADS 905 (1018)
Q Consensus 879 sf~~p~~t~~~~~~~g~~~~g~~~~~~ 905 (1018)
|=..+ --+.-.+-+.-.|.++..-
T Consensus 79 S~t~~---~~~~~~~~L~ddGnlvl~~ 102 (114)
T smart00108 79 SNTTG---ANGNYVLVLLDDGNLVIYD 102 (114)
T ss_pred ecccC---CCCceEEEEeCCCCEEEEC
Confidence 83321 1233445556667776553
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.6e-12 Score=117.45 Aligned_cols=50 Identities=46% Similarity=0.795 Sum_probs=35.4
Q ss_pred CeeEEEe-cCCC----C---cccCCCcEEEecCCCCeeeEeecCCCCccccCCCeeeec
Q 046791 846 ELLVWDA-NRDT----P---VLDKSGRLVKTDGTIKRVLWLSFEYPADTLLHGMKLGIN 896 (1018)
Q Consensus 846 ~~~vw~a-~~~~----~---~~~~~g~~~~~~~~~~~~~w~sf~~p~~t~~~~~~~g~~ 896 (1018)
.+++|.. +... + .+.++|||||.|. .+.++||||||||||+||+|+|+.+
T Consensus 38 ~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-~~~~lW~Sf~~ptdt~L~~q~l~~~ 95 (114)
T PF01453_consen 38 GSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-SGNVLWQSFDYPTDTLLPGQKLGDG 95 (114)
T ss_dssp TEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-TSEEEEESTTSSS-EEEEEET--TS
T ss_pred CCEEEEecccCCccccCeEEEEeCCCCEEEEee-cceEEEeecCCCccEEEeccCcccC
Confidence 4568877 3121 1 2678888888885 7899999999999999999999864
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.2e-10 Score=110.54 Aligned_cols=116 Identities=24% Similarity=0.244 Sum_probs=92.4
Q ss_pred eeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCC--Cccc----------------ccCCC
Q 046791 520 AVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHT--NLTD----------------SRRNN 581 (1018)
Q Consensus 520 ~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~--nlv~----------------~~~~~ 581 (1018)
+.+.||+|.++.||+++..+ ..++||....... ...+.+|+.++..++|. ++.+ .....
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999855 7899999865543 56789999999999874 3331 11112
Q ss_pred CC---ChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 582 RL---NWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 582 ~l---~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.+ +......++.+++++|++||......++|+|++|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 22 3467788999999999999997555699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.6e-10 Score=120.79 Aligned_cols=113 Identities=25% Similarity=0.266 Sum_probs=83.9
Q ss_pred eeec-cCCCcCeEEEEecccccceEEEecccc-------------cccHHHHHHHHHHHHHhcCCCcc--c---c-----
Q 046791 522 NKLG-EGGFGPVYKGQLLNGQEVAIKRLSRRS-------------GQGIVEFKNEAKLIAKLQHTNLT--D---S----- 577 (1018)
Q Consensus 522 ~~lG-~G~fG~Vy~~~~~~g~~vAvK~l~~~~-------------~~~~~~f~~E~~~l~~l~H~nlv--~---~----- 577 (1018)
..|| .||.|+||++... +..++||++.... ......+.+|+.++.+|+|+++. . .
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999874 6789999885421 12235678899999999998752 0 0
Q ss_pred ------------cCC-CCCCh-----hhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 ------------RRN-NRLNW-----ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 ------------~~~-~~l~~-----~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
... ..+.. ......+.+|+++|.+||+.| |+||||||+|||++.++.++|+|||.+..
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 000 11100 001234778999999999999 99999999999999988999999999875
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.7e-10 Score=98.92 Aligned_cols=68 Identities=26% Similarity=0.621 Sum_probs=55.2
Q ss_pred cCceeecccccccc----CCcccchhhhhhccCCcceeeeeccCCCCcceEEeccCCCccccC-CCCceEEEEEc
Q 046791 316 RGFMSVDGFKFKGS----NNMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRGSKFIEDN-NNTDARYISVW 385 (1018)
Q Consensus 316 ~~f~~~~~~~~~~~----~~~sl~~C~~~Cl~nCsC~Ayay~~~~~~~~C~~w~~~l~~~~~~-~~~~~~y~r~~ 385 (1018)
++|..+++++++.. .+.++++|++.||+||+|+||+|.+ ++++|++|...+.+.+.. ..+..+||||+
T Consensus 12 ~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 12 DGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNN--GSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecC--CCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 56888888884332 5678999999999999999999953 467899999999887766 44588999984
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.8e-09 Score=121.45 Aligned_cols=116 Identities=22% Similarity=0.266 Sum_probs=82.8
Q ss_pred eeeccCCCcCeEEEEecccccceEEEeccccccc----------------------------------------HHHHHH
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQG----------------------------------------IVEFKN 561 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~----------------------------------------~~~f~~ 561 (1018)
+.||.|++|.||+|++.+|+.||||+.+...... .-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999999999999999986542110 012556
Q ss_pred HHHHHHHhc-----CCCcc----------------cccCCCCCChh--------hHHHHHHHHHH-HHHHHhcCCCCcEE
Q 046791 562 EAKLIAKLQ-----HTNLT----------------DSRRNNRLNWE--------TRFSIIEGIAQ-GLLYLHKYSRLRVI 611 (1018)
Q Consensus 562 E~~~l~~l~-----H~nlv----------------~~~~~~~l~~~--------~~~~i~~qia~-gL~yLH~~~~~~iv 611 (1018)
|+..+.++. ++++. +...+..+... .+..++.++++ .+..+|..| ++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g---~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDG---FF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCC---ce
Confidence 666666663 22321 11122222211 24567777776 468899988 99
Q ss_pred ecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 612 HRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 612 H~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
|+|+||.||+++.++.++|+|||++..+.
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.4e-08 Score=103.26 Aligned_cols=115 Identities=20% Similarity=0.172 Sum_probs=84.9
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc---------------ccCCCCCCh
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD---------------SRRNNRLNW 585 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~---------------~~~~~~l~~ 585 (1018)
.+.|+.|.++.||+++.. ++.+++|....... ....+..|+.++..+.+.+++. ......+..
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT 80 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence 367899999999999874 77899998755432 2335688999999987655431 111222221
Q ss_pred --hhHHHHHHHHHHHHHHHhcCC--CCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 586 --ETRFSIIEGIAQGLLYLHKYS--RLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 586 --~~~~~i~~qia~gL~yLH~~~--~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.....++.+++++|+.||..+ +..++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 EDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 223456789999999999987 33469999999999999 66899999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.3e-09 Score=120.63 Aligned_cols=222 Identities=20% Similarity=0.272 Sum_probs=148.7
Q ss_pred Ccceeeeecc--CCCcCeEEEEe---cccccceEEEecccc--cccHHHHHHHHHHHHHh-cCCCcccc-----------
Q 046791 517 NFSAVNKLGE--GGFGPVYKGQL---LNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKL-QHTNLTDS----------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~--G~fG~Vy~~~~---~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l-~H~nlv~~----------- 577 (1018)
.|.+...+|. |.+|.||.+.. .++..+|+|+-+... ......=.+|+....++ .|+|.+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999987 347889999743322 12222224455444444 35565521
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHH----HHHHHhcCCCCcEEecccCCCcEEEcCC-CCceeeeeccee
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQ----GLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMAR 637 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kL~DFGla~ 637 (1018)
.....++....+.+..+..+ ||.++|+.. ++|-|+||.||++..+ ...++.|||+..
T Consensus 195 iqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeE
Confidence 11233677788888888888 999999999 9999999999999999 889999999999
Q ss_pred eecCCCCccc---ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 638 IFGLNQSETN---TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 638 ~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
.+....-... .....|...|++||.. ++.++.++|||++|.++.|..++........... |...+.+.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r~~~ 342 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLRQGY 342 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC--------cccccccc
Confidence 8865432211 1233577789999965 5578899999999999999999887643211111 11111111
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+-+ ++......++...+..+++.+|..|++.+.+..
T Consensus 343 ---ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 ---IPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---Cch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 111111223333777899999999988776654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.9e-08 Score=106.84 Aligned_cols=159 Identities=16% Similarity=0.181 Sum_probs=103.4
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee--cCCCCcccceeeeccccc
Q 046791 580 NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF--GLNQSETNTNRVVGTYGY 657 (1018)
Q Consensus 580 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~--~~~~~~~~~~~~~gt~~Y 657 (1018)
...+......+|+.||..||.|||+.. ++|+|+++..+-|++..++-+||.--.-.... -............+-++|
T Consensus 170 ~~a~~~~~wkkw~tqIlsal~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~ 248 (458)
T KOG1266|consen 170 QKALFQKAWKKWCTQILSALSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGF 248 (458)
T ss_pred hhhhhHHHHHHHHHHHHhhhhhhhccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCcc
Confidence 345666777899999999999999976 78999999999999999988887432111100 000111122234567899
Q ss_pred CChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCC-CCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHH
Q 046791 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTD-HPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCI 736 (1018)
Q Consensus 658 ~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 736 (1018)
.|||+=.....+.++|||+||+..+||..+..--...... ....-+.. .+..+-+..- .
T Consensus 249 ~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~--------~i~~len~lq------------r 308 (458)
T KOG1266|consen 249 SAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN--------VIIGLENGLQ------------R 308 (458)
T ss_pred ccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh--------heeeccCccc------------c
Confidence 9999877777888999999999999999877431111000 00000000 0000001111 1
Q ss_pred HHHHhccccCCCCCCCHHHHHHH
Q 046791 737 HVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 737 ~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.++..|++..|..||+|++++..
T Consensus 309 ~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 309 GSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred CcCcccccCCCCCCcchhhhhcC
Confidence 35568999999999999988764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.2e-06 Score=96.42 Aligned_cols=177 Identities=17% Similarity=0.146 Sum_probs=119.5
Q ss_pred CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCCh
Q 046791 581 NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSP 660 (1018)
Q Consensus 581 ~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP 660 (1018)
...+|.-.++.++.+|.+.+.||++| .+-+|+.++|+|+.+++.+.|.|=..-... .........+|...|.+|
T Consensus 112 P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~---~ng~~~~cpVg~~eftPP 185 (637)
T COG4248 112 PHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN---ANGTLHLCPVGVSEFTPP 185 (637)
T ss_pred CccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec---cCCceEecccCccccCCH
Confidence 34689999999999999999999999 888999999999999999999885443332 223334457888999999
Q ss_pred hhhc-----cCCCCccccchhHhHHHHHHHhC-CCCCCCCCCCCC--CchHHHHHHHhhcCcchhhhhhhhcC-----CC
Q 046791 661 EYAM-----SGVVSIKTDVFSFGVLVLEIVSG-KKNNGCYRTDHP--LNLIGYAWQLWNEGKVLELVDIALEG-----SF 727 (1018)
Q Consensus 661 E~~~-----~~~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~~-----~~ 727 (1018)
|.-. +-.-+...|.|.||+++++++.| ++||........ ..+.. .+..+.+...-|..... ..
T Consensus 186 ElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~----~Ia~g~f~ya~~~~~g~~p~P~~~ 261 (637)
T COG4248 186 ELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET----DIAHGRFAYASDQRRGLKPPPRSI 261 (637)
T ss_pred HHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh----hhhcceeeechhccCCCCCCCCCC
Confidence 9754 34457889999999999999987 999876532211 11110 11112222222211110 11
Q ss_pred ChH-HHHHHHHHHHhcccc--CCCCCCCHHHHHHHHhcCcCCC
Q 046791 728 SPN-EVLRCIHVGLLCVQD--QATDRPAMPDVVSMLANESLSL 767 (1018)
Q Consensus 728 ~~~-~~~~l~~li~~Cl~~--dP~~RPs~~evl~~Le~~~~~l 767 (1018)
+-+ ..+.+..+..+|+.. ++.-|||++..+..|....+.|
T Consensus 262 P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 262 PLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred ChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 111 224555667778764 4678999999999887654433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.3e-07 Score=93.06 Aligned_cols=115 Identities=16% Similarity=0.089 Sum_probs=82.8
Q ss_pred eeeccCCCcCeEEEEecc-------cccceEEEecccc----------------------cccHHHHH----HHHHHHHH
Q 046791 522 NKLGEGGFGPVYKGQLLN-------GQEVAIKRLSRRS----------------------GQGIVEFK----NEAKLIAK 568 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~-------g~~vAvK~l~~~~----------------------~~~~~~f~----~E~~~l~~ 568 (1018)
..||.|--+.||.|...+ +..+|||+.+... ....+.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 4789999874321 00122333 79999999
Q ss_pred hcCCCcc--------------cccC----------CCCCChhhHHHHHHHHHHHHHHH-hcCCCCcEEecccCCCcEEEc
Q 046791 569 LQHTNLT--------------DSRR----------NNRLNWETRFSIIEGIAQGLLYL-HKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 569 l~H~nlv--------------~~~~----------~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivH~Dlkp~NILld 623 (1018)
+....+. +... ...++.++...+..+++.+|..| |..+ +||+||++.|||++
T Consensus 83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~ 159 (197)
T cd05146 83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH 159 (197)
T ss_pred HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE
Confidence 8654321 1111 11334456677889999999999 8888 99999999999997
Q ss_pred CCCCceeeeecceeeec
Q 046791 624 DQMNPKISDFGMARIFG 640 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~ 640 (1018)
++.+.|+|||.+....
T Consensus 160 -~~~v~iIDF~qav~~~ 175 (197)
T cd05146 160 -DGKVWFIDVSQSVEPT 175 (197)
T ss_pred -CCcEEEEECCCceeCC
Confidence 4679999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.9e-08 Score=113.33 Aligned_cols=220 Identities=19% Similarity=0.277 Sum_probs=130.2
Q ss_pred HHHhCCcceeeeeccCCCc---CeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccccCCCCCChhh
Q 046791 512 SAATNNFSAVNKLGEGGFG---PVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSRRNNRLNWET 587 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG---~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~~~~~l~~~~ 587 (1018)
.....+|+..+.+|..+-| .+|.++-.+ +.+...|.. ...-+.....-+++++|.- .-....+.
T Consensus 33 ~~~~~~~~~~~~~~~~g~g~~~~ly~~~~~~sk~~~~~~s~------~~~~ld~~~~~~~~lr~~~------~vs~aTe~ 100 (700)
T KOG2137|consen 33 PKESQSYRSLNQVGSAGPGDAWKLYAGKKSGSKAPTLKKSA------VVWMLDKRASSLQQLRGLD------GVSKATED 100 (700)
T ss_pred cccccccccccceeecCCCchhhhhhhhccCccCcccccee------eeeecChhhhHHHHHhccc------chhhcccH
Confidence 3445677777777765544 455554332 222211111 0011222333445566611 11122334
Q ss_pred HHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC----ccc---ceeeecccccCCh
Q 046791 588 RFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS----ETN---TNRVVGTYGYMSP 660 (1018)
Q Consensus 588 ~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~----~~~---~~~~~gt~~Y~aP 660 (1018)
...=+.+++.||.|+|... .+||++|.|++|.++.++..||+.|+.+........ ... .....-...|.||
T Consensus 101 ~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 4444566779999999865 699999999999999999999999998865432111 000 0112335589999
Q ss_pred hhhccCCCCccccchhHhHHHHHHHhCCCC-CCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHH
Q 046791 661 EYAMSGVVSIKTDVFSFGVLVLEIVSGKKN-NGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVG 739 (1018)
Q Consensus 661 E~~~~~~~s~ksDV~SlGvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 739 (1018)
|++.+...+.++|+||+|+++|.+..|..+ +....... .+. .....+..-...+..+.+.++.+-+
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~--------~~~~~~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYS--------FSRNLLNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhh--------hhhcccccccccccccCcHHHHHHH
Confidence 999998899999999999999999955544 22111110 000 0000111111122334455666666
Q ss_pred HhccccCCCCCCCHHHHHH
Q 046791 740 LLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 740 ~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+.+..++.-||++.++..
T Consensus 246 ~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHhcCCcccCcchhhhhc
Confidence 7788899999998777655
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.5e-06 Score=101.45 Aligned_cols=145 Identities=16% Similarity=0.191 Sum_probs=103.6
Q ss_pred ecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccccC--------------CCC-------CChhhHHHHHHHH
Q 046791 537 LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSRR--------------NNR-------LNWETRFSIIEGI 595 (1018)
Q Consensus 537 ~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~~--------------~~~-------l~~~~~~~i~~qi 595 (1018)
..++.+|.|...+...........+-++-|+.++||||+.... -.+ +........+.||
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~Gl~qI 113 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLGLFQI 113 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHHHHHH
Confidence 4468899999887766544555788899999999999984321 112 2233445567899
Q ss_pred HHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccch
Q 046791 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVF 675 (1018)
Q Consensus 596 a~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~ 675 (1018)
+.||.+||+.+ .++|++|....|++++.|+-||++|.++........ ......--..|..|+.+.... -..|.|
T Consensus 114 l~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~ 187 (690)
T KOG1243|consen 114 LAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSW 187 (690)
T ss_pred HHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhh
Confidence 99999999766 599999999999999999999999998865432111 111122223466666443211 346999
Q ss_pred hHhHHHHHHHhC
Q 046791 676 SFGVLVLEIVSG 687 (1018)
Q Consensus 676 SlGvvl~elltG 687 (1018)
-||++++|++.|
T Consensus 188 ~Lg~li~el~ng 199 (690)
T KOG1243|consen 188 GLGCLIEELFNG 199 (690)
T ss_pred hHHHHHHHHhCc
Confidence 999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-07 Score=108.49 Aligned_cols=231 Identities=21% Similarity=0.194 Sum_probs=147.5
Q ss_pred ceeHHH-HHHHhCCcceeeeeccCCCcCeEEEEe--cccccceEEEeccccccc------HHHHHHHHHHHHHhcCCCcc
Q 046791 505 IFDFQT-ISAATNNFSAVNKLGEGGFGPVYKGQL--LNGQEVAIKRLSRRSGQG------IVEFKNEAKLIAKLQHTNLT 575 (1018)
Q Consensus 505 ~f~~~~-l~~~t~~y~~~~~lG~G~fG~Vy~~~~--~~g~~vAvK~l~~~~~~~------~~~f~~E~~~l~~l~H~nlv 575 (1018)
+|.-.+ ....+.+|..+..||.|.|+.|++... .++..+++|.+.+..... ..+..-|+.+...+.+.+..
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 344444 445567899999999999999999864 357789999886553222 12223333333333332211
Q ss_pred ----cc-------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC-CCceee
Q 046791 576 ----DS-------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKIS 631 (1018)
Q Consensus 576 ----~~-------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kL~ 631 (1018)
++ .-...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcc
Confidence 00 01123567778899999999999999988 9999999999999886 788999
Q ss_pred eecceeeecCCCCcccceeeeccccc-CChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh
Q 046791 632 DFGMARIFGLNQSETNTNRVVGTYGY-MSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 632 DFGla~~~~~~~~~~~~~~~~gt~~Y-~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
|||.+..+.-. .......+..| .+|+......+-.+.|++|||.-+.|.+++..--..... +...
T Consensus 410 ~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i 475 (524)
T KOG0601|consen 410 DFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTI 475 (524)
T ss_pred cccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceee
Confidence 99998743211 11111223334 355556677889999999999999999998854211100 0001
Q ss_pred hcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 711 NEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 711 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..+... ..+.....+..+...+...++..||.+.++..+.+-
T Consensus 476 ~~~~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 476 RSGDTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eccccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111110 011122445556667888999999999888776553
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.5e-07 Score=106.78 Aligned_cols=122 Identities=16% Similarity=0.195 Sum_probs=79.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccccccc----------------------------------H---
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQG----------------------------------I--- 556 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~----------------------------------~--- 556 (1018)
-..|+. +.||+|++|.||+|++++ |+.||||+.+...... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999988 9999999987542110 0
Q ss_pred ---HHHHHHHHHHHHhc----CCCcc-----------------cccCCCCCChhh--------HHHHHHHHHHH-HHHHh
Q 046791 557 ---VEFKNEAKLIAKLQ----HTNLT-----------------DSRRNNRLNWET--------RFSIIEGIAQG-LLYLH 603 (1018)
Q Consensus 557 ---~~f~~E~~~l~~l~----H~nlv-----------------~~~~~~~l~~~~--------~~~i~~qia~g-L~yLH 603 (1018)
-+|.+|+..+.+++ +.+.+ +...+.+++.-. +..++...++. +..++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 12455665555553 22211 111222332111 11233333332 34456
Q ss_pred cCCCCcEEecccCCCcEEEcCCC----Cceeeeecceeeec
Q 046791 604 KYSRLRVIHRDLKASNILLDDQM----NPKISDFGMARIFG 640 (1018)
Q Consensus 604 ~~~~~~ivH~Dlkp~NILld~~~----~~kL~DFGla~~~~ 640 (1018)
..| ++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 677 99999999999999888 89999999998764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.21 E-value=9.7e-06 Score=86.01 Aligned_cols=117 Identities=19% Similarity=0.255 Sum_probs=88.8
Q ss_pred eeeccCCCcCeEEEEecccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCc-----cccc----------------C
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNL-----TDSR----------------R 579 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nl-----v~~~----------------~ 579 (1018)
+.|+.|..+.||+++..+|+.+++|....... ....++..|++++..+++.++ +... .
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887778999998765432 245678999999999876433 1100 0
Q ss_pred C---------CCCChhhHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q 046791 580 N---------NRLNWETRFSIIEGIAQGLLYLHKYS-------------------------------------------- 606 (1018)
Q Consensus 580 ~---------~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------------------- 606 (1018)
+ ..++..++..++.++++.|..||+..
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW 163 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence 0 12456677889999999999999631
Q ss_pred ---------CCcEEecccCCCcEEEcC--CCCceeeeecceee
Q 046791 607 ---------RLRVIHRDLKASNILLDD--QMNPKISDFGMARI 638 (1018)
Q Consensus 607 ---------~~~ivH~Dlkp~NILld~--~~~~kL~DFGla~~ 638 (1018)
...++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=6.1e-07 Score=108.75 Aligned_cols=151 Identities=24% Similarity=0.260 Sum_probs=110.2
Q ss_pred CCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC-------------------
Q 046791 582 RLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN------------------- 642 (1018)
Q Consensus 582 ~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~------------------- 642 (1018)
.++.+.....+..+.++++|||... +.|+|++|.|+++..++..+++|||.....+.-
T Consensus 900 ~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~ 976 (1205)
T KOG0606|consen 900 CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLS 976 (1205)
T ss_pred CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccc
Confidence 3555566667778899999999987 899999999999999999999999854332110
Q ss_pred ------CCc----ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 643 ------QSE----TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 643 ------~~~----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
... .......+|+.|.+||...+......+|.|++|++++|.++|.+||....+..
T Consensus 977 ~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~-------------- 1042 (1205)
T KOG0606|consen 977 RSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ-------------- 1042 (1205)
T ss_pred ccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh--------------
Confidence 000 11234678999999999999999999999999999999999999986544332
Q ss_pred CcchhhhhhhhcCC-----CChHHHHHHHHHHHhccccCCCCCCCHH
Q 046791 713 GKVLELVDIALEGS-----FSPNEVLRCIHVGLLCVQDQATDRPAMP 754 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 754 (1018)
+++..+... .+.+...+..+++...+..+|.+|-.|.
T Consensus 1043 -----~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 -----IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred -----hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 111111111 1233345566677778888999997765
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.8e-05 Score=88.22 Aligned_cols=139 Identities=23% Similarity=0.351 Sum_probs=107.0
Q ss_pred cCeEEEE-ecccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc--------------------------------
Q 046791 530 GPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD-------------------------------- 576 (1018)
Q Consensus 530 G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~-------------------------------- 576 (1018)
.+.||+. ..||..+++|+++....+....-..-++..+++.|+|+|.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 4688886 4579999999996554443333455678899999999872
Q ss_pred --------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 577 --------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 577 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
...+..++++..+.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 122445778999999999999999999999 888999999999999999999998887766433
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCC
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKN 690 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p 690 (1018)
.. +| +. -..+-|.=.||.+++.|.||...
T Consensus 447 ~~--------------~~--le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT--------------EP--LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC--------------cc--hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 21 11 11 12367888999999999999754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.4e-05 Score=77.83 Aligned_cols=115 Identities=28% Similarity=0.386 Sum_probs=81.5
Q ss_pred eeeeeccCCCcCeEEEEecccccceEEEe-cccc-------cccHHHHHHHHHHHHHhcCCCcc----------------
Q 046791 520 AVNKLGEGGFGPVYKGQLLNGQEVAIKRL-SRRS-------GQGIVEFKNEAKLIAKLQHTNLT---------------- 575 (1018)
Q Consensus 520 ~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l-~~~~-------~~~~~~f~~E~~~l~~l~H~nlv---------------- 575 (1018)
.+..|-||+-+.|+++.. .|+...||.- .+.. .-...+.++|++++.+++--.|.
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999987 5677677643 2221 12345678899999998643332
Q ss_pred cc-------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC---ceeeeecceee
Q 046791 576 DS-------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDFGMARI 638 (1018)
Q Consensus 576 ~~-------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kL~DFGla~~ 638 (1018)
+. ........+....++..|-+.+.-||..+ |+|+||..+||+|..++. +.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 00 01112222333678899999999999999 999999999999975543 58999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.01 E-value=3e-05 Score=79.82 Aligned_cols=104 Identities=29% Similarity=0.309 Sum_probs=71.3
Q ss_pred eEEEEecccccceEEEeccccc--------------------------ccHHHHHHHHHHHHHhcCCCcc----------
Q 046791 532 VYKGQLLNGQEVAIKRLSRRSG--------------------------QGIVEFKNEAKLIAKLQHTNLT---------- 575 (1018)
Q Consensus 532 Vy~~~~~~g~~vAvK~l~~~~~--------------------------~~~~~f~~E~~~l~~l~H~nlv---------- 575 (1018)
||.|...+|..+|||..+.... .......+|++.|.++....+.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~~ 81 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNRN 81 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEETT
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeCC
Confidence 8999998999999998743210 0112367899999999766531
Q ss_pred ----cccC--C--------CCCChhhHHHHHHHHHHHHHH-HhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee
Q 046791 576 ----DSRR--N--------NRLNWETRFSIIEGIAQGLLY-LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 576 ----~~~~--~--------~~l~~~~~~~i~~qia~gL~y-LH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~ 639 (1018)
+... + ..++.+....++.++++.+.. +|..| |+|+||.+.|||++++ .+.|+|||.+...
T Consensus 82 ~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 82 VIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred EEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 1111 1 111235577888899986666 57888 9999999999999988 9999999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=2.9e-05 Score=77.76 Aligned_cols=112 Identities=22% Similarity=0.345 Sum_probs=77.3
Q ss_pred eeeccCCCcCeEEEEecccccceEEEecccc--cc------cHHHHHHHHHHHHHhcCCCcc----------------cc
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--GQ------GIVEFKNEAKLIAKLQHTNLT----------------DS 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~------~~~~f~~E~~~l~~l~H~nlv----------------~~ 577 (1018)
..+++|+-+.+|.+.+. |.++++|.-.+.. .. ..++-.+|++++.+++-..+. +.
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999663 3446666432221 11 123467899999998643321 11
Q ss_pred cCCCCCC---hhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 RRNNRLN---WETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 ~~~~~l~---~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.....+. +..+..++..+-+-+.-||..+ |+|+||.++||++.... +.++||||+..
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 1122221 1113568888888999999999 99999999999998775 99999999874
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.80 E-value=2.8e-05 Score=67.71 Aligned_cols=66 Identities=29% Similarity=0.539 Sum_probs=47.3
Q ss_pred cCceeeccccccc-----cCCcccchhhhhhcc-CCcceeeeeccCCCCcceEEec-cCCCccccC-CCCceEEEE
Q 046791 316 RGFMSVDGFKFKG-----SNNMSRDDCATKCLS-NCSCIAFAITNKNNNTACEIWS-RGSKFIEDN-NNTDARYIS 383 (1018)
Q Consensus 316 ~~f~~~~~~~~~~-----~~~~sl~~C~~~Cl~-nCsC~Ayay~~~~~~~~C~~w~-~~l~~~~~~-~~~~~~y~r 383 (1018)
..|..++++.+.. ....++++|++.|+. +|+|.||.|.+ +..+|.+|. +.+.+.+.. ..+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccceecccCCceeEEe
Confidence 3466777766431 235689999999999 99999999953 467899999 777776633 444555543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00012 Score=77.72 Aligned_cols=131 Identities=18% Similarity=0.182 Sum_probs=90.1
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEeccccc----------------------ccHHHHHHHH
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG----------------------QGIVEFKNEA 563 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~----------------------~~~~~f~~E~ 563 (1018)
+.+..+.....=..+..+||-|--+.||.|..+.|.++|||.-+.... -.....++|.
T Consensus 81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf 160 (304)
T COG0478 81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF 160 (304)
T ss_pred HHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence 334444444444567789999999999999999999999995422110 0123357889
Q ss_pred HHHHHhcCC------------Ccc--cccC-----CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC
Q 046791 564 KLIAKLQHT------------NLT--DSRR-----NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD 624 (1018)
Q Consensus 564 ~~l~~l~H~------------nlv--~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~ 624 (1018)
++|.+|... |.| +... .-+++.+..-.|+..|++-+.-+-..| |||+|+.+-||++++
T Consensus 161 ~~L~~L~~~G~~VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 161 EALQRLYPEGVKVPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred HHHHHhhhcCCCCCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 999998543 111 1111 122235555666666666666555667 999999999999999
Q ss_pred CCCceeeeecceeee
Q 046791 625 QMNPKISDFGMARIF 639 (1018)
Q Consensus 625 ~~~~kL~DFGla~~~ 639 (1018)
++.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00015 Score=79.15 Aligned_cols=106 Identities=17% Similarity=0.170 Sum_probs=74.4
Q ss_pred CcCeEEEEecccccceEEEeccccc-----------ccHHHHHHHHHHHHHhcCCCcc----------------------
Q 046791 529 FGPVYKGQLLNGQEVAIKRLSRRSG-----------QGIVEFKNEAKLIAKLQHTNLT---------------------- 575 (1018)
Q Consensus 529 fG~Vy~~~~~~g~~vAvK~l~~~~~-----------~~~~~f~~E~~~l~~l~H~nlv---------------------- 575 (1018)
...|++..+ +|+.+.||+...... .....+.+|...+.++...+|.
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 334667655 677899997643321 1112478999999888544432
Q ss_pred -c-ccC------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-------CCCceeeeec
Q 046791 576 -D-SRR------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-------QMNPKISDFG 634 (1018)
Q Consensus 576 -~-~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-------~~~~kL~DFG 634 (1018)
+ +.. ....+...+..++.++++.+.-||..| |+|+|+++.|||++. +..+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 0 000 112333466789999999999999999 999999999999975 4678999999
Q ss_pred ceee
Q 046791 635 MARI 638 (1018)
Q Consensus 635 la~~ 638 (1018)
.+..
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00017 Score=74.73 Aligned_cols=111 Identities=15% Similarity=0.192 Sum_probs=84.0
Q ss_pred eccCCCcCeEEEEecccccceEEEecccc------cccHHHHHHHHHHHHHhcCCCcc----------------------
Q 046791 524 LGEGGFGPVYKGQLLNGQEVAIKRLSRRS------GQGIVEFKNEAKLIAKLQHTNLT---------------------- 575 (1018)
Q Consensus 524 lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~H~nlv---------------------- 575 (1018)
-|+||.+-|++..+. |+.+-+|+-.... ..+...|.+|...|.+|...++.
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467888899997763 4468888764221 34567899999999999765542
Q ss_pred c-cc---------C---CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC--ceeeeecceee
Q 046791 576 D-SR---------R---NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN--PKISDFGMARI 638 (1018)
Q Consensus 576 ~-~~---------~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~--~kL~DFGla~~ 638 (1018)
+ +. . ..+.+...+..++.++++.+.-||..+ +.|+|+-+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 0 11 1 123355666899999999999999999 999999999999986666 99999987653
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=97.65 E-value=3.9e-05 Score=64.64 Aligned_cols=37 Identities=16% Similarity=0.487 Sum_probs=33.6
Q ss_pred cCCCCcceEEecCCCcCcccceeecCCCChhhHhhhcC
Q 046791 981 CSTGYSSVFKISPAAIMENGFIFKEDNMTLDDCKMRCL 1018 (1018)
Q Consensus 981 C~~~~~~f~~~~~~~~~~t~~~~~~~~~~~~~C~~~C~ 1018 (1018)
|+ .+|+|++|++||+|++..++++.+++++|||++|+
T Consensus 1 C~-~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl 37 (66)
T PF08276_consen 1 CG-SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACL 37 (66)
T ss_pred Cc-CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcC
Confidence 63 45999999999999999999988899999999997
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=97.58 E-value=9.2e-05 Score=69.48 Aligned_cols=47 Identities=26% Similarity=0.500 Sum_probs=38.1
Q ss_pred ccccccccccc----------ceeEeeccCCceeEEEEEccCCCCceEEEEECcCccc
Q 046791 918 FDNFNWSILSS----------SYYFSYSSNGKEKYFRYSALEGLQPFSSMRINPDGVF 965 (1018)
Q Consensus 918 ~~~~~~~~~~~----------~~~~~f~~n~~Evy~t~~~~~~~~~~srl~l~~~G~l 965 (1018)
||++||+|..+ .+.+.|+.|.+|+||+|...+. +.++|++|+++|.|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~-s~~~r~~ld~~G~l 57 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNS-SVLSRLVLDSDGQL 57 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCC-ceEEEEEEeeeeEE
Confidence 35556665444 4889999999999999977665 58999999999999
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0012 Score=69.65 Aligned_cols=134 Identities=19% Similarity=0.227 Sum_probs=93.1
Q ss_pred ccceeHHHHHHHhCCcceeeeecc---CCCcCeEEEEecccccceEEEecccccc-------------------cHHH--
Q 046791 503 LEIFDFQTISAATNNFSAVNKLGE---GGFGPVYKGQLLNGQEVAIKRLSRRSGQ-------------------GIVE-- 558 (1018)
Q Consensus 503 ~~~f~~~~l~~~t~~y~~~~~lG~---G~fG~Vy~~~~~~g~~vAvK~l~~~~~~-------------------~~~~-- 558 (1018)
+...+.+.|.....+..+....|. |--+.||+|...++..+|||+++..... ..++
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 334567778888888888777664 5556799998888999999998543211 1111
Q ss_pred ---HHHHHHHHHHhcCCC------------cc--c----------ccCCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcE
Q 046791 559 ---FKNEAKLIAKLQHTN------------LT--D----------SRRNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRV 610 (1018)
Q Consensus 559 ---f~~E~~~l~~l~H~n------------lv--~----------~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~i 610 (1018)
-.+|..-|.++.... ++ + ....-.+..++...+..++++.+.-|-. .+ +
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---L 188 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---L 188 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---c
Confidence 245677777764322 11 0 1112223333678888888998887766 56 9
Q ss_pred EecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 611 IHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 611 vH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
||+||..-|||+. ++.+.|+|||-|....
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccC
Confidence 9999999999999 8899999999987653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.00041 Score=73.08 Aligned_cols=54 Identities=28% Similarity=0.355 Sum_probs=48.0
Q ss_pred CChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC---Cceeeeecceeee
Q 046791 583 LNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM---NPKISDFGMARIF 639 (1018)
Q Consensus 583 l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kL~DFGla~~~ 639 (1018)
++......++.++++.+.-||+.| |+|+|+++.|||++.+. .+.|+||+.++..
T Consensus 115 ~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 115 LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 445667889999999999999999 99999999999999887 7999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0021 Score=76.14 Aligned_cols=116 Identities=17% Similarity=0.252 Sum_probs=74.1
Q ss_pred eeeccCCCcCeEEEEecccccceEEEeccccccc----------------------------------------HHHHHH
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQG----------------------------------------IVEFKN 561 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~----------------------------------------~~~f~~ 561 (1018)
+.|+.++-|.||+|++++|+.||||+.+..-.+. +-.|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5788999999999999999999999886542110 011344
Q ss_pred HHHHHHHhcC-----CCc-----c-----------cccCCCCCChh--------hHHHHHHHHHHHH-HHHhcCCCCcEE
Q 046791 562 EAKLIAKLQH-----TNL-----T-----------DSRRNNRLNWE--------TRFSIIEGIAQGL-LYLHKYSRLRVI 611 (1018)
Q Consensus 562 E~~~l~~l~H-----~nl-----v-----------~~~~~~~l~~~--------~~~~i~~qia~gL-~yLH~~~~~~iv 611 (1018)
|+.-+.++++ +++ . +...+.+++.. .+..++..++++. ..+-..| ++
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dg---ff 287 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDG---FF 287 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcC---cc
Confidence 5554444421 111 1 00111111111 1334555454442 3344456 99
Q ss_pred ecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 612 HRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 612 H~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
|.|..|.||+++.++.+.+.|||+...+.
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999987664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0052 Score=64.18 Aligned_cols=121 Identities=17% Similarity=0.199 Sum_probs=78.5
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHH---------HHHHHHHHHhcCCCc--------c
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEF---------KNEAKLIAKLQHTNL--------T 575 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f---------~~E~~~l~~l~H~nl--------v 575 (1018)
...++|.+.+.+-......|.+... +|+.+.+|..+.......+.| .+++..+.+++...+ +
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3567888888888877777777766 578899998766543322222 333444444432211 1
Q ss_pred ----------------cccCCCCCChhhH--HHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 576 ----------------DSRRNNRLNWETR--FSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 576 ----------------~~~~~~~l~~~~~--~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
+...+..+..-.. -.++..+++++.-||..| ++|+|..|.|+++.++ .++++||+..+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECcccc
Confidence 1122333322111 135567888999999999 9999999999999865 49999998765
Q ss_pred e
Q 046791 638 I 638 (1018)
Q Consensus 638 ~ 638 (1018)
.
T Consensus 183 ~ 183 (229)
T PF06176_consen 183 M 183 (229)
T ss_pred c
Confidence 3
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0003 Score=81.95 Aligned_cols=165 Identities=17% Similarity=0.145 Sum_probs=116.0
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcc-c-------------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT-D------------- 576 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv-~------------- 576 (1018)
++..+.-+...+-+++++++.++|.+..-.+....+.+... ....-++++|.+++|||.+ .
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 34445556666778999999999986533333334444322 4557789999999999932 1
Q ss_pred ---ccCC------------CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 577 ---SRRN------------NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 577 ---~~~~------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.... ..+...+...+.+.-+++|++||+.. =+|+| ||+..+ ...|..||+....+..
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCc
Confidence 0000 11222333455666778899999864 58888 777766 5789999999876643
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCC
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNN 691 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~ 691 (1018)
.. ......+++.++|||+.....+..+-|+|++++--.++--|.+|-
T Consensus 384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 32 344567899999999999999999999999998777777777664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0066 Score=64.62 Aligned_cols=50 Identities=16% Similarity=0.206 Sum_probs=39.3
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCC
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN 573 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n 573 (1018)
++.|+.|..+.||+....+ ..+++|..... .....+..|+.++..+....
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~ 51 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHG 51 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTT
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcC
Confidence 4689999999999999877 68999987554 44567788888888885443
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.014 Score=62.25 Aligned_cols=110 Identities=19% Similarity=0.135 Sum_probs=73.6
Q ss_pred eeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCc-----cc-------------ccCCC--
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL-----TD-------------SRRNN-- 581 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-----v~-------------~~~~~-- 581 (1018)
.+||+|..+.||+. .+..+++|...... ......+|.+++..+....+ +. ...+.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 25567888876533 33456889999988865443 11 11111
Q ss_pred -----CCChhhHHHHHHHHHHHHHHHhcC----------------------------------------CCCcEEecccC
Q 046791 582 -----RLNWETRFSIIEGIAQGLLYLHKY----------------------------------------SRLRVIHRDLK 616 (1018)
Q Consensus 582 -----~l~~~~~~~i~~qia~gL~yLH~~----------------------------------------~~~~ivH~Dlk 616 (1018)
..+......++.++++.+.-||+. ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 112223345666666666666642 12347899999
Q ss_pred CCcEEEcCCCCceeeeeccee
Q 046791 617 ASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 617 p~NILld~~~~~kL~DFGla~ 637 (1018)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0086 Score=59.89 Aligned_cols=114 Identities=23% Similarity=0.246 Sum_probs=77.8
Q ss_pred ceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcc-------------cccCCCCCCh
Q 046791 519 SAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT-------------DSRRNNRLNW 585 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv-------------~~~~~~~l~~ 585 (1018)
...+.|++|.+|.||+|.+. |.++|+|+-+..+ ....+..|+++|..++-.++. ....+.+|..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~ 101 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhh
Confidence 34578999999999999884 4588999765443 456789999999999876543 1222323332
Q ss_pred hhH---HHHHHHHHHHHHHHhcCCCCcEEecccC-CCcEEEcCCCCceeeeecceee
Q 046791 586 ETR---FSIIEGIAQGLLYLHKYSRLRVIHRDLK-ASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 586 ~~~---~~i~~qia~gL~yLH~~~~~~ivH~Dlk-p~NILld~~~~~kL~DFGla~~ 638 (1018)
... .+-+..+++.---|...| |-|+.|. |..++|-.+..+.|+||..|..
T Consensus 102 ~~~~~~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGGDRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcccHHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 222 344445666645566666 9999886 5555555555999999998874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.021 Score=59.02 Aligned_cols=121 Identities=24% Similarity=0.351 Sum_probs=83.2
Q ss_pred CccceeHHHHHHHhCCcceeeeeccCCC-cCeEEEEecccccceEEEeccc---c---------c---------ccHHHH
Q 046791 502 GLEIFDFQTISAATNNFSAVNKLGEGGF-GPVYKGQLLNGQEVAIKRLSRR---S---------G---------QGIVEF 559 (1018)
Q Consensus 502 ~~~~f~~~~l~~~t~~y~~~~~lG~G~f-G~Vy~~~~~~g~~vAvK~l~~~---~---------~---------~~~~~f 559 (1018)
.++.|+. -+.+++.++.||.|.- |.||++++ +|+.+|+|.++.- . . .....|
T Consensus 28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF 101 (207)
T PF13095_consen 28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF 101 (207)
T ss_pred CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence 3555666 2278999999999999 99999998 6779999994221 0 0 112348
Q ss_pred HHHHHHHHHhcCCC---c--cc------cc-------------CCC----------CCCh--hhHHHHHHHHHHHHHHHh
Q 046791 560 KNEAKLIAKLQHTN---L--TD------SR-------------RNN----------RLNW--ETRFSIIEGIAQGLLYLH 603 (1018)
Q Consensus 560 ~~E~~~l~~l~H~n---l--v~------~~-------------~~~----------~l~~--~~~~~i~~qia~gL~yLH 603 (1018)
..|.+...+|++-+ + ++ +. ... -.+. .....-+.+|.+-|..+|
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILH 181 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHH
Confidence 88999888885433 3 21 00 000 0111 123455678889999999
Q ss_pred cCCCCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 604 ~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 182 k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCC---eeeccCcccccc-----CCEEEecccC
Confidence 999 999999999976 4589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.033 Score=59.71 Aligned_cols=31 Identities=26% Similarity=0.429 Sum_probs=27.0
Q ss_pred CCcEEecccCCCcEEEcC-CCCceeeeeccee
Q 046791 607 RLRVIHRDLKASNILLDD-QMNPKISDFGMAR 637 (1018)
Q Consensus 607 ~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~ 637 (1018)
+..++|+|+.+.|||++. +..+.|+||..|.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 346999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.0045 Score=53.33 Aligned_cols=35 Identities=23% Similarity=0.571 Sum_probs=29.1
Q ss_pred CcccchhhhhhccCCcceeeeeccCCCCcceEEeccC
Q 046791 331 NMSRDDCATKCLSNCSCIAFAITNKNNNTACEIWSRG 367 (1018)
Q Consensus 331 ~~sl~~C~~~Cl~nCsC~Ayay~~~~~~~~C~~w~~~ 367 (1018)
..+.++|++.|+.+|+|.||.|. .+...|+++...
T Consensus 24 ~~s~~~Cq~~C~~~~~C~afT~~--~~~~~C~lk~~~ 58 (73)
T cd01100 24 ASSAEQCQAACTADPGCLAFTYN--TKSKKCFLKSSE 58 (73)
T ss_pred cCCHHHHHHHcCCCCCceEEEEE--CCCCeEEcccCC
Confidence 55889999999999999999995 335679987764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.027 Score=62.75 Aligned_cols=49 Identities=10% Similarity=0.033 Sum_probs=34.3
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCC
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN 573 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n 573 (1018)
.+.|..|....+|+....+ ..+++|+... ....+...|+.++..+.+..
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g 67 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERG 67 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCC
Confidence 4567778888999987644 4788898754 23456677888888875433
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.035 Score=60.53 Aligned_cols=29 Identities=28% Similarity=0.330 Sum_probs=25.6
Q ss_pred cEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 609 RVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 609 ~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.++|+|+.|.||++++++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999999876 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.064 Score=57.89 Aligned_cols=30 Identities=30% Similarity=0.318 Sum_probs=26.5
Q ss_pred CcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 608 LRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 608 ~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 348999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.1 Score=56.11 Aligned_cols=30 Identities=30% Similarity=0.471 Sum_probs=25.5
Q ss_pred cEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 609 RVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 609 ~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.++|+|+.+.|||++++...-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 389999999999999776567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.073 Score=60.03 Aligned_cols=30 Identities=33% Similarity=0.388 Sum_probs=25.9
Q ss_pred CcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 608 LRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 608 ~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
..++|+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 459999999999999977656899999875
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.016 Score=51.09 Aligned_cols=39 Identities=18% Similarity=0.472 Sum_probs=32.8
Q ss_pred CCCcCCCC--cceEEecCCCcCcccceeecCCCChhhHhhhcC
Q 046791 978 DPVCSTGY--SSVFKISPAAIMENGFIFKEDNMTLDDCKMRCL 1018 (1018)
Q Consensus 978 ~~~C~~~~--~~f~~~~~~~~~~t~~~~~~~~~~~~~C~~~C~ 1018 (1018)
+++|++++ ++|+++.++++|+..+.. .++++++||+.|+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl 42 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACL 42 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHh
Confidence 46897643 799999999999887765 7889999999996
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.062 Score=67.58 Aligned_cols=173 Identities=20% Similarity=0.218 Sum_probs=112.7
Q ss_pred HHHHHHHHHHHHHhcCCCccc------------------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcC
Q 046791 556 IVEFKNEAKLIAKLQHTNLTD------------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKY 605 (1018)
Q Consensus 556 ~~~f~~E~~~l~~l~H~nlv~------------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 605 (1018)
......|...+.++.|+|++. +..-..++.++.+.+..++.+||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 334566788889999999872 12234577788888999999999999998
Q ss_pred CCCcEEecccCCC---cEEEcCCCCceee--eecceeeecCCCCcccceeeecccccCChhhhccCCCCc--cccchhHh
Q 046791 606 SRLRVIHRDLKAS---NILLDDQMNPKIS--DFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI--KTDVFSFG 678 (1018)
Q Consensus 606 ~~~~ivH~Dlkp~---NILld~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~--ksDV~SlG 678 (1018)
. ..|.-+..+ +--.+..+...++ ||+.++......... ....+..+.+||......... ..|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 555444444 4444556666666 888887654322211 123344677888776655544 47999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 679 VLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 679 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....+..|..+-.... ....++ ..... ..+.+....|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~------------------~~~~~l----~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA------------------VPVSLL----DVLST----SELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCccccccc------------------chhhhh----ccccc----hhhhhhhhhhcchhhhhccchhhhhh
Confidence 99999999886522110 001111 10111 03455667899999999999999988
Q ss_pred HH
Q 046791 759 ML 760 (1018)
Q Consensus 759 ~L 760 (1018)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 54
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.078 Score=62.96 Aligned_cols=116 Identities=20% Similarity=0.302 Sum_probs=72.4
Q ss_pred eeeccCCCcCeEEEEecccccceEEEeccccccc-------------------------------------HHHHHHHHH
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQG-------------------------------------IVEFKNEAK 564 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~-------------------------------------~~~f~~E~~ 564 (1018)
+.||.-+.|.||+|++++|+.||||+-+..-... +-.|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5788999999999999999999999865432111 112555655
Q ss_pred HHHHh----cCCCcc--------------------cccCCCCCChh--------hHHHHHHHHHHHHH-HHhcCCCCcEE
Q 046791 565 LIAKL----QHTNLT--------------------DSRRNNRLNWE--------TRFSIIEGIAQGLL-YLHKYSRLRVI 611 (1018)
Q Consensus 565 ~l~~l----~H~nlv--------------------~~~~~~~l~~~--------~~~~i~~qia~gL~-yLH~~~~~~iv 611 (1018)
-..++ .|-++. +.-.+.+++.- ....|+..+.++.. -|-..| ++
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~G---ff 323 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTG---FF 323 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcC---Cc
Confidence 44433 343311 01111112111 11245555555433 233445 99
Q ss_pred ecccCCCcEEEcC----CCCceeeeecceeeec
Q 046791 612 HRDLKASNILLDD----QMNPKISDFGMARIFG 640 (1018)
Q Consensus 612 H~Dlkp~NILld~----~~~~kL~DFGla~~~~ 640 (1018)
|+|-.|.||++.. ++.+.+-|||+...+.
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 9999999999983 6789999999987654
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.018 Score=50.36 Aligned_cols=28 Identities=21% Similarity=0.273 Sum_probs=25.2
Q ss_pred CcceEEecCCCcCcccceeecCCCChhhHhhhcC
Q 046791 985 YSSVFKISPAAIMENGFIFKEDNMTLDDCKMRCL 1018 (1018)
Q Consensus 985 ~~~f~~~~~~~~~~t~~~~~~~~~~~~~C~~~C~ 1018 (1018)
+.+|.++.+||+|||.. ++++||+++|+
T Consensus 8 ~g~fl~~~~~klpd~~~------~s~~eC~~~Cl 35 (80)
T cd00129 8 AGTTLIKIALKIKTTKA------NTADECANRCE 35 (80)
T ss_pred CCeEEEeecccCCcccc------cCHHHHHHHHh
Confidence 37899999999999887 78999999996
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.15 Score=58.09 Aligned_cols=32 Identities=28% Similarity=0.467 Sum_probs=27.0
Q ss_pred CCcEEecccCCCcEEEcC-CCCceeeeecceee
Q 046791 607 RLRVIHRDLKASNILLDD-QMNPKISDFGMARI 638 (1018)
Q Consensus 607 ~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~~ 638 (1018)
+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 346899999999999986 46799999988753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.54 E-value=0.27 Score=55.17 Aligned_cols=31 Identities=35% Similarity=0.420 Sum_probs=27.1
Q ss_pred CCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 607 RLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 607 ~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
+..++|+|+.+.||+++.++...|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3569999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.086 Score=57.68 Aligned_cols=131 Identities=17% Similarity=0.193 Sum_probs=84.8
Q ss_pred eeHHHHHHHhC---CcceeeeeccCCCcCeEEEEecccccceEEEeccc----------------ccc------cHHHHH
Q 046791 506 FDFQTISAATN---NFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRR----------------SGQ------GIVEFK 560 (1018)
Q Consensus 506 f~~~~l~~~t~---~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~----------------~~~------~~~~f~ 560 (1018)
++|-.|....+ -+.+.++||-|--+.||.+...+|++.++|.-+-. ... ..-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 44444444443 46788999999999999999999999998843211 000 112245
Q ss_pred HHHHHHHHhcCC------------Ccc--cccCCCCCC----hhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE
Q 046791 561 NEAKLIAKLQHT------------NLT--DSRRNNRLN----WETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL 622 (1018)
Q Consensus 561 ~E~~~l~~l~H~------------nlv--~~~~~~~l~----~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl 622 (1018)
+|...|+.|... |+| ++....+|- ....-.+...+..-+--|-.+| +||+|..-=||++
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 688888877432 111 222222211 1222334444555556677788 9999999999999
Q ss_pred cCCCCceeeeecceeee
Q 046791 623 DDQMNPKISDFGMARIF 639 (1018)
Q Consensus 623 d~~~~~kL~DFGla~~~ 639 (1018)
+++..++++||--....
T Consensus 236 ~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVST 252 (465)
T ss_pred ecCCCEEEeechHhhcc
Confidence 99999999999765443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.36 Score=61.86 Aligned_cols=54 Identities=20% Similarity=0.364 Sum_probs=39.0
Q ss_pred eeeeccCCCcCeEEEEeccc---ccceEEEecccc-cccHHHHHHHHHHHHHhc-CCCc
Q 046791 521 VNKLGEGGFGPVYKGQLLNG---QEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQ-HTNL 574 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g---~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nl 574 (1018)
.++|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~v 101 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDV 101 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCC
Confidence 57889999999999877554 367777764432 223457889999999996 6654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.28 Score=54.80 Aligned_cols=32 Identities=34% Similarity=0.419 Sum_probs=27.9
Q ss_pred CCCcEEecccCCCcEEEcCC----CCceeeeeccee
Q 046791 606 SRLRVIHRDLKASNILLDDQ----MNPKISDFGMAR 637 (1018)
Q Consensus 606 ~~~~ivH~Dlkp~NILld~~----~~~kL~DFGla~ 637 (1018)
.+..++|+|+.|.|||++++ +.++|+||..|.
T Consensus 177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 44579999999999999985 789999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.069 Score=55.20 Aligned_cols=58 Identities=19% Similarity=0.108 Sum_probs=51.5
Q ss_pred CCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee
Q 046791 582 RLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 582 ~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~ 639 (1018)
.-+|..|.+|+.++++.+.+|++.-...+.-.|++|+|+-+++++++|++|...+...
T Consensus 55 ~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 55 QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 4689999999999999999999865556888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.26 Score=51.32 Aligned_cols=103 Identities=16% Similarity=0.247 Sum_probs=66.9
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEecccc----------------cccHHHHHHHHHHHHHhc-CCCcc-----c--
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS----------------GQGIVEFKNEAKLIAKLQ-HTNLT-----D-- 576 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~----------------~~~~~~f~~E~~~l~~l~-H~nlv-----~-- 576 (1018)
...||+|+.-.||. +++.....||+..... .....++.+|+.....+. +.++. +
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45899999999986 4566778889886654 223567888888887777 44432 0
Q ss_pred ------------------c-----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-
Q 046791 577 ------------------S-----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM- 626 (1018)
Q Consensus 577 ------------------~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~- 626 (1018)
. .....++. .+...+-+-..||-+++ |+.+|++|.||++....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHHHcC---CeecCCCcccEEEEecCC
Confidence 0 01112222 23333444456777777 99999999999996332
Q ss_pred ---Cceeee
Q 046791 627 ---NPKISD 632 (1018)
Q Consensus 627 ---~~kL~D 632 (1018)
.+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.4 Score=52.87 Aligned_cols=30 Identities=27% Similarity=0.570 Sum_probs=25.2
Q ss_pred cEEecccCCCcEEEcCCCC-ceeeeecceee
Q 046791 609 RVIHRDLKASNILLDDQMN-PKISDFGMARI 638 (1018)
Q Consensus 609 ~ivH~Dlkp~NILld~~~~-~kL~DFGla~~ 638 (1018)
.++|+|++|.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.89 E-value=1.2 Score=49.57 Aligned_cols=49 Identities=12% Similarity=-0.029 Sum_probs=33.9
Q ss_pred eeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcC
Q 046791 520 AVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH 571 (1018)
Q Consensus 520 ~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H 571 (1018)
..+.||.|..+.||+....++ .+.+|..+. ......|..|+..++.|..
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~ 66 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLAR 66 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHcc
Confidence 446899999999999876555 466666432 1123578888888877743
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.48 E-value=0.44 Score=53.25 Aligned_cols=115 Identities=18% Similarity=0.208 Sum_probs=84.1
Q ss_pred eeeccCCCcCeEEEEecccccceEEEecccc---------ccc-------------HH--H--HHHHHHHHHHhcCCCcc
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS---------GQG-------------IV--E--FKNEAKLIAKLQHTNLT 575 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~---------~~~-------------~~--~--f~~E~~~l~~l~H~nlv 575 (1018)
..|..|--+-||.+.-.+|..+|||+++... -.+ .+ . ...|++-|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4577888899999999999999999875321 000 11 1 24578888888654432
Q ss_pred ------------------------cccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceee
Q 046791 576 ------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKIS 631 (1018)
Q Consensus 576 ------------------------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~ 631 (1018)
.......++...+..+-.|+++-|.-|-+.+ ++||.||.--|+|+- +|.+.|+
T Consensus 230 ~PePIlLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~lyiI 306 (520)
T KOG2270|consen 230 CPEPILLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGKLYII 306 (520)
T ss_pred CCCceeeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCEEEEE
Confidence 1223455777788889999999998887777 599999999999885 4588999
Q ss_pred eecceeee
Q 046791 632 DFGMARIF 639 (1018)
Q Consensus 632 DFGla~~~ 639 (1018)
|-+-+...
T Consensus 307 DVSQSVE~ 314 (520)
T KOG2270|consen 307 DVSQSVEH 314 (520)
T ss_pred EccccccC
Confidence 98877644
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=91.47 E-value=0.84 Score=51.77 Aligned_cols=31 Identities=23% Similarity=0.387 Sum_probs=26.3
Q ss_pred CcEEecccCCCcEEEcC-CCCceeeeecceee
Q 046791 608 LRVIHRDLKASNILLDD-QMNPKISDFGMARI 638 (1018)
Q Consensus 608 ~~ivH~Dlkp~NILld~-~~~~kL~DFGla~~ 638 (1018)
..++|.|+.+.|||+++ ++.++++||..|..
T Consensus 182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 35799999999999974 57899999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=90.75 E-value=1.8 Score=50.08 Aligned_cols=48 Identities=19% Similarity=0.263 Sum_probs=36.3
Q ss_pred eeeccCCCcCeEEEEeccc-ccceEEEeccc------c-cccHHHHHHHHHHHHHh
Q 046791 522 NKLGEGGFGPVYKGQLLNG-QEVAIKRLSRR------S-GQGIVEFKNEAKLIAKL 569 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g-~~vAvK~l~~~------~-~~~~~~f~~E~~~l~~l 569 (1018)
+.||.|.+..||++...+| +.|+||.-... . ....+++..|.+.|..+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l 87 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQ 87 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHH
Confidence 5799999999999998877 58999985421 1 22456778888888775
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=90.65 E-value=0.088 Score=67.72 Aligned_cols=82 Identities=11% Similarity=0.024 Sum_probs=67.1
Q ss_pred CcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhC
Q 046791 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687 (1018)
Q Consensus 608 ~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG 687 (1018)
.-.+|+++|+-|.+|..+..+|+.++|+.+.... .........+++.|++|+....-.++.++|+|..|+-+|+.--|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 3478999999999999999999999999983221 22223346778889999988888899999999999999999888
Q ss_pred CCCC
Q 046791 688 KKNN 691 (1018)
Q Consensus 688 ~~p~ 691 (1018)
..++
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 7764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.28 E-value=2.6 Score=47.55 Aligned_cols=29 Identities=38% Similarity=0.658 Sum_probs=25.9
Q ss_pred cEEecccCCCcEEEcCCCC-ceeeeeccee
Q 046791 609 RVIHRDLKASNILLDDQMN-PKISDFGMAR 637 (1018)
Q Consensus 609 ~ivH~Dlkp~NILld~~~~-~kL~DFGla~ 637 (1018)
.+||+|+.|.||+++.+.. ..++||+-+.
T Consensus 198 ~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 198 QIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3999999999999998875 8899999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1018 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-26 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-114
Identities = 106/294 (36%), Positives = 158/294 (53%), Gaps = 34/294 (11%)
Query: 505 IFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGI-VEFKNEA 563
F + + A++NFS N LG GGFG VYKG+L +G VA+KRL QG ++F+ E
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 564 KLIAKLQHTNL--------TDSRR--------NN--------------RLNWETRFSIIE 593
++I+ H NL T + R N L+W R I
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 594 GIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653
G A+GL YLH + ++IHRD+KA+NILLD++ + DFG+A++ + T V G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRG 197
Query: 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKN--NGCYRTDHPLNLIGYAWQLWN 711
T G+++PEY +G S KTDVF +GV++LE+++G++ D + L+ + L
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 712 EGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765
E K+ LVD+ L+G++ EV + I V LLC Q +RP M +VV ML + L
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 343 bits (883), Expect = e-110
Identities = 93/305 (30%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 502 GLEIFDFQTISAATNNFS------AVNKLGEGGFGPVYKGQLLNGQEVAIKRLS----RR 551
F F + TNNF NK+GEGGFG VYKG +N VA+K+L+
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDIT 69
Query: 552 SGQGIVEFKNEAKLIAKLQHTNLT-----------------------------DSRRNNR 582
+ + +F E K++AK QH NL
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 583 LNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642
L+W R I +G A G+ +LH+ IHRD+K++NILLD+ KISDFG+AR
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNL 702
T+R+VGT YM+PE + G ++ K+D++SFGV++LEI++G +R L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243
Query: 703 IGYAWQLWNEGKVLE-LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761
+ ++ +E K +E +D + V V C+ ++ RP + V +L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 762 NESLS 766
+ S
Sbjct: 303 EMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = 4e-99
Identities = 92/308 (29%), Positives = 147/308 (47%), Gaps = 35/308 (11%)
Query: 484 STNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEV 543
+ + + + ATNNF +G G FG VYKG L +G +V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 544 AIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT---------------------------- 575
A+KR + S QGI EF+ E + ++ +H +L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 576 --DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633
++WE R I G A+GL YLH + +IHRD+K+ NILLD+ PKI+DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 634 GMARIF-GLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNG 692
G+++ L+Q+ +T V GT GY+ PEY + G ++ K+DV+SFGV++ E++ +
Sbjct: 184 GISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 693 CYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPA 752
+NL +A + N G++ ++VD L P + + + C+ + DRP+
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 753 MPDVVSML 760
M DV+ L
Sbjct: 303 MGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 1e-71
Identities = 64/317 (20%), Positives = 121/317 (38%), Gaps = 50/317 (15%)
Query: 493 GNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS 552
G+ H+ G++ + + + + G FG V+K QL + VA+K +
Sbjct: 2 GHHHHHHSSGVD-LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD 59
Query: 553 GQGIVEFKNEAKLIAKLQHTN-----------------------------LTDSRRNNRL 583
Q + + E + ++H N L+D + N +
Sbjct: 60 KQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVV 118
Query: 584 NWETRFSIIEGIAQGLLYLH-------KYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636
+W I E +A+GL YLH + + HRD+K+ N+LL + + I+DFG+A
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGV-----VSIKTDVFSFGVLVLEIVSGKKNN 691
F +S +T+ VGT YM+PE + ++ D+++ G+++ E+ S
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 692 GCYRTDHPLNLIGYAWQLWNEGKVLELVDI-----ALEGSFSPNEVLRCI-HVGLLCVQD 745
++ L Q + + E+V L + + + + C
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 746 QATDRPAMPDVVSMLAN 762
A R + V +
Sbjct: 299 DAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 9e-62
Identities = 57/334 (17%), Positives = 109/334 (32%), Gaps = 66/334 (19%)
Query: 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAK- 564
S +N + +G G +G VYKG L + + VA+K S + Q F NE
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 565 -LIAKLQHTN------------------------------LTDSRRNNRLNWETRFSIIE 593
+ ++H N L + +W + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH 118
Query: 594 GIAQGLLYLH------KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF------GL 641
+ +GL YLH + + + HRDL + N+L+ + ISDFG++
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 642 NQSETNTNRVVGTYGYMSPEYAMSGV-------VSIKTDVFSFGVLVLEIVSGKKNNGCY 694
+ + VGT YM+PE V + D+++ G++ EI +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 695 RTDHPLNLIGYAWQLWNEGKVLELVDI--------ALEGSFSPNEVLRCIHVGLL--CVQ 744
+ + + ++ N ++ + ++ N + + C
Sbjct: 239 ESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 745 DQATDRPAMPDVVSMLANESLSLPAPKQPAFFIN 778
A R +A + K + +
Sbjct: 298 QDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-45
Identities = 66/289 (22%), Positives = 124/289 (42%), Gaps = 57/289 (19%)
Query: 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTN------ 573
K+G G FG V++ + +G +VA+K L + + + EF E ++ +L+H N
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 574 -----------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRV 610
L S +L+ R S+ +A+G+ YLH +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
+HR+LK+ N+L+D + K+ DFG++R+ + ++ GT +M+PE +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 671 KTDVFSFGVLVLEIVSGKKNNGCYRTDHP---LNLIGYAWQLWNEGKVLELVDIALEGSF 727
K+DV+SFGV++ E+ + ++ P LN + + K LE+
Sbjct: 219 KSDVYSFGVILWELATLQQ---------PWGNLNPAQVVAAVGFKCKRLEI------PRN 263
Query: 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN-ESLSLPAPKQPAF 775
+V I C ++ RP+ ++ +L ++P P +
Sbjct: 264 LNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 42/204 (20%)
Query: 522 NKLGEGGFGPVYKGQLLNGQEVAIKRL----SRRSGQGIVEFKNEAKLIAKLQHTN---- 573
+G GGFG VY+ G EVA+K Q I + EAKL A L+H N
Sbjct: 13 EIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 574 ---------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
L R+ + + IA+G+ YLH + + +IH
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 613 RDLKASNILLDDQMNP--------KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
RDLK+SNIL+ ++ KI+DFG+AR T G Y +M+PE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAPEVIR 187
Query: 665 SGVVSIKTDVFSFGVLVLEIVSGK 688
+ + S +DV+S+GVL+ E+++G+
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGE 211
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 62/285 (21%), Positives = 111/285 (38%), Gaps = 60/285 (21%)
Query: 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN-------- 573
+G G FG V K + ++VAIK++ S F E + ++++ H N
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 574 -------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRD 614
L + S +QG+ YLH +IHRD
Sbjct: 71 LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 615 LKASNILLDDQMN-PKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTD 673
LK N+LL KI DFG A +T+ G+ +M+PE S K D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 674 VFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVL 733
VFS+G+++ E+++ +K + + G A++ ++ G+ P ++
Sbjct: 186 VFSWGIILWEVITRRK---PFD-----EIGGPAFR---------IMWAVHNGT-RP-PLI 226
Query: 734 RCIHVGLL-----CVQDQATDRPAMPDVVSMLANESLSLPAPKQP 773
+ + + C + RP+M ++V ++ + P +P
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 64/270 (23%), Positives = 117/270 (43%), Gaps = 47/270 (17%)
Query: 522 NKLGEGGFGPVYKGQLLNGQEVAIKRL--SRRSGQGIVEFKNEAKLIAKLQHTNL----- 574
++G G FG VYKG +G +VA+K L + + Q + FKNE ++ K +H N+
Sbjct: 30 QRIGSGSFGTVYKG-KWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 575 --TDS-------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
T + + I A+G+ YLH +IHR
Sbjct: 88 YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE---YAMSGVVSI 670
DLK++NI L + KI DFG+A ++ G+ +M+PE S S
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 671 KTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730
++DV++FG+++ E+++G+ Y + + I + +L + P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP---YSNINNRDQI--IEMVGRGSLSPDLSKVRSN---CPK 256
Query: 731 EVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
+ R + C++ + +RP+ P +++ +
Sbjct: 257 RMKRLM---AECLKKKRDERPSFPRILAEI 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 58/281 (20%), Positives = 115/281 (40%), Gaps = 63/281 (22%)
Query: 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQG-------IVEFKNEAKLIAKLQHTN 573
++G+GGFG V+KG+L+ + VAIK L +G EF+ E +++ L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 574 LTD-------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
+ + + + W + ++ IA G+ Y+
Sbjct: 85 IVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNP 143
Query: 609 RVIHRDLKASNILLDDQ-----MNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE-- 661
++HRDL++ NI L + K++DFG+++ S + + ++G + +M+PE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPETI 198
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721
A + K D +SF +++ I++G+ + ++ I + + EG +
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGP---FD-EYSYGKIKFINMIREEGLRPTI--- 251
Query: 722 ALEGSFSPNEVLRCIHVGLL--CVQDQATDRPAMPDVVSML 760
P + + ++ C RP +V L
Sbjct: 252 -------PEDCPPRL-RNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 64/298 (21%), Positives = 106/298 (35%), Gaps = 67/298 (22%)
Query: 522 NKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
LG+G FG K G+ + +K L R + F E K++ L+H N+
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 575 -TDS--------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
+++ W R S + IA G+ YLH + +IHR
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR------------VVGTYGYMSPE 661
DL + N L+ + N ++DFG+AR+ +++ R VVG +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721
K DVFSFG+++ EI+ A + + +++
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVN----------------ADPDYLPRTMDFGLNV 236
Query: 722 ALEGSFSPNEVLRC----IHVGLLCVQDQATDRPAMPDVVSMLAN--ESLSLPAPKQP 773
G C + + C RP+ + L L+ P P
Sbjct: 237 --RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 36/202 (17%), Positives = 71/202 (35%), Gaps = 44/202 (21%)
Query: 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTD--- 576
KL E G ++KG G ++ +K L R S + +F E + H N+
Sbjct: 16 TKLNENHSGELWKG-RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 577 ---------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLR 609
N ++ +A+G+ +LH L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL- 133
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE---YAMSG 666
+ L + ++++D+ M +IS + F + + +++PE
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPED 186
Query: 667 VVSIKTDVFSFGVLVLEIVSGK 688
D++SF VL+ E+V+ +
Sbjct: 187 TNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 70/336 (20%), Positives = 123/336 (36%), Gaps = 76/336 (22%)
Query: 479 NLSLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL 538
NLSL S ++ ++ +I F+ + +G+G FG VY G+
Sbjct: 5 NLSLLSARSFPRKASQTSIFLQ-EWDI-PFEQLEIG-------ELIGKGRFGQVYHGRW- 54
Query: 539 NGQEVAIKRL--SRRSGQGIVEFKNEAKLIAKLQHTNL-------TDS------------ 577
+G EVAI+ + R + + FK E + +H N+
Sbjct: 55 HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113
Query: 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPK 629
L+ I + I +G+ YLH ++H+DLK+ N+ D+
Sbjct: 114 RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDN-GKVV 169
Query: 630 ISDFGMARIFGLNQSETNTNR---VVGTYGYMSPE---------YAMSGVVSIKTDVFSF 677
I+DFG+ I G+ Q+ ++ G +++PE S +DVF+
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229
Query: 678 GVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIH 737
G + E+ + + ++T +I G L I + E+ +
Sbjct: 230 GTIWYELHAREWP---FKTQPAEAIIWQM----GTGMKPNLSQIGM-----GKEISDIL- 276
Query: 738 VGLLCVQDQATDRPAMPDVVSML-----ANESLSLP 768
L C + +RP ++ ML N LS P
Sbjct: 277 --LFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 48/216 (22%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKL--IAKLQHTN----- 573
+ +G+G +G V++G G+ VA+K S R + + E +L L+H N
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFI 68
Query: 574 ------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLH-----K 604
L D + L+ + I+ IA GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF--GLNQSETNTNRVVGTYGYMSPE- 661
+ + HRDLK+ NIL+ I+D G+A + NQ + N VGT YM+PE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 662 -----YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNG 692
+ D+++FG+++ E+ +NG
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 48/216 (22%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAK--LIAKLQHTN----- 573
V ++G+G +G V+ G+ G++VA+K + E + ++H N
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFI 97
Query: 574 ------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLH-----K 604
L D ++ L+ ++ + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF--GLNQSETNTNRVVGTYGYMSPE- 661
+ + HRDLK+ NIL+ I+D G+A F N+ + N VGT YM PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 662 -----YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNG 692
I D++SFG+++ E+ + G
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 51/218 (23%), Positives = 81/218 (37%), Gaps = 48/218 (22%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAK--LIAKLQHTN----- 573
+G+G FG V++G+ G+EVA+K S R + + EA+ L+H N
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFI 102
Query: 574 ------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLH-----K 604
L D + E + A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF--GLNQSETNTNRVVGTYGYMSPE- 661
+ + HRDLK+ NIL+ I+D G+A + + N VGT YM+PE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 662 -----YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCY 694
+ D+++ G++ EI G +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 53/235 (22%), Positives = 95/235 (40%), Gaps = 44/235 (18%)
Query: 494 NDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKR--LSRR 551
+ + + G E FQ++S +S + ++G GG V++ Q AIK L
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA 65
Query: 552 SGQGIVEFKNEAKLIAKLQHTN-----LTDS----------------------RRNNRLN 584
Q + ++NE + KLQ + L D ++ ++
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSID 125
Query: 585 WETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644
R S + + + + +H++ ++H DLK +N L+ D K+ DFG+A + +
Sbjct: 126 PWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTT 181
Query: 645 ETNTNRVVGTYGYMSPE-----------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+ VGT YM PE +S K+DV+S G ++ + GK
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 34/196 (17%)
Query: 523 KLGEGGFGPVYKGQ-LLNGQEVAIK--RLSRRSGQGIVE-FKNEAKLIAKLQHTN----- 573
KLG GG VY + + +VAIK + R + ++ F+ E ++L H N
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 574 --------------------LTDS-RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
L++ + L+ +T + I G+ + H +R++H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVH 134
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKT 672
RD+K NIL+D KI DFG+A+ S T TN V+GT Y SPE A T
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 673 DVFSFGVLVLEIVSGK 688
D++S G+++ E++ G+
Sbjct: 194 DIYSIGIVLYEMLVGE 209
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-32
Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 40/199 (20%)
Query: 521 VNKLGEGGFGPVYKGQL-LNGQEVAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL---- 574
++G G FG V+ G+L + VA+K +F EA+++ + H N+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 575 ---TDSR------------------RNNR--LNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
T + R L +T ++ A G+ YL I
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY----MSPEYAMSGV 667
HRDL A N L+ ++ KISDFGM+R ++ G +PE G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREE----ADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 668 VSIKTDVFSFGVLVLEIVS 686
S ++DV+SFG+L+ E S
Sbjct: 292 YSSESDVWSFGILLWETFS 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 44/220 (20%)
Query: 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKR--LSRRSGQGIVEFKNEAKLI 566
+ IS +S + ++G GG V++ Q AIK L Q + ++NE +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 567 AKLQHTN-----LTDS----------------------RRNNRLNWETRFSIIEGIAQGL 599
KLQ + L D ++ ++ R S + + + +
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659
+H++ ++H DLK +N L+ D K+ DFG+A + + + VGT YM
Sbjct: 122 HTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 660 PE-----------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
PE +S K+DV+S G ++ + GK
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 59/221 (26%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHT 572
+F + +G GGFG V+K + ++G+ IK + + + + E K +AKL H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDHV 64
Query: 573 NLT--------------------------------------------DSRRNNRLNWETR 588
N+ + RR +L+
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 589 FSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648
+ E I +G+ Y+H ++I+RDLK SNI L D KI DFG+ +++
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKR 178
Query: 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKK 689
R GT YMSPE S + D+++ G+++ E++
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 49/251 (19%), Positives = 93/251 (37%), Gaps = 54/251 (21%)
Query: 478 ENLSLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQL 537
+++ P D K + + ++ + + ++G GG V++
Sbjct: 28 QHMDSPDLGTDDDDKASSSANECISVKGRIYSIL----------KQIGSGGSSKVFQVLN 77
Query: 538 LNGQEVAIKR--LSRRSGQGIVEFKNEAKLIAKLQHTN-----LTDS------------- 577
Q AIK L Q + ++NE + KLQ + L D
Sbjct: 78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137
Query: 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628
++ ++ R S + + + + +H++ ++H DLK +N L+ D
Sbjct: 138 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GML 193
Query: 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPE-----------YAMSGVVSIKTDVFSF 677
K+ DFG+A + + + VG YM PE +S K+DV+S
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 678 GVLVLEIVSGK 688
G ++ + GK
Sbjct: 254 GCILYYMTYGK 264
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 48/224 (21%), Positives = 93/224 (41%), Gaps = 40/224 (17%)
Query: 496 HNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIK--RLSRRS 552
+ + G E FQ++ + + K+GEG FG + +G++ IK +SR S
Sbjct: 8 SSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63
Query: 553 GQGIVEFKNEAKLIAKLQHTN---LTDS-------------------------RRNNRLN 584
+ E + E ++A ++H N +S ++
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 585 WETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644
+ I L ++H +++HRD+K+ NI L ++ DFG+AR+
Sbjct: 124 EDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+GT Y+SPE + + K+D+++ G ++ E+ + K
Sbjct: 181 LARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 56/239 (23%), Positives = 89/239 (37%), Gaps = 48/239 (20%)
Query: 521 VNKLGEGGFGPVYKGQLLN-----GQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNL 574
+ LGEG FG V G+ VA+K L +G Q +K E ++ L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 575 -------TDSR--------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
D+ + + + I +G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---A 152
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG-----YMSPEY 662
IHRDL A N+LLD+ KI DFG+A+ V G + +PE
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAPEC 208
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720
+DV+SFGV + E+++ + L I Q+ ++ EL++
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTVL-RLTELLE 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 34/196 (17%)
Query: 523 KLGEGGFGPVYKGQ-LLNGQEVAIKRLSRR--SGQGIVE-FKNEAKLIAKLQHTNL---- 574
+G GG G VY+ + + + VA+K +S S + EA+ +LQ ++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 575 ----TDS------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
D RR L +I+ I L H H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGATH 157
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKT 672
RD+K NIL+ + DFG+A ++ T VGT YM+PE + +
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHATYRA 216
Query: 673 DVFSFGVLVLEIVSGK 688
D+++ ++ E ++G
Sbjct: 217 DIYALTCVLYECLTGS 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 38/201 (18%)
Query: 523 KLGEGGFGPVYKGQ-LLNGQEVAIK--RLSRRSGQGIVE-FKNEAKLIAKLQHTNL---- 574
LG GG V+ + L + ++VA+K R F+ EA+ A L H +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 575 ---TDS-----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
+ + +I Q L + H +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QN 135
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE-TNTNRVVGTYGYMSPEYAMSGV 667
+IHRD+K +NI++ K+ DFG+AR + + T T V+GT Y+SPE A
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 668 VSIKTDVFSFGVLVLEIVSGK 688
V ++DV+S G ++ E+++G+
Sbjct: 196 VDARSDVYSLGCVLYEVLTGE 216
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 46/207 (22%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE-----VAIKRLSRRSGQG-IVEFKNEAKLIAKLQHTNL 574
+ LG G FG VYKG + E VAIK L + E +EA ++A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 575 -------TDSR-----------------RNNR--LNWETRFSIIEGIAQGLLYLHKYSRL 608
S R ++ + + + IA+G+ YL
Sbjct: 80 CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDR 136
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG-----YMSPEYA 663
R++HRDL A N+L+ + KI+DFG+A++ G + E + G +M+ E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESI 191
Query: 664 MSGVVSIKTDVFSFGVLVLEIVS-GKK 689
+ + + ++DV+S+GV V E+++ G K
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 48/200 (24%), Positives = 78/200 (39%), Gaps = 44/200 (22%)
Query: 523 KLGEGGFGPVYKGQLLNG---QEVAIKRL--SRRSGQGIVEFKNEAKLIAKLQHTNL--- 574
+LG G FG V KG + VA+K L E EA ++ +L + +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 575 ----TDS------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
++N + + ++ ++ G+ YL +H
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL---EESNFVH 140
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG------YMSPEYAMSG 666
RDL A N+LL Q KISDFG+++ +++ + +PE
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPECINYY 195
Query: 667 VVSIKTDVFSFGVLVLEIVS 686
S K+DV+SFGVL+ E S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-29
Identities = 36/198 (18%), Positives = 71/198 (35%), Gaps = 43/198 (21%)
Query: 523 KLGEGGFGPVYKG--QLLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLTD--- 576
+ GG G +Y + +NG+ V +K L E + +A++ H ++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 577 --------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRV 610
+ +L + + I L YLH + +
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGL 203
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
++ DLK NI+L ++ K+ D G + + GT G+ +PE +G +
Sbjct: 204 VYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPEIVRTGPT-V 255
Query: 671 KTDVFSFGVLVLEIVSGK 688
TD+++ G + +
Sbjct: 256 ATDIYTVGRTLAALTLDL 273
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 59/195 (30%), Positives = 83/195 (42%), Gaps = 36/195 (18%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
V ++G G FG V+ G LN +VAIK + R +F EA+++ KL H L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 575 -TDSR------------------RNNR--LNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
+ R R ET + + +G+ YL VIHR
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHR 128
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY--MSPEYAMSGVVSIK 671
DL A N L+ + K+SDFGM R + T+ + SPE S K
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 672 TDVFSFGVLVLEIVS 686
+DV+SFGVL+ E+ S
Sbjct: 186 SDVWSFGVLMWEVFS 200
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 39/207 (18%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRL---SRRSGQGIVEFKNEAKLIAKLQH 571
NF K+G G F VY+ LL+G VA+K++ + + E L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 572 TNLT---DS-RRNNRLN--------------------WETRFS------IIEGIAQGLLY 601
N+ S +N LN + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
+H RV+HRD+K +N+ + K+ D G+ R F + ++ +VGT YMSPE
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+ K+D++S G L+ E+ + +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 55/196 (28%), Positives = 84/196 (42%), Gaps = 38/196 (19%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
+ +LG G FG V G+ +VAIK + + EF EAK++ L H L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 575 -TDSR------------------RNNR--LNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
T R R R + + + + + + YL + +HR
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHR 144
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYAMSGVVSI 670
DL A N L++DQ K+SDFG++R + VG+ + PE M S
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 671 KTDVFSFGVLVLEIVS 686
K+D+++FGVL+ EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 39/210 (18%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHT 572
++ + +G G +G K + +G+ + K + +E L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 573 N-------------------------------LTDSRRNNRLNWETR-FSIIEGIAQGLL 600
N +T + + E ++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 601 YLH--KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYM 658
H V+HRDLK +N+ LD + N K+ DFG+ARI + S T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 659 SPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
SPE + K+D++S G L+ E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 52/196 (26%), Positives = 82/196 (41%), Gaps = 38/196 (19%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
+ +LG G FG V G+ +VA+K + + EF EA+ + KL H L
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 575 -TDSR------------------RNNR--LNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
+ R++ L + + +G+ +L + IHR
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYAMSGVVSI 670
DL A N L+D + K+SDFGM R + VGT + +PE S
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 671 KTDVFSFGVLVLEIVS 686
K+DV++FG+L+ E+ S
Sbjct: 185 KSDVWAFGILMWEVFS 200
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 36/195 (18%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
V +LG G FG V+ G +VA+K L ++ F EA L+ +LQH L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 575 -TD--------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
T + +L + IA+G+ ++ IHR
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHR 133
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY--MSPEYAMSGVVSIK 671
DL+A+NIL+ D ++ KI+DFG+AR+ + T R + +PE G +IK
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 672 TDVFSFGVLVLEIVS 686
+DV+SFG+L+ EIV+
Sbjct: 191 SDVWSFGILLTEIVT 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 44/197 (22%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
+ +G+G FG V G G +VA+K + ++ F EA ++ +L+H+NL
Sbjct: 26 LQTIGKGEFGDVMLG-DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 575 -TD----------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
+ SR + L + + + + YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY--MSPEYAMSGVVS 669
HRDL A N+L+ + K+SDFG+ + E ++ + G +PE S
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 670 IKTDVFSFGVLVLEIVS 686
K+DV+SFG+L+ EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 45/208 (21%), Positives = 73/208 (35%), Gaps = 37/208 (17%)
Query: 512 SAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAK 568
S +F +++LG G +G V+K + +G+ A+K R + E K
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 569 L-QHTNLT---DS-RRNNRLN----------------WETRFS------IIEGIAQGLLY 601
+ QH + L W + L +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
LH ++H D+K +NI L + K+ DFG+ G G YM+PE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEV--QEGDPRYMAPE 226
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGKK 689
+ G DVFS G+ +LE+ +
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 45/200 (22%), Positives = 78/200 (39%), Gaps = 44/200 (22%)
Query: 523 KLGEGGFGPVYKGQLLNGQE---VAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL---- 574
+LG G FG V +G ++ VAIK L E EA+++ +L + +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 575 ---TDS-------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
+ + ++ ++ G+ YL +H
Sbjct: 77 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 133
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG------YMSPEYAMSG 666
RDL A N+LL ++ KISDFG+++ G + S + +PE
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECINFR 188
Query: 667 VVSIKTDVFSFGVLVLEIVS 686
S ++DV+S+GV + E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 50/239 (20%), Positives = 97/239 (40%), Gaps = 46/239 (19%)
Query: 521 VNKLGEGGFGPVYKGQLL-----NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL- 574
+ +LG+G FG V + G+ VA+K+L + + + +F+ E +++ LQH N+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 575 ------TDS----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
+ + R++ I +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---G 162
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG-----YMSPE 661
R IHRDL NIL++++ KI DFG+ ++ ++ V G + +PE
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPE 218
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720
S+ +DV+SFGV++ E+ + + + + + ++EL+
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 46/204 (22%)
Query: 521 VNKLGEGGFGPVYKGQLL----NGQEVAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL- 574
+G G G V G+L VAIK L + + + +F +EA ++ + H N+
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 575 ------TDSR--------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
T R + + ++ G+ G+ YL S L
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG------YMSPEY 662
+HRDL A N+L+D + K+SDFG++R+ + T T G + +PE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEA 225
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVS 686
S +DV+SFGV++ E+++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 55/222 (24%), Positives = 81/222 (36%), Gaps = 56/222 (25%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLS-RRSGQGIVEFKNEAKLIAKLQHTN 573
+F + LG GGFG V++ + ++ AIKR+ + E K +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 574 -------------------------------------LTD--SRRNNRLNWETRF--SII 592
L D + R E I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 593 EGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV- 651
IA+ + +LH ++HRDLK SNI K+ DFG+ ++ E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 652 ---------VGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEI 684
VGT YMSPE S K D+FS G+++ E+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 47/205 (22%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE-----VAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL 574
+G G FG VYKG L VAIK L + + + V+F EA ++ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 575 -------TDSR--------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+ + ++ + ++ GIA G+ YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---AN 165
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG------YMSPE 661
+ +HRDL A NIL++ + K+SDFG++R+ + T T T G + +PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRWTAPE 220
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVS 686
+ +DV+SFG+++ E+++
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 50/239 (20%), Positives = 97/239 (40%), Gaps = 46/239 (19%)
Query: 521 VNKLGEGGFGPVYKGQLL-----NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL- 574
+ +LG+G FG V + G+ VA+K+L + + + +F+ E +++ LQH N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 575 ------TDS----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
+ + R++ I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---G 131
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG-----YMSPE 661
R IHRDL NIL++++ KI DFG+ ++ ++ V G + +PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAPE 187
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720
S+ +DV+SFGV++ E+ + + + + + ++EL+
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 54/227 (23%), Positives = 86/227 (37%), Gaps = 58/227 (25%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN 573
++F + LG+G FG V K + L+ + AIK++ + + +E L+A L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 574 LT------DSRRNNRLNWETRFS-------------------IIEG-------------- 594
+ RRN I
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 595 -IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF------------GL 641
I + L Y+H +IHRDLK NI +D+ N KI DFG+A+ L
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 642 NQSETNTNRVVGTYGYMSPE-YAMSGVVSIKTDVFSFGVLVLEIVSG 687
S N +GT Y++ E +G + K D++S G++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 45/203 (22%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE-----VAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNL 574
+ LG G FG V+KG + E V IK + +SG Q + I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 575 -------TDSR-----------------RNNR--LNWETRFSIIEGIAQGLLYLHKYSRL 608
S R +R L + + IA+G+ YL
Sbjct: 78 VRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEH 134
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG-----YMSPEYA 663
++HR+L A N+LL +++DFG+A + + + + +M+ E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALESI 189
Query: 664 MSGVVSIKTDVFSFGVLVLEIVS 686
G + ++DV+S+GV V E+++
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMT 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 44/197 (22%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
+ +G+G FG V G G +VA+K + ++ F EA ++ +L+H+NL
Sbjct: 198 LQTIGKGEFGDVMLG-DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 575 -TDS--------------------RRNNR--LNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
+ R R L + + + + YL +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 311
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY--MSPEYAMSGVVS 669
HRDL A N+L+ + K+SDFG+ + E ++ + G +PE S
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 670 IKTDVFSFGVLVLEIVS 686
K+DV+SFG+L+ EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 66/319 (20%), Positives = 113/319 (35%), Gaps = 82/319 (25%)
Query: 509 QTISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIA 567
+ ++ + KLGEGGF V + L +G A+KR+ Q E + EA +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 568 KLQHTN---LTDS-------------------------RRNNRLNWETRFS------IIE 593
H N L + + ++
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 594 GIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVV- 652
GI +GL +H HRDLK +NILL D+ P + D G ++ + +
Sbjct: 142 GICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 653 ------GTYGYMSPE------YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700
T Y +PE + V+ +TDV+S G ++ ++ G+ P
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHC---VIDERTDVWSLGCVLYAMMFGE---------GPY 246
Query: 701 NLIGYAWQLWNEGKVLELVDIALEGSFSP------NEVLRCIHVGLLCVQDQATDRPAMP 754
+ + + V +A++ S + L + ++ V RP +P
Sbjct: 247 D---------MVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTV--DPHQRPHIP 295
Query: 755 DVVSMLANESLSLPAPKQP 773
++S L E+L PAP Q
Sbjct: 296 LLLSQL--EALQPPAPGQH 312
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 45/208 (21%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQE-----VAIKRLSRRSGQG-IVEFKNEAKLIAKL 569
F + LG G FG VYKG + E VAIK L + E +EA ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 570 QHTNL-------TDSR-----------------RNNR--LNWETRFSIIEGIAQGLLYLH 603
+ ++ S R ++ + + + IA+G+ YL
Sbjct: 75 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL- 133
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG-----YM 658
R++HRDL A N+L+ + KI+DFG+A++ G + E + G +M
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWM 186
Query: 659 SPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+ E + + + ++DV+S+GV V E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 36/195 (18%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------ 574
KLG G FG V+ +VA+K + + + F EA ++ LQH L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 575 -TD--------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
T S ++ IA+G+ ++ + IHR
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHR 308
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY--MSPEYAMSGVVSIK 671
DL+A+NIL+ + KI+DFG+AR+ + T R + +PE G +IK
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 672 TDVFSFGVLVLEIVS 686
+DV+SFG+L++EIV+
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 40/200 (20%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTNLT---D 576
++G G F VYKG EVA + + + FK EA+++ LQH N+ D
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 577 S---------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLR 609
S +R + + S I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPP 151
Query: 610 VIHRDLKASNILLDDQM-NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
+IHRDLK NI + + KI D G+A + + ++ V+GT +M+PE
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEEK-Y 206
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
DV++FG+ +LE+ + +
Sbjct: 207 DESVDVYAFGMCMLEMATSE 226
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 46/205 (22%)
Query: 521 VNKLGEGGFGPVYKGQLLNG----QEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNL- 574
+G G FG VY G LL+ A+K L+R + +F E ++ H N+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 575 ------TDSR-------------------RNNR--LNWETRFSIIEGIAQGLLYLHKYSR 607
S RN + +A+G+ YL +
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG------YMSPE 661
+ +HRDL A N +LD++ K++DFG+AR + V G +M+ E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKTGAKLPVKWMALE 202
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVS 686
+ + K+DV+SFGVL+ E+++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 52/241 (21%), Positives = 97/241 (40%), Gaps = 50/241 (20%)
Query: 521 VNKLGEGGFGPVYKGQLL-----NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNL 574
+ LGEG FG V + G++VA+K L SG I + K E +++ L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 575 -------TDS----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKY 605
T+ + N++N + + I +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL--- 142
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG-----YMSP 660
+ +HRDL A N+L++ + KI DFG+ + ++ V + +P
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSPVFWYAP 198
Query: 661 EYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719
E M I +DV+SFGV + E+++ ++ + + Q+ +++ +
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH-GQMTVT-RLVNTL 256
Query: 720 D 720
Sbjct: 257 K 257
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 32/193 (16%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD---- 576
KLG+G FG V+ G VAIK L + F EA+++ KL+H L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 577 -----------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
L + IA G+ Y+ R+ +HR
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 304
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTD 673
DL+A+NIL+ + + K++DFG+AR+ N+ + +PE A+ G +IK+D
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 363
Query: 674 VFSFGVLVLEIVS 686
V+SFG+L+ E+ +
Sbjct: 364 VWSFGILLTELTT 376
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-28
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 32/193 (16%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD---- 576
KLG+G FG V+ G VAIK L + F EA+++ KL+H L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 577 -----------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHR 613
L + IA G+ Y+ R+ +HR
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 387
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTD 673
DL+A+NIL+ + + K++DFG+AR+ N+ + +PE A+ G +IK+D
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 446
Query: 674 VFSFGVLVLEIVS 686
V+SFG+L+ E+ +
Sbjct: 447 VWSFGILLTELTT 459
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-28
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 40/201 (19%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE----VAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL- 574
+G G FG V G+L + VAIK L + + +F EA ++ + H N+
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 575 ------TDSR--------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
T S+ + + ++ GIA G+ YL S +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYAMS 665
+HRDL A NIL++ + K+SDFG+ R+ + T R G + SPE
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAY 224
Query: 666 GVVSIKTDVFSFGVLVLEIVS 686
+ +DV+S+G+++ E++S
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 48/202 (23%), Positives = 73/202 (36%), Gaps = 41/202 (20%)
Query: 521 VNKLGEGGFGPVYKGQLL----NGQEVAIKRL---SRRSGQGIVEFKNEAKLIAKLQHTN 573
+ KLG+G FG V +G+ VA+K L + + +F E + L H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 574 L-------TDS-------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
L + T +A+G+ YL
Sbjct: 83 LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ES 139
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYAM 664
R IHRDL A N+LL + KI DFG+ R N + + +PE
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLK 197
Query: 665 SGVVSIKTDVFSFGVLVLEIVS 686
+ S +D + FGV + E+ +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 72/315 (22%), Positives = 125/315 (39%), Gaps = 61/315 (19%)
Query: 521 VNKLGEGGFGPVYKGQLL-----NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL- 574
+++LG+G FG V + G VA+K+L +F+ E +++ L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 575 ------TDSRRN----------------------NRLNWETRFSIIEGIAQGLLYLHKYS 606
R RL+ I +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---G 144
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG-----YMSPE 661
R +HRDL A NIL++ + + KI+DFG+A++ L++ VV G + +PE
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPE 200
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720
+ S ++DV+SFGV++ E+ + K+ C + L ++G + ++LEL++
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLE 258
Query: 721 IALEG------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPA 774
EG P EV + LC DRP+ + L + A
Sbjct: 259 ---EGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312
Query: 775 FFINITAEEPPVSES 789
F + + +S S
Sbjct: 313 FTAHPEGKHHSLSFS 327
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 61/219 (27%)
Query: 521 VNKLGEGGFGPVYKGQLLNG------QEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574
+LGEG FG V+ + N VA+K L + +F+ EA+L+ LQH ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 575 -------TDSR------------------RNNRLNWETRF-----------------SII 592
D R + + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 593 EGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVV 652
IA G++YL + +HRDL N L+ + KI DFGM+R + T+ RV
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV- 191
Query: 653 GTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
G + +M PE M + ++DV+SFGV++ EI +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 60/218 (27%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE------VAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574
+LGEG FG V+ + N VA+K L S +F+ EA+L+ LQH ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 575 -------TDSR------------------RNNRLNWETR----------------FSIIE 593
T+ R R++ + + ++
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 594 GIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653
+A G++YL + L +HRDL N L+ + KI DFGM+R + T+ R VG
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VG 217
Query: 654 TYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M PE + + ++DV+SFGV++ EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 38/197 (19%)
Query: 521 VNKLGEGGFGPVYKGQLLNG-QEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL----- 574
+KLG G +G VY+G VA+K L + + EF EA ++ +++H NL
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 575 --TD---------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
T ++ + I+ + YL + I
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY--MSPEYAMSGVVS 669
HRDL A N L+ + K++DFG++R+ +T T + +PE S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 670 IKTDVFSFGVLVLEIVS 686
IK+DV++FGVL+ EI +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 44/203 (21%)
Query: 522 NKLGEGGFGPVYKGQLLNGQE----VAIKRLSRRSGQG-IVEFKNEAKLIAKLQHTNL-- 574
+G+G FG VY G+ ++ + AIK LSR + + F E L+ L H N+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 575 -----TDSR-------------------RNNR--LNWETRFSIIEGIAQGLLYLHKYSRL 608
R+ + + S +A+G+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQ 143
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG-----YMSPEYA 663
+ +HRDL A N +LD+ K++DFG+AR + E + + + + + E
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQ-QHRHARLPVKWTALESL 200
Query: 664 MSGVVSIKTDVFSFGVLVLEIVS 686
+ + K+DV+SFGVL+ E+++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-27
Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 34/195 (17%)
Query: 521 VNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL----- 574
+KLG G +G VY+G VA+K L + + EF EA ++ +++H NL
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 575 --TD---------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
T ++ + I+ + YL + I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIK 671
HR+L A N L+ + K++DFG++R+ + + + +PE SIK
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399
Query: 672 TDVFSFGVLVLEIVS 686
+DV++FGVL+ EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 41/200 (20%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE----VAIKRLSR-RSGQGIVEFKNEAKLIAKLQHTNL- 574
LGEG FG VY+G N + VA+K + + +F +EA ++ L H ++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 575 ------TDS------------------RRN-NRLNWETRFSIIEGIAQGLLYLHKYSRLR 609
+ RN N L T I + + YL +
Sbjct: 77 KLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESIN 133
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYAMSG 666
+HRD+ NIL+ K+ DFG++R + + + T +MSPE
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIE----DEDYYKASVTRLPIKWMSPESINFR 189
Query: 667 VVSIKTDVFSFGVLVLEIVS 686
+ +DV+ F V + EI+S
Sbjct: 190 RFTTASDVWMFAVCMWEILS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 39/199 (19%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE----VAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL- 574
+GEG FG V++G ++ + VAIK + S +F EA + + H ++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 575 ------TDS-------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLR 609
T++ R L+ + ++ L YL R
Sbjct: 80 KLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKR 136
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYAMSGV 667
+HRD+ A N+L+ K+ DFG++R + T G +M+PE
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 668 VSIKTDVFSFGVLVLEIVS 686
+ +DV+ FGV + EI+
Sbjct: 194 FTSASDVWMFGVCMWEILM 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 46/204 (22%)
Query: 522 NKLGEGGFGPVYKGQLLNG----QEVAIKRLSRRSGQG-IVEFKNEAKLIAKLQHTNL-- 574
+G G FG VY G LL+ A+K L+R + G + +F E ++ H N+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 575 -----TDSR-------------------RNNRLNWETR--FSIIEGIAQGLLYLHKYSRL 608
S RN N + +A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 211
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG------YMSPEY 662
+ +HRDL A N +LD++ K++DFG+AR + + V G +M+ E
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKWMALES 267
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVS 686
+ + K+DV+SFGVL+ E+++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 36/210 (17%)
Query: 518 FSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN--- 573
++ K+G+G G VY + GQEVAI++++ + NE ++ + ++ N
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 574 ----------------------LTDSRRNNRLNWETRFSII-EGIAQGLLYLHKYSRLRV 610
LTD ++ E + + + Q L +LH +V
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-EGQIAAVCRECLQALEFLHS---NQV 137
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
IHRD+K+ NILL + K++DFG + ++ + +VGT +M+PE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 671 KTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700
K D++S G++ +E++ G+ Y ++PL
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP---YLNENPL 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-26
Identities = 44/197 (22%), Positives = 78/197 (39%), Gaps = 38/197 (19%)
Query: 523 KLGEGGFGPVYKGQLLNGQE---VAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL---- 574
+LG G FG V +G ++ VAIK L E EA+++ +L + +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 575 ---TDS-------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612
+ + ++ ++ G+ YL +H
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 459
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT---YGYMSPEYAMSGVVS 669
R+L A N+LL ++ KISDFG+++ G + S + +PE S
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFS 517
Query: 670 IKTDVFSFGVLVLEIVS 686
++DV+S+GV + E +S
Sbjct: 518 SRSDVWSYGVTMWEALS 534
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 62/220 (28%)
Query: 521 VNKLGEGGFGPVYKGQLLNG------QEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTN 573
+ +LGE FG VYKG L Q VAIK L + G EF++EA L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 574 L-------TDSR------------------RNNRLNWETRF-----------------SI 591
+ T + + + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 592 IEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV 651
+ IA G+ YL S V+H+DL N+L+ D++N KISD G+ R + ++
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VYAADYYK--- 185
Query: 652 VGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+ +M+PE M G SI +D++S+GV++ E+ S
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 49/249 (19%), Positives = 93/249 (37%), Gaps = 61/249 (24%)
Query: 476 LGENLSLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKG 535
+G + SL +GD + + + + + LG G G +
Sbjct: 1 MGSSPSLEQDDGDEETSVVIVGKISFCPK-----------------DVLGHGAEGTIVYR 43
Query: 536 QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTN--------------------- 573
+ + ++VA+KR+ E +L+ + +H N
Sbjct: 44 GMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100
Query: 574 ---LTD---SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ-- 625
L + + L E ++++ GL +LH L ++HRDLK NIL+
Sbjct: 101 AATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNA 156
Query: 626 ---MNPKISDFGMARIFGLNQSE-TNTNRVVGTYGYMSPEY---AMSGVVSIKTDVFSFG 678
+ ISDFG+ + + + + + V GT G+++PE + D+FS G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 679 VLVLEIVSG 687
+ ++S
Sbjct: 217 CVFYYVISE 225
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 58/215 (26%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE----VAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNL 574
LGEG FG V +G L VA+K + S + I EF +EA + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 575 -------TDSR-----------------------RNNRLNWETR-------FSIIEGIAQ 597
+ +RL + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVGTYG 656
G+ YL S +HRDL A N +L D M ++DFG+++ I+ + R G
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY-----SGDYYRQ-GRIA 209
Query: 657 -----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+++ E V + K+DV++FGV + EI +
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 54/198 (27%), Positives = 79/198 (39%), Gaps = 38/198 (19%)
Query: 524 LGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD----SR 578
LG+G +G VY G L N +AIK + R + E L L+H N+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 579 RNNRLN--WE---------------TRFSIIEG--------IAQGLLYLHKYSRLRVIHR 613
N + E E I +GL YLH +++HR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHR 146
Query: 614 DLKASNILLDDQM-NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV--SI 670
D+K N+L++ KISDFG ++ T T GT YM+PE G
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 204
Query: 671 KTDVFSFGVLVLEIVSGK 688
D++S G ++E+ +GK
Sbjct: 205 AADIWSLGCTIIEMATGK 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 36/210 (17%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN--- 573
+ K+GEG G V + +G++VA+K + R Q NE ++ QH N
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 574 ----------------------LTDSRRNNRLNWETRFSII-EGIAQGLLYLHKYSRLRV 610
LTD RLN E + + + E + Q L YLH V
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN-EEQIATVCEAVLQALAYLHA---QGV 162
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
IHRD+K+ +ILL K+SDFG + + + +VGT +M+PE + +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYAT 220
Query: 671 KTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700
+ D++S G++V+E+V G+ Y +D P+
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP---YFSDSPV 247
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 58/215 (26%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE------VAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTN 573
+LG+G FG VY+G + VAIK ++ S + +EF NEA ++ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 574 L-------TDSR------------------RNNRLNWETR-----------FSIIEGIAQ 597
+ + + R+ R + IA
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVGTYG 656
G+ YL + + +HRDL A N ++ + KI DFGM R I+ ET+ R G G
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-----ETDYYR-KGGKG 200
Query: 657 Y-----MSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
MSPE GV + +DV+SFGV++ EI +
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 64/214 (29%), Positives = 82/214 (38%), Gaps = 56/214 (26%)
Query: 521 VNKLGEGGFGPVYKGQLLNG------QEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTN 573
+ LG G FG VY+GQ+ +VA+K L S Q ++F EA +I+K H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 574 L-------TDSR------------------RNNRLNWETR--------FSIIEGIAQGLL 600
+ S R R + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 601 YLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
YL IHRD+ A N LL KI DFGMAR + + R G
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK-GGCAM 206
Query: 658 -----MSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
M PE M G+ + KTD +SFGVL+ EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 59/216 (27%)
Query: 521 VNKLGEGGFGPVYKGQLLNG----QEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNL 574
LG+G FG V + QL +VA+K L + I EF EA + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 575 -------TDSR------------------------RNNR-------LNWETRFSIIEGIA 596
SR +R L +T + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 597 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLNQSETNTNRVVGTY 655
G+ YL S IHRDL A N +L + M ++DFG++R I+ + R G
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY-----SGDYYRQ-GCA 198
Query: 656 G-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+++ E + ++ +DV++FGV + EI++
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 64/214 (29%), Positives = 81/214 (37%), Gaps = 56/214 (26%)
Query: 521 VNKLGEGGFGPVYKGQLLNG------QEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTN 573
+ LG G FG VY+GQ+ +VA+K L S Q ++F EA +I+K H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 574 L-------TDSR------------------RNNRLNWETR--------FSIIEGIAQGLL 600
+ S R R + IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 601 YLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
YL IHRD+ A N LL KI DFGMAR + R G
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRK-GGCAM 247
Query: 658 -----MSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
M PE M G+ + KTD +SFGVL+ EI S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 32/198 (16%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQG-IVEFKNEAKLIAKLQHTN-- 573
F+ + K+G+G FG V+KG + VAIK + + I + + E ++++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 574 -----------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRV 610
D L+ +I+ I +GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS---EKK 140
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
IHRD+KA+N+LL + K++DFG+A Q + NT VGT +M+PE
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDS 198
Query: 671 KTDVFSFGVLVLEIVSGK 688
K D++S G+ +E+ G+
Sbjct: 199 KADIWSLGITAIELARGE 216
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 43/216 (19%), Positives = 77/216 (35%), Gaps = 65/216 (30%)
Query: 521 VNKLGEGGFGPVYKGQL--------LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHT 572
LG+G F ++KG L+ EV +K L + F A +++KL H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 573 NL-------TDSR------------------RNNR--LNWETRFSIIEGIAQGLLYLHKY 605
+L + N+ +N + + + +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL--- 129
Query: 606 SRLRVIHRDLKASNILLDDQMNP--------KISDFGMARIFGLNQSETNTNRVVGTYGY 657
+IH ++ A NILL + + K+SD G++ V+
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177
Query: 658 ------MSPEYAMSGVV-SIKTDVFSFGVLVLEIVS 686
+ PE + ++ TD +SFG + EI S
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-25
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 39/197 (19%)
Query: 523 KLGEGGFGPVYKGQLLNGQE----VAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTNL--- 574
+GEG FG V++G ++ + VAIK + S +F EA + + H ++
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 575 ----TDS-------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
T++ R L+ + ++ L YL R +
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFV 513
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY--GYMSPEYAMSGVVS 669
HRD+ A N+L+ K+ DFG++R + T G +M+PE +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 670 IKTDVFSFGVLVLEIVS 686
+DV+ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEILM 587
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 48/236 (20%), Positives = 99/236 (41%), Gaps = 39/236 (16%)
Query: 481 SLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-N 539
L D +++ + ++ + + ++F +++LG G G V+K +
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPS 57
Query: 540 GQEVAIKRLSRRSGQGIVEF-KNEAKLIAKLQHTNLTD---------------------- 576
G +A K + I E +++ + +
Sbjct: 58 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 577 ----SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD 632
++ R+ + + + +GL YL + +++HRD+K SNIL++ + K+ D
Sbjct: 118 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCD 175
Query: 633 FGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
FG++ L S N+ VGT YMSPE S+++D++S G+ ++E+ G+
Sbjct: 176 FGVSGQ--LIDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/199 (25%), Positives = 79/199 (39%), Gaps = 43/199 (21%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRS--GQGIVE-FKNEAKLIAKLQHTNL----- 574
LG+GGF ++ + A K + + E E + L H ++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 575 ---TDSR------------------RNNRLN-WETRFSIIEGIAQGLLYLHKYSRLRVIH 612
+ R L E R+ + I G YLH R RVIH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRVIH 138
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR---VVGTYGYMSPEYAMSGVVS 669
RDLK N+ L++ + KI DFG+A + E + R + GT Y++PE S
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 670 IKTDVFSFGVLVLEIVSGK 688
+ DV+S G ++ ++ GK
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 49/228 (21%), Positives = 82/228 (35%), Gaps = 70/228 (30%)
Query: 521 VNKLGEGGFGPVYKGQLLNG------QEVAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTN 573
V +GEG FG V++ + VA+K L S +F+ EA L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 574 L-------TDSR------------------RNNRLNWETRF------------------- 589
+ + R+ +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 590 ------SIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643
I +A G+ YL S + +HRDL N L+ + M KI+DFG++R N
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224
Query: 644 SETNTNRVVGTYGY-----MSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+ + M PE + ++DV+++GV++ EI S
Sbjct: 225 YSADYYKA-DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 47/231 (20%), Positives = 80/231 (34%), Gaps = 52/231 (22%)
Query: 509 QTISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIA 567
QT+ L EGGF VY+ Q + +G+E A+KRL + E +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 568 KLQ-HTN---LTDSRRNNRLNWET---------------------------RFS------ 590
KL H N + + +T S
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 591 IIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650
I + + ++H + +IHRDLK N+LL +Q K+ DFG A + + +
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 651 ----------VVGTYGYMSPE---YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
T Y +PE + + K D+++ G ++ + +
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 51/199 (25%), Positives = 79/199 (39%), Gaps = 43/199 (21%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRS--GQGIVE-FKNEAKLIAKLQHTNL----- 574
LG+GGF ++ + A K + + E E + L H ++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 575 ---TDSR------------------RNNRLN-WETRFSIIEGIAQGLLYLHKYSRLRVIH 612
+ R L E R+ + I G YLH R RVIH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLH---RNRVIH 164
Query: 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR---VVGTYGYMSPEYAMSGVVS 669
RDLK N+ L++ + KI DFG+A + E + R + GT Y++PE S
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 670 IKTDVFSFGVLVLEIVSGK 688
+ DV+S G ++ ++ GK
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 63/218 (28%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE---VAIKRL-SRRSGQGIVEFKNEAKLIAKL-QHTNL- 574
+ +GEG FG V K ++ AIKR+ S +F E +++ KL H N+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 575 ------TDSR------------------RNNR-----------------LNWETRFSIIE 593
R +R L+ +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 594 GIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG 653
+A+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVK-K 198
Query: 654 TYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
T G +M+ E V + +DV+S+GVL+ EIVS
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 44/200 (22%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRS--GQGIVE-FKNEAKLIAKLQHTNL----- 574
LG+G F VY+ + + G EVAIK + +++ G+V+ +NE K+ +L+H ++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 575 ---TDSR-------------------RNNRLN-WETRFSIIEGIAQGLLYLHKYSRLRVI 611
+ R + E R + I G+LYLH ++
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-FMHQIITGMLYLH---SHGIL 134
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR---VVGTYGYMSPEYAMSGVV 668
HRDL SN+LL MN KI+DFG+A Q + + + GT Y+SPE A
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
+++DV+S G + ++ G+
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 39/204 (19%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRR--SGQGIVE-FKNEAKLIAKLQH 571
+F LG+G FG VY + + +A+K L + G+ + E ++ + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 572 TNL--------TDSR------------------RNNRL-NWETRFSIIEGIAQGLLYLHK 604
N+ +R + ++ T I E +A L Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHS 127
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
RVIHRD+K N+LL KI+DFG + ++ + GT Y+ PE
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPPEMIE 180
Query: 665 SGVVSIKTDVFSFGVLVLEIVSGK 688
+ K D++S GVL E + GK
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 45/205 (21%), Positives = 92/205 (44%), Gaps = 40/205 (19%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT- 575
+ V +LG+G FG VYK + G A K + +S + + ++ E +++A H +
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 576 --DS-RRNNRLNW------------------ETRFS------IIEGIAQGLLYLHKYSRL 608
+ + +L W + + + + + L +LH
Sbjct: 81 LLGAYYHDGKL-WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---K 136
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
R+IHRDLKA N+L+ + + +++DFG++ + ++ +GT +M+PE M +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETM 194
Query: 669 S-----IKTDVFSFGVLVLEIVSGK 688
K D++S G+ ++E+ +
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 72/229 (31%)
Query: 521 VNKLGEGGFGPVYKGQLLNG------QEVAIKRL-SRRSGQGIVEFKNEAKLIAKLQHTN 573
LGEG FG V K + VA+K L S + + +E ++ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 574 L-------TDSR------------------RNNRLNWETRFSIIEG-------------- 594
+ + R +R
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 595 -----------IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR-IFGLN 642
I+QG+ YL + ++++HRDL A NIL+ + KISDFG++R ++
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY--- 201
Query: 643 QSETNTNRVVGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
E ++ + G +M+ E + + ++DV+SFGVL+ EIV+
Sbjct: 202 --EEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 47/198 (23%), Positives = 78/198 (39%), Gaps = 39/198 (19%)
Query: 522 NKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD---- 576
++G G FG V++ + G + A+K++ + E A L +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 577 SRRNNRLN---------------------WETRFSIIEG-IAQGLLYLHKYSRLRVIHRD 614
R +N E R G +GL YLH R++H D
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGD 175
Query: 615 LKASNILLDDQMNP-KISDFGMARIF---GLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
+KA N+LL + + DFG A GL +S + + GT +M+PE M
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 671 KTDVFSFGVLVLEIVSGK 688
K D++S ++L +++G
Sbjct: 236 KVDIWSSCCMMLHMLNGC 253
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 65/228 (28%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL--------NGQEVAIKRL-SRRSGQGIVEFKNEAKLI 566
+ + LGEG FG V + + VA+K L + + + + +E +++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 567 AKL-QHTNL-------TD---------------------SRRNNRLNWETRFSIIEG--- 594
+ +H N+ T +RR + + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 595 -----------IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI---- 207
Query: 644 SETNTNRVVGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
T G +M+PE V + ++DV+SFGVL+ EI +
Sbjct: 208 -NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 64/222 (28%)
Query: 521 VNKLGEGGFGPVYKGQLLN------GQEVAIKRL-SRRSGQGIVEFKNEAKLIAKL-QHT 572
LG G FG V + + VA+K L + +E K++ + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 573 NL-------TDSR-------------------RNNRLNWETRFSIIEG------------ 594
N+ T R+ R + E
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 595 -----IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649
+A+G+ +L + + IHRDL A NILL ++ KI DFG+AR + +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-----YKDPD 203
Query: 650 RVVGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
V +M+PE V +I++DV+SFGVL+ EI S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 61/224 (27%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQE------VAIKRL-SRRSGQGIVEFKNEAKLIAK 568
NN LG G FG V + + VA+K L S +E K+++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 569 L-QHTNL-------TDSR------------------RNNRLNWETRFSIIEG-------- 594
L QH N+ T R ET +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 595 -------IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647
+AQG+ +L + IHRD+ A N+LL + KI DFG+AR +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-----MND 217
Query: 648 TNRVVGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+N +V +M+PE V ++++DV+S+G+L+ EI S
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 37/203 (18%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN 573
F + KLGEG +G VYK GQ VAIK++ + E E ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 574 LT---DS-RRNNRLNW------------------ETRFS------IIEGIAQGLLYLHKY 605
+ S +N L W + I++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDL-WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF- 143
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+R IHRD+KA NILL+ + + K++DFG+A ++ NT V+GT +M+PE
Sbjct: 144 --MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQE 199
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
+ D++S G+ +E+ GK
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 65/228 (28%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL--------NGQEVAIKRL-SRRSGQGIVEFKNEAKLI 566
+ + LGEG FG V + + VA+K L + + + + +E +++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 567 AKL-QHTNL-------TD---------------------SRRNNRLNWETRFSIIEG--- 594
+ +H N+ T +RR + + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 595 -----------IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI---- 253
Query: 644 SETNTNRVVGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
T G +M+PE V + ++DV+SFGVL+ EI +
Sbjct: 254 -NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 55/228 (24%), Positives = 90/228 (39%), Gaps = 65/228 (28%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQE------VAIKRLSRR-SGQGIVEFKNEAKLIAK 568
N S LG G FG V + + VA+K L +E K+++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 569 L-QHTNL-------TD---------------------SRRNNRLNWETRFSIIEG----- 594
L H N+ T +R++ + +T +I+E
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 595 -----------IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643
+A+G+ +L + IHRDL A NILL KI DFG+AR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 194
Query: 644 SETNTNRVVGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+ ++N VV +M+PE + V + ++DV+S+G+ + E+ S
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 51/222 (22%)
Query: 512 SAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKL 569
S + + + + LG+G V++G+ G AIK + S V+ E +++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 570 QHTN-------------------------------LTDSRRNNRLNWETRFSIIEGIAQG 598
H N L + L ++ + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 599 LLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+ +L + ++HR++K NI+ D Q K++DFG AR + + + + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGT 178
Query: 655 YGYMSPEYAMSGVVSI--------KTDVFSFGVLVLEIVSGK 688
Y+ P+ V+ D++S GV +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-23
Identities = 53/206 (25%), Positives = 80/206 (38%), Gaps = 46/206 (22%)
Query: 523 KLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTN------- 573
+LG GGFG V + G++VAIK+ + E + E +++ KL H N
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 574 ----------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKY 605
L L +++ I+ L YLH+
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 606 SRLRVIHRDLKASNILLD---DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
R+IHRDLK NI+L ++ KI D G A+ VGT Y++PE
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGTLQYLAPEL 194
Query: 663 AMSGVVSIKTDVFSFGVLVLEIVSGK 688
++ D +SFG L E ++G
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 65/223 (29%)
Query: 521 VNKLGEGGFGPVYKGQLLN--------GQEVAIKRL-SRRSGQGIVEFKNEAKLIAKL-Q 570
LGEG FG V + + +VA+K L S + + + + +E +++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 571 HTNL-------TD---------------------SRRNNRLNWETRFSIIEG-------- 594
H N+ T +RR L + S
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 595 ------IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHID 245
Query: 649 NRVVGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
T G +M+PE + + ++DV+SFGVL+ EI +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-23
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 39/238 (16%)
Query: 483 PSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKG-QLLNGQ 541
+ G+ ++ +F + + V KLG G +G V +
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 542 EVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLT------DSRRN------------- 580
E AIK + + S + E ++ L H N+ + +RN
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 581 -NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKI 630
+ + +F+ II+ + G+ YLHK ++HRDLK N+LL + KI
Sbjct: 124 FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKI 180
Query: 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
DFG++ +F + +GT Y++PE + K DV+S GV++ +++G
Sbjct: 181 VDFGLSAVFENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 51/222 (22%)
Query: 512 SAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKL 569
S + + + + LG+G V++G+ G AIK + S V+ E +++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 570 QHTN-------------------------------LTDSRRNNRLNWETRFSIIEGIAQG 598
H N L + L ++ + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 599 LLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+ +L + ++HR++K NI+ D Q K++DFG AR + + + + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGT 178
Query: 655 YGYMSPEYAMSGVVSI--------KTDVFSFGVLVLEIVSGK 688
Y+ P+ V+ D++S GV +G
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 503 LEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ------- 554
L+I Q + + ++G G +G V K +GQ +A+KR+ +
Sbjct: 9 LKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 555 -------------GIVEFK----NEAKL----------IAKLQHTNLTDSRRNNRLNWET 587
IV+F E K S ++ + E
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKY--VYSVLDDVIP-EE 125
Query: 588 RFSII-EGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
I + L +L L++IHRD+K SNILLD N K+ DFG++ + ++T
Sbjct: 126 ILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183
Query: 647 NTNRVVGTYGYMSPE----YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
G YM+PE A +++DV+S G+ + E+ +G+
Sbjct: 184 RD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 53/218 (24%)
Query: 516 NNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLS-RRSGQGIVEFKNEAKLIAKLQHTN 573
+++ +G G V ++VAIKR++ + + E E + +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 574 -------------------------LTDSRRNNRLNWETRFSIIE--GIA-------QGL 599
+ D ++ E + +++ IA +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM-ARIFGLNQSETNTNR--VVGTYG 656
YLHK IHRD+KA NILL + + +I+DFG+ A + N R VGT
Sbjct: 135 EYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 657 YMSPEYAMSGVVS------IKTDVFSFGVLVLEIVSGK 688
+M+PE V+ K D++SFG+ +E+ +G
Sbjct: 192 WMAPE-----VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 54/301 (17%), Positives = 95/301 (31%), Gaps = 96/301 (31%)
Query: 512 SAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKR--LSRRSGQGIVEFKNEAKLIAK 568
S T F + K+G G FG V+K L+G AIKR E A
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 569 L-QHTNLT---DS-RRNNRLN--------------------WETRFS------IIEGIAQ 597
L QH+++ + ++ + + F ++ + +
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP-------------------KISDFGMARI 638
GL Y+H + ++H D+K SNI + P KI D G
Sbjct: 127 GLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182
Query: 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVV------SIKTDVFSFGVLVLEIVSGKKNNG 692
++ G +++ E V+ K D+F+ + V+ +
Sbjct: 183 -----RISSPQVEEGDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAE---- 228
Query: 693 CYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP--NEVLRCIHVGLLCVQDQATDR 750
PL G W +G++ + S E+L+ + + R
Sbjct: 229 ------PLPRNGDQWHEIRQGRLPR-----IPQVLSQEFTELLK------VMIHPDPERR 271
Query: 751 P 751
P
Sbjct: 272 P 272
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-22
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 54/210 (25%)
Query: 518 FSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLS---RRSGQGIVEFKNEAKLIAKLQHTN 573
FS + ++G G FG VY + + N + VAIK++S ++S + + E + + KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 574 LT---DS-RRNNRLNW---------------ETRFSIIEG-IA-------QGLLYLHKYS 606
R + W + + E IA QGL YLH
Sbjct: 116 TIQYRGCYLREHTA-WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-- 172
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
+IHRD+KA NILL + K+ DFG A I + N+ VGT +M+PE
Sbjct: 173 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--FVGTPYWMAPE----- 220
Query: 667 VVSI--------KTDVFSFGVLVLEIVSGK 688
V+ K DV+S G+ +E+ K
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 47/222 (21%), Positives = 87/222 (39%), Gaps = 55/222 (24%)
Query: 510 TISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKR--------------------L 548
++ ++ + +LG G +G V K + + +GQ +A+KR +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 549 SRRSGQGIVEFK----NEAKL----------IAKLQHTNLTDSRRNNRLNWETRFSII-E 593
V F E + + K + + + E I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVI---DKGQTIP-EDILGKIAV 116
Query: 594 GIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT---NR 650
I + L +LH S+L VIHRD+K SN+L++ K+ DFG++ + +
Sbjct: 117 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDI 168
Query: 651 VVGTYGYMSPE----YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
G YM+PE S+K+D++S G+ ++E+ +
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 39/204 (19%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRR--SGQGIVE-FKNEAKLIAKLQH 571
++F LG+G FG VY + N +A+K L + +G+ + E ++ + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 572 TNL--------TDSR------------------RNNRL-NWETRFSIIEGIAQGLLYLHK 604
N+ R ++ R + + E +A L Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCH- 131
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
+VIHRD+K N+L+ + KI+DFG + T + GT Y+ PE
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT--MCGTLDYLPPEMIE 185
Query: 665 SGVVSIKTDVFSFGVLVLEIVSGK 688
K D++ GVL E + G
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 54/228 (23%), Positives = 84/228 (36%), Gaps = 70/228 (30%)
Query: 521 VNKLGEGGFGPVYKGQLLNGQE------VAIKRL-SRRSGQGIVEFKNEAKLIAKL-QHT 572
LG G FG V + VA+K L + +E K++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 573 NL-------TDSR------------------RNNRLNWETRFSIIEG------------- 594
N+ T S R+ R + E
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 595 -----------IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643
+A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----D 221
Query: 644 SETNTNRVVGTYG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+++N VV +M+PE G+ +IK+DV+S+G+L+ EI S
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 51/240 (21%), Positives = 94/240 (39%), Gaps = 50/240 (20%)
Query: 484 STNGDGKRKG-NDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQ 541
S+ GK+ G +Y EI D + + ++G G G V+K + G
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLG----------EMGSGTCGQVWKMRFRKTGH 51
Query: 542 EVAIKRLSRRSGQGIVE-FKNEAKLIAKL-QHTNLT------------------------ 575
+A+K++ R + + + ++ K +
Sbjct: 52 VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE 111
Query: 576 --DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633
R + + I + L YL + VIHRD+K SNILLD++ K+ DF
Sbjct: 112 KLKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDF 169
Query: 634 GMARIFGLNQSETNTNRVVGTYGYMSPE-----YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
G++ ++++ + G YM+PE I+ DV+S G+ ++E+ +G+
Sbjct: 170 GISGRLVDDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 49/228 (21%)
Query: 503 LEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN 561
L+ D + F V +G G +G VYKG+ + GQ AIK + +G E K
Sbjct: 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQ 69
Query: 562 EAKLIAKL-QHTNLTD----------SRRNNRLNW-------------------ETRFS- 590
E ++ K H N+ +++L W
Sbjct: 70 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 591 -----IIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645
I I +GL +LH+ +VIHRD+K N+LL + K+ DFG++
Sbjct: 129 EWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 646 TNTNRVVGTYGYMSPEYAMSGVVS-----IKTDVFSFGVLVLEIVSGK 688
NT +GT +M+PE K+D++S G+ +E+ G
Sbjct: 186 RNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 54/221 (24%), Positives = 75/221 (33%), Gaps = 61/221 (27%)
Query: 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTN------- 573
LG G G V G+ VA+KR+ E KL+ + H N
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVIRYYCS 77
Query: 574 -----------------LTD--------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
L D S++ IA G+ +LH L
Sbjct: 78 ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 609 RVIHRDLKASNILLD-------------DQMNPKISDFGMARIFGLNQS--ETNTNRVVG 653
++IHRDLK NIL+ + + ISDFG+ + QS TN N G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 654 TYGYMSPEYAMSGVVSI-------KTDVFSFGVLVLEIVSG 687
T G+ +PE D+FS G + I+S
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 54/180 (30%), Positives = 81/180 (45%), Gaps = 43/180 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRL---SRRSG---QGIVEFKNEAKLIAK 568
NF V K+GEG +G VYK + L G+ VA+K++ + G I E L+ +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI----REISLLKE 58
Query: 569 LQHTN---------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLY 601
L H N D+ + S + + QGL +
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
H + RV+HRDLK N+L++ + K++DFG+AR FG+ T T+ VV T Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 173
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 40/232 (17%), Positives = 79/232 (34%), Gaps = 72/232 (31%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEF---------------- 559
N++ + L +G F + + + + A+K+ + + +F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 560 -KNEAKLIAKLQHTN-----------------------------------LTDSRRNNRL 583
KNE ++I +++ L +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 584 NWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643
+ II+ + Y+H + + HRD+K SNIL+D K+SDFG + +
Sbjct: 150 IQVIKC-IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKT-------DVFSFGVLVLEIVSGK 688
+ GTY +M PE S ++ D++S G+ + +
Sbjct: 207 IKG----SRGTYEFMPPE-----FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 33/174 (18%)
Query: 516 NNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGI-VEFKNEAKLIAKLQHTN 573
+ ++KLGEG + VYKG L VA+K + +G E L+ L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 574 ---LTD-----------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
L D N +N + + +GL Y H+
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ-- 119
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
+V+HRDLK N+L++++ K++DFG+AR + ++T N VV T Y P+
Sbjct: 120 -KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPD 170
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-21
Identities = 41/242 (16%), Positives = 83/242 (34%), Gaps = 40/242 (16%)
Query: 473 LRELGENLSLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAV----NKLGEGG 528
+ S DG + + + + + Q + + +LG G
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63
Query: 529 FGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL--------TDS-- 577
FG V++ + G+ K ++ KNE ++ +L H L
Sbjct: 64 FGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNI 620
+ +++ + + +GL ++H+ ++H D+K NI
Sbjct: 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENI 180
Query: 621 LLDDQMNP--KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFG 678
+ + + KI DFG+A ++ T + +PE V TD+++ G
Sbjct: 181 MCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 679 VL 680
VL
Sbjct: 238 VL 239
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 4e-21
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 41/178 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRL---SRRSG---QGIVEFKNEAKLIAKL 569
+ + K+GEG +G VYK + G+ VA+KR+ + G I E L+ +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI----REISLLKEL 76
Query: 570 QHTN---LTD-----------------------SRRNNRLNWETRFSIIEGIAQGLLYLH 603
H N L D L + + +G+ + H
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
++ R++HRDLK N+L++ K++DFG+AR FG+ + T+ VV T Y +P+
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPD 189
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 47/209 (22%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN--EAKLIAKLQHT 572
+ + +GEG +G V K + G+ VAIK+ +V+ E KL+ +L+H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 573 NL--------TDSR------------------RNNRLNWETRFSIIEGIAQGLLYLHKYS 606
NL R N L+++ + I G+ + H +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE----- 661
+IHRD+K NIL+ K+ DFG AR E + V T Y +PE
Sbjct: 144 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWYRAPELLVGD 199
Query: 662 --YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y + DV++ G LV E+ G+
Sbjct: 200 VKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 5e-21
Identities = 37/233 (15%), Positives = 76/233 (32%), Gaps = 43/233 (18%)
Query: 496 HNSMKYGLEIFDFQTISAATNNFSAVNKLGEG--GFGPVYKGQ-LLNGQEVAIKR--LSR 550
H+ L + + + +G+G V + G+ V ++R L
Sbjct: 5 HHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA 64
Query: 551 RSGQGIVEFKNEAKLIAKLQHTNLT----------------------------DSRRNNR 582
S + + + E + H N+ + +
Sbjct: 65 CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG 124
Query: 583 LNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642
+N I++G+ + L Y+H + +HR +KAS+IL+ +S +
Sbjct: 125 MNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181
Query: 643 QSETNT-----NRVVGTYGYMSPEYAMSGVV--SIKTDVFSFGVLVLEIVSGK 688
V ++SPE + K+D++S G+ E+ +G
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 47/209 (22%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN--EAKLIAKLQHT 572
+ + K+GEG +G V+K + GQ VAIK+ +++ E +++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 573 NL---------------------TD-----SRRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
NL R + SI Q + + HK+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE----- 661
IHRD+K NIL+ K+ DFG AR+ S+ + V T Y SPE
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPELLVGD 177
Query: 662 --YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y V DV++ G + E++SG
Sbjct: 178 TQYG-PPV-----DVWAIGCVFAELLSGV 200
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 5e-21
Identities = 18/120 (15%), Positives = 41/120 (34%), Gaps = 9/120 (7%)
Query: 574 LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633
L+ S + L R + + + L LH ++H L+ +I+LD + ++ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 634 GMARIFGLNQSETNTNRVVGTYGYMSPE-----YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
G + + R + +++ D ++ G+ + I
Sbjct: 256 EHLVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 5e-21
Identities = 36/119 (30%), Positives = 52/119 (43%), Gaps = 15/119 (12%)
Query: 577 SRRNNRLNWETRF--SIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 634
+RR + + E I IA+ + +LH ++HRDLK SNI K+ DFG
Sbjct: 153 NRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFG 209
Query: 635 MARIFGLNQSETNTN----------RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLE 683
+ ++ E VGT YMSPE S K D+FS G+++ E
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 2/60 (3%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLS-RRSGQGIVEFKNEAKLIAKLQHTN 573
+F + +G GGFG V++ + ++ AIKR+ + E K +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 5e-21
Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 42/179 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRL---SRRSG---QGIVEFKNEAKLIAK 568
+ + K+GEG +G V+K + + VA+KR+ G + E L+ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKE 57
Query: 569 LQHTN---LTD-----------------------SRRNNRLNWETRFSIIEGIAQGLLYL 602
L+H N L D N L+ E S + + +GL +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
H V+HRDLK N+L++ K+++FG+AR FG+ + VV T Y P+
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPD 171
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-21
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 40/199 (20%)
Query: 522 NKLGEGGFGPVYKG-QLLNGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLT-- 575
LG+G FG V + GQE A+K +S+R E +L+ +L H N+
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 576 ----DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVI 611
+ + + + RFS II + G+ Y+HK +++
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIV 148
Query: 612 HRDLKASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
HRDLK N+LL N +I DFG++ F ++ +GT Y++PE + G
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPE-VLHGTY 204
Query: 669 SIKTDVFSFGVLVLEIVSG 687
K DV+S GV++ ++SG
Sbjct: 205 DEKCDVWSTGVILYILLSG 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-21
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 39/224 (17%)
Query: 496 HNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRR--S 552
H+ + + ++ V LG+G FG V K + QE A+K +++
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 553 GQGIVEFKNEAKLIAKLQHTNLT------DSRRN--------------NRLNWETRFS-- 590
+ E +L+ KL H N+ + + + + RFS
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH 121
Query: 591 ----IIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARIFGLNQ 643
II+ + G+ Y+HK ++HRDLK NILL + + KI DFG++ F N
Sbjct: 122 DAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687
+GT Y++PE + G K DV+S GV++ ++SG
Sbjct: 179 KMK---DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 8e-21
Identities = 58/315 (18%), Positives = 106/315 (33%), Gaps = 53/315 (16%)
Query: 413 SCSLCFLARRKYKANEKWWISLTIAISAALTFIPLLSYLCYL-------IYGKIK----- 460
S + ++ +A W + T L + Y +G+ K
Sbjct: 39 SLVTNYTIEKR-EAMGGSWSPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCEPT 97
Query: 461 TKVERIMNQKKLLRELGENLSLPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSA 520
V +++K R + G G N N + + + Q + ++
Sbjct: 98 APVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLD 157
Query: 521 V----NKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT 575
+LG G FG V++ + G A K + + E + ++ L+H L
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 576 ------DSRRN--------------NRLNWET-RFS------IIEGIAQGLLYLHKYSRL 608
+ ++ E + S + + +GL ++H+
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---N 274
Query: 609 RVIHRDLKASNILLDDQMNP--KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
+H DLK NI+ + + K+ DFG+ QS GT + +PE A
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGK 331
Query: 667 VVSIKTDVFSFGVLV 681
V TD++S GVL
Sbjct: 332 PVGYYTDMWSVGVLS 346
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 9e-21
Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 46/186 (24%)
Query: 513 AATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN-----EAKLI 566
++++ F + KLG G + VYKG G VA+K + S +G E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57
Query: 567 AKLQHTN---------------------------LTDSRRNNRLNWETRFSIIEGIA--- 596
+L+H N DSR ++++
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 597 -QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY 655
QGL + H+ +++HRDLK N+L++ + K+ DFG+AR FG+ T ++ VV T
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV-TL 172
Query: 656 GYMSPE 661
Y +P+
Sbjct: 173 WYRAPD 178
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 39/216 (18%)
Query: 496 HNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRLSRR--S 552
H+ + + ++ V LG+G FG V K + QE A+K +++
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 553 GQGIVEFKNEAKLIAKLQHTNLT------DSRRN--------------NRLNWETRFS-- 590
+ E +L+ KL H N+ + + + + RFS
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH 121
Query: 591 ----IIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARIFGLNQ 643
II+ + G+ Y+HK ++HRDLK NILL + + KI DFG++ F N
Sbjct: 122 DAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGV 679
+GT Y++PE + G K DV+S GV
Sbjct: 179 K---MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 54/235 (22%), Positives = 94/235 (40%), Gaps = 44/235 (18%)
Query: 483 PSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAV------NKLGEGGFGPVYKG- 535
KR + FD + ++A ++ LG G FG V+K
Sbjct: 50 ERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCE 109
Query: 536 QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL--------TDS---------- 577
+ G ++A K + R + E KNE ++ +L H NL + +
Sbjct: 110 ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169
Query: 578 ---------RRNNRLN-WETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN 627
+ L +T ++ I +G+ ++H+ + ++H DLK NIL ++
Sbjct: 170 GGELFDRIIDESYNLTELDTI-LFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDA 225
Query: 628 P--KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVL 680
KI DFG+AR + + GT +++PE VS TD++S GV+
Sbjct: 226 KQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 51/191 (26%), Positives = 77/191 (40%), Gaps = 47/191 (24%)
Query: 512 SAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRL---SRRSGQGIVEFKN--EAKL 565
S AT+ + V ++G G +G VYK + +G VA+K + + G G + E L
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 566 IAKLQ---HTN--------------------------------LTDSRRNNRLNWETRFS 590
+ +L+ H N D L ET
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124
Query: 591 IIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR 650
++ +GL +LH ++HRDLK NIL+ K++DFG+ARI+ T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPV 179
Query: 651 VVGTYGYMSPE 661
VV T Y +PE
Sbjct: 180 VV-TLWYRAPE 189
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 3e-20
Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 41/178 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRL---SRRSG---QGIVEFKNEAKLIAKL 569
+ + K+GEG +G VYK Q G+ A+K++ G I E ++ +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI----REISILKEL 57
Query: 570 QHTN---LTD-----------------------SRRNNRLNWETRFSIIEGIAQGLLYLH 603
+H+N L D L T S + + G+ Y H
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
RV+HRDLK N+L++ + KI+DFG+AR FG+ T+ +V T Y +P+
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYRAPD 170
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 51/192 (26%), Positives = 79/192 (41%), Gaps = 42/192 (21%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLT----- 575
KLG G FG V+ + +G E IK +++ Q +E + E +++ L H N+
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 576 -DSRRN------------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRV 610
+ N + S +++ + L Y H V
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 611 IHRDLKASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGV 667
+H+DLK NIL KI DFG+A +F ++ TN GT YM+PE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYMAPE-VFKRD 201
Query: 668 VSIKTDVFSFGV 679
V+ K D++S GV
Sbjct: 202 VTFKCDIWSAGV 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 6e-20
Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 50/202 (24%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNL------- 574
LGEG +G V + + VA+K + + E K E + L H N+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 575 -TDSR------------------RNNRLN-WETRF---SIIEGIAQGLLYLHKYSRLRVI 611
+ + + + + ++ G+ YLH + +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGIT 127
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIK 671
HRD+K N+LLD++ N KISDFG+A +F N E N++ GT Y++PE ++ +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-----LLKRR 182
Query: 672 ------TDVFSFGVLVLEIVSG 687
DV+S G+++ +++G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAG 204
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 7e-20
Identities = 56/183 (30%), Positives = 83/183 (45%), Gaps = 47/183 (25%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIK--RLSRRSGQGIVEFKN--------EAK 564
+ ++ LGEG F VYK + Q VAIK +L RS E K+ E K
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTALREIK 64
Query: 565 LIAKLQHTN---LTD-----------------------SRRNNRLNWETRFSIIEGIAQG 598
L+ +L H N L D + L + + QG
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 599 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYM 658
L YLH++ ++HRDLK +N+LLD+ K++DFG+A+ FG + + T++VV T Y
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWYR 179
Query: 659 SPE 661
+PE
Sbjct: 180 APE 182
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-20
Identities = 44/197 (22%), Positives = 72/197 (36%), Gaps = 44/197 (22%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIK-----RLSRRSGQGIVEFKNEAKLIAKLQHTN--- 573
+G+G F V + GQ+ A+K + + G + K EA + L+H +
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 574 LTDS---------------------RRNNRLNWETRFS------IIEGIAQGLLYLHKYS 606
L ++ R + +S + I + L Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 607 RLRVIHRDLKASNILLDDQMNP---KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
+IHRD+K +LL + N K+ FG+A G + VGT +M+PE
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVV 205
Query: 664 MSGVVSIKTDVFSFGVL 680
DV+ GV+
Sbjct: 206 KREPYGKPVDVWGCGVI 222
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-20
Identities = 54/242 (22%), Positives = 95/242 (39%), Gaps = 50/242 (20%)
Query: 489 GKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKR 547
R+ + ++ + ++ V KLG G +G V + E AIK
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 548 LSRRSGQGIV-------------EFKNEAKLIAKLQHTNLT------DSRRN-------- 580
+ + E NE L+ L H N+ + ++
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 581 ------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQ 625
++ +F I++ I G+ YLHK ++HRD+K NILL +
Sbjct: 129 EGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185
Query: 626 MNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIV 685
+N KI DFG++ F + + +GT Y++PE + + K DV+S GV++ ++
Sbjct: 186 LNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILL 241
Query: 686 SG 687
G
Sbjct: 242 CG 243
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-19
Identities = 48/185 (25%), Positives = 75/185 (40%), Gaps = 45/185 (24%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ--LLNGQEVAIKR-----------------------LSR 550
+ V ++GEG +G V+K + G+ VA+KR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 551 RSGQGIVEFKNEAKLIAKLQHTNLT--------------DSRRNNRLNWETRFSIIEGIA 596
+V + + + T LT D + ET ++ +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 597 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYG 656
+GL +LH + RV+HRDLK NIL+ K++DFG+ARI+ T+ VV T
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVV-TLW 184
Query: 657 YMSPE 661
Y +PE
Sbjct: 185 YRAPE 189
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 45/187 (24%), Positives = 73/187 (39%), Gaps = 37/187 (19%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT------ 575
+G G +G V Q A K++ + + + FK E +++ L H N+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 576 DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHRDL 615
+ + R+ + F I++ + + Y HK L V HRDL
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDL 132
Query: 616 KASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKT 672
K N L K+ DFG+A F + VGT Y+SP+ + G+ +
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPYYVSPQ-VLEGLYGPEC 188
Query: 673 DVFSFGV 679
D +S GV
Sbjct: 189 DEWSAGV 195
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 63/208 (30%)
Query: 503 LEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN 561
+ + + + + K+G+G FG V+K + GQ+VA+K+ V +N
Sbjct: 5 YDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK---------VLMEN 54
Query: 562 EA-----------KLIAKLQHTN---LTD---SRRNNRLNWETRF--------------- 589
E K++ L+H N L + ++ + +
Sbjct: 55 EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL 114
Query: 590 -------------SIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636
+++ + GL Y+H+ +++HRD+KA+N+L+ K++DFG+A
Sbjct: 115 SNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
Query: 637 RIFGLNQSETN---TNRVVGTYGYMSPE 661
R F L ++ TNRVV T Y PE
Sbjct: 172 RAFSLAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 43/195 (22%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRS------GQGIVEFKNEAKLIAKLQHTNLT 575
+LG G F V K + G E A K + +R G E + E ++ ++ H N+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 576 ------DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLR 609
++R + + L + S I+ I G+ YLH +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KK 135
Query: 610 VIHRDLKASNILLDDQMNP----KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+ H DLK NI+L D+ P K+ DFG+A N + GT +++PE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEIVNY 192
Query: 666 GVVSIKTDVFSFGVL 680
+ ++ D++S GV+
Sbjct: 193 EPLGLEADMWSIGVI 207
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 50/194 (25%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNL------- 574
LGEG +G V + + VA+K + + E K E + L H N+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 575 -TDSR------------------RNNRLN-WETRF---SIIEGIAQGLLYLHKYSRLRVI 611
+ + + + + ++ G+ YLH + +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGIT 127
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIK 671
HRD+K N+LLD++ N KISDFG+A +F N E N++ GT Y++PE ++ +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-----LLKRR 182
Query: 672 ------TDVFSFGV 679
DV+S G+
Sbjct: 183 EFHAEPVDVWSCGI 196
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 44/187 (23%), Positives = 80/187 (42%), Gaps = 37/187 (19%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT------ 575
LG G F V+ Q L G+ A+K + + +NE ++ K++H N+
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 576 DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHRDL 615
+S + +R+ ++ +I+ + + YLH+ ++HRDL
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDL 132
Query: 616 KASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKT 672
K N+L ++ I+DFG++++ +T GT GY++PE S
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKME--QNGIMST--ACGTPGYVAPEVLAQKPYSKAV 188
Query: 673 DVFSFGV 679
D +S GV
Sbjct: 189 DCWSIGV 195
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 42/201 (20%)
Query: 515 TNNFSAV----NKLGEGGFGPVYKG-QLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIA 567
+ FS +LG+G F V + G E A K ++ + S + + + EA++
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 568 KLQHTNLT------DSRRN--------------NRLNWETRFS------IIEGIAQGLLY 601
KLQH N+ + +S I+ I + + Y
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARIFGLNQSETNTNRVVGTYGYM 658
H ++HR+LK N+LL + K++DFG+A +++ GT GY+
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 174
Query: 659 SPEYAMSGVVSIKTDVFSFGV 679
SPE S D+++ GV
Sbjct: 175 SPEVLKKDPYSKPVDIWACGV 195
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 55/255 (21%), Positives = 102/255 (40%), Gaps = 62/255 (24%)
Query: 479 NLSLPSTNGDGKRKGNDHNSMKYGLEIF-DFQTISAATNNFSAVNKLGEGGFGPVYKGQL 537
+ ++ + +G + + K + D +T ++ +G G FG V++ +L
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL 61
Query: 538 LNGQEVAIKRLSRRSGQGIVEFKN-EAKLIAKLQHTNL----------TDSRRNNRLNW- 585
+ EVAIK++ + FKN E +++ ++H N+ D + LN
Sbjct: 62 VESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 586 -----ETRFSIIEG-------------------IAQGLLYLHKYSRLRVIHRDLKASNIL 621
ET + + + L Y+H + + HRD+K N+L
Sbjct: 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLL 173
Query: 622 LDDQMNP-KISDFGMARIFGLNQSETNTNRVVGTYGYMSPE-------YAMSGVVSIKTD 673
LD K+ DFG A+I E N + + Y Y +PE Y + D
Sbjct: 174 LDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPELIFGATNY------TTNID 224
Query: 674 VFSFGVLVLEIVSGK 688
++S G ++ E++ G+
Sbjct: 225 IWSTGCVMAELMQGQ 239
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 62/223 (27%), Positives = 91/223 (40%), Gaps = 53/223 (23%)
Query: 500 KYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVE 558
K E F F I LGEG F V + L +E AIK L +R I++
Sbjct: 26 KKRPEDFKFGKI------------LGEGSFSTVVLARELATSREYAIKILEKRH---IIK 70
Query: 559 FK------NEAKLIAKLQH---TNL-----TDS------------------RRNNRL-NW 585
E ++++L H L D R+
Sbjct: 71 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645
TRF E I L YLH +IHRDLK NILL++ M+ +I+DFG A++ +
Sbjct: 131 CTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
N VGT Y+SPE +D+++ G ++ ++V+G
Sbjct: 187 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 43/195 (22%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRR------SGQGIVEFKNEAKLIAKLQHTNLT 575
+LG G F V K Q G+E A K + +R G E + E ++ +++H N+
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 576 ------DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLR 609
+++ + + L + + ++ I G+ YLH R
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KR 128
Query: 610 VIHRDLKASNILLDDQMNP----KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+ H DLK NI+L D+ P K+ DFG+A N + GT +++PE
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPEIVNY 185
Query: 666 GVVSIKTDVFSFGVL 680
+ ++ D++S GV+
Sbjct: 186 EPLGLEADMWSIGVI 200
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 47/210 (22%), Positives = 76/210 (36%), Gaps = 57/210 (27%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSR----RSGQGIVEFKNEAKLIAKLQHTN----- 573
LGEG +G V + A+K L + R G K E +L+ +L+H N
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 574 ------------------------LTDSRRNNRLN-WETR--FS-IIEGIAQGLLYLHKY 605
+ DS R + F +I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH-- 126
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
++H+D+K N+LL KIS G+A ++ G+ + PE
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE---- 181
Query: 666 GVVS-------IKTDVFSFGVLVLEIVSGK 688
+ + K D++S GV + I +G
Sbjct: 182 -IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 4e-19
Identities = 19/123 (15%), Positives = 41/123 (33%), Gaps = 20/123 (16%)
Query: 577 SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636
S + L R + + + L LH ++H L+ +I+LD + ++ F
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMS-----------GVVSIKTDVFSFGVLVLEIV 685
G + G+ PE +++ D ++ G+++ I
Sbjct: 254 VRDGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 686 SGK 688
Sbjct: 308 CAD 310
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 43/195 (22%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRR------SGQGIVEFKNEAKLIAKLQHTNLT 575
+LG G F V K + G E A K + +R G E + E ++ ++ H N+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 576 ------DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLR 609
++R + + L + S I+ I G+ YLH +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KK 135
Query: 610 VIHRDLKASNILLDDQMNP----KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+ H DLK NI+L D+ P K+ DFG+A N + GT +++PE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEIVNY 192
Query: 666 GVVSIKTDVFSFGVL 680
+ ++ D++S GV+
Sbjct: 193 EPLGLEADMWSIGVI 207
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 5e-19
Identities = 9/114 (7%), Positives = 25/114 (21%), Gaps = 10/114 (8%)
Query: 577 SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636
+ + + L ++H N+ + + D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSG--VVSIKTDVFSFGVLVLEIVSGK 688
G T Y E+ + + + + G+ + +
Sbjct: 242 WKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 46/195 (23%), Positives = 83/195 (42%), Gaps = 43/195 (22%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRR------SGQGIVEFKNEAKLIAKLQHTNLT 575
+LG G F V K + G + A K + +R G + + E ++ ++QH N+
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 576 ------DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLR 609
+++ + + L + + ++ I G+ YLH L+
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQ 134
Query: 610 VIHRDLKASNILLDDQMNP----KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+ H DLK NI+L D+ P KI DFG+A N + GT +++PE
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIVNY 191
Query: 666 GVVSIKTDVFSFGVL 680
+ ++ D++S GV+
Sbjct: 192 EPLGLEADMWSIGVI 206
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 50/183 (27%), Positives = 74/183 (40%), Gaps = 46/183 (25%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRL---SRRSG---QGIVEFKNEAKLIAK 568
+ + + KLGEG +G VYK + + VAIKR+ G I E L+ +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKE 89
Query: 569 LQHTN--------LTDSR-----------------RNNRLNWETRFSIIEGIAQGLLYLH 603
LQH N + R +N ++ S + + G+ + H
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 604 KYSRLRVIHRDLKASNILLDDQMNP-----KISDFGMARIFGLNQSETNTNRVVGTYGYM 658
R +HRDLK N+LL KI DFG+AR FG+ T+ ++ T Y
Sbjct: 150 SR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII-TLWYR 204
Query: 659 SPE 661
PE
Sbjct: 205 PPE 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 40/188 (21%), Positives = 68/188 (36%), Gaps = 37/188 (19%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL------- 574
LG G FG V++ + + + K + + G V K E ++ +H N+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 575 -TDS-------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRD 614
+ LN S + + + L +LH + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFD 127
Query: 615 LKASNILLDDQMNP--KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKT 672
++ NI+ + + KI +FG AR + + Y +PE VVS T
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTAT 184
Query: 673 DVFSFGVL 680
D++S G L
Sbjct: 185 DMWSLGTL 192
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 46/200 (23%), Positives = 73/200 (36%), Gaps = 49/200 (24%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVE---------FKNEAKLIAKL-QH 571
LG G V + +E A+K + G E ++ K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 572 TNLT------DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKY 605
N+ ++ + L + S I+ + + + LHK
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK- 142
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
L ++HRDLK NILLDD MN K++DFG + + V GT Y++PE
Sbjct: 143 --LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEIIEC 197
Query: 666 GVVSIKT------DVFSFGV 679
+ D++S GV
Sbjct: 198 SMNDNHPGYGKEVDMWSTGV 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLT---- 575
+LG+G F V + G E A K ++ + S + + + EA++ KLQH N+
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 576 --DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHR 613
+ +S I+ I + + Y H ++HR
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHR 152
Query: 614 DLKASNILLDDQMNP---KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
+LK N+LL + K++DFG+A +++ + GT GY+SPE S
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSK 209
Query: 671 KTDVFSFGV 679
D+++ GV
Sbjct: 210 PVDIWACGV 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 3e-18
Identities = 37/227 (16%), Positives = 64/227 (28%), Gaps = 51/227 (22%)
Query: 510 TISAATNNFSAVNKLGEGGFGPVYKGQ------LLNGQEVAIK----------------- 546
+ + LGEG F VY+ N Q+ +K
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 547 -RLSRRSGQGIV------EFKNEAKLIAK-------LQHTNLTDSRRNNRLNWETRFSII 592
RL + F+N + L+ + L NL + + S
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 593 EGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-----------KISDFGMARIFGL 641
+ + +H +IH D+K N +L + + D G + L
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
T T G+ E + + + D F V ++ G
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 42/208 (20%), Positives = 77/208 (37%), Gaps = 42/208 (20%)
Query: 490 KRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIKRL 548
+ SM E+ D+ + + +G G V + G E A+K +
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 549 SRRSGQGIVE--------FKNEAKLIAKL-QHTNLT------DSRRN------------- 580
+ + E + E ++ ++ H ++ +S
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 581 -NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633
+ L + S I+ + + + +LH ++HRDLK NILLDD M ++SDF
Sbjct: 188 FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDF 244
Query: 634 GMARIFGLNQSETNTNRVVGTYGYMSPE 661
G + + + GT GY++PE
Sbjct: 245 GFSCHLEPGEK---LRELCGTPGYLAPE 269
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 42/213 (19%), Positives = 76/213 (35%), Gaps = 53/213 (24%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRR--SGQGIVEFKNEAKL------IA 567
+S ++ LG G FG V+ +EV +K + + +E K+ ++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 568 KLQHTNL--------TDSR-------------------RNNRLNWETRFSIIEGIAQGLL 600
+++H N+ R+ RL+ I + +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSP 660
YL +IHRD+K NI++ + K+ DFG A + GT Y +P
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIEYCAP 198
Query: 661 EYAMSGVVSIK------TDVFSFGVLVLEIVSG 687
E V+ +++S GV + +V
Sbjct: 199 E-----VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 5e-18
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 49/183 (26%)
Query: 523 KLGEGGFGPVYKGQ---LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN------ 573
K+G G +G VYK + + ++ A+K++ +G + + E L+ +L+H N
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 574 ------------------------LTDSRRNNRLNWETRF------SIIEGIAQGLLYLH 603
+ R + + S++ I G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 604 KYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARIFGL-NQSETNTNRVVGTYGYM 658
V+HRDLK +NIL+ + KI+D G AR+F + + + VV T+ Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 659 SPE 661
+PE
Sbjct: 203 APE 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 9e-18
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 62/219 (28%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKN-EAKLIAKLQHT 572
+++ +G G FG VY+ +L +G+ VAIK++ + FKN E +++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHC 107
Query: 573 NL----------TDSRRNNRLNW------ETRFSIIEG-------------------IAQ 597
N+ + + LN ET + + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARIFGLNQSETNTNRVVGTYG 656
L Y+H + HRD+K N+LLD K+ DFG A+ L + E N + + Y
Sbjct: 168 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRY- 221
Query: 657 YMSPE-------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y +PE Y + DV+S G ++ E++ G+
Sbjct: 222 YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 54/204 (26%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNL------ 574
+G+G F V + +L G+EVAIK + + + + + E +++ L H N+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 575 --TDSR------------------RNNRLN-WETR--FS-IIEGIAQGLLYLHKYSRLRV 610
T+ + R+ E R F I+ + Y H + R+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH---QKRI 135
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE------YAM 664
+HRDLKA N+LLD MN KI+DFG + F + G Y +PE Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDAFCGAPPYAAPELFQGKKYD- 191
Query: 665 SGVVSIKTDVFSFGVLVLEIVSGK 688
+ DV+S GV++ +VSG
Sbjct: 192 ----GPEVDVWSLGVILYTLVSGS 211
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 47/197 (23%), Positives = 76/197 (38%), Gaps = 46/197 (23%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVE--------FKNEAKLIAKLQHTN 573
LG G G V + ++VAIK +S+R + E +++ KL H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 574 LT------DSRRN-------------NRLNWETRFS------IIEGIAQGLLYLHKYSRL 608
+ D+ +++ R + + YLH
Sbjct: 77 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---EN 133
Query: 609 RVIHRDLKASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE---Y 662
+IHRDLK N+LL ++ KI+DFG ++I G S T + GT Y++PE
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT--LCGTPTYLAPEVLVS 190
Query: 663 AMSGVVSIKTDVFSFGV 679
+ + D +S GV
Sbjct: 191 VGTAGYNRAVDCWSLGV 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 44/198 (22%), Positives = 74/198 (37%), Gaps = 44/198 (22%)
Query: 524 LGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTN---LTD-- 576
LGEG V L+ QE A+K + ++ G E +++ + Q H N L +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 577 -SRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHRDL 615
+ ++ F+ +++ +A L +LH + HRDL
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDL 137
Query: 616 KASNILLDDQMNP---KISDFGMARIFGLNQSETNTNR-----VVGTYGYMSPEYAMSGV 667
K NIL + KI DF + LN + + G+ YM+PE +
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 668 VSIKT-----DVFSFGVL 680
D++S GV+
Sbjct: 198 EEASIYDKRCDLWSLGVI 215
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-17
Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 37/189 (19%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLT---- 575
+LG+G F V + ++L GQE A ++ + S + + + EA++ L+H N+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 576 --DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHR 613
+ + +S I+ I + +L+ H+ + V+HR
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHR 134
Query: 614 DLKASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSI 670
+LK N+LL K++DFG+A Q GT GY+SPE
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGK 192
Query: 671 KTDVFSFGV 679
D+++ GV
Sbjct: 193 PVDLWACGV 201
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-17
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 53/214 (24%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRR---SGQGIVEFKNEAKLIAKLQH 571
+ F LG GGFG V+ Q+ ++ A K+L+++ +G E K++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 572 ---TNL-----TDSR----------------------RNNRLNWE-TRFSIIEGIAQGLL 600
+L T + N F + I GL
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLE 303
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSP 660
+LH+ +I+RDLK N+LLDD N +ISD G+A Q++T GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAP 358
Query: 661 E------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
E Y S D F+ GV + E+++ +
Sbjct: 359 ELLLGEEYDFS------VDYFALGVTLYEMIAAR 386
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 54/244 (22%), Positives = 87/244 (35%), Gaps = 66/244 (27%)
Query: 495 DHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKR-LSRRS 552
+ M + + F G+G FG V G+ G VAIK+ +
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 553 GQGIVEFKN----EAKLIAKLQHTN--------LTDSRRNNR---LNW------ETRFSI 591
F+N + +A L H N T R+ R LN +T
Sbjct: 62 ------FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRC 115
Query: 592 IEG-------------------IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KIS 631
+ + + LH S + V HRD+K N+L+++ K+
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 632 DFGMARIFGLNQSETNTNRVVGTYGYMSPE-------YAMSGVVSIKTDVFSFGVLVLEI 684
DFG A+ L+ SE N + Y Y +PE Y + D++S G + E+
Sbjct: 175 DFGSAKK--LSPSEPNVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEM 225
Query: 685 VSGK 688
+ G+
Sbjct: 226 MLGE 229
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 46/214 (21%), Positives = 82/214 (38%), Gaps = 64/214 (29%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIK-----RLSRRSGQGIVEFKNEAKL------------ 565
+G+G +G V + A+K +L R++G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 566 ------IA---KLQHTN---------------------------LTDSRRNNRLNWETRF 589
IA KL H N + + L+ +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 590 SIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649
+ + +G+ YLH ++IHRD+K SN+L+ + + KI+DFG++ F + + +
Sbjct: 141 FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN- 196
Query: 650 RVVGTYGYMSPEYAMSGVVSI----KTDVFSFGV 679
VGT +M+PE ++S I DV++ GV
Sbjct: 197 -TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 6e-17
Identities = 46/199 (23%), Positives = 80/199 (40%), Gaps = 46/199 (23%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRR--------SGQGIVEFKNEAKLIAKLQHTN 573
LG G G V + ++VAI+ +S+R + + E +++ KL H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 574 LT------DSRRN-------------NRLNWETRFS------IIEGIAQGLLYLHKYSRL 608
+ D+ +++ R + + YLH+
Sbjct: 202 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---N 258
Query: 609 RVIHRDLKASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE---Y 662
+IHRDLK N+LL ++ KI+DFG ++I G S T + GT Y++PE
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT--LCGTPTYLAPEVLVS 315
Query: 663 AMSGVVSIKTDVFSFGVLV 681
+ + D +S GV++
Sbjct: 316 VGTAGYNRAVDCWSLGVIL 334
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 46/193 (23%), Positives = 76/193 (39%), Gaps = 41/193 (21%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHT----NLT 575
+LG G F V + GQE A K + RR E +E ++ + NL
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 576 D-------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRV 610
+ ++ +I+ I +G+ YLH+ +
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNI 152
Query: 611 IHRDLKASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGV 667
+H DLK NILL + KI DFGM+R G ++GT Y++PE
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDP 209
Query: 668 VSIKTDVFSFGVL 680
++ TD+++ G++
Sbjct: 210 ITTATDMWNIGII 222
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 46/208 (22%), Positives = 74/208 (35%), Gaps = 55/208 (26%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSRRNN- 581
LG GGFG VY G + + VAIK + + E N ++ ++ S +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 582 -RLN--WETRFSII------EG-------------------------IAQGLLYLHKYSR 607
RL +E S + E + + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---N 167
Query: 608 LRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
V+HRD+K NIL+D ++ K+ DFG + GT Y PE
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPE----- 218
Query: 667 VVSIK------TDVFSFGVLVLEIVSGK 688
+ V+S G+L+ ++V G
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-16
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 49/211 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGIVEFKNEAKLIAK---LQH 571
N+FS +G GGFG VY + + ++ A+K L ++ I + E + + L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSL 245
Query: 572 TNLTDSR-------------------------------RNNRLNWE--TRFSIIEGIAQG 598
+ D + + E RF E I G
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IILG 304
Query: 599 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYM 658
L ++H V++RDLK +NILLD+ + +ISD G+A F S+ + VGT+GYM
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYM 357
Query: 659 SPEYAMSGVVSIKT-DVFSFGVLVLEIVSGK 688
+PE GV + D FS G ++ +++ G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-16
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 52/212 (24%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRR---SGQGIVEFKNEAKLIAKLQH 571
N F LG+GGFG V Q+ ++ A K+L ++ +G NE +++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 572 ---TNL-----TDSR------------------RNNRLNWE---TRFSIIEGIAQGLLYL 602
+L T + + F E I GL L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDL 302
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE- 661
H+ R+++RDLK NILLDD + +ISD G+A Q+ VGT GYM+PE
Sbjct: 303 HR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEV 356
Query: 662 -----YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y S D ++ G L+ E+++G+
Sbjct: 357 VKNERYTFS------PDWWALGCLLYEMIAGQ 382
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 38/187 (20%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT------ 575
+LG G VY+ Q + A+K L + + IV + E ++ +L H N+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPNIIKLKEIF 117
Query: 576 DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHRDL 615
++ +R+ + +S ++ I + + YLH+ ++HRDL
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDL 174
Query: 616 KASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKT 672
K N+L KI+DFG+++I V GT GY +PE +
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTPGYCAPEILRGCAYGPEV 231
Query: 673 DVFSFGV 679
D++S G+
Sbjct: 232 DMWSVGI 238
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 35/172 (20%), Positives = 64/172 (37%), Gaps = 41/172 (23%)
Query: 522 NKLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLT---- 575
+G G + + E A+K + + + E +++ + QH N+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKD 83
Query: 576 --DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHR 613
D + +++ + FS ++ I + + YLH V+HR
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHR 140
Query: 614 DLKASNILL----DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
DLK SNIL + + +I DFG A+ T T +++PE
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPE 190
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 4e-16
Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 13/97 (13%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+A+G+ +L + + IHRDL A NILL ++ KI DFG+AR + + V
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253
Query: 655 YG-----YMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+M+PE V +I++DV+SFGVL+ EI S
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 57/206 (27%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRS--GQGIVE-FKNEAKLIAKLQHTNL----- 574
LG G FG V G+ L G +VA+K L+R+ +V K E + + +H ++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 575 ---TDSR------------------RNNRLN-WETR--FS-IIEGIAQGLLYLHKYSRLR 609
T + ++ R+ E R F I+ + Y H R
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---RHM 131
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS-ETNTNRVVGTYGYMSPEYAMSGVV 668
V+HRDLK N+LLD MN KI+DFG++ + + T G+ Y +PE V+
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT----SCGSPNYAAPE-----VI 182
Query: 669 S------IKTDVFSFGVLVLEIVSGK 688
S + D++S GV++ ++ G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 56/205 (27%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRR--SGQGIVE-FKNEAKLIAKLQHTNL----- 574
LGEG FG V Q+VA+K +SR+ + + E + L+H ++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 575 ---TDSR-----------------RNNRLN-WETR--FS-IIEGIAQGLLYLHKYSRLRV 610
T + R+ E R F II I Y H R ++
Sbjct: 77 VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH---RHKI 129
Query: 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQS-ETNTNRVVGTYGYMSPEYAMSGVVS 669
+HRDLK N+LLDD +N KI+DFG++ I +T+ G+ Y +PE V++
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS----CGSPNYAAPE-----VIN 180
Query: 670 ------IKTDVFSFGVLVLEIVSGK 688
+ DV+S G+++ ++ G+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 49/209 (23%), Positives = 74/209 (35%), Gaps = 57/209 (27%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKL---IAKLQHTNLTDSRR 579
LG+GGFG V+ G L + +VAIK + R G + +A L
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 580 N-NRLN--WETRFSII-----------------------EG--------IAQGLLYLHKY 605
RL +ET+ + EG + + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH-- 156
Query: 606 SRLRVIHRDLKASNILLDDQMNP-KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
V+HRD+K NIL+D + K+ DFG + GT Y PE
Sbjct: 157 -SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTRVYSPPE--- 208
Query: 665 SGVVSIK------TDVFSFGVLVLEIVSG 687
+S V+S G+L+ ++V G
Sbjct: 209 --WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 44/189 (23%), Positives = 72/189 (38%), Gaps = 39/189 (20%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNLT----- 575
LGEG F K + Q A+K +S+R + E + + H N+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEV 74
Query: 576 -DSRRN--------------NRLNWETRFS------IIEGIAQGLLYLHKYSRLRVIHRD 614
+ + R+ + FS I+ + + ++H + V+HRD
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRD 131
Query: 615 LKASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIK 671
LK N+L +D + KI DFG AR+ + T T Y +PE
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDES 189
Query: 672 TDVFSFGVL 680
D++S GV+
Sbjct: 190 CDLWSLGVI 198
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 57/215 (26%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFK------NEAKLIAK 568
++F + +G+G FG V Q + A+K +++ Q VE E +++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK---QKCVERNEVRNVFKELQIMQG 71
Query: 569 LQH---TNLTDS-----------------------RRNNRL-NWETRFSIIEGIAQGLLY 601
L+H NL S ++N + I E + L Y
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-LVMALDY 130
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
L R+IHRD+K NILLD+ + I+DF +A + ET + GT YM+PE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGTKPYMAPE 184
Query: 662 YAMSGVVSIKT--------DVFSFGVLVLEIVSGK 688
+ S + D +S GV E++ G+
Sbjct: 185 -----MFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 9/105 (8%)
Query: 590 SIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL--DDQMNPKISDFGMARIFGLNQSETN 647
+I+ I L YLH + HRD+K N L + K+ DFG+++ F +
Sbjct: 172 NIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 648 T--NRVVGTYGYMSPE--YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
GT +++PE + K D +S GVL+ ++ G
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 17/85 (20%), Positives = 34/85 (40%), Gaps = 6/85 (7%)
Query: 496 HNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKG-QLLNGQEVAIK-----RLS 549
H+S F ++ + +G+G +G V + AIK ++
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 550 RRSGQGIVEFKNEAKLIAKLQHTNL 574
+ + + + K E +L+ KL H N+
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNI 90
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 7e-15
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 57/206 (27%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNL----- 574
LG G FG V G+ L G +VA+K L+R+ S + + + E + + +H ++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 575 ---TDSR------------------RNNRLN-WETR--FS-IIEGIAQGLLYLHKYSRLR 609
T S +N RL+ E+R F I+ G+ Y H R
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---RHM 136
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS-ETNTNRVVGTYGYMSPEYAMSGVV 668
V+HRDLK N+LLD MN KI+DFG++ + + T+ G+ Y +PE V+
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----CGSPNYAAPE-----VI 187
Query: 669 S------IKTDVFSFGVLVLEIVSGK 688
S + D++S GV++ ++ G
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 38/195 (19%), Positives = 64/195 (32%), Gaps = 49/195 (25%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNL------ 574
LG G G V + GQ+ A+K L + + E + ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDV 90
Query: 575 --TDSRRNNRL------------------NWETRFS------IIEGIAQGLLYLHKYSRL 608
L + F+ I+ I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---H 147
Query: 609 RVIHRDLKASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+ HRD+K N+L + K++DFG A+ N +T T Y++PE
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTPYYVAPEVLGP 203
Query: 666 GVVSIKTDVFSFGVL 680
D++S GV+
Sbjct: 204 EKYDKSCDMWSLGVI 218
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 53/196 (27%), Positives = 79/196 (40%), Gaps = 57/196 (29%)
Query: 524 LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTN-------- 573
+G G FG + L + VA+K + R G I E + E L+H N
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 574 LTDSR------------------RNNRLN-WETRF---SIIEGIAQGLLYLHKYSRLRVI 611
LT + R + E RF ++ G++ Y H +++
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YCH---SMQIC 138
Query: 612 HRDLKASNILLDDQ--MNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVS 669
HRDLK N LLD KI DFG ++ L+ S+ + VGT Y++PE V+
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS--TVGTPAYIAPE-----VLL 190
Query: 670 IK------TDVFSFGV 679
+ DV+S GV
Sbjct: 191 RQEYDGKIADVWSCGV 206
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-14
Identities = 39/222 (17%), Positives = 81/222 (36%), Gaps = 50/222 (22%)
Query: 484 STNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQE 542
S + ++ H+S K + + + + + +G G +G V + L +
Sbjct: 21 SGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV 80
Query: 543 VAIKRLSRRSGQGIVEFKN---------EAKLIAKLQHTNL------------------- 574
VAIK++ R F++ E ++ +L H ++
Sbjct: 81 VAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133
Query: 575 -------TD----SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623
+D R L +++ + G+ Y+H S ++HRDLK +N L++
Sbjct: 134 VVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH--SA-GILHRDLKPANCLVN 190
Query: 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+ K+ DFG+AR ++ + + M+
Sbjct: 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 58/240 (24%)
Query: 482 LPSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQL-LNG 540
L D +K + L+ FD LG G FG V + +G
Sbjct: 19 LAKAKEDFLKKWETPSQNTAQLDQFDRIKT------------LGTGSFGRVMLVKHKESG 66
Query: 541 QEVAIKRLSRRSGQGIVEFK------NEAKLIAKLQH---TNLTDS-------------- 577
A+K L ++ +V+ K NE +++ + L S
Sbjct: 67 NHYAMKILDKQK---VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 578 ---------RRNNRLNWET-RFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN 627
RR R + RF + I YLH +I+RDLK N+L+D Q
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 179
Query: 628 PKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687
+++DFG A+ + + T + GT ++PE +S + D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 50/213 (23%), Positives = 79/213 (37%), Gaps = 52/213 (24%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---------EAK 564
+ + +G G G V + + VAIK+LSR F+N E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76
Query: 565 LIAKLQHTNLT--------DSRRNN---------------------RLNWETRFSIIEGI 595
L+ + H N+ L+ E ++ +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY 655
G+ +LH +IHRDLK SNI++ KI DFG+AR G + T V T
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTR 190
Query: 656 GYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y +PE + D++S G ++ E++ G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 46/210 (21%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---------EAK 564
+ + +G G G V + + VAIK+LSR F+N E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113
Query: 565 LIAKLQHTNLTDSR-----RNNRLNWETRFSIIE--------GIAQGLLYLHK----YSR 607
L+ + H N+ + ++ + ++E I L + Y
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 608 LR---------VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYM 658
L +IHRDLK SNI++ KI DFG+AR G + T V T Y
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYR 230
Query: 659 SPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+PE + D++S G ++ E+V K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 38/195 (19%), Positives = 67/195 (34%), Gaps = 48/195 (24%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNL------ 574
LG G G V + ++ A+K L + + E +L + ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV 123
Query: 575 --TDSRRNNRL------------------NWETRFS------IIEGIAQGLLYLHKYSRL 608
L + F+ I++ I + + YLH +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 180
Query: 609 RVIHRDLKASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+ HRD+K N+L K++DFG A+ + S T T Y++PE
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGP 237
Query: 666 GVVSIKTDVFSFGVL 680
D++S GV+
Sbjct: 238 EKYDKSCDMWSLGVI 252
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 46/211 (21%), Positives = 91/211 (43%), Gaps = 52/211 (24%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HT 572
+++ V KLG G + V++ + N ++V +K L + + K E K++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 573 N---LTDSRRN------------------NRL-----NWETRFSIIEGIAQGLLYLHKYS 606
N L D ++ +L +++ RF + E I + L Y H S
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE-ILKALDYCH--S 148
Query: 607 RLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE---- 661
++HRD+K N+++D + ++ D+G+A + + + RV Y + PE
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVASRY-FKGPELLVD 204
Query: 662 ---YAMSGVVSIKTDVFSFGVLVLEIVSGKK 689
Y S D++S G ++ ++ K+
Sbjct: 205 YQMYDYS------LDMWSLGCMLASMIFRKE 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 70/228 (30%)
Query: 500 KYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGIVE 558
KY L+ F LG G FG V+ + + A+K L + +V
Sbjct: 2 KYSLQDFQILRT------------LGTGSFGRVHLIRSRHNGRYYAMKVLKKEI---VVR 46
Query: 559 FK------NEAKLIAKLQH---TNLTDS-----------------------RRNNRLNWE 586
K +E +++ + H + + R++ R
Sbjct: 47 LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP 106
Query: 587 -TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645
+F E + L YLH +I+RDLK NILLD + KI+DFG A+
Sbjct: 107 VAKFYAAE-VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVP 157
Query: 646 TNTNRVVGTYGYMSPE------YAMSGVVSIKTDVFSFGVLVLEIVSG 687
T + GT Y++PE Y S D +SFG+L+ E+++G
Sbjct: 158 DVTYTLCGTPDYIAPEVVSTKPYNKS------IDWWSFGILIYEMLAG 199
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 54/216 (25%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---------EAK 564
++ ++ +GEG +G V LN VAIK++S F++ E K
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 565 LIAKLQHTNL--------------------------TDSR---RNNRLNWETRFSIIEGI 595
++ + +H N+ TD + L+ + + I
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI 137
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN--TNRVVG 653
+GL Y+H S V+HRDLK SN+LL+ + KI DFG+AR+ + T T V
Sbjct: 138 LRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA- 193
Query: 654 TYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGK 688
T Y +PE ++ + D++S G ++ E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 50/243 (20%), Positives = 84/243 (34%), Gaps = 55/243 (22%)
Query: 489 GKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRL 548
G + + E+ + ++ + G +G V G G VAIKR+
Sbjct: 1 GMQAKGEAAMRDLIAELHAM------QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV 54
Query: 549 SRRSGQGIVE--FKN---------EAKLIAKLQHTNL----------------------- 574
G + E +L+ H N+
Sbjct: 55 FNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE 114
Query: 575 ---TD-----SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM 626
TD + ++ + + I GL LH+ V+HRDL NILL D
Sbjct: 115 LMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNN 171
Query: 627 NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIV 685
+ I DF +AR + ++T+ V Y +PE M + D++S G ++ E+
Sbjct: 172 DITICDFNLAREDTADANKTHY---VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
Query: 686 SGK 688
+ K
Sbjct: 229 NRK 231
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 48/212 (22%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGIVE------FKNEAKLIAK 568
+F + +G G FG V +L N +V A+K L++ +++ F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE---MLKRAETACFREERDVLVN 130
Query: 569 LQH---TNL-----TD-------------------SRRNNRL-NWETRFSIIEGIAQGLL 600
T L D S+ +RL RF + E + +
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE-MVIAID 189
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSP 660
+H+ L +HRD+K NIL+D + +++DFG + + ++ VGT Y+SP
Sbjct: 190 SVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISP 245
Query: 661 EYAMSGVVSIKT-----DVFSFGVLVLEIVSG 687
E + D +S GV + E++ G
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 19/195 (9%), Positives = 47/195 (24%), Gaps = 62/195 (31%)
Query: 523 KLGEGGFGPVYKG--QLLNGQEVAIKRLSRRSG---QGIVEFKNEAKLIAKLQHTNLT-- 575
G ++ L ++VA+ + + + E + ++++ +
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 576 -DSRRNNRLNW---------------ETRFS------IIEGIAQGLLYLHKYSRLRVIHR 613
D +T S ++ +A H R V
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALS 153
Query: 614 DLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTD 673
S + +S G V+ M + + D
Sbjct: 154 IDHPSRVR--------VSIDGDV--------------VLAYPATMPD-------ANPQDD 184
Query: 674 VFSFGVLVLEIVSGK 688
+ G + ++ +
Sbjct: 185 IRGIGASLYALLVNR 199
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 32/108 (29%), Positives = 50/108 (46%), Gaps = 12/108 (11%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
RF + E I + +H+ L +HRD+K NILLD + +++DFG +
Sbjct: 164 ARFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTV 218
Query: 647 NTNRVVGTYGYMSPE--YAMSGVVSIKT-----DVFSFGVLVLEIVSG 687
+ VGT Y+SPE A+ G + D ++ GV E+ G
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 46/215 (21%), Positives = 86/215 (40%), Gaps = 56/215 (26%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---------EAK 564
+ + +G G +G V G +VAIK+L R F++ E +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELR 76
Query: 565 LIAKLQHTNLTDSR------------------------------RNNRLNWETRFSIIEG 594
L+ ++H N+ ++ +L + ++
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+ +GL Y+H +IHRDLK N+ +++ KI DFG+AR + V T
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-----VVT 188
Query: 655 YGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGK 688
Y +PE ++ + D++S G ++ E+++GK
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 55/214 (25%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---------EAK 564
+ + +G G +G V +G++VAIK+LSR F++ E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75
Query: 565 LIAKLQHTNLT--------DSRRNN---------------------RLNWETRFSIIEGI 595
L+ +QH N+ S N + + E ++ +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM 135
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTY 655
+GL Y+H V+HRDLK N+ +++ KI DFG+AR T VV T
Sbjct: 136 LKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH----ADAEMTGYVV-TR 187
Query: 656 GYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGK 688
Y +PE +S + D++S G ++ E+++GK
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 65/226 (28%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---------EAK 564
+ + + LG GG G V+ + VAIK++ + E K
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 565 LIAKLQHTNLT---------DSRRNNRLNWETRFS---------------IIEG------ 594
+I +L H N+ S+ + + T + ++E
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 595 --------IAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSE 645
+ +GL Y+H + V+HRDLK +N+ ++ + + KI DFG+ARI + S
Sbjct: 121 HARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 646 TN--TNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGK 688
+ +V T Y SP +S + D+++ G + E+++GK
Sbjct: 178 KGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 45/209 (21%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEV-AIKRLSRRSGQGIVE------FKNEAKLIAK 568
++ V +G G FG V + + ++V A+K LS+ +++ F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE---MIKRSDSAFFWEERDIMAF 125
Query: 569 LQH---TNL-----TDSR-----------------RNNRLNWE-TRFSIIEGIAQGLLYL 602
L D N + + RF E + L +
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE-VVLALDAI 184
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
H + IHRD+K N+LLD + K++DFG + VGT Y+SPE
Sbjct: 185 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEV 240
Query: 663 AMSGVVSIK----TDVFSFGVLVLEIVSG 687
S D +S GV + E++ G
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 36/108 (33%), Positives = 61/108 (56%), Gaps = 18/108 (16%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
+F + E +A L +LH L +I+RDLK NILLD++ + K++DFG+++ ++ +
Sbjct: 128 VKFYLAE-LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183
Query: 647 NTNRVVGTYGYMSPE------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+ GT YM+PE + S D +SFGVL+ E+++G
Sbjct: 184 YS--FCGTVEYMAPEVVNRRGHTQS------ADWWSFGVLMFEMLTGT 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 34/108 (31%), Positives = 56/108 (51%), Gaps = 15/108 (13%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
+ + E I L +LHK L +I+RD+K NILLD + ++DFG+++ F +++E
Sbjct: 161 VQIYVGE-IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216
Query: 647 NTNRVVGTYGYMSPE------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
GT YM+P+ V D +S GVL+ E+++G
Sbjct: 217 -AYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGA 259
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
RF E I L YLH S V++RDLK N++LD + KI+DFG+ + + +
Sbjct: 250 ARFYGAE-IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306
Query: 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
T GT Y++PE D + GV++ E++ G+
Sbjct: 307 KT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-11
Identities = 59/248 (23%), Positives = 99/248 (39%), Gaps = 70/248 (28%)
Query: 483 PSTNGDGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQE 542
P + ++S + G++ +F F V LG+G FG V ++ +
Sbjct: 2 PKESSKEGNGIGVNSSNRLGID--NF--------EFIRV--LGKGSFGKVMLARVKETGD 49
Query: 543 V-AIKRLSRRSGQGIVEFKNEAK--------LIAKLQH---TNL-----TDSR------- 578
+ A+K L + I++ ++ + L H T L T R
Sbjct: 50 LYAVKVLKKDV---ILQ-DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF 105
Query: 579 -----------RNNRLNWE-TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM 626
++ R + RF E I L++LH +I+RDLK N+LLD +
Sbjct: 106 VNGGDLMFHIQKSRRFDEARARFYAAE-IISALMFLHD---KGIIYRDLKLDNVLLDHEG 161
Query: 627 NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE------YAMSGVVSIKTDVFSFGVL 680
+ K++DFGM + N T T GT Y++PE Y + D ++ GVL
Sbjct: 162 HCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEILQEMLYGPA------VDWWAMGVL 213
Query: 681 VLEIVSGK 688
+ E++ G
Sbjct: 214 LYEMLCGH 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 38/219 (17%), Positives = 72/219 (32%), Gaps = 56/219 (25%)
Query: 488 DGKRKGNDHNSMKYGLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIK 546
N G++ +N+ + +G G +G VY + VAIK
Sbjct: 4 HHHHSSGRENLYFQGIKNVHV------PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK 57
Query: 547 RLSRRSGQGIVEFKN---------EAKLIAKLQHTNL----------------------- 574
+++R F++ E ++ +L+ +
Sbjct: 58 KVNR-------MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110
Query: 575 ---TD----SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN 627
+D + L E +I+ + G ++H +IHRDLK +N LL+ +
Sbjct: 111 IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCS 167
Query: 628 PKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
K+ DFG+AR + N + +
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 5e-11
Identities = 32/108 (29%), Positives = 57/108 (52%), Gaps = 18/108 (16%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
F + E I+ L +LH+ +I+RDLK NI+L+ Q + K++DFG+ + + + T
Sbjct: 123 ACFYLAE-ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178
Query: 647 NTNRVVGTYGYMSPE------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+T GT YM+PE + + D +S G L+ ++++G
Sbjct: 179 HT--FCGTIEYMAPEILMRSGHNRA------VDWWSLGALMYDMLTGA 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 18/108 (16%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
RF E I+ L YLH+ +I+RDLK N+LLD + + K++D+GM + T
Sbjct: 112 ARFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167
Query: 647 NTNRVVGTYGYMSPE------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+T GT Y++PE Y S D ++ GVL+ E+++G+
Sbjct: 168 ST--FCGTPNYIAPEILRGEDYGFS------VDWWALGVLMFEMMAGR 207
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 18/108 (16%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
RF E I L YLH V++RD+K N++LD + KI+DFG+ + G++ T
Sbjct: 107 ARFYGAE-IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGAT 161
Query: 647 NTNRVVGTYGYMSPE------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
GT Y++PE Y + D + GV++ E++ G+
Sbjct: 162 -MKTFCGTPEYLAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGR 202
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 27/102 (26%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP-KISDFGMARIFGLNQSETNTNRVVG 653
+ + + ++H L + HRD+K N+L++ + N K+ DFG A+ L SE + +
Sbjct: 150 LFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKK--LIPSEPSVAYICS 204
Query: 654 TYGYMSPE-------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+ Y +PE Y + D++S G + E++ GK
Sbjct: 205 RF-YRAPELMLGATEY------TPSIDLWSIGCVFGELILGK 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-11
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
RF E IA L YLH L +++RDLK NILLD Q + ++DFG+ + + S T
Sbjct: 141 ARFYAAE-IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196
Query: 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+T GT Y++PE D + G ++ E++ G
Sbjct: 197 ST--FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 18/108 (16%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
RF E I+ L YLH+ +I+RDLK N+LLD + + K++D+GM + T
Sbjct: 155 ARFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210
Query: 647 NTNRVVGTYGYMSPE------YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+T GT Y++PE Y S D ++ GVL+ E+++G+
Sbjct: 211 ST--FCGTPNYIAPEILRGEDYGFS------VDWWALGVLMFEMMAGR 250
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 49/222 (22%), Positives = 84/222 (37%), Gaps = 59/222 (26%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---------EAK 564
+++F + LGEG +G V G+ VAIK++ F E K
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 565 LIAKLQHTNLTDSR-----------------------------RNNRLNWETRFSIIEGI 595
++ +H N+ L+ + I
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRV---- 651
+ + LH + VIHRDLK SN+L++ + K+ DFG+ARI + ++ +
Sbjct: 122 LRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 652 ----VGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGK 688
V T Y +PE ++ S DV+S G ++ E+ +
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 56/215 (26%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---------EAK 564
+ ++ +G G +G V G VA+K+LSR F++ E +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------PFQSIIHAKRTYRELR 80
Query: 565 LIAKLQHTNLTDSR------------------------------RNNRLNWETRFSIIEG 594
L+ ++H N+ + +L + +I
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
I +GL Y+H +IHRDLK SN+ +++ KI DFG+AR ++ T V T
Sbjct: 141 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH----TADEMTGYVA-T 192
Query: 655 YGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGK 688
Y +PE ++ + D++S G ++ E+++G+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 39/101 (38%), Positives = 56/101 (55%), Gaps = 6/101 (5%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
F E I GL +LH +++RDLK NILLD + KI+DFGM + L ++T
Sbjct: 120 ATFYAAE-IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175
Query: 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG 687
NT GT Y++PE + + D +SFGVL+ E++ G
Sbjct: 176 NT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 25/139 (17%)
Query: 556 IVEFKNEAKLIAKLQHTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615
++E+ N L+ +Q F E IA GL +L +I+RDL
Sbjct: 420 VMEYVNGGDLMYHIQQVGRFKEPH-------AVFYAAE-IAIGLFFLQS---KGIIYRDL 468
Query: 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE------YAMSGVVS 669
K N++LD + + KI+DFGM + + T T GT Y++PE Y S
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQPYGKS---- 522
Query: 670 IKTDVFSFGVLVLEIVSGK 688
D ++FGVL+ E+++G+
Sbjct: 523 --VDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 35/102 (34%), Positives = 54/102 (52%), Gaps = 6/102 (5%)
Query: 587 TRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646
F E IA GL +L +I+RDLK N++LD + + KI+DFGM + + T
Sbjct: 123 AVFYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178
Query: 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
T GT Y++PE D ++FGVL+ E+++G+
Sbjct: 179 KT--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 45/218 (20%), Positives = 83/218 (38%), Gaps = 59/218 (27%)
Query: 521 VNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTNLTDSR 578
V KLG G F V+ + ++N VA+K + R + E ++E KL+ ++ + T
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 579 RNNR------------------------------------LNWETRFSI--IEGIAQ--- 597
+ ++ I++
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 598 -GLLYLHKYSRLRVIHRDLKASNILLDDQMNP------KISDFGMARIFGLNQSETNTNR 650
GL Y+H+ R +IH D+K N+L++ +P KI+D G A + + +
Sbjct: 142 LGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----- 194
Query: 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+ T Y SPE + D++S L+ E+++G
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 1e-09
Identities = 45/292 (15%), Positives = 93/292 (31%), Gaps = 59/292 (20%)
Query: 525 GEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGI--VEFKNEAK---LIAKLQHTNLTDSRR 579
G G G K + ++ + I + KN ++ LQ L
Sbjct: 157 GVLGSG---K-TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ--KL---LY 207
Query: 580 NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD-FGM-AR 637
NW +R I + + R + + + ++L + N K + F + +
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK 267
Query: 638 IFGLNQSETNTNRVVG-TYGYMSPEYAMSGVVSIKT-DVFS------FGVLVLEIVSGKK 689
I + + T+ + T ++S ++ + + + L E+++
Sbjct: 268 ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT-- 325
Query: 690 NNGCYRTDHPL--NLIGYA-------WQLW---NEGKVLELVDIALEGSFSPNEVLRC-- 735
+P ++I + W W N K+ +++ +L P E +
Sbjct: 326 --------NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN-VLEPAEYRKMFD 376
Query: 736 ----------IHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPAFFI 777
I LL + + + VV+ L SL PK+ I
Sbjct: 377 RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 1e-05
Identities = 88/605 (14%), Positives = 172/605 (28%), Gaps = 198/605 (32%)
Query: 147 VLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSED---SPAEGE 203
++ + R W +++ + L+ +++ + +E S
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMV--QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 204 FTLNIDP--NVSNQLIIQR---RGEVLWT-----CGLFPH--------------WRAVDL 239
+ D N NQ+ + R + L P W A+D+
Sbjct: 112 YIEQRDRLYN-DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170
Query: 240 DSDFHFSYTSNEKERYFN-YSLN-GNFTSFPTLQIDSKGSLTVTGALPISCPGSEGCVRL 297
+ + + F + LN N S P ++ L I +
Sbjct: 171 CLSYKV-----QCKMDFKIFWLNLKNCNS-PETVLEMLQKLLYQ----IDPNWTSRSDHS 220
Query: 298 SSCKGYFLDDFELNWA--RKRGFMSVDGFKFKGSNNMSRDDCATKCL------SNCSCI- 348
S+ K ++ R + ++ CL N
Sbjct: 221 SNIK------LRIHSIQAELRRLLKSKPYE--------------NCLLVLLNVQNAKAWN 260
Query: 349 AFAITNKNNNTACEIW--SRGSKFIEDNNNTDARYISVWE-PKGIEEKKC------WL-- 397
AF ++ C+I +R + + + +IS+ + + +L
Sbjct: 261 AFNLS-------CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 398 ---------CLIIPLAVALPVGILSCSLCFLARRKYKANEKWWISLTIAISAALT----- 443
P +++ + L K+ +K LT I ++L
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK----LTTIIESSLNVLEPA 369
Query: 444 -----------F-----IPLLSYLCYLIYGKIKTKVERIMNQ--KKLLRELGEN---LSL 482
F IP L + + IK+ V ++N+ K L E +S+
Sbjct: 370 EYRKMFDRLSVFPPSAHIP-TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 483 PSTNGDGKRKGND----HNSM--KYGL-EIFDFQTISAATNN---FSAVNKLGEGGFGPV 532
PS + K K + H S+ Y + + FD + + +S
Sbjct: 429 PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYS------------- 475
Query: 533 YKG----QLLNGQEVAIKR---LSRRSGQGIVEFKNEAKLIAKLQHTNLTDSRRNNRLNW 585
+ G + + + + + R L R F L K++H + W
Sbjct: 476 HIGHHLKNIEHPERMTLFRMVFLDFR-------F-----LEQKIRHDS---------TAW 514
Query: 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645
SI+ + Q L Y + N +++ I DF L + E
Sbjct: 515 NASGSILNTLQQ----LKFY-------KPYICDNDPKYERLVNAILDF-------LPKIE 556
Query: 646 TNTNR 650
N
Sbjct: 557 ENLIC 561
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 41/180 (22%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHT-- 572
N + K+G G FG +Y G + G+EVAIK ++ + E+K+ +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66
Query: 573 -----------------------NLTDSRR--NNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+L D + + + +T + + + + Y+H +
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 608 LRVIHRDLKASNILLDDQMNPK---ISDFGMARIFGLNQSET-----NTNRVVGTYGYMS 659
IHRD+K N L+ I DFG+A+ + ++ + GT Y S
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 51/210 (24%), Positives = 79/210 (37%), Gaps = 57/210 (27%)
Query: 521 VNKLGEGGFGPVYKGQ-LLNGQEVAIKRL---SRRSGQGIVEFK----------NEAKLI 566
+ +G+G FG V K Q VA+K + R Q E + + +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 567 AKL-------QHT---------NLTDSRRNNRLNWETRFSI--IEGIAQ----GLLYLHK 604
+ H NL + + N+ FS+ + A L LHK
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQ---GFSLPLVRKFAHSILQCLDALHK 218
Query: 605 YSRLRVIHRDLKASNILLDDQMNP--KISDFGMARIFGLNQSETNTNRVVGTY----GYM 658
R+IH DLK NILL Q K+ DFG S ++ V TY Y
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFG---------SSCYEHQRVYTYIQSRFYR 266
Query: 659 SPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+PE + + D++S G ++ E+++G
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 39/180 (21%), Positives = 69/180 (38%), Gaps = 41/180 (22%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHT-- 572
N F K+G G FG +Y G + +EVAIK + ++ + + E+K+ LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTG 64
Query: 573 -----------------------NLTDSRR--NNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+L D + +L+ +T + + + + ++H S
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123
Query: 608 LRVIHRDLKASNILLDDQMNPK---ISDFGMARIFGLNQSET-----NTNRVVGTYGYMS 659
+HRD+K N L+ I DFG+A+ + + + GT Y S
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 38/182 (20%), Positives = 65/182 (35%), Gaps = 43/182 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHT-- 572
NF K+G G FG + G+ L + VAIK +S + E + +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 573 -----------------------NLTDSRR--NNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+L D + + +T I + + Y+H +
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125
Query: 608 LRVIHRDLKASNILLDDQMNPK-----ISDFGMARIFGLNQSET-----NTNRVVGTYGY 657
+I+RD+K N L+ N I DF +A+ + +++ + GT Y
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 658 MS 659
MS
Sbjct: 184 MS 185
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 42/184 (22%), Positives = 76/184 (41%), Gaps = 47/184 (25%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKN---------EAK 564
+ V KLG+G +G V+K G+ VA+K++ F+N E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIM 60
Query: 565 LIAKLQ-HTNLTDSR--------------------------RNNRLNWETRFSIIEGIAQ 597
++ +L H N+ + R N L + ++ + +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIK 120
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGY 657
+ YLH S ++HRD+K SNILL+ + + K++DFG++R F + TN +
Sbjct: 121 VIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 658 MSPE 661
+ +
Sbjct: 178 ENFD 181
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 29/151 (19%), Positives = 51/151 (33%), Gaps = 45/151 (29%)
Query: 523 KLGEGGFGPVYKG-QLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNL------ 574
LG G G V + ++ A+K L + + E +L + Q ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV 79
Query: 575 --TDSRRNNRL------------------NWETRFS------IIEGIAQGLLYLHKYSRL 608
L + F+ I++ I + + YLH +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 136
Query: 609 RVIHRDLKASNILL---DDQMNPKISDFGMA 636
+ HRD+K N+L K++DFG A
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 38/182 (20%), Positives = 69/182 (37%), Gaps = 43/182 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHT-- 572
++ ++GEG FG +++G LLN Q+VAIK RRS + E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTG 67
Query: 573 -----------------------NLTDSRR--NNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+L D + + +T + + + +H+ S
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 608 LRVIHRDLKASNILLDDQMNPK-----ISDFGMARIFGLNQSET-----NTNRVVGTYGY 657
+++RD+K N L+ + + DFGM + + ++ + GT Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 658 MS 659
MS
Sbjct: 185 MS 186
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 51/216 (23%), Positives = 77/216 (35%), Gaps = 55/216 (25%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIK---RLSRRSGQGIVEFK---------- 560
+ + + +G+G FG V K + + VAIK Q +E +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 561 NEAKLIAKL-------QHT---------NLTDSRRNNRLNWETRFSI--IEGIAQ----G 598
I L H NL D RN S+ AQ
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFR---GVSLNLTRKFAQQMCTA 169
Query: 599 LLYLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARIFGLNQSETNTNRVVGTY- 655
LL+L L +IH DLK NILL + KI DFG + + + Y
Sbjct: 170 LLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---------CQLGQRIYQYI 219
Query: 656 ---GYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y SPE + + D++S G +++E+ +G+
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 3e-07
Identities = 24/135 (17%), Positives = 41/135 (30%), Gaps = 17/135 (12%)
Query: 571 HTNLTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI 630
+ R + T SI+ + L LR HRDL N+LL K+
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKL 203
Query: 631 SDFGMARIFGLNQSETNTNRVVGTYGY--MSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+ + + G +Y +S + VF + ++ +G
Sbjct: 204 HYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252
Query: 689 KNNGC--YRTDHPLN 701
+ YR N
Sbjct: 253 GDYQFDIYRLMKKEN 267
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 15/84 (17%), Positives = 28/84 (33%), Gaps = 3/84 (3%)
Query: 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQH 571
T K+GEG FG V++ + VAIK + K +++ ++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 572 TNLTDSRRNNRLNWETRFSIIEGI 595
+ N F + +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSV 100
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 31/173 (17%), Positives = 61/173 (35%), Gaps = 52/173 (30%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQ------EVAIKRLSRRSGQGIVEFKNEAKLIAKL 569
+ +G+GGFG +Y + + + +K +G E K +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 570 QHTNLTDSRRNNRL--------------NWETRFSIIE--G------------------- 594
Q +R+ L RF I++ G
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 595 --IAQGLL----YLHKYSRLRVIHRDLKASNILLDDQMNPKI--SDFGMARIF 639
++ +L Y+H++ +H D+KASN+LL+ + ++ D+G+A +
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 32/188 (17%), Positives = 64/188 (34%), Gaps = 54/188 (28%)
Query: 523 KLGEGGFGPVYKGQ-LLNGQEVA---IKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR 578
K+G GGFG +Y ++ A +K + +G E K ++ K + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 579 RNNRL----------------------------------NWETRFSI--IEGIAQGLL-- 600
+ + L F + + +L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 601 --YLHKYSRLRVIHRDLKASNILLDDQMNPKI--SDFGMARIFGLNQS-----ETNTNRV 651
Y+H+ +H D+KA+N+LL + ++ +D+G++ + N + E
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 652 VGTYGYMS 659
GT + S
Sbjct: 221 NGTIEFTS 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 27/199 (13%), Positives = 58/199 (29%), Gaps = 59/199 (29%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ---------LLNGQEVAIKRLSRRSGQGIVEFKNEAKLI 566
+ + G +Y+ Q+ ++K L + G+ E +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 567 AKLQHTNLTDSRRNN-----RLNW------ETRFSIIE--G------------------- 594
LQ + RF ++ G
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS 160
Query: 595 ---IAQGLL----YLHKYSRLRVIHRDLKASNILLDDQMNPKI--SDFGMARIFGLNQ-- 643
+A LL +LH+ +H ++ A NI +D + ++ + +G A + +
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 644 ---SETNTNRVVGTYGYMS 659
E + + G ++S
Sbjct: 218 VAYVEGSRSPHEGDLEFIS 236
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-06
Identities = 26/138 (18%), Positives = 44/138 (31%), Gaps = 32/138 (23%)
Query: 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKI 86
+D L G L G L G + + D L ++ +
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQN-----DCNLVLYDN----------------- 36
Query: 87 NQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGNTSAALYETGNF 146
N+ VW + N + + DGNL I ++ + GN L N
Sbjct: 37 NRAVWASGTNGKASGCVLKMQ---NDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNV 93
Query: 147 VLYEMNPSGSMERELWQS 164
V+Y + S + +W +
Sbjct: 94 VIY--DNSNNA---IWAT 106
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 44/263 (16%), Positives = 82/263 (31%), Gaps = 97/263 (36%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN 573
+ + KLG G F V+ + + VA+K + + + +E +L+ +++++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 574 LTDSRRNN---------------------------------RLNWETRF------SIIEG 594
D R + II+
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILL-------------------------------- 622
+ QGL YLH ++ R+IH D+K NILL
Sbjct: 155 VLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 623 -----------------DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+++ KI+D G A + +E + T Y S E +
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVLIG 267
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
+ D++S + E+ +G
Sbjct: 268 SGYNTPADIWSTACMAFELATGD 290
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-05
Identities = 31/141 (21%), Positives = 45/141 (31%), Gaps = 35/141 (24%)
Query: 28 DTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKIN 87
+ L G+ L G L + D L ++ H +
Sbjct: 2 NLLTNGEGLYAGQSLDV--EPYHFIM-----QEDCNLVLYDH-----------------S 37
Query: 88 QPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQ-AMGNTSAALYETGNF 146
VW + NT I K G + DGN + G S+ S GN L E GN
Sbjct: 38 TSVWAS--NTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNV 95
Query: 147 VLYEMNPSGSMERELWQSFDY 167
V+Y ++W + Y
Sbjct: 96 VIY--------GSDIWSTGTY 108
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-05
Identities = 47/227 (20%), Positives = 73/227 (32%), Gaps = 73/227 (32%)
Query: 521 VNKLGEGGFGPVYKGQ--LLNGQEVAIK---RLSRRSGQGIVEFK----------NEAKL 565
V+ LGEG FG V + G+ VA+K + R E + N
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 566 IAKL-------QHT---------NLTDSRRNNRLNWETRFSI--IEGIAQGLL----YLH 603
++ H + D + N F + I +A + +LH
Sbjct: 79 CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFL---PFRLDHIRKMAYQICKSVNFLH 135
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI-------------FGLNQSETNTNR 650
++ H DLK NIL + + + R FG S T +
Sbjct: 136 S---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDE 189
Query: 651 VVGTY----GYMSPEYAMSGVV-----SIKTDVFSFGVLVLEIVSGK 688
T Y +PE V+ S DV+S G +++E G
Sbjct: 190 HHSTLVSTRHYRAPE-----VILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 43/239 (17%), Positives = 71/239 (29%), Gaps = 85/239 (35%)
Query: 515 TNNFSAVNKLGEGGFGPVYKG--QLLNGQEVAIK---RLSRRSGQGIVEF---------- 559
+ V LGEG FG V + +VA+K + + +E
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKD 77
Query: 560 KNEAKLIAKLQHT----------------NLTDSRRNNRLNWETRFSI--IEGIAQGLL- 600
K L + N + + N + + + +A L
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQ---PYPLPHVRHMAYQLCH 134
Query: 601 ---YLHKYSRLRVIHRDLKASNILLDDQMNP-------------------KISDFGMARI 638
+LH+ ++ H DLK NIL + +++DFG
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---- 187
Query: 639 FGLNQSETNTNRVVGTY----GYMSPEYAMSGVV-----SIKTDVFSFGVLVLEIVSGK 688
S T + T Y PE V+ + DV+S G ++ E G
Sbjct: 188 -----SATFDHEHHTTIVATRHYRPPE-----VILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 51/236 (21%), Positives = 80/236 (33%), Gaps = 75/236 (31%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKL-IAKLQHT 572
N F + K+G+G FG V Q + N + A+K + R+ + ++ AK+ L+
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIK---KYTRSAKIEADILKKI 88
Query: 573 NLTDSRRNN-----------------------------RLNWETRFSI--IEGIAQGLL- 600
D NN N F I I+ +L
Sbjct: 89 QNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 601 ---YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR------- 650
YL K + + H DLK NILLDD K G T
Sbjct: 149 ALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 651 -------------VVGTYGYMSPEYAMSGVV-----SIKTDVFSFGVLVLEIVSGK 688
++ T Y +PE V+ + +D++SFG ++ E+ +G
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPE-----VILNLGWDVSSDMWSFGCVLAELYTGS 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1018 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.98 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.98 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.98 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.98 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.98 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.98 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.98 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.98 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.98 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.98 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.98 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.98 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.98 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.98 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.98 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.98 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.98 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.98 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.98 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.98 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.98 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.98 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.98 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.98 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.98 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.98 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.98 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.98 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.98 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.98 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.98 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.98 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.98 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.98 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.98 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.8 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.78 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.76 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.75 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.74 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.74 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.72 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.7 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.68 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.63 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.6 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.55 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.52 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.5 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.49 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.47 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.43 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.4 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.39 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.35 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.22 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.97 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.93 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.69 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.68 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.66 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.43 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.4 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.37 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.97 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.48 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.37 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.88 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.78 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.77 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.32 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.96 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.53 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 95.28 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.13 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.02 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.57 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.43 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 93.34 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 93.22 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.32 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 87.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 87.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 84.72 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.94 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=396.90 Aligned_cols=231 Identities=26% Similarity=0.359 Sum_probs=187.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec------ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46888999999999999999864 367899999987777777889999999999999999831
Q ss_pred ---------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCcee
Q 046791 578 ---------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI 630 (1018)
Q Consensus 578 ---------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL 630 (1018)
.....++|.+++.|+.|||+||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 01246899999999999999999999998 999999999999999999999
Q ss_pred eeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHH
Q 046791 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||..... .. +...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~-~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NE-VIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HH-HHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HH-HHHH
Confidence 99999987654333333344679999999999999999999999999999999999 8999864321 11 1111
Q ss_pred hhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 710 WNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
...+. ....+...++++.+|+.+||+.||++||||+||+++|++...
T Consensus 243 i~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 123344556788999999999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=398.90 Aligned_cols=231 Identities=26% Similarity=0.344 Sum_probs=180.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec------ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778899999999999999864 377899999987777777889999999999999999831
Q ss_pred -----------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCc
Q 046791 578 -----------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 578 -----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
....++++.+++.|+.|||+||+|||+++ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 01246899999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 707 (1018)
||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||..... .. +.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~-~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TE-AI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HH-HH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HH-HH
Confidence 9999999997654444444455789999999999999999999999999999999999 8999864321 11 11
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.....+ .+...+...++++.+|+.+||+.||++||||.||+++|+...+
T Consensus 271 ~~i~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DCITQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 111111 1223344556788899999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=392.45 Aligned_cols=238 Identities=26% Similarity=0.432 Sum_probs=182.3
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
+++.+.++||+|+||+||+|++.+ .||||+++.. .....++|.+|+.++++++|||||.+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~ 113 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWC 113 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcC
Confidence 567888999999999999998754 5999998654 33456789999999999999999831
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.+++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+..........
T Consensus 114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 22457999999999999999999999998 99999999999999999999999999987654433344
Q ss_pred ceeeecccccCChhhhcc---CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 648 TNRVVGTYGYMSPEYAMS---GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.....||+.|||||++.+ +.++.++|||||||+||||+||+.||...... .........+.. .+.+
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~----~p~~- 259 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYA----SPDL- 259 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCC----CCCS-
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCC----CCCc-
Confidence 456789999999999964 46899999999999999999999998643211 111111111111 0111
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPA 769 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp~ 769 (1018)
...+...++.+.+|+.+||+.||++||||.||++.|+....++|.
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 122334567788999999999999999999999999877665543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=391.53 Aligned_cols=228 Identities=30% Similarity=0.414 Sum_probs=183.9
Q ss_pred CcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4667889999999999999863 46789999997653 3456789999999999999999831
Q ss_pred --------------c----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC
Q 046791 578 --------------R----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN 627 (1018)
Q Consensus 578 --------------~----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 627 (1018)
. ....+++.+++.|+.|||+||+|||+++ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 0 0235899999999999999999999998 999999999999999999
Q ss_pred ceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHH
Q 046791 628 PKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYA 706 (1018)
Q Consensus 628 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 706 (1018)
+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||..... .. +
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------~~-~ 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QD-V 256 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------HH-H
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------HH-H
Confidence 99999999987654433334445689999999999999999999999999999999998 8999864321 11 1
Q ss_pred HHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 707 WQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 707 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
......+. ....+...+..+.+|+.+||+.||++||||.||+++|+..
T Consensus 257 ~~~i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111221 1233455667889999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=379.69 Aligned_cols=224 Identities=23% Similarity=0.283 Sum_probs=182.9
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
..|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999875 589999999977666666779999999999999999841
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.... ....
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~ 228 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 228 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBC
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cccc
Confidence 22457999999999999999999999999 9999999999999999999999999999875332 2334
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .... ......+.. + ......
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~-~~~i~~~~~-----~--~~~~~~ 294 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKA-MKMIRDNLP-----P--RLKNLH 294 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHH-HHHHHHSSC-----C--CCSCGG
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHH-HHHHHcCCC-----C--CCCccc
Confidence 5789999999999999999999999999999999999999985321 1111 111111100 0 011223
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+.+.+|+.+||+.||++|||+.|+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 34577889999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=381.66 Aligned_cols=222 Identities=21% Similarity=0.357 Sum_probs=174.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
++|+++++||+|+||+||+|+.. +|+.||||+++.. .....++|.+|++++++|+|||||++
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999865 5899999999754 23446779999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.. .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence 12345788899999999999999999999 99999999999999999999999999987532 1
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ......... .+..
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~-~~~~--------- 242 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKII-SGSF--------- 242 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHH-HTCC---------
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHH-cCCC---------
Confidence 122334689999999999999999999999999999999999999995321 111111111 1111
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+......+.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123344567889999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=375.53 Aligned_cols=222 Identities=25% Similarity=0.336 Sum_probs=183.9
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|++++++++|||||++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999865 5899999999754 24456789999999999999999841
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
...+.+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+......
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 23467999999999999999999999999 999999999999999999999999999987655444
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......+||+.|||||++.+..++.++|||||||++|||++|+.||.... ....... ...+. .
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~-i~~~~----------~ 251 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAK-IIKLE----------Y 251 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH-HHHTC----------C
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHH-HHcCC----------C
Confidence 55566899999999999999999999999999999999999999995321 1111111 11111 1
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVV 757 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 757 (1018)
.++....+++.+|+.+||+.||++|||++|++
T Consensus 252 ~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 23444556788999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=365.64 Aligned_cols=220 Identities=21% Similarity=0.337 Sum_probs=166.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ......+.+|++++++++||||++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 58999999996542 334567999999999999999984
Q ss_pred ----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 577 ----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 577 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
+.....+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..... .
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~ 166 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---N 166 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC---C
Confidence 233568999999999999999999999999 999999999999999999999999999875432 2
Q ss_pred cceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......||+.|||||++.+..+ +.++|||||||++|||++|+.||.... ... ..+....+. .
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~-~~~~i~~~~----------~ 229 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPV-LFKNISNGV----------Y 229 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHH-HHHHHHHTC----------C
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHH-HHHHHHcCC----------C
Confidence 2335789999999999998776 589999999999999999999995321 111 111111111 1
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.++....+.+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 223344567889999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=381.19 Aligned_cols=239 Identities=27% Similarity=0.370 Sum_probs=190.7
Q ss_pred eHHHHHHHhCCcceeeeeccCCCcCeEEEEecc------cccceEEEeccccc-ccHHHHHHHHHHHHHhcC-CCcccc-
Q 046791 507 DFQTISAATNNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQH-TNLTDS- 577 (1018)
Q Consensus 507 ~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H-~nlv~~- 577 (1018)
+..+.+...++|++.++||+|+||+||+|+... ++.||||+++.... ...++|.+|+++|.++.| ||||++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 333344445789999999999999999998643 35799999976543 345679999999999966 898831
Q ss_pred --------------------------c----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEeccc
Q 046791 578 --------------------------R----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDL 615 (1018)
Q Consensus 578 --------------------------~----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dl 615 (1018)
. ....+++.+++.|+.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 0 1234889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCC
Q 046791 616 KASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCY 694 (1018)
Q Consensus 616 kp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~ 694 (1018)
||+||||++++.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997765544444556789999999999999999999999999999999998 89998643
Q ss_pred CCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 695 RTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 695 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.... ........+ .+...+....+++.+++.+||+.||++|||+.||++.|+..
T Consensus 292 ~~~~------~~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 292 KIDE------EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSH------HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHH------HHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 3221 111112121 12233445567888999999999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=375.54 Aligned_cols=228 Identities=19% Similarity=0.223 Sum_probs=179.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.+.|.+.++||+|+||.||+|+.. +|+.||||+++.... +.+|+.++++++|||||++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888999999999999999875 489999999975432 2579999999999999831
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-CceeeeecceeeecCCCCc-
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARIFGLNQSE- 645 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kL~DFGla~~~~~~~~~- 645 (1018)
...+.+++.++..++.||++||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 23467999999999999999999999999 99999999999999987 5999999999987543221
Q ss_pred --ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 646 --TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 646 --~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......+||+.|||||++.+..++.++|||||||++|||++|+.||....... +.... ......
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i---~~~~~~-------- 274 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKI---ASEPPP-------- 274 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHH---HHSCCG--------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHH---HcCCCC--------
Confidence 12234679999999999999999999999999999999999999996543322 11111 111100
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
....++...+.+.+++.+||+.||++|||+.||++.|....
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 01233445677889999999999999999999999887643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.70 Aligned_cols=220 Identities=26% Similarity=0.381 Sum_probs=172.5
Q ss_pred ceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 519 SAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++.++||+|+||+||+|+.. +++.||||++... .....++|.+|++++++++|||||++
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66778999999999999875 4889999999654 23445679999999999999999842
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-CCCCceeeeecceeeecCCCC
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..|+.||++||+|||+++ ++||||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 12356899999999999999999999986 4699999999999998 479999999999985432
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......+||+.|||||++.+ .++.++|||||||++|||+||+.||..... ..........+.....
T Consensus 185 -~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~~~~------ 250 (290)
T 3fpq_A 185 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPAS------ 250 (290)
T ss_dssp -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGG------
T ss_pred -CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCCCCC------
Confidence 23345789999999998865 699999999999999999999999853221 1111112212111111
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+....+++.+|+.+||+.||++|||++|+++
T Consensus 251 --~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 --FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11222356788999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=370.38 Aligned_cols=239 Identities=23% Similarity=0.270 Sum_probs=176.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4688889999999999999987 689999999965432 22233456666678999999831
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCC-----CCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYS-----RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....++++.+.+|+.|+++||+|||+++ .++||||||||+||||+.++.+||+|||+|+....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 12356899999999999999999999872 33599999999999999999999999999998754
Q ss_pred CCCc--ccceeeecccccCChhhhccC------CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCC--------chHHH
Q 046791 642 NQSE--TNTNRVVGTYGYMSPEYAMSG------VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL--------NLIGY 705 (1018)
Q Consensus 642 ~~~~--~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--------~l~~~ 705 (1018)
.... .......||+.|||||++.+. .++.++|||||||+||||+||++|+......... .....
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 4322 223346899999999999764 3678999999999999999999887543322110 00111
Q ss_pred HHHHhhcCcchhhhhhhhcCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 706 AWQLWNEGKVLELVDIALEGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 706 ~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
..... .+..++... +.+.+..+.+|+.+||+.||++||||.||+++|++..
T Consensus 241 ~~~~~--------~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 241 MRKVV--------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHH--------TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH--------hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11111 111122222 2345678889999999999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=380.04 Aligned_cols=224 Identities=24% Similarity=0.296 Sum_probs=183.0
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999875 589999999987666667789999999999999999842
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++.++..|+.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.... ....
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~ 305 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 305 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBC
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--cccc
Confidence 22457999999999999999999999999 9999999999999999999999999999875332 2334
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .... ......+. .+.+ ....
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~-~~~i~~~~-----~~~~--~~~~ 371 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKA-MKMIRDNL-----PPRL--KNLH 371 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHH-HHHHHHSC-----CCCC--SCTT
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHH-HHHHHcCC-----CCCC--cccc
Confidence 5789999999999999999999999999999999999999985322 1111 11111110 0011 1122
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+.+.+|+.+||+.||++|||+.|+++
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 34567889999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=365.27 Aligned_cols=221 Identities=22% Similarity=0.288 Sum_probs=170.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec----ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++|++.+.||+|+||+||+|+.. .++.||||++++.. .....++.+|++++++++|||||++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999853 36789999997542 2334578999999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 23467999999999999999999999999 9999999999999999999999999998654322
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
.......||+.|||||++.+..++.++|||||||++|||++|+.||.... ......... .+
T Consensus 181 --~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~-~~---------- 241 (304)
T 3ubd_A 181 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD------RKETMTMIL-KA---------- 241 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HC----------
T ss_pred --ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC------HHHHHHHHH-cC----------
Confidence 22334789999999999999999999999999999999999999996322 111111111 11
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAM-----PDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 758 (1018)
...++....+++.+|+.+||+.||++|||+ +|+++
T Consensus 242 ~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 112334456778899999999999999984 66664
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=354.80 Aligned_cols=215 Identities=19% Similarity=0.165 Sum_probs=171.7
Q ss_pred ccccccCccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCC
Q 046791 21 GPCYSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPIT 100 (1018)
Q Consensus 21 ~~~~~~~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~ 100 (1018)
+.|++++|+|++||+|++|++|||++|+||||||..+ ++|| |+ + .+ |||+|||++|+.
T Consensus 8 ~~~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~-------------~~-vvW~Anr~~p~~ 65 (276)
T 3m7h_A 8 PFNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--N-------------GA-TVWVANEQQPFS 65 (276)
T ss_dssp ECCCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--T-------------TE-EEEECSTTSTTE
T ss_pred eeccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--C-------------CC-eEEECCCCCCcC
Confidence 4577888999999999999999999999999999432 6787 76 5 56 999999999998
Q ss_pred CC----CCceEEeccCCcEEE--EcCCCCeEEEEEeecC-------cceEEEEeecCcEEEEecCCCCCcccceecccCC
Q 046791 101 DK----SGSLTIDSRDGNLKI--LRKGGNSIVVSSVQAM-------GNTSAALYETGNFVLYEMNPSGSMERELWQSFDY 167 (1018)
Q Consensus 101 ~~----~~~l~~~~~~G~Lvl--~~~~~~~~~wss~~~~-------~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~ 167 (1018)
++ +++|+|+. ||+|+| .| +++.+||+++++. .+++|+|+|+|||||+| +.+|||| |
T Consensus 66 ~~~~~~~~~l~l~~-~G~Lvl~~~~-~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS--~ 134 (276)
T 3m7h_A 66 STIPLRNKKAPLAF-YVQYGAFLDD-YSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG--T 134 (276)
T ss_dssp EEEECCCTTCCSEE-EESSSEEEEE-GGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES--C
T ss_pred CcccccceEEEEeC-CCcEEEEEeC-CCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc--c
Confidence 85 78999998 999999 66 6678999998753 36789999999999996 3579999 9
Q ss_pred CcccccCCCeecccccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEecc-CeeEEEeCCCCCc-ccccCCCCcee
Q 046791 168 PTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRR-GEVLWTCGLFPHW-RAVDLDSDFHF 245 (1018)
Q Consensus 168 PTDTlLPg~klg~~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~-~~~yw~sg~w~~~-~~~~~~~~~~~ 245 (1018)
||||||||||||.+.++|.. | ++.+||++|.|+++++++|. +++++. +.+||++|+|... ....++..+++
T Consensus 135 ptdtlLpg~~~~~~l~~g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l~l~~dGnL 207 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLAPGSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRAVFQGDGNL 207 (276)
T ss_dssp TTSCCCCSCTTCEEECSSEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEEEECTTSCE
T ss_pred cccccccccccccccccCcc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEEEEcCCCeE
Confidence 99999999999999988865 5 67899999999999999984 556654 5899999998533 23344555667
Q ss_pred eeeecCc-eeEEEEEecCCcc-----ccceEEEeee
Q 046791 246 SYTSNEK-ERYFNYSLNGNFT-----SFPTLQIDSK 275 (1018)
Q Consensus 246 ~~~~n~~-e~~~~~~~~~~~~-----~~g~l~~~~~ 275 (1018)
.+.++.+ .+..+++...... .+|+|++|.|
T Consensus 208 vl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~ 243 (276)
T 3m7h_A 208 VVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE 243 (276)
T ss_dssp EEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE
T ss_pred EEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC
Confidence 6666544 3333332211111 1899999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=354.12 Aligned_cols=219 Identities=25% Similarity=0.376 Sum_probs=160.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccccC--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDSRR-------------- 579 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~~~-------------- 579 (1018)
++|++++.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999865 589999999975443 34567999999999999999984210
Q ss_pred ------------------------C---CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeee
Q 046791 580 ------------------------N---NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD 632 (1018)
Q Consensus 580 ------------------------~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~D 632 (1018)
. ...++..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 1 12334557889999999999999999 99999999999999999999999
Q ss_pred ecceeeecCCCCcc----------cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCch
Q 046791 633 FGMARIFGLNQSET----------NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 633 FGla~~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l 702 (1018)
||+|+.+....... .....+||+.|||||++.+..++.++|||||||++|||++ ||...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-------- 230 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-------- 230 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--------
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--------
Confidence 99998775432211 1234579999999999999999999999999999999996 65311
Q ss_pred HHHHHHHhhcCcchhhhhhhhcCCCCh---HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 703 IGYAWQLWNEGKVLELVDIALEGSFSP---NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~~~~d~~l~~~~~~---~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.... ..+.......+++ ...+.+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~----------~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 231 MERV----------RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH----------HHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cHHH----------HHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 0011111112222 23345678999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=352.03 Aligned_cols=257 Identities=35% Similarity=0.560 Sum_probs=220.3
Q ss_pred ceeHHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-------
Q 046791 505 IFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------- 577 (1018)
Q Consensus 505 ~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------- 577 (1018)
.+.+.++..++++|++.+.||+|+||.||+|+..+++.||||++........+++.+|+.++++++||||++.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 4555667778999999999999999999999988899999999987776777889999999999999998731
Q ss_pred -------------------c----CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeec
Q 046791 578 -------------------R----RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 634 (1018)
Q Consensus 578 -------------------~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFG 634 (1018)
. ....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 0 1124889999999999999999999999 9999999999999999999999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||.............+.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99876533333333456789999999999999999999999999999999999999987666666666666666666677
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
....+++.+.....++....+.+++.+||+.||++|||+.||++.|+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 77777777777778889999999999999999999999999999998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=358.23 Aligned_cols=238 Identities=21% Similarity=0.301 Sum_probs=178.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999865 59999999997543 2345678999999999999999842
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++.++..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 23567999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCC--CcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc---
Q 046791 641 LNQ--SETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK--- 714 (1018)
Q Consensus 641 ~~~--~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 714 (1018)
... ........+||+.|||||++.+. .++.++||||+||++|||++|++||...... ..............
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCGGG
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCCChHH
Confidence 321 12233457899999999998875 5699999999999999999999999643211 11111111110000
Q ss_pred --------chhhhhhhh-cCCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 --------VLELVDIAL-EGSFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 --------~~~~~d~~l-~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+.... ....+ +...+.+.+|+.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000 00001 122457789999999999999999999887
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=345.71 Aligned_cols=262 Identities=39% Similarity=0.682 Sum_probs=217.8
Q ss_pred CccceeHHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc---
Q 046791 502 GLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS--- 577 (1018)
Q Consensus 502 ~~~~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~--- 577 (1018)
.+..|++.++..++++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++|+||+++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4678999999999999999999999999999999988899999999976532 233478999999999999999731
Q ss_pred ---------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCcee
Q 046791 578 ---------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI 630 (1018)
Q Consensus 578 ---------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL 630 (1018)
.....+++..+..|+.|++.||.|||++...+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 11234899999999999999999999992222999999999999999999999
Q ss_pred eeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCC--CCCCCCchHHHHHH
Q 046791 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCY--RTDHPLNLIGYAWQ 708 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~--~~~~~~~l~~~~~~ 708 (1018)
+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ..........+...
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999987653322 2233456999999999999999999999999999999999999998632 12233445556555
Q ss_pred HhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 709 LWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 709 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
...........+..+....+......+.+++.+||+.||++|||+.||+++|++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 56666677777777777888899999999999999999999999999999999754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=343.88 Aligned_cols=180 Identities=24% Similarity=0.378 Sum_probs=147.8
Q ss_pred HHHHHHhCCcceeeeeccCCCcCeEEEEec----ccccceEEEecccccccHHHHHHHHHHHHHh-cCCCccccc-----
Q 046791 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDSR----- 578 (1018)
Q Consensus 509 ~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~~----- 578 (1018)
+.+....++|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|++++.++ +||||+++.
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 344556789999999999999999999753 36789999986543 346788999999998 699998421
Q ss_pred -----------C-------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC-CCceeeeecceeee
Q 046791 579 -----------R-------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARIF 639 (1018)
Q Consensus 579 -----------~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kL~DFGla~~~ 639 (1018)
. -+.+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+..
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 1 146899999999999999999999999 9999999999999876 78999999999865
Q ss_pred cCCCCc--------------------------ccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCC
Q 046791 640 GLNQSE--------------------------TNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNG 692 (1018)
Q Consensus 640 ~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~ 692 (1018)
...... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 432111 112335799999999999875 58999999999999999999999985
Q ss_pred C
Q 046791 693 C 693 (1018)
Q Consensus 693 ~ 693 (1018)
.
T Consensus 249 ~ 249 (361)
T 4f9c_A 249 K 249 (361)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=358.08 Aligned_cols=225 Identities=20% Similarity=0.260 Sum_probs=180.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++||||+++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999875 589999999977665666789999999999999999831
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC--CCceeeeecceeeecCCCC
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ--MNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~--~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 12356899999999999999999999999 9999999999999854 88999999999987532
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......+||+.|||||++.+..++.++|||||||++|||++|+.||..... ..... ....... .+.
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~-~i~~~~~------~~~ 376 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLR-NVKSCDW------NMD 376 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHH-HHHTTCC------CCC
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHH-HHHhCCC------CCC
Confidence 233456899999999999999999999999999999999999999863221 11111 1111110 000
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
........+.+.+|+.+||+.||++|||+.|+++
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011223467789999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=321.54 Aligned_cols=255 Identities=35% Similarity=0.576 Sum_probs=203.3
Q ss_pred CccceeHHHHHHHhCCccee------eeeccCCCcCeEEEEecccccceEEEecccc----cccHHHHHHHHHHHHHhcC
Q 046791 502 GLEIFDFQTISAATNNFSAV------NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS----GQGIVEFKNEAKLIAKLQH 571 (1018)
Q Consensus 502 ~~~~f~~~~l~~~t~~y~~~------~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H 571 (1018)
....|++.++..++++|... +.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 46789999999999999988 8999999999999987 68899999986532 3345779999999999999
Q ss_pred CCcccc-----------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE
Q 046791 572 TNLTDS-----------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL 622 (1018)
Q Consensus 572 ~nlv~~-----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl 622 (1018)
|||++. .....+++..+..++.||++||.|||+++ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 998731 12345899999999999999999999999 9999999999999
Q ss_pred cCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCch
Q 046791 623 DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 623 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l 702 (1018)
+.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ +
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 9999999999999987654333333344678999999998865 588999999999999999999999875443322 1
Q ss_pred HHHHHHHhh-cCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 703 IGYAWQLWN-EGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 703 ~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
......... ...+.+.+++.+ ...+......+.+++.+||+.||.+||++.+|++.|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111111 122333333333 2345677788999999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=354.95 Aligned_cols=222 Identities=25% Similarity=0.301 Sum_probs=174.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHH---HHHHHHHhcCCCcccc-----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKN---EAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~---E~~~l~~l~H~nlv~~----------- 577 (1018)
++|++.+.||+|+||.||+|+.. +|+.||||++++.. ........+ ++.++..++|||||.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999875 48999999996542 223333444 4666677899999841
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 23467999999999999999999999999 999999999999999999999999999976532
Q ss_pred CCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||........ ....... ..
T Consensus 346 ----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i---------~~- 408 (689)
T 3v5w_A 346 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMT---------LT- 408 (689)
T ss_dssp ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHH---------HH-
T ss_pred ----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhh---------cC-
Confidence 2334689999999999975 5799999999999999999999999964332221 1100000 00
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
....++....+.+.+|+.+||+.||.+|++ ++||++
T Consensus 409 -~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 409 -MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111234445677889999999999999998 678775
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.77 Aligned_cols=229 Identities=25% Similarity=0.434 Sum_probs=177.6
Q ss_pred CCcceeeeeccCCCcCeEEEEec-cccc----ceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQE----VAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~----vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++|++.++||+|+||.||+|+.. +++. ||+|.+... .....++|.+|+.++++++||||+++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 57999999999999999999854 3554 577777543 34556789999999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..++.|+.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 12456899999999999999999999999 9999999999999999999999999998776544
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.........+|..|+|||++.+..++.++||||||+++|||++ |+.||...... .+...+...
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~~~~~~ 235 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------------EISSILEKG 235 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------GHHHHHHTT
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----------------HHHHHHHcC
Confidence 4444445567889999999999999999999999999999999 99998643221 111222222
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.....+......+.+++.+||+.||++||++.||++.|+..
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 22234455667888999999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=327.44 Aligned_cols=237 Identities=24% Similarity=0.391 Sum_probs=177.0
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
...++|++.+.||+|+||.||+|+. +++.||||++.... ....++|.+|++++++++||||+.+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456899999999999999999987 67889999987653 3345679999999999999999831
Q ss_pred -------------cCC---CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 -------------RRN---NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 -------------~~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
... ..+++..++.++.||++||+|||+++ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 111 12889999999999999999999986 3599999999999999999999999999986432
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...... ...
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~---------~~~ 254 (309)
T 3p86_A 192 T--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAV---------GFK 254 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHH---------HHS
T ss_pred c--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH---------Hhc
Confidence 2 12233467899999999999999999999999999999999999998643211 111100 001
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCC
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLP 768 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp 768 (1018)
......+......+.+++.+||+.||++|||+.||++.|+.......
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 11122344455678899999999999999999999999998765433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=330.73 Aligned_cols=242 Identities=23% Similarity=0.341 Sum_probs=185.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.++|++.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999875 7899999996543 334556779999999999999841
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcC----------CCCcEEecccCCCcEEEcCCCCceeeeecc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKY----------SRLRVIHRDLKASNILLDDQMNPKISDFGM 635 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~----------~~~~ivH~Dlkp~NILld~~~~~kL~DFGl 635 (1018)
.....+++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCc
Confidence 1124588999999999999999999998 7 99999999999999999999999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhccC-----CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMSG-----VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||.............. ..
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~---~~ 254 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE---IG 254 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH---HC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh---hc
Confidence 9887654444344446799999999999863 456789999999999999999999976544332222111 00
Q ss_pred hcCcchhhhhhhh----cCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 711 NEGKVLELVDIAL----EGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 711 ~~~~~~~~~d~~l----~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
......++.+... .... .......+.+++.+||+.||++|||+.||++.|+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111111111 1111 1245667999999999999999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.75 Aligned_cols=234 Identities=26% Similarity=0.407 Sum_probs=186.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|.+.++||+|+||.||+|+.. +++.||+|++........+.|.+|++++++++||||++.
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357899999999999999999875 488999999977666777889999999999999999831
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 11457899999999999999999999999 9999999999999999999999999998764332211
Q ss_pred ------------cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 647 ------------NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 647 ------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
......||+.|+|||++.+..++.++||||||+++|||++|..|+........... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----------~~ 235 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------LN 235 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------BC
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------hh
Confidence 11145799999999999999999999999999999999999999865433221100 00
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.....+. ..+....+.+.+++.+||+.||++|||+.|+++.|+....
T Consensus 236 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 236 VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 1233344567889999999999999999999999987644
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=321.12 Aligned_cols=237 Identities=25% Similarity=0.326 Sum_probs=189.9
Q ss_pred ccceeHHHHHHHhCC----------cceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcC
Q 046791 503 LEIFDFQTISAATNN----------FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH 571 (1018)
Q Consensus 503 ~~~f~~~~l~~~t~~----------y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H 571 (1018)
.+.|++++++.+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356889999888875 788899999999999999976 699999999987777777889999999999999
Q ss_pred CCcccc-------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC
Q 046791 572 TNLTDS-------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM 626 (1018)
Q Consensus 572 ~nlv~~-------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~ 626 (1018)
+||+.. .....+++..+..++.||++||.|||+++ |+||||||+|||++.++
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDG 178 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTC
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCC
Confidence 999831 12346899999999999999999999999 99999999999999999
Q ss_pred CceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHH
Q 046791 627 NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYA 706 (1018)
Q Consensus 627 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~ 706 (1018)
.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...
T Consensus 179 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~- 249 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQA- 249 (321)
T ss_dssp CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHH-
T ss_pred cEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH-
Confidence 999999999987653322 22346799999999999999999999999999999999999999853221 111
Q ss_pred HHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 707 WQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 707 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......... +.+ .........+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~-----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 MKRLRDSPP-----PKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHHSSC-----CCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhcCCC-----CCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111110 000 111233467889999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=328.18 Aligned_cols=231 Identities=25% Similarity=0.358 Sum_probs=184.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEec--------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCccccc------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL--------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSR------ 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~------ 578 (1018)
.++|.+.+.||+|+||.||+|+.. ++..||||+++... ....+++.+|+.+++++ +||||+++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999853 35579999997653 33456799999999999 899998310
Q ss_pred ------------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE
Q 046791 579 ------------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL 622 (1018)
Q Consensus 579 ------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl 622 (1018)
....+++.+++.++.||++||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 0134788999999999999999999999 9999999999999
Q ss_pred cCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCc
Q 046791 623 DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLN 701 (1018)
Q Consensus 623 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~ 701 (1018)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999987654333333334567889999999999999999999999999999999 99998643211 1
Q ss_pred hHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 702 LIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 702 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
+. ..+........+......+.+++.+||+.||++||++.||++.|+...
T Consensus 314 ~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 LF-------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HH-------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 111111122234445677889999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=320.45 Aligned_cols=225 Identities=23% Similarity=0.334 Sum_probs=182.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||++.
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999986 4588999999987766677889999999999999999841
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++.++..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 173 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 173 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CB
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--cc
Confidence 11345889999999999999999999999 99999999999999999999999999987653322 23
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..........+. .....+
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~--------~~~~~~ 239 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT--------PELQNP 239 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCS--------CCCSCG
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC--------CCCCCc
Confidence 346799999999999999999999999999999999999999853221 111111111110 011123
Q ss_pred hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 344567889999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.83 Aligned_cols=240 Identities=21% Similarity=0.352 Sum_probs=183.3
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-----cccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-----LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.++|++.++||+|+||.||+++. .+++.||||++........+.|.+|+.++++++||||++.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36799999999999999999984 2478999999987766667889999999999999999731
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 11234889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC------
Q 046791 641 LNQSE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG------ 713 (1018)
Q Consensus 641 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------ 713 (1018)
..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... .........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------EFMRMIGNDKQGQMI 237 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--------HHHHHHCTTCCTHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH--------HHHhhhcCccccchh
Confidence 33221 122234567789999999999999999999999999999999998753210 000011110
Q ss_pred --cchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 714 --KVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 714 --~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
...+.+........+......+.+++.+||+.||++|||+.||+++|+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 0111122222223344556788999999999999999999999999987644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=328.68 Aligned_cols=242 Identities=25% Similarity=0.340 Sum_probs=191.0
Q ss_pred ceeHHHHHHHhCCcceeeeeccCCCcCeEEEEe------cccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCccc
Q 046791 505 IFDFQTISAATNNFSAVNKLGEGGFGPVYKGQL------LNGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTD 576 (1018)
Q Consensus 505 ~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~ 576 (1018)
.+...+.+...++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 455666677789999999999999999999974 236789999997653 33456799999999999 8899983
Q ss_pred cc---------------------------C--------------------------------------------------
Q 046791 577 SR---------------------------R-------------------------------------------------- 579 (1018)
Q Consensus 577 ~~---------------------------~-------------------------------------------------- 579 (1018)
+. .
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 10 0
Q ss_pred ----------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 580 ----------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 580 ----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 111888999999999999999999999 9999999999999999999999999998765444
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.........||+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....... ..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~---------~~ 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLK---------EG 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHH---------HT
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHH---------cC
Confidence 4444455678999999999999999999999999999999998 999986433221 1111111 11
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.....+....+.+.+++.+||+.||++|||+.||++.|+...
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 112233344567889999999999999999999999998643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=317.99 Aligned_cols=237 Identities=22% Similarity=0.330 Sum_probs=178.8
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
..++|++.++||+|+||.||+|+..+++.||||++.... ......+.+|++++++++||||+++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457899999999999999999999889999999996543 2234678999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 173 (311)
T 3niz_A 99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-- 173 (311)
T ss_dssp ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc--
Confidence 12345899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch---hhhh-
Q 046791 646 TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL---ELVD- 720 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~d- 720 (1018)
.......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ............... ...+
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGTTS
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhhcc
Confidence 22234578999999999876 568999999999999999999999997544332 122222211111100 0000
Q ss_pred -----hhhc--CC-----CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 -----IALE--GS-----FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 -----~~l~--~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.... .. ..+...+++.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 00 01123457789999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=322.01 Aligned_cols=232 Identities=23% Similarity=0.358 Sum_probs=182.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEec----ccccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.++|++.+.||+|+||.||+|+.. .+..||||+++.. .....++|.+|+.++++++||||+++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999874 2445999999765 33445679999999999999999731
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 12357899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 643 QSE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 643 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... . .. ..+.
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~-~~---------~~~~ 268 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------D-VI---------SSVE 268 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------H-HH---------HHHH
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------H-HH---------HHHH
Confidence 221 12223456778999999999999999999999999999999 99998532211 1 11 1111
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.......+......+.+++.+||+.||++||++.||+++|+....
T Consensus 269 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 269 EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111222344556788899999999999999999999999998654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=323.84 Aligned_cols=232 Identities=25% Similarity=0.420 Sum_probs=177.3
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccc----eEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEV----AIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~v----AvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
.++|++.++||+|+||.||+|+.. +++.+ |+|.+... .....+++.+|+.++++++||||+++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 468999999999999999999864 46655 66666443 34567789999999999999999832
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 12456889999999999999999999999 999999999999999999999999999877544
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~~~~~~~ 234 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILEK 234 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHHHHT
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHc
Confidence 43333444567889999999999999999999999999999999 999986432211 1112222
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
......+......+.+++.+||+.||++||++.|+++.|+....
T Consensus 235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22223344456678899999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=323.28 Aligned_cols=234 Identities=23% Similarity=0.322 Sum_probs=171.7
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEecc-c---ccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCccccc--------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLLN-G---QEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDSR-------- 578 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g---~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~~-------- 578 (1018)
...++|++.+.||+|+||.||+|+... + ..||||+++.. .....+++.+|+.++++++||||++..
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999998754 3 27999999765 344567899999999999999997321
Q ss_pred ------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCc
Q 046791 579 ------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 579 ------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 0114888999999999999999999999 9999999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 707 (1018)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~--- 250 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYN--- 250 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH---
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHH---
Confidence 9999999987654333333334567789999999999999999999999999999999 89998643221 1111
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.... ......+......+.+++.+||+.||++|||+.++++.|++...
T Consensus 251 -~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 251 -YLIG---------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp -HHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHhc---------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0101 11122334455778899999999999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=321.62 Aligned_cols=222 Identities=25% Similarity=0.371 Sum_probs=178.9
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
..++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999987 468999999996542 3445678999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 12356899999999999999999999999 9999999999999999999999999997654322
Q ss_pred cccceeeecccccCChhhhccCCCC-ccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVS-IKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......||+.|+|||++.+..+. .++|||||||++|||++|+.||.... ...... ....+
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~-~i~~~---------- 229 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRE-RVLRG---------- 229 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHH-HHHHC----------
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHH-HHHhC----------
Confidence 23346799999999999987765 89999999999999999999985322 111111 11111
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+......+.+++.+||+.||.+|||++|+++
T Consensus 230 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11223344567889999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=312.11 Aligned_cols=237 Identities=24% Similarity=0.337 Sum_probs=179.3
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHH--hcCCCcccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK--LQHTNLTDS-------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~nlv~~-------------- 577 (1018)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356899999999999999999987 6889999998653 34567778887777 799998732
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHh--------cCCCCcEEecccCCCcEEEcCCCCceeeeec
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLH--------KYSRLRVIHRDLKASNILLDDQMNPKISDFG 634 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivH~Dlkp~NILld~~~~~kL~DFG 634 (1018)
.....+++..++.++.||++||+||| +.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCC
Confidence 12356889999999999999999999 777 9999999999999999999999999
Q ss_pred ceeeecCCCCcc--cceeeecccccCChhhhccC------CCCccccchhHhHHHHHHHhC----------CCCCCCCCC
Q 046791 635 MARIFGLNQSET--NTNRVVGTYGYMSPEYAMSG------VVSIKTDVFSFGVLVLEIVSG----------KKNNGCYRT 696 (1018)
Q Consensus 635 la~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~s~ksDV~SlGvvl~elltG----------~~p~~~~~~ 696 (1018)
+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 998765433221 12335799999999999876 455799999999999999999 777654332
Q ss_pred CCCCchHHHHHHHhhc-CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 697 DHPLNLIGYAWQLWNE-GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 697 ~~~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.... . ......... ....... ....+......+.+++.+||+.||++|||+.||+++|+.+
T Consensus 239 ~~~~-~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPS-F-EDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCC-H-HHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcc-h-hhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2211 1 111111111 1000000 0011234668899999999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=330.98 Aligned_cols=230 Identities=24% Similarity=0.329 Sum_probs=181.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|.+.+.||+|+||.||+|+.. +++.||||.++... ....++|.+|++++++++||||+++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467899999999999999999986 58899999987543 2334568999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 01235889999999999999999999999 999999999999999999999999999865432211
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......++..|+|||.+.++.++.++||||||+++|||++ |+.||...... .... .+.....
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~---------~~~~~~~ 333 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTRE---------FVEKGGR 333 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHH---------HHHTTCC
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHH---------HHHcCCC
Confidence 11222346778999999999999999999999999999998 99998543211 1111 1111112
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
...+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 223344556788999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=334.75 Aligned_cols=237 Identities=26% Similarity=0.397 Sum_probs=184.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
..++|++.++||+|+||.||+|+..++..||||+++... ...++|.+|+.++++++||||+++
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhh
Confidence 346789999999999999999999887889999997653 346789999999999999999831
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence 01245889999999999999999999999 9999999999999999999999999998764322 11
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .. .... +....+.
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~-~~~~---------i~~~~~~ 400 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------RE-VLDQ---------VERGYRM 400 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HH-HHHH---------HHTTCCC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HH-HHHH---------HHcCCCC
Confidence 2223456789999999999999999999999999999999 8999853221 11 1111 1111122
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPK 771 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp~p~ 771 (1018)
..+....+.+.+++.+||+.||++|||+++|+++|+......++..
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 3344556788899999999999999999999999998766544433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=322.76 Aligned_cols=231 Identities=22% Similarity=0.350 Sum_probs=179.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec-cccc----ceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQE----VAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~----vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++|++.+.||+|+||.||+|+.. +++. ||+|.+.... .....++.+|+.++++++|+||+++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 57999999999999999999864 4555 6777664432 3344568899999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 11347889999999999999999999999 9999999999999999999999999998875544
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . .+.+...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~-------------~~~~~~~ 233 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---V-------------PDLLEKG 233 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---H-------------HHHHHTT
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---H-------------HHHHHcC
Confidence 4444455678889999999999999999999999999999999 999986433211 1 1111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.....+......+.+++.+||+.||++||++.|+++.|+....
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1112233344567789999999999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=318.87 Aligned_cols=228 Identities=24% Similarity=0.341 Sum_probs=178.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTD---------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~---------------- 576 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+||++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 58899999986543 233466899999999999999983
Q ss_pred ----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 577 ----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 577 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
+.....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 123446899999999999999999999999 9999999999999999999999999998765443333
Q ss_pred cceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ . ...+... ....
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~----~~~~~~~--------~~~~ 228 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEK--------KTYL 228 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--H----HHHHHTT--------CTTS
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHHhcc--------cccC
Confidence 3445689999999999987765 7899999999999999999999965432211 0 0011111 0000
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1112345677889999999999999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=324.45 Aligned_cols=228 Identities=23% Similarity=0.335 Sum_probs=175.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecccccceEEEeccc--ccccHHHHHHHHHHHHHhcC--CCcccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQH--TNLTDS------------ 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H--~nlv~~------------ 577 (1018)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+.+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35679999999999999999999888999999998654 33445779999999999987 888731
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++ ++.+||+|||+++.......
T Consensus 87 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 87 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 22457899999999999999999999999 99999999999997 56899999999987654433
Q ss_pred cccceeeecccccCChhhhcc-----------CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC
Q 046791 645 ETNTNRVVGTYGYMSPEYAMS-----------GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG 713 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 713 (1018)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~-------- 229 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISK-------- 229 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHH--------
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHH--------
Confidence 333445689999999999865 6789999999999999999999999853221 1111
Q ss_pred cchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 714 KVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 714 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
....+++......+......+.+++.+||+.||.+|||+.|+++.
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 -LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 112223333333444445678899999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=336.17 Aligned_cols=232 Identities=26% Similarity=0.400 Sum_probs=186.2
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc--------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR-------------- 578 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~-------------- 578 (1018)
...++|++.+.||+|+||.||+|+..+++.||||+++... ...++|.+|+.++++++||||+++.
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~ 263 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF 263 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEee
Confidence 3456899999999999999999999888899999997643 4578899999999999999998421
Q ss_pred -------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 579 -------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 579 -------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-H
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-e
Confidence 1125788889999999999999999999 9999999999999999999999999998654211 1
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......++..|+|||++....++.++||||||+++|||++ |+.||..... .. .... +.....
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------~~-~~~~---------i~~~~~ 403 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PE-VIRA---------LERGYR 403 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HH-HHHH---------HHHTCC
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------HH-HHHH---------HHcCCC
Confidence 11223446788999999999999999999999999999999 9999854221 11 1111 111112
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
...+....+.+.+++.+||+.||++|||+.+|+++|+....
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 22334456778899999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.11 Aligned_cols=228 Identities=29% Similarity=0.441 Sum_probs=174.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccc----cccHHHHHHHHHHHHHhcCCCccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS----GQGIVEFKNEAKLIAKLQHTNLTD-------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~nlv~-------------- 576 (1018)
.++|++.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 368999999999999999999874 8899999986543 234577999999999999999973
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC--------CCCceeeeeccee
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD--------QMNPKISDFGMAR 637 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~--------~~~~kL~DFGla~ 637 (1018)
......+++..+..++.|+++||.|||+++..+|+||||||+|||++. ++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 123467899999999999999999999998666999999999999986 6789999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ........
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~------- 227 (271)
T 3dtc_A 165 EWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVA------- 227 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHH-------
T ss_pred cccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhh-------
Confidence 654221 2245789999999999999999999999999999999999999854221 11111111
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
........+....+.+.+++.+||+.||++|||+.|+++.|+.
T Consensus 228 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 --MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111222334455778899999999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.03 Aligned_cols=230 Identities=25% Similarity=0.333 Sum_probs=183.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.++|++.+.||+|+||.||+|+..++..||||+++... ...+++.+|+.++.+++||||++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46899999999999999999998888899999997643 345789999999999999999831
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.++..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS 161 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence 01235899999999999999999999999 99999999999999999999999999987643322 12
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+ ....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~-~~~~~---------~~~~ 225 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVL-KVSQG---------HRLY 225 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHH-HHHTT---------CCCC
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHH-HHHcC---------CCCC
Confidence 223456778999999999899999999999999999999 99998533211 1111 11111 1111
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.+....+.+.+++.+||+.||++|||+.|+++.|+....
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 223335678899999999999999999999999998654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=326.16 Aligned_cols=231 Identities=30% Similarity=0.387 Sum_probs=180.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec------ccccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS---------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~---------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++++++|+||+++
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367999999999999999999843 3668999999654 34455679999999999999999831
Q ss_pred -----------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC---Cceee
Q 046791 578 -----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM---NPKIS 631 (1018)
Q Consensus 578 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kL~ 631 (1018)
.....+++.+++.++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 11235889999999999999999999999 99999999999999554 59999
Q ss_pred eecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHh
Q 046791 632 DFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 632 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .. ...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~-~~~-- 297 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QE-VLE-- 297 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HH-HHH--
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHH--
Confidence 9999986543322233334567899999999999999999999999999999998 9999853221 11 111
Q ss_pred hcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 711 NEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 711 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.+........+......+.+|+.+||+.||++||++.||++.|+...
T Consensus 298 -------~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 298 -------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11111112233444567889999999999999999999999998643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=326.16 Aligned_cols=231 Identities=26% Similarity=0.400 Sum_probs=172.3
Q ss_pred hCCcceeeeeccCCCcCeEEEEec----ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....++|.+|+.++++++||||+++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999865 47789999997653 3445679999999999999999831
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 11346899999999999999999999999 999999999999999999999999999876533
Q ss_pred CCc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 643 QSE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 643 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... .......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .. ..+.+.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------~~----------~~~~i~ 264 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------QD----------VIKAVD 264 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------HH----------HHHHHH
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HH----------HHHHHH
Confidence 221 11222345778999999999999999999999999999998 9999853221 01 111122
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.......+......+.+++.+||+.||++||++.||+++|+...
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 22222334455678889999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.54 Aligned_cols=237 Identities=24% Similarity=0.375 Sum_probs=178.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR----------------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~----------------- 578 (1018)
++|++.+.||+|+||.||+|+.. ++.||||++... ...+.|.+|++++++++||||++..
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCC
Confidence 57899999999999999999874 788999998643 3457899999999999999997311
Q ss_pred -------CC---CCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC-ceeeeecceeeecCCCCccc
Q 046791 579 -------RN---NRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-PKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 579 -------~~---~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~-~kL~DFGla~~~~~~~~~~~ 647 (1018)
.. ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----- 159 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----- 159 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence 11 23678889999999999999999933233999999999999998887 799999999765321
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+... .+. ....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~~~---------~~~~ 225 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVH-NGT---------RPPL 225 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHH-TTC---------CCCC
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHh-cCC---------CCCc
Confidence 22346899999999999999999999999999999999999998643221 111111111 111 1112
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCCCCCCCc
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPA 774 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp~p~~p~ 774 (1018)
.......+.+++.+||+.||++|||+.||+++|+.....++.+..|.
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 23344678899999999999999999999999998766565555444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.55 Aligned_cols=229 Identities=25% Similarity=0.472 Sum_probs=181.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccc-------cHHHHHHHHHHHHHhcCCCcccc---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ-------GIVEFKNEAKLIAKLQHTNLTDS--------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-------~~~~f~~E~~~l~~l~H~nlv~~--------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+++.+|+.++++++|+||++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 468999999999999999999875 5889999998654322 12679999999999999999831
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC-----ceeeeecce
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-----PKISDFGMA 636 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~-----~kL~DFGla 636 (1018)
.....+++..+..++.|+++||+|||+++ .+|+||||||+|||++.++. +||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 13456899999999999999999999986 35999999999999988776 999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhc--cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAM--SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
+.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||....... ......
T Consensus 177 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~------ 241 (287)
T 4f0f_A 177 QQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINM------ 241 (287)
T ss_dssp BCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHH------
T ss_pred ccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHH------
Confidence 75432 233467899999999984 4567899999999999999999999986433221 111111
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..........+....+.+.+++.+||+.||++|||+.||++.|++
T Consensus 242 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 ---IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ---HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111112223344556788899999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=314.88 Aligned_cols=235 Identities=19% Similarity=0.211 Sum_probs=181.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~--------------- 577 (1018)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ..++.+|+.+++++ +|+||+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999986 4689999999865432 34689999999999 99998731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC-----ceeeeecceeeecC
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-----PKISDFGMARIFGL 641 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~-----~kL~DFGla~~~~~ 641 (1018)
.....+++..++.++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 11467999999999999999999999999 999999999999998887 99999999997654
Q ss_pred CCCcc-----cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 642 NQSET-----NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 642 ~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||................ .....
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~~ 238 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG----DTKRA 238 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH----HHHHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH----hhhcc
Confidence 32211 1235689999999999999999999999999999999999999997654332111111110 00000
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
... ..+. .. .+.+.+++..||+.||.+||++.+|++.|++..
T Consensus 239 ~~~-~~~~----~~-~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 239 TPI-EVLC----EN-FPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp SCH-HHHT----TT-CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCH-HHHh----cc-ChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000 0000 01 127889999999999999999999999998643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=312.22 Aligned_cols=224 Identities=24% Similarity=0.307 Sum_probs=171.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--------------------------ccHHHHHHHHHHHH
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--------------------------QGIVEFKNEAKLIA 567 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--------------------------~~~~~f~~E~~~l~ 567 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999865 588999999865421 12356899999999
Q ss_pred HhcCCCccc---------------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcE
Q 046791 568 KLQHTNLTD---------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNI 620 (1018)
Q Consensus 568 ~l~H~nlv~---------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NI 620 (1018)
+++||||++ ......+++.++..++.||++||.|||+++ |+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 999999873 122356899999999999999999999999 99999999999
Q ss_pred EEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCC---CCccccchhHhHHHHHHHhCCCCCCCCCCC
Q 046791 621 LLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGV---VSIKTDVFSFGVLVLEIVSGKKNNGCYRTD 697 (1018)
Q Consensus 621 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDV~SlGvvl~elltG~~p~~~~~~~ 697 (1018)
|++.++.+||+|||+++...... .......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-- 244 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-- 244 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred EECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc--
Confidence 99999999999999998765322 2223467999999999988755 4788999999999999999999985321
Q ss_pred CCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 698 HPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 698 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...... ..... .......+...+.+.+++.+||+.||++||++.|+++
T Consensus 245 ----~~~~~~-~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 ----IMCLHS-KIKSQ--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ----HHHHHH-HHHHC--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----HHHHHH-HHhcc--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111111 11111 1111112234567889999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=327.39 Aligned_cols=233 Identities=24% Similarity=0.336 Sum_probs=185.9
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec--------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCccccc-----
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL--------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSR----- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~----- 578 (1018)
..++|.+.+.||+|+||.||+|+.. .++.||||++.... .....++.+|+++++++ +||||+++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3468999999999999999999853 23579999997653 34457799999999999 999998310
Q ss_pred -------------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEE
Q 046791 579 -------------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNIL 621 (1018)
Q Consensus 579 -------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NIL 621 (1018)
....+++.+++.|+.||++||.|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 0135899999999999999999999999 999999999999
Q ss_pred EcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCC
Q 046791 622 LDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPL 700 (1018)
Q Consensus 622 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~ 700 (1018)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---- 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987654433333444567889999999999999999999999999999999 9999853221
Q ss_pred chHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 701 NLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 701 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
......... ......+......+.+++.+||+.||++||++.||++.|+....
T Consensus 300 ---~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 ---EELFKLLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp ---HHHHHHHHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHc---------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111111 11222334455678899999999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=309.80 Aligned_cols=228 Identities=29% Similarity=0.379 Sum_probs=182.4
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|++.+.||+|+||.||+|+..+++.||||++.... ...+++.+|+.++++++||||++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5789999999999999999998888899999997543 345789999999999999999831
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 164 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-cccc
Confidence 12345899999999999999999999999 9999999999999999999999999998653221 1122
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ..... .......
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~-~~~~~---------~~~~~~~ 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEV-VEDIS---------TGFRLYK 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHH-HHHHH---------TTCCCCC
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHH-HHHHh---------cCccCCC
Confidence 23456778999999999999999999999999999999 8999853221 111 11111 1111222
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
+......+.+++.+||+.||++||++.|+++.|++..
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 3334567889999999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=317.74 Aligned_cols=232 Identities=26% Similarity=0.365 Sum_probs=185.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc--------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR-------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~-------- 578 (1018)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++++++||||++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4578999999999999999999852 35789999997643 34457799999999999999998310
Q ss_pred ------------------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccC
Q 046791 579 ------------------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLK 616 (1018)
Q Consensus 579 ------------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlk 616 (1018)
....+++.+++.++.||++||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 0123788999999999999999999999 9999999
Q ss_pred CCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCC
Q 046791 617 ASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYR 695 (1018)
Q Consensus 617 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~ 695 (1018)
|+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987754443333344567889999999999999999999999999999999 999985432
Q ss_pred CCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 696 TDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 696 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.. .+. +.+........+....+.+.+++.+||+.||++||++.||++.|+...
T Consensus 258 ~~---~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 PE---RLF-------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GG---GHH-------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHH-------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 21 111 111111112233445677889999999999999999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=308.05 Aligned_cols=236 Identities=22% Similarity=0.280 Sum_probs=178.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 48899999996543 3334678999999999999999841
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 156 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--R 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--S
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc--c
Confidence 12467999999999999999999999999 9999999999999999999999999998764322 2
Q ss_pred cceeeecccccCChhhhccCC-CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch------hhh
Q 046791 647 NTNRVVGTYGYMSPEYAMSGV-VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL------ELV 719 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~~~ 719 (1018)
......||+.|+|||++.+.. ++.++||||||+++|||++|..|+.... ................... ...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 223457899999999998765 8999999999999999999988853211 1111111111111110000 000
Q ss_pred hh---------hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 720 DI---------ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 720 d~---------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+. .......+.....+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 0000112234567889999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=320.83 Aligned_cols=237 Identities=24% Similarity=0.366 Sum_probs=186.7
Q ss_pred HHHHHhCCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc----
Q 046791 510 TISAATNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR---- 578 (1018)
Q Consensus 510 ~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~---- 578 (1018)
.+....++|++.+.||+|+||.||+|+.. +++.||||+++... ....++|.+|+.++++++||||++..
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34445689999999999999999999874 34789999997653 33456799999999999999997310
Q ss_pred ----------------------C------------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEe
Q 046791 579 ----------------------R------------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612 (1018)
Q Consensus 579 ----------------------~------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 612 (1018)
. ...+++.+++.++.||++||.|||+++ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 0 156889999999999999999999999 999
Q ss_pred cccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCC
Q 046791 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNN 691 (1018)
Q Consensus 613 ~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~ 691 (1018)
|||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986643322233344567899999999999999999999999999999999 99998
Q ss_pred CCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 692 GCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 692 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
..... . ........+.. ...+......+.+++.+||+.||++||++.+|++.|++...
T Consensus 278 ~~~~~------~-~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 278 YGMAH------E-EVIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTSCH------H-HHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCh------H-HHHHHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 53221 1 11111111111 12233445678899999999999999999999999998755
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=310.05 Aligned_cols=234 Identities=26% Similarity=0.456 Sum_probs=172.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|++.++||+|+||.||+|+... .||||+++... ....+.|.+|+.++++++|+||+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence 5689999999999999999998643 59999986543 3445679999999999999999731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 23456889999999999999999999999 9999999999999999999999999998664333333
Q ss_pred cceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 647 NTNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......||+.|+|||.+. +..++.++||||||+++|||++|+.||...... .........+......
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~---- 247 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSPDL---- 247 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCCCT----
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCcch----
Confidence 344567899999999987 577899999999999999999999998643221 1111111111111100
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
..........+.+++.+||+.||++||++.||+++|+...
T Consensus 248 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 -SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0122344577889999999999999999999999999764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=309.08 Aligned_cols=237 Identities=18% Similarity=0.218 Sum_probs=183.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~--------------- 577 (1018)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+|+.++.++ +|+|++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46899999999999999999986 468999999986543 334688999999999 78887621
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC-----ceeeeecceeeecC
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN-----PKISDFGMARIFGL 641 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~-----~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 87 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred ecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 11346899999999999999999999999 999999999999987766 99999999997754
Q ss_pred CCCc-----ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 642 NQSE-----TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 642 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 3221 12345679999999999999999999999999999999999999997654332211111111111000000
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.+ .....+.+.+++.+||+.||++||++.+|++.|++...
T Consensus 244 -----~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 244 -----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp -----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----HH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 01 11234678899999999999999999999999998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=305.59 Aligned_cols=239 Identities=19% Similarity=0.219 Sum_probs=182.6
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
...++|++.+.||+|+||.||+|+. .+++.||||++..... ..++.+|+.++.+++|++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3567899999999999999999986 4588999998755432 235889999999999988651
Q ss_pred ----------c--cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE---cCCCCceeeeecceeeecC
Q 046791 577 ----------S--RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 577 ----------~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kL~DFGla~~~~~ 641 (1018)
. .....+++..+..++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 0 12456899999999999999999999999 9999999999999 7889999999999998754
Q ss_pred CCCc-----ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 642 NQSE-----TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 642 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-
Confidence 3321 1223567899999999999999999999999999999999999999765544433332221111101000
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
+... ......+.+++.+||+.||++||++.+|++.|++...
T Consensus 240 ----~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 240 ----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ----HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----hhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0001 1224578899999999999999999999999987543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=319.11 Aligned_cols=235 Identities=26% Similarity=0.385 Sum_probs=183.9
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccc--------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDS-------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~-------- 577 (1018)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.++ +||||++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999862 35689999997542 34457899999999999 99998731
Q ss_pred ------------------cC-----------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccC
Q 046791 578 ------------------RR-----------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLK 616 (1018)
Q Consensus 578 ------------------~~-----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlk 616 (1018)
.. ...+++..++.++.||++||.|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 00 023788999999999999999999999 9999999
Q ss_pred CCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCC
Q 046791 617 ASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYR 695 (1018)
Q Consensus 617 p~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~ 695 (1018)
|+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654443333445677889999999999999999999999999999998 999986443
Q ss_pred CCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCC
Q 046791 696 TDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLS 766 (1018)
Q Consensus 696 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~ 766 (1018)
... .... .+........+....+.+.+++.+||+.||.+||++.||++.|+.....
T Consensus 280 ~~~------~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDA------NFYK---------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSH------HHHH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHH------HHHH---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 211 1111 1111122223344567788999999999999999999999999986553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=316.78 Aligned_cols=222 Identities=23% Similarity=0.280 Sum_probs=179.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|++.+.||+|+||.||+++.. +|+.||||++++. .......+.+|+.++++++||||+.+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357999999999999999999875 5899999999764 34456789999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-- 158 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC--
Confidence 12356889999999999999999999999 999999999999999999999999999864322
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
........||+.|+|||++.+..++.++||||||+++|||++|+.||.... .... ......+ .
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~-~~~i~~~----------~ 221 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERL-FELILME----------E 221 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHH-HHHHHHC----------C
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHH-HHHHHcC----------C
Confidence 222345789999999999999999999999999999999999999985321 1111 1111011 1
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
..++......+.+++.+||+.||++|| +++||++
T Consensus 222 ~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 123344556788999999999999999 8999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.83 Aligned_cols=230 Identities=30% Similarity=0.439 Sum_probs=183.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.++|++.+.||+|+||.||+|+..+++.||||.+.... ...+.+.+|++++++++|+||++.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCC
Confidence 46899999999999999999998888899999997543 346789999999999999998731
Q ss_pred --------cC--CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 --------RR--NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 --------~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.. ...+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 166 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TA 166 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-EC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-cc
Confidence 00 125889999999999999999999999 99999999999999999999999999987653221 12
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .. .......+ ....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~-~~~~~~~~---------~~~~ 230 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PE-VIQNLERG---------YRMV 230 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HH-HHHHHHTT---------CCCC
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HH-HHHHHhcc---------cCCC
Confidence 223456788999999998999999999999999999999 8988853221 11 11111111 1112
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.+......+.+++.+||+.||++|||+.+|+++|++...
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 233445678899999999999999999999999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=309.90 Aligned_cols=242 Identities=18% Similarity=0.234 Sum_probs=186.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|.+.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3679999999999999999998765 8899999997643 3456778999999999999999831
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE----cCCCCceeeeeccee
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMAR 637 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl----d~~~~~kL~DFGla~ 637 (1018)
.....+++.+++.++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 01122899999999999999999999999 9999999999999 788889999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhc--------cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAM--------SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~ 239 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKI 239 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHH
Confidence 765332 223457899999999986 57889999999999999999999999865433221 11111222
Q ss_pred hhcCc---chhh---h--------hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 710 WNEGK---VLEL---V--------DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 710 ~~~~~---~~~~---~--------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
..... ...+ . +..............+.+++.+||+.||++|||++|+++...+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11110 0000 0 001112344567778889999999999999999999999988754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=325.83 Aligned_cols=227 Identities=22% Similarity=0.334 Sum_probs=174.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccc--cccHHHHHHHHHHHHHhcC--CCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQH--TNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H--~nlv~~------------- 577 (1018)
.++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++| +||+++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35699999999999999999998889999999986542 3455789999999999974 898732
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++ ++.+||+|||+++.+......
T Consensus 135 ~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 135 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 12356788899999999999999999999 99999999999996 578999999999876543333
Q ss_pred ccceeeecccccCChhhhcc-----------CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 646 TNTNRVVGTYGYMSPEYAMS-----------GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~--------- 276 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISK--------- 276 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHH---------
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHH---------
Confidence 33345679999999999875 4689999999999999999999999853221 1111
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+..++++......+......+.+++.+||+.||++||++.||++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 112222222223333335678899999999999999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=315.51 Aligned_cols=239 Identities=24% Similarity=0.335 Sum_probs=176.9
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEecc----cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------- 577 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------- 577 (1018)
+....++|.+.+.||+|+||.||+|+... ++.||||+++... ....+.+.+|+.++++++||||++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 33456789999999999999999998643 4579999987542 3345679999999999999998731
Q ss_pred ------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC
Q 046791 578 ------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN 627 (1018)
Q Consensus 578 ------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 627 (1018)
.....+++..++.++.||++||.|||+++ |+||||||+|||++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 12245889999999999999999999999 999999999999999999
Q ss_pred ceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHH
Q 046791 628 PKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYA 706 (1018)
Q Consensus 628 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~ 706 (1018)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~-- 260 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYD-- 260 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH--
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH--
Confidence 99999999987654332233334567889999999999999999999999999999999 88887543211 1111
Q ss_pred HHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCC
Q 046791 707 WQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLP 768 (1018)
Q Consensus 707 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp 768 (1018)
....+ .....+......+.+++.+||+.||++||++.+|++.|+.....+|
T Consensus 261 --~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 --YLLHG---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp --HHHTT---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --HHHcC---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 01111 1112233445678899999999999999999999999998655443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=319.26 Aligned_cols=245 Identities=18% Similarity=0.187 Sum_probs=183.7
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc------cccceEEEeccccccc-----------HHHHHHHHHHHHHhcCCCccc
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRSGQG-----------IVEFKNEAKLIAKLQHTNLTD 576 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~------g~~vAvK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~nlv~ 576 (1018)
..++|++.++||+|+||.||+|++.. ++.||||++....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 4789999986543211 112344555667778999873
Q ss_pred c------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc--C
Q 046791 577 S------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD--D 624 (1018)
Q Consensus 577 ~------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld--~ 624 (1018)
+ .....+++.+++.|+.||+.||.|||+++ |+||||||+|||++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 2 12367999999999999999999999999 99999999999999 8
Q ss_pred CCCceeeeecceeeecCCCCcc-----cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCC
Q 046791 625 QMNPKISDFGMARIFGLNQSET-----NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP 699 (1018)
Q Consensus 625 ~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~ 699 (1018)
++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~- 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP- 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH-
Confidence 8999999999998764322111 1133569999999999999999999999999999999999999997533221
Q ss_pred CchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCC
Q 046791 700 LNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSL 767 (1018)
Q Consensus 700 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~l 767 (1018)
......... ....+.+++++.+.. ...+..+.+++..||+.+|++||++.+|+++|++....+
T Consensus 269 -~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 269 -KYVRDSKIR-YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp -HHHHHHHHH-HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HHHHHHHHH-hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 111111111 122344555555432 223456788899999999999999999999998755433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=332.51 Aligned_cols=230 Identities=25% Similarity=0.375 Sum_probs=186.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
..+|.+.++||+|+||.||+|+... ++.||||+++... ...++|.+|+.++++++||||+++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4578999999999999999999865 8899999997643 456889999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence 12345889999999999999999999999 9999999999999999999999999998764322 1
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... . +.+.+....+
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~-------------~~~~~~~~~~ 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q-------------VYELLEKDYR 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G-------------HHHHHHTTCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---H-------------HHHHHHcCCC
Confidence 12223456778999999999999999999999999999999 99998643211 1 1112222222
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
...+......+.+|+.+||+.||++|||+.+|+++|+....
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 23344556788899999999999999999999999997643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=305.55 Aligned_cols=238 Identities=19% Similarity=0.224 Sum_probs=186.7
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc----------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD---------------- 576 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~---------------- 576 (1018)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ..++.+|+.++.+++|++++.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 457899999999999999999986 5689999999865433 346899999999999988651
Q ss_pred ----------c-cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE---cCCCCceeeeecceeeecCC
Q 046791 577 ----------S-RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 577 ----------~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kL~DFGla~~~~~~ 642 (1018)
+ .....+++.++..++.||++||+|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 0 12456899999999999999999999999 9999999999999 58889999999999877543
Q ss_pred CCcc-----cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 643 QSET-----NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 643 ~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence 3211 123567999999999999999999999999999999999999999765544333332222111100000
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
+.+ .....+.+.+++.+||+.||++||++.+|++.|++...
T Consensus 240 ---~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 240 ---EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ---HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---HHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 001 11234668899999999999999999999999987544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=308.32 Aligned_cols=235 Identities=24% Similarity=0.340 Sum_probs=174.8
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.+.||+|+||.||+|+..+++.||||++.... ......+.+|+.++++++||||++.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998779999999986543 2334678999999999999999831
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 156 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RK 156 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--cc
Confidence 12356899999999999999999999999 9999999999999999999999999998654221 12
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc------hh--h
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV------LE--L 718 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~--~ 718 (1018)
.....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ............... .+ .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhcccc
Confidence 234578999999999976 46899999999999999999999998643211 111111111111000 00 0
Q ss_pred hhhhhc-------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 719 VDIALE-------GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 719 ~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.++... ........+.+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0011224567789999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=313.72 Aligned_cols=233 Identities=24% Similarity=0.363 Sum_probs=185.8
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe------cccccceEEEeccccc-ccHHHHHHHHHHHHHh-cCCCccccc-------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL------LNGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKL-QHTNLTDSR------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nlv~~~------- 578 (1018)
..++|++.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.++.++ +||||++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999985 2467899999976543 3457799999999999 999997310
Q ss_pred -------------------C------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEE
Q 046791 579 -------------------R------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNIL 621 (1018)
Q Consensus 579 -------------------~------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NIL 621 (1018)
. ...+++..++.++.||++||.|||+++ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 0 114899999999999999999999999 999999999999
Q ss_pred EcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCC
Q 046791 622 LDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPL 700 (1018)
Q Consensus 622 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~ 700 (1018)
++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 255 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--
Confidence 99999999999999987654443333444567889999999999999999999999999999999 999986433211
Q ss_pred chHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 701 NLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 701 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
... ..+........+......+.+++.+||+.||.+|||+.||+++|++..
T Consensus 256 ----~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 256 ----KFY---------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ----HHH---------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHH---------HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111 111111222223345577889999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=327.54 Aligned_cols=223 Identities=24% Similarity=0.355 Sum_probs=180.2
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
..++|++.+.||+|+||.||+|+.. ++.||||+++... ..++|.+|+.++++++||||+++
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467999999999999999999874 7799999997653 55789999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 01123688899999999999999999999 999999999999999999999999999864321
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ..... ..
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~---------~~ 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEK---------GY 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH----HHHHT---------TC
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHc---------CC
Confidence 122356889999999999999999999999999999998 999986543221 11 11111 11
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
+...+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2233445567888999999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=310.37 Aligned_cols=221 Identities=21% Similarity=0.276 Sum_probs=177.8
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
..++|.+.+.||+|+||.||+++.. +++.||+|.+... ......+.+|+.++++++||||+++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3578999999999999999999875 4889999998654 3445678999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC--CCCceeeeecceeeecCCC
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD--QMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~--~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 11246899999999999999999999999 999999999999987 789999999999876432
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .+..
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~-~~~~-------- 220 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIM-NAEY-------- 220 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-HTCC--------
T ss_pred --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHH-cCCC--------
Confidence 223456799999999999998899999999999999999999999853221 11111111 1110
Q ss_pred cCCCCh----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 724 EGSFSP----NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.++. .....+.+++.+||+.||++|||+.|+++
T Consensus 221 --~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 221 --TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 23467889999999999999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=317.47 Aligned_cols=218 Identities=22% Similarity=0.305 Sum_probs=167.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHh-cCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKL-QHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l-~H~nlv~~-------------- 577 (1018)
++|++.++||+|+||+||+|+.. +++.||||++.... .....++..|+..+.++ +|+||+++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999976 68999999986542 23334556666666665 99999842
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--- 210 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--- 210 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC---
Confidence 11346999999999999999999999999 999999999999999999999999999876432
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......||+.|+|||++.+ .++.++||||||+++|||++|..|+... ..+.....+.... .
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~~----~--- 272 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLPP----E--- 272 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCCH----H---
T ss_pred CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCCc----c---
Confidence 22234568999999998876 7899999999999999999997765311 0111111111111 0
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+....+.+.+++.+||+.||++|||+.|+++
T Consensus 273 -~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 -FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11123467889999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-33 Score=314.95 Aligned_cols=222 Identities=22% Similarity=0.281 Sum_probs=178.0
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc------ccHHHHHHHHHHHHHhcCCCccc----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG------QGIVEFKNEAKLIAKLQHTNLTD---------- 576 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~nlv~---------- 576 (1018)
..++|++.+.||+|+||.||+++.. +|+.||||+++.... ...+.+.+|+.++.+++||||+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4568999999999999999999875 488999999976532 23578999999999999999983
Q ss_pred ----------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC----Cceeeeecce
Q 046791 577 ----------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDFGMA 636 (1018)
Q Consensus 577 ----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~----~~kL~DFGla 636 (1018)
+.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 123456899999999999999999999999 99999999999998776 7999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... .... .....+.
T Consensus 167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~-~~i~~~~-- 234 (361)
T 2yab_A 167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETL-ANITAVS-- 234 (361)
T ss_dssp EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHH-HHHHTTC--
T ss_pred eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHH-HHHHhcC--
Confidence 8765322 22346799999999999999999999999999999999999999853211 1111 1111110
Q ss_pred hhhhhhhcCCCCh----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 ELVDIALEGSFSP----NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 ~~~d~~l~~~~~~----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..++. .....+.+++.+||+.||++|||+.|+++
T Consensus 235 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 --------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111 22456789999999999999999999886
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=308.87 Aligned_cols=228 Identities=27% Similarity=0.371 Sum_probs=179.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.++|++.+.||+|+||.||+++..++..||||++.... ...+++.+|++++.+++|+||++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46899999999999999999999888899999997653 345789999999999999999731
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.++..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 177 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence 11356899999999999999999999999 9999999999999999999999999998653221 111
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... . +.......
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~-~---------~~~~~~~~ 241 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAE-H---------IAQGLRLY 241 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHH-H---------HHTTCCCC
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHH-H---------HhcccCCC
Confidence 223456778999999999999999999999999999998 99998543211 1111 1 11111222
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.+....+.+.+++.+||+.||++|||+.|+++.|+..
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 2333456788999999999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=312.24 Aligned_cols=237 Identities=24% Similarity=0.293 Sum_probs=182.8
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||++.
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999987 4689999999977666667889999999999999998731
Q ss_pred -------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 -------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 01356899999999999999999999999 99999999999999999999999999876
Q ss_pred ecCCCCcc-------cceeeecccccCChhhhccCC---CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHH
Q 046791 639 FGLNQSET-------NTNRVVGTYGYMSPEYAMSGV---VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQ 708 (1018)
Q Consensus 639 ~~~~~~~~-------~~~~~~gt~~Y~aPE~~~~~~---~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 708 (1018)
........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------- 253 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---------- 253 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT----------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc----------
Confidence 43211100 112345689999999987544 6899999999999999999999984211110
Q ss_pred HhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCC
Q 046791 709 LWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSL 767 (1018)
Q Consensus 709 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~l 767 (1018)
......+...............+.+++.+||+.||.+||++.||++.|+......
T Consensus 254 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 254 ----DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp ----SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred ----chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 0111111111111222344567889999999999999999999999999875533
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=307.53 Aligned_cols=235 Identities=25% Similarity=0.379 Sum_probs=179.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.|.+|+.++.+++||||+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999865 58899999985432 3345678999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS- 165 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc-
Confidence 12346899999999999999999999999 9999999999999999999999999998654221
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ...... .
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~-~~~~~~-~--- 234 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQD-SVPNVT-T--- 234 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSS-CCCCHH-H---
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhc-cCCCcc-h---
Confidence 1223346799999999999999999999999999999999999999854321 1111111111 111110 0
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCcC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRP-AMPDVVSMLANESL 765 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~Le~~~~ 765 (1018)
......++.+.+++.+||+.||++|| +++++.+.|+....
T Consensus 235 -~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 235 -DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 11223456788999999999999998 99999999987644
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-33 Score=313.83 Aligned_cols=242 Identities=17% Similarity=0.175 Sum_probs=176.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEec----ccccceEEEecccccc-----------cHHHHHHHHHHHHHhcCCCcccc--
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRRSGQ-----------GIVEFKNEAKLIAKLQHTNLTDS-- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~nlv~~-- 577 (1018)
.++|.+.+.||+|+||.||+|+.. ++..||||++...... ....+.+|+.++..++|+||+..
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999875 5778999998754321 12346778889999999999731
Q ss_pred ---------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC--Cc
Q 046791 578 ---------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM--NP 628 (1018)
Q Consensus 578 ---------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~--~~ 628 (1018)
.....+++.+++.++.||++||.|||+++ |+||||||+|||++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcE
Confidence 12337899999999999999999999999 99999999999999877 99
Q ss_pred eeeeecceeeecCCCCc-----ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchH
Q 046791 629 KISDFGMARIFGLNQSE-----TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~ 703 (1018)
||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~ 270 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP--VAV 270 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH--HHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc--HHH
Confidence 99999999876432211 11234578999999999999999999999999999999999999985322211 111
Q ss_pred HHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 704 GYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 704 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
......... .....+..... .......+.+++.+||+.||++||++.+|++.|++...
T Consensus 271 ~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 271 QTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111111 11111111110 11344578899999999999999999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=314.52 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=188.3
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR 578 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~ 578 (1018)
+..++.+...++|.+.+.||+|+||.||+|+.. +++.||||.+.... .....++.+|+.++++++|+||++..
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455567789999999999999999999764 36789999997553 33455799999999999999987310
Q ss_pred ----------------C--------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE
Q 046791 579 ----------------R--------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL 622 (1018)
Q Consensus 579 ----------------~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl 622 (1018)
. ...+++..++.++.||++||.|||+++ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 0 134688899999999999999999999 9999999999999
Q ss_pred cCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCc
Q 046791 623 DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLN 701 (1018)
Q Consensus 623 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~ 701 (1018)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----- 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----
Confidence 9999999999999986543332223334567889999999999999999999999999999999 8888753221
Q ss_pred hHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 702 LIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 702 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.. .......+.. ...+......+.+++.+||+.||++|||+.|+++.|++...
T Consensus 247 -~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 -EQ-VLRFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -HH-HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HH-HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 1111111111 12233445678899999999999999999999999998654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=312.56 Aligned_cols=241 Identities=26% Similarity=0.362 Sum_probs=189.3
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEe------cccccceEEEeccccc-ccHHHHHHHHHHHHHh-cCCCcccc
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQL------LNGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKL-QHTNLTDS 577 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nlv~~ 577 (1018)
+...+.....++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||+..
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44555566678999999999999999999974 2467899999976533 3456799999999999 78998731
Q ss_pred c---------------------------C----------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecc
Q 046791 578 R---------------------------R----------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRD 614 (1018)
Q Consensus 578 ~---------------------------~----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~D 614 (1018)
. . ...+++..+..++.||++||.|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 0 0 112788899999999999999999999 99999
Q ss_pred cCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCC
Q 046791 615 LKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGC 693 (1018)
Q Consensus 615 lkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~ 693 (1018)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654433333445678899999999999999999999999999999998 9999864
Q ss_pred CCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 694 YRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 694 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
..... ........+ .....+....+.+.+++.+||+.||.+|||+.||++.|+...
T Consensus 254 ~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKIDE------EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCSH------HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhH------HHHHHhccC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 33211 111111111 111223334567889999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=305.77 Aligned_cols=229 Identities=23% Similarity=0.326 Sum_probs=171.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.++|++.+.||+|+||.||+|+... +..||||++.... ....+.+.+|+.++++++||||++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 4689999999999999999998643 4569999987643 3345679999999999999999731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccc
Confidence 11336899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
. .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .... ....+
T Consensus 171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~----~i~~~--------- 233 (281)
T 1mp8_A 171 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG----RIENG--------- 233 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH----HHHTT---------
T ss_pred c-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHH----HHHcC---------
Confidence 1 12233456789999999999999999999999999999997 99998643221 1111 11111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.....+......+.+++.+||+.||++||++.|+++.|+..
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11123344567788999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=325.24 Aligned_cols=236 Identities=22% Similarity=0.221 Sum_probs=174.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccccC-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDSRR----------- 579 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~~~----------- 579 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++||||+++..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999865 4889999999754 3344567899999999999999984211
Q ss_pred ------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 580 ------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 580 ------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 234788899999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC------cc
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG------KV 715 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~ 715 (1018)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............. ..
T Consensus 217 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~---~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 S---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHHHHTTS
T ss_pred C---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHHHHc
Confidence 2 2234468999999999999999999999999999999999999999643211 1111111110000 00
Q ss_pred ----hhhhh---------------hhhcCCC---ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 ----LELVD---------------IALEGSF---SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 ----~~~~d---------------~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...++ ..+.... .......+.+|+.+||+.||++|||++|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0000000 0112567889999999999999999999988
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=320.84 Aligned_cols=240 Identities=23% Similarity=0.360 Sum_probs=187.9
Q ss_pred CCcceeeeeccCCCcCeEEEEe-----cccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-----LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++|+||+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5799999999999999999984 3578999999987766667789999999999999998731
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 01235889999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhh---c---Cc
Q 046791 642 NQSE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWN---E---GK 714 (1018)
Q Consensus 642 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~---~~ 714 (1018)
.... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||...... ....... . ..
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE-------FLRMMGCERDVPALSR 252 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-------HHHHCC----CCHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch-------hhhhcccccccccHHH
Confidence 3321 1223356788899999999999999999999999999999999997532110 0000000 0 01
Q ss_pred chhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 715 VLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
..+.+........+....+.+.+++.+||+.||++|||+.||++.|+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 112222222334455566788999999999999999999999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=321.93 Aligned_cols=241 Identities=22% Similarity=0.286 Sum_probs=170.0
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhc-CCCcccc-----------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQ-HTNLTDS----------- 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~-H~nlv~~----------- 577 (1018)
...++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++.++. |+||+++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45689999999999999999999865 5889999998654 2344567889999999997 9999842
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 11346888899999999999999999999 999999999999999999999999999875321
Q ss_pred C-------------------CcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCch
Q 046791 643 Q-------------------SETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 643 ~-------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l 702 (1018)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|++||....... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~ 239 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN---Q 239 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 1 1112234579999999999986 678999999999999999999999986432111 1
Q ss_pred HHHHHHHhhcCcc-----------hhhhhh----------------------hhcCCCChHHHHHHHHHHHhccccCCCC
Q 046791 703 IGYAWQLWNEGKV-----------LELVDI----------------------ALEGSFSPNEVLRCIHVGLLCVQDQATD 749 (1018)
Q Consensus 703 ~~~~~~~~~~~~~-----------~~~~d~----------------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~ 749 (1018)
............. ...++. ...........+.+.+|+.+||+.||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 1111111100000 000000 0000001123457889999999999999
Q ss_pred CCCHHHHHHH
Q 046791 750 RPAMPDVVSM 759 (1018)
Q Consensus 750 RPs~~evl~~ 759 (1018)
|||++|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=314.38 Aligned_cols=221 Identities=25% Similarity=0.364 Sum_probs=170.7
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccccC------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSRR------------ 579 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~~------------ 579 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999976 68999999997543 335577999999999999999985321
Q ss_pred --------------------------------------------------------------------------CCCCCh
Q 046791 580 --------------------------------------------------------------------------NNRLNW 585 (1018)
Q Consensus 580 --------------------------------------------------------------------------~~~l~~ 585 (1018)
....++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 011234
Q ss_pred hhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc----------ccceeeeccc
Q 046791 586 ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE----------TNTNRVVGTY 655 (1018)
Q Consensus 586 ~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~ 655 (1018)
..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 457899999999999999999 999999999999999999999999999987543211 1223357999
Q ss_pred ccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC---hHHH
Q 046791 656 GYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS---PNEV 732 (1018)
Q Consensus 656 ~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~---~~~~ 732 (1018)
.|+|||++.+..++.++||||||+++|||++|..|+. .. .. ..........+ ....
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~-~~------------~~~~~~~~~~~~~~~~~~ 299 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ER-VR------------IITDVRNLKFPLLFTQKY 299 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HH-HH------------HHHHHHTTCCCHHHHHHC
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HH-HH------------HHHHhhccCCCcccccCC
Confidence 9999999999999999999999999999999876531 00 00 01111111112 2334
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 733 LRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 733 ~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+.+.+++.+||+.||++|||+.|+++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 56788999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=316.33 Aligned_cols=232 Identities=22% Similarity=0.256 Sum_probs=168.2
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhc-CCCcccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNLTDS-------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nlv~~-------------- 577 (1018)
...+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4468999999999999999999865 58899999997766666778999999999996 9999742
Q ss_pred ----------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecc
Q 046791 578 ----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGM 635 (1018)
Q Consensus 578 ----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGl 635 (1018)
.....+++.+++.++.||+.||.|||+++ ++|+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 12346899999999999999999999876 3599999999999999999999999999
Q ss_pred eeeecCCCCcc----------cceeeecccccCChhhh---ccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCch
Q 046791 636 ARIFGLNQSET----------NTNRVVGTYGYMSPEYA---MSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 636 a~~~~~~~~~~----------~~~~~~gt~~Y~aPE~~---~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l 702 (1018)
++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765322211 11235689999999998 56778999999999999999999999985322110
Q ss_pred HHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 703 IGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.+...............+.+++.+||+.||++||++.|+++.|+....
T Consensus 261 ---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ---------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111111122223446789999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=307.76 Aligned_cols=229 Identities=26% Similarity=0.384 Sum_probs=185.7
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
..++|++.+.||+|+||.||+|+... ++.||||++... ....+++.+|+.++++++|+||++.
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45789999999999999999999765 788999999754 3456789999999999999998731
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 12345899999999999999999999999 99999999999999999999999999986643222
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
.......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . ..+.+....
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~-------------~~~~~~~~~ 229 (288)
T 3kfa_A 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q-------------VYELLEKDY 229 (288)
T ss_dssp -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G-------------HHHHHHTTC
T ss_pred -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H-------------HHHHHhccC
Confidence 22234567889999999999999999999999999999999 99988543211 1 111122222
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
....+....+.+.+++.+||+.||.+||++.||+++|+..
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 2233444567788999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=309.39 Aligned_cols=225 Identities=22% Similarity=0.315 Sum_probs=177.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc------ccHHHHHHHHHHHHHhcCCCccc-----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG------QGIVEFKNEAKLIAKLQHTNLTD----------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~nlv~----------- 576 (1018)
.++|.+.+.||+|+||.||+++.. +++.||||++..... ...+++.+|+.++++++||||+.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457999999999999999999875 488999999865432 24678999999999999999983
Q ss_pred ---------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC----Cceeeeeccee
Q 046791 577 ---------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDFGMAR 637 (1018)
Q Consensus 577 ---------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~----~~kL~DFGla~ 637 (1018)
+.....+++..+..++.||++||.|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 123456899999999999999999999999 99999999999999887 79999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...... ...... .
T Consensus 167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~-~~~~~~-~ 235 (326)
T 2y0a_A 167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLAN-VSAVNY-E 235 (326)
T ss_dssp ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHH-HHHTCC-C
T ss_pred ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------HHHHHH-HHhcCC-C
Confidence 765322 22345799999999999999999999999999999999999999853221 111111 100000 0
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+. ........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 FEDE-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCHH-----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCcc-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 00122456788999999999999999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=311.57 Aligned_cols=236 Identities=25% Similarity=0.334 Sum_probs=173.8
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc-----cccHHHHHHHHHHHHHhc---CCCcccc-------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS-----GQGIVEFKNEAKLIAKLQ---HTNLTDS------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~---H~nlv~~------- 577 (1018)
.+++|++.++||+|+||+||+|+. .+++.||||++.... ......+.+|+.++++++ ||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999996 458899999986432 122356778888887775 9999731
Q ss_pred -------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeee
Q 046791 578 -------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD 632 (1018)
Q Consensus 578 -------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~D 632 (1018)
.....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence 01123899999999999999999999999 99999999999999999999999
Q ss_pred ecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 633 FGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 633 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 164 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~ 237 (308)
T 3g33_A 164 FGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGL 237 (308)
T ss_dssp CSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred CccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCC
Confidence 9999865422 2223467899999999999999999999999999999999999998643211 111111111100
Q ss_pred Ccchh------hhhhhhcC--C-----CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 713 GKVLE------LVDIALEG--S-----FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 713 ~~~~~------~~d~~l~~--~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... ........ . ..++..+.+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000 00000000 0 01233467889999999999999999999886
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=319.53 Aligned_cols=246 Identities=25% Similarity=0.331 Sum_probs=185.7
Q ss_pred CCc-ceeeeeccCCCcCeEEEEec-----ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 516 NNF-SAVNKLGEGGFGPVYKGQLL-----NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 516 ~~y-~~~~~lG~G~fG~Vy~~~~~-----~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
++| ++.++||+|+||.||+++.. +++.||||+++... ....+.+.+|++++++++||||+..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 345 89999999999999998642 57889999997653 3445679999999999999999831
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 12345889999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 642 NQSE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 642 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... .................+.++
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHHh
Confidence 3221 12234567888999999999999999999999999999999999975321000 000000000000111222333
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.......+......+.+++.+||+.||++|||+.|+++.|+....
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 333334455566789999999999999999999999999987544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=313.70 Aligned_cols=225 Identities=20% Similarity=0.251 Sum_probs=175.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-----cccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-----GQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457999999999999999999865 58999999986432 2246789999999999999999831
Q ss_pred -------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC---ceeeeecc
Q 046791 578 -------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDFGM 635 (1018)
Q Consensus 578 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kL~DFGl 635 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 01224788999999999999999999999 999999999999986654 99999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcc
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV 715 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 715 (1018)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........+..
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKY 249 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCC
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCC
Confidence 98765322 22334679999999999999999999999999999999999999985321 011111111110
Q ss_pred hhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 LELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.. .+... ......+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~--~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KM--NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000 122467889999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=315.81 Aligned_cols=223 Identities=23% Similarity=0.346 Sum_probs=178.7
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+++... ++.||||++... .....+.+.+|+.++++++||||+.+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 579999999999999999998754 888999998654 23456789999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--- 168 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC---
Confidence 23457899999999999999999999999 999999999999999999999999999876432
Q ss_pred ccceeeecccccCChhhhcc---CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 646 TNTNRVVGTYGYMSPEYAMS---GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .. ......
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~---~~-~~~~~~---------- 234 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK---EI-VHTFET---------- 234 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH---HH-HHHHHH----------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH---HH-HHHHhh----------
Confidence 22345689999999999874 45899999999999999999999998643322211 11 111100
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPA-MPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~ 758 (1018)
....++......+.+|+.+||+.||.+||+ +++|++
T Consensus 235 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111234445677889999999999999998 777765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-33 Score=307.31 Aligned_cols=231 Identities=24% Similarity=0.355 Sum_probs=184.1
Q ss_pred CCcceee-eeccCCCcCeEEEEec---ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 516 NNFSAVN-KLGEGGFGPVYKGQLL---NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~-~lG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
++|.+.+ .||+|+||.||+|+.. +++.||||+++... ....+++.+|++++++++||||++.
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 5677776 9999999999999854 47789999997653 3456779999999999999998731
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 12356899999999999999999999999 99999999999999999999999999987753322
Q ss_pred c-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 645 E-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 645 ~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......+
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~----~~~i~~~--------- 229 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV----MAFIEQG--------- 229 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HH----HHHHHTT---------
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHhcC---------
Confidence 1 12223456889999999998899999999999999999998 99998543211 11 1111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.....+....+.+.+++.+||+.||++||++.|+++.|+....
T Consensus 230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1123344556788899999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-33 Score=335.30 Aligned_cols=234 Identities=26% Similarity=0.401 Sum_probs=186.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
..++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|++++++++|+||+++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence 456789999999999999999999888889999997653 346789999999999999999831
Q ss_pred ---------c--CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 ---------R--RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 ---------~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
. ....+++.+++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...... ..
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HH
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-ee
Confidence 0 1245889999999999999999999999 9999999999999999999999999998653211 11
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......++..|+|||.+.+..++.++||||||++||||++ |+.||..... .. ....... ..+.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~-~~~~i~~---------~~~~ 483 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------RE-VLDQVER---------GYRM 483 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HH-HHHHHHT---------TCCC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHc---------CCCC
Confidence 1223346788999999999999999999999999999999 8999853221 11 1111111 1122
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCC
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLP 768 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp 768 (1018)
..+......+.+|+.+||+.||++|||+++|+++|+.......
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 2334456778899999999999999999999999998765443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-33 Score=316.33 Aligned_cols=221 Identities=22% Similarity=0.305 Sum_probs=178.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++.++||||+++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999996 458899999986542 2334678999999999999999841
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--- 161 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--- 161 (336)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---
T ss_pred EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC---
Confidence 12456899999999999999999999999 999999999999999999999999999865432
Q ss_pred ccceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ..+.. ..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~-~~ 224 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNS-CV 224 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCS-SC
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHc-CC
Confidence 22334579999999999988775 78999999999999999999998643322110 00000 01
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+......+.+++.+||+.||.+|||++|+++
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1223344567889999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-33 Score=317.72 Aligned_cols=222 Identities=23% Similarity=0.308 Sum_probs=173.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHh-cCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKL-QHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nlv~~------------ 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++++. .....+.+.+|..++..+ +||||+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999875 4889999999754 234556788999999998 79999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~- 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN- 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC-
Confidence 12356899999999999999999999999 999999999999999999999999999853321
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+
T Consensus 178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~-~~---------- 239 (353)
T 3txo_A 178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAIL-ND---------- 239 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HC----------
T ss_pred -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHH-cC----------
Confidence 2233456899999999999999999999999999999999999999853221 11111111 11
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAM------PDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~ 758 (1018)
...++......+.+++.+||+.||++||++ .||++
T Consensus 240 ~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 112334455678899999999999999998 77765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=317.61 Aligned_cols=224 Identities=22% Similarity=0.310 Sum_probs=174.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~~------------ 577 (1018)
.++|++.++||+|+||.||+++... ++.||||++++.. ......+.+|..++.++ +||||+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 3579999999999999999999764 7899999997653 23345688999999887 89999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence 12357899999999999999999999999 999999999999999999999999999853221
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCC--CchHHHHHHHhhcCcchhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP--LNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........+.....
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------- 277 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------- 277 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--------
T ss_pred -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--------
Confidence 2233457899999999999999999999999999999999999999964332211 11111111111111
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAM 753 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 753 (1018)
...++......+.+|+.+||+.||++||++
T Consensus 278 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 --QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 112344556778899999999999999995
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.98 E-value=9.8e-33 Score=315.47 Aligned_cols=226 Identities=21% Similarity=0.269 Sum_probs=177.2
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
..++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999875 48899999996543 3345678999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC---CCceeeeecceeeecC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~---~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 23456899999999999999999999999 9999999999999865 4599999999987643
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ........+....
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~-~~~~~i~~~~~~~---- 249 (362)
T 2bdw_A 184 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------H-RLYAQIKAGAYDY---- 249 (362)
T ss_dssp CC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------H-HHHHHHHHTCCCC----
T ss_pred Cc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------H-HHHHHHHhCCCCC----
Confidence 22 22346799999999999999999999999999999999999999853211 1 1111111111100
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...........+.+++.+||+.||++||++.|+++
T Consensus 250 --~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 --PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp --CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00001223567889999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.7e-33 Score=310.98 Aligned_cols=236 Identities=23% Similarity=0.312 Sum_probs=163.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR-------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~-------------- 578 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999865 48899999996543 33456789999999999999998310
Q ss_pred -----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 579 -----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 579 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 1135888999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc---chh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK---VLE 717 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~ 717 (1018)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .............. ...
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 161 PVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp CCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGG
T ss_pred Ccc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhh
Confidence 221 2234578999999999986 46899999999999999999999998643221 11111111110000 000
Q ss_pred h-----------------hhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 L-----------------VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~-----------------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. +...+...........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000000111123457889999999999999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=303.47 Aligned_cols=230 Identities=25% Similarity=0.332 Sum_probs=179.0
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
..++|.+.+.||+|+||.||+|+..+ +..||||.+.... ....+.|.+|+.++++++||||++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 34689999999999999999998643 3359999997653 3456779999999999999999831
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 11245889999999999999999999999 999999999999999999999999999865432
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.. .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+..
T Consensus 167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~-------------~~~~ 229 (281)
T 3cc6_A 167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIG-------------VLEK 229 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHH-------------HHHH
T ss_pred cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHH-------------HHhc
Confidence 21 12233456789999999999999999999999999999998 99998533221 1111 1111
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
......+....+.+.+++.+||+.||++||++.|+++.|+..
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 111122333456788999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=322.95 Aligned_cols=228 Identities=21% Similarity=0.250 Sum_probs=177.1
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
...++|++.+.||+|+||.||+++.. +|+.+|+|++.... ....+.+.+|+.++++++||||+++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34678999999999999999999864 58899999986543 3345678999999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc---CCCCceeeeecceeeec
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 12456899999999999999999999999 99999999999998 56789999999998764
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... .......||+.|+|||++.+..++.++|||||||++|||++|..||..... . ........+...
T Consensus 165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~-~~~~~i~~~~~~---- 231 (444)
T 3soa_A 165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------H-RLYQQIKAGAYD---- 231 (444)
T ss_dssp TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------H-HHHHHHHHTCCC----
T ss_pred CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------H-HHHHHHHhCCCC----
Confidence 322 222346799999999999999999999999999999999999999853211 1 111111111110
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..........+.+.+++.+||+.||++|||+.|+++
T Consensus 232 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 --FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000011233567889999999999999999999988
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=311.52 Aligned_cols=232 Identities=25% Similarity=0.370 Sum_probs=182.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEec--------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccc-------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL--------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDS------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~------- 577 (1018)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.+++++ +||||++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999863 46789999997653 34456799999999999 99999731
Q ss_pred -------------------cC----------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE
Q 046791 578 -------------------RR----------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL 622 (1018)
Q Consensus 578 -------------------~~----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl 622 (1018)
.. ...+++..++.++.||++||.|||+++ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 00 124888999999999999999999999 9999999999999
Q ss_pred cCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCc
Q 046791 623 DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLN 701 (1018)
Q Consensus 623 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~ 701 (1018)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 9999999999999987754433333334567889999999999999999999999999999999 9999853221
Q ss_pred hHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 702 LIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 702 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.. .......+ .....+......+.+++.+||+.||.+||++.||++.|+....
T Consensus 266 -~~-~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 -EE-LFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp -HH-HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HH-HHHHHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11 11111111 1122333455678899999999999999999999999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-33 Score=319.95 Aligned_cols=184 Identities=28% Similarity=0.371 Sum_probs=156.0
Q ss_pred CccceeHHHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhc-----CCCcc
Q 046791 502 GLEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-----HTNLT 575 (1018)
Q Consensus 502 ~~~~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----H~nlv 575 (1018)
+...|++.+.....++|++.++||+|+||.||+|+.. +++.||||+++.. ......+..|+.++++++ |+||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3455667777778899999999999999999999874 5889999999643 344567888999999997 99987
Q ss_pred cc---------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC----
Q 046791 576 DS---------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---- 624 (1018)
Q Consensus 576 ~~---------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---- 624 (1018)
+. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp CEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 31 11235889999999999999999999999 999999999999975
Q ss_pred ---------------------CCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHH
Q 046791 625 ---------------------QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLE 683 (1018)
Q Consensus 625 ---------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~e 683 (1018)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 788999999999864321 234578999999999999999999999999999999
Q ss_pred HHhCCCCCCCC
Q 046791 684 IVSGKKNNGCY 694 (1018)
Q Consensus 684 lltG~~p~~~~ 694 (1018)
|++|+.||...
T Consensus 252 ll~g~~pf~~~ 262 (360)
T 3llt_A 252 LYTGSLLFRTH 262 (360)
T ss_dssp HHHSSCSCCCS
T ss_pred HHHCCCCCCCC
Confidence 99999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-32 Score=319.30 Aligned_cols=226 Identities=23% Similarity=0.356 Sum_probs=181.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTD-------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~-------------- 576 (1018)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999875 58999999996542 234567999999999999999983
Q ss_pred ------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 577 ------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 577 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
+.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 223567899999999999999999999999 9999999999999999999999999998764322
Q ss_pred cccceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ... ......+.
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~-~~~i~~~~--------- 232 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTL-FKKICDGI--------- 232 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHH-HHHHHTTC---------
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHH-HHHHhcCC---------
Confidence 2234579999999999988765 7899999999999999999999863221 111 11111111
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS--MLANE 763 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~Le~~ 763 (1018)
...+......+.+++.+||+.||++|||+.||++ .+.+.
T Consensus 233 -~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 -FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0122234467889999999999999999999997 55543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=310.22 Aligned_cols=234 Identities=26% Similarity=0.375 Sum_probs=184.3
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEecc-c-----ccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCccccc-----
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLLN-G-----QEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDSR----- 578 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g-----~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~~----- 578 (1018)
+...++|++.+.||+|+||.||+|+... + ..||||.+.... ....+.+.+|+.++.++ +||||++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345789999999999999999998643 2 369999997653 23456799999999999 899998310
Q ss_pred -----------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 579 -----------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 579 -----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
....+++..++.++.||++||.|||+++ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 1235788999999999999999999999 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCch
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l 702 (1018)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 274 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---- 274 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH----
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH----
Confidence 999999999999987654433333444667889999999999999999999999999999998 888986432211
Q ss_pred HHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 703 IGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
... ..+........+......+.+++.+||+.||.+|||+.||++.|+..
T Consensus 275 --~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 --KFY---------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp --HHH---------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHH---------HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111 11111112222333456788999999999999999999999999864
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=294.80 Aligned_cols=207 Identities=18% Similarity=0.225 Sum_probs=157.1
Q ss_pred cccCccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCC
Q 046791 24 YSQTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKS 103 (1018)
Q Consensus 24 ~~~~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~ 103 (1018)
+++.|+|.+||+|++|++| ++|.|+|||+.+++ +.+|+ .+|+||+|||+.| .+
T Consensus 5 ~~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~ly~-----------------~~~~vW~an~~~~---~~ 57 (236)
T 1dlp_A 5 FGLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD-----------------SDVRVWASNTAGA---TG 57 (236)
T ss_dssp BCSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE-----------------SSSEEECCCCCSC---SC
T ss_pred eeccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEEEE-----------------CCEEEEECCCCCC---CC
Confidence 4677999999999999999 59999999987654 33433 2578999999998 46
Q ss_pred CceEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcccc-cCCCeecc
Q 046791 104 GSLTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDIL-LPGMKLGL 180 (1018)
Q Consensus 104 ~~l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTl-LPg~klg~ 180 (1018)
+.|+++. ||||||+| +++.+||++++. ..+.+|+|+|+|||||++ .++||||||||||+ ||+| |.
T Consensus 58 ~~l~l~~-dGnLvl~d-~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~p~~t~~lp~~--g~ 125 (236)
T 1dlp_A 58 CRAVLQS-DGLLVILT-AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTSNKGSVVVANN--GN 125 (236)
T ss_dssp CBCCBCS-SSCBCCBC-TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECSCCCSSCCCCSSC--CC
T ss_pred eEEEEcC-CCcEEEEc-CCCcEEEeCCccccCCcEEEEEeCCCCEEEec--------CCEEECCCCCCcccccCCc--cc
Confidence 8899998 99999999 677899999876 335689999999999983 26999999999887 6666 55
Q ss_pred cc-cCCC-----ceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCCCC--CcccccCCCCcee-eeeecC
Q 046791 181 NL-QTGH-----EWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLFP--HWRAVDLDSDFHF-SYTSNE 251 (1018)
Q Consensus 181 ~~-~tg~-----~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~w~--~~~~~~~~~~~~~-~~~~n~ 251 (1018)
|. .+|+ +++|+| .+||++|.|+|+++++| +++++++..+||++++|. +...+.|+....+ .|..+.
T Consensus 126 d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~ 200 (236)
T 1dlp_A 126 SILYSTQGNDNHPQTLHA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQN 200 (236)
T ss_dssp EECCCC--CCCCCCEECS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTT
T ss_pred eEEecCCcCCCccceEEc---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCCCceEEEECCCCcEEEEeCCC
Confidence 55 5555 667884 78999999999999998 688888888999999994 2345566655553 333344
Q ss_pred ceeEEEEEecCCcc------ccceEEEee
Q 046791 252 KERYFNYSLNGNFT------SFPTLQIDS 274 (1018)
Q Consensus 252 ~e~~~~~~~~~~~~------~~g~l~~~~ 274 (1018)
++.+.+|....... .+|++++|.
T Consensus 201 ~~vw~s~~~~~~~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 201 IAVWTSGNSRSAGRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp EEEEECCCCCSSSCCEEEECSSSCEEEEC
T ss_pred cEEEEeCCCCCCCCEEEEEcCCCcEEEeC
Confidence 45555554332211 167777764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=306.52 Aligned_cols=236 Identities=24% Similarity=0.290 Sum_probs=172.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.++|++.+.||+|+||.||+|+... ++.||||++..... ...+.+.+|+.++++++|+||++.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3689999999999999999999764 88999999865432 234668899999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 22456899999999999999999999999 99999999999999999999999999987643222
Q ss_pred ccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh-----------hcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW-----------NEG 713 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-----------~~~ 713 (1018)
......||..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......... ...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD---QLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHHTC
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhcccccccccccccc
Confidence 2234578999999999976 678999999999999999999999986433211 111111111 000
Q ss_pred cchhhhh-hhhcCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 KVLELVD-IALEGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~~~~~~d-~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....... +...... .+.....+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 0000000 0123456889999999999999999999987
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=306.60 Aligned_cols=218 Identities=25% Similarity=0.314 Sum_probs=177.9
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+++.. +|+.||||++++.. ....+.+.+|+.+++.++||||+++
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57999999999999999999875 58999999997542 3456778999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 12456889999999999999999999999 99999999999999999999999999987542
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......... ... .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~---------~~~--~ 220 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKIL---------NAE--L 220 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHH---------HCC--C
T ss_pred -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHH---------hCC--C
Confidence 2234679999999999999999999999999999999999999985321 111111111 111 1
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
.++......+.+++.+||+.||++|| +++||++
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 23344456788999999999999999 8888885
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=304.17 Aligned_cols=233 Identities=25% Similarity=0.316 Sum_probs=179.1
Q ss_pred CcceeeeeccCCCcCeEEEEecc----cccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.|.+.++||+|+||.||+|+..+ +..||+|.+..... ...+.+.+|+.++++++||||++.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677999999999999998643 23699999976433 445779999999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 11356788999999999999999999999 9999999999999999999999999998653322
Q ss_pred --CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 644 --SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 644 --~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.........+++.|+|||.+.+..++.++||||||+++|||++|..|+.... ...... ..+..
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~-------------~~~~~ 243 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLT-------------HFLAQ 243 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHH-------------HHHHT
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHH-------------HHhhc
Confidence 1122234567889999999999999999999999999999999666542211 111111 11111
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCC
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSL 767 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~l 767 (1018)
......+......+.+++.+||+.||.+|||+.+++++|++....+
T Consensus 244 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 244 GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 1112223344567889999999999999999999999998864433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-33 Score=310.28 Aligned_cols=233 Identities=24% Similarity=0.336 Sum_probs=171.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEeccccc---ccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSG---QGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|++.+.||+|+||.||+++. .+++.||||+++.... .....+.+|+.++.+++||||++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 57899999999999999999986 4688999999976532 334578999999999999999831
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 12346889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCC-cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 641 LNQS-ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 641 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... .................
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~- 240 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIPPS- 240 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCCHH-
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcCCCCCcc-
Confidence 3322 122334678999999999999999999999999999999999999985322 11111222211111000
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHH-HHHhcC
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVV-SMLANE 763 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl-~~Le~~ 763 (1018)
.. .......+.+++.+||+.||++||++.+++ ..|...
T Consensus 241 --~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 --AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00 112346688999999999999999665544 455443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=303.62 Aligned_cols=232 Identities=25% Similarity=0.320 Sum_probs=177.3
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
..+|++.+.||+|+||.||+|+..+ ...||||.+.... ....+++.+|+.++++++||||++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568899999999999999998643 2358999987643 3445679999999999999998831
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 12345788999999999999999999999 99999999999999999999999999986643
Q ss_pred CCC--cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhC-CCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 642 NQS--ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSG-KKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 642 ~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
... ........+|+.|+|||.+.+..++.++||||||+++|||++| .+||....... .... ...+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~----~~~~----- 248 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQG----- 248 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH----HHTT-----
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH----HhcC-----
Confidence 221 1122345677899999999999999999999999999999995 45554322111 1111 0011
Q ss_pred hhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 719 VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 719 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.....+......+.+++.+||+.||++||++.|++++|+....
T Consensus 249 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 249 ----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111223345678899999999999999999999999988654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=313.75 Aligned_cols=226 Identities=19% Similarity=0.259 Sum_probs=179.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++|+||+++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999875 588999999977655556789999999999999999831
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC--CCCceeeeecceeeecCCCC
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD--QMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~--~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 12236899999999999999999999999 999999999999974 5779999999998765322
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... ...
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~-~~~~------~~~ 270 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVK-RCDW------EFD 270 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHH-HCCC------CCC
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCC------CCC
Confidence 23345799999999999999999999999999999999999999864221 11111111 1100 001
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
..........+.+++.+||+.||++|||+.|+++.
T Consensus 271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11122345678899999999999999999999873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.2e-33 Score=305.67 Aligned_cols=232 Identities=25% Similarity=0.331 Sum_probs=180.7
Q ss_pred HhCCcceee-eeccCCCcCeEEEEec---ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------
Q 046791 514 ATNNFSAVN-KLGEGGFGPVYKGQLL---NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------- 577 (1018)
Q Consensus 514 ~t~~y~~~~-~lG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------- 577 (1018)
..++|.+.+ .||+|+||.||+|... .++.||||+++... ....+++.+|+.++++++||||++.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 93 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM 93 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence 346788888 9999999999999643 36789999997653 2335779999999999999999831
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 12356899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcc-cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 643 QSET-NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 643 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~------- 236 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKG------- 236 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTT-------
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC-------
Confidence 3221 1223446788999999999889999999999999999999 99998542211 111111111
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.....+......+.+++.+||+.||++||++.+|++.|++..
T Consensus 237 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 237 --ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112233445677889999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=313.16 Aligned_cols=226 Identities=22% Similarity=0.277 Sum_probs=167.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|++.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999976 58899999997543 334678999999999999999831
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC--ceeeeecceeeecCCCCc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN--PKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~--~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+|||+++.... .
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---H 171 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc---c
Confidence 12356899999999999999999999999 999999999999987765 99999999975322 1
Q ss_pred ccceeeecccccCChhhhccCCCCcc-ccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIK-TDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~k-sDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......||+.|+|||++.+..+..+ +|||||||++|||++|+.||........ ......... .....
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~---------~~~~~ 240 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRIL---------SVKYS 240 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHH---------TTCCC
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHh---------cCCCC
Confidence 22234579999999999988887666 8999999999999999999965433221 111111111 11111
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..........+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 241 IPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1111123567889999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.4e-33 Score=301.06 Aligned_cols=228 Identities=29% Similarity=0.388 Sum_probs=181.6
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|++.+.||+|+||.||+++..+++.||||++.... ...+++.+|++++++++||||++.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5789999999999999999998888899999997653 345789999999999999999731
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 162 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cccc
Confidence 11245889999999999999999999999 9999999999999999999999999998653211 1112
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ......+ .....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~-~~~i~~~---------~~~~~ 226 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEV-VEDISTG---------FRLYK 226 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHH-HHHHHTT---------CCCCC
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHH-HHHHhcC---------CcCCC
Confidence 23456778999999999999999999999999999999 8999853221 111 1111111 11122
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
+......+.+++.+||+.||++||++.|+++.|++..
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3334567889999999999999999999999998753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=311.25 Aligned_cols=226 Identities=20% Similarity=0.296 Sum_probs=163.2
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
...++|++.+.||+|+||.||+|+... ++.||||+++... ..+.+.+|+.++++++|+||++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 356789999999999999999999764 7889999997543 3467889999999999999983
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---CCCceeeeecceeeecCC
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kL~DFGla~~~~~~ 642 (1018)
+.....+++.++..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 123456899999999999999999999999 999999999999975 889999999999875422
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .............
T Consensus 205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~------ 269 (349)
T 2w4o_A 205 ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYY------ 269 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCC------
T ss_pred ---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCc------
Confidence 2223467899999999999999999999999999999999999998532211 1111111111100
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
............+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112234567889999999999999999999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=320.20 Aligned_cols=234 Identities=20% Similarity=0.263 Sum_probs=182.8
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc----
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS---- 577 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~---- 577 (1018)
+.+.++....++|++.++||+|+||+||+|+... ++.||||++++.. ......+.+|..++..++|+||+.+
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456677778999999999999999999999765 7889999997532 2233448999999999999999831
Q ss_pred ----------------------c-CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeec
Q 046791 578 ----------------------R-RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 634 (1018)
Q Consensus 578 ----------------------~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFG 634 (1018)
. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 1 1467899999999999999999999999 9999999999999999999999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ........
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~------~~~~~~~i 293 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKI 293 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHH
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC------hhHHHHhh
Confidence 9987643322 2223468999999999987 4678999999999999999999999986322 11111111
Q ss_pred hhcCcchhhhhhhhcCCCC---hHHHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 046791 710 WNEGKVLELVDIALEGSFS---PNEVLRCIHVGLLCVQDQATD--RPAMPDVVS 758 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~~---~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~ 758 (1018)
+.......++ ....+.+.+|+.+||+.+|++ ||+++||++
T Consensus 294 ---------~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 294 ---------MNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ---------HTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ---------hhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111011111 224567888999999888888 999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=298.54 Aligned_cols=227 Identities=24% Similarity=0.354 Sum_probs=179.3
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTD---------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~---------------- 576 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+||++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999876 58899999986543 344577999999999999999873
Q ss_pred ----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 577 ----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 577 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
+.....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 122456889999999999999999999999 9999999999999999999999999998765333333
Q ss_pred cceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||........ . ...+..... ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~--------~~ 228 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKT--------YL 228 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--H----HHHHHTTCT--------TS
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHhhhccc--------cc
Confidence 3345678999999999987665 7899999999999999999999965432211 0 111111100 00
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 111233467788999999999999999999876
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=315.15 Aligned_cols=233 Identities=25% Similarity=0.341 Sum_probs=171.2
Q ss_pred CCcceeeeeccCCCcCeEEEEecc----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
..|.+.+.||+|+||.||+|+..+ +..||||.++... ....++|.+|+.++++++||||++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 357788999999999999998643 2468999987543 3456789999999999999999832
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 11235778889999999999999999999 999999999999999999999999999866432
Q ss_pred CCc--ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 643 QSE--TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 643 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....... .... ...+.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~~~~----- 313 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGR----- 313 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HHTTC-----
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HHcCC-----
Confidence 211 12233567789999999999999999999999999999999 667765433221 1111 11111
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCC
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSL 767 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~l 767 (1018)
....+......+.+++.+||+.||++||++.||++.|+.....+
T Consensus 314 ----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 314 ----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11123334567889999999999999999999999999865433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=309.36 Aligned_cols=223 Identities=22% Similarity=0.312 Sum_probs=174.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~~------------- 577 (1018)
++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.++ +||||+++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999976 48899999997653 23455688999999988 89999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-- 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-- 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC--
Confidence 12356899999999999999999999999 999999999999999999999999999864322
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCC--chHHHHHHHhhcCcchhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL--NLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......... .............
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--------- 234 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------- 234 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC---------
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC---------
Confidence 12234568999999999999999999999999999999999999999643221110 1111111111111
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAM 753 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 753 (1018)
...++......+.+++.+||+.||++||++
T Consensus 235 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 -QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 112344456778899999999999999995
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=304.18 Aligned_cols=237 Identities=23% Similarity=0.381 Sum_probs=182.1
Q ss_pred CCcceeeeeccCCCcCeEEEEe-----cccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-----LNGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++|+||+..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4589999999999999999983 358899999997543 3456789999999999999999731
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 11345889999999999999999999999 9999999999999999999999999998775
Q ss_pred CCCCc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc-------
Q 046791 641 LNQSE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE------- 712 (1018)
Q Consensus 641 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------- 712 (1018)
..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.... .........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM--------ALFLKMIGPTHGQMTV 249 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--------HHHHHHHCSCCGGGHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh--------hHHhhccCCcccccCH
Confidence 43321 22234567888999999999999999999999999999999998853210 000000000
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
......+........+....+.+.+++.+||+.||++|||+.|++++|+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 001111111222234455567889999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=310.18 Aligned_cols=238 Identities=20% Similarity=0.291 Sum_probs=177.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999974 58999999986543 2335678899999999999998732
Q ss_pred --------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 578 --------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 578 --------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 11246899999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCC--cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 638 IFGLNQS--ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 638 ~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..............
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCC
Confidence 7653222 222234678999999999876 56899999999999999999999998643221 11111111110000
Q ss_pred ---chhh-----hhhh---hcCCCC-hH------HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 ---VLEL-----VDIA---LEGSFS-PN------EVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ---~~~~-----~d~~---l~~~~~-~~------~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.... .+.. ...... .+ ..+.+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 0000 000000 01 1245789999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=312.06 Aligned_cols=217 Identities=21% Similarity=0.309 Sum_probs=176.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--------ccHHHHHHHHHHHHHhcCCCcccc-------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--------QGIVEFKNEAKLIAKLQHTNLTDS------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~nlv~~------- 577 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999864 588999999976431 133467889999999999999831
Q ss_pred --------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 578 --------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 578 --------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
.....+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 12346899999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 179 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------- 235 (335)
T 3dls_A 179 YLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------- 235 (335)
T ss_dssp ECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------------
T ss_pred ECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------------
Confidence 765322 2334679999999999988776 8899999999999999999999853111
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
...... ..+......+.+++.+||+.||++|||+.|+++.
T Consensus 236 -~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 1122234668899999999999999999999883
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=310.38 Aligned_cols=218 Identities=25% Similarity=0.309 Sum_probs=178.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999875 58999999996542 3456788999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 12356899999999999999999999999 999999999999999999999999999876422
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ......+. .
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~-~~~i~~~~----------~ 255 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQI-YEKIVSGK----------V 255 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH-HHHHHHCC----------C
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHH-HHHHHcCC----------C
Confidence 234689999999999999999999999999999999999999985321 1111 11111111 1
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
.++......+.+++.+||+.||++||+ ++||++
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 233344567889999999999999998 888876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=300.54 Aligned_cols=221 Identities=27% Similarity=0.402 Sum_probs=179.3
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR-------------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~-------------- 578 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999976 68999999996543 3578999999999999987320
Q ss_pred ------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCc
Q 046791 579 ------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 579 ------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 1245788899999999999999999999 9999999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQ 708 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~ 708 (1018)
||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.. ......
T Consensus 162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFT 229 (284)
T ss_dssp EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHH
T ss_pred EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHH
Confidence 999999998765332 22335689999999999999999999999999999999999987521 000111
Q ss_pred HhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 709 LWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 709 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
... ....+......+.+++.+||+.||++||++.|+++.|+....
T Consensus 230 ~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 230 DLR------------DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHH------------TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred Hhh------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 111 111222334567789999999999999999999999987654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-33 Score=304.94 Aligned_cols=225 Identities=21% Similarity=0.320 Sum_probs=176.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-c-------ccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-G-------QEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g-------~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------- 577 (1018)
.++|.+.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3579999999999999999998654 3 4699999987777777889999999999999999831
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC--------ceee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN--------PKIS 631 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~--------~kL~ 631 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence 11223889999999999999999999999 999999999999998887 9999
Q ss_pred eecceeeecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh
Q 046791 632 DFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 632 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
|||++.... ......+|..|+|||.+.+ ..++.++||||||+++|||++|..|+..... .... ....
T Consensus 164 Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~-~~~~ 231 (289)
T 4fvq_A 164 DPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRK-LQFY 231 (289)
T ss_dssp CCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHH-HHHH
T ss_pred cCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHHH-HHHh
Confidence 999986432 1223567899999999987 7799999999999999999996554321111 1110 1111
Q ss_pred hcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 711 NEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 711 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.. ....+......+.+++.+||+.||++|||+.|+++.|+....
T Consensus 232 ~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 232 ED-----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HT-----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hc-----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 111222334567789999999999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=321.59 Aligned_cols=170 Identities=24% Similarity=0.366 Sum_probs=132.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++++++|+||+.+
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999865 58899999996542 3345679999999999999999842
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 12345899999999999999999999999 99999999999999999999999999987642
Q ss_pred CCCc-------------------------ccceeeecccccCChhhh-ccCCCCccccchhHhHHHHHHHhC
Q 046791 642 NQSE-------------------------TNTNRVVGTYGYMSPEYA-MSGVVSIKTDVFSFGVLVLEIVSG 687 (1018)
Q Consensus 642 ~~~~-------------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDV~SlGvvl~elltG 687 (1018)
.... ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 2111 122345789999999986 456799999999999999999994
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-33 Score=320.39 Aligned_cols=233 Identities=21% Similarity=0.255 Sum_probs=182.3
Q ss_pred HHHHHHHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc------
Q 046791 508 FQTISAATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------ 577 (1018)
Q Consensus 508 ~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------ 577 (1018)
+.++....++|++.+.||+|+||.||+|+... ++.||||++++.. ......+.+|+.+++.++||||+++
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 45566677899999999999999999999764 8899999996532 2334568899999999999999841
Q ss_pred -------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 -------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 12346889999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCcccceeeecccccCChhhhccCC----CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGV----VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
..... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ......
T Consensus 218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~------- 283 (410)
T 3v8s_A 218 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYS------- 283 (410)
T ss_dssp CCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHH-------
T ss_pred eccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhhHHH-------
Confidence 64322 12233568999999999998755 7899999999999999999999985322 111111
Q ss_pred chhhhhhhhcCCCC--hHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 046791 715 VLELVDIALEGSFS--PNEVLRCIHVGLLCVQDQATD--RPAMPDVVSM 759 (1018)
Q Consensus 715 ~~~~~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 759 (1018)
.++.......++ ......+.+|+.+||+.+|.+ ||+++||++.
T Consensus 284 --~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 284 --KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111111111111 234567889999999999988 9999999983
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=309.10 Aligned_cols=231 Identities=26% Similarity=0.415 Sum_probs=174.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
.++|.+.+.||+|+||.||+|+... +..||||+++... .....++.+|+.++++++||||++.
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3578889999999999999998653 2359999997653 3345679999999999999999731
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 12356899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 642 NQSE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 642 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
.... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... . ........+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~-~~~~~~~~~------ 266 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------H-EVMKAINDG------ 266 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------H-HHHHHHHTT------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------H-HHHHHHHCC------
Confidence 3221 12223456788999999999999999999999999999999 9999853221 1 111111111
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.....+......+.+++.+||+.||++||++.+|++.|+...
T Consensus 267 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 267 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223345567889999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=308.06 Aligned_cols=222 Identities=23% Similarity=0.323 Sum_probs=167.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEe----cccccceEEEecccc----cccHHHHHHHHHHHHHhcCCCcccc---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL----LNGQEVAIKRLSRRS----GQGIVEFKNEAKLIAKLQHTNLTDS--------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~nlv~~--------- 577 (1018)
.++|++.+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++++++||||+++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999986 468899999997642 2344568899999999999999841
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 12356888999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~---------~ 235 (327)
T 3a62_A 173 HDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKIL---------K 235 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHH---------H
T ss_pred cCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHH---------h
Confidence 221 122345789999999999999999999999999999999999999853221 11111111 1
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
. ....++.....+.+++.+||+.||++|| ++.|+++
T Consensus 236 ~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 236 C--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp T--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred C--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1 1123344557788999999999999999 7778776
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=298.88 Aligned_cols=229 Identities=20% Similarity=0.260 Sum_probs=180.5
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc----cccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS----GQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
..++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++|+||++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999975 48899999997542 3446789999999999999998731
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~ 639 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 12356889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCcccceeeecccccCChhhhccCC--CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMSGV--VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
.............||..|+|||++.+.. .+.++||||||+++|||++|+.||.... .... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~-~~~i~~~~--- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKL-FENIGKGS--- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHH-HHHHHHCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHH-HHHHhcCC---
Confidence 5433333334567899999999998644 4789999999999999999999986321 1111 11111111
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS--MLAN 762 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~Le~ 762 (1018)
...+......+.+++.+||+.||++||++.|+++ .+.+
T Consensus 230 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 230 -------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred -------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 1223344567889999999999999999999997 4544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=298.34 Aligned_cols=221 Identities=21% Similarity=0.280 Sum_probs=178.0
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
..++|++.+.||+|+||.||+|+... +..||+|++........+.+.+|++++++++||||++.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45679999999999999999998765 77899999987766778899999999999999999831
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE---cCCCCceeeeecceeeecCCC
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.|+++||.|||+++ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 12345889999999999999999999999 9999999999999 788999999999998765322
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......||+.|+|||.+.+. ++.++||||||+++|||++|+.||..... ... ......+..
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~-~~~~~~~~~-------- 224 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD------SEV-MLKIREGTF-------- 224 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHCCC--------
T ss_pred ---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH------HHH-HHHHHhCCC--------
Confidence 22345789999999988654 89999999999999999999999854221 111 111111110
Q ss_pred cCCCCh----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 724 EGSFSP----NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+. ...+.+.+++.+||+.||++||++.|+++
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 --TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 23467889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=311.44 Aligned_cols=244 Identities=21% Similarity=0.239 Sum_probs=179.0
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccc-----------cHHHHHHHHHHHHHhcCCCc
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQ-----------GIVEFKNEAKLIAKLQHTNL 574 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~nl 574 (1018)
...+++....++|.+.+.||+|+||.||+|+..+++.||||++...... ..+.+.+|+.++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3467888999999999999999999999999888999999998654221 23779999999999999999
Q ss_pred ccc-------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 575 TDS-------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 575 v~~-------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
+++ .....+++..+..++.||++||.|||+++ |+||||||+|||++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLA 168 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEc
Confidence 842 12336899999999999999999999999 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCch
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l 702 (1018)
.++.+||+|||+++..... .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~ 242 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQ 242 (362)
T ss_dssp TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH
T ss_pred CCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---HH
Confidence 9999999999999754322 22334678999999999887 77999999999999999999999998643211 11
Q ss_pred HHHHHHHhhcCcch-----------hhhhhhhcC-------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 703 IGYAWQLWNEGKVL-----------ELVDIALEG-------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~-----------~~~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.............. +.+...... ...+...+.+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111111111 000000000 011223456889999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-33 Score=310.62 Aligned_cols=237 Identities=24% Similarity=0.351 Sum_probs=177.6
Q ss_pred cceeHHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccc--cccHHHHHHHHHHHHHhcC--CCcccc--
Q 046791 504 EIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQH--TNLTDS-- 577 (1018)
Q Consensus 504 ~~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H--~nlv~~-- 577 (1018)
..+.++.+....++|++.+.||+|+||.||+++..+++.||||++.... ....+.+.+|+.++.+++| +||++.
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 4455566666778999999999999999999998889999999986542 3455789999999999974 888731
Q ss_pred -----------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeec
Q 046791 578 -----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 634 (1018)
Q Consensus 578 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFG 634 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||+++ +.+||+|||
T Consensus 96 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 96 YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred EeecCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 12456889999999999999999999999 999999999999975 789999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhcc-----------CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchH
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAMS-----------GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~ 703 (1018)
+++...............|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~ 246 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QI 246 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HH
Confidence 9987654333333345678999999999875 4788999999999999999999999853221 11
Q ss_pred HHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 704 GYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 704 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.. ....+++......+......+.+++.+||+.||++||++.|+++
T Consensus 247 ~~---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 SK---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HH---------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH---------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11 11122222222333334567889999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=312.14 Aligned_cols=225 Identities=24% Similarity=0.324 Sum_probs=177.9
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHh-cCCCcccc---------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKL-QHTNLTDS--------- 577 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~H~nlv~~--------- 577 (1018)
....++|.+.+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|..++.++ +||||+++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999975 48899999997642 34566788999999987 99999831
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 12356899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......+
T Consensus 170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~-~~~~i~~~------- 233 (345)
T 1xjd_A 170 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EE-LFHSIRMD------- 233 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHC-------
T ss_pred cCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HH-HHHHHHhC-------
Confidence 221 223457899999999999999999999999999999999999999853221 11 11111111
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMP-DVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~ 758 (1018)
...++......+.+++.+||+.||++||++. ||++
T Consensus 234 ---~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 234 ---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1123334456788999999999999999997 6653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-33 Score=314.70 Aligned_cols=239 Identities=21% Similarity=0.357 Sum_probs=185.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-----cccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-----LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++|+||++.
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35789999999999999999984 3588999999987766677889999999999999998731
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 11245889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCcc-cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC------
Q 046791 641 LNQSET-NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG------ 713 (1018)
Q Consensus 641 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------ 713 (1018)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+.... ..........
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~--------~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--------AEFMRMIGNDKQGQMI 268 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--------HHHHHHHCTTCCTHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH--------HHHHHhhccccchhhh
Confidence 432211 1223456778999999999899999999999999999999998864210 0000000000
Q ss_pred --cchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 714 --KVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 714 --~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.+.+.+........+......+.+++.+||+.||++||++.||++.|++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011122211122234455678889999999999999999999999998753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=300.86 Aligned_cols=222 Identities=23% Similarity=0.349 Sum_probs=172.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccccC---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSRR--------------- 579 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~~--------------- 579 (1018)
.++|++.+.||+|+||.||+++. .++.||||+++... ..+.+.+|+.++++++|+||++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46899999999999999999987 48899999997543 5578999999999999999974110
Q ss_pred --------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 580 --------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 580 --------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 112678889999999999999999999 999999999999999999999999999765321
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..... ...
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~----~~~~~---------~~~ 232 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PRVEK---------GYK 232 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH----HHHTT---------TCC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhc---------CCC
Confidence 123457889999999999999999999999999999998 99998643211 111 11111 111
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
...+......+.+++.+||+.||++||++.|+++.|+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 223344567788999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=298.48 Aligned_cols=226 Identities=21% Similarity=0.272 Sum_probs=176.9
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++|+||++.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999875 48899999986543 3345678999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC---ceeeeecceeeecC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDFGMARIFGL 641 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 12345889999999999999999999999 999999999999986655 99999999987643
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .. .......+....
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~-~~~~~~~~~~~~---- 226 (284)
T 3kk8_A 161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HR-LYAQIKAGAYDY---- 226 (284)
T ss_dssp SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHTCCCC----
T ss_pred Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hH-HHHHHHhccccC----
Confidence 22 22345789999999999999999999999999999999999999853221 11 111111111100
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.........+.+.+++.+||+.||++|||+.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 --PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00011233467889999999999999999999988
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=311.71 Aligned_cols=221 Identities=29% Similarity=0.397 Sum_probs=175.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999986 468899999996543 2334578999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence 12457899999999999999999999999 99999999999999999999999999986532
Q ss_pred cccceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.....||+.|+|||++. ...++.++||||||+++|||++|+.||.... .............
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~------- 270 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNES------- 270 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC-------
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCC-------
Confidence 22457899999999985 5778999999999999999999999985322 1111111111110
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
....+......+.+++.+||+.||++|||+.++++.
T Consensus 271 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 --PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 001122334567889999999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-32 Score=318.74 Aligned_cols=236 Identities=20% Similarity=0.255 Sum_probs=183.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc----------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD---------------- 576 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~---------------- 576 (1018)
..++|++.++||+|+||.||+|+. .+++.||||++..... ..++..|++++..++|.+.+.
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 357899999999999999999986 4589999998765432 235889999999999866431
Q ss_pred ---------c--cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE---cCCCCceeeeecceeeecCC
Q 046791 577 ---------S--RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 577 ---------~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kL~DFGla~~~~~~ 642 (1018)
+ .....+++.+++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.....
T Consensus 83 e~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 0 12457999999999999999999999999 9999999999999 68899999999999987543
Q ss_pred CCcc-----cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 643 QSET-----NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 643 ~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
.... ......||..|+|||++.+..++.++|||||||+||||++|+.||................. .....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----~~~~~ 235 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----KKVAT 235 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH----HHHHS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh----ccccc
Confidence 3221 22356799999999999999999999999999999999999999976544322211111111 11111
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.++... .....++.+++..||+.+|++||++.+|+++|+..
T Consensus 236 ~~~~l~-----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 236 SIEALC-----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp CHHHHH-----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cHHHHh-----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111111 12245788999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=306.12 Aligned_cols=238 Identities=23% Similarity=0.320 Sum_probs=175.6
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHh--cCCCcccc-----------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL--QHTNLTDS----------- 577 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l--~H~nlv~~----------- 577 (1018)
-....++|++.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +|+||++.
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445678999999999999999999875 889999998543 234455666666554 99999731
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcC--------CCCcEEecccCCCcEEEcCCCCceee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKY--------SRLRVIHRDLKASNILLDDQMNPKIS 631 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~--------~~~~ivH~Dlkp~NILld~~~~~kL~ 631 (1018)
.....+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEE
Confidence 1124578899999999999999999998 6 9999999999999999999999
Q ss_pred eecceeeecCCCCcc--cceeeecccccCChhhhccCCCCcc------ccchhHhHHHHHHHhC----------CCCCCC
Q 046791 632 DFGMARIFGLNQSET--NTNRVVGTYGYMSPEYAMSGVVSIK------TDVFSFGVLVLEIVSG----------KKNNGC 693 (1018)
Q Consensus 632 DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~k------sDV~SlGvvl~elltG----------~~p~~~ 693 (1018)
|||+++......... ......||+.|+|||++.+.....+ +|||||||++|||++| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998764332221 1224579999999999988766655 9999999999999999 455433
Q ss_pred CCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 694 YRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 694 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
....... .......... .......+ ....+.+.+++.+||+.||++|||+.||++.|+....
T Consensus 265 ~~~~~~~--~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 265 LVPSDPS--YEDMREIVCI--------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TSCSSCC--HHHHHHHHTT--------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCc--hhhhHHHHhh--------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 2222111 1111111111 11111222 2567789999999999999999999999999987644
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=312.81 Aligned_cols=235 Identities=18% Similarity=0.264 Sum_probs=176.3
Q ss_pred hCCcceeeeeccC--CCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEG--GFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G--~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.++|++.++||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999976 58999999997553 3345678899999999999999831
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 11256899999999999999999999999 99999999999999999999999999876432
Q ss_pred CCC-----cccceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 642 NQS-----ETNTNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 642 ~~~-----~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.... .+.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-----~~~ 253 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKL-----NGT 253 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC---------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHh-----cCC
Confidence 211 111223478899999999987 6799999999999999999999999965432221 10000 000
Q ss_pred chhhhhh------------------------------------hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 VLELVDI------------------------------------ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ~~~~~d~------------------------------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+.+. ......+....+.+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0000000 0000112233467889999999999999999999986
Q ss_pred H
Q 046791 759 M 759 (1018)
Q Consensus 759 ~ 759 (1018)
.
T Consensus 334 h 334 (389)
T 3gni_B 334 H 334 (389)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=310.49 Aligned_cols=223 Identities=22% Similarity=0.290 Sum_probs=177.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccc---ccccHHHHHHHHHHHHHh-cCCCcccc-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR---SGQGIVEFKNEAKLIAKL-QHTNLTDS----------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nlv~~----------- 577 (1018)
..++|++.+.||+|+||.||+|+... ++.||||++++. .....+.+..|..++..+ +||+|+.+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34689999999999999999999764 889999999764 234567789999999988 89998731
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 12356899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ..
T Consensus 175 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~---------~~- 236 (353)
T 2i0e_A 175 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM---------EH- 236 (353)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH---------HC-
T ss_pred --CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHH---------hC-
Confidence 2233456899999999999999999999999999999999999999853211 11111111 11
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
...++......+.+++.+||+.||++||+ ++||++
T Consensus 237 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 237 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11233445677889999999999999995 566665
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=302.20 Aligned_cols=226 Identities=22% Similarity=0.262 Sum_probs=177.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc------ccHHHHHHHHHHHHHhcCCCcccc---------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG------QGIVEFKNEAKLIAKLQHTNLTDS--------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~H~nlv~~--------- 577 (1018)
..++|++.+.||+|+||.||+++.. +++.||||++..... ...+++.+|+.++++++||||+..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999875 488999999976432 246789999999999999999731
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC----Cceeeeecce
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDFGMA 636 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~----~~kL~DFGla 636 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 22456789999999999999999999999 99999999999999887 7999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... .......
T Consensus 167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~-~i~~~~~- 235 (321)
T 2a2a_A 167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLA-NITSVSY- 235 (321)
T ss_dssp EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHH-HHHTTCC-
T ss_pred eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHH-HHHhccc-
Confidence 8765322 22345789999999999999999999999999999999999999853221 11111 1111100
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..++... ......+.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 -DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000 122356789999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=305.55 Aligned_cols=233 Identities=23% Similarity=0.349 Sum_probs=171.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....++.+|+.++++++|+||++.
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999864 68999999997532 3345678999999999999999731
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 12345889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ....... .......
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~----- 255 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCK-KIEQCDY----- 255 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHH-HHHTTCS-----
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHH-HhhcccC-----
Confidence 322 122345789999999999999999999999999999999999999853221 1111111 1111111
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
...........+.+++.+||+.||++||++.+|++.|++..+
T Consensus 256 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 256 ---PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp ---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 001112345678899999999999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-33 Score=311.12 Aligned_cols=240 Identities=21% Similarity=0.337 Sum_probs=171.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccc-cHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ-GIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++|+||+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 5889999998654322 12245689999999999999831
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~ 156 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKT 156 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--ccc
Confidence 12346889999999999999999999999 999999999999999999999999999865422 122
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc---chhhhhh--
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK---VLELVDI-- 721 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d~-- 721 (1018)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .............. .......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhcchh
Confidence 234578999999999886 67899999999999999999999998643221 11111111111100 0000000
Q ss_pred ----hhcC-------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 046791 722 ----ALEG-------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS--MLANE 763 (1018)
Q Consensus 722 ----~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~Le~~ 763 (1018)
.... ...+.....+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0000 001123456789999999999999999999988 44443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=332.30 Aligned_cols=230 Identities=24% Similarity=0.353 Sum_probs=178.4
Q ss_pred hCCcceee-eeccCCCcCeEEEEec---ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 515 TNNFSAVN-KLGEGGFGPVYKGQLL---NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~-~lG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.+++.+.+ .||+|+||.||+|... ++..||||+++... ....++|.+|++++++++|+||+++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv 413 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 413 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEE
Confidence 34555555 8999999999999864 46679999997653 3457889999999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 12456899999999999999999999999 9999999999999999999999999998764322
Q ss_pred Cc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 644 SE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 644 ~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.. .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... . .......+
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~----~~~~i~~~-------- 555 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---E----VMAFIEQG-------- 555 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---H----HHHHHHTT--------
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---H----HHHHHHcC--------
Confidence 21 11223345689999999999999999999999999999998 99998643221 1 11111111
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.....+......+.+|+.+||+.||++||++.+|+++|+..
T Consensus 556 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 556 -KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 12233445567888999999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=298.47 Aligned_cols=221 Identities=24% Similarity=0.358 Sum_probs=174.7
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
+.++|++.+.||+|+||.||+|+... ++.||||++.... ......+.+|+.++++++||||+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 35689999999999999999998754 7789999986542 2345678999999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 12356889999999999999999999998 999999999999999999999999998654321
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .... ...... .
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~-~~~~~~----------~ 222 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQET-YKRISR----------V 222 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHH-HHHHHH----------T
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc------HHHH-HHHHHh----------C
Confidence 2234578999999999999999999999999999999999999985321 1111 111100 1
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+......+.+++.+||+.||++||++.||++
T Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11233344567889999999999999999999997
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=316.60 Aligned_cols=175 Identities=25% Similarity=0.361 Sum_probs=144.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+++.+|+.++++++|+||+.+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 5789999999999999999998754 8899999997542 3345679999999999999999842
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 12345899999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCc--------------------ccceeeecccccCChhhh-ccCCCCccccchhHhHHHHHHHhCCCCCC
Q 046791 642 NQSE--------------------TNTNRVVGTYGYMSPEYA-MSGVVSIKTDVFSFGVLVLEIVSGKKNNG 692 (1018)
Q Consensus 642 ~~~~--------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDV~SlGvvl~elltG~~p~~ 692 (1018)
.... .......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 3211 122456889999999986 45679999999999999999998665543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=313.38 Aligned_cols=242 Identities=19% Similarity=0.235 Sum_probs=186.3
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|.+.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999999765 8999999997643 3446778999999999999999831
Q ss_pred -------------c---CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE----cCCCCceeeeeccee
Q 046791 578 -------------R---RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKISDFGMAR 637 (1018)
Q Consensus 578 -------------~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl----d~~~~~kL~DFGla~ 637 (1018)
. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 0 1122899999999999999999999999 9999999999999 778889999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhcc--------CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMS--------GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .......
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~ 239 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence 764322 2234578999999999875 56788999999999999999999999654432221 1112222
Q ss_pred hhcCcchhhh---------------hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 710 WNEGKVLELV---------------DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 710 ~~~~~~~~~~---------------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
... .....+ +..............+.+++.+||+.||++||++.|+++.++....
T Consensus 240 ~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 211 111000 0011123345677888899999999999999999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=310.43 Aligned_cols=220 Identities=25% Similarity=0.283 Sum_probs=168.8
Q ss_pred eeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc---------------------
Q 046791 520 AVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------------------- 577 (1018)
Q Consensus 520 ~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------------------- 577 (1018)
..+.||+|+||.||+|+.. +|+.||||+++.......+++.+|+.++++++||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999864 589999999987665667789999999999999999831
Q ss_pred ------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE--cCCCCceeeeecceeeecCCCCcccce
Q 046791 578 ------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL--DDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl--d~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||+++...... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~ 246 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLK 246 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccc
Confidence 12345889999999999999999999999 9999999999999 567889999999998765332 222
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. .......
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~-------~~~~~~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACRWD-------LEDEEFQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC-------SCSGGGT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCC-------CChhhhc
Confidence 35699999999999999999999999999999999999999854321 1111111111000 0000011
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+.+.+++.+||+.||++||++.|+++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 23467889999999999999999999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=309.64 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=173.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHH--HHHhcCCCccccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKL--IAKLQHTNLTDSR-------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~--l~~l~H~nlv~~~-------------- 578 (1018)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++|+||++..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999976 68899999986442 3445555555 4458999987421
Q ss_pred ----------------CCCCCChhhHHHHHHHHHHHHHHHhcC---------CCCcEEecccCCCcEEEcCCCCceeeee
Q 046791 579 ----------------RNNRLNWETRFSIIEGIAQGLLYLHKY---------SRLRVIHRDLKASNILLDDQMNPKISDF 633 (1018)
Q Consensus 579 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~---------~~~~ivH~Dlkp~NILld~~~~~kL~DF 633 (1018)
.....++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeec
Confidence 123457788899999999999999999 7 999999999999999999999999
Q ss_pred cceeeecCCCC------cccceeeecccccCChhhhcc-------CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCC
Q 046791 634 GMARIFGLNQS------ETNTNRVVGTYGYMSPEYAMS-------GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700 (1018)
Q Consensus 634 Gla~~~~~~~~------~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~ 700 (1018)
|+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987653221 112223468999999999986 45678899999999999999998776433222111
Q ss_pred chHHHHHHHhhcCcchh---h-hhhhhcCCC------ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 701 NLIGYAWQLWNEGKVLE---L-VDIALEGSF------SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 701 ~l~~~~~~~~~~~~~~~---~-~d~~l~~~~------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
..... ..........+ . ......... .......+.+++.+||+.||++|||+.||++.|+....
T Consensus 245 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 245 QMAFQ-TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCTTH-HHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhh-cccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 10000 00000000000 0 000111111 22356689999999999999999999999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=308.86 Aligned_cols=235 Identities=21% Similarity=0.231 Sum_probs=180.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhc--------CCCcccc--------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ--------HTNLTDS-------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--------H~nlv~~-------- 577 (1018)
.++|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.++++++ |+||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 4889999999654 344567899999999997 6667631
Q ss_pred -----------------------cCCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCC-------
Q 046791 578 -----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQM------- 626 (1018)
Q Consensus 578 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~------- 626 (1018)
.....+++..+..++.||++||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhh
Confidence 1124689999999999999999999998 8 99999999999999775
Q ss_pred ------------------------------------------CceeeeecceeeecCCCCcccceeeecccccCChhhhc
Q 046791 627 ------------------------------------------NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664 (1018)
Q Consensus 627 ------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 664 (1018)
.+||+|||++...... .....||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence 7999999999876422 23357899999999999
Q ss_pred cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhh-cCcc-hhhh-----------------------
Q 046791 665 SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWN-EGKV-LELV----------------------- 719 (1018)
Q Consensus 665 ~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-~~~~-~~~~----------------------- 719 (1018)
+..++.++|||||||++|||++|+.||.................... .+.. ...+
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 99999999999999999999999999976544332211111111100 0000 0000
Q ss_pred -----hhh-hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 720 -----DIA-LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 720 -----d~~-l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+.. -....+......+.+|+.+||+.||++|||+.||++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 011235667788999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=298.97 Aligned_cols=225 Identities=18% Similarity=0.315 Sum_probs=177.4
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
++|++.+.||+|+||.||+|+.. ++.||||+++... ....++|.+|+.++++++||||++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57899999999999999999984 8889999997653 3445679999999999999998731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++.++..++.||++||.|||+++ .+|+||||||+|||++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 11124899999999999999999999876 459999999999999999999999998875422
Q ss_pred CcccceeeecccccCChhhhccCCCC---ccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVS---IKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s---~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.....||+.|+|||.+.+...+ .++||||||+++|||++|+.||..... ....... ..
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~---------~~ 225 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKV---------AL 225 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHH---------HH
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHH---------Hh
Confidence 1234678999999999876544 489999999999999999999853221 1111111 11
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.......+......+.+++.+||+.||++|||+.|+++.|+...
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11122334445667889999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=305.85 Aligned_cols=231 Identities=30% Similarity=0.394 Sum_probs=175.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEec------ccccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS---------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~---------- 577 (1018)
.++|.+.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||++.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 468999999999999999999842 4678999999654 33455679999999999999999731
Q ss_pred -----------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---CCCceee
Q 046791 578 -----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKIS 631 (1018)
Q Consensus 578 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kL~ 631 (1018)
.....+++..++.++.||++||.|||+++ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 01134888999999999999999999999 999999999999984 4569999
Q ss_pred eecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHh
Q 046791 632 DFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 632 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. .....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~-~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QE-VLEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HH-HHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HH-HHHHH
Confidence 9999976543332223334567889999999999999999999999999999998 8888753221 11 11111
Q ss_pred hcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 711 NEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 711 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
..+ .....+......+.+++.+||+.||.+||++.+|++.|+...
T Consensus 259 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 TSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 111 111223344567889999999999999999999999998643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=302.04 Aligned_cols=232 Identities=25% Similarity=0.360 Sum_probs=172.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc--cc--cceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN--GQ--EVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS---------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~--g~--~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~---------- 577 (1018)
.++|++.+.||+|+||.||+|+... ++ .||||+++.. .....+++.+|++++++++|+||++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 3579999999999999999998532 33 6899998754 23456789999999999999999831
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 01245889999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 642 NQSE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 642 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~------ 241 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEG------ 241 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSC------
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccC------
Confidence 3322 12234567788999999999889999999999999999999 9999853321 11111111111
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.....+......+.+++.+||+.||++||++.++++.|++..
T Consensus 242 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 111223344577889999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=305.38 Aligned_cols=238 Identities=19% Similarity=0.219 Sum_probs=176.7
Q ss_pred HHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc-----ccccHHHHHHHHHHHHHhcCCCccccc-----
Q 046791 510 TISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR-----SGQGIVEFKNEAKLIAKLQHTNLTDSR----- 578 (1018)
Q Consensus 510 ~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nlv~~~----- 578 (1018)
++....++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++.
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 35667789999999999999999999875 4788999998654 234567899999999999999998421
Q ss_pred -----------CC--------------------------------------------------CCCChhhHHHHHHHHHH
Q 046791 579 -----------RN--------------------------------------------------NRLNWETRFSIIEGIAQ 597 (1018)
Q Consensus 579 -----------~~--------------------------------------------------~~l~~~~~~~i~~qia~ 597 (1018)
.. ..+++..+..++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 00 11246677889999999
Q ss_pred HHHHHhcCCCCcEEecccCCCcEEEcCCC--CceeeeecceeeecCCCC--cccceeeecccccCChhhhcc--CCCCcc
Q 046791 598 GLLYLHKYSRLRVIHRDLKASNILLDDQM--NPKISDFGMARIFGLNQS--ETNTNRVVGTYGYMSPEYAMS--GVVSIK 671 (1018)
Q Consensus 598 gL~yLH~~~~~~ivH~Dlkp~NILld~~~--~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~--~~~s~k 671 (1018)
||+|||+++ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998776 899999999987643221 112345679999999999975 678999
Q ss_pred ccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCC
Q 046791 672 TDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRP 751 (1018)
Q Consensus 672 sDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 751 (1018)
+||||||+++|||++|+.||..... .............. ...........+.+++.+||+.||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND------ADTISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999853321 11111111111100 0000112346788999999999999999
Q ss_pred CHHHHHH--HHhcC
Q 046791 752 AMPDVVS--MLANE 763 (1018)
Q Consensus 752 s~~evl~--~Le~~ 763 (1018)
++.|+++ .+++.
T Consensus 324 s~~~~l~hp~~~~~ 337 (345)
T 3hko_A 324 DAMRALQHPWISQF 337 (345)
T ss_dssp CHHHHHHSHHHHTT
T ss_pred CHHHHhcChhhccC
Confidence 9999988 34443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=311.76 Aligned_cols=228 Identities=10% Similarity=0.052 Sum_probs=164.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc---ccHHHHHHHHHHHHHh--cCCCcccccC---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG---QGIVEFKNEAKLIAKL--QHTNLTDSRR--------- 579 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l--~H~nlv~~~~--------- 579 (1018)
..+|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++..+ +||||++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 446899999999999999999965 689999999977542 3455678887666666 5999653110
Q ss_pred -----------------------------------------CCCCChhhH------HHHHHHHHHHHHHHhcCCCCcEEe
Q 046791 580 -----------------------------------------NNRLNWETR------FSIIEGIAQGLLYLHKYSRLRVIH 612 (1018)
Q Consensus 580 -----------------------------------------~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~ivH 612 (1018)
...+++..+ ..++.||++||+|||+++ |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 112344555 678899999999999999 999
Q ss_pred cccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCC
Q 046791 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKN 690 (1018)
Q Consensus 613 ~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p 690 (1018)
|||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999987532 1113456799999999987 7899999999999999999999999
Q ss_pred CCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 691 NGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 691 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
|.......... +......................+.+.+++.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 97654322110 0000000001111111112244577889999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=313.47 Aligned_cols=239 Identities=22% Similarity=0.292 Sum_probs=179.3
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+.+.
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999865 58899999997543 33346789999999999999997421
Q ss_pred ----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 579 ----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 579 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 1345889999999999999999999999 999999999999999999999999999876533
Q ss_pred CCcc-cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch----
Q 046791 643 QSET-NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL---- 716 (1018)
Q Consensus 643 ~~~~-~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---- 716 (1018)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...............
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHHHHHT
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHH
Confidence 2211 2234689999999998764 558999999999999999999999986443221 121111111110000
Q ss_pred -------hhhhhhh-cCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 -------ELVDIAL-EGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 -------~~~d~~l-~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....... .... .+.....+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0001 1223467889999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=315.67 Aligned_cols=228 Identities=25% Similarity=0.326 Sum_probs=168.9
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc--------cccHHHHHHHHHHHHHhcCCCccc-------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS--------GQGIVEFKNEAKLIAKLQHTNLTD------- 576 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nlv~------- 576 (1018)
...++|.+.+.||+|+||.||+|.... ++.||||++.... ......+.+|+.++++++||||++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456899999999999999999998654 8899999986542 112235889999999999999983
Q ss_pred ------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC---CCceeeeecc
Q 046791 577 ------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGM 635 (1018)
Q Consensus 577 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~---~~~kL~DFGl 635 (1018)
+.....+++.++..++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 123457899999999999999999999999 9999999999999754 4599999999
Q ss_pred eeeecCCCCcccceeeecccccCChhhhcc---CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 636 ARIFGLNQSETNTNRVVGTYGYMSPEYAMS---GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 636 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+.. ....
T Consensus 289 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~----~i~~ 359 (419)
T 3i6u_A 289 SKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD----QITS 359 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH----HHHT
T ss_pred ceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH----HHhc
Confidence 9876422 22334679999999999863 678899999999999999999999986433221 1111 1111
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+...... . . .....+.+.+++.+||+.||++||++.|+++
T Consensus 360 ~~~~~~~-~-~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYNFIP-E-V----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCCCCH-H-H----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCc-h-h----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1110000 0 0 0123467889999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=298.96 Aligned_cols=224 Identities=25% Similarity=0.394 Sum_probs=180.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTD---------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~---------------- 576 (1018)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+||+.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356999999999999999999864 58899999996553 345678999999999999999873
Q ss_pred ---------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 577 ---------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 577 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
......+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK 175 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CC
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc--cc
Confidence 122457899999999999999999999999 9999999999999999999999999998765332 22
Q ss_pred ceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ....+ .....
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~-~~~~~---------~~~~~ 239 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------MKVLF-LIPKN---------NPPTL 239 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHH-HHHHS---------CCCCC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHH-HhhcC---------CCCCC
Confidence 2346789999999999999999999999999999999999999853221 11111 11111 11122
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 23345668899999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-33 Score=318.49 Aligned_cols=215 Identities=13% Similarity=0.125 Sum_probs=166.7
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe-cccccceEEEeccc---ccccHHHHHHHH---HHHHHhcCCCccccc--------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRR---SGQGIVEFKNEA---KLIAKLQHTNLTDSR-------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~f~~E~---~~l~~l~H~nlv~~~-------- 578 (1018)
..++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +++++++||||+++.
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356899999999999999999996 45899999999743 334567899999 556666899986321
Q ss_pred --------------------------------C---------CCCCC-------hhhHHHHHHHHHHHHHHHhcCCCCcE
Q 046791 579 --------------------------------R---------NNRLN-------WETRFSIIEGIAQGLLYLHKYSRLRV 610 (1018)
Q Consensus 579 --------------------------------~---------~~~l~-------~~~~~~i~~qia~gL~yLH~~~~~~i 610 (1018)
. ...++ +..++.|+.||++||+|||+++ |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 0 01122 3677789999999999999999 9
Q ss_pred EecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccC-----------CCCccccchhHhH
Q 046791 611 IHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG-----------VVSIKTDVFSFGV 679 (1018)
Q Consensus 611 vH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDV~SlGv 679 (1018)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998632 12334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 680 LVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 680 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
++|||++|+.||......... ..+. . ......+.+.+++.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~~---------------~~~~----~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS---------------EWIF----R--SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS---------------GGGG----S--SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch---------------hhhh----h--hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999998543322111 1111 1 01223466788999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=306.05 Aligned_cols=240 Identities=23% Similarity=0.266 Sum_probs=171.6
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccc-----cHHHHHHHHHHHHHhcCCCcccc--------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ-----GIVEFKNEAKLIAKLQHTNLTDS-------- 577 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~H~nlv~~-------- 577 (1018)
....++|++.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++++++|+||++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 345678999999999999999999975 4889999998654221 12468899999999999999831
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~ 639 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 12346889999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch--
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL-- 716 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 716 (1018)
.... .......+|+.|+|||++.+ ..++.++||||||+++|||++|.+||..... .................
T Consensus 163 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 163 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTS
T ss_pred cCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChhhh
Confidence 4322 22234578999999999976 4589999999999999999999998754321 11111111111110000
Q ss_pred ----hhhhhhhcCC---CC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 717 ----ELVDIALEGS---FS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 717 ----~~~d~~l~~~---~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
...+...... .+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000000 01 2234678899999999999999999999884
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=312.80 Aligned_cols=233 Identities=21% Similarity=0.277 Sum_probs=171.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|++++++++|+||+++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999999874 58999999986542 23456789999999999999998421
Q ss_pred -----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 579 -----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 579 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 1245788899999999999999999999 99999999999999999999999999987542
Q ss_pred CCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC-------
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG------- 713 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------- 713 (1018)
. .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .............
T Consensus 181 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 181 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHT
T ss_pred c-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHHHH
Confidence 2 234578999999999887 78999999999999999999999998643211 1111111110000
Q ss_pred ----cchhhhhhhh---c---CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 ----KVLELVDIAL---E---GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ----~~~~~~d~~l---~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....+.... . ....+...+.+.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000 0 0111233567889999999999999999999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=312.82 Aligned_cols=237 Identities=13% Similarity=0.102 Sum_probs=179.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc---------cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc--------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN---------GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS-------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~-------- 577 (1018)
.++|.+.+.||+|+||.||+|+... ++.||||++... ..+.+|++++++++|+||++.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998763 789999998654 368899999999999987630
Q ss_pred ---------------------------------cC--CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE
Q 046791 578 ---------------------------------RR--NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL 622 (1018)
Q Consensus 578 ---------------------------------~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl 622 (1018)
.. ...+++.+++.++.||++||.|||+++ |+||||||+|||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred ccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 01 256899999999999999999999999 9999999999999
Q ss_pred cCCC--CceeeeecceeeecCCCCc-----ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCC
Q 046791 623 DDQM--NPKISDFGMARIFGLNQSE-----TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYR 695 (1018)
Q Consensus 623 d~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~ 695 (1018)
+.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999876432211 11133578999999999999999999999999999999999999987543
Q ss_pred CCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 696 TDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 696 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
... .........+.. ....+.+... ........+.+++.+||+.||++||++.+|+++|++...
T Consensus 273 ~~~--~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 273 PNT--EDIMKQKQKFVD-KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TCH--HHHHHHHHHHHH-SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCH--HHHHHHHHhccC-Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 221 111111111100 0011111000 011234678899999999999999999999999988654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=301.97 Aligned_cols=233 Identities=17% Similarity=0.257 Sum_probs=175.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhc-CCCccccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNLTDSR-------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nlv~~~-------------- 578 (1018)
.++|++.+.||+|+||.||+|+. .+++.||||+++.. ..+.+.+|+.++++++ |+||+.+.
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36899999999999999999986 45889999998643 3577999999999997 99987321
Q ss_pred ----C-------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-CceeeeecceeeecCCCCcc
Q 046791 579 ----R-------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 579 ----~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kL~DFGla~~~~~~~~~~ 646 (1018)
. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++......
T Consensus 112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--- 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--- 185 (330)
T ss_dssp EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---
T ss_pred EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---
Confidence 0 134788899999999999999999999 99999999999999776 89999999998765332
Q ss_pred cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh-----
Q 046791 647 NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD----- 720 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----- 720 (1018)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .................+.++
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2234578999999999987 77999999999999999999999998432211 111111111110000111110
Q ss_pred ------------------hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 ------------------IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ------------------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..............+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111112224578889999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=314.47 Aligned_cols=234 Identities=21% Similarity=0.286 Sum_probs=164.2
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR------------ 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~------------ 578 (1018)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+.++++++|+||+.+.
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3579999999999999999999864 58899999996542 33456789999999999999997421
Q ss_pred ------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 579 ------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 579 ------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 1246889999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc-----
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK----- 714 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----- 714 (1018)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHT
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHH
Confidence 2 1234678999999999987 78999999999999999999999998643211 11111111110000
Q ss_pred ------chhhhhhhhc-CCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 ------VLELVDIALE-GSFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ------~~~~~d~~l~-~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+..... .... +...+.+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000000 0001 122456789999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=323.17 Aligned_cols=222 Identities=22% Similarity=0.254 Sum_probs=168.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+.+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999865 5889999999754 33445678899999999999999731
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD- 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC-
Confidence 123568899999999999999999998 88 999999999999999999999999999753221
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ..
T Consensus 303 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~-~~---------- 364 (446)
T 4ejn_A 303 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELIL-ME---------- 364 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HC----------
T ss_pred -CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHH-hC----------
Confidence 2223346899999999999999999999999999999999999999853221 11111111 00
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
...++....+.+.+++.+||+.||++|| +++|+++
T Consensus 365 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1123344557788999999999999999 9999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-32 Score=304.33 Aligned_cols=237 Identities=24% Similarity=0.318 Sum_probs=181.6
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHH--hcCCCcccc-----------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK--LQHTNLTDS----------- 577 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~H~nlv~~----------- 577 (1018)
-....++|.+.+.||+|+||.||+|+. +++.||||++... ....+.+|++++.. ++||||++.
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 345567899999999999999999987 5889999999643 34678899999988 799999731
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHh--------cCCCCcEEecccCCCcEEEcCCCCceee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLH--------KYSRLRVIHRDLKASNILLDDQMNPKIS 631 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivH~Dlkp~NILld~~~~~kL~ 631 (1018)
.....+++.+++.++.||++||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEEC
T ss_pred ceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEE
Confidence 11235788999999999999999999 677 9999999999999999999999
Q ss_pred eecceeeecCCCCcc--cceeeecccccCChhhhccCC------CCccccchhHhHHHHHHHhC----------CCCCCC
Q 046791 632 DFGMARIFGLNQSET--NTNRVVGTYGYMSPEYAMSGV------VSIKTDVFSFGVLVLEIVSG----------KKNNGC 693 (1018)
Q Consensus 632 DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~------~s~ksDV~SlGvvl~elltG----------~~p~~~ 693 (1018)
|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++| +.||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 999998775433221 223457899999999998752 34789999999999999999 566644
Q ss_pred CCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 694 YRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 694 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
....... . ......... ..+.... ..+....+.+++.+||+.||++|||+.||++.|+...
T Consensus 270 ~~~~~~~-~-~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 270 LVPSDPS-V-EEMRKVVCE--------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TSCSSCC-H-HHHHHHHTT--------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCcCccc-H-HHHHHHHHH--------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 3222111 1 111111111 1111111 2356678999999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=296.24 Aligned_cols=222 Identities=27% Similarity=0.458 Sum_probs=157.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||++.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999987 468999999996542 2345779999999999999999731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 12356899999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... . .....
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------~-----~~~~~-- 227 (278)
T 3cok_A 167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------N-----KVVLA-- 227 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS--
T ss_pred C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------H-----HHhhc--
Confidence 1 222357899999999999999999999999999999999999998643322110 0 00000
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+......+.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01122334567789999999999999999999886
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=315.81 Aligned_cols=236 Identities=19% Similarity=0.233 Sum_probs=180.4
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc----
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS---- 577 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~---- 577 (1018)
+.++++....++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.+++|+||+.+
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 455666677889999999999999999999975 58999999997532 2234458999999999999999831
Q ss_pred ----------------------c-CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeec
Q 046791 578 ----------------------R-RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 634 (1018)
Q Consensus 578 ----------------------~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFG 634 (1018)
. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 1 1247899999999999999999999999 9999999999999999999999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhc-------cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAM-------SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 707 (1018)
+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .....
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~ 280 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AETYG 280 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHH
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HHHHH
Confidence 9987653322 1223468999999999997 35789999999999999999999999853221 11111
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCC---CCHHHHHH
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDR---PAMPDVVS 758 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~evl~ 758 (1018)
..... .........+......+.+++.+||+ +|++| |+++||++
T Consensus 281 ~i~~~------~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 281 KIVHY------KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHTH------HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHhc------ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11100 00000001112345678899999999 99998 68999876
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=309.97 Aligned_cols=238 Identities=21% Similarity=0.276 Sum_probs=167.4
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
...++|++.++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++++++|+||+++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44578999999999999999999864 588999999965432 234568899999999999999841
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-----CCCCceeeeecceeee
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-----DQMNPKISDFGMARIF 639 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-----~~~~~kL~DFGla~~~ 639 (1018)
.....+++..+..|+.||++||.|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 111 v~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 111 IFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 22456899999999999999999999999 99999999999994 4555999999999865
Q ss_pred cCCCCcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc---c
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK---V 715 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~ 715 (1018)
.... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............. .
T Consensus 188 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 188 GIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTS
T ss_pred CCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCchhhh
Confidence 4221 222345789999999999874 5899999999999999999999998643211 11111111110000 0
Q ss_pred hhhhh-hhhcCC------------CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 LELVD-IALEGS------------FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 ~~~~d-~~l~~~------------~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... +..... ........+.+|+.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 000000 00113467789999999999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=308.17 Aligned_cols=228 Identities=21% Similarity=0.247 Sum_probs=154.3
Q ss_pred Cccee---eeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhc-CCCcccc--------------
Q 046791 517 NFSAV---NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNLTDS-------------- 577 (1018)
Q Consensus 517 ~y~~~---~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nlv~~-------------- 577 (1018)
+|++. +.||+|+||.||+++.. +++.||||++... ....+.+|+.++.++. ||||+++
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 45543 78999999999999875 4889999999643 3567889999999997 9999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC---CceeeeecceeeecCC
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM---NPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kL~DFGla~~~~~~ 642 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 22456899999999999999999999999 99999999999997665 7999999999875432
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................+....
T Consensus 163 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~----- 235 (325)
T 3kn6_A 163 N--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF----- 235 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-----
T ss_pred C--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-----
Confidence 2 222346789999999999999999999999999999999999999975443221111111111111111100
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.........+.+.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 -EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00000123567889999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=332.30 Aligned_cols=223 Identities=26% Similarity=0.348 Sum_probs=174.9
Q ss_pred eeeccCCCcCeEEEEec---ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-------------------
Q 046791 522 NKLGEGGFGPVYKGQLL---NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------------- 577 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------------- 577 (1018)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|++++++++|+||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999999653 36789999997653 3346789999999999999999841
Q ss_pred ------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc-cccee
Q 046791 578 ------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE-TNTNR 650 (1018)
Q Consensus 578 ------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~ 650 (1018)
.....+++.+++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .....
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 22456899999999999999999999999 999999999999999999999999999876433221 22233
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
..+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .. .+.+........+.
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~---------~~~i~~~~~~~~p~ 595 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EV---------TAMLEKGERMGCPA 595 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HH---------HHHHHTTCCCCCCT
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HH---------HHHHHcCCCCCCCC
Confidence 456789999999999999999999999999999998 99998543211 11 11122222223344
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.....+.+|+.+||+.||++||++.+|+++|++.
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 5567889999999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=307.14 Aligned_cols=232 Identities=22% Similarity=0.226 Sum_probs=169.2
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccccC------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSRR------------ 579 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~~------------ 579 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999865 58899999996542 334567899999999999999984210
Q ss_pred -----------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 580 -----------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 580 -----------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
...+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 135788899999999999999999999 999999999999999999999999999865422
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc-C--------
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE-G-------- 713 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~-------- 713 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... +
T Consensus 181 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 181 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI------DQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHC-CCCCCHHHHT
T ss_pred ---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCCHHHHH
Confidence 1223467899999999999999999999999999999999999998643211 111111100 0
Q ss_pred -------------------cchhhhhhhhcCCC---ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 -------------------KVLELVDIALEGSF---SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 -------------------~~~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.............. .......+.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000000000 1123567889999999999999999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=294.59 Aligned_cols=223 Identities=23% Similarity=0.317 Sum_probs=178.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||++.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999876 47889999986542 3345679999999999999999731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence 12346889999999999999999999999 999999999999999999999999999765422
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .. ..
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~-~~----------~~ 229 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIV-NV----------DL 229 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-TT----------CC
T ss_pred -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHh-cc----------cc
Confidence 22345789999999999999999999999999999999999999853221 11111111 10 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS--MLAN 762 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~Le~ 762 (1018)
..+......+.+++.+||+.||.+||++.|+++ .+..
T Consensus 230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 233344567889999999999999999999987 4444
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=313.35 Aligned_cols=230 Identities=21% Similarity=0.310 Sum_probs=172.3
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
.+|++.+.||+|+||.||+|+.. +++.||||++..... .+.+|++++++++|+||+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999975 489999999865432 23579999999999999842
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC-CCceeeeecceee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ-MNPKISDFGMARI 638 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kL~DFGla~~ 638 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+||||+.+ +.+||+|||+++.
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 11356888889999999999999999999 9999999999999965 5689999999997
Q ss_pred ecCCCCcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .................
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHHH
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHH
Confidence 643322 2235789999999999764 7999999999999999999999998643211 11111111111110000
Q ss_pred hh--hh--------hhcC-----CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LV--DI--------ALEG-----SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~--d~--------~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+. .+ .+.. .+++.....+.+|+.+||+.||++||++.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00 00 0000 012234567889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=300.85 Aligned_cols=225 Identities=21% Similarity=0.304 Sum_probs=162.6
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
..++|++.+.||+|+||.||+++.. +++.||||+++.... ...+.+.++...++.++||||+..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999874 688999999976532 223335556666888999999731
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..+..++.||+.||.|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 1245789999999999999999999998 8 9999999999999999999999999998764
Q ss_pred CCCCcccceeeecccccCChhhh----ccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYA----MSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
.. .......||+.|+|||++ .+..++.++||||||+++|||++|+.||...... ........
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~------ 227 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVV------ 227 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHH------
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHh------
Confidence 32 222234789999999996 4567899999999999999999999998532211 11111111
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...............+.+++.+||+.||++|||+.|+++
T Consensus 228 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 228 ---EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111112234567889999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=304.40 Aligned_cols=237 Identities=22% Similarity=0.272 Sum_probs=172.3
Q ss_pred hCCccee-eeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc--------------
Q 046791 515 TNNFSAV-NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~-~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~-------------- 577 (1018)
.+.|++. +.||+|+||.||+|+.. +++.||||++..........+.+|+.++.++ +||||++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578884 78999999999999864 5889999999877666678899999999995 79999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC---ceeeeecceeeecCC
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 12356899999999999999999999999 999999999999998776 999999999865422
Q ss_pred CC-----cccceeeecccccCChhhhcc-----CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 643 QS-----ETNTNRVVGTYGYMSPEYAMS-----GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 643 ~~-----~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
.. ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.................
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---- 243 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP---- 243 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH----
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch----
Confidence 11 111223568999999999875 5688999999999999999999999975543221100000000
Q ss_pred CcchhhhhhhhcC--CCCh----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 713 GKVLELVDIALEG--SFSP----NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 713 ~~~~~~~d~~l~~--~~~~----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....+......+ ..+. .....+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000011111111 1121 13467889999999999999999999988
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=320.61 Aligned_cols=226 Identities=25% Similarity=0.337 Sum_probs=180.5
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
..++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.++++++||||+.+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999875 5899999999654 23456678999999999999999831
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 11234899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~--------- 403 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKE--------- 403 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHH---------
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhc---------
Confidence 22 223458999999999999999999999999999999999999999654322111 111111110
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
....++......+.+|+.+||+.||++|| +++||++
T Consensus 404 -~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 404 -VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11223344557788999999999999999 7788876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=299.25 Aligned_cols=231 Identities=23% Similarity=0.320 Sum_probs=178.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||++.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 3468999999999999999999875 58899999996543 3345679999999999999999831
Q ss_pred -------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCC--CCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 578 -------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYS--RLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 578 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
.....+++..++.++.||++||.|||+.+ ..+|+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 01234889999999999999999999976 234999999999999999999999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
+...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .. .......+..
T Consensus 164 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~i~~~~~- 233 (279)
T 2w5a_A 164 RILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KE-LAGKIREGKF- 233 (279)
T ss_dssp HHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHTCC-
T ss_pred eeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HH-HHHHHhhccc-
Confidence 7654221 112235689999999999999999999999999999999999999864321 11 1111111111
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
...+......+.+++.+||+.||++||++.||++.+..
T Consensus 234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 12233445678899999999999999999999987653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=308.60 Aligned_cols=236 Identities=24% Similarity=0.320 Sum_probs=172.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.++|++.+.||+|+||.||+|+... ++.||||++..... ...+.+.+|+.++++++|+||++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3579999999999999999998764 88999999865432 234568899999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 178 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence 22456899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHH-----------HhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQ-----------LWNEG 713 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~~~~ 713 (1018)
.......||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ....... .+...
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID---QLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhhhHhhhc
Confidence 222345789999999999875 78999999999999999999999986432211 1111100 00000
Q ss_pred cc-hhhhhhhhcCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 KV-LELVDIALEGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~~-~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.. .....+.+.... .+...+.+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000001011 1123567889999999999999999999886
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=299.10 Aligned_cols=233 Identities=21% Similarity=0.250 Sum_probs=172.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc---ccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG---QGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+.++++++||||+..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999875 588999999976532 234678999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK- 188 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc-
Confidence 12356899999999999999999999999 9999999999999999999999999998654322
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ............ . .
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~-~------~ 254 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIP-R------P 254 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCC-C------G
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCC-C------c
Confidence 1222345789999999999999999999999999999999999999853211 111111111100 0 0
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcCcC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRP-AMPDVVSMLANESL 765 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~Le~~~~ 765 (1018)
...++.....+.+++.+||+.||++|| +++++++.|+....
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 011223345678899999999999999 99999999998755
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=307.12 Aligned_cols=235 Identities=17% Similarity=0.223 Sum_probs=173.4
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc-----------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR----------- 578 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~----------- 578 (1018)
++...++|++.+.||+|+||.||+|+. .+|+.||||++...... ..+|+.+++.++|+||+++.
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678999999999999999999986 45899999998654322 34799999999999987421
Q ss_pred --------------------------------------------------------CCCCCChhhHHHHHHHHHHHHHHH
Q 046791 579 --------------------------------------------------------RNNRLNWETRFSIIEGIAQGLLYL 602 (1018)
Q Consensus 579 --------------------------------------------------------~~~~l~~~~~~~i~~qia~gL~yL 602 (1018)
....+++..+..++.||++||.||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 124578888999999999999999
Q ss_pred hcCCCCcEEecccCCCcEEEc-CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccC-CCCccccchhHhHH
Q 046791 603 HKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVL 680 (1018)
Q Consensus 603 H~~~~~~ivH~Dlkp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvv 680 (1018)
|+++ |+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 99999999999998 688999999999987643322 2345789999999998874 58999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh---------------hhhcCCCChHHHHHHHHHHHhcccc
Q 046791 681 VLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD---------------IALEGSFSPNEVLRCIHVGLLCVQD 745 (1018)
Q Consensus 681 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---------------~~l~~~~~~~~~~~l~~li~~Cl~~ 745 (1018)
+|||++|+.||...... .................+.. .......+......+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~---~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI---DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999998643211 11111111111111111000 0000012233456788999999999
Q ss_pred CCCCCCCHHHHHH
Q 046791 746 QATDRPAMPDVVS 758 (1018)
Q Consensus 746 dP~~RPs~~evl~ 758 (1018)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=295.48 Aligned_cols=223 Identities=23% Similarity=0.325 Sum_probs=169.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|.+.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999875 48899999987653 3456789999999999999999831
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE---cCCCCceeeeecceeee
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARIF 639 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kL~DFGla~~~ 639 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 11256889999999999999999999999 9999999999999 45678999999999865
Q ss_pred cCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
... .......||+.|+|||.+. +.++.++||||||+++|||++|+.||..... .......... ..
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~-~~---- 242 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYK-EP---- 242 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-CC----
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccC-Cc----
Confidence 432 2233467899999999875 5689999999999999999999999854221 1111110000 00
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... .......+.+.+++.+||+.||++|||+.||++
T Consensus 243 --~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 --NYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 001113456778999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=312.67 Aligned_cols=231 Identities=19% Similarity=0.298 Sum_probs=173.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR---------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~---------------- 578 (1018)
..+|.+.+.||+|+||.||+|+...+..||+|++...... ..+|++++++++|+||+++.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999877777999988654322 24799999999999998420
Q ss_pred -------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-CCCCceeeeecceee
Q 046791 579 -------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARI 638 (1018)
Q Consensus 579 -------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kL~DFGla~~ 638 (1018)
....+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 1456888899999999999999999999 99999999999999 799999999999987
Q ss_pred ecCCCCcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
...... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... .................
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI---DQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHH
Confidence 643322 2235789999999998764 5899999999999999999999998643211 11111111111100000
Q ss_pred h--hhhh-------------hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 L--VDIA-------------LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~--~d~~-------------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+ ..+. ....+.....+.+.+|+.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 0000 000112234567889999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=301.50 Aligned_cols=227 Identities=22% Similarity=0.325 Sum_probs=180.8
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
..++|.+.+.||+|+||.||+++..+ ++.||+|++.... ....+.+.+|+.++++++|+||++.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34689999999999999999998765 7889999986542 2345678999999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 11356889999999999999999999999 9999999999999999999999999998764322
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
. ......||..|+|||++.+..++.++||||||+++|||++|+.||.... .... .......
T Consensus 196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~-~~~~~~~---------- 256 (335)
T 2owb_A 196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKET-YLRIKKN---------- 256 (335)
T ss_dssp C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHH-HHHHHHT----------
T ss_pred c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHHH-HHHHhcC----------
Confidence 2 2234678999999999999999999999999999999999999985322 1111 1111111
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS--MLAN 762 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~Le~ 762 (1018)
....+......+.+++.+||+.||++||++.|+++ .+.+
T Consensus 257 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 257 EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 11122334466788999999999999999999997 4544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=311.70 Aligned_cols=172 Identities=24% Similarity=0.309 Sum_probs=145.5
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhc------CCCcccc---------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ------HTNLTDS--------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~------H~nlv~~--------- 577 (1018)
...+|++.++||+|+||.||+|+... ++.||||+++.. .....++.+|+.++..++ |+||+..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 35689999999999999999998654 889999999754 334567888999999984 4577631
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC--ceeeeeccee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN--PKISDFGMAR 637 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~--~kL~DFGla~ 637 (1018)
.....+++..+..|+.||++||+|||+++ |+||||||+||||+.++. +||+|||++.
T Consensus 174 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 11234899999999999999999999999 999999999999999887 9999999997
Q ss_pred eecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCC
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCY 694 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~ 694 (1018)
.... ......||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 6432 122357899999999999999999999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=291.94 Aligned_cols=225 Identities=21% Similarity=0.300 Sum_probs=173.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc------cccHHHHHHHHHHHHHhcCCCcccc----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS------GQGIVEFKNEAKLIAKLQHTNLTDS---------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~H~nlv~~---------- 577 (1018)
.++|++.+.||+|+||.||+++.. +++.||||.++... ....+++.+|+.++++++||||++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999976 58999999986542 1246789999999999999999831
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC----Cceeeeeccee
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDFGMAR 637 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~----~~kL~DFGla~ 637 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 12356899999999999999999999999 99999999999998877 79999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
...... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ...........
T Consensus 161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~- 229 (283)
T 3bhy_A 161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QE-TLTNISAVNYD- 229 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HH-HHHHHHTTCCC-
T ss_pred eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HH-HHHHhHhcccC-
Confidence 764322 22345689999999999999999999999999999999999999854221 11 11111111000
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... .......+.+++.+||+.||++||++.|+++
T Consensus 230 -~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 -FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00000 0122456788999999999999999999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=316.03 Aligned_cols=226 Identities=24% Similarity=0.347 Sum_probs=179.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|.+.+.||+|+||.||+++.. +|+.||||++.+.. ......+.+|+.++++++||||+.+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999975 58999999996542 3456778999999999999999731
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 01346899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ ..
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i---------~~ 407 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRV---------LE 407 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHH---------HH
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHH---------hh
Confidence 3322 23345899999999999999999999999999999999999999965432211 11111111 11
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAM-----PDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 758 (1018)
. ...++......+.+++.+||+.||++||++ .+|++
T Consensus 408 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1 112344456778899999999999999975 56654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=304.09 Aligned_cols=226 Identities=21% Similarity=0.281 Sum_probs=174.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS-------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~-------------- 577 (1018)
..++|++.+.||+|+||.||+++.. +++.||||++...... +.+|++++.++ +||||+++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4568999999999999999999875 4889999999765432 35788888888 79999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC----CCceeeeecceeeecC
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ----MNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~----~~~kL~DFGla~~~~~ 641 (1018)
.....+++.++..++.||+.||.|||+++ |+||||||+|||+..+ +.+||+|||+++....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 23456899999999999999999999999 9999999999998533 3499999999987653
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........+...
T Consensus 173 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~~~~i~~~~~~----- 241 (342)
T 2qr7_A 173 ENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE----EILARIGSGKFS----- 241 (342)
T ss_dssp TTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH----HHHHHHHHCCCC-----
T ss_pred CCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH----HHHHHHccCCcc-----
Confidence 322 223467899999999999888999999999999999999999999643322111 111111111110
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+...........+.+++.+||+.||++||++.|+++
T Consensus 242 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 -LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111122334567889999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=296.31 Aligned_cols=222 Identities=23% Similarity=0.315 Sum_probs=178.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|.+.+.||+|+||.||+++..+ ++.||+|++.... ....+.+.+|+.++++++|+||++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4679999999999999999999764 7889999986542 2345678999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 11356889999999999999999999999 99999999999999999999999999987643222
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ....... .
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~-~~~~~~~----------~ 231 (294)
T 2rku_A 171 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KET-YLRIKKN----------E 231 (294)
T ss_dssp --CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHH-HHHHHTT----------C
T ss_pred --ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH-HHHHhhc----------c
Confidence 22346789999999999999999999999999999999999999853221 111 1111111 1
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+......+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1123334467888999999999999999999997
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=302.21 Aligned_cols=233 Identities=20% Similarity=0.303 Sum_probs=179.0
Q ss_pred eHHHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--------ccHHHHHHHHHHHHHh-cCCCccc
Q 046791 507 DFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--------QGIVEFKNEAKLIAKL-QHTNLTD 576 (1018)
Q Consensus 507 ~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l-~H~nlv~ 576 (1018)
.........++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.++ +||||+.
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34445666788999999999999999999986 699999999865431 1245688999999999 8999973
Q ss_pred c--------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCcee
Q 046791 577 S--------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKI 630 (1018)
Q Consensus 577 ~--------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL 630 (1018)
. .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 1 11346889999999999999999999999 999999999999999999999
Q ss_pred eeecceeeecCCCCcccceeeecccccCChhhhcc------CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHH
Q 046791 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS------GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG 704 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~ 704 (1018)
+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ...
T Consensus 242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------~~~ 312 (365)
T 2y7j_A 242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR------QIL 312 (365)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHH
T ss_pred EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC------HHH
Confidence 9999998765322 2234679999999999864 358899999999999999999999985321 111
Q ss_pred HHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 705 YAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 705 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. ......+.... ..+.. ......+.+++.+||+.||++||++.|+++
T Consensus 313 ~-~~~i~~~~~~~-~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 M-LRMIMEGQYQF-SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H-HHHHHHTCCCC-CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-HHHHHhCCCCC-CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 11111111000 00000 122356889999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=307.21 Aligned_cols=229 Identities=21% Similarity=0.312 Sum_probs=177.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEe----cccccceEEEecccc----cccHHHHHHHHHHHHHh-cCCCcccc--------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL----LNGQEVAIKRLSRRS----GQGIVEFKNEAKLIAKL-QHTNLTDS-------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nlv~~-------- 577 (1018)
.++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +|+||+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 368899999987542 23446678899999999 69998731
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~ 639 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 12356889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCcccceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~------ 280 (355)
T 1vzo_A 210 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILK------ 280 (355)
T ss_dssp CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHH------
T ss_pred ccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhc------
Confidence 43221 22334579999999999986 4578999999999999999999999864432221 1111111110
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVSML 760 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~L 760 (1018)
.....+......+.+++.+||+.||++|| ++.|+++..
T Consensus 281 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 281 -----SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11223444556788999999999999999 999998743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=294.24 Aligned_cols=217 Identities=21% Similarity=0.285 Sum_probs=171.9
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHh-cCCCccccc-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKL-QHTNLTDSR----------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l-~H~nlv~~~----------- 578 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+..+.++ +||||++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999876 5899999998754 234456789999999999 999998310
Q ss_pred -------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---------------
Q 046791 579 -------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD--------------- 624 (1018)
Q Consensus 579 -------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~--------------- 624 (1018)
....+++.++..++.||++||.|||+++ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 1156899999999999999999999999 999999999999984
Q ss_pred ----CCCceeeeecceeeecCCCCcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCC
Q 046791 625 ----QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP 699 (1018)
Q Consensus 625 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~ 699 (1018)
...+||+|||++...... ....||+.|+|||.+.+. .++.++||||||+++|||++|.+++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence 447999999999876432 124589999999999875 6678999999999999999999775311
Q ss_pred CchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 700 LNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 700 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.. ......+.. ...+......+.+++.+||+.||++|||+.|+++
T Consensus 235 -~~----~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 -DQ----WHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HH----HHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hH----HHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00 111111111 1223344567889999999999999999999886
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=312.75 Aligned_cols=239 Identities=22% Similarity=0.318 Sum_probs=160.5
Q ss_pred hCCcce-eeeeccCCCcCeEEEEec---ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccccC-----------
Q 046791 515 TNNFSA-VNKLGEGGFGPVYKGQLL---NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSRR----------- 579 (1018)
Q Consensus 515 t~~y~~-~~~lG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~~----------- 579 (1018)
.+.|++ .++||+|+||.||+|+.. +++.||||++.... ....+.+|+.++++++||||+.+..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345666 458999999999999965 47889999997543 2357889999999999999984210
Q ss_pred -------------------------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE----cCCCCcee
Q 046791 580 -------------------------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL----DDQMNPKI 630 (1018)
Q Consensus 580 -------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl----d~~~~~kL 630 (1018)
...+++..+..|+.||+.||.|||+++ |+||||||+|||| +.++.+||
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 113888999999999999999999999 9999999999999 77889999
Q ss_pred eeecceeeecCCCC-cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCC------Cch
Q 046791 631 SDFGMARIFGLNQS-ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP------LNL 702 (1018)
Q Consensus 631 ~DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~------~~l 702 (1018)
+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....+.. ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987643221 123345688999999999987 4589999999999999999999999965433210 011
Q ss_pred HHHHHHHhhcCc---ch---------hhhhhhhcC------------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 703 IGYAWQLWNEGK---VL---------ELVDIALEG------------SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 703 ~~~~~~~~~~~~---~~---------~~~d~~l~~------------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.......+.... .. ......... .........+.+|+.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111110000 00 000000000 000111356788999999999999999999988
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=294.41 Aligned_cols=223 Identities=25% Similarity=0.357 Sum_probs=170.8
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
.|.....||+|+||.||+|+.. +++.||||.+........+.+.+|+.++++++|+||++.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555569999999999999864 588999999987766667889999999999999999731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-CCCceeeeecceeeecCCCCc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 01224568888999999999999999999 999999999999987 8999999999998764322
Q ss_pred ccceeeecccccCChhhhccCC--CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGV--VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.||....... ..... ......
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~---------~~~~~~ 243 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFK---------VGMFKV 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHH---------HHHHCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHh---------hccccc
Confidence 1223457899999999997643 8899999999999999999999985322110 00000 000111
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+......+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22334445677889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=299.15 Aligned_cols=239 Identities=22% Similarity=0.292 Sum_probs=174.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR--------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~--------------- 578 (1018)
.++|++.+.||+|+||.||+|+... ++.||||++........+++.+|+.++++++||||++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999765 889999999876666678899999999999999998531
Q ss_pred -----------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-CCCCceeeeec
Q 046791 579 -----------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFG 634 (1018)
Q Consensus 579 -----------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kL~DFG 634 (1018)
....+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+||+|||
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCc
Confidence 1345788999999999999999999999 99999999999997 56789999999
Q ss_pred ceeeecCCCC-cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 635 MARIFGLNQS-ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 635 la~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~~~ 240 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL------EQMQLILES 240 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHh
Confidence 9987642211 112223456889999998875 78999999999999999999999998643211 111111110
Q ss_pred Cc-------------chhhhhhhhc-CCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 046791 713 GK-------------VLELVDIALE-GSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS--MLAN 762 (1018)
Q Consensus 713 ~~-------------~~~~~d~~l~-~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~Le~ 762 (1018)
.. ....+..... ... .+.....+.+++.+||+.||++|||+.|+++ .+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 00 0000000010 001 1123567889999999999999999999987 4543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=302.34 Aligned_cols=228 Identities=26% Similarity=0.380 Sum_probs=175.4
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-ccc--ceEEEeccc-ccccHHHHHHHHHHHHHh-cCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQE--VAIKRLSRR-SGQGIVEFKNEAKLIAKL-QHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~~--vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nlv~~------------- 577 (1018)
++|++.+.||+|+||.||+|+... +.. ||||.+... .....+.+.+|++++.++ +||||++.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 579999999999999999998654 554 599998653 334456799999999999 99999731
Q ss_pred -------------c----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCc
Q 046791 578 -------------R----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 578 -------------~----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
. ....+++.+++.++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 0 1136899999999999999999999999 9999999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~ 707 (1018)
||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. ..
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~-~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AE-LY 251 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH-HH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HH-HH
Confidence 9999999974321 112223456789999999999899999999999999999998 9999853221 11 11
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
..... ......+......+.+++.+||+.||++||++.|+++.|+....
T Consensus 252 ~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 252 EKLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HHGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11122333455778899999999999999999999999987544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=310.21 Aligned_cols=221 Identities=22% Similarity=0.272 Sum_probs=165.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccc---cccHHHHHHHHHH-HHHhcCCCcccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRS---GQGIVEFKNEAKL-IAKLQHTNLTDS------------ 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~f~~E~~~-l~~l~H~nlv~~------------ 577 (1018)
.++|++.+.||+|+||.||+++... ++.||||++++.. ......+..|..+ ++.++||||+++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3579999999999999999999764 7889999997653 2334456777776 577899999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 12356888999999999999999999999 999999999999999999999999999853222
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....... ++...
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~---------i~~~~- 255 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDN---------ILNKP- 255 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHH---------HHHSC-
T ss_pred -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHH---------HHhcc-
Confidence 122345689999999999999999999999999999999999999985321 1111111 11111
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVV 757 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 757 (1018)
..+++.....+.+++.+||+.||.+||++.+.+
T Consensus 256 -~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 256 -LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 122334456788999999999999999985433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=305.41 Aligned_cols=226 Identities=15% Similarity=0.126 Sum_probs=178.0
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEE------ecccccceEEEecccccccHHHHHHHHHHHHHhc---CCCcccc-----
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQ------LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ---HTNLTDS----- 577 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~------~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---H~nlv~~----- 577 (1018)
+...++|.+.++||+|+||.||+|+ ..+++.||||+++.. ...++..|++++.+++ |+|++..
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456889999999999999999994 445889999999654 3567888888888887 8887620
Q ss_pred --------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-------
Q 046791 578 --------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD------- 624 (1018)
Q Consensus 578 --------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~------- 624 (1018)
.....+++..++.|+.||++||+|||+++ |+||||||+||||+.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 12456999999999999999999999999 999999999999998
Q ss_pred ----CCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCC
Q 046791 625 ----QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700 (1018)
Q Consensus 625 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~ 700 (1018)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 89999999999987653333344455679999999999999999999999999999999999999984322110
Q ss_pred chHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHhcCc
Q 046791 701 NLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDR-PAMPDVVSMLANES 764 (1018)
Q Consensus 701 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-Ps~~evl~~Le~~~ 764 (1018)
..+...+... ...+.+.+++..|++.+|.+| |+++++.+.|+...
T Consensus 293 ----------------~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 ----------------CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ----------------EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ----------------eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0011111111 124456678889999999999 68888888888653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=301.40 Aligned_cols=234 Identities=21% Similarity=0.293 Sum_probs=179.0
Q ss_pred eeHHHHHHHhCCccee-eeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhc-CCCcccc---
Q 046791 506 FDFQTISAATNNFSAV-NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQ-HTNLTDS--- 577 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~-~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~-H~nlv~~--- 577 (1018)
..++..+...++|.+. +.||+|+||.||+|+.. +++.||||++.... .....++.+|+.++.++. ||||+++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4455566677889888 89999999999999876 48999999987543 344678999999999995 5998731
Q ss_pred -------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---CCCce
Q 046791 578 -------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPK 629 (1018)
Q Consensus 578 -------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~k 629 (1018)
.....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 12356899999999999999999999999 999999999999997 78999
Q ss_pred eeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH
Q 046791 630 ISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 630 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....
T Consensus 175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~- 244 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------ETYLN- 244 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-
T ss_pred EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHH-
Confidence 99999998764322 223467999999999999999999999999999999999999998542211 11000
Q ss_pred hhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 710 WNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... ..............+.+++.+||+.||++|||++|+++
T Consensus 245 i~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 245 ISQVN------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHTC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhcc------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00000 00011112234567889999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=298.86 Aligned_cols=233 Identities=21% Similarity=0.258 Sum_probs=175.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHhc-----------CCCcccc-----
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-----------HTNLTDS----- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~nlv~~----- 577 (1018)
.++|.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++ |+||++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999986 45889999999743 334567899999999987 7787631
Q ss_pred --------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEc------C
Q 046791 578 --------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLD------D 624 (1018)
Q Consensus 578 --------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld------~ 624 (1018)
.....+++..+..++.||+.||+|||++ + |+||||||+|||++ .
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcC
Confidence 1134588999999999999999999998 8 99999999999994 4
Q ss_pred CCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHH
Q 046791 625 QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG 704 (1018)
Q Consensus 625 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~ 704 (1018)
.+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 457999999999876422 223578999999999999999999999999999999999999997544322111111
Q ss_pred HHHHHhh-cCcc--------------------------------hhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCC
Q 046791 705 YAWQLWN-EGKV--------------------------------LELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRP 751 (1018)
Q Consensus 705 ~~~~~~~-~~~~--------------------------------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 751 (1018)
....... -+.. .+.+. .....+......+.+|+.+||+.||++||
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCccccC
Confidence 1111100 0000 00000 01234567788899999999999999999
Q ss_pred CHHHHHH
Q 046791 752 AMPDVVS 758 (1018)
Q Consensus 752 s~~evl~ 758 (1018)
|+.||++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999988
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=298.30 Aligned_cols=229 Identities=21% Similarity=0.306 Sum_probs=176.9
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
..++|.+.+.||+|+||.||+++.. +|+.||||++........+.+.+|+.++++++||||+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999875 588999999986655556679999999999999999731
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE---cCCCCceeeeecceeeecCCC
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 12346789999999999999999999999 9999999999999 7889999999999875432
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .. .......+.. ..
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~-~~~~i~~~~~------~~ 226 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SK-LFEKIKEGYY------EF 226 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HH-HHHHHHHCCC------CC
T ss_pred --CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HH-HHHHHHcCCC------CC
Confidence 122235689999999999999999999999999999999999999853221 11 1111111110 00
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS--MLAN 762 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~Le~ 762 (1018)
...........+.+++.+||+.||++||++.|+++ .+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 11122334567889999999999999999999987 4443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=298.27 Aligned_cols=227 Identities=25% Similarity=0.331 Sum_probs=172.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--------cccHHHHHHHHHHHHHhcCCCccc--------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--------GQGIVEFKNEAKLIAKLQHTNLTD-------- 576 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nlv~-------- 576 (1018)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||++
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999875 48899999986542 122345889999999999999973
Q ss_pred -----------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC---ceeeeecce
Q 046791 577 -----------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDFGMA 636 (1018)
Q Consensus 577 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kL~DFGla 636 (1018)
+.....+++..+..++.||++||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 123457889999999999999999999999 999999999999987654 999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG 713 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 713 (1018)
+..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+.... ..+
T Consensus 165 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----~~~ 235 (322)
T 2ycf_A 165 KILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----TSG 235 (322)
T ss_dssp EECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----HHT
T ss_pred eecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----HhC
Confidence 876422 1223456899999999974 4678999999999999999999999986543221 111111 111
Q ss_pred cchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 KVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... +.. .......+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~--~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KYNFI--PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCCC--HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccC--chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11000 000 0123467889999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=300.77 Aligned_cols=239 Identities=22% Similarity=0.275 Sum_probs=176.3
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... .....++.+|+.++++++|+||++..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999875 58899999996543 33456788999999999999998421
Q ss_pred ----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 579 ----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 579 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 1245889999999999999999999999 999999999999999999999999999876532
Q ss_pred CCcc--------cceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC
Q 046791 643 QSET--------NTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG 713 (1018)
Q Consensus 643 ~~~~--------~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 713 (1018)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~ 242 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGIIGTP 242 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCC
Confidence 2111 1223578999999998765 789999999999999999999999986432110 011111111000
Q ss_pred c------------chhhhhhhhcC-C-----CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 K------------VLELVDIALEG-S-----FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~------------~~~~~d~~l~~-~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. ..+.+...... . ..+.....+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00000000000 0 01233467789999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=306.22 Aligned_cols=239 Identities=18% Similarity=0.213 Sum_probs=170.0
Q ss_pred HHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------
Q 046791 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------- 577 (1018)
Q Consensus 509 ~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------- 577 (1018)
.+.....++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|++.+..++||||+++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455677889999999999999999999975 58899999986543 334567888999999999999842
Q ss_pred --------------------------cCCCCCChhhHHHHHHHHHHHHHHHh--cCCCCcEEecccCCCcEEEcC-CCCc
Q 046791 578 --------------------------RRNNRLNWETRFSIIEGIAQGLLYLH--KYSRLRVIHRDLKASNILLDD-QMNP 628 (1018)
Q Consensus 578 --------------------------~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~ivH~Dlkp~NILld~-~~~~ 628 (1018)
.....+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 12345778888999999999999999 888 999999999999996 8999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~ 707 (1018)
||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .......
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~ 245 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIV 245 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHH
Confidence 9999999987653322 2235689999999998764 4899999999999999999999998643211 1111111
Q ss_pred HHhhcCcchhhhhh-------------------hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 708 QLWNEGKVLELVDI-------------------ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~-------------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... ...+.+.. .............+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 246 RVLGC-PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCC-CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHcCC-CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11100 00000000 0011122335678999999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=305.07 Aligned_cols=223 Identities=18% Similarity=0.196 Sum_probs=165.5
Q ss_pred hCCccee-eeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHH-HhcCCCcccc--------------
Q 046791 515 TNNFSAV-NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIA-KLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~-~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~-~l~H~nlv~~-------------- 577 (1018)
.++|.+. +.||+|+||.||+++.. +++.||||++... ..+.+|+.++. ..+|+||+++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 78999999999999875 4889999998532 46788888874 4589998731
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---CCCceeeeecce
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMA 636 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kL~DFGla 636 (1018)
.....+++.++..|+.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 01235899999999999999999999999 999999999999997 788999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCc-hHHHHHHHhhcCcc
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLN-LIGYAWQLWNEGKV 715 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~ 715 (1018)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .... ...+..
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~ 284 (400)
T 1nxk_A 212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCC
T ss_pred cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCcc
Confidence 875422 22335678999999999999999999999999999999999999996543322111 1111 111110
Q ss_pred hhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 716 LELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 716 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. ............+.+|+.+||+.||++|||+.||++
T Consensus 285 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp C------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 000011234567889999999999999999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=315.87 Aligned_cols=225 Identities=26% Similarity=0.340 Sum_probs=174.6
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
..++|++.++||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999875 5889999998654 23456789999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc---CCCCceeeeecceeeecC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 12356899999999999999999999999 99999999999995 456799999999986543
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
. .......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... .... .....+....
T Consensus 177 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~-~~i~~~~~~~---- 241 (486)
T 3mwu_A 177 N---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDIL-KRVETGKYAF---- 241 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHTCCCS----
T ss_pred C---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH-HHHHhCCCCC----
Confidence 2 22234579999999999875 599999999999999999999999853221 1111 1111111100
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...........+.+++.+||+.||++|||+.|+++
T Consensus 242 --~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 --DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp --CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00001233467889999999999999999999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=326.10 Aligned_cols=223 Identities=22% Similarity=0.294 Sum_probs=178.5
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccc---ccccHHHHHHHHHHHHHh-cCCCcccc-----------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRR---SGQGIVEFKNEAKLIAKL-QHTNLTDS----------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nlv~~----------- 577 (1018)
..++|++.+.||+|+||.||+|+... ++.||||++++. .....+.+..|..++..+ +|++|+.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45789999999999999999998754 788999999754 234566788999999987 78888631
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 12356899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+
T Consensus 496 ~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~-~~--------- 557 (674)
T 3pfq_A 496 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM-EH--------- 557 (674)
T ss_dssp T--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-SS---------
T ss_pred C--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHH-hC---------
Confidence 2 234457899999999999999999999999999999999999999864221 11111111 11
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAM-----PDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 758 (1018)
...++.....++.+|+.+||+.||++||++ +||++
T Consensus 558 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 112444556788899999999999999997 67664
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=301.31 Aligned_cols=235 Identities=26% Similarity=0.392 Sum_probs=174.1
Q ss_pred ccceeHHHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc---
Q 046791 503 LEIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS--- 577 (1018)
Q Consensus 503 ~~~f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~--- 577 (1018)
+..+++.++....++|++.+.||+|+||.||+|+.. +++.||||++.... ....++.+|+.++.++ +|+||+..
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 344566667778899999999999999999999874 58899999986543 3457899999999999 89998731
Q ss_pred -------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC
Q 046791 578 -------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM 626 (1018)
Q Consensus 578 -------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~ 626 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence 01245788899999999999999999999 99999999999999999
Q ss_pred CceeeeecceeeecCCCCcccceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCc
Q 046791 627 NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLN 701 (1018)
Q Consensus 627 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~ 701 (1018)
.+||+|||++....... .......|++.|+|||++. +..++.++||||||+++|||++|+.||.....
T Consensus 167 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----- 239 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----- 239 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----
Confidence 99999999998654221 1223457899999999987 56789999999999999999999999853221
Q ss_pred hHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 702 LIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 702 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.......... . ............+.+++.+||+.||++||++.|+++
T Consensus 240 -~~~~~~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 -MRALFLIPRN-P--------APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -HHHHHHHHHS-C--------CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHHHhhcC-c--------cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111111 0 001112233467889999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=295.52 Aligned_cols=226 Identities=20% Similarity=0.320 Sum_probs=173.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
..++|++.+.||+|+||.||+|+... ++.||+|++........+.+.+|+.++++++||||++.
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 34689999999999999999999764 88999999987777778899999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L 171 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence 11356899999999999999999999999 999999999999999999999999997543211 1
Q ss_pred ccceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 646 TNTNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.......||+.|+|||++. +..++.++||||||+++|||++|+.||..... .......... ...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~---- 240 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKS-DPP---- 240 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS-CCC----
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhcc-CCc----
Confidence 1122357899999999984 67789999999999999999999999864321 1111111111 000
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+......+.+++.+||+.||++|||+.|+++
T Consensus 241 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 ---TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00112233567889999999999999999999876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=298.45 Aligned_cols=235 Identities=23% Similarity=0.371 Sum_probs=159.0
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++.+++||||++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999864 58899999986543 3345678999999999999999731
Q ss_pred --------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeeccee
Q 046791 578 --------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMAR 637 (1018)
Q Consensus 578 --------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~ 637 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 02345899999999999999999999999 9999999999999999999999999997
Q ss_pred eecCCCC---cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC
Q 046791 638 IFGLNQS---ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG 713 (1018)
Q Consensus 638 ~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 713 (1018)
....... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .. ......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~~- 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---MLTLQN- 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHTS-
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HHHhcc-
Confidence 6543211 112234578999999999876 578999999999999999999999986543211 11 111111
Q ss_pred cchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 KVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....................+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111110000111112233457888999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=317.46 Aligned_cols=225 Identities=25% Similarity=0.345 Sum_probs=177.2
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
..++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999876 58999999986542 3456789999999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE---cCCCCceeeeecceeeec
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL---DDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kL~DFGla~~~~ 640 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 23467899999999999999999999999 9999999999999 567889999999998764
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... .... .....+....
T Consensus 181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~-~~i~~~~~~~--- 246 (484)
T 3nyv_A 181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDIL-KKVEKGKYTF--- 246 (484)
T ss_dssp CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHCCCCC---
T ss_pred ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHH-HHHHcCCCCC---
Confidence 322 2234579999999999876 699999999999999999999999864321 1111 1111111100
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.........+.+.+++.+||+.||.+|||+.|+++
T Consensus 247 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ---ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ---CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00011234567889999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=305.51 Aligned_cols=237 Identities=21% Similarity=0.302 Sum_probs=177.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++|+||+.+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999876 58899999997653 3345679999999999999999831
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 184 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc----
Confidence 1234688899999999999999999996 7 99999999999999999999999999875431
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchH----------------------
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI---------------------- 703 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~---------------------- 703 (1018)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 1223457899999999999999999999999999999999999998643211000000
Q ss_pred -HHHHHHhhcCcchhhhhhhhcCC----CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 704 -GYAWQLWNEGKVLELVDIALEGS----FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 704 -~~~~~~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+...........+.++...... ........+.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000111122222222211 11223567889999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=290.79 Aligned_cols=223 Identities=26% Similarity=0.368 Sum_probs=172.6
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
+.|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||++.
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788899999999999999875 47789999986542 3445679999999999999999832
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-CCCCceeeeecceeeecC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||++||.|||+++ .+|+||||||+|||++ .++.+||+|||++.....
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 11256888999999999999999999986 3599999999999998 789999999999975432
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.......||+.|+|||.+. +.++.++||||||+++|||++|+.||..... .. ........+.....
T Consensus 185 ----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~-~~~~~~~~~~~~~~--- 250 (290)
T 1t4h_A 185 ----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AA-QIYRRVTSGVKPAS--- 250 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HH-HHHHHHTTTCCCGG---
T ss_pred ----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HH-HHHHHHhccCCccc---
Confidence 2233457899999999876 4589999999999999999999999853221 11 11111111111111
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+....+.+.+++.+||+.||.+|||+.|+++
T Consensus 251 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11222356889999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=300.96 Aligned_cols=242 Identities=23% Similarity=0.320 Sum_probs=172.9
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
....++|++.+.||+|+||.||+|+... .||||+++... ....+.+.+|+.++++++|+||++.
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3346789999999999999999998743 69999986542 3334568899999999999999731
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++ ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 11236899999999999999999999999 99999999999998 679999999998765321
Q ss_pred C---CcccceeeecccccCChhhhcc---------CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh
Q 046791 643 Q---SETNTNRVVGTYGYMSPEYAMS---------GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 643 ~---~~~~~~~~~gt~~Y~aPE~~~~---------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
. .........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...... .
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~-~ 255 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EAIIWQ-M 255 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HHHHHH-H
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-h
Confidence 1 1122234568999999999874 4578999999999999999999999853221 111111 1
Q ss_pred hcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCCCCCCCc
Q 046791 711 NEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPA 774 (1018)
Q Consensus 711 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp~p~~p~ 774 (1018)
..+... . .........+.+++.+||+.||++|||+.+|+++|+...........|.
T Consensus 256 ~~~~~~-----~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~ 311 (319)
T 2y4i_B 256 GTGMKP-----N---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG 311 (319)
T ss_dssp HTTCCC-----C---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------
T ss_pred ccCCCC-----C---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence 111110 0 0111233567889999999999999999999999998765444433333
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=291.00 Aligned_cols=221 Identities=23% Similarity=0.342 Sum_probs=168.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+||++.
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999976 58999999986542 3445689999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||++||.|||+++ |+|+||||+|||++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence 12346789999999999999999999999 9999999999999999999999999998654321
Q ss_pred cccceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.... .. ........+.
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~-~~~~~~~~~~--------- 227 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VP-TLFKKIRGGV--------- 227 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HH-HHHHHHHHCC---------
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HH-HHHHHhhcCc---------
Confidence 2234578999999999987765 689999999999999999999985321 11 1111111110
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+......+.+++.+||+.||++|||+.||++
T Consensus 228 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 -FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1122334467888999999999999999999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=303.15 Aligned_cols=234 Identities=21% Similarity=0.270 Sum_probs=174.0
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR------------ 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~------------ 578 (1018)
..++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+.++++++||||+.+.
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999865 58899999997643 23356789999999999999998421
Q ss_pred -----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 579 -----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 579 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 1234889999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC-------
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG------- 713 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------- 713 (1018)
. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .............
T Consensus 197 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 197 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHHTT
T ss_pred C-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCcHHHHHH
Confidence 2 233567999999999987 78999999999999999999999998643211 1111111100000
Q ss_pred ----cchhhhhhhhcCC------CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 ----KVLELVDIALEGS------FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ----~~~~~~d~~l~~~------~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
............. ..+...+.+.+|+.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000000000 01223567889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-31 Score=298.28 Aligned_cols=233 Identities=21% Similarity=0.273 Sum_probs=174.7
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+.++++++||||++..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999875 58999999996542 23356789999999999999998421
Q ss_pred ----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 579 ----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 579 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA- 178 (353)
T ss_dssp CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence 1235789999999999999999999999 99999999999999999999999999976432
Q ss_pred CCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC--------
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG-------- 713 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 713 (1018)
......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .............
T Consensus 179 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 179 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCHHHHTTC
T ss_pred ----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHHH
Confidence 1234578999999999987 78899999999999999999999998643211 1111111110000
Q ss_pred ---cchhhhhhhh---c---CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 ---KVLELVDIAL---E---GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ---~~~~~~d~~l---~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.....+.... . ....+.....+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0 0112344678889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=313.54 Aligned_cols=225 Identities=26% Similarity=0.344 Sum_probs=173.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccccc-------------ccHHHHHHHHHHHHHhcCCCcccc--
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG-------------QGIVEFKNEAKLIAKLQHTNLTDS-- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~-------------~~~~~f~~E~~~l~~l~H~nlv~~-- 577 (1018)
..++|.+.++||+|+||.||+|+... ++.||||++..... ...+++.+|+.++++++||||+++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 56789999999999999999999764 78999999865421 335679999999999999999831
Q ss_pred ------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC---Ccee
Q 046791 578 ------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM---NPKI 630 (1018)
Q Consensus 578 ------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kL 630 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEE
Confidence 12356899999999999999999999999 99999999999998775 6999
Q ss_pred eeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh
Q 046791 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
+|||+++...... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||..... .. .....
T Consensus 191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~-~~~~i 259 (504)
T 3q5i_A 191 VDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND------QD-IIKKV 259 (504)
T ss_dssp CCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHH
T ss_pred EECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HH-HHHHH
Confidence 9999998765332 233467999999999987 4689999999999999999999999864221 11 11111
Q ss_pred hcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 711 NEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 711 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+....... . .......+.+++.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~-~-----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 EKGKYYFDFN-D-----WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHCCCCCCHH-H-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCCCCCcc-c-----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111100000 0 0123467889999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=314.05 Aligned_cols=225 Identities=25% Similarity=0.319 Sum_probs=170.8
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999975 58899999997643 3446789999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---CCCceeeeecceeeecC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 12346889999999999999999999999 999999999999976 45599999999987653
Q ss_pred CCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
.. ......||+.|+|||++. +.++.++|||||||++|||++|+.||..... ... ......+.... ..+
T Consensus 192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~-~~~i~~~~~~~-~~~ 259 (494)
T 3lij_A 192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEI-LRKVEKGKYTF-DSP 259 (494)
T ss_dssp TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHTCCCC-CSG
T ss_pred Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHH-HHHHHhCCCCC-Cch
Confidence 22 233467999999999886 5699999999999999999999999864321 111 11111111100 000
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
........+.+++.+||+.||.+|||+.|+++
T Consensus 260 -----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 -----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00123467889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=297.88 Aligned_cols=230 Identities=19% Similarity=0.255 Sum_probs=176.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEeccccccc-----------------HHHHHHHHHHHHHhcCCCccc-
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQG-----------------IVEFKNEAKLIAKLQHTNLTD- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~-----------------~~~f~~E~~~l~~l~H~nlv~- 576 (1018)
.++|.+.+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++.+++||||+.
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999998 89999999986542211 178999999999999999872
Q ss_pred -------------------------------ccC--CCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEE
Q 046791 577 -------------------------------SRR--NNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILL 622 (1018)
Q Consensus 577 -------------------------------~~~--~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILl 622 (1018)
+.. ...+++..+..++.||++||.|||+ ++ |+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 111 4568899999999999999999999 88 9999999999999
Q ss_pred cCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccC-CCCc-cccchhHhHHHHHHHhCCCCCCCCCCCCCC
Q 046791 623 DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG-VVSI-KTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700 (1018)
Q Consensus 623 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-ksDV~SlGvvl~elltG~~p~~~~~~~~~~ 700 (1018)
+.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence 99999999999999876432 23346789999999999887 6666 999999999999999999998643321
Q ss_pred chHHHHHHHhhcCcchhh------hhhhh---cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 701 NLIGYAWQLWNEGKVLEL------VDIAL---EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 701 ~l~~~~~~~~~~~~~~~~------~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. ........+..... ..+.. ...........+.+++.+||+.||++||++.|+++
T Consensus 259 --~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --V-ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --H-HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --H-HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 11111111111000 00000 00011334567889999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=297.98 Aligned_cols=231 Identities=19% Similarity=0.220 Sum_probs=175.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEe--cccccceEEEecccccccHHHHHHHHHHHHHhcCCC------cccc---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL--LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN------LTDS--------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n------lv~~--------- 577 (1018)
.++|++.+.||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+.++++++|++ ++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 35889999999654 344567899999999998876 4420
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---------------
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD--------------- 624 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~--------------- 624 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccc
Confidence 11236889999999999999999999999 999999999999987
Q ss_pred ----CCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCC
Q 046791 625 ----QMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700 (1018)
Q Consensus 625 ----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~ 700 (1018)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-- 241 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-- 241 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH--
T ss_pred ccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH--
Confidence 678999999999864321 224578999999999999999999999999999999999999986433211
Q ss_pred chHHHHHHHhhcCcchhhhh------------------------------hh-hcCCCChHHHHHHHHHHHhccccCCCC
Q 046791 701 NLIGYAWQLWNEGKVLELVD------------------------------IA-LEGSFSPNEVLRCIHVGLLCVQDQATD 749 (1018)
Q Consensus 701 ~l~~~~~~~~~~~~~~~~~d------------------------------~~-l~~~~~~~~~~~l~~li~~Cl~~dP~~ 749 (1018)
......... ......... +. ..........+.+.+++.+||+.||++
T Consensus 242 -~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 242 -HLAMMERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp -HHHHHHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred -HHHHHHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 111111111 000000000 00 001123455678999999999999999
Q ss_pred CCCHHHHHH
Q 046791 750 RPAMPDVVS 758 (1018)
Q Consensus 750 RPs~~evl~ 758 (1018)
|||+.|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=293.93 Aligned_cols=237 Identities=24% Similarity=0.330 Sum_probs=176.5
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEe--cccccceEEEeccccc--ccHHHHHHHHHHHHHh---cCCCccccc-------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQL--LNGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKL---QHTNLTDSR------- 578 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~--~~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l---~H~nlv~~~------- 578 (1018)
.+.++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.+++++ +||||++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4568999999999999999999997 3588999999865432 2234577888887777 899987421
Q ss_pred -------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeee
Q 046791 579 -------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDF 633 (1018)
Q Consensus 579 -------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DF 633 (1018)
....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 1234889999999999999999999999 999999999999999999999999
Q ss_pred cceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC
Q 046791 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG 713 (1018)
Q Consensus 634 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 713 (1018)
|+++..... .......||..|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 165 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~ 238 (326)
T 1blx_A 165 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLP 238 (326)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCC
T ss_pred cccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCC
Confidence 999865421 2233467899999999999999999999999999999999999998643211 1111111111000
Q ss_pred cchhh------hhhhh-------cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 KVLEL------VDIAL-------EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~~~~~------~d~~l-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... ..... ...........+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 00000 00112234567789999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=289.21 Aligned_cols=226 Identities=21% Similarity=0.266 Sum_probs=175.7
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---------cccHHHHHHHHHHHHHhc-CCCcccc-----
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---------GQGIVEFKNEAKLIAKLQ-HTNLTDS----- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---------~~~~~~f~~E~~~l~~l~-H~nlv~~----- 577 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.++. ||||++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999875 58899999986542 122456889999999996 9999831
Q ss_pred ---------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecce
Q 046791 578 ---------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMA 636 (1018)
Q Consensus 578 ---------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla 636 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccch
Confidence 12346889999999999999999999999 999999999999999999999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhc------cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAM------SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
....... ......+++.|+|||++. ...++.++||||||+++|||++|+.||..... ... ....
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~-~~~~ 241 (298)
T 1phk_A 172 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLM-LRMI 241 (298)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHH
T ss_pred hhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHH-HHHH
Confidence 8765322 223457899999999985 45688999999999999999999999853211 111 1111
Q ss_pred hcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 711 NEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 711 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+... ............+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111100 000111234567889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=291.54 Aligned_cols=224 Identities=26% Similarity=0.367 Sum_probs=173.0
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
..++|++.+.||+|+||.||+|+... |+.||||.+.... ..+++.+|+.++.+++|+||+..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 45789999999999999999998764 8999999997543 45789999999999999999731
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 12457899999999999999999999999 99999999999999999999999999987643222
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .... ...
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~-------~~~ 245 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIP-TNPP-------PTF 245 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH-HSCC-------CCC
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHh-cCCC-------ccc
Confidence 22345789999999999999999999999999999999999999853221 11111110 0000 000
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+......+.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112233467889999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=298.17 Aligned_cols=174 Identities=24% Similarity=0.338 Sum_probs=144.7
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhc-CCC-----cccc-------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTN-----LTDS------- 577 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~n-----lv~~------- 577 (1018)
....++|++.+.||+|+||.||+|+.. +++.||||+++.. .....++..|+.++..++ |++ ++.+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 345689999999999999999999865 4789999999753 334567888999999986 554 4321
Q ss_pred --------------------cCCCCCChhhHHHHHHHHHHHHHHHhc--CCCCcEEecccCCCcEEEc--CCCCceeeee
Q 046791 578 --------------------RRNNRLNWETRFSIIEGIAQGLLYLHK--YSRLRVIHRDLKASNILLD--DQMNPKISDF 633 (1018)
Q Consensus 578 --------------------~~~~~l~~~~~~~i~~qia~gL~yLH~--~~~~~ivH~Dlkp~NILld--~~~~~kL~DF 633 (1018)
.....+++..+..++.||+.||.|||+ .+ |+||||||+|||++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 112458999999999999999999995 45 99999999999994 5788999999
Q ss_pred cceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCC
Q 046791 634 GMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCY 694 (1018)
Q Consensus 634 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~ 694 (1018)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999876422 22457899999999999999999999999999999999999998643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=308.15 Aligned_cols=217 Identities=15% Similarity=0.150 Sum_probs=165.9
Q ss_pred HHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcC-CCcc-----------
Q 046791 512 SAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQH-TNLT----------- 575 (1018)
Q Consensus 512 ~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H-~nlv----------- 575 (1018)
...+.+|...++||+|+||.||+|+.. +|+.||||++.... ....+.|.+|+.+++.++| +|..
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 344556888899999999999999954 58999999987433 2336789999999999987 2210
Q ss_pred ----c-------------------------------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCC
Q 046791 576 ----D-------------------------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608 (1018)
Q Consensus 576 ----~-------------------------------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~ 608 (1018)
. ......+++..++.|+.||++||+|||+++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 0 001233667788999999999999999999
Q ss_pred cEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhh----------ccCCCCccccchhHh
Q 046791 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA----------MSGVVSIKTDVFSFG 678 (1018)
Q Consensus 609 ~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~ksDV~SlG 678 (1018)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 999999999999999999999999999865321 334567 999999999 555688999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 679 VLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 679 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
|++|||++|+.||....... ..+..+... ...++.+.+|+.+||+.||++||++.|+++
T Consensus 305 vil~elltg~~Pf~~~~~~~-------------------~~~~~~~~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALG-------------------GSEWIFRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGS-------------------CSGGGGSSC--CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHCCCCCCCcchhh-------------------hHHHHHhhc--ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999986432211 111111111 122366889999999999999999766643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=294.92 Aligned_cols=231 Identities=18% Similarity=0.212 Sum_probs=174.3
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-c-ccceEEEecccccccHHHHHHHHHHHHHhcCCC------ccc----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-G-QEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN------LTD---------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g-~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n------lv~---------- 576 (1018)
.++|++.+.||+|+||.||+|+... + +.||||+++.. ....+.+.+|+.++++++|++ ++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4789999999999999999998753 4 68999999654 344567899999999998766 331
Q ss_pred -----------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEE-----------------
Q 046791 577 -----------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILL----------------- 622 (1018)
Q Consensus 577 -----------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILl----------------- 622 (1018)
......+++.++..++.||++||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccc
Confidence 011246899999999999999999999999 9999999999999
Q ss_pred --cCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCC
Q 046791 623 --DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL 700 (1018)
Q Consensus 623 --d~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~ 700 (1018)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-- 246 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-- 246 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred cccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 56789999999999864321 223578999999999999999999999999999999999999986433211
Q ss_pred chHHHHHHHhhcCcchhhh--------------------------hh-----hhcCCCChHHHHHHHHHHHhccccCCCC
Q 046791 701 NLIGYAWQLWNEGKVLELV--------------------------DI-----ALEGSFSPNEVLRCIHVGLLCVQDQATD 749 (1018)
Q Consensus 701 ~l~~~~~~~~~~~~~~~~~--------------------------d~-----~l~~~~~~~~~~~l~~li~~Cl~~dP~~ 749 (1018)
.......... ....... .. .............+.+|+.+||+.||++
T Consensus 247 -~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 -HLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp -HHHHHHHHHC-CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred -HHHHHHHHcC-CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 1111111110 0000000 00 0001122344668889999999999999
Q ss_pred CCCHHHHHH
Q 046791 750 RPAMPDVVS 758 (1018)
Q Consensus 750 RPs~~evl~ 758 (1018)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=297.77 Aligned_cols=227 Identities=22% Similarity=0.313 Sum_probs=154.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHH-HHHHhcCCCccccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAK-LIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~-~l~~l~H~nlv~~~------------- 578 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....++..|+. +++.++||||++..
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368999999999999999999875 58899999997653 233445666665 77888999998311
Q ss_pred -----------------CCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 579 -----------------RNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 579 -----------------~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 146788999999999999999999998 8 9999999999999999999999999998654
Q ss_pred CCCCcccceeeecccccCChhhh----ccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYA----MSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ ... ...
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~~--~~~ 243 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QLT--QVV 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CCC
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HHH--HHh
Confidence 221 22234789999999998 456789999999999999999999999864321100 000 000
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+.+...........+.+++.+||+.||++||++.||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000011111112234567889999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=320.79 Aligned_cols=233 Identities=21% Similarity=0.282 Sum_probs=180.0
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEecc----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc--------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS-------- 577 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~-------- 577 (1018)
.....++|++.+.||+|+||.||+|+... +..||||+++... ....+.|.+|+.++++++||||+++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 464 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP 464 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCc
Confidence 33445789999999999999999998643 4569999987643 3344679999999999999999831
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeee
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~ 639 (1018)
.....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 11235889999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .. ......
T Consensus 542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~-~~~i~~------ 607 (656)
T 2j0j_A 542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DV-IGRIEN------ 607 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HH-HHHHHH------
T ss_pred CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HH-HHHHHc------
Confidence 43221 22233456789999999999999999999999999999997 99998532211 11 111111
Q ss_pred hhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 719 VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 719 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
......+......+.+++.+||+.||++||++.||++.|+..
T Consensus 608 ---~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 608 ---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111123444557788999999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=293.05 Aligned_cols=219 Identities=24% Similarity=0.380 Sum_probs=169.8
Q ss_pred HHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccc------cHHHHHHHHHHHHHh----cCCCcccc-
Q 046791 510 TISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ------GIVEFKNEAKLIAKL----QHTNLTDS- 577 (1018)
Q Consensus 510 ~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l----~H~nlv~~- 577 (1018)
+.+...++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +|+||++.
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34456688999999999999999999864 5889999999655321 233467899999999 89999831
Q ss_pred --------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-CCCCcee
Q 046791 578 --------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKI 630 (1018)
Q Consensus 578 --------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kL 630 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 11345899999999999999999999999 99999999999999 8899999
Q ss_pred eeecceeeecCCCCcccceeeecccccCChhhhccCCCC-ccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH
Q 046791 631 SDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVS-IKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL 709 (1018)
Q Consensus 631 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~ 709 (1018)
+|||++...... ......|+..|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 182 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------- 243 (312)
T 2iwi_A 182 IDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------- 243 (312)
T ss_dssp CCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------
T ss_pred EEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------------
Confidence 999999876432 22345689999999999876664 58999999999999999999985210
Q ss_pred hhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 710 WNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 710 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+..+. ....+......+.+++.+||+.||++||++.|+++
T Consensus 244 -------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 -------EILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -------HHHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------HHhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 11223344567889999999999999999999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=296.15 Aligned_cols=220 Identities=24% Similarity=0.366 Sum_probs=172.9
Q ss_pred HHHHHHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccc------cHHHHHHHHHHHHHhcC--CCcccc--
Q 046791 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ------GIVEFKNEAKLIAKLQH--TNLTDS-- 577 (1018)
Q Consensus 509 ~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l~H--~nlv~~-- 577 (1018)
.+.....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++| +|+++.
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344456688999999999999999999864 5889999999665321 23457889999999975 888731
Q ss_pred -------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-CCCCceee
Q 046791 578 -------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKIS 631 (1018)
Q Consensus 578 -------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kL~ 631 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++ +++.+||+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 12356889999999999999999999999 99999999999999 78899999
Q ss_pred eecceeeecCCCCcccceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh
Q 046791 632 DFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW 710 (1018)
Q Consensus 632 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~ 710 (1018)
|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ...
T Consensus 193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~ 256 (320)
T 3a99_A 193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII 256 (320)
T ss_dssp CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH
T ss_pred eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhh
Confidence 99999876432 2234568999999999987665 688999999999999999999985210 000
Q ss_pred hcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 711 NEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 711 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. +. ...+......+.+++.+||+.||++||++.||++
T Consensus 257 ~-~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 257 R-GQ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp H-CC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-cc----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 0122233467889999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=286.88 Aligned_cols=226 Identities=26% Similarity=0.340 Sum_probs=174.9
Q ss_pred HHhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 513 AATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 513 ~~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||++.
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999876 58899999986543 3456789999999999999999731
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC---CCceeeeecceeeec
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ---MNPKISDFGMARIFG 640 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~---~~~kL~DFGla~~~~ 640 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+||+++.+ +.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 12346889999999999999999999999 9999999999999754 469999999998654
Q ss_pred CCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
... ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||..... ... ......+......
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~-~~~~~~~~~~~~~- 243 (287)
T 2wei_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDI-LKRVETGKYAFDL- 243 (287)
T ss_dssp CCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHCCCCCCS-
T ss_pred CCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHH-HHHHHcCCCCCCc-
Confidence 322 1223468899999998875 489999999999999999999999854221 111 1111111110000
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.........+.+++.+||+.||++|||+.|+++
T Consensus 244 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 -----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000123467889999999999999999999997
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=289.72 Aligned_cols=225 Identities=23% Similarity=0.343 Sum_probs=157.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc--ccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG--QGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.++..+++.++|+||++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999975 589999999976532 222345555667888999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..+..++.||++||.|||++ + |+||||||+|||++.++.+||+|||++.......
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 1135789999999999999999999995 8 9999999999999999999999999997654322
Q ss_pred cccceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
......+++.|+|||++. ...++.++||||||+++|||++|+.||...... .......... ...
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~-~~~--- 248 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQE-EPP--- 248 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHS-CCC---
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhcc-CCC---
Confidence 223457899999999994 567889999999999999999999998642211 1111111111 000
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+ .........+.+++.+||+.||.+||++.||++
T Consensus 249 --~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 --LL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 011123467889999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=286.23 Aligned_cols=226 Identities=23% Similarity=0.381 Sum_probs=167.2
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDSR-------------- 578 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~~-------------- 578 (1018)
..++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3568999999999999999999875 6889999999643 34457799999999999999987421
Q ss_pred --------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeee
Q 046791 579 --------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD 632 (1018)
Q Consensus 579 --------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~D 632 (1018)
....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 1224567888899999999999999999 99999999999999999999999
Q ss_pred ecceeeecCCCC------------cccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCC
Q 046791 633 FGMARIFGLNQS------------ETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHP 699 (1018)
Q Consensus 633 FGla~~~~~~~~------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~ 699 (1018)
||++........ ........|++.|+|||++.+. .++.++||||||+++|||++ |+....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---- 232 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---- 232 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch----
Confidence 999986542210 1122345789999999999864 78999999999999999998 432100
Q ss_pred CchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 700 LNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 700 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.... ........ ........+......+.+++.+||+.||++|||+.|+++
T Consensus 233 -~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -ERVN-ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHH-HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hHHH-HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0000 11111110 111122334455667889999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=300.54 Aligned_cols=225 Identities=26% Similarity=0.302 Sum_probs=161.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHh-cCCCccccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDSR---------------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~~---------------- 578 (1018)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445667889999999998776678999999998653 245678999999987 899998421
Q ss_pred ---------CCC-------CCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCC-------------CCce
Q 046791 579 ---------RNN-------RLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQ-------------MNPK 629 (1018)
Q Consensus 579 ---------~~~-------~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-------------~~~k 629 (1018)
... ...+..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 92 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 000 1133456789999999999999999 9999999999999754 4799
Q ss_pred eeeecceeeecCCCCcc--cceeeecccccCChhhhcc-------CCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCC
Q 046791 630 ISDFGMARIFGLNQSET--NTNRVVGTYGYMSPEYAMS-------GVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHP 699 (1018)
Q Consensus 630 L~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~ 699 (1018)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-- 246 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-- 246 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--
Confidence 99999999875432211 2234679999999999976 678999999999999999999 99998532211
Q ss_pred CchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 700 LNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 700 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. .......... +.............+.+++.+||+.||++|||+.||++
T Consensus 247 --~----~~i~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 --E----SNIIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --H----HHHHHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --H----HHHhcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 0111110000 00111123455678899999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-30 Score=297.51 Aligned_cols=224 Identities=22% Similarity=0.324 Sum_probs=161.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~---------------- 577 (1018)
..+|.+.+.||+|+||+||.....+++.||||++...... .+.+|+.+++++ +||||+++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3568999999999999976655667899999999654322 357899999999 89999842
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-----CCCceeeeecceeeecCC
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-----QMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-----~~~~kL~DFGla~~~~~~ 642 (1018)
.....+.+..+..++.||++||.|||+++ |+||||||+|||++. ...+||+|||+++.....
T Consensus 100 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp CSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 11234556678899999999999999999 999999999999953 345789999999876533
Q ss_pred CC-cccceeeecccccCChhhhc---cCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 643 QS-ETNTNRVVGTYGYMSPEYAM---SGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 643 ~~-~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
.. ........||+.|+|||++. ...++.++|||||||++|||++ |..||...... ........... .
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~~-~ 248 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLGACSL-D 248 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTTCCCC-T
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhccCCc-c
Confidence 21 12234467999999999997 4677889999999999999999 89998532111 11111101000 0
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. ..........+.+|+.+||+.||++|||+.||++
T Consensus 249 ~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 C------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp T------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0112234556788999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-30 Score=287.90 Aligned_cols=229 Identities=18% Similarity=0.192 Sum_probs=150.0
Q ss_pred HhCCcceee-eeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 514 ATNNFSAVN-KLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~-~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
..++|.+.+ .||+|+||.||+|+.. +++.||||++.... .........+..+.|+||+.+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456899865 6999999999999876 58999999986432 222333445677899998721
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---CCCceeeeecce
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMA 636 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kL~DFGla 636 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 11236899999999999999999999999 999999999999976 455999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
+..... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||........... .......+
T Consensus 179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~--- 248 (336)
T 3fhr_A 179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLG--- 248 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcc---
Confidence 865422 22345789999999999888999999999999999999999999864432211000 00000000
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS--MLAN 762 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~Le~ 762 (1018)
...............+.+++.+||+.||++|||+.|+++ .+.+
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 000011111234567889999999999999999999998 5554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-29 Score=302.24 Aligned_cols=230 Identities=24% Similarity=0.312 Sum_probs=169.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|+.++++++||||+..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999874 5899999998764 33445679999999999999998731
Q ss_pred --------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC---ceeeeec
Q 046791 578 --------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN---PKISDFG 634 (1018)
Q Consensus 578 --------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kL~DFG 634 (1018)
.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 01125888999999999999999999999 999999999999997665 8999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHH-----
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQL----- 709 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~----- 709 (1018)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+....
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC----
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccc
Confidence 998764322 22346789999999999999999999999999999999999999854210 00000000
Q ss_pred ---hh----cCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHH
Q 046791 710 ---WN----EGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPD 755 (1018)
Q Consensus 710 ---~~----~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 755 (1018)
.. .+.....................+.+++.+||+.||++|||+.|
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00 00000000000111234556788999999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=304.51 Aligned_cols=214 Identities=19% Similarity=0.283 Sum_probs=170.4
Q ss_pred hCCcceeeeeccCCCcCeEEEEec--ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL--NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~--~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999975 48899999986543 34456789999999999999998310
Q ss_pred ----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 579 ----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 579 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
....+++.+++.|+.||++||.|||+++ |+||||||+|||++.+ .+||+|||+++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 1236889999999999999999999999 9999999999999986 8999999999876422
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
....||+.|+|||++.+.. +.++|||||||++|||++|..|+........ .
T Consensus 235 ------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------~------ 285 (681)
T 2pzi_A 235 ------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------P------ 285 (681)
T ss_dssp ------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------C------
T ss_pred ------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------c------
Confidence 3457999999999987764 8999999999999999999888653211100 0
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCC-HHHHHHHHhc
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPA-MPDVVSMLAN 762 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~Le~ 762 (1018)
...........+.+++.+||+.||++||+ ++++.+.|..
T Consensus 286 -~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 -EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00001122356788999999999999995 6666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-28 Score=265.92 Aligned_cols=208 Identities=9% Similarity=0.042 Sum_probs=157.1
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEeccccc---ccHHHHHHHHHHHHHhcCCCccccc------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSG---QGIVEFKNEAKLIAKLQHTNLTDSR------------ 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~H~nlv~~~------------ 578 (1018)
.++|++.+.||+|+||.||+|+... ++.||||++..... ...++|.+|+.++.+++|+||++..
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4689999999999999999999764 89999999976532 2346799999999999999998310
Q ss_pred ----C--------CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 579 ----R--------NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 579 ----~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
. .......++.+|+.||++||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------------
Confidence 0 122455678899999999999999999 9999999999999999999997543
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
|++| ++.++||||||+++|||++|+.||............. ... .+..... ..
T Consensus 175 ----------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~-~~~~~~~--~~---- 227 (286)
T 3uqc_A 175 ----------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDT-AGQPIEP--AD---- 227 (286)
T ss_dssp ----------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCT-TSCBCCH--HH----
T ss_pred ----------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHh-ccCCCCh--hh----
Confidence 3433 6889999999999999999999997544322110000 000 0000000 00
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
........+.+++.+||+.||++| |+.|+++.|+....
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 112234568899999999999999 99999999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=260.71 Aligned_cols=199 Identities=19% Similarity=0.231 Sum_probs=150.9
Q ss_pred hCCccee-eeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHH-HHhcCCCcccc--------------
Q 046791 515 TNNFSAV-NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLI-AKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~-~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l-~~l~H~nlv~~-------------- 577 (1018)
.++|.+. +.||+|+||.||+++.. +++.||||+++. ...+.+|+.++ +.++||||++.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567777 78999999999999874 588999999854 24678888888 66699998731
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---CCCceeeeecce
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMA 636 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kL~DFGla 636 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 11235899999999999999999999999 999999999999998 788999999998
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
.... +..++.++||||||+++|||++|+.||......... .....
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHH
Confidence 7542 134677999999999999999999998643321100 00000
Q ss_pred hhhhhhhcCCCC----hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 ELVDIALEGSFS----PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 ~~~d~~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... ....+ ......+.+++.+||+.||++|||+.|+++
T Consensus 213 ~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 00111 123467889999999999999999999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=269.42 Aligned_cols=212 Identities=17% Similarity=0.150 Sum_probs=160.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEecccc--------cccHHHHHHHHHHHHHhc---------CCCcccc
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--------GQGIVEFKNEAKLIAKLQ---------HTNLTDS 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~f~~E~~~l~~l~---------H~nlv~~ 577 (1018)
.++|++.++||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++ |+|++.+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999988 78999999997642 233478999999999997 5554311
Q ss_pred -------------------------------------------------------cCCCCCChhhHHHHHHHHHHHHHHH
Q 046791 578 -------------------------------------------------------RRNNRLNWETRFSIIEGIAQGLLYL 602 (1018)
Q Consensus 578 -------------------------------------------------------~~~~~l~~~~~~~i~~qia~gL~yL 602 (1018)
.....+++.++..|+.||+.||+||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 0124578999999999999999999
Q ss_pred h-cCCCCcEEecccCCCcEEEcCCC--------------------CceeeeecceeeecCCCCcccceeeecccccCChh
Q 046791 603 H-KYSRLRVIHRDLKASNILLDDQM--------------------NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661 (1018)
Q Consensus 603 H-~~~~~~ivH~Dlkp~NILld~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE 661 (1018)
| +++ |+||||||+||||+.++ .+||+|||+|+.... ....||+.|+|||
T Consensus 178 H~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 178 EASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9 898 99999999999999887 899999999987642 1358999999999
Q ss_pred hhccCCCCccccchhHhHH-HHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh-cC----CCChHHHHHH
Q 046791 662 YAMSGVVSIKTDVFSFGVL-VLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL-EG----SFSPNEVLRC 735 (1018)
Q Consensus 662 ~~~~~~~s~ksDV~SlGvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~~----~~~~~~~~~l 735 (1018)
++.+.. +.++|||||+++ .++++.|..||.. ..|.... ...+..... .. .......+.+
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYL-----TDKMLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHH-----HHHHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHH-----HHhhhhhhccCcccchhhhhhcCHHH
Confidence 998766 899999998776 7888889888631 0010000 001110000 00 1123456789
Q ss_pred HHHHHhccccCCCCCCCHHHHH
Q 046791 736 IHVGLLCVQDQATDRPAMPDVV 757 (1018)
Q Consensus 736 ~~li~~Cl~~dP~~RPs~~evl 757 (1018)
.+|+.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=7.7e-21 Score=229.00 Aligned_cols=159 Identities=16% Similarity=0.140 Sum_probs=103.3
Q ss_pred eeccCCCcCeEEEE-ecccccceEEEecccc----------cccHHHHHHHHHHHHHh-cCCCccc--------------
Q 046791 523 KLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRS----------GQGIVEFKNEAKLIAKL-QHTNLTD-------------- 576 (1018)
Q Consensus 523 ~lG~G~fG~Vy~~~-~~~g~~vAvK~l~~~~----------~~~~~~f~~E~~~l~~l-~H~nlv~-------------- 576 (1018)
.++.|+.|.+..++ .--|+.+|||.+.... ....++|.+|+++|+++ .|+||++
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45677777776654 3348999999986531 23456799999999999 7999873
Q ss_pred ------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 577 ------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 577 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
+....+++.. +|+.||++||+|||++| ||||||||+||||+.++.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~- 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC- 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence 1234556543 58999999999999999 9999999999999999999999999998764332
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCC
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKN 690 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p 690 (1018)
......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22334789999999999875 467789999999998887665443
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-19 Score=191.34 Aligned_cols=179 Identities=15% Similarity=0.061 Sum_probs=116.8
Q ss_pred CCccccCCcccccCCceeccccceeeeeecCCCCCccEEEEEEecCCCCeeEEEecCCCCccc------------CCCcE
Q 046791 798 NSDKLQQGQVLRDGDQLVSAFGRFRLAFFSPRSTTKHYLGIWYDKSEDELLVWDANRDTPVLD------------KSGRL 865 (1018)
Q Consensus 798 ~~dti~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~vw~a~~~~~~~~------------~~g~~ 865 (1018)
+.|+|++||+|..+++|+|++|.|+||||.++ ++|| |+ +.+ +||+|||++||.+ .+|||
T Consensus 13 ~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~L 83 (276)
T 3m7h_A 13 GTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQY 83 (276)
T ss_dssp TSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEESS
T ss_pred cCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCCcE
Confidence 46899999999999999999999999999432 4566 76 667 9999999999633 46777
Q ss_pred EE--ecC-----------C------C-----------------CeeeEeecCCCCccccCCCeeeecCC-----------
Q 046791 866 VK--TDG-----------T------I-----------------KRVLWLSFEYPADTLLHGMKLGINPK----------- 898 (1018)
Q Consensus 866 ~~--~~~-----------~------~-----------------~~~~w~sf~~p~~t~~~~~~~g~~~~----------- 898 (1018)
|| .|+ . . +.+|||| |||||+|||||+|++.+
T Consensus 84 vl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L~S~~dp 161 (276)
T 3m7h_A 84 GAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNG--TPAIPLVPGAIDSLLLAPGSELVQGVVY 161 (276)
T ss_dssp SEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEEEEEEEES--CTTSCCCCSCTTCEEECSSEEECTTCEE
T ss_pred EEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecCCceeeCc--ccccccccccccccccccCcccccCCCC
Confidence 77 441 0 0 3579999 99999999999887754
Q ss_pred --CceeEeecccc----CCCCCCcccccccccccccc------eeEeeccC-CceeEEEEEccCCCCceEEEEECcCccc
Q 046791 899 --GQVLADSRPLL----SDNFSPHYFDNFNWSILSSS------YYFSYSSN-GKEKYFRYSALEGLQPFSSMRINPDGVF 965 (1018)
Q Consensus 899 --g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~f~~n-~~Evy~t~~~~~~~~~~srl~l~~~G~l 965 (1018)
|.+...+++.. .......+|++..|...... -.+.+.++ +.++.+++.. .. ...|++|+.||+|
T Consensus 162 s~G~fsl~l~~dGnlvLy~~~~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~vWsS~t~--~~-~~~rl~Ld~dGnL 238 (276)
T 3m7h_A 162 GAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTG--GH-ASAVLRLQANGSI 238 (276)
T ss_dssp EETTEEEEECTTSCEEEECTTSSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEEEECSCT--TC-TTCEEEECTTSCE
T ss_pred CCceEEEeecCCceEEEEeCCCeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEEEEecCC--CC-CCEEEEEcCCccE
Confidence 44444443311 11123456666555432211 11122222 3455555422 22 3589999999999
Q ss_pred ccccCcccCCcCCCCcCCCCcceEEecC
Q 046791 966 ETYLGALSSAINDPVCSTGYSSVFKISP 993 (1018)
Q Consensus 966 ~~~~~c~~~~~~~~~C~~~~~~f~~~~~ 993 (1018)
..+.. ..-|++--.+ .+..+.++-+
T Consensus 239 vly~~-~~~Wqsf~~~--P~~~~~~~~~ 263 (276)
T 3m7h_A 239 AILDE-KPVWARFGFQ--PTYRHIRKIN 263 (276)
T ss_dssp EEEEE-EEEEESSSCC--TTSCEEEEEC
T ss_pred EEEcC-CCeEEccCcc--CCccccceeC
Confidence 77765 3446555544 2366666655
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.5e-19 Score=214.64 Aligned_cols=167 Identities=20% Similarity=0.200 Sum_probs=122.6
Q ss_pred ceeeeeccCCCcCeEEEEecccccceEEEeccccc--------ccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 519 SAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG--------QGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
...++||+|+||.||+|+. .++.+|+|+...... ...++|.+|++++++++||||+..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4457899999999999954 578899998644321 123458999999999999999821
Q ss_pred ---cCCCCCCh--hhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc-----c
Q 046791 578 ---RRNNRLNW--ETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET-----N 647 (1018)
Q Consensus 578 ---~~~~~l~~--~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~-----~ 647 (1018)
.....|.. ..+..++.||++||.|||+++ |+||||||+|||++. .+||+|||+++......... .
T Consensus 418 mE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~ 492 (540)
T 3en9_A 418 MSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVF 492 (540)
T ss_dssp EECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred EECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhh
Confidence 01111110 015689999999999999999 999999999999999 99999999999875322111 1
Q ss_pred ceeeecccccCChhhhcc--CCCCccccchhHhHHHHHHHhCCCCC
Q 046791 648 TNRVVGTYGYMSPEYAMS--GVVSIKTDVFSFGVLVLEIVSGKKNN 691 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~SlGvvl~elltG~~p~ 691 (1018)
.....||+.|+|||++.. ..|+..+|+||..+-.++.+.++.++
T Consensus 493 ~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 493 KKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 235689999999999987 66888899999999999988887765
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.9e-18 Score=156.92 Aligned_cols=103 Identities=19% Similarity=0.314 Sum_probs=87.2
Q ss_pred CccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCce
Q 046791 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSL 106 (1018)
Q Consensus 27 ~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l 106 (1018)
.|+|.+||.|.+|+.|+| |.|.|.|...++ |.++. ..++||+|||++|..+ .+.|
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~-----------------~~~~vW~ant~~~~~~-~~~L 55 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD-----------------HSTSTWASNTEIGGKS-GCSA 55 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE-----------------TTEEEEECCCCCTTCC-SCEE
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE-----------------CCEEEEEecCCCCCCc-cEEE
Confidence 378999999999999998 889999987665 77763 3578999999999865 5689
Q ss_pred EEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecc
Q 046791 107 TIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQS 164 (1018)
Q Consensus 107 ~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQS 164 (1018)
.++. ||||||+| +++.+||+|+++ ....+|+|+|+|||||++. .||||
T Consensus 56 ~l~~-dGnLvL~d-~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 56 VLQS-DGNFVVYD-SSGRSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp EECT-TSCEEEEC-TTCCEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EEeC-CccEEEEC-CCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 9998 99999999 777899999876 3456899999999999852 49998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.74 E-value=6.4e-18 Score=159.27 Aligned_cols=106 Identities=24% Similarity=0.353 Sum_probs=89.6
Q ss_pred ccCccccCCCccCCCCEEE--cCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCC
Q 046791 25 SQTDTLLLGQLLKDGDELV--SAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDK 102 (1018)
Q Consensus 25 ~~~d~i~~~~~l~~~~~lv--S~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~ 102 (1018)
++.|+|.+||+|.+|++|+ |++|.|+|+|+..++ | +||++ .++||+|||+.| +.
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~----------------~~~vW~sn~~~~--~~ 61 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN----------------NNPIWATNTGGL--GN 61 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET----------------TEEEEECCCTTS--CS
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC----------------CEEEEeCCCccC--CC
Confidence 6679999999999999999 999999999998765 2 57753 478999999877 33
Q ss_pred CCceEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecc
Q 046791 103 SGSLTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQS 164 (1018)
Q Consensus 103 ~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQS 164 (1018)
++.+.+.. ||||||+| .++.++|++.+. .+..+++|+|+|||||++ .++|||
T Consensus 62 ~~~l~l~~-dGNLVl~d-~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~S 115 (119)
T 1b2p_A 62 GCRAVLQP-DGVLVVIT-NENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWAT 115 (119)
T ss_dssp SCEEEECT-TSCEEEEC-TTCCEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred ceEEEEcc-CCEEEEEe-CCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC--------ccEeCC
Confidence 57899987 99999999 677899999865 345689999999999985 259998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=7.3e-18 Score=156.82 Aligned_cols=108 Identities=21% Similarity=0.346 Sum_probs=90.1
Q ss_pred CccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCce
Q 046791 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSL 106 (1018)
Q Consensus 27 ~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l 106 (1018)
+|+|.+||.|.+|++|+ ++|.|+|+|+..++ | |+|+ . .++||.||++.|- .++.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~--------------~~~vW~sn~~~~~--~~~~l 55 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--S--------------GKPVWASNTGGLG--SGCRL 55 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--T--------------TEEEEECCCTTSC--SSCEE
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--C--------------CEEEEECCCCCCC--CcEEE
Confidence 58999999999999999 99999999987765 3 5675 2 4789999998773 35689
Q ss_pred EEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCc
Q 046791 107 TIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPT 169 (1018)
Q Consensus 107 ~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PT 169 (1018)
.+.. ||||||++ .++.++|+|.+. .+..+++|+|+|||||++ + .+||||+||.
T Consensus 56 ~l~~-dGNLVl~~-~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~-------~-~~W~S~~~~~ 110 (110)
T 3a0c_A 56 TLHN-NGNLVIYD-QSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYG-------P-VVWATGSGPA 110 (110)
T ss_dssp EECT-TSCEEEEC-TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC-------S-EEEECSCCC-
T ss_pred EEeC-CCCEEEEC-CCCcEEEecCCCCCCCCEEEEEeCCccEEEEC-------C-CEecCCCcCC
Confidence 9987 99999999 567899999876 345589999999999974 2 5999999983
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=6.7e-18 Score=185.40 Aligned_cols=141 Identities=17% Similarity=0.128 Sum_probs=111.6
Q ss_pred eeHHHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEeccccc------------------ccHHHHHHHHHHHH
Q 046791 506 FDFQTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG------------------QGIVEFKNEAKLIA 567 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~f~~E~~~l~ 567 (1018)
+.+..+......|++.+.||+|+||.||+|+..+|+.||||.++.... .....+.+|+.+++
T Consensus 80 ~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~ 159 (282)
T 1zar_A 80 YSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 159 (282)
T ss_dssp HHHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHH
Confidence 345566677778889999999999999999997799999999964321 13456899999999
Q ss_pred HhcCCCccc------------ccCCC---CCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeee
Q 046791 568 KLQHTNLTD------------SRRNN---RLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD 632 (1018)
Q Consensus 568 ~l~H~nlv~------------~~~~~---~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~D 632 (1018)
+++|.++.. ...+. .+.......++.||++||.|||+++ |+||||||+|||++ ++.+||+|
T Consensus 160 ~l~~~~v~~~~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 160 KLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp HTTTSSSCCEEEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred hccCCCcCeEEeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence 998655432 11111 1444667789999999999999999 99999999999999 99999999
Q ss_pred ecceeeecCCCCcccceeeecccccCChhhhcc
Q 046791 633 FGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665 (1018)
Q Consensus 633 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 665 (1018)
||+++.. ..++|||++.+
T Consensus 236 FG~a~~~---------------~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVEV---------------GEEGWREILER 253 (282)
T ss_dssp CTTCEET---------------TSTTHHHHHHH
T ss_pred CCCCeEC---------------CCCCHHHHHHH
Confidence 9998743 35789998753
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.9e-17 Score=153.35 Aligned_cols=108 Identities=27% Similarity=0.362 Sum_probs=89.1
Q ss_pred CccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCce
Q 046791 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSL 106 (1018)
Q Consensus 27 ~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l 106 (1018)
.|||.+||+|.+|++|+ +|.|+|+|+..++ .. +|+ . .++||+|||+.|. .++.|
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn---lv---ly~--~--------------~~~vW~sn~~~~~--~~~~l 55 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN---LV---KYQ--N--------------GRQIWASNTDRRG--SGCRL 55 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC---EE---EEE--T--------------TEEEEECSCTTSC--SSCEE
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc---EE---EEe--C--------------CEEEEeCCCCCCC--CceEE
Confidence 48999999999999998 7999999987664 22 353 2 5789999999884 35789
Q ss_pred EEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcc
Q 046791 107 TIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTD 170 (1018)
Q Consensus 107 ~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTD 170 (1018)
.+.. +|||||+| .++.++|++... .+..+|+|+|+|||||++ . ++||||.+++.
T Consensus 56 ~l~~-~GnLvl~d-~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~-------~-~~W~S~~~~~~ 111 (115)
T 2dpf_A 56 TLLS-DGNLVIYD-HNNNDVWGSACWGDNGKYALVLQKDGRFVIYG-------P-VLWSLGPNGCR 111 (115)
T ss_dssp EECT-TSCEEEEC-TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC-------S-EEECSSTTCBC
T ss_pred EECC-CCcEEEEC-CCceEEEEcCCCCCCCCEEEEEeCCCeEEEEC-------C-CEEECCCCCCc
Confidence 9987 99999999 567899999875 345689999999999984 2 69999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.68 E-value=9.8e-17 Score=149.96 Aligned_cols=108 Identities=27% Similarity=0.446 Sum_probs=88.4
Q ss_pred CccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCce
Q 046791 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSL 106 (1018)
Q Consensus 27 ~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l 106 (1018)
+|||.+||+|.+|++| ++|.|+|+|+..++ | ++|+. .++||+||++.+ +.++.+
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~----------------~~~vW~sn~~~~--~~~~~l 54 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN----------------NRAVWASGTNGK--ASGCVL 54 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET----------------TEEEEECCCTTS--CSSEEE
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC----------------CEEEEeCCCcCC--CCCEEE
Confidence 5899999999999999 58999999998775 2 35642 478999999864 345789
Q ss_pred EEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCC
Q 046791 107 TIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYP 168 (1018)
Q Consensus 107 ~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~P 168 (1018)
.+.. +|||||++ ++.++|++.+. .+..+++|+++|||||++.. +.++||||+|.
T Consensus 55 ~l~~-~GNLvl~d--~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-----~~~~W~S~~~~ 110 (112)
T 1xd5_A 55 KMQN-DGNLVIYS--GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNV 110 (112)
T ss_dssp EECT-TSCEEEEE--TTEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCC
T ss_pred EEeC-CCCEEEEc--CCEEEEECCccCCCCCEEEEEeCCCcEEEECCC-----CceEEECCCcc
Confidence 9987 99999998 56799998765 34568999999999998744 56899999984
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-15 Score=162.11 Aligned_cols=160 Identities=15% Similarity=0.123 Sum_probs=103.8
Q ss_pred cCCccccCCcccccCCceeccccceeeeeecCCCCCccEEEEEEecCCCCeeEEEecCCCCc-----ccCCCcEEEecCC
Q 046791 797 NNSDKLQQGQVLRDGDQLVSAFGRFRLAFFSPRSTTKHYLGIWYDKSEDELLVWDANRDTPV-----LDKSGRLVKTDGT 871 (1018)
Q Consensus 797 ~~~dti~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~vw~a~~~~~~-----~~~~g~~~~~~~~ 871 (1018)
+..|+|++||.|..|++| .+|.|+|||+.+++ +.+ |.. .++||+|||+.|- +.++|||||.|.+
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~---~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~ 74 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS---DVRVWASNTAGATGCRAVLQSDGLLVILTAQ 74 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES---SSEEECCCCCSCSCCBCCBCSSSCBCCBCTT
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC---CEEEEECCCCCCCCeEEEEcCCCcEEEEcCC
Confidence 445899999999999998 48999999986443 223 443 6999999999872 5577888877631
Q ss_pred C----------------------------CeeeEeecCCCCcc----------ccCCCeeeecCC----------CceeE
Q 046791 872 I----------------------------KRVLWLSFEYPADT----------LLHGMKLGINPK----------GQVLA 903 (1018)
Q Consensus 872 ~----------------------------~~~~w~sf~~p~~t----------~~~~~~~g~~~~----------g~~~~ 903 (1018)
. ..++|||||||+|| |+||||++++.. |.+..
T Consensus 75 ~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d~s~G~~~l 154 (236)
T 1dlp_A 75 NTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRL 154 (236)
T ss_dssp TCCSCCCCCCCCSSCCEEEECSSSCEEEECSEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCCCBCSSCEE
T ss_pred CcEEEeCCccccCCcEEEEEeCCCCEEEecCCEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcEeecCcEEE
Confidence 1 13789999999855 488886654321 55555
Q ss_pred eecccc---CCCCCCcccccccccccccc--------eeEeeccCCceeEEEEEccCCCCceEEEEECcCccccccc
Q 046791 904 DSRPLL---SDNFSPHYFDNFNWSILSSS--------YYFSYSSNGKEKYFRYSALEGLQPFSSMRINPDGVFETYL 969 (1018)
Q Consensus 904 ~~~~~~---~~~~~~~~~~~~~~~~~~~~--------~~~~f~~n~~Evy~t~~~~~~~~~~srl~l~~~G~l~~~~ 969 (1018)
.+.+.. ..+....+|++.+|.+.... ..+.+..+.++++++|..... .++|++|+++|+++.+.
T Consensus 155 ~l~~dG~LvL~~~~~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~--~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 155 SMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA--GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp EEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECCCCCSS--SCCEEEECSSSCEEEEC
T ss_pred EECCCCcEEEEcCCEeEEeCCCcCCCCceEEEECCCCcEEEEeCCCcEEEEeCCCCCC--CCEEEEEcCCCcEEEeC
Confidence 554311 11122456676666532100 112233466778887744332 46899999999998875
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.7e-15 Score=139.33 Aligned_cols=101 Identities=27% Similarity=0.454 Sum_probs=82.1
Q ss_pred ccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCceE
Q 046791 28 DTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLT 107 (1018)
Q Consensus 28 d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l~ 107 (1018)
+||.|||.|.+|++|+ +|.|+|+|+..++ |-+ |+. .++||.||++.+ +.++.|.
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~----------------~~~vW~snt~~~--~~~~~l~ 55 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV----------------DKPIWATNTGGL--DRRCHLS 55 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET----------------TEEEEECCCTTS--SSSCEEE
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC----------------CEEEEECCcccC--CCCEEEE
Confidence 6899999999999997 7999999987765 323 432 368999999876 3357899
Q ss_pred EeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecc
Q 046791 108 IDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQS 164 (1018)
Q Consensus 108 ~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQS 164 (1018)
+.. ||||||+| .++.++|++++. ....+|+|+|+|||||++. .+|||
T Consensus 56 l~~-dGNLvl~~-~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s 104 (109)
T 3dzw_A 56 MQS-DGNLVVYS-PRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWAT 104 (109)
T ss_dssp ECT-TSCEEEEC-TTSCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCC
T ss_pred EeC-CCCEEEEC-CCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeC
Confidence 987 99999998 567899999875 2346899999999999852 58998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=6.4e-15 Score=159.53 Aligned_cols=124 Identities=16% Similarity=0.193 Sum_probs=95.3
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEe-ccccc--ceEEEecccccc------------------------cHHHHHHHH
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQL-LNGQE--VAIKRLSRRSGQ------------------------GIVEFKNEA 563 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~--vAvK~l~~~~~~------------------------~~~~f~~E~ 563 (1018)
+.....-|++.+.||+|+||.||+|+. .+|+. ||||+++..... ....+.+|+
T Consensus 42 ~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 121 (258)
T 1zth_A 42 LSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEF 121 (258)
T ss_dssp HHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHH
T ss_pred HHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHH
Confidence 333333477889999999999999997 67888 999987543111 113688999
Q ss_pred HHHHHhcCCCcc--------------cccCC-C----C-------CChhhHHHHHHHHHHHHHHHh-cCCCCcEEecccC
Q 046791 564 KLIAKLQHTNLT--------------DSRRN-N----R-------LNWETRFSIIEGIAQGLLYLH-KYSRLRVIHRDLK 616 (1018)
Q Consensus 564 ~~l~~l~H~nlv--------------~~~~~-~----~-------l~~~~~~~i~~qia~gL~yLH-~~~~~~ivH~Dlk 616 (1018)
.++.+++|+++. +.... + . .++..+..++.|++++|.||| +.+ |+|||||
T Consensus 122 ~~l~~l~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 122 RNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp HHHHHHHHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred HHHHHHHhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 999999887642 11110 0 1 224478899999999999999 888 9999999
Q ss_pred CCcEEEcCCCCceeeeecceeee
Q 046791 617 ASNILLDDQMNPKISDFGMARIF 639 (1018)
Q Consensus 617 p~NILld~~~~~kL~DFGla~~~ 639 (1018)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.8e-14 Score=132.41 Aligned_cols=102 Identities=21% Similarity=0.292 Sum_probs=80.1
Q ss_pred cCccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCc
Q 046791 26 QTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGS 105 (1018)
Q Consensus 26 ~~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~ 105 (1018)
++|||.+||.|.+|+.|+| |.|.|-|...++ |.+ |+. ++||.+|++.. ..++.
T Consensus 5 ~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~-----------------~~vW~snt~~~--~~~~~ 57 (110)
T 3r0e_B 5 TNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG-----------------KYGWQSNTHGN--GEHCF 57 (110)
T ss_dssp BTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS-----------------SSCEECCCTTS--SSSCE
T ss_pred ccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC-----------------eEEEECCCcCC--CcCEE
Confidence 5699999999999999998 458887654443 555 432 35999999863 33468
Q ss_pred eEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecc
Q 046791 106 LTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQS 164 (1018)
Q Consensus 106 l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQS 164 (1018)
+.+.. ||||||+| .++.++|++++. ....+|+|+|+|||||++ ..+|+|
T Consensus 58 l~l~~-dGNLvl~d-~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~--------~~~W~t 108 (110)
T 3r0e_B 58 LRLNH-KGELIIKD-DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG--------PAIFET 108 (110)
T ss_dssp EEECT-TSCEEEEC-TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred EEEeC-CCcEEEEe-CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec--------CCEecC
Confidence 99987 99999999 567899999875 344689999999999985 258987
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.50 E-value=4.2e-14 Score=132.05 Aligned_cols=94 Identities=19% Similarity=0.363 Sum_probs=77.1
Q ss_pred CCCCCCCCceEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcccccC
Q 046791 97 TPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLP 174 (1018)
Q Consensus 97 ~Pi~~~~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLP 174 (1018)
.|+.+....|.+.. ||||+|++. +.++|++++. ..+.+|+|+|+|||||++ + +.++||||+
T Consensus 14 ~~L~~~~~~L~~~~-dgnlvl~~~--~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~-----~~~~W~S~~-------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQN-DCNLVLYDN--NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G-----SRAIWASNT-------- 76 (112)
T ss_dssp CEEEETTEEEEECT-TSCEEEEET--TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T-----TEEEEECCC--------
T ss_pred CEEeCCCEEEEEcC-CCcEEEEEC--CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C-----CEEEEECCc--------
Confidence 44545567899987 999999983 6899999876 235789999999999998 5 678999993
Q ss_pred CCeecccccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEec-cCeeEEEeCCCC
Q 046791 175 GMKLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQR-RGEVLWTCGLFP 232 (1018)
Q Consensus 175 g~klg~~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~-~~~~yw~sg~w~ 232 (1018)
||++|.|++.++++|. ++++. .+.+||++++|.
T Consensus 77 -----------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 77 -----------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp -----------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCC
T ss_pred -----------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCcc
Confidence 5667899999999997 66776 467999999884
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=5e-14 Score=130.89 Aligned_cols=87 Identities=23% Similarity=0.396 Sum_probs=72.9
Q ss_pred CCCceEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcccccCCCeec
Q 046791 102 KSGSLTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLG 179 (1018)
Q Consensus 102 ~~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLPg~klg 179 (1018)
....|.+.. ||||||++ .+.+||++++. .....|+|+|+|||||++.+ +.++||||
T Consensus 20 ~~~~l~~~~-dGnlvl~~--~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-----~~~~W~S~-------------- 77 (110)
T 3a0c_A 20 PSYRLIMQG-DCNFVLYD--SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-----NRVIWQTK-------------- 77 (110)
T ss_dssp TTEEEEECT-TSCEEEEE--TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECC--------------
T ss_pred CCEEEEEcC-CCcEEEEE--CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-----CcEEEecC--------------
Confidence 357899987 99999998 36899999876 23568999999999999865 67899999
Q ss_pred ccccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCCC
Q 046791 180 LNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLF 231 (1018)
Q Consensus 180 ~~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~w 231 (1018)
++|++|.|++.++++|. +++++. +||+++++
T Consensus 78 -----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 -----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp -----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred -----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35678999999999997 677765 89999875
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.47 E-value=1.9e-13 Score=127.57 Aligned_cols=105 Identities=17% Similarity=0.258 Sum_probs=83.8
Q ss_pred cCccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCc
Q 046791 26 QTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGS 105 (1018)
Q Consensus 26 ~~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~ 105 (1018)
+.|+|.+||.|.+|+.|.+ |.|.|-|...++ |.++. .- ..++||.+|+..+- ..+.
T Consensus 5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~-~~--------------~~~~vWssnt~~~~--~~~~ 60 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTK-GS--------------KTNIVWESGTSGRG--QHCF 60 (113)
T ss_dssp CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE-TT--------------TTEEEEECCCTTSC--SSCE
T ss_pred cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEE-CC--------------CCEEEEECCcccCC--cCEE
Confidence 4689999999999999975 789999876654 66643 21 25789999998763 3568
Q ss_pred eEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecc
Q 046791 106 LTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQS 164 (1018)
Q Consensus 106 l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQS 164 (1018)
+.+.. +|||||++ .++.++|++++. .+..+|+|+|+|||||++ ..+|+|
T Consensus 61 l~l~~-dGNLVl~d-~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~--------~~~W~s 111 (113)
T 3mez_B 61 MRLGH-SGELDITD-DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG--------PAVWST 111 (113)
T ss_dssp EEECT-TSCEEEEC-TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred EEEeC-CCcEEEEC-CCCCEEEECCCcCCCCCEEEEEcCCceEEEec--------CCEecC
Confidence 99987 99999999 567789999875 334689999999999985 359987
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.43 E-value=3.3e-13 Score=127.01 Aligned_cols=84 Identities=20% Similarity=0.364 Sum_probs=70.8
Q ss_pred CceEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcccccCCCeeccc
Q 046791 104 GSLTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLN 181 (1018)
Q Consensus 104 ~~l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLPg~klg~~ 181 (1018)
..|.+.. ||||+|++. +.+||+++.. ..+..|+|+|+|||||+|.+ +.++||||
T Consensus 32 ~~L~~~~-dgnlvly~~--~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~-----~~~lW~S~---------------- 87 (119)
T 1b2p_A 32 YRFIMQT-DCNLVLYDN--NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP---------------- 87 (119)
T ss_dssp EEEEECT-TSCEEEEET--TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS----------------
T ss_pred EEEEEec-CCCEEEEEC--CEEEEeCCCccCCCceEEEEccCCEEEEEeCC-----CcEEEcCC----------------
Confidence 4688887 999999983 7899999876 23578999999999999865 67899999
Q ss_pred ccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCC
Q 046791 182 LQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGL 230 (1018)
Q Consensus 182 ~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~ 230 (1018)
+||++|.|++.++++|. +++++ .+||++|+
T Consensus 88 ---------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 ---------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp ---------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred ---------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 46788999999999997 67776 48999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=6.8e-13 Score=124.36 Aligned_cols=87 Identities=24% Similarity=0.419 Sum_probs=72.8
Q ss_pred CCceEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcccccCCCeecc
Q 046791 103 SGSLTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGL 180 (1018)
Q Consensus 103 ~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLPg~klg~ 180 (1018)
...|.+.. ||||+|++ .+.++|++++. ..+..++|+++|||||+|.+ +.++||||||
T Consensus 21 ~~~L~~~~-dgnlvly~--~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-----~~~vW~S~~~------------- 79 (115)
T 2dpf_A 21 AYTLTIQN-KCNLVKYQ--NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-----NNDVWGSACW------------- 79 (115)
T ss_dssp TEEEEECT-TSCEEEEE--TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCC-------------
T ss_pred CEEEEEcC-CCcEEEEe--CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-----ceEEEEcCCC-------------
Confidence 46788877 99999997 47899999875 23568999999999999865 6789999998
Q ss_pred cccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCCCC
Q 046791 181 NLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLFP 232 (1018)
Q Consensus 181 ~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~w~ 232 (1018)
|++|.|++.++++|. +++++. +||++++|.
T Consensus 80 ------------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~ 109 (115)
T 2dpf_A 80 ------------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNG 109 (115)
T ss_dssp ------------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTC
T ss_pred ------------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCC
Confidence 456889999999997 777764 899999994
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.39 E-value=7.7e-13 Score=122.46 Aligned_cols=100 Identities=27% Similarity=0.398 Sum_probs=79.6
Q ss_pred cCccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCc
Q 046791 26 QTDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGS 105 (1018)
Q Consensus 26 ~~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~ 105 (1018)
++|||.|||.|.+|+.| .+|.|.|.|...++ |-+ |. . +|.+|+..+ ..+..
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~--~-----------------~Wssnt~~~--~~~~~ 52 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YN--G-----------------NWQSNTANN--GRDCK 52 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ET--T-----------------TEECCCTTS--CSSCE
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-Ee--C-----------------eEEcCCCCC--CCcEE
Confidence 56999999999999999 57999999876664 333 31 1 699998865 23578
Q ss_pred eEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecc
Q 046791 106 LTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQS 164 (1018)
Q Consensus 106 l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQS 164 (1018)
|.+.. ||||||+| .++.++|++++. ....+|+|+|+|||||++ ..+|+|
T Consensus 53 l~l~~-dGnLvl~d-~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~--------~~~W~s 103 (109)
T 3r0e_A 53 LTLTD-YGELVIKN-GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVFKI 103 (109)
T ss_dssp EEECT-TSCEEEEC-TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC--------SEEEEE
T ss_pred EEEcC-CCeEEEEe-CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe--------cCEECC
Confidence 99987 99999998 567899998875 234689999999999985 359997
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.2e-12 Score=147.63 Aligned_cols=128 Identities=17% Similarity=0.164 Sum_probs=93.0
Q ss_pred HHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEeccccc--------------ccHHH--------HHHHHHHH
Q 046791 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG--------------QGIVE--------FKNEAKLI 566 (1018)
Q Consensus 509 ~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~--------------~~~~~--------f~~E~~~l 566 (1018)
..+.....-|++.++||+|+||.||+|...+|+.||||+++.... ..... ...|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 334444444999999999999999999998999999998753210 01111 23567777
Q ss_pred HHhcCCCcc--------------cccC----CCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCC-
Q 046791 567 AKLQHTNLT--------------DSRR----NNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMN- 627 (1018)
Q Consensus 567 ~~l~H~nlv--------------~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~- 627 (1018)
.++.+..+. +... ......+....++.||+.+|.|||++| ||||||||.|||+++++.
T Consensus 168 ~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp HHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECS
T ss_pred HHHHhcCCCCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCc
Confidence 777655432 1111 112334566789999999999999999 999999999999987763
Q ss_pred ---------ceeeeecceeee
Q 046791 628 ---------PKISDFGMARIF 639 (1018)
Q Consensus 628 ---------~kL~DFGla~~~ 639 (1018)
+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 889999987653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.2e-11 Score=113.05 Aligned_cols=102 Identities=19% Similarity=0.330 Sum_probs=78.7
Q ss_pred CccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCce
Q 046791 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSL 106 (1018)
Q Consensus 27 ~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l 106 (1018)
+|+|.+||.|.+|+.| .+|.|.|.|...++ |-+ |.. .. ||.+|+..+- ....+
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~----------------~~-vW~snt~~~~--~~~~l 54 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE----------------AG-GFQSNTHGRG--VDCTL 54 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS----------------SC-CEECCCTTSC--SSCEE
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC----------------CC-EEECCcccCC--cCEEE
Confidence 5899999999999999 46889999876664 433 321 23 9999998762 34688
Q ss_pred EEeccCCcEEEEcCCCCeEEEEEeec----CcceEEEEeecCcEEEEecCCCCCcccceecc
Q 046791 107 TIDSRDGNLKILRKGGNSIVVSSVQA----MGNTSAALYETGNFVLYEMNPSGSMERELWQS 164 (1018)
Q Consensus 107 ~~~~~~G~Lvl~~~~~~~~~wss~~~----~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQS 164 (1018)
.+.. +|||||++..+..++|++++. ....+|+|+|+|||||++ ..+|+|
T Consensus 55 ~l~~-dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 55 RLNN-RGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp EECT-TSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred EEcC-CCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 9987 999999994444569998853 235689999999999985 358987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.97 E-value=1.4e-09 Score=101.33 Aligned_cols=95 Identities=18% Similarity=0.252 Sum_probs=72.5
Q ss_pred CCCCCCCCCCceEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcccc
Q 046791 95 RNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDIL 172 (1018)
Q Consensus 95 r~~Pi~~~~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTl 172 (1018)
.+.|+.+....|.+.. ||||||++...+.++|++++. ..+..|+|+|+|||||++.+ +.++|||=.+
T Consensus 17 ~g~~L~~g~~~L~~q~-dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-----~~~iW~S~t~----- 85 (113)
T 3mez_B 17 DNAQLATRDYSLVMRD-DCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-----LNTVFVSNTV----- 85 (113)
T ss_dssp TTCEEEETTEEEEECT-TSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECSCC-----
T ss_pred CCCEeEcCCEEEEEcC-CCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-----CCEEEECCCc-----
Confidence 4667776678899987 999999984357899999876 23568999999999999865 5679997321
Q ss_pred cCCCeecccccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCC
Q 046791 173 LPGMKLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGL 230 (1018)
Q Consensus 173 LPg~klg~~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~ 230 (1018)
-..|.|.+.++.+|. ++++. ...|.+|+
T Consensus 86 --------------------------~~~~~~~~~L~~dGn--lvly~--~~~W~s~~ 113 (113)
T 3mez_B 86 --------------------------GQEGDYVLILQINGQ--AVVYG--PAVWSTAA 113 (113)
T ss_dssp --------------------------CSSSCCEEEECTTSC--EEEEC--SEEEESCC
T ss_pred --------------------------CCCCCEEEEEcCCce--EEEec--CCEecCCC
Confidence 012458899999997 55665 68899875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.93 E-value=1.8e-09 Score=100.12 Aligned_cols=93 Identities=14% Similarity=0.282 Sum_probs=69.2
Q ss_pred CCCCCCCCCceEEeccCCcEEEEcCCCCeEEEEEeecC--cceEEEEeecCcEEEEecCCCCCccc-ceecccCCCcccc
Q 046791 96 NTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAM--GNTSAALYETGNFVLYEMNPSGSMER-ELWQSFDYPTDIL 172 (1018)
Q Consensus 96 ~~Pi~~~~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~~--~~~~a~LldsGNlVl~~~~~~~~~~~-~lWQSFD~PTDTl 172 (1018)
+.++.+....|.+.. ||||||++ .++ +|++++.. ....|+|+|+|||||++.+ +. ++|||.-+
T Consensus 14 g~~L~~g~~~L~~q~-dGnLvl~~-~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~-----~~~~vW~S~t~----- 79 (111)
T 3mez_A 14 DNQLSYESAAFVMQG-DCNLVLYN-EAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSAN-----SNTPVWVYPRS----- 79 (111)
T ss_dssp TCEEEETTEEEEECT-TSCEEEEC-SSC--CEECCCTTSCSSCEEEECTTSCEEEECSS-----CSSCSEEESSS-----
T ss_pred CCEEecCCEEEEEcc-CCeEEEEC-CCC--EEECCcccCCcCEEEEEcCCCcEEEEeCC-----CCEEEEEeccc-----
Confidence 445555567899987 99999998 444 99998762 3478999999999999765 43 59998721
Q ss_pred cCCCeecccccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCC
Q 046791 173 LPGMKLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGL 230 (1018)
Q Consensus 173 LPg~klg~~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~ 230 (1018)
.....|.|.+.++++|. ++++. ..+|.+++
T Consensus 80 ------------------------~~~~~~~~~l~Lq~dGN--lvly~--~~~W~s~t 109 (111)
T 3mez_A 80 ------------------------VNTVRGNYAATLGPDQH--VTIYG--PAIWSTPA 109 (111)
T ss_dssp ------------------------CCCCSSCCEEEECTTSC--EEEEC--SEEEECCC
T ss_pred ------------------------cCCCCcCEEEEECCCCe--EEEec--cCEEccCC
Confidence 01134789999999997 55665 78999874
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=3.7e-08 Score=90.98 Aligned_cols=85 Identities=15% Similarity=0.311 Sum_probs=64.2
Q ss_pred CCceEEeccCCcEEEEcCCCCeEEEEEeecC--cceEEEEeecCcEEEEecCCCCCcccceecccCCCcccccCCCeecc
Q 046791 103 SGSLTIDSRDGNLKILRKGGNSIVVSSVQAM--GNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGL 180 (1018)
Q Consensus 103 ~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~~--~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLPg~klg~ 180 (1018)
...|.+.. ||||||++. +.++|++++.. ....++|+|+|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~-dGnLvly~~--~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-----~~~~W~S~t~~------------ 79 (109)
T 3dzw_A 20 RYVFIMQE-DCNLVLYDV--DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-----NNPIWASNTGG------------ 79 (109)
T ss_dssp TEEEEECT-TSCEEEEET--TEEEEECCCTTSSSSCEEEECTTSCEEEECTT-----SCEEEECCCCC------------
T ss_pred CEEEEEcC-CCcEEEEeC--CEEEEECCcccCCCCEEEEEeCCCCEEEECCC-----CCEEEECCCCC------------
Confidence 46788887 999999983 68999998762 3568999999999999765 66899885321
Q ss_pred cccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCC
Q 046791 181 NLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGL 230 (1018)
Q Consensus 181 ~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~ 230 (1018)
..+.|.+.++.+|. ++++.. +.|.+|.
T Consensus 80 -------------------~~~~~~~~L~ddGN--lvly~~--~~W~s~t 106 (109)
T 3dzw_A 80 -------------------ENGNYVCVLQKDRN--VVIYGT--ARWATGT 106 (109)
T ss_dssp -------------------SSSCEEEEECTTSC--EEEEES--CCCCCCC
T ss_pred -------------------CCCCEEEEEeCCCE--EEEECC--CEEeCCC
Confidence 12467889999987 555653 6787764
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.68 E-value=2.6e-08 Score=91.92 Aligned_cols=91 Identities=16% Similarity=0.300 Sum_probs=68.2
Q ss_pred CCCCCCCCCCceEEeccCCcEEEEcCCCCeEEEEEeecC--cceEEEEeecCcEEEEecCCCCCcccceecccCCCcccc
Q 046791 95 RNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAM--GNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDIL 172 (1018)
Q Consensus 95 r~~Pi~~~~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~~--~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTl 172 (1018)
.+.|+.+....|.+.. ||||||++ + +|++++.. ....++|+++|||||+|.+ +.++|+|- |
T Consensus 14 ~g~~L~~g~~~L~~q~-dGNLvl~~-~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-----~~~vWss~-----t- 76 (109)
T 3r0e_A 14 TEGHLKNGDFDLVMQD-DCNLVLYN-G----NWQSNTANNGRDCKLTLTDYGELVIKNGD-----GSTVWKSG-----A- 76 (109)
T ss_dssp TTCEEEETTEEEEECT-TSCEEEET-T----TEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECC-----C-
T ss_pred CCCEeECCCEEEEEec-CCeEEEEe-C----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-----CCEEEcCC-----C-
Confidence 3555655567899987 99999998 2 69998762 3568999999999999765 56789652 1
Q ss_pred cCCCeecccccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCCC
Q 046791 173 LPGMKLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLF 231 (1018)
Q Consensus 173 LPg~klg~~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~w 231 (1018)
....+.|.+.++++|. ++++. .+.|.+++|
T Consensus 77 -------------------------~~~~~~~~~~L~~dGN--lvly~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 -------------------------QSVKGNYAAVVHPDGR--LVVFG--PSVFKIDPW 106 (109)
T ss_dssp -------------------------CCSSSCCEEEEETTTE--EEEEC--SEEEEECTT
T ss_pred -------------------------cCCCcCEEEEEcCCCe--EEEEe--cCEECCCCc
Confidence 0023568899999987 55565 689999987
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.66 E-value=3.4e-08 Score=91.32 Aligned_cols=88 Identities=17% Similarity=0.239 Sum_probs=65.1
Q ss_pred CCCCCCceEEeccCCcEEEEcCCCCeEEEEEeecC--cceEEEEeecCcEEEEecCCCCCcccceecccCCCcccccCCC
Q 046791 99 ITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAM--GNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGM 176 (1018)
Q Consensus 99 i~~~~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~~--~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLPg~ 176 (1018)
+......|.+.. ||||||++. .++|++++.. ....++|+|+|||||++.+ +.++|||-.+-
T Consensus 21 L~sg~~~L~~q~-dGnLvl~~~---~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-----~~~iW~S~t~~-------- 83 (110)
T 3r0e_B 21 LTAKNHQLVMQG-DCNLVLYGG---KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-----FKTIWSSRSSS-------- 83 (110)
T ss_dssp EECSSCEEEECT-TSCEEEECS---SSCEECCCTTSSSSCEEEECTTSCEEEECTT-----CCEEEECCCCC--------
T ss_pred EEeCCEEEEEcC-CCeEEEECC---eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-----CCEEEEcCCcC--------
Confidence 333457888987 999999973 4789998762 3468999999999999865 67899985310
Q ss_pred eecccccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCC
Q 046791 177 KLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGL 230 (1018)
Q Consensus 177 klg~~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~ 230 (1018)
..|.|.+.++.+|. ++++. ...|.+|+
T Consensus 84 -----------------------~~~~~~~~L~~dGN--lvly~--~~~W~t~~ 110 (110)
T 3r0e_B 84 -----------------------KQGEYVLILQDDGF--GVIYG--PAIFETSS 110 (110)
T ss_dssp -----------------------SSSCCEEEECTTSC--EEEEC--SEEEESCC
T ss_pred -----------------------CCCCEEEEEcCCcc--EEEec--CCEecCCC
Confidence 12457889999997 55665 47898763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.43 E-value=2.5e-07 Score=99.04 Aligned_cols=122 Identities=16% Similarity=0.122 Sum_probs=87.1
Q ss_pred HhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCc-cc----------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL-TD---------------- 576 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nl-v~---------------- 576 (1018)
...++.+....+.|..+.||++...+|+.++||..... ....+..|+.+++.+.+.++ +.
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34456654444456669999998877888999997653 23457899999999976554 21
Q ss_pred -ccCCCCCC--hhhHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 046791 577 -SRRNNRLN--WETRFSIIEGIAQGLLYLHKYS----------------------------------------------- 606 (1018)
Q Consensus 577 -~~~~~~l~--~~~~~~i~~qia~gL~yLH~~~----------------------------------------------- 606 (1018)
...+..+. ......++.++++.|..||+..
T Consensus 95 e~i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 95 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EecCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 11122222 2234578899999999999754
Q ss_pred --------CCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 607 --------RLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 607 --------~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=4.7e-07 Score=97.44 Aligned_cols=127 Identities=18% Similarity=0.167 Sum_probs=92.0
Q ss_pred HHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcC-CCccc-------------
Q 046791 511 ISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH-TNLTD------------- 576 (1018)
Q Consensus 511 l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H-~nlv~------------- 576 (1018)
+......|.+...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+.+ ..+.+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 4455578998899999999999999754 68899999875322334468999999999864 22211
Q ss_pred ---ccCCCCC-----ChhhHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 046791 577 ---SRRNNRL-----NWETRFSIIEGIAQGLLYLHKY------------------------------------------- 605 (1018)
Q Consensus 577 ---~~~~~~l-----~~~~~~~i~~qia~gL~yLH~~------------------------------------------- 605 (1018)
...+..+ +......++.+++++|..||+.
T Consensus 88 v~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 1111111 2334568899999999999981
Q ss_pred -------------CCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 606 -------------SRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 606 -------------~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998766667999998754
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.6e-06 Score=79.27 Aligned_cols=82 Identities=26% Similarity=0.461 Sum_probs=60.7
Q ss_pred CceEEeccCCcEEEEcCCCCeEEEEEeec---CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcccccCCCeecc
Q 046791 104 GSLTIDSRDGNLKILRKGGNSIVVSSVQA---MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGL 180 (1018)
Q Consensus 104 ~~l~~~~~~G~Lvl~~~~~~~~~wss~~~---~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLPg~klg~ 180 (1018)
-.|.+.. ||||||++ .+.+||++++. .....++|.++|||||.|.+ ++++|+|-
T Consensus 21 y~l~~q~-DgNLvly~--~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-----~~~vWss~--------------- 77 (105)
T 4h3o_A 21 YHFIMQD-DCNLVLYD--HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-----GRSLWASH--------------- 77 (105)
T ss_dssp EEEEECT-TSCEEEEE--TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-----CCEEEECC---------------
T ss_pred EEEEECC-CCeEEEEE--CCEEEEEecCCCCCCccEEEEEeCCccEEEECCC-----cEEEEEec---------------
Confidence 4688877 99999997 45789999875 34568999999999999876 67789761
Q ss_pred cccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEe
Q 046791 181 NLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTC 228 (1018)
Q Consensus 181 ~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~s 228 (1018)
+....|.|.+.++++|. ++++. ...|.|
T Consensus 78 ----------------t~~~~~~~~l~L~ddGN--lVly~--~~~W~S 105 (105)
T 4h3o_A 78 ----------------STRGSGNYILILQDDGN--VIIYG--SDIWST 105 (105)
T ss_dssp ----------------CCCCSSCEEEEECTTSC--EEEEE--SEEEEC
T ss_pred ----------------CCCCCCCEEEEEeCCCe--EEEEC--CcEecC
Confidence 11134678899999997 55554 246753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.11 E-value=1.5e-06 Score=95.75 Aligned_cols=162 Identities=20% Similarity=0.239 Sum_probs=104.2
Q ss_pred eeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhc-CCCcc-----c----------------ccC
Q 046791 522 NKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNLT-----D----------------SRR 579 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nlv-----~----------------~~~ 579 (1018)
+.++.|....||+.. ..+++|+.... .....+.+|+.+++.+. +..+. . ...
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999863 57889986432 34567899999999884 33321 0 011
Q ss_pred CC--------CCChhhHHHHHHHHHHHHHHHhcCC---------------------------------------------
Q 046791 580 NN--------RLNWETRFSIIEGIAQGLLYLHKYS--------------------------------------------- 606 (1018)
Q Consensus 580 ~~--------~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------------------- 606 (1018)
+. .++.+++..++.++++.|..||...
T Consensus 100 G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 100 GVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp CEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred CeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 11 2344566789999999999999621
Q ss_pred ----------CCcEEecccCCCcEEEcC--CCCceeeeecceeeecCCCCcccc------------eeeecccccCC-hh
Q 046791 607 ----------RLRVIHRDLKASNILLDD--QMNPKISDFGMARIFGLNQSETNT------------NRVVGTYGYMS-PE 661 (1018)
Q Consensus 607 ----------~~~ivH~Dlkp~NILld~--~~~~kL~DFGla~~~~~~~~~~~~------------~~~~gt~~Y~a-PE 661 (1018)
.+.++|+|++|.||++++ ...+.|+||+.+..-......... .......+... |+
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~ 259 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPT 259 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHH
Confidence 245899999999999998 556789999998764221100000 00001111222 33
Q ss_pred hhccCCCCccccchhHhHHHHHHHhCCCCC
Q 046791 662 YAMSGVVSIKTDVFSFGVLVLEIVSGKKNN 691 (1018)
Q Consensus 662 ~~~~~~~s~ksDV~SlGvvl~elltG~~p~ 691 (1018)
..... ....+.|+++.++|++.+|..++
T Consensus 260 ~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 260 VLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22211 22368999999999999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.97 E-value=1.7e-05 Score=89.40 Aligned_cols=118 Identities=13% Similarity=0.230 Sum_probs=84.4
Q ss_pred eeeeeccCCCcCeEEEEecccccceEEEec--ccc-cccHHHHHHHHHHHHHhcCCCc-----c----------------
Q 046791 520 AVNKLGEGGFGPVYKGQLLNGQEVAIKRLS--RRS-GQGIVEFKNEAKLIAKLQHTNL-----T---------------- 575 (1018)
Q Consensus 520 ~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~--~~~-~~~~~~f~~E~~~l~~l~H~nl-----v---------------- 575 (1018)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+.+.++ +
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45789999999999998754 678888775 322 1234568899999999975433 1
Q ss_pred cccCC--------CCCChhhHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 046791 576 DSRRN--------NRLNWETRFSIIEGIAQGLLYLHKYS----------------------------------------- 606 (1018)
Q Consensus 576 ~~~~~--------~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------------- 606 (1018)
+...+ ..++..++..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 00111 13457778899999999999999731
Q ss_pred --------------CCcEEecccCCCcEEEcCCCC--ceeeeecceee
Q 046791 607 --------------RLRVIHRDLKASNILLDDQMN--PKISDFGMARI 638 (1018)
Q Consensus 607 --------------~~~ivH~Dlkp~NILld~~~~--~kL~DFGla~~ 638 (1018)
+..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 356999999999999997753 68999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0023 Score=69.39 Aligned_cols=54 Identities=22% Similarity=0.193 Sum_probs=44.5
Q ss_pred CcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhc
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ 570 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~ 570 (1018)
.....+.+|.|..+.||+.++.||+.+.||+...........|..|+..|+.|.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLG 69 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence 455668899999999999999999999999876554444556889999999885
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0036 Score=68.64 Aligned_cols=112 Identities=24% Similarity=0.238 Sum_probs=79.5
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCC-c-c-c-----------------ccCC
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN-L-T-D-----------------SRRN 580 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n-l-v-~-----------------~~~~ 580 (1018)
.+.++.|....||+. +..++||+-.. ......+.+|+.++..+.+.. + + + ...+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888899987 67889998532 234567899999999997631 1 0 0 0111
Q ss_pred --------CCCChhhHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 046791 581 --------NRLNWETRFSIIEGIAQGLLYLHKYS---------------------------------------------- 606 (1018)
Q Consensus 581 --------~~l~~~~~~~i~~qia~gL~yLH~~~---------------------------------------------- 606 (1018)
..++..++..++.++++.|..||+..
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 12344567778888888888888642
Q ss_pred -----------CCcEEecccCCCcEEEcC---CCC-ceeeeecceee
Q 046791 607 -----------RLRVIHRDLKASNILLDD---QMN-PKISDFGMARI 638 (1018)
Q Consensus 607 -----------~~~ivH~Dlkp~NILld~---~~~-~kL~DFGla~~ 638 (1018)
+..++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 234699999999999987 455 48999998865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0058 Score=68.34 Aligned_cols=118 Identities=12% Similarity=0.089 Sum_probs=76.9
Q ss_pred eeee-ccCCCcCeEEEEec-------ccccceEEEecccc---cccHHHHHHHHHHHHHhcCC-Cc-----c--------
Q 046791 521 VNKL-GEGGFGPVYKGQLL-------NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHT-NL-----T-------- 575 (1018)
Q Consensus 521 ~~~l-G~G~fG~Vy~~~~~-------~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~-nl-----v-------- 575 (1018)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+... .+ +
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88888999998765 26788899765432 11124577888888877432 21 1
Q ss_pred --------cccCCC----------------CCChhhHHHHHHHHHHHHHHHhcC--------------------------
Q 046791 576 --------DSRRNN----------------RLNWETRFSIIEGIAQGLLYLHKY-------------------------- 605 (1018)
Q Consensus 576 --------~~~~~~----------------~l~~~~~~~i~~qia~gL~yLH~~-------------------------- 605 (1018)
+...+. .++..++..++.++++.|.-||+.
T Consensus 105 ~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNW 184 (357)
T ss_dssp TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHH
T ss_pred cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHH
Confidence 001111 133444556677777777666631
Q ss_pred -----------------------------------CCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 606 -----------------------------------SRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 606 -----------------------------------~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.+..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 185 VRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 135689999999999999654578999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.96 E-value=0.0085 Score=68.15 Aligned_cols=50 Identities=14% Similarity=0.184 Sum_probs=34.8
Q ss_pred eeeeccCCCcCeEEEEec-ccccceEEEeccccc-------ccHHHHHHHHHHHHHhc
Q 046791 521 VNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG-------QGIVEFKNEAKLIAKLQ 570 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~f~~E~~~l~~l~ 570 (1018)
.+.||.|..+.||+++.. +++.++||....... ....++..|++++..+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~ 92 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG 92 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHH
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhh
Confidence 468999999999999764 467899998643211 23346788999888774
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.92 E-value=0.02 Score=62.90 Aligned_cols=63 Identities=8% Similarity=0.053 Sum_probs=38.9
Q ss_pred ceeHHHHHHHhCCcce-----eeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhc
Q 046791 505 IFDFQTISAATNNFSA-----VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ 570 (1018)
Q Consensus 505 ~f~~~~l~~~t~~y~~-----~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~ 570 (1018)
.++.+++.....+|.+ .+.|+.|....+|+....+| .+++|...... ...++..|+.++..+.
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~ 73 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLA 73 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHH
Confidence 3455666666666654 34567788889999987555 68899886531 2234566777777764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.53 E-value=0.032 Score=61.51 Aligned_cols=32 Identities=19% Similarity=0.276 Sum_probs=28.0
Q ss_pred CCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 607 ~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 35699999999999998888999999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=95.28 E-value=0.044 Score=58.32 Aligned_cols=120 Identities=17% Similarity=0.145 Sum_probs=79.1
Q ss_pred hCCcceeeeeccCCCc-CeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcC----CCccc------------
Q 046791 515 TNNFSAVNKLGEGGFG-PVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH----TNLTD------------ 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG-~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H----~nlv~------------ 576 (1018)
...|+. +.+..|..| .||+..... +..+.||+-... ...++.+|+..|+.+.. |.++.
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 334543 355566666 589887654 667899976433 34568889999988853 11111
Q ss_pred -ccCCCC------CChhhHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 046791 577 -SRRNNR------LNWETRFSIIEGIAQGLLYLHKYS------------------------------------------- 606 (1018)
Q Consensus 577 -~~~~~~------l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------- 606 (1018)
...... ........+..++++.|..||...
T Consensus 100 e~l~G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp ECCCSEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred EeeCCccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 011111 123445667888888888888521
Q ss_pred ------------CCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 607 ------------RLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 607 ------------~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
+..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999887778999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.13 E-value=0.047 Score=59.38 Aligned_cols=111 Identities=14% Similarity=0.106 Sum_probs=72.3
Q ss_pred eeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcc---------------ccc-CCCCCC
Q 046791 521 VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT---------------DSR-RNNRLN 584 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv---------------~~~-~~~~l~ 584 (1018)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+. +.. ....++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTMS 96 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccCC
Confidence 468888999999998 57888877543211 11235677777776432222 112 333444
Q ss_pred hhhHH---HHHHHHHHHHHHHhcCC--------------------------------------------------CCcEE
Q 046791 585 WETRF---SIIEGIAQGLLYLHKYS--------------------------------------------------RLRVI 611 (1018)
Q Consensus 585 ~~~~~---~i~~qia~gL~yLH~~~--------------------------------------------------~~~iv 611 (1018)
..... .++.++++.|.-||... +..++
T Consensus 97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~ 176 (301)
T 3dxq_A 97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAAC 176 (301)
T ss_dssp HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEE
T ss_pred HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceee
Confidence 43332 36777888888888643 12379
Q ss_pred ecccCCCcEEEcCCCCceeeeecceee
Q 046791 612 HRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 612 H~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
|+|+.+.||| ..++.+.|+||..+..
T Consensus 177 HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 177 HCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ccCCCcCCEE-ECCCCEEEEecccccC
Confidence 9999999999 5666789999998865
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.02 E-value=0.061 Score=61.80 Aligned_cols=52 Identities=12% Similarity=0.180 Sum_probs=36.4
Q ss_pred eeeeccCCCcCeEEEEecc--------cccceEEEecccccccHHHHHHHHHHHHHhcCCCc
Q 046791 521 VNKLGEGGFGPVYKGQLLN--------GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nl 574 (1018)
.+.|+.|-...||+....+ ++.+++|+.... .....+.+|+.++..+...++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~ 137 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHL 137 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTS
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCC
Confidence 4678888889999998753 467888887432 112556689998888854443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.57 E-value=0.099 Score=53.38 Aligned_cols=92 Identities=12% Similarity=0.077 Sum_probs=59.2
Q ss_pred CCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccC
Q 046791 580 NNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYM 658 (1018)
Q Consensus 580 ~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~ 658 (1018)
+.+|++++++.++.|.+.+|.-+-. .. + ..+=+.|..|+|..+|.+.+.+ ..+. .....+.
T Consensus 43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~ 104 (229)
T 2yle_A 43 NQPINEEQAWAVCYQCCGSLRAAARRRQ--P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPV 104 (229)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTC--C-CCCCCSGGGEEEETTSCEEECC-C------------------------
T ss_pred CCCcCHHHHHHHHHHHHHHHHhhhhccc--C-CceecCCcceEEecCCceeccc-cccc--------------ccccCCC
Confidence 5689999999999999999887621 11 0 1223457899999999887754 1110 1122456
Q ss_pred ChhhhccCCCCccccchhHhHHHHHHHhCCCC
Q 046791 659 SPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKN 690 (1018)
Q Consensus 659 aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p 690 (1018)
|||... ...+.+.=|||||++||..+--..|
T Consensus 105 ~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 105 AGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred Chhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 888653 3556888999999999999864443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.43 E-value=0.12 Score=59.63 Aligned_cols=53 Identities=15% Similarity=0.197 Sum_probs=33.1
Q ss_pred eeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCc
Q 046791 521 VNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nl 574 (1018)
.+.|+.|-...+|+....+ +..+++|+....... ...-.+|..++..|...++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl 166 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNI 166 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCC
Confidence 3678888889999998765 467888877433211 1112578888888865443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.10 E-value=0.11 Score=58.52 Aligned_cols=49 Identities=18% Similarity=0.198 Sum_probs=29.7
Q ss_pred eeeccCCCcCeEEEEecc--------cccceEEEecccccccHHHHHHHHHHHHHhcC
Q 046791 522 NKLGEGGFGPVYKGQLLN--------GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH 571 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H 571 (1018)
+.|..|-...+|+....+ ++.+++|+.... ........+|.++++.|..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~ 112 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAE 112 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHH
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHh
Confidence 567778888999988652 467888876332 2345667789998888754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.02 E-value=0.17 Score=55.49 Aligned_cols=65 Identities=15% Similarity=0.069 Sum_probs=41.9
Q ss_pred cceeHHHHHHHhCCcce-----eeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhc
Q 046791 504 EIFDFQTISAATNNFSA-----VNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ 570 (1018)
Q Consensus 504 ~~f~~~~l~~~t~~y~~-----~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~ 570 (1018)
...+.+++..+...|.+ ...|+ |....||+....+|+.+++|...... ....++..|..++..+.
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~ 78 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLV 78 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHH
Confidence 33444555544444432 24566 77889999887778889999986331 23456677888877774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=93.34 E-value=0.26 Score=53.83 Aligned_cols=47 Identities=26% Similarity=0.180 Sum_probs=36.7
Q ss_pred eeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhc
Q 046791 520 AVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ 570 (1018)
Q Consensus 520 ~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~ 570 (1018)
..+.|+.|....+|+... ++..++||+.... ....|..|+..|+.|.
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~ 86 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLA 86 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHH
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHH
Confidence 346799999999999976 4678889987543 3567889999988885
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=93.22 E-value=0.13 Score=57.57 Aligned_cols=30 Identities=23% Similarity=0.454 Sum_probs=25.0
Q ss_pred CcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 608 LRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 608 ~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
..++|+|+++.|||++.+. +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4589999999999998654 89999988764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=87.77 E-value=0.41 Score=54.57 Aligned_cols=78 Identities=9% Similarity=0.136 Sum_probs=48.1
Q ss_pred CCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeec--ccccCChhhhccC---CCCccccchhHhHHH
Q 046791 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVG--TYGYMSPEYAMSG---VVSIKTDVFSFGVLV 681 (1018)
Q Consensus 607 ~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~---~~s~ksDV~SlGvvl 681 (1018)
...++|+|++|.|||++.++ ++|+||+.+..-... ........ ...|++|+..... ......++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 34599999999999998876 999999998753211 00000111 1345666654311 112235566788888
Q ss_pred HHHHhCC
Q 046791 682 LEIVSGK 688 (1018)
Q Consensus 682 ~elltG~ 688 (1018)
|+.+.++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=87.20 E-value=0.65 Score=52.95 Aligned_cols=30 Identities=33% Similarity=0.541 Sum_probs=26.8
Q ss_pred CcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 608 LRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 608 ~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 46899999999999 8888999999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=84.72 E-value=0.9 Score=49.72 Aligned_cols=33 Identities=27% Similarity=0.401 Sum_probs=28.1
Q ss_pred CCcEEecccCCCcEEEcCC----CCceeeeecceeee
Q 046791 607 RLRVIHRDLKASNILLDDQ----MNPKISDFGMARIF 639 (1018)
Q Consensus 607 ~~~ivH~Dlkp~NILld~~----~~~kL~DFGla~~~ 639 (1018)
+..++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4569999999999999874 67899999988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.94 E-value=2.3 Score=48.01 Aligned_cols=30 Identities=27% Similarity=0.411 Sum_probs=25.4
Q ss_pred cEEecccCCCcEEE------cCCCCceeeeecceee
Q 046791 609 RVIHRDLKASNILL------DDQMNPKISDFGMARI 638 (1018)
Q Consensus 609 ~ivH~Dlkp~NILl------d~~~~~kL~DFGla~~ 638 (1018)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1018 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-30 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-12 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 5e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 7e-11 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 6e-07 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-55
Identities = 62/282 (21%), Positives = 114/282 (40%), Gaps = 43/282 (15%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN-- 573
+ ++G G FG VYKG+ V + ++ + Q + FKNE ++ K +H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 574 ----------------------LTD--SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLR 609
L + I AQG+ YLH
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM---SG 666
+IHRDLK++NI L + + KI DFG+A + ++ G+ +M+PE
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 667 VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726
S ++DV++FG+++ E+++G+ Y + + I + G + +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQI---IFMVGRGYLSPDLS-----K 233
Query: 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLP 768
N + C++ + +RP P +++ + + SLP
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-52
Identities = 64/286 (22%), Positives = 109/286 (38%), Gaps = 47/286 (16%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL- 574
+ KLG+G FG V+ G VAIK L + F EA+++ KL+H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 575 --------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
L + IA G+ Y+ +
Sbjct: 76 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 132
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
+HRDL+A+NIL+ + + K++DFG+AR+ N+ + +PE A+ G
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRF 191
Query: 669 SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728
+IK+DV+SFG+L+ E+ + + + +VL+ V+
Sbjct: 192 TIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCP 236
Query: 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPA 774
P + C + + +RP + + L + S QP
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 8e-52
Identities = 65/272 (23%), Positives = 111/272 (40%), Gaps = 47/272 (17%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL- 574
V +LG G FG V+ G +VA+K L ++ F EA L+ +LQH L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 575 --------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
+ +L + IA+G+ ++ +
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---R 128
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
IHRDL+A+NIL+ D ++ KI+DFG+AR+ N+ + +PE G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTF 187
Query: 669 SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728
+IK+DV+SFG+L+ EIV+ + + +V++ ++
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVRP 232
Query: 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
N + LC +++ DRP + S+L
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 47/272 (17%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT 575
+ + V ++G G FG V+ G LN +VAIK + R +F EA+++ KL H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 576 ---------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
+ ET + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---A 120
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
VIHRDL A N L+ + K+SDFGM R + T++ + SPE
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 669 SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728
S K+DV+SFGVL+ E+ S K ++ + +V+E +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGK---------------IPYENRSNSEVVEDISTGFRLYKP 224
Query: 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
+ C +++ DRPA ++ L
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-50
Identities = 57/285 (20%), Positives = 98/285 (34%), Gaps = 49/285 (17%)
Query: 523 KLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN--------- 573
+G+G FG V++G+ G+EVA+K S R + + E L+H N
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 574 --------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHK-----YSRL 608
L D + E + A GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIF--GLNQSETNTNRVVGTYGYMSPEYAMSG 666
+ HRDLK+ NIL+ I+D G+A + + N VGT YM+PE
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 667 V------VSIKTDVFSFGVLVLEIVSGKKNNGCYRTD----HPLNLIGYAWQLWNEGKVL 716
+ + D+++ G++ EI G + + L + + +
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 717 ELVDIALEGSFSPNEVLRCIH-VGLLCVQDQATDRPAMPDVVSML 760
+ + + + E LR + + C R + L
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 63/313 (20%), Positives = 119/313 (38%), Gaps = 64/313 (20%)
Query: 518 FSAVNKLGEGGFGPVYKGQLLNGQE-----VAIKRLSRR-SGQGIVEFKNEAKLIAKLQH 571
F + LG G FG VYKG + E VAIK L S + E +EA ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 572 TNL--------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKY 605
++ + + + + IA+G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-- 128
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
R++HRDL A N+L+ + KI+DFG+A++ G + E + +M+ E +
Sbjct: 129 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 666 GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725
+ + ++DV+S+GV V E+++ + ++ +++
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKGERL 232
Query: 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML--------------ANESLSLPAPK 771
P + + + C A RP +++ +E + LP+P
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292
Query: 772 QPAFFINITAEEP 784
F+ + EE
Sbjct: 293 DSNFYRALMDEED 305
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-49
Identities = 60/272 (22%), Positives = 105/272 (38%), Gaps = 47/272 (17%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT 575
+ + + +LG G FG V G+ +VAIK + S EF EAK++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 576 ---------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
+R + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SK 119
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
+ +HRDL A N L++DQ K+SDFG++R + T++ + PE M
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 669 SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728
S K+D+++FGVL+ EI S K ++ + + E + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYRP 223
Query: 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
+ + C ++A +RP ++S +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 60/285 (21%), Positives = 111/285 (38%), Gaps = 52/285 (18%)
Query: 510 TISAATNNFSAVNKLGEGGFGPVYKGQLLNGQE-----VAIKRLSRRSGQG-IVEFKNEA 563
T + + +G G FG VYKG L VAIK L + V+F EA
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 564 KLIAKLQHTNLT---------------------------DSRRNNRLNWETRFSIIEGIA 596
++ + H N+ ++ + ++ GIA
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 597 QGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT-NRVVGTY 655
G+ YL + +HRDL A NIL++ + K+SDFG++R+ + T T +
Sbjct: 121 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 656 GYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKV 715
+ +PE + +DV+SFG+++ E+++ + + + +V
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------------YWELSNHEV 222
Query: 716 LELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
++ ++ + + + C Q + RP D+VS+L
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-48
Identities = 44/203 (21%), Positives = 88/203 (43%), Gaps = 34/203 (16%)
Query: 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQH 571
++F +++LG G G V+K +G +A K + I E +++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 572 TNL--------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKY 605
+ ++ R+ + + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-- 121
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+ +++HRD+K SNIL++ + K+ DFG++ ++ N VGT YMSPE
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQG 177
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
S+++D++S G+ ++E+ G+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 2e-48
Identities = 60/299 (20%), Positives = 108/299 (36%), Gaps = 62/299 (20%)
Query: 506 FDFQTISAATNNFSA---------VNKLGEGGFGPVYKGQLL----NGQEVAIKRL-SRR 551
F F+ + A F+ +G G FG V G L VAIK L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 552 SGQGIVEFKNEAKLIAKLQHTNLT---------------------------DSRRNNRLN 584
+ + +F +EA ++ + H N+ + + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 585 WETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644
++ GIA G+ YL +HRDL A NIL++ + K+SDFG++R + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 645 ETNTNRVVG---TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLN 701
+ +G + +PE + +DV+S+G+++ E++S +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------------ 231
Query: 702 LIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
+ V+ ++ + + L C Q RP +V+ L
Sbjct: 232 ---RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 5e-48
Identities = 56/274 (20%), Positives = 104/274 (37%), Gaps = 49/274 (17%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574
+ + +KLG G +G VY+G VA+K L + + + EF EA ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 575 T----------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
+ IHRDL A N L+ + K++DFG++R+ + + + +PE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 191
Query: 667 VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726
SIK+DV++FGVL+ EI + + + + +V EL++
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLEKDYRME 236
Query: 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
+ + C Q +DRP+ ++
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 2e-46
Identities = 61/302 (20%), Positives = 102/302 (33%), Gaps = 75/302 (24%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRSGQGIV-EFKNEAKLIAK 568
NN V +GEG FG V++ + VA+K L + + +F+ EA L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 569 LQHTN--------------------------------------------------LTDSR 578
+ N S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 579 RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638
L+ + I +A G+ YL + + +HRDL N L+ + M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDH 698
+M PE + ++DV+++GV++ EI S Y
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMA 247
Query: 699 PLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758
+I +G +L N L ++ LC DRP+ +
Sbjct: 248 HEEVI----YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 759 ML 760
+L
Sbjct: 295 IL 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-46
Identities = 57/295 (19%), Positives = 107/295 (36%), Gaps = 50/295 (16%)
Query: 514 ATNNFSAVN-KLGEGGFGPVYKGQLL---NGQEVAIKRLSRRSGQGIVE-FKNEAKLIAK 568
+N + +LG G FG V +G +VAIK L + + + E EA+++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 569 LQHTNLTD--------------------------SRRNNRLNWETRFSIIEGIAQGLLYL 602
L + + + + ++ ++ G+ YL
Sbjct: 66 LDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE-TNTNRVVGTYGYMSPE 661
+HRDL A N+LL ++ KISDFG+++ G + S T + + +PE
Sbjct: 126 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721
S ++DV+S+GV + E +S + P ++ +V+ ++
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQ--------KP-------YKKMKGPEVMAFIEQ 227
Query: 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQPAFF 776
P + C + DRP V + SL + +
Sbjct: 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-45
Identities = 56/272 (20%), Positives = 97/272 (35%), Gaps = 49/272 (18%)
Query: 522 NKLGEGGFGPVYKGQLLN---GQEVAIKRLSRRSGQGIV--EFKNEAKLIAKLQHTNL-- 574
+LG G FG V KG + VA+K L + + E EA ++ +L + +
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 575 -----------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVI 611
++N + + ++ ++ G+ YL +
Sbjct: 73 MIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 129
Query: 612 HRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN-RVVGTYGYMSPEYAMSGVVSI 670
HRDL A N+LL Q KISDFG+++ +++ + +PE S
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 671 KTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPN 730
K+DV+SFGVL+ E S + ++ +V +++
Sbjct: 190 KSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMGCPAG 234
Query: 731 EVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762
+ LC +RP V L N
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-44
Identities = 57/274 (20%), Positives = 98/274 (35%), Gaps = 55/274 (20%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT 575
+ +G+G FG V G G +VA+K + + F EA ++ +L+H+NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLV 63
Query: 576 -----------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
SR + L + + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
+HRDL A N+L+ + K+SDFG+ + + + + +PE
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREK 175
Query: 667 VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726
S K+DV+SFG+L+ EI S + Y +++ +G ++ D
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVV----PRVEKGYKMDAPD-----G 224
Query: 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
P V C A RP+ + L
Sbjct: 225 CPP----AVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-44
Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 32/202 (15%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHTN 573
++ V LGEG +G V + VA+K + + E K E + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 574 LTD--------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+ + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 121
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG- 666
+ + HRD+K N+LLD++ N KISDFG+A +F N E N++ GT Y++PE
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 667 VVSIKTDVFSFGVLVLEIVSGK 688
+ DV+S G+++ +++G+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-43
Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 55/279 (19%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQH 571
+F+ +G G FG VY G LL+ A+K L+R + G V F E ++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 572 TNLT----------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLH 603
N+ + + +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---K 144
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR--VVGTYGYMSPE 661
+ + +HRDL A N +LD++ K++DFG+AR + ++ N+ +M+ E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721
+ + K+DV+SFGVL+ E+++ Y + ++ Y Q G+ L
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQ----GRRL----- 253
Query: 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
L+ + P+ + V L C +A RP+ ++VS +
Sbjct: 254 -LQPEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 66/271 (24%), Positives = 108/271 (39%), Gaps = 54/271 (19%)
Query: 522 NKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTN---LT 575
++G G F VYKG EVA L R + FK EA+++ LQH N
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 576 DS---------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
DS +R + + S I +GL +LH +
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 609 RVIHRDLKASNILLDDQ-MNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGV 667
+IHRDLK NI + + KI D G+A + + V+GT +M+PE
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-YEEK 188
Query: 668 VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727
DV++FG+ +LE+ + + +P + A Q++ +V V A
Sbjct: 189 YDESVDVYAFGMCMLEMATSE---------YPYSECQNAAQIYR--RVTSGVKPASFDKV 237
Query: 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758
+ EV I C++ +R ++ D+++
Sbjct: 238 AIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 9e-43
Identities = 69/274 (25%), Positives = 104/274 (37%), Gaps = 57/274 (20%)
Query: 518 FSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQG---IVEFKNEAKLIAKLQHTN 573
FS + ++G G FG VY + + N + VAIK++S Q + E + + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 574 L--------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
L ++ G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---S 133
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS-- 665
+IHRD+KA NILL + K+ DFG A I N VGT +M+PE ++
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAMD 187
Query: 666 -GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724
G K DV+S G+ +E+ K PL + L+ + + AL+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERK---------PPLFNMNAMSALY---HIAQNESPALQ 235
Query: 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758
+ C+Q DRP ++
Sbjct: 236 SGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 62/306 (20%), Positives = 112/306 (36%), Gaps = 63/306 (20%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRR-SGQGIVEFKNEAKLIAK 568
+ +LG+G FG VY+G VAIK ++ S + +EF NEA ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 569 LQHTN------------------------------------LTDSRRNNRLNWETRFSII 592
+ + ++ + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 593 EGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVV 652
IA G+ YL+ + +HRDL A N ++ + KI DFGM R + +
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 653 GTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712
+MSPE GV + +DV+SFGV++ EI + + +Q +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSN 241
Query: 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQ 772
+VL V N + +C Q RP+ +++S + + P ++
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI--KEEMEPGFRE 299
Query: 773 PAFFIN 778
+F+ +
Sbjct: 300 VSFYYS 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-42
Identities = 57/279 (20%), Positives = 96/279 (34%), Gaps = 51/279 (18%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAK 568
+ + KLG+G FG V +G+ VA+K L + + +F E +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 569 LQHTNL--------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYL 602
L H NL + T +A+G+ YL
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE-TNTNRVVGTYGYMSPE 661
R IHRDL A N+LL + KI DFG+ R N + + +PE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721
+ S +D + FGV + E+ + + + + ++ ++ EG+ L
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQIL---HKIDKEGERLP---- 235
Query: 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
+ +V + C + DRP + L
Sbjct: 236 -----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-42
Identities = 61/305 (20%), Positives = 101/305 (33%), Gaps = 74/305 (24%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLN------GQEVAIKRLSRRSGQGIVE-FKNEAKLIAK 568
N LG G FG V +VA+K L ++ E +E K++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 569 L-QHTNL-------------------------------------------------TDSR 578
L H N+ +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 579 RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638
N L +E +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDH 698
+ + +M+PE G+ +IK+DV+S+G+L+ EI S N Y
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIP 271
Query: 699 PLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758
++L G ++ + C + RP+ P++ S
Sbjct: 272 VDANF---YKLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 759 MLANE 763
L +
Sbjct: 320 FLGCQ 324
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-42
Identities = 58/292 (19%), Positives = 104/292 (35%), Gaps = 68/292 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNG---QEVAIKRLSRR-SGQGIVEFKNEAKLIAKL-Q 570
N+ + +GEG FG V K ++ + AIKR+ S +F E +++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 571 HTNL------------------------------------------TDSRRNNRLNWETR 588
H N+ + + L+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 589 FSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648
+A+G+ YL + + IHRDL A NIL+ + KI+DFG++R +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQ 708
+M+ E V + +DV+S+GVL+ EIVS +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYC 228
Query: 709 LWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
++ E + N + C +++ +RP+ ++ L
Sbjct: 229 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 8e-42
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 38/207 (18%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN 573
+ + + +LG+G FG VYK Q A K + +S + + ++ E ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 574 LT---------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
+ L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS- 665
++IHRDLKA NIL + K++DFG++ ++ + +GT +M+PE M
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 666 ----GVVSIKTDVFSFGVLVLEIVSGK 688
K DV+S G+ ++E+ +
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 54/275 (19%), Positives = 100/275 (36%), Gaps = 58/275 (21%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQH 571
+F LG+G FG VY + + +A+K L + + + E ++ + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 572 TNL--------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKY 605
N+ + ++ ++ + + + I +A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH-- 123
Query: 606 SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
RVIHRD+K N+LL KI+DFG + + + + GT Y+ PE
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEG 178
Query: 666 GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725
+ K D++S GVL E + GK + E
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKP-------------------PFEANTYQETYKRISRV 219
Query: 726 SFSPNEVL--RCIHVGLLCVQDQATDRPAMPDVVS 758
F+ + + + ++ + RP + +V+
Sbjct: 220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 57/278 (20%), Positives = 104/278 (37%), Gaps = 55/278 (19%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTN 573
++ + +G G +G K + +G+ + K L S +E L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 574 LT--------------------------------DSRRNNRLNWETRFSIIEGIAQGLLY 601
+ ++ L+ E ++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 602 LHKYSR--LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659
H+ S V+HRDLK +N+ LD + N K+ DFG+ARI + S VGT YMS
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719
PE + K+D++S G L+ E+ + + L GK+ E
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELA---------GKIREGK 230
Query: 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVV 757
+ +S + + + RP++ +++
Sbjct: 231 FRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 1e-41
Identities = 56/297 (18%), Positives = 94/297 (31%), Gaps = 69/297 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRSGQGIVE-FKNEAKLIAK 568
N S LG G FG V + VA+K L + E +E K+++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 569 L-QHTNL--------------------------------------------TDSRRNNRL 583
L H N+ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 584 NWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643
+ E S +A+G+ +L IHRDL A NILL KI DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703
+ +M+PE + V + ++DV+S+G+ + E+ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 704 GYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
+ + K +++ + + C RP +V ++
Sbjct: 247 -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-41
Identities = 60/298 (20%), Positives = 95/298 (31%), Gaps = 68/298 (22%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRSGQG-IVEFKNEAKLIAK 568
+ LG G FG V + + VA+K L + +E K++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 569 LQHTN--------------------------------------------LTDSRRNNRLN 584
+ H + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 585 WETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644
E +A+G+ +L + IHRDL A NILL ++ KI DFG+AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG 704
+M+PE V +I++DV+SFGVL+ EI S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244
Query: 705 YAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762
+ EG + D L C + + RP ++V L N
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-40
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 510 TISAATNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAK 568
++ ++ K+G+G G VY + GQEVAI++++ + NE ++ +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 569 LQHTN-------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLH 603
++ N LTD ++ ++ Q L +LH
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
+VIHRD+K+ NILL + K++DFG QS+ +T +VGT +M+PE
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 188
Query: 664 MSGVVSIKTDVFSFGVLVLEIVSGK 688
K D++S G++ +E++ G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-40
Identities = 52/276 (18%), Positives = 94/276 (34%), Gaps = 50/276 (18%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQ 570
+GEG FG V++G ++ VAIK + + E F EA + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 571 HTNLT--------------------------DSRRNNRLNWETRFSIIEGIAQGLLYLHK 604
H ++ R L+ + ++ L YL
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE- 125
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
R +HRD+ A N+L+ K+ DFG++R + + ++ +M+PE
Sbjct: 126 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 182
Query: 665 SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724
+ +DV+ FGV + EI+ P +Q V+ ++
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGV--------KP-------FQGVKNNDVIGRIENGER 227
Query: 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
PN + C + RP ++ + L
Sbjct: 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 58/297 (19%), Positives = 103/297 (34%), Gaps = 70/297 (23%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL--------NGQEVAIKRLSRR-SGQGIVEFKNEAKLI 566
+ LGEG FG V + + +VA+K L + + + + +E +++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 567 AKL-QHTNL------------------------------------------TDSRRNNRL 583
+ +H N+ +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 584 NWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643
+ + S +A+G+ YL + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703
T +M+PE + + ++DV+SFGVL+ EI + + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 246
Query: 704 GYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSML 760
++L EG ++ N + C + RP +V L
Sbjct: 247 ---FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 48/202 (23%), Positives = 80/202 (39%), Gaps = 33/202 (16%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHT 572
+F LGEG F V + L +E AIK L +R + E ++++L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 573 NL--------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
R+ + A+ + L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSALEYLH 125
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
+IHRDLK NILL++ M+ +I+DFG A++ + N VGT Y+SPE
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 667 VVSIKTDVFSFGVLVLEIVSGK 688
+D+++ G ++ ++V+G
Sbjct: 186 SACKSSDLWALGCIIYQLVAGL 207
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 137 bits (347), Expect = 6e-36
Identities = 41/203 (20%), Positives = 80/203 (39%), Gaps = 36/203 (17%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574
+++ +LG G FG V++ G A K + + E + ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 575 TD---------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+ + +N+++ + + + +GL ++H+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE--- 142
Query: 608 LRVIHRDLKASNILLDDQMNP--KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
+H DLK NI+ + + K+ DFG+ + + GT + +PE A
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEG 199
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
V TD++S GVL ++SG
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 133 bits (336), Expect = 2e-34
Identities = 39/203 (19%), Positives = 77/203 (37%), Gaps = 36/203 (17%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574
+ + + +LG G FG V++ G+ K ++ KNE ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 575 TD---------------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+ + + +++ + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---E 145
Query: 608 LRVIHRDLKASNILLDDQMNP--KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS 665
++H D+K NI+ + + KI DFG+A + T + +PE
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDR 202
Query: 666 GVVSIKTDVFSFGVLVLEIVSGK 688
V TD+++ GVL ++SG
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-34
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 36/222 (16%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHT 572
++ ++ +GEG +G V +N VAIK++S Q + E K++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 573 NL-----------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLH 603
N+ + L+ + + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT-NRVVGTYGYMSPEY 662
V+HRDLK SN+LL+ + KI DFG+AR+ + T V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 663 AMSGVVSI-KTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703
++ D++S G ++ E++S + LN I
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 2e-34
Identities = 48/283 (16%), Positives = 93/283 (32%), Gaps = 50/283 (17%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574
N + K+G G FG +Y G + G+EVAIK ++ + E+K+ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVG 64
Query: 575 ---------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+ + + + +T + + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 121
Query: 608 LRVIHRDLKASNIL---LDDQMNPKISDFGMARIFGLNQSETN-----TNRVVGTYGYMS 659
IHRD+K N L I DFG+A+ + ++ + + GT Y S
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719
+ S + D+ S G +++ G + + + L
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762
P+E ++ C + D+P + + N
Sbjct: 242 K------GYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (326), Expect = 1e-33
Identities = 46/201 (22%), Positives = 79/201 (39%), Gaps = 32/201 (15%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQH 571
+F + LG G FG V+ + NG+ A+K L + + + +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 572 TNL-----------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
+ + A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVV 668
+I+RDLK NILLD + KI+DFG A+ T + GT Y++PE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 669 SIKTDVFSFGVLVLEIVSGKK 689
+ D +SFG+L+ E+++G
Sbjct: 179 NKSIDWWSFGILIYEMLAGYT 199
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 128 bits (323), Expect = 2e-33
Identities = 44/285 (15%), Positives = 95/285 (33%), Gaps = 52/285 (18%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574
++ ++GEG FG +++G LLN Q+VAIK RRS + ++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTG 62
Query: 575 ---------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+ + +T + + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119
Query: 608 LRVIHRDLKASNILLDDQMNP-----KISDFGMARIFGLNQSETN-----TNRVVGTYGY 657
+++RD+K N L+ + + DFGM + + ++ + + GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717
MS + S + D+ + G + + + G ++ + G+ +
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSL---PWQGLKAATNK---QKYERIGEKKQ 233
Query: 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762
+ + P E + +H P + + +
Sbjct: 234 STPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 128 bits (322), Expect = 2e-33
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 38/209 (18%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQG---IVEFKNEAKLIAKLQ 570
++ + LG GG V+ + L ++VA+K L + + F+ EA+ A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 571 HTNL------------------------------TDSRRNNRLNWETRFSIIEGIAQGLL 600
H + + + +I Q L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE-TNTNRVVGTYGYMS 659
+ H + +IHRD+K +NI++ K+ DFG+AR + + T T V+GT Y+S
Sbjct: 126 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
PE A V ++DV+S G ++ E+++G+
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 127 bits (319), Expect = 3e-32
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSR---RSGQGIVEFKNEAKLIAKLQH 571
N+FS +G GGFG VY + G+ A+K L + + QG NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 572 TN-----------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYL 602
+ ++ + I GL ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
H V++RDLK +NILLD+ + +ISD G+A F S+ + VGT+GYM+PE
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEV 176
Query: 663 AMSGV-VSIKTDVFSFGVLVLEIVSGK 688
GV D FS G ++ +++ G
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-32
Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 45/214 (21%)
Query: 514 ATNNFSAVNKLGEGGFGPVYKGQLL--NGQEVAIKRLSRRSGQG--IVEFKNEAKLIAKL 569
A + V ++GEG +G V+K + L G+ VA+KR+ ++G+ + E ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 570 ---QHTN--------------------------------LTDSRRNNRLNWETRFSIIEG 594
+H N D + ET ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 595 IAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGT 654
+ +GL +LH RV+HRDLK NIL+ K++DFG+ARI+ + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 655 YGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y +PE + + D++S G + E+ K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 7e-32
Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 34/202 (16%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTN 573
NF V K+GEG +G VYK + L G+ VA+K RL + E L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 574 ---------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
D+ + S + + QGL + H +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
RV+HRDLK N+L++ + K++DFG+AR FG T T+ VV +
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 667 VVSIKTDVFSFGVLVLEIVSGK 688
S D++S G + E+V+ +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 120 bits (302), Expect = 8e-31
Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 34/202 (16%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHTN 573
+ + K+GEG +G VYK Q G+ A+K RL + E ++ +L+H+N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 574 L--------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSR 607
+ L T S + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 608 LRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM-SG 666
RV+HRDLK N+L++ + KI+DFG+AR FG+ + + T Y +P+ M S
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSK 176
Query: 667 VVSIKTDVFSFGVLVLEIVSGK 688
S D++S G + E+V+G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-30
Identities = 45/215 (20%), Positives = 77/215 (35%), Gaps = 46/215 (21%)
Query: 504 EIFDFQTISAATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNE 562
E+++ + LG G FG V++ + + K + + G V K E
Sbjct: 2 ELYE---------KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKE 51
Query: 563 AKLIAKLQHTNLTD---------------------------SRRNNRLNWETRFSIIEGI 595
++ +H N+ + LN S + +
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQV 111
Query: 596 AQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP--KISDFGMARIFGLNQSETNTNRVVG 653
+ L +LH + H D++ NI+ + + KI +FG AR N +
Sbjct: 112 CEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFT 165
Query: 654 TYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y +PE VVS TD++S G LV ++SG
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 120 bits (301), Expect = 1e-30
Identities = 46/215 (21%), Positives = 77/215 (35%), Gaps = 49/215 (22%)
Query: 517 NFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE---------FKNEAKLI 566
N+ LG G V + +E A+K + G E ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 567 AKLQ--------------------------HTNLTDS-RRNNRLNWETRFSIIEGIAQGL 599
K+ L D L+ + I+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 600 LYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659
LH +L ++HRDLK NILLDD MN K++DFG + V GT Y++
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLA 177
Query: 660 PEYAMSGVV------SIKTDVFSFGVLVLEIVSGK 688
PE + + D++S GV++ +++G
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 42/202 (20%), Positives = 76/202 (37%), Gaps = 33/202 (16%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQH 571
N+F + LG+G FG V + G+ A+K L + + + E++++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 572 TN-------------------------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
L R+ E R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--GAEIVSALEYLH 122
Query: 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSG 666
V++RD+K N++LD + KI+DFG+ + GT Y++PE
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 667 VVSIKTDVFSFGVLVLEIVSGK 688
D + GV++ E++ G+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-30
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 36/204 (17%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG---QGIVEFKNEAKLIAK-LQ 570
+F LG+G FG V+ + Q AIK L + + E ++++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 571 HTNLTDS--------------------------RRNNRLNWETRFSIIEGIAQGLLYLHK 604
H LT + ++ + I GL +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 605 YSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAM 664
+++RDLK NILLD + KI+DFGM + L ++TNT GT Y++PE +
Sbjct: 122 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILL 176
Query: 665 SGVVSIKTDVFSFGVLVLEIVSGK 688
+ D +SFGVL+ E++ G+
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 4e-30
Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 37/205 (18%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE-FKNEAKLIAKLQHT 572
+ + + LG G F V + + VAIK +++++ +G +NE ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 573 NL--------TDS------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYS 606
N+ + +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL- 126
Query: 607 RLRVIHRDLKASNILL---DDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
++HRDLK N+L D+ ISDFG++++ + + GT GY++PE
Sbjct: 127 --GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---PGSVLSTACGTPGYVAPEVL 181
Query: 664 MSGVVSIKTDVFSFGVLVLEIVSGK 688
S D +S GV+ ++ G
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-30
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 38/200 (19%)
Query: 522 NKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVE-----FKNEAKLIAKLQHTNL- 574
+ LGEG F VYK + N Q VAIK++ + E KL+ +L H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 575 -------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLR 609
+ L + + QGL YLH++
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---W 120
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS-GVV 668
++HRDLK +N+LLD+ K++DFG+A+ FG V T Y +PE +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 669 SIKTDVFSFGVLVLEIVSGK 688
+ D+++ G ++ E++
Sbjct: 179 GVGVDMWAVGCILAELLLRV 198
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (299), Expect = 9e-30
Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 47/242 (19%)
Query: 486 NGDGKRKGNDHNSMKYGLE------IFDFQTISAAT---NNFSAVNKLGEGGFGPVYKGQ 536
N +KG++ S+K L + ++T S T + F + LG G FG V +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 537 -LLNGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTN------------------- 573
+G A+K L ++ + I NE +++ +
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 574 -------LTDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM 626
+ RR R + I YLH L +I+RDLK N+L+D Q
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 627 NPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS 686
+++DFG A+ + + T + GT ++PE +S + D ++ GVL+ E+ +
Sbjct: 179 YIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 687 GK 688
G
Sbjct: 234 GY 235
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-29
Identities = 49/228 (21%), Positives = 93/228 (40%), Gaps = 43/228 (18%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQG--IVEFKNEAKLIAKLQHT 572
+ + + K+G+G FG V+K + GQ+VA+K++ + + + E K++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 573 NL----------------------------------TDSRRNNRLNWETRFSIIEGIAQG 598
N+ S + +++ + G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 599 LLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR--VVGTYG 656
L Y+H+ +++HRD+KA+N+L+ K++DFG+AR F L ++ V T
Sbjct: 130 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 657 YMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703
Y PE + D++ G ++ E+ + H L LI
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 4e-29
Identities = 42/200 (21%), Positives = 77/200 (38%), Gaps = 27/200 (13%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIK--RLSRRSGQGIVEFKNEAKLIAKLQHT 572
+ + K+GEG +G V+K + + VA+K RL E L+ +L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 573 NL-----------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLR 609
N+ ++ + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 610 VIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVS 669
V+HRDLK N+L++ K+++FG+AR FG+ + VV + + + S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 670 IKTDVFSFGVLVLEIVSGKK 689
D++S G + E+ + +
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-28
Identities = 61/324 (18%), Positives = 110/324 (33%), Gaps = 69/324 (21%)
Query: 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN-- 573
+++ +G G FG VY+ +L +G+ VAIK++ + E +++ KL H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 574 ---------------------------------LTDSRRNNRLNWETRFSIIEGIAQGLL 600
SR L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 601 YLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMS 659
Y+H + HRD+K N+LLD D K+ DFG A+ + E N + + Y
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 191
Query: 660 PEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNL---------------IG 704
+ + DV+S G ++ E++ G+ + D ++ I
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 705 YAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDV-----VSM 759
+ E K ++ F P I + ++ T R +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
Query: 760 LANESLSLPAPKQPAFFINITAEE 783
L + ++ LP + N T +E
Sbjct: 309 LRDPNVKLPNGRDTPALFNFTTQE 332
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 1e-27
Identities = 48/211 (22%), Positives = 74/211 (35%), Gaps = 45/211 (21%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVE------FKNEAKLIAK 568
+ + LG GGFG VY G + + VAIK + + E E L+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 569 LQH-----TNLTDS------------------------RRNNRLNWETRFSIIEGIAQGL 599
+ L D L E S + + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 600 LYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYM 658
+ H V+HRD+K NIL+D ++ K+ DFG + +T GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 176
Query: 659 SPEYAMSG-VVSIKTDVFSFGVLVLEIVSGK 688
PE+ V+S G+L+ ++V G
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-27
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 43/210 (20%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSR------RSGQGIVEFKNEAKLIAK 568
+ + +LG G F V K + G + A K + + R G + + E ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 569 LQHTNL--------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYL 602
+QH N+ L E ++ I G+ YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNP----KISDFGMARIFGLNQSETNTNRVVGTYGYM 658
H L++ H DLK NI+L D+ P KI DFG+A + GT ++
Sbjct: 130 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFV 183
Query: 659 SPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+PE + ++ D++S GV+ ++SG
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-26
Identities = 38/211 (18%), Positives = 75/211 (35%), Gaps = 49/211 (23%)
Query: 516 NNFSAVNK-LGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHT 572
+++ ++ LG G G V + ++ A+K L + + E +L + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCP 65
Query: 573 NLT--------------------------------DSRRNNRLNWETRFSIIEGIAQGLL 600
++ R + I++ I + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 601 YLHKYSRLRVIHRDLKASNILLDDQMNP---KISDFGMARIFGLNQSETNTNRVVGTYGY 657
YLH + + HRD+K N+L + K++DFG A+ S + T Y
Sbjct: 126 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---TSHNSLTTPCYTPYY 179
Query: 658 MSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
++PE D++S GV++ ++ G
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-26
Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 42/207 (20%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSR--RSGQGIVEFKNEAKLIAKLQHT 572
+ + +G G +G V G +VAIK+L R +S E +L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 573 NL------------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYL 602
N+ ++ +L + ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 603 HKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEY 662
H +IHRDLK N+ +++ KI DFG+AR Q+++ V T Y +PE
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 663 AMSGV-VSIKTDVFSFGVLVLEIVSGK 688
++ + + D++S G ++ E+++GK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-24
Identities = 45/207 (21%), Positives = 89/207 (42%), Gaps = 35/207 (16%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSR----RSGQGIVEFKNEAKLIA 567
NF + LG G +G V+ + + G+ A+K L + + + + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 568 KLQHTN---------LTDSRRN------------NRLNWETRFS---IIEGIAQGLLYLH 603
++ + T+++ + L+ RF+ + + + +L L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
+L +I+RD+K NILLD + ++DFG+++ F GT YM+P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAPDIV 202
Query: 664 MSGVVSI--KTDVFSFGVLVLEIVSGK 688
G D +S GVL+ E+++G
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 6e-24
Identities = 49/220 (22%), Positives = 79/220 (35%), Gaps = 38/220 (17%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSR--RSGQGIVEFKNEAKLIAKLQHT 572
+ + +G G G V + + VAIK+LSR ++ E L+ + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 573 NL-----------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLH 603
N+ L+ E ++ + G+ +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 604 KYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYA 663
+IHRDLK SNI++ KI DFG+AR G + V T Y +PE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 190
Query: 664 MSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703
+ D++S G ++ E+V K N +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 99.5 bits (247), Expect = 4e-23
Identities = 37/202 (18%), Positives = 79/202 (39%), Gaps = 38/202 (18%)
Query: 516 NNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTN 573
+++ V KLG G + V++ + N ++V +K L + + K E K++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 574 L-------------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
+ + L + I + L Y H +
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS---M 148
Query: 609 RVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMS-G 666
++HRD+K N+++D + ++ D+G+A + N V + + PE +
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 667 VVSIKTDVFSFGVLVLEIVSGK 688
+ D++S G ++ ++ K
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 1e-22
Identities = 45/207 (21%), Positives = 82/207 (39%), Gaps = 40/207 (19%)
Query: 515 TNNFSAVNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSR--RSGQGIVEFKNEAKLIAKLQH 571
+ ++ +G G +G V G VA+K+LSR +S E +L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 572 TNL------------------------------TDSRRNNRLNWETRFSIIEGIAQGLLY 601
N+ + + +L + +I I +GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 602 LHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPE 661
+H +IHRDLK SN+ +++ KI DFG+AR + T V +
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 189
Query: 662 YAMSGVVSIKTDVFSFGVLVLEIVSGK 688
+ D++S G ++ E+++G+
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.3 bits (238), Expect = 9e-22
Identities = 39/212 (18%), Positives = 75/212 (35%), Gaps = 47/212 (22%)
Query: 521 VNKLGEGGFGPVYKGQ-LLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT---- 575
V KLG G F V+ + ++N VA+K + R ++E KL+ ++ + T
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 576 --------------------------------------DSRRNNRLNWETRFSIIEGIAQ 597
+ + I + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 598 GLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQSETNTNRVVGTYG 656
GL Y+H+ R +IH D+K N+L++ + +A + + + + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 657 YMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK 688
Y SPE + D++S L+ E+++G
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 2e-20
Identities = 33/196 (16%), Positives = 61/196 (31%), Gaps = 44/196 (22%)
Query: 522 NKLGEGGFGPVYKGQLLNGQEVAIK--RLSRRSGQ--------GIVEFKNEAKLIAKLQH 571
+GEG V+ E +K ++ S + G + F A A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 572 TNL-----------------------TDSRRNNRLNWETRFSIIEGIAQGLLYLHKYSRL 608
L D++ R+ E +++ I + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR--- 122
Query: 609 RVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNR-VVGTYGYMSPEYAMSGV 667
++H DL N+L+ + I DF + G R V Y S Y
Sbjct: 123 GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY----- 176
Query: 668 VSIKTDVFSFGVLVLE 683
+ D+ S +L+
Sbjct: 177 -RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 63.1 bits (153), Expect = 1e-12
Identities = 30/141 (21%), Positives = 45/141 (31%), Gaps = 35/141 (24%)
Query: 28 DTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKIN 87
+ L G+ L G L + D L ++ H +
Sbjct: 2 NLLTNGEGLYAGQSLDV--EPYHFIMQE-----DCNLVLYDH-----------------S 37
Query: 88 QPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVS-SVQAMGNTSAALYETGNF 146
VW +N + S DGN + G S+ S SV+ GN L E GN
Sbjct: 38 TSVWASNTGILGKKGCK-AVLQS-DGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNV 95
Query: 147 VLYEMNPSGSMERELWQSFDY 167
V+Y ++W + Y
Sbjct: 96 VIY--------GSDIWSTGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 38.4 bits (89), Expect = 5e-04
Identities = 17/88 (19%), Positives = 24/88 (27%), Gaps = 19/88 (21%)
Query: 800 DKLQQGQVLRDGDQLVSAFGRFRLAFFSPRSTTKHYLGIWYDKSEDELLVWDANRDTPV- 858
+ L G+ L G L + L ++ + VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDC-----NLVLYDHSTS----VWASNTGILGK 50
Query: 859 ------LDKSGRLVKTDGTIKRVLWLSF 880
L G V D R LW S
Sbjct: 51 KGCKAVLQSDGNFVVYDAE-GRSLWASH 77
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 58.3 bits (140), Expect = 7e-11
Identities = 25/144 (17%), Positives = 43/144 (29%), Gaps = 32/144 (22%)
Query: 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKI 86
+D L G L G L G + + D L ++ +
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQN-----DCNLVLYDN----------------- 36
Query: 87 NQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGNTSAALYETGNF 146
N+ VW + N + + DGNL I ++ + GN L N
Sbjct: 37 NRAVWASGTNGKASGCVLKMQ---NDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNV 93
Query: 147 VLYEMNPSGSMERELWQSFDYPTD 170
V+Y + +W + +
Sbjct: 94 VIY-----DNSNNAIWATHTNVGN 112
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 47.2 bits (112), Expect = 6e-07
Identities = 10/86 (11%), Positives = 25/86 (29%), Gaps = 6/86 (6%)
Query: 81 YGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMGNTSAAL 140
Y + + + + L++++ D NL + + ++ A L
Sbjct: 14 YSTQGNDNHPQTLHATQSLQLSPYRLSMET-DCNLVLFDRDDRVWSTNTAGKGTGCRAVL 72
Query: 141 YETGNFVLYEMNPSGSMERELWQSFD 166
G + +W S +
Sbjct: 73 QPNGRMDVLTNQ-----NIAVWTSGN 93
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 44.2 bits (104), Expect = 4e-06
Identities = 24/141 (17%), Positives = 41/141 (29%), Gaps = 36/141 (25%)
Query: 28 DTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKIN 87
+ L G+ L G+ L G+F D L ++ +
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQ-----EDCNLVLYDV-----------------D 37
Query: 88 QPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQAMG-NTSAALYETGNF 146
+P+W N S+ D NL + I S+ N L + N
Sbjct: 38 KPIWATNTGGLSRSCFLSMQTDG---NLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNV 94
Query: 147 VLYEMNPSGSMERELWQSFDY 167
V+Y + W + +
Sbjct: 95 VIY--------GTDRWATGTH 107
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1018 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.78 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.77 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.72 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.72 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.54 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.4 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.3 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.9 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.62 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.59 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.57 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.54 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.97 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.86 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 94.74 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=373.37 Aligned_cols=238 Identities=26% Similarity=0.443 Sum_probs=182.3
Q ss_pred hCCcceeeeeccCCCcCeEEEEecccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
.++|++.++||+|+||+||+|+... .||||+++.. .....++|.+|+.++++++||||+++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEec
Confidence 3678899999999999999998643 5999998654 34566789999999999999999831
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++.+++.|+.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.........
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 23456999999999999999999999998 9999999999999999999999999998765444444
Q ss_pred cceeeecccccCChhhhcc---CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 647 NTNRVVGTYGYMSPEYAMS---GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
......||+.|||||++.+ ..++.++|||||||++|||+||+.||...... .........+......
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~p~~---- 231 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRGYLSPDL---- 231 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHTSCCCCG----
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCCCcc----
Confidence 4456789999999999964 45899999999999999999999998643221 1111111111111000
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCC
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLP 768 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp 768 (1018)
...+...++.+.+|+.+||+.||++|||++||++.|+....++|
T Consensus 232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 01223345678899999999999999999999999998766554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=366.72 Aligned_cols=229 Identities=29% Similarity=0.370 Sum_probs=174.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578899999999999999999988889999999754 3456789999999999999999831
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..++.|+.|||+||.|||+++ |+||||||+|||+++++.+||+|||+++....... ...
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence 23456889999999999999999999999 99999999999999999999999999987653322 222
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
....||+.|+|||++.+..++.++|||||||++|||+|+..|+.... ..... ... +....+...+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~-~~~---------i~~~~~~~~p 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEV-VED---------ISTGFRLYKP 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHH-HHH---------HHHTCCCCCC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHH-HHH---------HHhcCCCCCc
Confidence 34678999999999999999999999999999999999655432111 11111 111 1111222233
Q ss_pred hHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
....+++.+++.+||+.||++||||+||++.|+++.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 445577889999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=370.32 Aligned_cols=227 Identities=30% Similarity=0.411 Sum_probs=183.3
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|++.++||+|+||.||+|++++++.||||+++.. ....++|.+|++++++++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCC
Confidence 578999999999999999999988889999999754 3456789999999999999999841
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++.+++.|+.||++||.|||+++ |+||||||+||||++++.+||+|||+|+.+..... ...
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~ 167 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAR 167 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECC
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-ccc
Confidence 11235899999999999999999999998 99999999999999999999999999998754322 222
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
....||+.|+|||++.++.++.++|||||||++|||+||..|+..... .. ........ ..+...+
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~-~~~~~i~~---------~~~~~~p 232 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NP-EVIQNLER---------GYRMVRP 232 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HH-HHHHHHHT---------TCCCCCC
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HH-HHHHHHHh---------cCCCCCc
Confidence 345789999999999999999999999999999999997666432111 11 11111111 1122233
Q ss_pred hHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
....+.+.+|+.+||+.||++||||+||+++|+.
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 4455678899999999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=366.76 Aligned_cols=226 Identities=24% Similarity=0.347 Sum_probs=178.5
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTD----------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~----------------- 576 (1018)
++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|++++++++||||++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999875 58999999996543 334467999999999999999983
Q ss_pred ---------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 577 ---------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 577 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
+.....+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+..........
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 234567999999999999999999999999 99999999999999999999999999998754444444
Q ss_pred ceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCC
Q 046791 648 TNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGS 726 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 726 (1018)
....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ .. ....... ....
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~----~~~~~~~--------~~~~ 227 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY----SDWKEKK--------TYLN 227 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HH----HHHHTTC--------TTST
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HH----HHHhcCC--------CCCC
Confidence 456789999999999988776 6789999999999999999999964432211 10 0111110 0111
Q ss_pred CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 727 FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 727 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+.+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11233467788999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-41 Score=370.18 Aligned_cols=230 Identities=24% Similarity=0.379 Sum_probs=172.1
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cc---cceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQ---EVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~---~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
++|++.++||+|+||+||+|++.. ++ .||||++... .....++|.+|++++++++|||||++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 457778999999999999998753 33 5899988654 34456789999999999999999831
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++.+++.|+.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 22456899999999999999999999998 9999999999999999999999999998765433
Q ss_pred Ccc---cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 644 SET---NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 644 ~~~---~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
... ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+ . ..+
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~----~---------~~i 246 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DV----I---------NAI 246 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----H---------HHH
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HH----H---------HHH
Confidence 222 1223467899999999999999999999999999999998 89998533211 11 1 111
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
....+...+...++.+.+|+.+||+.||++||||.||++.|+...
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 247 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111222344556678889999999999999999999999998753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-41 Score=366.87 Aligned_cols=238 Identities=26% Similarity=0.382 Sum_probs=185.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|++.+.||+|+||.||+|++.+++.||||+++.. ....++|.+|+.++++++|+|||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence 579999999999999999999988888999999654 3456789999999999999999841
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++.+++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++....... ...
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~ 171 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR 171 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-eee
Confidence 11346899999999999999999999999 99999999999999999999999999987643322 223
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFS 728 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 728 (1018)
....||+.|+|||++.++.++.++|||||||++|||++|..|+..... .... . ..+........+
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~-~---------~~i~~~~~~~~~ 236 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREV-L---------DQVERGYRMPCP 236 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHH-H---------HHHHTTCCCCCC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHH-H---------HHHHhcCCCCCC
Confidence 346789999999999999999999999999999999997766532211 1111 1 111111222344
Q ss_pred hHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcCCCCCCCCC
Q 046791 729 PNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESLSLPAPKQP 773 (1018)
Q Consensus 729 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~~lp~p~~p 773 (1018)
....+++.+++.+||+.||++||+|++|+++|+......+++.+|
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 555678899999999999999999999999999876655544444
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-41 Score=367.37 Aligned_cols=230 Identities=25% Similarity=0.357 Sum_probs=186.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEecc-cccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLLN-GQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|++.++||+|+||+||+|++.+ ++.||||+++.. ....++|.+|++++++++||||+++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 3578999999999999999999764 889999999754 3456789999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~- 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc-
Confidence 22457899999999999999999999999 99999999999999999999999999987643322
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......|++.|+|||++.+..++.++|||||||++|||++|..|+..... . .... +.+......
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~-~~~~---------~~i~~~~~~ 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----L-SQVY---------ELLEKDYRM 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----H-HHHH---------HHHHTTCCC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----H-HHHH---------HHHhcCCCC
Confidence 222345688999999999999999999999999999999998777532111 1 1111 122222233
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
..+...++++.+|+.+||+.||++|||++||++.|+...
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 344555678899999999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=365.38 Aligned_cols=232 Identities=25% Similarity=0.391 Sum_probs=177.1
Q ss_pred CCcceeeeeccCCCcCeEEEEeccc-----ccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNG-----QEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g-----~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
..|++.++||+|+||+||+|++... ..||||+++... .....+|.+|++++++++|||||++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999987542 369999997653 3345679999999999999999831
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 23467999999999999999999999999 999999999999999999999999999876543
Q ss_pred CCc-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 643 QSE-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 643 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
... .......||+.|+|||++.++.++.++|||||||++|||++|..|+...... .. +.+.+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~---------~~~~i~~ 228 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HE---------VMKAIND 228 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH---------HHHHHHT
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HH---------HHHHHhc
Confidence 222 2233457899999999999999999999999999999999977665322111 01 1112222
Q ss_pred hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 722 ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 722 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
..+...+...+.++.+|+.+||+.||++||||.||+++|+....
T Consensus 229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 22334445566788999999999999999999999999987543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=365.22 Aligned_cols=224 Identities=22% Similarity=0.334 Sum_probs=183.0
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
++|++.++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.++++++||||+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999864 599999999987766677889999999999999999831
Q ss_pred --------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccce
Q 046791 578 --------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTN 649 (1018)
Q Consensus 578 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 649 (1018)
.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.... ....
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~ 174 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 174 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBC
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--cccc
Confidence 22457899999999999999999999999 9999999999999999999999999999875332 2234
Q ss_pred eeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 650 RVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 650 ~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...........+. .....+.
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~~~~~~~--------~~~~~~~ 240 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRALYLIATNGT--------PELQNPE 240 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHHCS--------CCCSSGG
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC------HHHHHHHHHhCCC--------CCCCCcc
Confidence 5689999999999999999999999999999999999999985322 1111111111111 0111233
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+.+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 44577889999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=357.09 Aligned_cols=226 Identities=27% Similarity=0.380 Sum_probs=186.0
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|++.++||+|+||+||+|+.++++.||||+++... ...++|.+|+.++++++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788999999999999999999888899999997653 456789999999999999999831
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETNT 648 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 648 (1018)
.....+++..+.+++.||++||.|||+++ |+||||||+|||+++++.+||+|||+++....... ...
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-eee
Confidence 23456889999999999999999999999 99999999999999999999999999987654322 233
Q ss_pred eeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCC
Q 046791 649 NRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSF 727 (1018)
Q Consensus 649 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 727 (1018)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... . ....... ..+...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~-~~~~i~~---------~~~~~~ 222 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------E-TAEHIAQ---------GLRLYR 222 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------H-HHHHHHT---------TCCCCC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------H-HHHHHHh---------CCCCCC
Confidence 34678999999999999999999999999999999998 78898643211 1 1111111 112233
Q ss_pred ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 728 SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 728 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
+....+.+.+++.+||+.||++|||++||++.|.+
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 44455778899999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=358.41 Aligned_cols=219 Identities=24% Similarity=0.356 Sum_probs=179.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+++.+|++++++++||||+++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999975 5889999998653 23456789999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 23467999999999999999999999999 999999999999999999999999999865422
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... ........ ..
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~-~~~~i~~~----------~~ 221 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQE-TYKRISRV----------EF 221 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHH-HHHHHHTT----------CC
T ss_pred -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC------HHH-HHHHHHcC----------CC
Confidence 2334679999999999999999999999999999999999999985322 111 11111111 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..+....+.+.+++.+||+.||++|||++|+++
T Consensus 222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 233445567889999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=367.77 Aligned_cols=229 Identities=25% Similarity=0.431 Sum_probs=180.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccc----cceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQ----EVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~----~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~------------ 577 (1018)
.+|+++++||+|+||+||+|+.. +|+ +||||+++.. .....++|.+|+.++++++||||+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 36999999999999999999864 344 5888888654 34567889999999999999999841
Q ss_pred --------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCC
Q 046791 578 --------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 578 --------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~ 643 (1018)
.....+++..++.++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 23567999999999999999999999998 9999999999999999999999999999876554
Q ss_pred CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 644 SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 644 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.........||+.|+|||++.++.++.++|||||||++|||+| |++||...... .+ ...+...
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~-------------~~~i~~~ 229 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI-------------SSILEKG 229 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GH-------------HHHHHHT
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HH-------------HHHHHcC
Confidence 4444555678999999999999999999999999999999998 78887543211 11 1112222
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.+...++...+.+.+|+.+||+.||++|||+.||++.|+..
T Consensus 230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 22234455667889999999999999999999999988754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-40 Score=367.82 Aligned_cols=236 Identities=24% Similarity=0.359 Sum_probs=185.2
Q ss_pred HHHHHhCCcceeeeeccCCCcCeEEEEec------ccccceEEEeccccc-ccHHHHHHHHHHHHHhcCCCcccc-----
Q 046791 510 TISAATNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRSG-QGIVEFKNEAKLIAKLQHTNLTDS----- 577 (1018)
Q Consensus 510 ~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~H~nlv~~----- 577 (1018)
+++...++|++.+.||+|+||+||+|+.. +++.||||+++.... ...++|.+|++++++++|||++..
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999864 357899999976543 345679999999999999998721
Q ss_pred ---------------------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEe
Q 046791 578 ---------------------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIH 612 (1018)
Q Consensus 578 ---------------------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 612 (1018)
.....+++..++.|+.||+.||+|||+++ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 01234788999999999999999999999 999
Q ss_pred cccCCCcEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCC-CCC
Q 046791 613 RDLKASNILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK-KNN 691 (1018)
Q Consensus 613 ~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~-~p~ 691 (1018)
|||||+|||||.++.+||+|||+++.+.............|++.|+|||.+.+..++.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998765444444444567899999999999999999999999999999999996 455
Q ss_pred CCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 692 GCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 692 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
..... .+. ......+.. ...+...++++.+|+.+||+.+|++||||.||+++|+++.
T Consensus 244 ~~~~~------~e~-~~~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAH------EEV-IYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCH------HHH-HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCH------HHH-HHHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 43211 111 111222221 1234445578899999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=359.77 Aligned_cols=229 Identities=25% Similarity=0.368 Sum_probs=184.0
Q ss_pred CCcceee-eeccCCCcCeEEEEec---ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccc--------------
Q 046791 516 NNFSAVN-KLGEGGFGPVYKGQLL---NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTD-------------- 576 (1018)
Q Consensus 516 ~~y~~~~-~lG~G~fG~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~-------------- 576 (1018)
++|.+.+ +||+|+||+||+|... ++..||||+++... ....++|.+|++++++++||||++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 4567777 4999999999999764 24579999997653 344678999999999999999983
Q ss_pred ------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 577 ------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 577 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
......+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 123457999999999999999999999999 99999999999999999999999999998754332
Q ss_pred c-ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 645 E-TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 645 ~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... . +......+.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~----~~~~i~~~~-------- 229 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---E----VMAFIEQGK-------- 229 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---H----HHHHHHTTC--------
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCC--------
Confidence 2 22234568899999999999999999999999999999998 89998643211 1 111122221
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
+...++..++++.+|+.+||+.||++|||+.+|++.|+..
T Consensus 230 -~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 -RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2234445567888999999999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=361.24 Aligned_cols=225 Identities=24% Similarity=0.341 Sum_probs=169.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999865 58999999987653 3345679999999999999999831
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCC--CCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYS--RLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.....+++..++.++.||++||.|||+++ ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 12356899999999999999999999865 23599999999999999999999999999987
Q ss_pred ecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......+..
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~-~~~~i~~~~~--- 231 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KE-LAGKIREGKF--- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHHTCC---
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HH-HHHHHHcCCC---
Confidence 64322 223357899999999999999999999999999999999999999853221 11 1111111111
Q ss_pred hhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 719 VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 719 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...+....+++.+|+.+||+.||++|||+.||++
T Consensus 232 ------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1223344567889999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=359.37 Aligned_cols=222 Identities=26% Similarity=0.353 Sum_probs=176.2
Q ss_pred eeeccCCCcCeEEEEecc---cccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccc--------------------
Q 046791 522 NKLGEGGFGPVYKGQLLN---GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTD-------------------- 576 (1018)
Q Consensus 522 ~~lG~G~fG~Vy~~~~~~---g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~-------------------- 576 (1018)
++||+|+||+||+|.+.+ ++.||||+++... ....++|.+|++++++++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 579999999999998653 5679999996543 334567999999999999999984
Q ss_pred -----ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc-cccee
Q 046791 577 -----SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE-TNTNR 650 (1018)
Q Consensus 577 -----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~~~ 650 (1018)
+.....+++.+++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .....
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 123567999999999999999999999998 999999999999999999999999999987543322 22334
Q ss_pred eecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcCCCCh
Q 046791 651 VVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEGSFSP 729 (1018)
Q Consensus 651 ~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 729 (1018)
..||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... . ........+ .+...+.
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------~-~~~~~i~~~---------~~~~~p~ 233 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------S-EVTAMLEKG---------ERMGCPA 233 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------H-HHHHHHHTT---------CCCCCCT
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH------H-HHHHHHHcC---------CCCCCCc
Confidence 678999999999999999999999999999999998 8999864221 1 111111121 1223344
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 046791 730 NEVLRCIHVGLLCVQDQATDRPAMPDVVSMLAN 762 (1018)
Q Consensus 730 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~ 762 (1018)
..++++.+|+.+||+.||++|||+++|+++|+.
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 456778899999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-40 Score=365.84 Aligned_cols=228 Identities=26% Similarity=0.393 Sum_probs=180.8
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-c-----ccceEEEeccc-ccccHHHHHHHHHHHHHh-cCCCccccc---------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-G-----QEVAIKRLSRR-SGQGIVEFKNEAKLIAKL-QHTNLTDSR--------- 578 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g-----~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nlv~~~--------- 578 (1018)
++|++.++||+|+||+||+|+... + ..||||.+... .......|.+|+.++.++ +|||||++.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 579999999999999999998653 2 36899998654 334456799999999999 899998310
Q ss_pred ----------------------------------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCC
Q 046791 579 ----------------------------------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKAS 618 (1018)
Q Consensus 579 ----------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~ 618 (1018)
....+++..++.++.||++||+|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 0134889999999999999999999999 999999999
Q ss_pred cEEEcCCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCC
Q 046791 619 NILLDDQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTD 697 (1018)
Q Consensus 619 NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~ 697 (1018)
|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||++ |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987665444444445778999999999999999999999999999999998 89998643322
Q ss_pred CCCchHHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 046791 698 HPLNLIGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLA 761 (1018)
Q Consensus 698 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le 761 (1018)
. .... ++....+...+....+++.+|+.+||+.||++|||++||+++|.
T Consensus 274 ~------~~~~---------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 A------NFYK---------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H------HHHH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H------HHHH---------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 1111 11122222344455678899999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-40 Score=359.43 Aligned_cols=223 Identities=25% Similarity=0.340 Sum_probs=178.2
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+.+|++++++++||||+++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999875 5899999999653 24456789999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
...+.+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 23467999999999999999999999999 999999999999999999999999999987644444
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...... ....+ ..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~-~i~~~----------~~ 227 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EYLIFQ-KIIKL----------EY 227 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHH-HHHTT----------CC
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC------HHHHHH-HHHcC----------CC
Confidence 44455789999999999999999999999999999999999999986321 111111 11111 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.++....+.+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 233445577889999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-40 Score=359.38 Aligned_cols=224 Identities=22% Similarity=0.319 Sum_probs=180.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS----------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~----------------- 577 (1018)
+.|++.+.||+|+||+||+|+.. +++.||||+++.......++|.+|++++++++||||+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999875 588999999987776777889999999999999999831
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence 12456999999999999999999999999 999999999999999999999999999865321 122
Q ss_pred ceeeecccccCChhhhc-----cCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 648 TNRVVGTYGYMSPEYAM-----SGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||...... ... ..... +...
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~---~~i~~-~~~~------ 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVL---LKIAK-SEPP------ 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHH---HHHHH-SCCC------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHH---HHHHc-CCCC------
Confidence 33468999999999984 456899999999999999999999998643221 111 11111 1100
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+....+.+.+|+.+||+.||++|||++|+++
T Consensus 234 -~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 -TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122344577889999999999999999999876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-39 Score=349.48 Aligned_cols=220 Identities=26% Similarity=0.380 Sum_probs=171.8
Q ss_pred ceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 519 SAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 519 ~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++.++||+|+||+||+|+.. +++.||||++... .....+.|.+|++++++++||||+++
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999875 4889999998654 23445679999999999999999842
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc-CCCCceeeeecceeeecCCCC
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD-DQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence 12356889999999999999999999976 4599999999999996 578999999999986432
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... . .........+.....
T Consensus 168 -~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~-~~~~~~i~~~~~~~~------ 233 (270)
T d1t4ha_ 168 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----A-AQIYRRVTSGVKPAS------ 233 (270)
T ss_dssp -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----H-HHHHHHHTTTCCCGG------
T ss_pred -CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----H-HHHHHHHHcCCCCcc------
Confidence 22345689999999998865 699999999999999999999999853221 1 111111211111111
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.+....+++.+|+.+||+.||++|||++|+++
T Consensus 234 --~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 --FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11223456788999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-40 Score=364.93 Aligned_cols=238 Identities=21% Similarity=0.299 Sum_probs=179.4
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
..++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.++++++||||+++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999864 58999999997653 3345679999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcC-CCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKY-SRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.+...+++..+..++.||++||.|||++ + |+||||||+||||+.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence 2345799999999999999999999974 7 99999999999999999999999999986532
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHH-H------------------
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIG-Y------------------ 705 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~-~------------------ 705 (1018)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||............. .
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 22335689999999999999999999999999999999999999996533211000000 0
Q ss_pred ----HHHHhhcCcchhhhhhhhcCCC---C-hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 706 ----AWQLWNEGKVLELVDIALEGSF---S-PNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 706 ----~~~~~~~~~~~~~~d~~l~~~~---~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...........+..+....... + .....++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000011111211111111 1 122467889999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-39 Score=356.37 Aligned_cols=231 Identities=26% Similarity=0.360 Sum_probs=174.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccc---------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDS--------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~--------- 577 (1018)
-++|++.++||+|+||.||+|+.. +++.||||+++... ....+++.+|..++.++ +|+||+..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 367999999999999999999853 24679999997543 34456788898888887 57787620
Q ss_pred ----------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 578 ----------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 578 ----------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
.....+++.+++.++.||++||.|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 01235889999999999999999999999 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCC-CCCCCCCCCCCCch
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK-KNNGCYRTDHPLNL 702 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~-~p~~~~~~~~~~~l 702 (1018)
+++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||.......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---- 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---- 244 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH----
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999998776554444555678999999999999999999999999999999999975 4664322211
Q ss_pred HHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 703 IGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
........+ .....+....+++.+++.+||+.||++|||++||+++|++.
T Consensus 245 --~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 --EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp --HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111111121 12233444556788999999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-39 Score=357.28 Aligned_cols=219 Identities=29% Similarity=0.411 Sum_probs=175.7
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
+.|+.++.||+|+||+||+|+.. +++.||||+++... ....+++.+|++++++++||||+++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999864 58899999997653 2334578999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++.++..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 23567999999999999999999999999 99999999999999999999999999986532
Q ss_pred ccceeeecccccCChhhhcc---CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 646 TNTNRVVGTYGYMSPEYAMS---GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.....||+.|+|||++.+ +.++.++|||||||++|||++|+.||.... ........... ..
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~------~~~~~~~i~~~-~~------- 231 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQN-ES------- 231 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS-CC-------
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhC-CC-------
Confidence 234679999999999864 568999999999999999999999985321 11111111111 10
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
....+....+.+.+|+.+||+.||++|||++|+++
T Consensus 232 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 -PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11112233567889999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=352.08 Aligned_cols=230 Identities=25% Similarity=0.351 Sum_probs=173.8
Q ss_pred CCcceeeeeccCCCcCeEEEEecc--c--ccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN--G--QEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~--g--~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
++|++.+.||+|+||.||+|+... + ..||||+++.. .....++|.+|+.++++++||||++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 569999999999999999998642 2 36899998654 23445789999999999999999841
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..++.++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 12356999999999999999999999998 999999999999999999999999999987544
Q ss_pred CCcc-cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhh
Q 046791 643 QSET-NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVD 720 (1018)
Q Consensus 643 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 720 (1018)
.... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.... .........+.+
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~------- 231 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEG------- 231 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSC-------
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCC-------
Confidence 3322 2334567889999999999999999999999999999998 899985322 111112222221
Q ss_pred hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 721 IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 721 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.+...+...+..+.+|+.+||+.||++||||.||++.|++.
T Consensus 232 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 --ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122334456788999999999999999999999999763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.2e-38 Score=356.30 Aligned_cols=226 Identities=19% Similarity=0.262 Sum_probs=181.6
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~----------------- 576 (1018)
-++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999864 58999999998776666778999999999999999983
Q ss_pred ---------c-cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc--CCCCceeeeecceeeecCCCC
Q 046791 577 ---------S-RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD--DQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 577 ---------~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld--~~~~~kL~DFGla~~~~~~~~ 644 (1018)
+ .....+++.++..|+.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 1 23456999999999999999999999999 99999999999996 4678999999999986532
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......||+.|||||++.+..++.++|||||||++|||++|+.||..... ........ .... ...
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~-~~~~------~~~ 245 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVK-SCDW------NMD 245 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HTCC------CSC
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCC------CCC
Confidence 233457899999999999999999999999999999999999999853321 11111111 1100 000
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
........+.+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112334678899999999999999999999883
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-39 Score=348.40 Aligned_cols=228 Identities=23% Similarity=0.334 Sum_probs=172.6
Q ss_pred CCcceeeeeccCCCcCeEEEEecc----cccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN----GQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
++|++.+.||+|+||.||+|+... +..||||.++... ....+.|.+|+.++++++||||+++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 579999999999999999998643 3468999986553 3345679999999999999999831
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 23456899999999999999999999999 99999999999999999999999999987643222
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhh
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIAL 723 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 723 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++ |.+||...... .+.. ....+.
T Consensus 164 -~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~----~i~~~~--------- 226 (273)
T d1mp8a_ 164 -YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG----RIENGE--------- 226 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH----HHHTTC---------
T ss_pred -eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCC---------
Confidence 23334678999999999999999999999999999999998 88888643321 1111 111111
Q ss_pred cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 724 EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 724 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
....++..++.+.+|+.+||+.||++|||+.||++.|+..
T Consensus 227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1123445567888999999999999999999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-38 Score=351.78 Aligned_cols=226 Identities=19% Similarity=0.265 Sum_probs=164.2
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCccc---------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTD--------------- 576 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~--------------- 576 (1018)
..+.|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++||||++
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999875 58899999997553 233456889999999999999983
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc---CCCCceeeeecceeeecCC
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kL~DFGla~~~~~~ 642 (1018)
+.....+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 123567999999999999999999999999 99999999999994 5789999999999875432
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIA 722 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 722 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......+.. .
T Consensus 164 ---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~-~~~~i~~~~~------~ 227 (307)
T d1a06a_ 164 ---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AK-LFEQILKAEY------E 227 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHTTCC------C
T ss_pred ---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HH-HHHHHhccCC------C
Confidence 223346799999999999999999999999999999999999999853221 11 1111111110 0
Q ss_pred hcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 723 LEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 723 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
......+...+.+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111122344567889999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=344.01 Aligned_cols=221 Identities=24% Similarity=0.366 Sum_probs=172.9
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|++.+.||+|+||.||+|++ .|++||||+++.. ...++|.+|++++++++||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4688899999999999999998 5778999999654 345789999999999999999841
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
.....+++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-----
Confidence 11234899999999999999999999998 99999999999999999999999999986532
Q ss_pred cceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 647 NTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......++..|+|||++.++.++.++||||||+++|||+| |+.|+...... .+... +....+.
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~-------------i~~~~~~ 219 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR-------------VEKGYKM 219 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH-------------HTTTCCC
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH-------------HHcCCCC
Confidence 2223567889999999999999999999999999999998 67776432211 11111 1111223
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
..+....+++.+|+.+||+.||++||||.||+++|+..
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 34455567888999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-38 Score=351.74 Aligned_cols=218 Identities=25% Similarity=0.299 Sum_probs=178.9
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++++.||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|++++++++||||+++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999875 5999999998653 23456789999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 23457999999999999999999999999 999999999999999999999999999976422
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.... ......... .+ ..
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~-~~----------~~ 255 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIV-SG----------KV 255 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HC----------CC
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHh-cC----------CC
Confidence 234689999999999999999999999999999999999999985321 111111111 11 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
..+....+.+.+++.+||+.||.+|+ |++|+++
T Consensus 256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 22334556788999999999999994 8999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-38 Score=350.42 Aligned_cols=231 Identities=25% Similarity=0.337 Sum_probs=184.4
Q ss_pred CCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc-----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS----------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~----------- 577 (1018)
++|++.++||+|+||+||+|.+. +++.||||+++... ......|.+|++++++++||||+++
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 67899999999999999999863 35789999997543 3444569999999999999999831
Q ss_pred -------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeee
Q 046791 578 -------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISD 632 (1018)
Q Consensus 578 -------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~D 632 (1018)
.....+++..+..++.|+|+||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 11234688899999999999999999998 99999999999999999999999
Q ss_pred ecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCC-CCCCCCCCCCCCchHHHHHHHhh
Q 046791 633 FGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGK-KNNGCYRTDHPLNLIGYAWQLWN 711 (1018)
Q Consensus 633 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 711 (1018)
||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .|+.... .... .....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~-~~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQV-LRFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHH-HHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHH-HHHHH
Confidence 99998765444444445567899999999999999999999999999999999985 5553221 1111 11111
Q ss_pred cCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 712 EGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 712 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
.+. ....+......+.+++.+||+.+|++||||.||+++|++..+
T Consensus 250 ~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 112233445779999999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.4e-38 Score=354.07 Aligned_cols=230 Identities=19% Similarity=0.262 Sum_probs=183.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS---------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~---------------- 577 (1018)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++++++||||+++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999864 599999999987665566788999999999999999831
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc--CCCCceeeeecceeeecCCCC
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD--DQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld--~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....+++.++..|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 12346999999999999999999999999 99999999999998 6789999999999987532
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+.. ...
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~-~~~~------~~~ 248 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVK-RCDW------EFD 248 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHH-HCCC------CCC
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCC------CCC
Confidence 233456899999999999999999999999999999999999999853221 11111111 1110 011
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM--LANE 763 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--Le~~ 763 (1018)
........+.+.+|+.+||+.||.+|||+.|+++. +++.
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11223345678899999999999999999999873 5543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-38 Score=347.75 Aligned_cols=230 Identities=25% Similarity=0.345 Sum_probs=180.7
Q ss_pred CCcceeeeeccCCCcCeEEEEecc--------cccceEEEeccccc-ccHHHHHHHHHHHHHh-cCCCcccc--------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN--------GQEVAIKRLSRRSG-QGIVEFKNEAKLIAKL-QHTNLTDS-------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~--------g~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~H~nlv~~-------- 577 (1018)
++|++.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +||||+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578999999999999999998532 34799999976543 4457899999999999 89999831
Q ss_pred ----------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 578 ----------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 578 ----------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
.....+++.+++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 01245899999999999999999999999 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHh-CCCCCCCCCCCCCCch
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVS-GKKNNGCYRTDHPLNL 702 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ellt-G~~p~~~~~~~~~~~l 702 (1018)
.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |++||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 999999999999998765544444555788999999999999999999999999999999998 6777753221
Q ss_pred HHHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 703 IGYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 703 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
......+.. ......+....+++.+|+.+||+.||++|||+.||+++|+++.
T Consensus 244 -~~~~~~i~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 -EELFKLLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -HHHHHHHHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHHc---------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 112222222 2222334445577899999999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=342.80 Aligned_cols=225 Identities=22% Similarity=0.303 Sum_probs=177.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc------cccHHHHHHHHHHHHHhcCCCcccc----------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS------GQGIVEFKNEAKLIAKLQHTNLTDS---------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~H~nlv~~---------- 577 (1018)
.++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.|.+|+.++++++||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999974 58999999986542 2346789999999999999999831
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC----Cceeeeeccee
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM----NPKISDFGMAR 637 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~----~~kL~DFGla~ 637 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 23457999999999999999999999999 99999999999998776 49999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchh
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLE 717 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 717 (1018)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... ....+...
T Consensus 166 ~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~-~i~~~~~~- 234 (293)
T d1jksa_ 166 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLA-NVSAVNYE- 234 (293)
T ss_dssp ECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHHTTCCC-
T ss_pred hcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHH-HHHhcCCC-
Confidence 865332 22346789999999999999999999999999999999999999863221 11111 11111100
Q ss_pred hhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 718 LVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 718 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
.. . ..++.....+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~-~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FE-D----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-H----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-c----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 001123456789999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.2e-38 Score=347.46 Aligned_cols=218 Identities=25% Similarity=0.322 Sum_probs=178.7
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.++++++||||+++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999974 5899999999654 24456789999999999999999841
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 23456788899999999999999999999 999999999999999999999999999986432
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......... .+ ..
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~-~~----------~~ 218 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKIL-NA----------EL 218 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHH-HC----------CC
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHH-cC----------CC
Confidence 234689999999999999999999999999999999999999985321 111111111 11 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRP-----AMPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 758 (1018)
..++...+.+.+++.+||+.||.+|| |++|+++
T Consensus 219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 23344556788999999999999996 8999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-38 Score=347.79 Aligned_cols=231 Identities=23% Similarity=0.328 Sum_probs=184.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec------ccccceEEEecccc-cccHHHHHHHHHHHHHh-cCCCcccc----------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL------NGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKL-QHTNLTDS---------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~H~nlv~~---------- 577 (1018)
++|++.++||+|+||.||+|++. +++.||||+++... .....+|.+|+.+++++ +||||+++
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 68899999999999999999852 35689999997654 33455799999999999 69999831
Q ss_pred ----------------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc
Q 046791 578 ----------------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD 623 (1018)
Q Consensus 578 ----------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld 623 (1018)
.....+++..+..++.||++||+|||+++ |+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 01235889999999999999999999999 99999999999999
Q ss_pred CCCCceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchH
Q 046791 624 DQMNPKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLI 703 (1018)
Q Consensus 624 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~ 703 (1018)
.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|+..|+.......
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~----- 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----- 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-----
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999998765544445556789999999999999999999999999999999999555533222111
Q ss_pred HHHHHHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 704 GYAWQLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 704 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.. +.++++...+...+......+.+|+.+||+.||++||||.||+++|+..
T Consensus 255 ~~---------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 SK---------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HH---------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11 1122222233334445567889999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-38 Score=350.14 Aligned_cols=221 Identities=23% Similarity=0.284 Sum_probs=180.6
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
++|++.+.||+|+||.||+|+.. +|+.||||++++. .....+++.+|+.+|++++||||+++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999864 5999999999754 24456789999999999999999831
Q ss_pred ------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 578 ------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 578 ------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--G 159 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--T
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC--C
Confidence 23467899999999999999999999999 999999999999999999999999999865432 2
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......+ ..
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~-~~~~i~~~----------~~ 222 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ER-LFELILME----------EI 222 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHC----------CC
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HH-HHHHHhcC----------CC
Confidence 233457899999999999999999999999999999999999999864321 11 11111111 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
.++....+++.+|+.+||+.||++||+ ++|+++
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 234445667889999999999999995 788876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-37 Score=339.15 Aligned_cols=232 Identities=25% Similarity=0.346 Sum_probs=176.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHHHHHHHHhcCCCcccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNEAKLIAKLQHTNLTDS------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~H~nlv~~------------- 577 (1018)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....++|.+|++++++++||||++.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 578999999999999999999864 69999999997643 2334579999999999999999831
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++.+++.++.||++||+|||+++ |+||||||+|||++.++..+|+|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhc
Confidence 22457899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCC-CcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh
Q 046791 641 LNQ-SETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV 719 (1018)
Q Consensus 641 ~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 719 (1018)
... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.... ................
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~~-- 234 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIPP-- 234 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCCG--
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCCC--
Confidence 322 2223345689999999999999999999999999999999999999985322 1111222222211100
Q ss_pred hhhhcCCCChHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhc
Q 046791 720 DIALEGSFSPNEVLRCIHVGLLCVQDQATDRP-AMPDVVSMLAN 762 (1018)
Q Consensus 720 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~Le~ 762 (1018)
....+..++.+.+++.+||+.||++|| |++++++.|..
T Consensus 235 -----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 -----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 011123346788999999999999999 89999988864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=344.63 Aligned_cols=227 Identities=25% Similarity=0.343 Sum_probs=177.3
Q ss_pred eeeeccCCCcCeEEEEeccc----ccceEEEeccc-ccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 521 VNKLGEGGFGPVYKGQLLNG----QEVAIKRLSRR-SGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g----~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++||||+++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999987542 25899999754 44456789999999999999999842
Q ss_pred ----------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc--
Q 046791 578 ----------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE-- 645 (1018)
Q Consensus 578 ----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~-- 645 (1018)
.....+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 12345678889999999999999999999 999999999999999999999999999876543222
Q ss_pred ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhcC
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALEG 725 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 725 (1018)
.......||+.|+|||.+.++.++.++||||||+++|||++|+.|+....... ..... ...+. +.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~----i~~g~---------~~ 253 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY----LLQGR---------RL 253 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTC---------CC
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCC---------CC
Confidence 22234578999999999999999999999999999999999888865322111 11111 11111 11
Q ss_pred CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 726 SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 726 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
..+....+.+.+|+.+||+.||++||+|.||++.|++...
T Consensus 254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2233445678899999999999999999999999988644
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-38 Score=345.20 Aligned_cols=236 Identities=22% Similarity=0.247 Sum_probs=172.8
Q ss_pred eeeeeccCCCcCeEEEEec-ccccceEEEecccccc-----cHHHHHHHHHHHHHhcCCCccc-----------------
Q 046791 520 AVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQ-----GIVEFKNEAKLIAKLQHTNLTD----------------- 576 (1018)
Q Consensus 520 ~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~H~nlv~----------------- 576 (1018)
.+++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++++++||||++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999975 5899999998654322 1346899999999999999983
Q ss_pred ---------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 577 ---------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 577 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
......+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RA 156 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--cc
Confidence 123567999999999999999999999999 9999999999999999999999999998654322 22
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhh------h
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELV------D 720 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------d 720 (1018)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .......+........... .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhccch
Confidence 234578999999999875 46799999999999999999999998643211 1111111111110000000 0
Q ss_pred hhhc---CCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 046791 721 IALE---GSFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVS--MLANE 763 (1018)
Q Consensus 721 ~~l~---~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~Le~~ 763 (1018)
.... ...+ +...+.+.+|+.+||+.||++|||++|+++ .+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000 0011 123467889999999999999999999987 45543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=343.63 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=180.1
Q ss_pred CCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~---------------- 576 (1018)
++|+++++||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++||||++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999986 468999999996543 234678999999999999999983
Q ss_pred -----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCc
Q 046791 577 -----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSE 645 (1018)
Q Consensus 577 -----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~ 645 (1018)
......+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-- 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc--
Confidence 123567999999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccceeeecccccCChhhhccCC-CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc---chhhh-h
Q 046791 646 TNTNRVVGTYGYMSPEYAMSGV-VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK---VLELV-D 720 (1018)
Q Consensus 646 ~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~-d 720 (1018)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||...... .............. ..... .
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhccccccc
Confidence 2233468999999999887655 589999999999999999999998643211 11111111110000 00000 0
Q ss_pred hhhcCCC-----------ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcCcC
Q 046791 721 IALEGSF-----------SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM--LANESL 765 (1018)
Q Consensus 721 ~~l~~~~-----------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--Le~~~~ 765 (1018)
+...... .+...+.+.+|+.+||+.||++|||+.|+++. +++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 0000000 01223677899999999999999999999984 665543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.8e-38 Score=343.72 Aligned_cols=235 Identities=25% Similarity=0.358 Sum_probs=177.2
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccc-----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTD----------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~----------------- 576 (1018)
++|+++++||+|+||+||+|+..+|+.||||+++... ....+.+.+|+.++++++||||++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999996543 334678999999999999999983
Q ss_pred ---------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCccc
Q 046791 577 ---------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 577 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 647 (1018)
......+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RK 156 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--cc
Confidence 134677999999999999999999999998 9999999999999999999999999998764322 22
Q ss_pred ceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc------chhhh-
Q 046791 648 TNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK------VLELV- 719 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~~- 719 (1018)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... .............. .....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhhhhh
Confidence 334578999999999876 55799999999999999999999998643211 11111111111100 00000
Q ss_pred -hhhhc-------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 720 -DIALE-------GSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 720 -d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+.... ....+...+.+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0111223467889999999999999999999974
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-37 Score=340.27 Aligned_cols=239 Identities=23% Similarity=0.277 Sum_probs=175.0
Q ss_pred CCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
++|.+.++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++||||+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5678889999999999999986 688999999965421 12223445555668899999831
Q ss_pred -----------cCCCCCChhhHHHHHHHHHHHHHHHhcCC-----CCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 -----------RRNNRLNWETRFSIIEGIAQGLLYLHKYS-----RLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 -----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+++++.|+|.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 12346899999999999999999999741 23599999999999999999999999999998754
Q ss_pred CCCc--ccceeeecccccCChhhhccCC------CCccccchhHhHHHHHHHhCCCCCCCCCCCCCC--------chHHH
Q 046791 642 NQSE--TNTNRVVGTYGYMSPEYAMSGV------VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPL--------NLIGY 705 (1018)
Q Consensus 642 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~------~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~--------~l~~~ 705 (1018)
.... .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+......... .....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 4322 2334578999999999987643 578899999999999999999887543322110 01111
Q ss_pred HHHHhhcCcchhhhhhhhcCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 706 AWQLWNEGKVLELVDIALEGSF-----SPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 706 ~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
..... .+..++... +.+....+.+|+.+||+.||++|||+.||+++|++..
T Consensus 241 ~~~~~--------~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 241 MRKVV--------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHH--------TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH--------hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11111 111111111 2245567889999999999999999999999998643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-37 Score=343.22 Aligned_cols=228 Identities=25% Similarity=0.357 Sum_probs=176.5
Q ss_pred CCcceeeeeccCCCcCeEEEEecc-cc--cceEEEeccc-ccccHHHHHHHHHHHHHh-cCCCcccc-------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLLN-GQ--EVAIKRLSRR-SGQGIVEFKNEAKLIAKL-QHTNLTDS------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~~-g~--~vAvK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nlv~~------------- 577 (1018)
++|++.++||+|+||+||+|++.+ +. .||||+++.. .....++|.+|++++.++ +||||+++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999998754 43 5788988654 344566899999999999 79999831
Q ss_pred -----------------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCc
Q 046791 578 -----------------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNP 628 (1018)
Q Consensus 578 -----------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 628 (1018)
.....+++..+.+++.|||+||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 12357899999999999999999999998 9999999999999999999
Q ss_pred eeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCC-CCCCCCCCCCCchHHHHH
Q 046791 629 KISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKK-NNGCYRTDHPLNLIGYAW 707 (1018)
Q Consensus 629 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~-p~~~~~~~~~~~l~~~~~ 707 (1018)
||+|||+++.... ........||..|+|||.+.++.++.++|||||||++|||++|.. ||.... ... ..
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~-~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAE-LY 236 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHH-HH
T ss_pred EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHH-HH
Confidence 9999999986432 222234578999999999999999999999999999999999765 553211 111 11
Q ss_pred HHhhcCcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCcC
Q 046791 708 QLWNEGKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANESL 765 (1018)
Q Consensus 708 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~~ 765 (1018)
..... ..+...+....+++.+|+.+||+.||++||||+||++.|+....
T Consensus 237 ~~i~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 237 EKLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHh---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 11223344556788999999999999999999999999987643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=342.59 Aligned_cols=236 Identities=25% Similarity=0.339 Sum_probs=176.0
Q ss_pred HhCCcceeeeeccCCCcCeEEEEec-c-cccceEEEecccc--cccHHHHHHHHHHHHHh---cCCCcccc---------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQLL-N-GQEVAIKRLSRRS--GQGIVEFKNEAKLIAKL---QHTNLTDS--------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~~-~-g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nlv~~--------- 577 (1018)
..++|+++++||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+++.| +||||+++
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3578999999999999999999863 4 6679999986542 22234567788877766 79999731
Q ss_pred -----------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeec
Q 046791 578 -----------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFG 634 (1018)
Q Consensus 578 -----------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFG 634 (1018)
.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 23456889999999999999999999999 9999999999999999999999999
Q ss_pred ceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc
Q 046791 635 MARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK 714 (1018)
Q Consensus 635 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 714 (1018)
+++... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 162 ~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 162 LARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPG 235 (305)
T ss_dssp SCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCC
T ss_pred hhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCc
Confidence 988653 223344578999999999999999999999999999999999999999643211 11111111110000
Q ss_pred chh------hhhhhh-------cCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 VLE------LVDIAL-------EGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ~~~------~~d~~l-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
... ...... .........+.+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 000000 00112233467788999999999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-36 Score=333.16 Aligned_cols=235 Identities=20% Similarity=0.229 Sum_probs=179.7
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~----------------- 576 (1018)
.++|++.++||+|+||.||+|+.. +|+.||||++..... ..++..|++++++++|+|++.
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 467999999999999999999864 589999999865432 245889999999999888651
Q ss_pred ----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEc---CCCCceeeeecceeeecCCC
Q 046791 577 ----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLD---DQMNPKISDFGMARIFGLNQ 643 (1018)
Q Consensus 577 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kL~DFGla~~~~~~~ 643 (1018)
......+++..+..++.|+++||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 123567999999999999999999999999 99999999999986 45679999999999875433
Q ss_pred Cc-----ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 644 SE-----TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 644 ~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---- 236 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---- 236 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC----
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC----
Confidence 21 123456899999999999999999999999999999999999999976544332221111110000000
Q ss_pred hhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcC
Q 046791 719 VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANE 763 (1018)
Q Consensus 719 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~ 763 (1018)
.+.+. ...++++.+++..||+.+|++||++.++.+.|+..
T Consensus 237 -~~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 -IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -HHHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -hhHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 01111 12345678899999999999999999999888753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-36 Score=344.75 Aligned_cols=220 Identities=26% Similarity=0.322 Sum_probs=172.8
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc---cccHHHHHHH---HHHHHHhcCCCccc------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS---GQGIVEFKNE---AKLIAKLQHTNLTD------------ 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~f~~E---~~~l~~l~H~nlv~------------ 576 (1018)
++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+.+| +.+++.++||||+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999875 58999999986432 2233344444 66677778999983
Q ss_pred --------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 577 --------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 577 --------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
+.....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 123456889999999999999999999999 999999999999999999999999999976532
Q ss_pred CCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhh
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDI 721 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 721 (1018)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ .. +...
T Consensus 161 ----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~-------------~~~~ 220 (364)
T d1omwa3 161 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HE-------------IDRM 220 (364)
T ss_dssp ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HH-------------HHHH
T ss_pred ----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HH-------------HHHh
Confidence 2334679999999999975 5689999999999999999999999965433221 11 1111
Q ss_pred hh--cCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 722 AL--EGSFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 722 ~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
.. ....+....+.+.+|+.+||+.||++||| ++|+++
T Consensus 221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 221 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11 11223344567889999999999999999 688875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-37 Score=335.60 Aligned_cols=214 Identities=24% Similarity=0.368 Sum_probs=171.8
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc------ccHHHHHHHHHHHHHhc--CCCcccc--------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG------QGIVEFKNEAKLIAKLQ--HTNLTDS-------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~--H~nlv~~-------- 577 (1018)
.++|++.++||+|+||+||+|+.. +|+.||||+++.... ....++.+|+.++++++ ||||+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999864 589999999865421 12234778999999997 8999831
Q ss_pred -------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-CCCceeeeeccee
Q 046791 578 -------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-QMNPKISDFGMAR 637 (1018)
Q Consensus 578 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kL~DFGla~ 637 (1018)
.....+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 23457899999999999999999999999 999999999999985 4789999999998
Q ss_pred eecCCCCcccceeeecccccCChhhhccCCC-CccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 638 IFGLNQSETNTNRVVGTYGYMSPEYAMSGVV-SIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ... .+.
T Consensus 160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~-~~~-- 220 (273)
T d1xwsa_ 160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII-RGQ-- 220 (273)
T ss_dssp ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH-HCC--
T ss_pred ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHh-hcc--
Confidence 75422 2334689999999999987665 577999999999999999999985310 000 010
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..++....+++.+++.+||+.||++|||++|+++
T Consensus 221 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 --------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1122334567889999999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-36 Score=329.51 Aligned_cols=224 Identities=22% Similarity=0.285 Sum_probs=177.0
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccccc---------ccHHHHHHHHHHHHHhc-CCCccc--------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSG---------QGIVEFKNEAKLIAKLQ-HTNLTD-------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~---------~~~~~f~~E~~~l~~l~-H~nlv~-------- 576 (1018)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.++++++ ||||++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999864 589999999865431 12345889999999997 999983
Q ss_pred ------------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 577 ------------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 577 ------------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
+.....+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence 123567999999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcccceeeecccccCChhhhcc------CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhc
Q 046791 639 FGLNQSETNTNRVVGTYGYMSPEYAMS------GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNE 712 (1018)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 712 (1018)
+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .. .......
T Consensus 160 ~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~-~~~~i~~ 229 (277)
T d1phka_ 160 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------ML-MLRMIMS 229 (277)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHH
T ss_pred ccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HH-HHHHHHh
Confidence 75432 2234679999999999863 4568899999999999999999999864321 11 1111111
Q ss_pred CcchhhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 713 GKVLELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 713 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+... ..........+++.+++.+||+.||++|||++||++
T Consensus 230 ~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1110 011112244577889999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-36 Score=334.54 Aligned_cols=220 Identities=20% Similarity=0.267 Sum_probs=176.7
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCccc-----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTD----------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~----------------- 576 (1018)
.++|++.+.||+|+||+||+|+.. +++.||||.++... .....+.+|+++|++++||||++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 578999999999999999999875 58899999997653 33456889999999999999983
Q ss_pred ---------cc-CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC--CCCceeeeecceeeecCCCC
Q 046791 577 ---------SR-RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD--QMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 577 ---------~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~--~~~~kL~DFGla~~~~~~~~ 644 (1018)
+. ....+++.++..|+.||++||.|||+++ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 11 2336899999999999999999999999 999999999999985 457999999999876432
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......+|+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........ .+.
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~-~~~---------- 219 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIM-NAE---------- 219 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-HTC----------
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCC----------
Confidence 223456789999999999999999999999999999999999999864321 11111111 110
Q ss_pred CCCCh----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 725 GSFSP----NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 725 ~~~~~----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..++. ...+++.+|+.+||+.||.+|||+.|+++
T Consensus 220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111 22456789999999999999999999988
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-37 Score=338.91 Aligned_cols=221 Identities=24% Similarity=0.340 Sum_probs=177.0
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc---ccccHHHHHHHHHHHH-HhcCCCccc--------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR---SGQGIVEFKNEAKLIA-KLQHTNLTD-------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~f~~E~~~l~-~l~H~nlv~-------------- 576 (1018)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++||||++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 5899999999754 2345567778877765 689999983
Q ss_pred ------------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 577 ------------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 577 ------------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
+.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 123467899999999999999999999999 9999999999999999999999999998654322
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhhhhhhhc
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLELVDIALE 724 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 724 (1018)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+ .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~~~----------~ 219 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMD----------N 219 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC----------C
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC----------C
Confidence 2333468999999999999999999999999999999999999998642211 111111111 1
Q ss_pred CCCChHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 046791 725 GSFSPNEVLRCIHVGLLCVQDQATDRPAMP-DVVS 758 (1018)
Q Consensus 725 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~ 758 (1018)
..++....+++.+|+.+||+.||++||++. |+++
T Consensus 220 ~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 123334456788999999999999999995 6754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-36 Score=336.55 Aligned_cols=237 Identities=21% Similarity=0.306 Sum_probs=174.5
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEeccc--ccccHHHHHHHHHHHHHhcCCCcccc---------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRR--SGQGIVEFKNEAKLIAKLQHTNLTDS--------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~H~nlv~~--------------- 577 (1018)
++|++.++||+|+||+||+|+.. +|+.||||++... .....+++.+|+++|++++|+|++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999974 6899999998654 33455778999999999999998731
Q ss_pred -------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 578 -------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 578 -------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeee
Confidence 22456888999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCC--cccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC--
Q 046791 639 FGLNQS--ETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG-- 713 (1018)
Q Consensus 639 ~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 713 (1018)
...... ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSITP 243 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH---HHHHHHHHhcCCCCh
Confidence 653322 1222335799999999998864 6899999999999999999999998643211 1111111111000
Q ss_pred c---------chhhhhhhhcCCCCh-------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 714 K---------VLELVDIALEGSFSP-------NEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 714 ~---------~~~~~d~~l~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
. ............... ...+.+++|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 000000000000011 11245678999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=341.36 Aligned_cols=240 Identities=21% Similarity=0.291 Sum_probs=176.6
Q ss_pred HhCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc-cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 514 ATNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS-GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 514 ~t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.+.+|+++++||+|+||+||+|+. .+|+.||||+++... ....+++.+|+.+|++++|||++++
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356899999999999999999986 469999999997543 3345678999999999999998731
Q ss_pred ---------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 578 ---------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 578 ---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
.....+++..+..++.||++||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 12357899999999999999999999999 999999999999999999999999999876433
Q ss_pred CC-cccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch----
Q 046791 643 QS-ETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL---- 716 (1018)
Q Consensus 643 ~~-~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---- 716 (1018)
.. ........||+.|+|||++.. ..++.++||||+||++|||++|+.||....... ...............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChhhhhh
Confidence 22 222345679999999999854 567899999999999999999999986432111 111111111000000
Q ss_pred -------hhhhhhh-cCCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 046791 717 -------ELVDIAL-EGSFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVSM 759 (1018)
Q Consensus 717 -------~~~d~~l-~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 759 (1018)
....... ....+ +....++.+|+.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00011 1223568899999999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=332.51 Aligned_cols=224 Identities=18% Similarity=0.194 Sum_probs=171.5
Q ss_pred hCCcceee-eeccCCCcCeEEEEe-cccccceEEEecccccccHHHHHHHHHHHHHh-cCCCcccc--------------
Q 046791 515 TNNFSAVN-KLGEGGFGPVYKGQL-LNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKL-QHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~-~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~H~nlv~~-------------- 577 (1018)
.++|.+.. .||+|+||.||+|+. .+++.||||+++.. ..+.+|+.++.++ +||||+++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 599999999999986 45899999998642 4678899987655 89999831
Q ss_pred ------------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC---CCCceeeeecce
Q 046791 578 ------------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD---QMNPKISDFGMA 636 (1018)
Q Consensus 578 ------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kL~DFGla 636 (1018)
.....+++.++..|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 11346899999999999999999999999 999999999999985 567999999999
Q ss_pred eeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 637 RIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........+..
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~~- 234 (335)
T d2ozaa1 162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQY- 234 (335)
T ss_dssp EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCCC-
Confidence 8765332 2334679999999999999999999999999999999999999996543222110 00000000000
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
...........+++.+|+.+||+.||++|||+.|+++
T Consensus 235 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000001133467889999999999999999999988
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-35 Score=331.78 Aligned_cols=238 Identities=21% Similarity=0.264 Sum_probs=174.0
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.++|+++++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||++++
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999864 59999999997542 3345678999999999999999842
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCC
Confidence 12356899999999999999999999999 99999999999999999999999999987642
Q ss_pred CCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh--------hc
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW--------NE 712 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~--------~~ 712 (1018)
. .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... ......... ..
T Consensus 174 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 174 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHT
T ss_pred c-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHHHHhccCCCcHHHHhh
Confidence 2 234678999999999876 467899999999999999999999986432111 111000000 00
Q ss_pred Ccch--hhhhhhh---cC----CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcC
Q 046791 713 GKVL--ELVDIAL---EG----SFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSM--LANE 763 (1018)
Q Consensus 713 ~~~~--~~~d~~l---~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--Le~~ 763 (1018)
.... ......+ .. .......+.+.+|+.+||+.||++|||+.|+++. +++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000 0000000 00 0112234567899999999999999999999983 5554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=333.87 Aligned_cols=228 Identities=22% Similarity=0.311 Sum_probs=172.2
Q ss_pred CcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCCcccc------------------
Q 046791 517 NFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLTDS------------------ 577 (1018)
Q Consensus 517 ~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv~~------------------ 577 (1018)
+|+..++||+|+||+||+|+.. +|+.||||++...... +.+|++++++++|+||+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999975 5899999999765422 3579999999999999831
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-Cceeeeecceeee
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARIF 639 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kL~DFGla~~~ 639 (1018)
.....+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 12446889999999999999999999999 99999999999999775 8999999999877
Q ss_pred cCCCCcccceeeecccccCChhhhcc-CCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 640 GLNQSETNTNRVVGTYGYMSPEYAMS-GVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 640 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
..... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ........... ...+.
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~---~l~~i~~~~g~-~~~~~ 246 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGT-PTREQ 246 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCC-CCHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH---HHHHHHHHhCC-ChHHh
Confidence 53322 234579999999998875 578999999999999999999999986432111 11111111000 00000
Q ss_pred hh----------------hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 719 VD----------------IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 719 ~d----------------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+. ........+...+.+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000112234567889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-35 Score=321.00 Aligned_cols=236 Identities=22% Similarity=0.284 Sum_probs=178.5
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTD---------------- 576 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~---------------- 576 (1018)
++|+++++||+|+||+||+|+.. +++.||||+++... .....++.+|+.++++++|+||++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999964 58899999986543 344678999999999999999983
Q ss_pred ----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCCcc
Q 046791 577 ----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQSET 646 (1018)
Q Consensus 577 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 646 (1018)
....+.+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence 134567899999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeecccccCChhhhccCC-CCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCc---c---hhhh
Q 046791 647 NTNRVVGTYGYMSPEYAMSGV-VSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGK---V---LELV 719 (1018)
Q Consensus 647 ~~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~~~~ 719 (1018)
......++..|+|||.+.... ++.++|||||||++|||++|+.||.... ................. . ....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 222356788999999988654 6899999999999999999999974222 11111111111111100 0 0000
Q ss_pred hh---------hhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 720 DI---------ALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 720 d~---------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
+. ...........+.+.+|+.+||+.||.+|||++||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000122233467889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-34 Score=319.07 Aligned_cols=236 Identities=18% Similarity=0.217 Sum_probs=179.5
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcC-CCccc----------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH-TNLTD---------------- 576 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H-~nlv~---------------- 576 (1018)
.++|++.++||+|+||+||+|+.. +|+.||||++..... ...+.+|+++++.++| +|++.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 478999999999999999999965 588999998865432 2457889999999977 56541
Q ss_pred ----------ccCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcC-----CCCceeeeecceeeecC
Q 046791 577 ----------SRRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDD-----QMNPKISDFGMARIFGL 641 (1018)
Q Consensus 577 ----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~-----~~~~kL~DFGla~~~~~ 641 (1018)
......+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 122457899999999999999999999999 999999999999974 56799999999998653
Q ss_pred CCCc-----ccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcch
Q 046791 642 NQSE-----TNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVL 716 (1018)
Q Consensus 642 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (1018)
.... .......||+.|||||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 3221 12335689999999999999999999999999999999999999997544333221111111111001111
Q ss_pred hhhhhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcCc
Q 046791 717 ELVDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVSMLANES 764 (1018)
Q Consensus 717 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~Le~~~ 764 (1018)
.+... .++++.+++..|++.+|++||+++.+.+.|++..
T Consensus 239 -----~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 239 -----ELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp -----HHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -----HhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111 2356788889999999999999999988887643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-34 Score=321.85 Aligned_cols=232 Identities=17% Similarity=0.232 Sum_probs=174.5
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhc-CCCcccc----------------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQ-HTNLTDS---------------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-H~nlv~~---------------- 577 (1018)
++|+++++||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+++|++++ ||||+++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 58999999999999999999874 5899999998653 3567899999999995 9999831
Q ss_pred ---------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCC-CceeeeecceeeecCCCCccc
Q 046791 578 ---------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQM-NPKISDFGMARIFGLNQSETN 647 (1018)
Q Consensus 578 ---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kL~DFGla~~~~~~~~~~~ 647 (1018)
...+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+...... .
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~ 185 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---E 185 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---C
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC---c
Confidence 11357899999999999999999999999 99999999999998655 58999999998765332 2
Q ss_pred ceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHh---------hcC--c-
Q 046791 648 TNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLW---------NEG--K- 714 (1018)
Q Consensus 648 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~---------~~~--~- 714 (1018)
.....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ......... ... .
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhhhccccc
Confidence 3346789999999998865 579999999999999999999999864332111 000000000 000 0
Q ss_pred chhhh-----------hhhhcCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 715 VLELV-----------DIALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 715 ~~~~~-----------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... .............+++.+|+.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000011111223467889999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-34 Score=323.89 Aligned_cols=238 Identities=21% Similarity=0.288 Sum_probs=175.3
Q ss_pred hCCcceeeeeccCCCcCeEEEEe-cccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCcccc--------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQL-LNGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDS-------------- 577 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~-------------- 577 (1018)
.++|+++++||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++|+|++++
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999986 469999999997543 3345678999999999999998731
Q ss_pred ----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecC
Q 046791 578 ----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGL 641 (1018)
Q Consensus 578 ----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~ 641 (1018)
.....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT-
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC-
Confidence 22457999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCcccceeeecccccCChhhhccC-CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcC-------
Q 046791 642 NQSETNTNRVVGTYGYMSPEYAMSG-VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEG------- 713 (1018)
Q Consensus 642 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------- 713 (1018)
.......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 173 ----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 173 ----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp ----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHHTT
T ss_pred ----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChHHhhh
Confidence 223346789999999987765 5689999999999999999999998643211 1111111110000
Q ss_pred -cc---hhhhhhhhc-CCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcC
Q 046791 714 -KV---LELVDIALE-GSFS-----PNEVLRCIHVGLLCVQDQATDRPAMPDVVS--MLANE 763 (1018)
Q Consensus 714 -~~---~~~~d~~l~-~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~Le~~ 763 (1018)
.. ......... .... ....+.+.+|+.+||+.||++|||+.|+++ .+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00 000000000 0000 122456789999999999999999999997 45543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=321.57 Aligned_cols=226 Identities=21% Similarity=0.314 Sum_probs=175.6
Q ss_pred CCcceeeeeccCCCcCeEEEEec----ccccceEEEecccc----cccHHHHHHHHHHHHHhcC-CCcccc---------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL----NGQEVAIKRLSRRS----GQGIVEFKNEAKLIAKLQH-TNLTDS--------- 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~H-~nlv~~--------- 577 (1018)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999752 37899999986542 2345678999999999988 788731
Q ss_pred -----------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeec
Q 046791 578 -----------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFG 640 (1018)
Q Consensus 578 -----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~ 640 (1018)
.....+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 23456788899999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcccceeeecccccCChhhhccC--CCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHHHhhcCcchhh
Q 046791 641 LNQSETNTNRVVGTYGYMSPEYAMSG--VVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQLWNEGKVLEL 718 (1018)
Q Consensus 641 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 718 (1018)
.... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||......... ........
T Consensus 181 ~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~------- 249 (322)
T d1vzoa_ 181 ADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRIL------- 249 (322)
T ss_dssp GGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHH-------
T ss_pred cccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcc-------
Confidence 3222 223346789999999999764 4788999999999999999999999755433221 11111110
Q ss_pred hhhhhcCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 046791 719 VDIALEGSFSPNEVLRCIHVGLLCVQDQATDRPA-----MPDVVS 758 (1018)
Q Consensus 719 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 758 (1018)
......+....+++.+++.+||+.||++||| ++|+++
T Consensus 250 ---~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 ---KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0111234456678889999999999999994 788876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-34 Score=320.68 Aligned_cols=235 Identities=22% Similarity=0.211 Sum_probs=169.9
Q ss_pred hCCcceeeeeccCCCcCeEEEEec-ccccceEEEecccc--cccHHHHHHHHHHHHHhcCCCccccc-------------
Q 046791 515 TNNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRS--GQGIVEFKNEAKLIAKLQHTNLTDSR------------- 578 (1018)
Q Consensus 515 t~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~H~nlv~~~------------- 578 (1018)
.++|+++++||+|+||+||+|+.. +|+.||||++.... .....++.+|+.++++++||||+++.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999975 59999999997543 33455789999999999999998421
Q ss_pred ----------------CCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCC
Q 046791 579 ----------------RNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLN 642 (1018)
Q Consensus 579 ----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~ 642 (1018)
....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccc
Confidence 1346889999999999999999999999 999999999999999999999999998865432
Q ss_pred CCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHHHHH--------------
Q 046791 643 QSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGYAWQ-------------- 708 (1018)
Q Consensus 643 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~~~~-------------- 708 (1018)
.......+|+.|+|||++.+..++.++||||+||++|||++|+.||...... ........
T Consensus 173 ---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~---~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 173 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHTTSC
T ss_pred ---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH---HHHHHHHHhccCCCHHHHHHhh
Confidence 2334467899999999999999999999999999999999999998543211 01100000
Q ss_pred -----HhhcC------cchhhhhhhhcCC---CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 046791 709 -----LWNEG------KVLELVDIALEGS---FSPNEVLRCIHVGLLCVQDQATDRPAMPDVVS 758 (1018)
Q Consensus 709 -----~~~~~------~~~~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 758 (1018)
..... ............. ........+.+|+.+||+.||++|||++||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 0000010011100 11234567889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=2.4e-32 Score=309.60 Aligned_cols=234 Identities=21% Similarity=0.252 Sum_probs=173.1
Q ss_pred CCcceeeeeccCCCcCeEEEEec-ccccceEEEecccccccHHHHHHHHHHHHHhcCCC-----------cccc------
Q 046791 516 NNFSAVNKLGEGGFGPVYKGQLL-NGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN-----------LTDS------ 577 (1018)
Q Consensus 516 ~~y~~~~~lG~G~fG~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n-----------lv~~------ 577 (1018)
++|+++++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++|++ |+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999864 69999999997543 23467889999999987654 4421
Q ss_pred -------------------------cCCCCCChhhHHHHHHHHHHHHHHHhc-CCCCcEEecccCCCcEEEcCCCC----
Q 046791 578 -------------------------RRNNRLNWETRFSIIEGIAQGLLYLHK-YSRLRVIHRDLKASNILLDDQMN---- 627 (1018)
Q Consensus 578 -------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivH~Dlkp~NILld~~~~---- 627 (1018)
.....+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 234578889999999999999999998 77 999999999999986553
Q ss_pred --ceeeeecceeeecCCCCcccceeeecccccCChhhhccCCCCccccchhHhHHHHHHHhCCCCCCCCCCCCCCchHHH
Q 046791 628 --PKISDFGMARIFGLNQSETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVLEIVSGKKNNGCYRTDHPLNLIGY 705 (1018)
Q Consensus 628 --~kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~elltG~~p~~~~~~~~~~~l~~~ 705 (1018)
+||+|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||..............
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 89999999986432 22346799999999999999999999999999999999999999865433222111111
Q ss_pred HHHHhh-cCcc-hhh----------h-----------------h--hhhcCCCChHHHHHHHHHHHhccccCCCCCCCHH
Q 046791 706 AWQLWN-EGKV-LEL----------V-----------------D--IALEGSFSPNEVLRCIHVGLLCVQDQATDRPAMP 754 (1018)
Q Consensus 706 ~~~~~~-~~~~-~~~----------~-----------------d--~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 754 (1018)
...... -+.. .+. . . ..............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 111000 0000 000 0 0 0011234456778899999999999999999999
Q ss_pred HHHH
Q 046791 755 DVVS 758 (1018)
Q Consensus 755 evl~ 758 (1018)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9987
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.78 E-value=3e-19 Score=164.70 Aligned_cols=110 Identities=25% Similarity=0.411 Sum_probs=90.2
Q ss_pred CccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCce
Q 046791 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSL 106 (1018)
Q Consensus 27 ~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l 106 (1018)
+|||.|||.|.+|++|+| |.|+|+|+..++ |.|+. ..++||.||++.|.. .+.+
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~-----------------~~~~vW~s~~~~~~~--~~~l 54 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD-----------------NNRAVWASGTNGKAS--GCVL 54 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE-----------------TTEEEEECCCTTSCS--SEEE
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc-----------------CCcEEEEccCccCCC--CcEE
Confidence 599999999999999985 899999998776 66764 256799999998854 3579
Q ss_pred EEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcc
Q 046791 107 TIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTD 170 (1018)
Q Consensus 107 ~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTD 170 (1018)
.++. ||+|+|++ +++ ++|++++. .+..+|+|+|+|||||++.+ +.++|||+.||++
T Consensus 55 ~l~~-dGnLvl~~-~~~-~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 55 KMQN-DGNLVIYS-GSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVGN 112 (112)
T ss_dssp EECT-TSCEEEEE-TTE-EEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCCC
T ss_pred EEec-cccEEEEe-cCC-eEEEEeeccCCCceEEEEcCCCCEEEECCC-----CcEEecCCCccCC
Confidence 9988 99999998 554 45555443 45668999999999999865 6789999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.77 E-value=7.7e-20 Score=186.44 Aligned_cols=156 Identities=20% Similarity=0.162 Sum_probs=110.7
Q ss_pred cceeeeeccCCCcCeEEEEecccccceEEEeccccc------------------ccHHHHHHHHHHHHHhcCCCcccc--
Q 046791 518 FSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSG------------------QGIVEFKNEAKLIAKLQHTNLTDS-- 577 (1018)
Q Consensus 518 y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~nlv~~-- 577 (1018)
+.+.++||+|+||+||+|+..+|++||||+++.... ........|...+.++.|.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999998999999998753210 012235678889999999887631
Q ss_pred -------------cCCCCCChhhHHHHHHHHHHHHHHHhcCCCCcEEecccCCCcEEEcCCCCceeeeecceeeecCCCC
Q 046791 578 -------------RRNNRLNWETRFSIIEGIAQGLLYLHKYSRLRVIHRDLKASNILLDDQMNPKISDFGMARIFGLNQS 644 (1018)
Q Consensus 578 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~~~~~~~ 644 (1018)
.....++......++.|++++|+|||+++ |+||||||+|||++++ .++|+|||+|........
T Consensus 82 ~~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~ 157 (191)
T d1zara2 82 WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW 157 (191)
T ss_dssp EETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTH
T ss_pred ecCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCCc
Confidence 12234677888999999999999999999 9999999999999965 489999999986542221
Q ss_pred cccceeeecccccCChhhhccCCCCccccchhHhHHHH
Q 046791 645 ETNTNRVVGTYGYMSPEYAMSGVVSIKTDVFSFGVLVL 682 (1018)
Q Consensus 645 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~SlGvvl~ 682 (1018)
.......+. . -.|. ..+.++.++|+||..--++
T Consensus 158 ~~~l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 158 REILERDVR---N-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp HHHHHHHHH---H-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred HHHHHHHHH---H-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 110000000 0 0122 2356788999999765443
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.72 E-value=6.3e-18 Score=154.18 Aligned_cols=105 Identities=25% Similarity=0.420 Sum_probs=88.2
Q ss_pred CccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCce
Q 046791 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSL 106 (1018)
Q Consensus 27 ~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l 106 (1018)
.|+|.+||.|.+|+.|. +|.|+|.|+..++ |.|+. ..++||.||++.|-. .+.+
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~-----------------~~~~vW~s~~~~~~~--~~~l 54 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD-----------------VDKPIWATNTGGLSR--SCFL 54 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE-----------------TTEEEEECCCTTSCS--SCEE
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe-----------------CCceeeEeCCCCCCC--ccEE
Confidence 37899999999999995 6999999998886 77764 246799999998843 4679
Q ss_pred EEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCC
Q 046791 107 TIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDY 167 (1018)
Q Consensus 107 ~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~ 167 (1018)
.+.. +|+|+|.+ +++.++|++++. ....+|+|+|+|||||++. .+||||+|
T Consensus 55 ~l~~-~Gnlvl~~-~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 55 SMQT-DGNLVVYN-PSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp EECT-TSCEEEEC-TTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred EEec-cceEEEEC-CCccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9987 99999999 778899999865 3455799999999999853 38999998
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.72 E-value=1.2e-17 Score=152.30 Aligned_cols=106 Identities=23% Similarity=0.340 Sum_probs=87.9
Q ss_pred CccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCce
Q 046791 27 TDTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSL 106 (1018)
Q Consensus 27 ~d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l 106 (1018)
.|+|.+||.|.+|+.|.+ |.|.|+|...++ |-++. ..++||+||++.|... .+.|
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~-----------------~~~~vW~ant~~~~~~-~~~l 55 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD-----------------HSTSVWASNTGILGKK-GCKA 55 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE-----------------TTEEEEECCCCCTTCC-CCEE
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe-----------------CCEEEEEeCCCCCCce-eEEE
Confidence 378999999999999974 889999986665 65653 2467999999999865 5779
Q ss_pred EEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCC
Q 046791 107 TIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDY 167 (1018)
Q Consensus 107 ~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~ 167 (1018)
.++. ||+|||.+ +++.++|+++++ .++.+|+|+|+|||||++. .+|||+-|
T Consensus 56 ~l~~-dGnLvl~~-~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 56 VLQS-DGNFVVYD-AEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp EECT-TSCEEEEC-SSSCEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred EEcC-CceEEEEe-CCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 9988 99999999 788899999876 4556899999999999842 39999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.54 E-value=2.7e-15 Score=138.82 Aligned_cols=107 Identities=21% Similarity=0.312 Sum_probs=84.6
Q ss_pred EEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCceEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEee
Q 046791 65 GIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYE 142 (1018)
Q Consensus 65 gIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~Lld 142 (1018)
-|||..++ .++++|++|++.|+......|.+.. ||||+|.+ . +.++|++++. .....|+|+|
T Consensus 11 ~il~~~~~-------------~~~~~~~l~~~q~l~~g~y~L~~q~-DGNLvL~~-~-~~~vW~s~t~~~~~~~~~~l~~ 74 (120)
T d1dlpa2 11 SILYSTQG-------------NDNHPQTLHATQSLQLSPYRLSMET-DCNLVLFD-R-DDRVWSTNTAGKGTGCRAVLQP 74 (120)
T ss_dssp EECCCC---------------CCCCCCEECSSCCCBCSSCEEEEET-TTEEEEEB-T-TBCCSCCCCCSSCSSCEEEEET
T ss_pred eEEEcCCC-------------CCCcccEEcCCCeeEcCCEEEEEcC-CCcEEEec-C-CcEEEEEccccCCCcEEEEEeC
Confidence 47888888 5788999999999988777899998 99999998 4 4577887765 3457899999
Q ss_pred cCcEEEEecCCCCCcccceecccCCCcccccCCCeecccccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccC
Q 046791 143 TGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRG 222 (1018)
Q Consensus 143 sGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLPg~klg~~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~ 222 (1018)
+|||||++.+ +++|||||. +.++|.|.+.++++|. +++|.
T Consensus 75 ~GnLvl~d~~-----~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGn--lvlY~-- 114 (120)
T d1dlpa2 75 NGRMDVLTNQ-----NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRN--LAIYG-- 114 (120)
T ss_dssp TTEEEEEETT-----TEEEEECCC-------------------------------CCSSSCCEEEECSSSC--EEEEC--
T ss_pred CeeEEEEcCC-----CCEEEEeCC-------------------------------CCCCCcEEEEECCCCc--EEEeC--
Confidence 9999999876 788999983 3467889999999998 45553
Q ss_pred eeEEE
Q 046791 223 EVLWT 227 (1018)
Q Consensus 223 ~~yw~ 227 (1018)
.++|.
T Consensus 115 ~~~W~ 119 (120)
T d1dlpa2 115 GALWT 119 (120)
T ss_dssp CCCCB
T ss_pred CCccc
Confidence 34554
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.40 E-value=5e-14 Score=128.80 Aligned_cols=102 Identities=23% Similarity=0.297 Sum_probs=84.4
Q ss_pred CCeeEEEccCCCCCCCCCCceEEeccCCcEEEEcCCCCeEEEEEeec-CcceEEEEeecCcEEEEecCCCCCcccceecc
Q 046791 86 INQPVWVANRNTPITDKSGSLTIDSRDGNLKILRKGGNSIVVSSVQA-MGNTSAALYETGNFVLYEMNPSGSMERELWQS 164 (1018)
Q Consensus 86 ~~t~VWvANr~~Pi~~~~~~l~~~~~~G~Lvl~~~~~~~~~wss~~~-~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQS 164 (1018)
+.+..|..+.+.++.+....|.+.. ||||||.+ ++.++|++++. ..+..|.|+|+|||||++.+ +++||||
T Consensus 10 ~~~~~~tl~~~~~l~~g~~~l~~q~-DGNLvL~~--~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~-----~~~vWsS 81 (115)
T d1dlpa1 10 EGSHPQTLHAAQSLELSSFRFTMQS-DCNLVLFD--SDVRVWASNTAGATGCRAVLQSDGLLVILTAQ-----NTIRWSS 81 (115)
T ss_dssp SSCSCSCCCTTCEECSTTEEEEECT-TSCEEEEE--SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTT-----TCCSCCC
T ss_pred CCCCcceecCCCcEEcCCEEEEECC-CCeEEEEc--CCeeEEEcccCCCCceEEEEeccCCEEEEccC-----CCEEEEc
Confidence 5666799999999988777899988 99999997 35688999876 56788999999999998766 6789998
Q ss_pred cCCCcccccCCCeecccccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCC
Q 046791 165 FDYPTDILLPGMKLGLNLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGL 230 (1018)
Q Consensus 165 FD~PTDTlLPg~klg~~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~ 230 (1018)
+- +.++|.|.+.|+++|. ++++ +..+|.+|.
T Consensus 82 ~t-------------------------------~~~~g~y~l~Lq~DGN--lvlY--~~~~Wssgt 112 (115)
T d1dlpa1 82 GT-------------------------------KGSIGNYVLVLQPDRT--VTIY--GPGLWDSGT 112 (115)
T ss_dssp CC-------------------------------CCCSSCCEEEECSSSC--EEEE--CSEEEECSC
T ss_pred CC-------------------------------CCCCCCEEEEECCCCc--EEEe--CCCeecCCC
Confidence 63 3467999999999998 5566 458999875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.30 E-value=4.6e-12 Score=116.35 Aligned_cols=101 Identities=23% Similarity=0.332 Sum_probs=79.9
Q ss_pred ccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCceE
Q 046791 28 DTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLT 107 (1018)
Q Consensus 28 d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l~ 107 (1018)
++|.++|+| .+.+..|.|.|.|...++ |-++ . ..++||.||+..|.. ...|.
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~----------------~~~~vWssnt~~~~~--~~~l~ 66 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D----------------NNNPIWATNTGGLGN--GCRAV 66 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E----------------TTEEEEECCCTTSCS--SCEEE
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E----------------CCeEEEEecCCCCCc--ceEEE
Confidence 567777776 567789999999988776 5553 2 356899999987753 36799
Q ss_pred EeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccC
Q 046791 108 IDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFD 166 (1018)
Q Consensus 108 ~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD 166 (1018)
+.. ||+|+|.| +++.++|++++. ....+|+|+|+|||||++ ..+|||-.
T Consensus 67 l~~-dGnLvL~d-~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T 117 (119)
T d1b2pa_ 67 LQP-DGVLVVIT-NENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWATQT 117 (119)
T ss_dssp ECT-TSCEEEEC-TTCCEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEECCC
T ss_pred EEe-CCCEEEEC-CCCcEEEECCCcCCCCceEEEEcCCCCEEEEC--------CCEeccCC
Confidence 988 99999999 778899998875 345579999999999983 35999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.90 E-value=5.6e-10 Score=101.46 Aligned_cols=95 Identities=28% Similarity=0.391 Sum_probs=70.5
Q ss_pred CccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCceEEeccCC
Q 046791 34 QLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLTIDSRDG 113 (1018)
Q Consensus 34 ~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l~~~~~~G 113 (1018)
|.|.+++.| .+|.|.|.|...++ |.++.. .++||.+|...+ ..+.+.+.+ +|
T Consensus 15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~~-----------------~~~vW~s~t~~~---~~~~l~l~~-dG 66 (115)
T d1dlpa1 15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS-----------------DVRVWASNTAGA---TGCRAVLQS-DG 66 (115)
T ss_dssp SCCCTTCEE--CSTTEEEEECTTSC-----EEEEES-----------------SSEEECCCCCSC---SCCBCCBCS-SS
T ss_pred ceecCCCcE--EcCCEEEEECCCCe-----EEEEcC-----------------CeeEEEcccCCC---CceEEEEec-cC
Confidence 444444444 35679999987776 767531 356999997643 356788887 99
Q ss_pred cEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceeccc
Q 046791 114 NLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSF 165 (1018)
Q Consensus 114 ~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSF 165 (1018)
||||.| .++.+||++.+. .+..+++|+++|||||++ ..+|+|-
T Consensus 67 NLvl~d-~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssg 111 (115)
T d1dlpa1 67 LLVILT-AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSG 111 (115)
T ss_dssp CBCCBC-TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECS
T ss_pred CEEEEc-cCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC--------CCeecCC
Confidence 999999 677899998765 445579999999999983 3489984
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.62 E-value=3.8e-08 Score=89.20 Aligned_cols=60 Identities=23% Similarity=0.459 Sum_probs=45.5
Q ss_pred ccccCCcccccCCceeccccceeeeeecCCCCCccEEEEEEecCCCCeeEEEecCCCCc------ccCCCcEEEecC
Q 046791 800 DKLQQGQVLRDGDQLVSAFGRFRLAFFSPRSTTKHYLGIWYDKSEDELLVWDANRDTPV------LDKSGRLVKTDG 870 (1018)
Q Consensus 800 dti~~~~~l~~~~~l~s~~~~f~~gf~~~~~~~~~~~~~~~~~~~~~~~vw~a~~~~~~------~~~~g~~~~~~~ 870 (1018)
|+|.+||.|..|+.|+ +|.|+|.|...++ |.|+. ..++||.||++.|. +..+|+|+|.++
T Consensus 2 DtL~~gq~L~~g~~l~--~g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 2 DRLNSGHQLDTGGSLA--EGGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCSSEEEEECTTSCEEEEET
T ss_pred CEecCCCEecCCCEEE--ECCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCCCcEEEEeccccEEEEec
Confidence 8999999999999997 4899999986443 44543 35899999988764 556666666553
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.59 E-value=5.3e-08 Score=89.04 Aligned_cols=95 Identities=21% Similarity=0.346 Sum_probs=66.2
Q ss_pred ccccCCCccCCCCEEEcCCCeEEEeeecCCCCCCeEEEEEEeCCCCCCCCCCcCCCCCCCeeEEEccCCCCCCCCCCceE
Q 046791 28 DTLLLGQLLKDGDELVSAFGNFRMGFFSYMSSGDRYLGIWYHRPTDPSDSHWSYGSPKINQPVWVANRNTPITDKSGSLT 107 (1018)
Q Consensus 28 d~i~~~~~l~~~~~lvS~~g~F~lGFf~~~~~~~~ylgIw~~~~~~~~~~~~~~~~~~~~t~VWvANr~~Pi~~~~~~l~ 107 (1018)
+++.++|+|..| .|.|.|-..++ |.|+- ...+||.+|-.. ......+.
T Consensus 24 ~~l~~~q~l~~g--------~y~L~~q~DGN-----LvL~~-----------------~~~~vW~s~t~~--~~~~~~~~ 71 (120)
T d1dlpa2 24 QTLHATQSLQLS--------PYRLSMETDCN-----LVLFD-----------------RDDRVWSTNTAG--KGTGCRAV 71 (120)
T ss_dssp CEECSSCCCBCS--------SCEEEEETTTE-----EEEEB-----------------TTBCCSCCCCCS--SCSSCEEE
T ss_pred cEEcCCCeeEcC--------CEEEEEcCCCc-----EEEec-----------------CCcEEEEEcccc--CCCcEEEE
Confidence 566666666544 46666654443 55542 234589887433 33346788
Q ss_pred EeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecc
Q 046791 108 IDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQS 164 (1018)
Q Consensus 108 ~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQS 164 (1018)
+.. +|||||.| .++.++|++.+. ....+++|.++|||||++ ..+|.|
T Consensus 72 l~~-~GnLvl~d-~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~--------~~~W~t 120 (120)
T d1dlpa2 72 LQP-NGRMDVLT-NQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG--------GALWTT 120 (120)
T ss_dssp EET-TTEEEEEE-TTTEEEEECCCCCSSSCCEEEECSSSCEEEEC--------CCCCBC
T ss_pred EeC-CeeEEEEc-CCCCEEEEeCCCCCCCcEEEEECCCCcEEEeC--------CCcccC
Confidence 887 99999999 678899999875 455579999999999983 248875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.57 E-value=9.4e-08 Score=87.05 Aligned_cols=83 Identities=20% Similarity=0.383 Sum_probs=62.8
Q ss_pred ceEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcccccCCCeecccc
Q 046791 105 SLTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLNL 182 (1018)
Q Consensus 105 ~l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLPg~klg~~~ 182 (1018)
.|.+.. ||||||.+ ++.++|++++. ..++.+.|.++|||||.+.+ +.++|+|.
T Consensus 33 ~l~mQ~-DGNLVLy~--~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-----g~~vWsS~----------------- 87 (119)
T d1b2pa_ 33 RFIMQT-DCNLVLYD--NNNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP----------------- 87 (119)
T ss_dssp EEEECT-TSCEEEEE--TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-----------------
T ss_pred EEEECC-CCcEEEEE--CCeEEEEecCCCCCcceEEEEEeCCCEEEECCC-----CcEEEECC-----------------
Confidence 466777 99999997 35688998876 34678999999999999766 67788752
Q ss_pred cCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCC
Q 046791 183 QTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGL 230 (1018)
Q Consensus 183 ~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~ 230 (1018)
+.-+.|.|.+.++++|. ++++. .+.|.|+.
T Consensus 88 --------------t~~~~~~~~l~Lq~DGN--lvlYg--~~~W~S~T 117 (119)
T d1b2pa_ 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CcCCCCceEEEEcCCCC--EEEEC--CCEeccCC
Confidence 11245678899999997 55563 57899875
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.54 E-value=1.6e-07 Score=84.21 Aligned_cols=85 Identities=25% Similarity=0.485 Sum_probs=64.1
Q ss_pred CceEEeccCCcEEEEcCCCCeEEEEEeec---CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcccccCCCeecc
Q 046791 104 GSLTIDSRDGNLKILRKGGNSIVVSSVQA---MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGL 180 (1018)
Q Consensus 104 ~~l~~~~~~G~Lvl~~~~~~~~~wss~~~---~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLPg~klg~ 180 (1018)
-.|.+.. ||||||.. .+.+||++++. .....+.|.++|||||++.+ ++++|+|
T Consensus 21 ~~l~~q~-dgnLvl~~--~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~s---------------- 76 (109)
T d1kj1a_ 21 YHFIMQE-DCNLVLYD--HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-----GRSLWAS---------------- 76 (109)
T ss_dssp EEEEECT-TSCEEEEE--TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-----SCEEEEC----------------
T ss_pred EEEEecC-CCeEEEEe--CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-----CcEEEEE----------------
Confidence 4677777 99999987 45789998875 33567999999999999876 7788976
Q ss_pred cccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeCCC
Q 046791 181 NLQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCGLF 231 (1018)
Q Consensus 181 ~~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg~w 231 (1018)
....+.|.|.+.++++|. ++++. ...|.|+.+
T Consensus 77 ---------------~t~~~~~~~~l~L~ddGN--lvly~--~~~W~S~t~ 108 (109)
T d1kj1a_ 77 ---------------HSVRGNGNYVLVLQEDGN--VVIYG--SDIWSTGTY 108 (109)
T ss_dssp ---------------CCCCCSSCCEEEECTTSC--EEEEC--CEEEECCCC
T ss_pred ---------------eeECCCCCEEEEEeCCCc--EEEEC--CCEecCCCc
Confidence 111235678899999998 55664 468988754
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.48 E-value=1.4e-07 Score=84.51 Aligned_cols=83 Identities=16% Similarity=0.346 Sum_probs=62.0
Q ss_pred CceEEeccCCcEEEEcCCCCeEEEEEeec--CcceEEEEeecCcEEEEecCCCCCcccceecccCCCcccccCCCeeccc
Q 046791 104 GSLTIDSRDGNLKILRKGGNSIVVSSVQA--MGNTSAALYETGNFVLYEMNPSGSMERELWQSFDYPTDILLPGMKLGLN 181 (1018)
Q Consensus 104 ~~l~~~~~~G~Lvl~~~~~~~~~wss~~~--~~~~~a~LldsGNlVl~~~~~~~~~~~~lWQSFD~PTDTlLPg~klg~~ 181 (1018)
-.|.+.. ||||||.+ .+.+||+++.. .....++|.++|||||++.+ ++++|+|
T Consensus 21 ~~l~~q~-DGNLvly~--~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-----g~~vWsS----------------- 75 (108)
T d1jpca_ 21 FVFIMQE-DCNLVLYD--VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-----NKPIWAS----------------- 75 (108)
T ss_dssp EEEEECT-TSCEEEEE--TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC-----------------
T ss_pred EEEEECC-CCeEEEEe--CCceeeEeCCCCCCCccEEEEeccceEEEECCC-----ccceEEc-----------------
Confidence 4677877 99999997 45789998876 23568999999999999876 7789976
Q ss_pred ccCCCceEEEEecCCCCCCCceeEEeeCCCCCcceeEeccCeeEEEeC
Q 046791 182 LQTGHEWFLRSWTSEDSPAEGEFTLNIDPNVSNQLIIQRRGEVLWTCG 229 (1018)
Q Consensus 182 ~~tg~~~~L~Swks~~dps~G~fsl~~d~~g~~ql~~~~~~~~yw~sg 229 (1018)
....+.+.|.+.++++|. ++++. .+.|.|+
T Consensus 76 --------------~t~~~~~~~~l~L~ddGN--lVly~--~~~W~S~ 105 (108)
T d1jpca_ 76 --------------NTGGQNGNYVCILQKDRN--VVIYG--TDRWATG 105 (108)
T ss_dssp --------------CCCCSCSCEEEEECTTSC--EEEEE--CCCCCCC
T ss_pred --------------cccCCCCcEEEEEcCCCC--EEEeC--CCcccCC
Confidence 112245678899999997 55563 3467665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.97 E-value=0.00096 Score=68.55 Aligned_cols=129 Identities=18% Similarity=0.176 Sum_probs=86.9
Q ss_pred HHHHHHhCCcceeeeeccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcC----CCcccc-------
Q 046791 509 QTISAATNNFSAVNKLGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQH----TNLTDS------- 577 (1018)
Q Consensus 509 ~~l~~~t~~y~~~~~lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H----~nlv~~------- 577 (1018)
.++...-..|+..+..+.++.+.||+... +++.+.||+...........+.+|+.++..+.- |-++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46677777888766655455578998864 556678898876655555567889888887742 222210
Q ss_pred ------cCC-----CCCChhhHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 046791 578 ------RRN-----NRLNWETRFSIIEGIAQGLLYLHKYS---------------------------------------- 606 (1018)
Q Consensus 578 ------~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~---------------------------------------- 606 (1018)
... ...+......++.++++.|..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred EEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 001 11233445567778888888888521
Q ss_pred ----------------CCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 607 ----------------RLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 607 ----------------~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877677999998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.94 E-value=0.0074 Score=63.60 Aligned_cols=65 Identities=8% Similarity=0.053 Sum_probs=41.0
Q ss_pred eeHHHHHHHhCCcceeee-----eccCCCcCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCC
Q 046791 506 FDFQTISAATNNFSAVNK-----LGEGGFGPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN 573 (1018)
Q Consensus 506 f~~~~l~~~t~~y~~~~~-----lG~G~fG~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n 573 (1018)
.+.++++....+|.+.+. |..|---+.|+.+..+| .+++|+..... ..++...|++++..|.+.+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g 72 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKG 72 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcc
Confidence 456788888888876443 34555677899887655 58999886532 2345566777888876544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.86 E-value=0.0088 Score=63.46 Aligned_cols=43 Identities=14% Similarity=0.095 Sum_probs=33.5
Q ss_pred cCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCC
Q 046791 530 GPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTN 573 (1018)
Q Consensus 530 G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~n 573 (1018)
-.||+++..+|+.+++|..+.. ....+++..|...+..|....
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~g 78 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDE 78 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTT
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcC
Confidence 4799999999999999998654 234567888999888886433
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=94.74 E-value=0.021 Score=57.71 Aligned_cols=113 Identities=18% Similarity=0.147 Sum_probs=71.9
Q ss_pred eeccCCC-cCeEEEEecccccceEEEecccccccHHHHHHHHHHHHHhcCCCcc------------------cccCCCCC
Q 046791 523 KLGEGGF-GPVYKGQLLNGQEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNLT------------------DSRRNNRL 583 (1018)
Q Consensus 523 ~lG~G~f-G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nlv------------------~~~~~~~l 583 (1018)
.+..|.. +.||+....++..+.+|....... ..+..|+..++.+....+. +......+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 578999887788889998654432 3467888888887654431 01111111
Q ss_pred C--hhhHHHHHHHHHHHHHHHhcCC-------------------------------------------------------
Q 046791 584 N--WETRFSIIEGIAQGLLYLHKYS------------------------------------------------------- 606 (1018)
Q Consensus 584 ~--~~~~~~i~~qia~gL~yLH~~~------------------------------------------------------- 606 (1018)
. +.....++.++++.|.-||+..
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 1 1122334456666666666311
Q ss_pred CCcEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 607 RLRVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 607 ~~~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
++.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12389999999999999877678999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.06 E-value=0.11 Score=56.11 Aligned_cols=29 Identities=28% Similarity=0.423 Sum_probs=25.6
Q ss_pred cEEecccCCCcEEEcCCCCceeeeecceee
Q 046791 609 RVIHRDLKASNILLDDQMNPKISDFGMARI 638 (1018)
Q Consensus 609 ~ivH~Dlkp~NILld~~~~~kL~DFGla~~ 638 (1018)
.++|+|+.|.|||++++ .++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 59999999999999876 489999998865
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.05 E-value=0.13 Score=55.52 Aligned_cols=52 Identities=12% Similarity=0.165 Sum_probs=34.1
Q ss_pred eeeeccCCCcCeEEEEeccc--------ccceEEEecccccccHHHHHHHHHHHHHhcCCCc
Q 046791 521 VNKLGEGGFGPVYKGQLLNG--------QEVAIKRLSRRSGQGIVEFKNEAKLIAKLQHTNL 574 (1018)
Q Consensus 521 ~~~lG~G~fG~Vy~~~~~~g--------~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~H~nl 574 (1018)
++.|+.|-.-.+|+....++ +.|.+++.. . ........+|..+++.+.-.++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl 106 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHL 106 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCC
Confidence 36788888889999987543 335555543 2 2334456788888888854444
|